Psyllid ID: psy7825
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 357 | 2.2.26 [Sep-21-2011] | |||||||
| Q9D411 | 328 | Testis-specific serine/th | yes | N/A | 0.745 | 0.810 | 0.507 | 6e-77 | |
| Q6SA08 | 328 | Testis-specific serine/th | yes | N/A | 0.745 | 0.810 | 0.489 | 3e-72 | |
| Q3SZW1 | 367 | Testis-specific serine/th | no | N/A | 0.778 | 0.757 | 0.446 | 2e-68 | |
| Q61241 | 365 | Testis-specific serine/th | no | N/A | 0.778 | 0.761 | 0.436 | 8e-68 | |
| O54863 | 358 | Testis-specific serine/th | no | N/A | 0.823 | 0.821 | 0.415 | 1e-66 | |
| Q9BXA7 | 367 | Testis-specific serine/th | no | N/A | 0.778 | 0.757 | 0.432 | 2e-66 | |
| Q96PF2 | 358 | Testis-specific serine/th | no | N/A | 0.820 | 0.818 | 0.407 | 8e-66 | |
| Q9D2E1 | 268 | Testis-specific serine/th | no | N/A | 0.725 | 0.966 | 0.443 | 1e-63 | |
| Q96PN8 | 268 | Testis-specific serine/th | no | N/A | 0.725 | 0.966 | 0.443 | 8e-63 | |
| Q9BXA6 | 273 | Testis-specific serine/th | no | N/A | 0.725 | 0.948 | 0.422 | 5e-57 |
| >sp|Q9D411|TSSK4_MOUSE Testis-specific serine/threonine-protein kinase 4 OS=Mus musculus GN=Tssk4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 288 bits (736), Expect = 6e-77, Method: Compositional matrix adjust.
Identities = 140/276 (50%), Positives = 180/276 (65%), Gaps = 10/276 (3%)
Query: 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV 118
+VME +GY +GK+IG GSY TV A T+ VAVK++SK +A DYL KFLPREI V+
Sbjct: 18 SVMEEYGYEVGKIIGHGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 77
Query: 119 KGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
K LRH LI F QAIETT RVYII+E A+ G +L++IQR G E KWF Q+ I
Sbjct: 78 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACAETLAGKWFSQMALGIA 137
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP----------LSDT 228
Y H +G+VHRD+K ENLL+D N+K+SDFGFA+ + H SP LS T
Sbjct: 138 YLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSSQPVHSSPSYRQMNSLSHLSQT 197
Query: 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF 288
+CGS+AYA PEIL G+PY P SD WSMGV+LY + RLPFDDTN +LL++ Q +V F
Sbjct: 198 YCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLRETQKEVTF 257
Query: 289 PTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWV 324
P +S ECK L+ ++ R + D+ +DPW+
Sbjct: 258 PANLTISQECKNLILQLLRQSTKRATILDVLRDPWM 293
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6SA08|TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (696), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 135/276 (48%), Positives = 179/276 (64%), Gaps = 10/276 (3%)
Query: 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV 118
++M+ +GY +GK IG GSY +V A T+ VAVK++SK +A DYL KFLPREI V+
Sbjct: 18 SLMDEYGYEVGKAIGHGSYGSVYEAFYTKQKVMVAVKIISKKKASDDYLNKFLPREIQVM 77
Query: 119 KGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
K LRH LI F +AIE+T RVYII+E A+ G +L++IQR G EP KWF QL I
Sbjct: 78 KVLRHKYLINFYRAIESTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQLTLGIA 137
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKCKSGHQ-----SPLSDT 228
Y H + +VHRD+K ENLL+D N+K+SDFGFA+ + C ++ S LS T
Sbjct: 138 YLHSKSIVHRDLKLENLLLDKWENVKISDFGFAKMVPSNQPVGCSPSYRQVNCFSHLSQT 197
Query: 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF 288
+CGS+AYA PEIL+G+PY P SD WSMGV+LY + LPFDDTN +LL++ Q +V F
Sbjct: 198 YCGSFAYACPEILRGLPYNPFLSDTWSMGVILYTLVVAHLPFDDTNLKKLLRETQKEVTF 257
Query: 289 PTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWV 324
P +S ECK L+ ++ R + DI +D WV
Sbjct: 258 PANHTISQECKNLILQMLRQATKRATILDIIKDSWV 293
|
May be involved in a signaling pathway during male germ cell development or mature sperm function (By similarity). Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus GN=TSSK1B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (663), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 126/282 (44%), Positives = 192/282 (68%), Gaps = 4/282 (1%)
Query: 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV 117
+ V++ GY++G +G GSYA VK A S R +VAVK++ + +AP D+L+KFLPREI++
Sbjct: 4 AAVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEI 63
Query: 118 VKGLRHPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
+ L H ++I+ + ET+ +VYI+ME +G LL+FI+ G + E +K F QL A
Sbjct: 64 LAMLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSA 123
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
I YCH+ VVHRD+KCENLL+D ++NIKLSDFGF++ ++ SG + LS TFCGS AYA
Sbjct: 124 IKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLT-LSKTFCGSAAYA 182
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK-QVQTKVVFPTEPNVS 295
+PE+L+G+PY P D+WS+GV+LY M G +P+DD+N ++L+ Q + +V FP +++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 296 AECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAASAGV 336
ECK L+ ++ P + R+ + +I WV+ +A +SA V
Sbjct: 243 GECKDLIYRMLQPDVTRRLHIDEILSHCWVQPKARGLSSAAV 284
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q61241|TSSK1_MOUSE Testis-specific serine/threonine-protein kinase 1 OS=Mus musculus GN=Tssk1b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 257 bits (657), Expect = 8e-68, Method: Compositional matrix adjust.
Identities = 123/282 (43%), Positives = 191/282 (67%), Gaps = 4/282 (1%)
Query: 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV 117
+ V++ GY++G +G GSYA VK A S R +VAVK++ + +AP D+L+KFLPREI++
Sbjct: 4 AAVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPSDFLEKFLPREIEI 63
Query: 118 VKGLRHPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
+ L H ++++ + ET+ +VYI+ME +G LL+FI+ G + E +K F QL A
Sbjct: 64 LAMLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSA 123
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
I YCH+ VVHRD+KCENLL+D ++NIKLSDFGF++ ++ SG + LS TFCGS AYA
Sbjct: 124 IKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSG-RLILSKTFCGSAAYA 182
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK-QVQTKVVFPTEPNVS 295
+PE+L+G+PY P D+WS+GV+LY M G +P+DD+N ++L+ Q + +V FP +++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 296 AECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAASAGV 336
ECK L+ ++ P + R+ + +I WV+ +A +S +
Sbjct: 243 GECKDLIYRMLQPDVNRRLHIDEILNHCWVQPKARGLSSGAI 284
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54863|TSSK2_MOUSE Testis-specific serine/threonine-protein kinase 2 OS=Mus musculus GN=Tssk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 253 bits (646), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 126/303 (41%), Positives = 196/303 (64%), Gaps = 9/303 (2%)
Query: 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV 117
+ V+ GY++G +G GSYA VK A S R +VAVK++ + + P D++++FLPRE+D+
Sbjct: 4 AAVLRKKGYIVGINLGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDI 63
Query: 118 VKGLRHPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
+ + H ++I+ + ET+ R+YI+ME +G LL+FI+ G + E +K FRQL A
Sbjct: 64 LATVNHRSIIKTYEIFETSDGRIYIVMELGVQGDLLEFIKCRGALHEDVARKMFRQLSSA 123
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
+ YCH+ VVHRD+KCENLL+D ++NIKLSDFGF++ ++ SG + LS TFCGS AYA
Sbjct: 124 VKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDGSG-RIVLSKTFCGSAAYA 182
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK-QVQTKVVFPTEPNVS 295
+PE+L+G+PY P D+WS+GV+LY M G +P+DD++ ++L+ Q + +V FP N++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQKEHRVDFPRSKNLT 242
Query: 296 AECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAASAGV-----ETKTLNQSKIDTQ 349
ECK L+ +I P + R+ + +I W++ A S+ E K K+DT+
Sbjct: 243 GECKDLIYRILQPDVNRRLHIDEILSHSWLQPPKPKAMSSASFKREGEGKYRADCKLDTR 302
Query: 350 ANS 352
S
Sbjct: 303 PGS 305
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA7|TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 122/282 (43%), Positives = 190/282 (67%), Gaps = 4/282 (1%)
Query: 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV 117
+ V++ GY+LG +G GSYA VK A S R +VA+K++ + +AP D+L+KFLPREI++
Sbjct: 4 AAVLKRRGYLLGINLGEGSYAKVKSAYSERLKFNVAIKIIDRKKAPADFLEKFLPREIEI 63
Query: 118 VKGLRHPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
+ L H ++I+ + ET+H +VYI+ME A +G LL+ I+ G + E +K F QL A
Sbjct: 64 LAMLNHCSIIKTYEIFETSHGKVYIVMELAVQGDLLELIKTRGALHEDEARKKFHQLSLA 123
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
I YCH+ VVHRD+KC+NLL+D ++NIKLSDF F++ ++ SG + LS TFCGS AYA
Sbjct: 124 IKYCHDLDVVHRDLKCDNLLLDKDFNIKLSDFSFSKRCLRDDSGRMA-LSKTFCGSPAYA 182
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK-QVQTKVVFPTEPNVS 295
+PE+L+G+PY P D+WS+GV+LY M G +P+DD+N ++L+ Q + +V FP +++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 296 AECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAASAGV 336
ECK L+ + P + R+ + +I W++ +A + S +
Sbjct: 243 GECKDLIYHMLQPDVNRRLHIDEILSHCWMQPKARGSPSVAI 284
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PF2|TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 251 bits (640), Expect = 8e-66, Method: Compositional matrix adjust.
Identities = 123/302 (40%), Positives = 197/302 (65%), Gaps = 9/302 (2%)
Query: 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV 117
+TV+ GY++G +G GSYA VK A S R +VAVK++ + + P D++++FLPRE+D+
Sbjct: 4 ATVLRKKGYIVGINLGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDI 63
Query: 118 VKGLRHPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
+ + H ++I+ + ET+ R+YIIME +G LL+FI+ +G + E +K FRQL A
Sbjct: 64 LATVNHGSIIKTYEIFETSDGRIYIIMELGVQGDLLEFIKCQGALHEDVARKMFRQLSSA 123
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
+ YCH+ +VHRD+KCENLL+D ++NIKLSDFGF++ ++ +G + LS TFCGS AYA
Sbjct: 124 VKYCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDSNG-RIILSKTFCGSAAYA 182
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK-QVQTKVVFPTEPNVS 295
+PE+L+ +PY P D+WS+GV+LY M G +P+DD++ ++L+ Q + +V FP N++
Sbjct: 183 APEVLQSIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIRKMLRIQKEHRVDFPRSKNLT 242
Query: 296 AECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAASAGV-----ETKTLNQSKIDTQ 349
ECK L+ ++ P + R+ + +I W++ A S+ E K + K+DT+
Sbjct: 243 CECKDLIYRMLQPDVSQRLHIDEILSHSWLQPPKPKATSSASFKREGEGKYRAECKLDTK 302
Query: 350 AN 351
Sbjct: 303 TG 304
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates TSKS at 'Ser-288' and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9D2E1|TSSK3_MOUSE Testis-specific serine/threonine-protein kinase 3 OS=Mus musculus GN=Tssk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 118/266 (44%), Positives = 175/266 (65%), Gaps = 7/266 (2%)
Query: 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
++GY LGK IG G+Y+ VK A S +H VA+K++ K+ P +++++FLPRE+ +V+ L
Sbjct: 7 SNGYQLGKTIGEGTYSKVKEAFSKKHQRKVAIKIIDKMGGPEEFIQRFLPRELQIVRTLD 66
Query: 123 HPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
H N+I+ + +E+ ++Y++ME AE G + D + G + E R K FRQ+V+AI YCH
Sbjct: 67 HKNIIQVYEMLESADGKIYLVMELAEGGDVFDCVLNGGPLPESRAKALFRQMVEAIRYCH 126
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
GV HRD+KCEN L+ G +N+KL+DFGFA+ K + LS TFCGS AYA+PE+L
Sbjct: 127 GCGVAHRDLKCENALLQG-FNLKLTDFGFAKVLPKSRR----ELSQTFCGSTAYAAPEVL 181
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301
+G+P+ DVWSMGVVLY M LPFDDT+ ++L Q Q V FPT +S EC+ L
Sbjct: 182 QGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQKGVSFPTHLGISTECQDL 241
Query: 302 LSKIFSP-IKFRIRLKDIKQDPWVKT 326
L ++ P + R ++++ PW+ +
Sbjct: 242 LKRLLEPDMILRPSIEEVSWHPWLAS 267
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PN8|TSSK3_HUMAN Testis-specific serine/threonine-protein kinase 3 OS=Homo sapiens GN=TSSK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 8e-63, Method: Compositional matrix adjust.
Identities = 118/266 (44%), Positives = 174/266 (65%), Gaps = 7/266 (2%)
Query: 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
++GY LGK IG G+Y+ VK A S +H VA+KV+ K+ P +++++FLPRE+ +V+ L
Sbjct: 7 SNGYQLGKTIGEGTYSKVKEAFSKKHQRKVAIKVIDKMGGPEEFIQRFLPRELQIVRTLD 66
Query: 123 HPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
H N+I+ + +E+ ++ ++ME AE G + D + G + E R K FRQ+V+AI YCH
Sbjct: 67 HKNIIQVYEMLESADGKICLVMELAEGGDVFDCVLNGGPLPESRAKALFRQMVEAIRYCH 126
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
GV HRD+KCEN L+ G +N+KL+DFGFA K LS TFCGS AYA+PE+L
Sbjct: 127 GCGVAHRDLKCENALLQG-FNLKLTDFGFA----KVLPKSHRELSQTFCGSTAYAAPEVL 181
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301
+G+P+ DVWSMGVVLY M LPFDDT+ ++L Q Q V FPT ++SA+C+ L
Sbjct: 182 QGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQKGVSFPTHLSISADCQDL 241
Query: 302 LSKIFSP-IKFRIRLKDIKQDPWVKT 326
L ++ P + R ++++ PW+ +
Sbjct: 242 LKRLLEPDMILRPSIEEVSWHPWLAS 267
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA6|TSSK6_HUMAN Testis-specific serine/threonine-protein kinase 6 OS=Homo sapiens GN=TSSK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (564), Expect = 5e-57, Method: Compositional matrix adjust.
Identities = 115/272 (42%), Positives = 172/272 (63%), Gaps = 13/272 (4%)
Query: 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVK 119
++ GY LG+ IG GSY+ VK+ATS ++ VA+KVV + APPD++ KFLPRE+ +++
Sbjct: 6 LLSELGYKLGRTIGEGSYSKVKVATSKKYKGTVAIKVVDRRRAPPDFVNKFLPRELSILR 65
Query: 120 GLRHPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
G+RHP+++ + IE + ++YI+ME A LL +QR G I + + F Q+ A+
Sbjct: 66 GVRHPHIVHVFEFIEVCNGKLYIVMEAAAT-DLLQAVQRNGRIPGVQARDLFAQIAGAVR 124
Query: 179 YCHERGVVHRDIKCENLLID-GEYNIKLSDFGFARGHMKCKSGHQSP-LSDTFCGSYAYA 236
Y H+ +VHRD+KCEN+L+ E +KL+DFGF R H P LS T+CGS AYA
Sbjct: 125 YLHDHHLVHRDLKCENVLLSPDERRVKLTDFGFGR------QAHGYPDLSTTYCGSAAYA 178
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSA 296
SPE+L G+PY P DVWSMGVVLY M G +PFDD++ L ++ + V++P +S
Sbjct: 179 SPEVLLGIPYDPKKYDVWSMGVVLYVMVTGCMPFDDSDIAGLPRRQKRGVLYPEGLELSE 238
Query: 297 ECKTLLSKI--FSPIKFRIRLKDIKQDPWVKT 326
CK L++++ FSP R + ++ W++
Sbjct: 239 RCKALIAELLQFSP-SARPSAGQVARNCWLRA 269
|
Required for sperm production and function. Plays a role in DNA condensation during postmeiotic chromatin remodeling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 357 | ||||||
| 91087563 | 340 | PREDICTED: similar to CG9222 CG9222-PA [ | 0.815 | 0.855 | 0.698 | 1e-122 | |
| 270010686 | 327 | hypothetical protein TcasGA2_TC010125 [T | 0.815 | 0.889 | 0.698 | 1e-122 | |
| 242016558 | 386 | cAMP-dependent protein kinase catalytic | 0.750 | 0.694 | 0.736 | 1e-119 | |
| 380027639 | 345 | PREDICTED: testis-specific serine/threon | 0.798 | 0.826 | 0.704 | 1e-119 | |
| 350401037 | 363 | PREDICTED: testis-specific serine/threon | 0.809 | 0.796 | 0.689 | 1e-119 | |
| 340709608 | 363 | PREDICTED: testis-specific serine/threon | 0.826 | 0.812 | 0.678 | 1e-118 | |
| 328776257 | 351 | PREDICTED: testis-specific serine/threon | 0.753 | 0.766 | 0.729 | 1e-118 | |
| 357614817 | 329 | putative cAMP-dependent protein kinase c | 0.826 | 0.896 | 0.658 | 1e-117 | |
| 383852844 | 364 | PREDICTED: testis-specific serine/threon | 0.803 | 0.788 | 0.671 | 1e-116 | |
| 332019401 | 361 | Testis-specific serine/threonine-protein | 0.823 | 0.814 | 0.649 | 1e-114 |
| >gi|91087563|ref|XP_971036.1| PREDICTED: similar to CG9222 CG9222-PA [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1139), Expect = e-122, Method: Compositional matrix adjust.
Identities = 204/292 (69%), Positives = 239/292 (81%), Gaps = 1/292 (0%)
Query: 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREI 115
KK TV+E+HGY+LGK IG GSYATV++A S RH +VAVK+VSK AP DYLKKFLPREI
Sbjct: 27 KKQTVLESHGYILGKTIGSGSYATVRMAHSERHNMNVAVKIVSKFSAPADYLKKFLPREI 86
Query: 116 DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD 175
+VVKGL+HPNLIRFLQAIETTHRVYIIMEYAE GSLL+ I+++ YIDE R++KWFRQLVD
Sbjct: 87 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLLEIIRKDSYIDEIRSRKWFRQLVD 146
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235
A+DYCHERGVVHRDIKCENLL++ EY IKLSDFGFARGHMK K+G Q+PLS+TFCGSYAY
Sbjct: 147 AVDYCHERGVVHRDIKCENLLLNTEYEIKLSDFGFARGHMKIKNG-QAPLSETFCGSYAY 205
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295
ASPEILKG+PY P +SD+WSMGVVL+AM +GRLPFDDTNY L+KQV KVVFP EP VS
Sbjct: 206 ASPEILKGIPYQPQFSDIWSMGVVLFAMVYGRLPFDDTNYRDLVKQVTNKVVFPKEPKVS 265
Query: 296 AECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKID 347
CK L++KI +P+K RIR+ IK DPW N + E ++ D
Sbjct: 266 LMCKALINKILAPLKARIRIPGIKTDPWYTYNTNDGSHGSRERNVVSNPTSD 317
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270010686|gb|EFA07134.1| hypothetical protein TcasGA2_TC010125 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1139), Expect = e-122, Method: Compositional matrix adjust.
Identities = 204/292 (69%), Positives = 239/292 (81%), Gaps = 1/292 (0%)
Query: 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREI 115
KK TV+E+HGY+LGK IG GSYATV++A S RH +VAVK+VSK AP DYLKKFLPREI
Sbjct: 27 KKQTVLESHGYILGKTIGSGSYATVRMAHSERHNMNVAVKIVSKFSAPADYLKKFLPREI 86
Query: 116 DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD 175
+VVKGL+HPNLIRFLQAIETTHRVYIIMEYAE GSLL+ I+++ YIDE R++KWFRQLVD
Sbjct: 87 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLLEIIRKDSYIDEIRSRKWFRQLVD 146
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235
A+DYCHERGVVHRDIKCENLL++ EY IKLSDFGFARGHMK K+G Q+PLS+TFCGSYAY
Sbjct: 147 AVDYCHERGVVHRDIKCENLLLNTEYEIKLSDFGFARGHMKIKNG-QAPLSETFCGSYAY 205
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295
ASPEILKG+PY P +SD+WSMGVVL+AM +GRLPFDDTNY L+KQV KVVFP EP VS
Sbjct: 206 ASPEILKGIPYQPQFSDIWSMGVVLFAMVYGRLPFDDTNYRDLVKQVTNKVVFPKEPKVS 265
Query: 296 AECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKID 347
CK L++KI +P+K RIR+ IK DPW N + E ++ D
Sbjct: 266 LMCKALINKILAPLKARIRIPGIKTDPWYTYNTNDGSHGSRERNVVSNPTSD 317
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242016558|ref|XP_002428853.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212513589|gb|EEB16115.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1120), Expect = e-119, Method: Compositional matrix adjust.
Identities = 198/269 (73%), Positives = 233/269 (86%), Gaps = 1/269 (0%)
Query: 55 KKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPRE 114
+KK TV+E HGY LGK IG GSYATVK+A S RH C VAVK+VSK +AP DYLKKFLPRE
Sbjct: 42 EKKLTVLETHGYTLGKTIGTGSYATVKVARSERHDCLVAVKIVSKFQAPADYLKKFLPRE 101
Query: 115 IDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLV 174
I+VVKGL+H NLIRFLQAIETTHRVYIIMEYAE GSLLD I+++ YIDE R +K+FRQL+
Sbjct: 102 IEVVKGLKHINLIRFLQAIETTHRVYIIMEYAENGSLLDVIRKDQYIDEVRARKYFRQLI 161
Query: 175 DAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
DA+DYCHERGVVHRDIKCENLL+D + N+KLSDFGFARGHM+ K+G +PLSDTFCGSYA
Sbjct: 162 DAVDYCHERGVVHRDIKCENLLMDHDNNVKLSDFGFARGHMRIKNG-VAPLSDTFCGSYA 220
Query: 235 YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294
YASPEILKGVPY P SD+WS GVVLYA+ +GRLPFDDTNY QLLKQVQ+K+ FP EP +
Sbjct: 221 YASPEILKGVPYQPQLSDIWSTGVVLYAIVYGRLPFDDTNYNQLLKQVQSKISFPKEPKI 280
Query: 295 SAECKTLLSKIFSPIKFRIRLKDIKQDPW 323
SA CK+L++KI +P+KFR+++ I+ DPW
Sbjct: 281 SANCKSLITKILAPVKFRLKIPAIRSDPW 309
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380027639|ref|XP_003697528.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 435 bits (1118), Expect = e-119, Method: Compositional matrix adjust.
Identities = 203/288 (70%), Positives = 241/288 (83%), Gaps = 3/288 (1%)
Query: 39 DASSRSTL-IAANKRD-VKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKV 96
D S +S L + +K D +KK T++E+HGY LGK IG GSYATVK+A S RH C VAVK+
Sbjct: 8 DNSPKSLLKLVEDKNDKSEKKLTILESHGYTLGKTIGAGSYATVKIAKSDRHDCQVAVKI 67
Query: 97 VSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ 156
VSK +AP DYLKKFLPREI+VVKGL+HPNLIRFLQAIETTHRVYIIMEYA+ GSLLD I+
Sbjct: 68 VSKFQAPGDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDIIR 127
Query: 157 REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216
R+ +IDE R+++WFRQL++AIDYCH RGVVHRDIKCENLL+D +NIKLSDFGFARG MK
Sbjct: 128 RDTFIDEFRSRRWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQMK 187
Query: 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI 276
K+G +PLS+TFCGSYAYASPEILKGVPY P SD+WSMGVVLYAM +GRLPFDDTNY
Sbjct: 188 PKNG-TNPLSETFCGSYAYASPEILKGVPYLPQLSDIWSMGVVLYAMVYGRLPFDDTNYS 246
Query: 277 QLLKQVQTKVVFPTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWV 324
QLLKQVQ KVVFP EPNVS C++L+S+I P + R+ + +I+ D W+
Sbjct: 247 QLLKQVQNKVVFPKEPNVSQACRSLISRILVPQRIRMNIDNIRNDTWL 294
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350401037|ref|XP_003486034.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 434 bits (1115), Expect = e-119, Method: Compositional matrix adjust.
Identities = 200/290 (68%), Positives = 237/290 (81%), Gaps = 1/290 (0%)
Query: 45 TLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP 104
T+ N ++KK T++E+HGY LGK IG GSYATVK+A S RH C VAVK+VSK +AP
Sbjct: 17 TVEGKNDEKLEKKLTILESHGYTLGKTIGTGSYATVKIAKSNRHDCQVAVKIVSKFQAPG 76
Query: 105 DYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEP 164
DYLKKFLPREI+VVKGL+HPNLIRFLQAIETTHRVYIIMEYA GSLLD I+R+ +IDE
Sbjct: 77 DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYARCGSLLDMIRRDTFIDEF 136
Query: 165 RTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224
R+++WFRQL++AIDYCH RGVVHRDIKCENLL+D +NIKLSDFGFARG MK K+G +P
Sbjct: 137 RSRRWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQMKSKNG-IAP 195
Query: 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT 284
LS+TFCGSYAYASPEILKGVPY P SDVWSMGVVLYAM +GRLPFDDTNY QLLKQVQ
Sbjct: 196 LSETFCGSYAYASPEILKGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQN 255
Query: 285 KVVFPTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAASA 334
KV+FP EPNVS C++L+S+I + R+ + I+ D W+ T A ++
Sbjct: 256 KVIFPKEPNVSQACRSLISRILVSQRIRLHIDHIRNDVWLATSLVTAQTS 305
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340709608|ref|XP_003393396.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1111), Expect = e-118, Method: Compositional matrix adjust.
Identities = 203/299 (67%), Positives = 241/299 (80%), Gaps = 4/299 (1%)
Query: 39 DASSRSTLIAA---NKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVK 95
D S +S L A N ++KK T++E+HGY LGK IG GSYATVK+A S RH C VAVK
Sbjct: 8 DNSPKSLLKAVEGKNDEKLEKKLTILESHGYTLGKTIGTGSYATVKIAKSNRHDCQVAVK 67
Query: 96 VVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI 155
+VSK +AP DYLKKFLPREI+VVKGL+HPNLIRFLQAIETTHRVYIIMEYA+ GSLLD I
Sbjct: 68 IVSKFQAPGDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDMI 127
Query: 156 QREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215
+R+ +IDE R+++WFRQL++AIDYCH RGVVHRDIKCENLL+D +NIKLSDFGFARG M
Sbjct: 128 RRDTFIDEFRSRRWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQM 187
Query: 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY 275
K K+G +PLS+TFCGSYAYASPEIL GVPY P SDVWSMGVVLYAM +GRLPFDDTNY
Sbjct: 188 KSKNG-IAPLSETFCGSYAYASPEILMGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNY 246
Query: 276 IQLLKQVQTKVVFPTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAASA 334
QLLKQVQ KV+FP EPNVS C++L+S+I + R+ + I+ D W+ T A ++
Sbjct: 247 SQLLKQVQNKVIFPKEPNVSQACRSLISRILVSQRIRLDIDHIRNDVWLATSLVTAQTS 305
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328776257|ref|XP_395246.3| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1109), Expect = e-118, Method: Compositional matrix adjust.
Identities = 197/270 (72%), Positives = 231/270 (85%), Gaps = 1/270 (0%)
Query: 55 KKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPRE 114
+K T++E+HGY LGK IG GSYATVK+A S RH C VAVK+VSK +AP DYLKKFLPRE
Sbjct: 32 EKXLTILESHGYTLGKPIGAGSYATVKIAKSDRHDCQVAVKIVSKFQAPGDYLKKFLPRE 91
Query: 115 IDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLV 174
I+VVKGL+HPNLIRFLQAIETTHRVYIIMEYA+ GSLLD I+R+ +IDE R+++WFRQL+
Sbjct: 92 IEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDIIRRDTFIDELRSRRWFRQLL 151
Query: 175 DAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
+AIDYCH RGVVHRDIKCENLL+D +NIKLSDFGFARG MK K+G +PLS+TFCGSYA
Sbjct: 152 EAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQMKAKNG-INPLSETFCGSYA 210
Query: 235 YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294
YASPEILKGVPY P SDVWSMGVVLYAM +GRLPFDDTNY QLLKQVQ KVVFP EPNV
Sbjct: 211 YASPEILKGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNKVVFPKEPNV 270
Query: 295 SAECKTLLSKIFSPIKFRIRLKDIKQDPWV 324
S C++L+S+I P + R+ + +I+ D W+
Sbjct: 271 SQACRSLISRILVPQRIRMNIDNIRNDTWL 300
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357614817|gb|EHJ69292.1| putative cAMP-dependent protein kinase catalytic subunit [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1095), Expect = e-117, Method: Compositional matrix adjust.
Identities = 199/302 (65%), Positives = 243/302 (80%), Gaps = 7/302 (2%)
Query: 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREI 115
+K TV+E HGY+LG+ IG GSYATVK+ATS RH C VA+K++SK +AP DYLKKFLPREI
Sbjct: 19 RKLTVLETHGYILGRTIGSGSYATVKVATSERHNCQVAIKIISKFQAPGDYLKKFLPREI 78
Query: 116 DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD 175
+VVKGL+H NLIRFLQAIETTHRVYI+MEYAE GSLLD I+++ +IDE R ++WF+QLV+
Sbjct: 79 EVVKGLKHENLIRFLQAIETTHRVYIVMEYAENGSLLDIIRKDQHIDEQRGRRWFKQLVE 138
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235
A+DYCHERGVVHRDIKCENLL+D NIKLSDFGFARGHMK K+G + LS+TFCGSYAY
Sbjct: 139 AVDYCHERGVVHRDIKCENLLMDHGLNIKLSDFGFARGHMKPKNGVYA-LSETFCGSYAY 197
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295
ASPEILKGVPY P SD+WSMGVVLYA+ +GRLPFDDTNY QLLKQVQ KV FP EP VS
Sbjct: 198 ASPEILKGVPYRPQDSDIWSMGVVLYAIVYGRLPFDDTNYTQLLKQVQNKVSFPREPKVS 257
Query: 296 AECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKIDTQANSNSL 355
EC+ L++KI +P+K R ++ I DPW+ + SA + + L+ + + QA+ +
Sbjct: 258 TECRKLITKILAPLKLRSKIPQILADPWL------SPSAPTKDEELDTNPDNAQASKEEI 311
Query: 356 SS 357
S
Sbjct: 312 KS 313
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383852844|ref|XP_003701935.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1089), Expect = e-116, Method: Compositional matrix adjust.
Identities = 198/295 (67%), Positives = 240/295 (81%), Gaps = 8/295 (2%)
Query: 48 AANKRDVK--KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD 105
A N+ D K KK TV+E+HGY LGK IG GSYATVK+A S RH C VA+K+VSK +AP +
Sbjct: 18 ADNEHDEKTDKKLTVLESHGYNLGKTIGSGSYATVKIAKSCRHDCQVAIKIVSKFQAPGE 77
Query: 106 YLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPR 165
YLKKFLPREI+VVKGLRHPNLIRFLQAIETTHRVYIIMEYA+ GSLLD I+R+ +IDE R
Sbjct: 78 YLKKFLPREIEVVKGLRHPNLIRFLQAIETTHRVYIIMEYAQNGSLLDIIRRDTFIDEVR 137
Query: 166 TKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL 225
+++WFRQL++AIDYCH RGVVHRD+KCENLL+D +N+KLSDFGFARG MK K+G +PL
Sbjct: 138 SRRWFRQLLEAIDYCHGRGVVHRDVKCENLLMDSNFNVKLSDFGFARGQMKPKNG-INPL 196
Query: 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK 285
S+TFCGSYAYASPEILKG+PY P SDVWSMGVVLYAM +GRLPFDDTNY QLLKQVQ++
Sbjct: 197 SETFCGSYAYASPEILKGIPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYNQLLKQVQSR 256
Query: 286 VVFPTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKT 340
+ FP +P VS C++L+S+I P + R+ + I+ D W+ A+ V+T T
Sbjct: 257 ITFPKDPKVSQSCRSLISRILVPQRTRLHIDRIRNDVWLS-----ASLVTVQTST 306
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332019401|gb|EGI59887.1| Testis-specific serine/threonine-protein kinase 4 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1071), Expect = e-114, Method: Compositional matrix adjust.
Identities = 193/297 (64%), Positives = 234/297 (78%), Gaps = 3/297 (1%)
Query: 50 NKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKK 109
N +KK TV+E+HGY LGK IG GSYATVK+A S R+G VAVK+VSK +AP +YL K
Sbjct: 25 NGEKSEKKLTVLESHGYTLGKTIGAGSYATVKVAKSDRYGYQVAVKIVSKFQAPGEYLTK 84
Query: 110 FLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKW 169
FLPREI+VVKGL+HPNLI FLQAIETTHRVYIIMEYA+ GSLLD I+R+ YIDE R+++W
Sbjct: 85 FLPREIEVVKGLKHPNLIHFLQAIETTHRVYIIMEYAQNGSLLDIIRRDTYIDELRSRRW 144
Query: 170 FRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTF 229
FRQL++AI+YCHE G+VHRD+KCENLL+D +NIKLSDFGFARG MK K+G + PLS T+
Sbjct: 145 FRQLLEAIEYCHEHGIVHRDVKCENLLMDFRFNIKLSDFGFARGQMKLKNG-EWPLSTTY 203
Query: 230 CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP 289
CGSYAYASPEIL+G+PY P SD+WSMGVVLYAM GRLPFDDTNY QLLKQVQ +VVFP
Sbjct: 204 CGSYAYASPEILRGIPYQPQLSDIWSMGVVLYAMVHGRLPFDDTNYAQLLKQVQNRVVFP 263
Query: 290 TEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKI 346
P VS C++L+S+I P R+R+ IK D W++T A + K + + I
Sbjct: 264 KHPKVSQPCRSLISRILVPQFARLRINSIKNDAWLETSV--VAQTSISDKLIGEPTI 318
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 357 | ||||||
| FB|FBgn0031784 | 337 | CG9222 [Drosophila melanogaste | 0.873 | 0.925 | 0.506 | 9.1e-84 | |
| UNIPROTKB|D4A7Q4 | 339 | D4A7Q4 "Uncharacterized protei | 0.431 | 0.454 | 0.536 | 7.6e-74 | |
| UNIPROTKB|I3LBD3 | 340 | TSSK4 "Uncharacterized protein | 0.431 | 0.452 | 0.536 | 4.1e-73 | |
| UNIPROTKB|F6RLA2 | 326 | TSSK4 "Uncharacterized protein | 0.745 | 0.815 | 0.528 | 1.1e-69 | |
| MGI|MGI:1918349 | 328 | Tssk4 "testis-specific serine | 0.745 | 0.810 | 0.507 | 1e-68 | |
| UNIPROTKB|Q6SA08 | 328 | TSSK4 "Testis-specific serine/ | 0.745 | 0.810 | 0.489 | 1.2e-65 | |
| UNIPROTKB|G3N2D2 | 367 | TSSK1B "Testis-specific serine | 0.778 | 0.757 | 0.446 | 4.7e-64 | |
| UNIPROTKB|Q3SZW1 | 367 | TSSK1B "Testis-specific serine | 0.778 | 0.757 | 0.446 | 4.7e-64 | |
| UNIPROTKB|F1RK80 | 364 | TSSK1B "Uncharacterized protei | 0.778 | 0.763 | 0.432 | 7.6e-64 | |
| MGI|MGI:1347557 | 365 | Tssk1 "testis-specific serine | 0.778 | 0.761 | 0.436 | 3.3e-63 |
| FB|FBgn0031784 CG9222 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 9.1e-84, P = 9.1e-84
Identities = 159/314 (50%), Positives = 218/314 (69%)
Query: 11 SENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKK-KSTVMENHGYVLG 69
S+++ TD + +E K S + S ++ D K + T++E HG +LG
Sbjct: 20 SQDLVTDQNSGRRQEQKVYTFSDRPPQPKPPAPSGVVPVKADDKSKPQKTILEEHGIILG 79
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
KVIG G+YA VK+ S +G VAVK++SKV+AP +Y +KFLPREI+ VKGL H NLI F
Sbjct: 80 KVIGTGNYAKVKIGFSEEYGKRVAVKIISKVKAPSEYTQKFLPREIEAVKGLHHENLITF 139
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
Q+IET+HRVY+IM+ AE G+LLD+++ ++DEP+++ F+QLV A++Y H +GVVHRD
Sbjct: 140 YQSIETSHRVYLIMQLAENGTLLDYVRERKFLDEPQSRTLFKQLVSAVEYIHSKGVVHRD 199
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
IKCENLL+D +N+KL DFGFAR + S +Q LS TFCGSYAYASPEILKGV Y P
Sbjct: 200 IKCENLLLDENWNLKLIDFGFARKDTRT-SDNQVILSKTFCGSYAYASPEILKGVAYDPF 258
Query: 250 YSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFSPI 309
SD+W+ GVV YAM FGRLP+D +N LLK++ +VFP P+ S+ECK ++ I +P+
Sbjct: 259 MSDIWACGVVCYAMVFGRLPYDGSNVHILLKRINQSLVFPKSPSASSECKHMIMHILAPV 318
Query: 310 KFRIRLKDIKQDPW 323
K R + +K+DPW
Sbjct: 319 KIRYNIPQVKEDPW 332
|
|
| UNIPROTKB|D4A7Q4 D4A7Q4 "Uncharacterized protein" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 409 (149.0 bits), Expect = 7.6e-74, Sum P(2) = 7.6e-74
Identities = 88/164 (53%), Positives = 109/164 (66%)
Query: 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV 118
+VME +GY +GKVIG GSY TV A T+ VAVK++SK +A DYL KFLPREI V+
Sbjct: 18 SVMEEYGYEVGKVIGHGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 77
Query: 119 KGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
K LRH LI F QAIETT RVYII+E A+ G +L++IQR G E KWF Q+ I
Sbjct: 78 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACSETLAGKWFSQMALGIA 137
Query: 179 YCHERGVVHR----------DIKCENLLIDGEYNIKLSDFGFAR 212
Y H +G+VHR D+K ENLL+D N+K+SDFGFA+
Sbjct: 138 YLHSKGIVHRLTPSLSAAGRDLKLENLLLDKRENVKISDFGFAK 181
|
|
| UNIPROTKB|I3LBD3 TSSK4 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 413 (150.4 bits), Expect = 4.1e-73, Sum P(2) = 4.1e-73
Identities = 89/166 (53%), Positives = 110/166 (66%)
Query: 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV 118
+VME +GY +GKVIG GSY TV A T+ VAVK++SK +A DYL KFLPREI V+
Sbjct: 18 SVMEEYGYEVGKVIGNGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 77
Query: 119 KGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
K LRH LI F QAIETT RVYII+E A+ G +L++IQR G EP KWF Q+ I
Sbjct: 78 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQMTLGIA 137
Query: 179 YCHERGVVHR------------DIKCENLLIDGEYNIKLSDFGFAR 212
Y H +G+VHR D+K ENLL+D N+K+SDFGFA+
Sbjct: 138 YLHSKGIVHRPLLTPSLSAAGRDLKLENLLLDKRENVKISDFGFAK 183
|
|
| UNIPROTKB|F6RLA2 TSSK4 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 706 (253.6 bits), Expect = 1.1e-69, P = 1.1e-69
Identities = 146/276 (52%), Positives = 180/276 (65%)
Query: 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV 118
+VME +GY +GKVIG GSY TV A T+ VAVK++SK +A DYL KFLPREI V+
Sbjct: 16 SVMEEYGYEVGKVIGNGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 75
Query: 119 KGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
K LRH LI F QAIETT RVYII+E A+ G +L++IQR G EP KWF QL I
Sbjct: 76 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQLTLGIA 135
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP----------LSDT 228
Y H +G+VHRD+K ENLL+D N+K+SDFGFA+ +S SP LS T
Sbjct: 136 YLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSNQSVRNSPSYRQMNCFSHLSQT 195
Query: 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF 288
+CGS+AYA PEIL G+PY P SD WSMGV+LY + RLPFDDTN +LLK+ Q +V F
Sbjct: 196 YCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLKETQKEVTF 255
Query: 289 PTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWV 324
P +S ECK L+ + R + DI +DPWV
Sbjct: 256 PPNYAISQECKNLILQTLRQAPKRATILDIIKDPWV 291
|
|
| MGI|MGI:1918349 Tssk4 "testis-specific serine kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 697 (250.4 bits), Expect = 1.0e-68, P = 1.0e-68
Identities = 140/276 (50%), Positives = 180/276 (65%)
Query: 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV 118
+VME +GY +GK+IG GSY TV A T+ VAVK++SK +A DYL KFLPREI V+
Sbjct: 18 SVMEEYGYEVGKIIGHGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 77
Query: 119 KGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
K LRH LI F QAIETT RVYII+E A+ G +L++IQR G E KWF Q+ I
Sbjct: 78 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACAETLAGKWFSQMALGIA 137
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP----------LSDT 228
Y H +G+VHRD+K ENLL+D N+K+SDFGFA+ + H SP LS T
Sbjct: 138 YLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSSQPVHSSPSYRQMNSLSHLSQT 197
Query: 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF 288
+CGS+AYA PEIL G+PY P SD WSMGV+LY + RLPFDDTN +LL++ Q +V F
Sbjct: 198 YCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLRETQKEVTF 257
Query: 289 PTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWV 324
P +S ECK L+ ++ R + D+ +DPW+
Sbjct: 258 PANLTISQECKNLILQLLRQSTKRATILDVLRDPWM 293
|
|
| UNIPROTKB|Q6SA08 TSSK4 "Testis-specific serine/threonine-protein kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 1.2e-65, P = 1.2e-65
Identities = 135/276 (48%), Positives = 179/276 (64%)
Query: 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV 118
++M+ +GY +GK IG GSY +V A T+ VAVK++SK +A DYL KFLPREI V+
Sbjct: 18 SLMDEYGYEVGKAIGHGSYGSVYEAFYTKQKVMVAVKIISKKKASDDYLNKFLPREIQVM 77
Query: 119 KGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
K LRH LI F +AIE+T RVYII+E A+ G +L++IQR G EP KWF QL I
Sbjct: 78 KVLRHKYLINFYRAIESTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQLTLGIA 137
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKCKSGHQ-----SPLSDT 228
Y H + +VHRD+K ENLL+D N+K+SDFGFA+ + C ++ S LS T
Sbjct: 138 YLHSKSIVHRDLKLENLLLDKWENVKISDFGFAKMVPSNQPVGCSPSYRQVNCFSHLSQT 197
Query: 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF 288
+CGS+AYA PEIL+G+PY P SD WSMGV+LY + LPFDDTN +LL++ Q +V F
Sbjct: 198 YCGSFAYACPEILRGLPYNPFLSDTWSMGVILYTLVVAHLPFDDTNLKKLLRETQKEVTF 257
Query: 289 PTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWV 324
P +S ECK L+ ++ R + DI +D WV
Sbjct: 258 PANHTISQECKNLILQMLRQATKRATILDIIKDSWV 293
|
|
| UNIPROTKB|G3N2D2 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
Identities = 126/282 (44%), Positives = 192/282 (68%)
Query: 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV 117
+ V++ GY++G +G GSYA VK A S R +VAVK++ + +AP D+L+KFLPREI++
Sbjct: 4 AAVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEI 63
Query: 118 VKGLRHPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
+ L H ++I+ + ET+ +VYI+ME +G LL+FI+ G + E +K F QL A
Sbjct: 64 LAMLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSA 123
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
I YCH+ VVHRD+KCENLL+D ++NIKLSDFGF++ ++ SG + LS TFCGS AYA
Sbjct: 124 IKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLT-LSKTFCGSAAYA 182
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK-QVQTKVVFPTEPNVS 295
+PE+L+G+PY P D+WS+GV+LY M G +P+DD+N ++L+ Q + +V FP +++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 296 AECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAASAGV 336
ECK L+ ++ P + R+ + +I WV+ +A +SA V
Sbjct: 243 GECKDLIYRMLQPDVTRRLHIDEILSHCWVQPKARGLSSAAV 284
|
|
| UNIPROTKB|Q3SZW1 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
Identities = 126/282 (44%), Positives = 192/282 (68%)
Query: 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV 117
+ V++ GY++G +G GSYA VK A S R +VAVK++ + +AP D+L+KFLPREI++
Sbjct: 4 AAVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEI 63
Query: 118 VKGLRHPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
+ L H ++I+ + ET+ +VYI+ME +G LL+FI+ G + E +K F QL A
Sbjct: 64 LAMLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSA 123
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
I YCH+ VVHRD+KCENLL+D ++NIKLSDFGF++ ++ SG + LS TFCGS AYA
Sbjct: 124 IKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLT-LSKTFCGSAAYA 182
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK-QVQTKVVFPTEPNVS 295
+PE+L+G+PY P D+WS+GV+LY M G +P+DD+N ++L+ Q + +V FP +++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 296 AECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAASAGV 336
ECK L+ ++ P + R+ + +I WV+ +A +SA V
Sbjct: 243 GECKDLIYRMLQPDVTRRLHIDEILSHCWVQPKARGLSSAAV 284
|
|
| UNIPROTKB|F1RK80 TSSK1B "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 7.6e-64, P = 7.6e-64
Identities = 122/282 (43%), Positives = 192/282 (68%)
Query: 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV 117
+ V++ GY++G +G GSYA VK A S R +VAVK++ + +AP D+L+KFLPREI++
Sbjct: 4 AAVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEI 63
Query: 118 VKGLRHPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
+ L H ++++ + ET+ +VYI+ME +G LL+FI+ G + E +K F QL A
Sbjct: 64 LAMLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSA 123
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
I YCH+ +VHRD+KCENLL+D ++NIKLSDFGF++ ++ SG + LS TFCGS AYA
Sbjct: 124 IKYCHDMDIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLT-LSKTFCGSAAYA 182
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK-QVQTKVVFPTEPNVS 295
+PE+L+G+PY P D+WS+GV+LY M G +P+DD+N ++L+ Q + +V FP +++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 296 AECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAASAGV 336
ECK L+ ++ P + R+ + ++ WV+ +A +SA +
Sbjct: 243 GECKDLIYRMLQPDVNRRLHIDEVLSHCWVQPKARGLSSAAI 284
|
|
| MGI|MGI:1347557 Tssk1 "testis-specific serine kinase 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 645 (232.1 bits), Expect = 3.3e-63, P = 3.3e-63
Identities = 123/282 (43%), Positives = 190/282 (67%)
Query: 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV 117
+ V++ GY++G +G GSYA VK A S R +VAVK++ + +AP D+L+KFLPREI++
Sbjct: 4 AAVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPSDFLEKFLPREIEI 63
Query: 118 VKGLRHPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
+ L H ++++ + ET+ +VYI+ME +G LL+FI+ G + E +K F QL A
Sbjct: 64 LAMLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSA 123
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
I YCH+ VVHRD+KCENLL+D ++NIKLSDFGF++ ++ SG LS TFCGS AYA
Sbjct: 124 IKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDSGRLI-LSKTFCGSAAYA 182
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK-QVQTKVVFPTEPNVS 295
+PE+L+G+PY P D+WS+GV+LY M G +P+DD+N ++L+ Q + +V FP +++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 296 AECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAASAGV 336
ECK L+ ++ P + R+ + +I WV+ +A +S +
Sbjct: 243 GECKDLIYRMLQPDVNRRLHIDEILNHCWVQPKARGLSSGAI 284
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6SA08 | TSSK4_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.4891 | 0.7450 | 0.8109 | yes | N/A |
| Q9D411 | TSSK4_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.5072 | 0.7450 | 0.8109 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 357 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-88 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-79 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-63 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-60 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-58 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-54 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-43 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-43 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-43 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-41 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-40 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-38 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-38 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-37 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-37 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-37 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-35 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-35 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-34 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-34 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-34 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-34 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-34 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-33 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-33 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-32 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-32 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-32 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-32 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-31 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-31 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-31 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-31 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-31 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-31 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-30 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-30 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-30 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-29 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-29 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-28 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-28 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-28 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-28 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-28 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-28 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-28 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-28 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-28 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-28 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-27 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-27 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-27 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-26 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-25 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-25 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-24 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-23 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-23 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-23 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-22 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-21 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-21 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-21 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-21 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-20 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-20 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-19 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-19 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-19 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-18 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-18 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-14 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 9e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 265 bits (681), Expect = 2e-88
Identities = 90/264 (34%), Positives = 149/264 (56%), Gaps = 15/264 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + + +G GS+ V LA + G VA+KV+ K + D ++ + REI ++K L+HPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++R E ++Y++MEY E G L D +++ G + E + + RQ++ A++Y H +G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
VHRD+K EN+L+D + ++KL+DFG AR TF G+ Y +PE+L G
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR------QLDPGEKLTTFVGTPEYMAPEVLLGKG 172
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPF-DDTNYIQLLKQVQTK--VVFPTEPNVSAECKTLL 302
Y D+WS+GV+LY + G+ PF D ++L K++ P E ++S E K L+
Sbjct: 173 YG-KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI 231
Query: 303 SKIFS--PIKFRIRLKDIKQDPWV 324
K+ P K R+ ++ Q P+
Sbjct: 232 RKLLVKDPEK-RLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 2e-79
Identities = 92/267 (34%), Positives = 139/267 (52%), Gaps = 15/267 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y L + +G GS+ TV A G VAVK++ K + REI +++ L HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++R + A E +Y++MEY E G L D++ R G + E KK Q++ ++Y H G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRD+K EN+L+D +K++DFG A K S L TF G+ Y +PE+L G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLA----KKLLKSSSSL-TTFVGTPWYMAPEVLLGGN 174
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNY---IQLLKQV---QTKVVFPTEPNVSAECK 299
DVWS+GV+LY + G+ PF N +QL++++ + P + S E K
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 300 TLLSKI--FSPIKFRIRLKDIKQDPWV 324
L+ K P K R ++I Q PW
Sbjct: 235 DLIKKCLNKDPSK-RPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 3e-63
Identities = 69/194 (35%), Positives = 112/194 (57%), Gaps = 9/194 (4%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
+G G + TV LA + G VA+K++ K + L + L REI+++K L HPN+++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI 190
E + +Y++MEY E GSL D ++ EG + E + Q+++ ++Y H G++HRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 191 KCENLLID-GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
K EN+L+D +KL+DFG ++ L T G+ AY +PE+L G Y
Sbjct: 119 KPENILLDSDNGKVKLADFGLSK-----LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 250 YSDVWSMGVVLYAM 263
SD+WS+GV+LY +
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 2e-60
Identities = 75/249 (30%), Positives = 131/249 (52%), Gaps = 17/249 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ G+++G GS+ +V LA G +AVK V + L+ REI ++ L+HPN
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE-REIRILSSLQHPN 60
Query: 126 LIRFL--QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
++R+ + E + + I +EY GSL +++ G + EP +K+ RQ+++ + Y H
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
G+VHRDIK N+L+D + +KL+DFG A+ + + + G+ + +PE+++G
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAK---RLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 244 VPYTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTKVVFPTEP-----NVSAE 297
Y +D+WS+G + MA G+ P+ + N + L K+ EP ++S E
Sbjct: 178 EEYG-RAADIWSLGCTVIEMATGKPPWSELGNPMAALY----KIGSSGEPPEIPEHLSEE 232
Query: 298 CKTLLSKIF 306
K L K
Sbjct: 233 AKDFLRKCL 241
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 2e-58
Identities = 76/262 (29%), Positives = 129/262 (49%), Gaps = 12/262 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + K IG GS+ V L G +K + + + ++ E+ ++K L HPN
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID-LSNMSEKEREDALNEVKILKKLNHPN 60
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCH 181
+I++ ++ E ++ I+MEYA+ G L I+++ E + WF QL A+ Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
R ++HRDIK +N+ + +KL DFG ++ L+ T G+ Y SPE+
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISK-----VLSSTVDLAKTVVGTPYYLSPELC 175
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301
+ PY + SD+WS+G VLY + + PF+ N ++L ++ P S+E + L
Sbjct: 176 QNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL 234
Query: 302 LSKIFSPI-KFRIRLKDIKQDP 322
+S + + R + I Q P
Sbjct: 235 VSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 8e-54
Identities = 79/260 (30%), Positives = 138/260 (53%), Gaps = 19/260 (7%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
+G GS+ V L G A+KV+ K + + E +++ + HP +++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
A +T ++Y+++EYA G L + +EG E R + + ++V A++Y H G+++RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS 251
EN+L+D + +IKL+DFG A+ G + ++TFCG+ Y +PE+L G Y
Sbjct: 121 PENILLDADGHIKLTDFGLAK--ELSSEGSR---TNTFCGTPEYLAPEVLLGKGYGK-AV 174
Query: 252 DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECKTLLSKI--FSP 308
D WS+GV+LY M G+ PF + ++ +++ + FP +S E + L+S + P
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP--EFLSPEARDLISGLLQKDP 232
Query: 309 IKFRIRLK-----DIKQDPW 323
K RL +IK P+
Sbjct: 233 TK---RLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 5e-49
Identities = 81/284 (28%), Positives = 143/284 (50%), Gaps = 33/284 (11%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV----EAPPDYLKKFLPREIDVVKGL 121
+ GK+IG GS++TV LA + A+K++ K E Y+K E +V+ L
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVK----IEKEVLTRL 58
Query: 122 -RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
HP +I+ + +Y ++EYA G LL +I++ G +DE T+ + +++ A++Y
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-----------GHMKCKSGHQSPLS--- 226
H +G++HRD+K EN+L+D + +IK++DFG A+ Q +
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 227 -DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QT 284
+F G+ Y SPE+L P SD+W++G ++Y M G+ PF +N +++ +
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237
Query: 285 KVVFPTEPNVSAECKTLLSKIF--SP---IKFRIRLKDIKQDPW 323
+ FP PN + K L+ K+ P + ++K P+
Sbjct: 238 EYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-46
Identities = 82/260 (31%), Positives = 137/260 (52%), Gaps = 8/260 (3%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y LG +IG G++ V + G VA+K +S + + LK + +EID++K L+HPN
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHPN 60
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++++ +IET+ +YII+EYAE GSL I++ G E + Q++ + Y HE+GV
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRDIK N+L + +KL+DFG A K S + G+ + +PE+++
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVA-----TKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305
+ SD+WS+G + + G P+ D N + L ++ P +S E K L +
Sbjct: 176 ASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC 234
Query: 306 FSP-IKFRIRLKDIKQDPWV 324
F R K + + PW+
Sbjct: 235 FQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 22/249 (8%)
Query: 67 VLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
LGK +G G++ V T +VAVK + K +A +++FL RE +++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFL-REARIMRKLD 59
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDAIDYC 180
HPN+++ L + I+MEY G LLD+++ R + + Q+ ++Y
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYA 236
+ +HRD+ N L+ +K+SDFG +R G + P +
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP--------IRWM 171
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295
+PE LK +T SDVWS GV+L+ + G P+ + ++L+ ++ P PN
Sbjct: 172 APESLKEGKFT-SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP 230
Query: 296 AECKTLLSK 304
E L+ +
Sbjct: 231 PELYKLMLQ 239
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-44
Identities = 74/232 (31%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYL------KKFLPREIDVVKGLRH 123
+ IG GS+ TV+ G + K + DY K+ L E+++++ L+H
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEI-------DYGNMTEKEKQQLVSEVNILRELKH 58
Query: 124 PNLIRFLQAI--ETTHRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAI 177
PN++R+ I + +YI+MEY E G L IQ+ YI+E + QL+ A+
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 178 DYCHERG-----VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGS 232
CH R V+HRD+K N+ +D N+KL DFG A+ GH S + T+ G+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-----ILGHDSSFAKTYVGT 173
Query: 233 YAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT 284
Y SPE L + Y SD+WS+G ++Y + PF N +QL +++
Sbjct: 174 PYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQLQLASKIKE 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 63/242 (26%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ + + IG G + V A R G +VA+KV+ K+E+ + + EI ++K +HPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKK--EKIINEIQILKKCKHPN 58
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERG 184
++++ + ++I+ME+ GSL D ++ + E + ++L+ ++Y H G
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
++HRDIK N+L+ + +KL DFG + +T G+ + +PE++ G
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGL------SAQLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSK 304
PY +D+WS+G+ +A G+ P+ + ++ L ++ T P N S
Sbjct: 173 PYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPGLRN-----PEKWSD 225
Query: 305 IF 306
F
Sbjct: 226 EF 227
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 72/265 (27%), Positives = 129/265 (48%), Gaps = 15/265 (5%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
I G+Y V LA G A+KV+ K + + E D++ + P +++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ + +Y++MEY G L ++ G +DE + + ++V A++Y H G++HRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 192 CENLLIDGEYNIKLSDFGFAR-GHMK--CKSGHQSPLSDTFCGSYAYASPEILKGVPYTP 248
+N+LID ++KL+DFG ++ G ++ G+ Y +PE++ G ++
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180
Query: 249 HYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECKTLLSKI-- 305
D WS+G +LY G PF ++ + + K+ +P + VS E L+SK+
Sbjct: 181 T-VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 306 FSPIKFRIRL-----KDIKQDPWVK 325
P K RL ++IK P+ K
Sbjct: 240 PDPEK---RLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-43
Identities = 67/248 (27%), Positives = 116/248 (46%), Gaps = 21/248 (8%)
Query: 67 VLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
LGK +G G++ V + +VAVK + K +A +++FL RE +++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFL-REARIMRKLD 59
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCH 181
HPN+++ L +YI+MEY E G LL +++ + + Q+ ++Y
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYAS 237
+ +HRD+ N L+ +K+SDFG +R K G + P + +
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP--------IRWMA 171
Query: 238 PEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSA 296
PE LK +T SDVWS GV+L+ + G P+ + ++L+ ++ P PN
Sbjct: 172 PESLKEGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP 230
Query: 297 ECKTLLSK 304
E L+ +
Sbjct: 231 ELYDLMLQ 238
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 3e-43
Identities = 85/305 (27%), Positives = 143/305 (46%), Gaps = 15/305 (4%)
Query: 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
Y + + +G GS+ V LA + VA+KV++K + REI ++ L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 125 -NLIRFLQAIETTHRVYIIMEYAEKGSLLDFI---QREGYIDEPRTKKWFRQLVDAIDYC 180
N+++ + +Y++MEY + GSL D + R+G + E Q++ A++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 181 HERGVVHRDIKCENLLIDGEYN-IKLSDFGFARG-HMKCKSGHQSPLSDTFCGSYAYASP 238
H +G++HRDIK EN+L+D + +KL DFG A+ + L T G+ Y +P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 239 EILKG--VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN----YIQLLKQVQTKVVFPTEP 292
E+L G + Y SD+WS+G+ LY + G PF+ Q LK +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 293 NVSAECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKIDTQANS 352
+S L+SK S + ++ KD K ++ + A ++ K + S + +S
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 353 NSLSS 357
L
Sbjct: 298 APLRL 302
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 85/269 (31%), Positives = 137/269 (50%), Gaps = 20/269 (7%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
G IG G++ V A + G +AVK + + P +K+ + E+ V++ L+HPNL+
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLV 62
Query: 128 RFLQAIETTHR--VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ +E HR VYI MEY G+L + ++ +DE + + QL++ + Y H G+
Sbjct: 63 KYY-GVEV-HREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD--TFCGSYAYASPEILKG 243
VHRDIK N+ +D IKL DFG A K K+ + + + G+ AY +PE++ G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAV---KLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 244 VPYTPHY--SDVWSMGVVLYAMAFGRLPFD--DTNYIQLLKQV--QTKVVFPTEPNVSAE 297
H +D+WS+G V+ MA G+ P+ D + Q++ V K P +S E
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAGHKPPIPDSLQLSPE 236
Query: 298 CKTLLSKIFS--PIKFRIRLKDIKQDPWV 324
K L + P K R ++ Q P+V
Sbjct: 237 GKDFLDRCLESDPKK-RPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 65/217 (29%), Positives = 114/217 (52%), Gaps = 12/217 (5%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
KV+G GS V G A+K + V+ ++ K+ L RE+ ++ P +++
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQ-LLRELKTLRSCESPYVVKC 64
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH-ERGVVHR 188
A + I++EY + GSL D +++ G I EP RQ++ +DY H +R ++HR
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHR 124
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTP 248
DIK NLLI+ + +K++DFG + ++ +TF G+ Y SPE ++G Y
Sbjct: 125 DIKPSNLLINSKGEVKIADFGIS-KVLENTLD----QCNTFVGTVTYMSPERIQGESY-S 178
Query: 249 HYSDVWSMGVVLYAMAFGRLPFDDTN---YIQLLKQV 282
+ +D+WS+G+ L A G+ PF + +L++ +
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI 215
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 69/255 (27%), Positives = 110/255 (43%), Gaps = 34/255 (13%)
Query: 67 VLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
LGK +G G++ V T VAVK + K A + ++FL E ++K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFL-EEASIMKKLS 59
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAIDYCH 181
HPN++R L +YI+ EY G LLDF+++ G + + Q+ ++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA----- 236
+ VHRD+ N L+ +K+SDFG +R D + Y
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSR--------------DIYEDDYYRKRGGGK 165
Query: 237 ------SPEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQTKVVFP 289
+PE LK +T SDVWS GV+L+ G P+ + ++L+ ++ P
Sbjct: 166 LPIKWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLP 224
Query: 290 TEPNVSAECKTLLSK 304
N E L+ +
Sbjct: 225 RPENCPDELYELMLQ 239
|
Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-40
Identities = 83/274 (30%), Positives = 136/274 (49%), Gaps = 30/274 (10%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK---VEAPPDYLK--KFLPREIDVVKG 120
+ K +G GS+ V L G A+K++SK V+ LK + + E +++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK-----LKQVEHVLNEKRILQS 57
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
+RHP L+ + + +Y++MEY G L +++ G EP + + Q+V A++Y
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H +V+RD+K ENLL+D + IK++DFGFA+ + T CG+ Y +PEI
Sbjct: 118 HSLDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEYLAPEI 169
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECK 299
+ Y D W++G+++Y M G PF D N IQ+ ++ ++ KV FP S + K
Sbjct: 170 ILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP--SFFSPDAK 226
Query: 300 TLLSKIFSPIKFRIRL-------KDIKQDPWVKT 326
L+ + + RL DIK PW
Sbjct: 227 DLIRNLLQVDLTK-RLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 4e-39
Identities = 82/295 (27%), Positives = 136/295 (46%), Gaps = 43/295 (14%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKK----FLPREIDVVKGL 121
+ + KVIG G++ V L G A+KV+ K D +K+ + E D++
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK----SDMIKRNQIAHVRAERDILADA 58
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
P +++ + + +Y++MEY G L++ + R+ E + + +LV A+D H
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP----------------- 224
+ G +HRDIK +N+LID + +IKL+DFG K
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLC---KKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 225 ----------LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF-DDT 273
+++ G+ Y +PE+L+G PY D WS+GV+LY M +G PF DT
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDT 234
Query: 274 NYIQLLKQVQTKV--VFPTEPNVSAECKTLLSKIFSPIKFRI-RLKDIKQDPWVK 325
K + K FP +P VS E L+ ++ + R+ ++IK P+ K
Sbjct: 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 29/232 (12%)
Query: 70 KVIGIGSYATVKLATSTR---HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
K +G G++ V +VAVK + + +A + K FL +E V+K L HPN+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE-DASEEERKDFL-KEARVMKKLGHPNV 58
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTK-------KWFRQLVDAI 177
+R L +Y+++EY E G LLD+++ R + ++ + Q+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 178 DYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKCKSGHQSPLSDTFCGS 232
+Y + VHRD+ N L+ + +K+SDFG +R + + K+G + P+
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI------- 171
Query: 233 YAYASPEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
+ +PE LK +T SDVWS GV+L+ G P+ + ++L+ ++
Sbjct: 172 -RWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 94/285 (32%), Positives = 140/285 (49%), Gaps = 46/285 (16%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK--------VEAPPDYLKKF-LPREIDVVKG 120
KV+G GS+ V LA AVKV+ K VE + L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG------- 53
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
+HP L + +T R++ +MEY G L+ IQR G DEPR + + ++V + +
Sbjct: 54 -KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPE 239
HERG+++RD+K +N+L+D E +IK++DFG CK G + TFCG+ Y +PE
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFGM------CKEGILGGVTTSTFCGTPDYIAPE 166
Query: 240 ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-VVFPTEPNVSAE- 297
IL PY P D W++GV+LY M G+ PF+ + +L + + V +P + A+
Sbjct: 167 ILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKS 225
Query: 298 -CKTLLSKIFSPIKFRIRL-------KDIKQDP------WVKTEA 328
K+ L+K +P K RL +DIK P W K E
Sbjct: 226 ILKSFLTK--NPEK---RLGCLPTGEQDIKGHPFFREIDWDKLER 265
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 71/239 (29%), Positives = 124/239 (51%), Gaps = 9/239 (3%)
Query: 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLK--KFLPREIDVVKGLRHPNL 126
G+++G GS+ +V + G AVK VS + + K L +EI ++ L+HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVV 186
+++L +YI +E GSL +++ G EP + + RQ++ ++Y H+R V
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPY 246
HRDIK N+L+D +KL+DFG A+ + S +S F GS + +PE++
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKS-----FKGSPYWMAPEVIAQQGG 178
Query: 247 TPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ-LLKQVQTKVVFPTEPNVSAECKTLLSK 304
+D+WS+G + MA G+ P+ + + K ++K + P ++S E K + K
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 9e-38
Identities = 87/304 (28%), Positives = 130/304 (42%), Gaps = 69/304 (22%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVV----SKVEAPPDYLKKFLPREIDVVKGL 121
Y + +G G+Y V A + G VA+K + + P L REI ++K L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-----REISLLKEL 55
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEK--GSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
+HPN+++ L I T ++Y++ EY + LD + K QL+ + Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGP--LSPNLIKSIMYQLLRGLAY 113
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA----- 234
CH ++HRD+K +N+LI+ + +KL+DFG AR PL +Y
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFG-------IPLR-----TYTHEVVT 161
Query: 235 --YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPF-DDTNYIQLLKQVQT---- 284
Y +PEIL G + HYS D+WS+G + M G+ F D+ QL K Q
Sbjct: 162 LWYRAPEILLG---SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP 218
Query: 285 --------------KVVFP---------TEPNVSAECKTLLSKIFS--PIKFRIRLKDIK 319
K FP P + E LLSK+ P K RI K+
Sbjct: 219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RISAKEAL 277
Query: 320 QDPW 323
+ P+
Sbjct: 278 KHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 78/254 (30%), Positives = 132/254 (51%), Gaps = 16/254 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVV--SKVEAPPDYLKK----FLPREIDVVK 119
++ G +IG GS+ +V L + G +AVK V V A K+ L REI ++K
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 120 GLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
L+H N++++L + + I +EY GS+ + G +E + + RQ++ ++Y
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAY 235
H RG++HRDIK N+L+D + IK+SDFG ++ + K+ P + GS +
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP---SLQGSVFW 178
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP-NV 294
+PE++K YT +D+WS+G ++ M G+ PF D +Q + ++ P P N+
Sbjct: 179 MAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS-PEIPSNI 236
Query: 295 SAECKTLLSKIFSP 308
S+E L K F
Sbjct: 237 SSEAIDFLEKTFEI 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 5e-37
Identities = 82/267 (30%), Positives = 133/267 (49%), Gaps = 28/267 (10%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
+G+G + V+L A+K V K ++ + E ++++ HP +++ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ +Y++MEY G L ++ G DE + + +V A +Y H RG+++RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS 251
ENLL+D +KL DFGFA+ K KSG ++ TFCG+ Y +PEI+ Y
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK---KLKSGQKTW---TFCGTPEYVAPEIILNKGYD-FSV 173
Query: 252 DVWSMGVVLYAMAFGRLPF--DDTN----YIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305
D WS+G++LY + GR PF DD + Y +LK K+ FP + K L+ ++
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-KLEFP--NYIDKAAKDLIKQL 230
Query: 306 FS--PIKFRIRL-------KDIKQDPW 323
P + RL KDIK+ W
Sbjct: 231 LRRNPEE---RLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 8e-37
Identities = 82/241 (34%), Positives = 128/241 (53%), Gaps = 21/241 (8%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
K++G G++ V L G A+K++ K V D + L E V++ RHP L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLQNTRHPFLTA 59
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+ +T R+ +MEYA G L + RE E R + + ++V A+ Y H VV+R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD-----TFCGSYAYASPEILKG 243
D+K ENL++D + +IK++DFG CK G +SD TFCG+ Y +PE+L+
Sbjct: 120 DLKLENLMLDKDGHIKITDFGL------CKEG----ISDGATMKTFCGTPEYLAPEVLED 169
Query: 244 VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-VVFPTEPNVSAECKTLL 302
Y D W +GVV+Y M GRLPF + ++ +L + + + + FP +S E K+LL
Sbjct: 170 NDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLL 226
Query: 303 S 303
+
Sbjct: 227 A 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 75/224 (33%), Positives = 121/224 (54%), Gaps = 10/224 (4%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
+V+G GS+ V LA G AVKV+ K V D ++ + + + HP L +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+T R++ +ME+ G L+ IQ+ DE R + + ++ A+ + H++G+++R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K +N+L+D E + KL+DFG CK G + TFCG+ Y +PEIL+ + Y
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM------CKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPT 290
P D W+MGV+LY M G PF+ N L + + +VV+PT
Sbjct: 175 PSV-DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 72/247 (29%), Positives = 115/247 (46%), Gaps = 30/247 (12%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
+G G+ V G +AVK + ++E K+ L RE+D++ P ++ F
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQIL-RELDILHKCNSPYIVGF 64
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHE-RGVVH 187
A + I MEY + GSL ++ +G I E K ++ + Y HE ++H
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ-SPLSDTFCGSYAYASPEILKGVPY 246
RD+K N+L++ IKL DFG SG + L+ TF G+ +Y +PE ++G Y
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGV--------SGQLVNSLAKTFVGTSSYMAPERIQGNDY 176
Query: 247 TPHYSDVWSMGVVLYAMAFGRLPFDDTNY-----IQLLKQVQTKVVFPTEPNVSAECKTL 301
+ SD+WS+G+ L +A GR P+ N +LL+ + V+ L
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-----------VNEPPPRL 224
Query: 302 LSKIFSP 308
S FSP
Sbjct: 225 PSGKFSP 231
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 73/244 (29%), Positives = 129/244 (52%), Gaps = 10/244 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + K IG GS+ + LA + +K + + P K+ +E+ ++ ++HPN
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEID-LTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYI--DEPRTKKWFRQLVDAIDYCHER 183
++ F + + R++I+MEY + G L+ I R+ + E + WF Q+ + + H+R
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 184 GVVHRDIKCENLLIDGEYNI-KLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
++HRDIK +N+ + + KL DFG AR + L+ T G+ Y SPEI +
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-----QLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302
PY + +D+WS+G VLY + + PF+ N QL+ ++ P PN S + ++L+
Sbjct: 176 NRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI 234
Query: 303 SKIF 306
S++F
Sbjct: 235 SQLF 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 9/215 (4%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFL 130
V+G G+Y V + G VA+K + E D K L RE+ V++ LRH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-REVKVLRQLRHENIVNLK 66
Query: 131 QAIETTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+A R+Y++ EY E+ +LL+ ++ G + + + QL+ AI YCH ++HRD
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRD 125
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-VPYTP 248
IK EN+L+ +KL DFGFAR ++ + SPL+D + + Y +PE+L G Y
Sbjct: 126 IKPENILVSESGVLKLCDFGFAR-ALRARP--ASPLTD-YVATRWYRAPELLVGDTNYGK 181
Query: 249 HYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ 283
DVW++G ++ + G F + I L +Q
Sbjct: 182 P-VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 84/288 (29%), Positives = 125/288 (43%), Gaps = 41/288 (14%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
LGK IG G+Y V A G VA+K + K L REI ++K L HPN+I
Sbjct: 4 LGK-IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL-REIKLLKELNHPNII 61
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAIDYCHERGVV 186
+ L +Y++ E+ + L I+ + E K + QL+ + +CH G++
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPY 246
HRD+K ENLLI+ E +KL+DFG AR P + + Y +PE+L G
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLAR----SFGSPVRPYTHYVVTRW-YRAPELLLGDKG 175
Query: 247 TPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQVQT-------------------KV 286
D+WS+G + + R F + I QL K +T K
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 287 VFPTE---------PNVSAECKTLLSKI--FSPIKFRIRLKDIKQDPW 323
FP + PN S + LLS++ + P K RI + P+
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK-RITAEQALAHPY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 3e-34
Identities = 82/237 (34%), Positives = 127/237 (53%), Gaps = 13/237 (5%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
K++G G++ V L G A+K++ K V D + + E V++ RHP L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPFLTA 59
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
A +T R+ +MEYA G L + RE E R + + ++V A++Y H R VV+R
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
DIK ENL++D + +IK++DFG CK G TFCG+ Y +PE+L+ Y
Sbjct: 120 DIKLENLMLDKDGHIKITDFGL------CKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECKTLLS 303
D W +GVV+Y M GRLPF + ++ +L + + ++ FP +S E K+LL+
Sbjct: 174 -RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLA 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 77/235 (32%), Positives = 125/235 (53%), Gaps = 10/235 (4%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV-VKGLRHPNLIR 128
KVIG GS+ V LA G AVKV+ K +K + E +V +K ++HP L+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+ +T ++Y +++Y G L +QRE EPR + + ++ A+ Y H +++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ-SPLSDTFCGSYAYASPEILKGVPYT 247
D+K EN+L+D + ++ L+DFG CK G + S + TFCG+ Y +PE+L+ PY
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL------CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302
D W +G VLY M +G PF + ++ + K + +PN+S + LL
Sbjct: 175 -RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPNISVSARHLL 227
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 9/203 (4%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHPNLIR 128
KVIG GS+ V LA G AVKV+ K +K + E +V+ K ++HP L+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+ +TT ++Y ++++ G L +QRE EPR + + ++ A+ Y H +V+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K EN+L+D + ++ L+DFG CK G QS + TFCG+ Y +PE+++ PY
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL------CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 248 PHYSDVWSMGVVLYAMAFGRLPF 270
+ D W +G VLY M +G PF
Sbjct: 175 -NTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 71/203 (34%), Positives = 108/203 (53%), Gaps = 9/203 (4%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHPNLIR 128
KVIG GS+ V LA G AVKV+ K + + E +V+ K L+HP L+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+ +T ++Y +++Y G L +QRE EPR + + ++ AI Y H +++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K EN+L+D + ++ L+DFG CK G + TFCG+ Y +PE+L+ PY
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL------CKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 248 PHYSDVWSMGVVLYAMAFGRLPF 270
D W +G VLY M +G PF
Sbjct: 175 -RTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-33
Identities = 76/237 (32%), Positives = 125/237 (52%), Gaps = 14/237 (5%)
Query: 70 KVIGIGSYATVKLATSTRHGCD---VAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHPN 125
KVIG GS+ V LA RH + AVKV+ K +K + E +V+ K ++HP
Sbjct: 1 KVIGKGSFGKVLLA---RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 57
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
L+ + +T ++Y +++Y G L +QRE EPR + + ++ A+ Y H +
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
V+RD+K EN+L+D + +I L+DFG + +++ + TFCG+ Y +PE+L P
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-----TTSTFCGTPEYLAPEVLHKQP 172
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302
Y D W +G VLY M +G PF N ++ + K + +PN++ + LL
Sbjct: 173 YD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLL 227
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 81/257 (31%), Positives = 126/257 (49%), Gaps = 25/257 (9%)
Query: 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVE-----APPDYLKKFLPREIDVVK 119
+ + K IG G ++ V A G VA+K V E A D LK EID++K
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-----EIDLLK 57
Query: 120 GLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ----REGYIDEPRTKKWFRQLVD 175
L HPN+I++L + + + I++E A+ G L I+ ++ I E K+F QL
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235
A+++ H + ++HRDIK N+ I +KL D G R ++ + + G+ Y
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYY 172
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF--DDTNYIQLLKQVQTKVVFPTEPN 293
SPE + Y SD+WS+G +LY MA + PF D N L K++ K +P P
Sbjct: 173 MSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EKCDYPPLPA 230
Query: 294 --VSAECKTLLSKIFSP 308
S E + L+S+ +P
Sbjct: 231 DHYSEELRDLVSRCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 76/225 (33%), Positives = 120/225 (53%), Gaps = 14/225 (6%)
Query: 70 KVIGIGSYATVKLATSTRHGCD--VAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNL 126
KV+G GS+ V LA G D A+KV+ K V D + + + + +HP L
Sbjct: 1 KVLGKGSFGKVMLAE--LKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVV 186
+T R++ +MEY G L+ IQR DEPR++ + ++ A+ + H GV+
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVP 245
+RD+K +N+L+D E + KL+DFG CK G + TFCG+ Y +PEIL+ +
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGM------CKEGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFP 289
Y P D W++GV++Y M G+ PF+ N L + + V++P
Sbjct: 173 YGPSV-DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-32
Identities = 82/240 (34%), Positives = 128/240 (53%), Gaps = 13/240 (5%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
K++G G++ V L G A+K++ K V D + L E V+K RHP L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHPFLTS 59
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+ +T R+ +MEY G L + RE E RT+ + ++V A+DY H +V+R
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K ENL++D + +IK++DFG CK G + TFCG+ Y +PE+L+ Y
Sbjct: 120 DLKLENLMLDKDGHIKITDFGL------CKEGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECKTLLSKIF 306
D W +GVV+Y M GRLPF + ++ +L + + + FP +SA+ K+LLS +
Sbjct: 174 -RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-32
Identities = 74/262 (28%), Positives = 121/262 (46%), Gaps = 13/262 (4%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFL 130
++G G + V++ G A+KV+ K F E D++ P + +
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 131 QAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
A + +Y++MEY G LL + R E DE + + +LV AI H+ G VHRD
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
IK EN+LID +IKL+DFG A + + + G+ Y +PE+L +
Sbjct: 128 IKPENVLIDRTGHIKLADFGSA-ARLT-ANKMVNSKLPV--GTPDYIAPEVLTTMNGDGK 183
Query: 250 YS-----DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV---QTKVVFPTEPNVSAECKTL 301
+ D WS+GV+ Y M +GR PF + + + Q + FP +P VS++ L
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDL 243
Query: 302 LSKIFSPIKFRIRLKDIKQDPW 323
+ + K R+ + + P+
Sbjct: 244 IQSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 64/231 (27%), Positives = 116/231 (50%), Gaps = 9/231 (3%)
Query: 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVE---APPDYLKKFLPREIDVVKGLRHPN 125
G+ +G G++++ A + G +AVK V+ V + + + + L +EI ++ L HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+IR L A + +E+ GS+ + + G E + QL+ + Y HE +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 186 VHRDIKCENLLIDGE-YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
+HRD+K NLLID ++++DFG A + K G+ A+ +PE+L+G
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAA-ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDT---NYIQLLKQVQTKVVFPTEP 292
Y DVWS+G V+ MA + P++ N++ L+ ++ + P+ P
Sbjct: 184 QYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 83/241 (34%), Positives = 131/241 (54%), Gaps = 14/241 (5%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
K++G G++ V L G A+K++ K V D + L E V++ RHP L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-ENRVLQNSRHPFLTA 59
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH-ERGVVH 187
+ +T R+ +MEYA G L + RE E R + + ++V A+DY H E+ VV+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS-DTFCGSYAYASPEILKGVPY 246
RD+K ENL++D + +IK++DFG CK G + + TFCG+ Y +PE+L+ Y
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGL------CKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 173
Query: 247 TPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECKTLLSKI 305
D W +GVV+Y M GRLPF + ++ +L + + ++ FP +S E K+LLS +
Sbjct: 174 G-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLSGL 230
Query: 306 F 306
Sbjct: 231 L 231
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 28/270 (10%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF----LPREIDVVKGLRHPN 125
K I G++ +V LA G A+KV+ K + + R I +++G P
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKK--SDMIAKNQVTNVKAERAIMMIQG-ESPY 58
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+ + + ++ +Y++MEY G I+ G + E K++ ++V ++ H+RG+
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR-GHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
+HRDIK ENLLID ++KL+DFG +R G K F G+ Y +PE + GV
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK----------FVGTPDYLAPETILGV 168
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPTEPN--VSAECKTL 301
SD WS+G V++ FG PF + + ++ + +P E S E L
Sbjct: 169 GDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDL 227
Query: 302 LSKIFSPIKFRIRL-----KDIKQDPWVKT 326
++++ RL ++IK P+ K+
Sbjct: 228 INRLLCM-DPAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 16/263 (6%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK--VEAPPDYLKKFLPREIDVVKGLRHPNLI 127
KV+G GS+ V LA A+K + K V D + R + + HP L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRV-LALAWEHPFLT 59
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
+T ++ +MEY G L+ IQ G DE R + + +++ + + H++G+++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYT 247
RD+K +N+L+D + +IK++DFG + +M + + TFCG+ Y +PEILKG Y
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-----KASTFCGTPDYIAPEILKGQKYN 174
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPN-VSAECKTLLSKIF 306
D WS GV+LY M G+ PF + +L + P P +S E K LSK+F
Sbjct: 175 -ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--PHFPRWISKEAKDCLSKLF 231
Query: 307 --SPIKFRIRLK-DIKQDPWVKT 326
P K R+ + DI+Q P+ +
Sbjct: 232 ERDPTK-RLGVDGDIRQHPFFRG 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 81/268 (30%), Positives = 131/268 (48%), Gaps = 44/268 (16%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP----REIDVVKGLRHPNLI 127
IG G+Y V A + + G VA+K K+ + K+ P REI +++ LRHPN++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALK---KI--RMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 128 RFLQAIETTHR---VYIIMEYAEK--GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
R L+ I T+ +Y++ EY + LLD E E + K + +QL++ + Y H
Sbjct: 62 R-LKEIVTSKGKGSIYMVFEYMDHDLTGLLD--SPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA-------Y 235
G++HRDIK N+LI+ + +KL+DFG AR P + Y Y
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLAR-----------PYTKRNSADYTNRVITLWY 167
Query: 236 ASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE--- 291
PE+L G Y P D+WS+G +L + G+ F + ++ L+++ PT+
Sbjct: 168 RPPELLLGATRYGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226
Query: 292 PNVSAECKTLLSKIFSPIK-FRIRLKDI 318
P VS K + P K ++ RL++
Sbjct: 227 PGVS---KLPWFENLKPKKPYKRRLREF 251
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 74/246 (30%), Positives = 125/246 (50%), Gaps = 14/246 (5%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLK--KFLPREIDVVKGLRHPN 125
GK++G G++ V L G ++AVK V P+ K L EI ++K L+H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++++ + + I MEY GS+ D ++ G + E T+K+ RQ+++ ++Y H +
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFA-RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
VHRDIK N+L D N+KL DFG + R C SG + G+ + SPE++ G
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG---TGMKSVTGTPYWMSPEVISGE 182
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP----NVSAECKT 300
Y +DVWS+G + M + P+ + + + ++ T+ PT P +VS + +
Sbjct: 183 GYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ---PTNPQLPSHVSPDARN 238
Query: 301 LLSKIF 306
L + F
Sbjct: 239 FLRRTF 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 71/246 (28%), Positives = 125/246 (50%), Gaps = 21/246 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + IG G+ V AT G +VA+K + ++ K+ + EI ++K +HPN
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQN---KELIINEILIMKDCKHPN 76
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERG 184
++ + + ++++MEY + GSL D I Q ++EP+ R+++ ++Y H +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFA----RGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
V+HRDIK +N+L+ + ++KL+DFGFA + K S G+ + +PE+
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS---------VVGTPYWMAPEV 187
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAEC 298
+K Y P D+WS+G++ MA G P+ ++ L + TK + S E
Sbjct: 188 IKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF 246
Query: 299 KTLLSK 304
K L+K
Sbjct: 247 KDFLNK 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 67/234 (28%), Positives = 112/234 (47%), Gaps = 35/234 (14%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVV-SKVEAPPDYLKKFLPREIDVVKGLR-- 122
Y + K +G G++ +V LA + G VA+K + K + + + RE VK LR
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL---RE---VKSLRKL 54
Query: 123 --HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREG-YIDEPRTKKWFRQLVDAID 178
HPN+++ + +Y + EY E G+L + R+G E + Q++ +
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA---- 234
+ H+ G HRD+K ENLL+ G +K++DFG AR ++ + P +D Y
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSR----PPYTD-----YVSTRW 163
Query: 235 YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQVQT 284
Y +PEIL + YS D+W++G ++ + R F ++ I QL K
Sbjct: 164 YRAPEILL---RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV 214
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 70/212 (33%), Positives = 115/212 (54%), Gaps = 25/212 (11%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH------ 123
+VIG GSYA V L + A+KV+ K D +ID V+ +H
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD-------EDIDWVQTEKHVFETAS 53
Query: 124 --PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
P L+ +T R++ ++E+ G L+ +QR+ + E + + ++ A+++ H
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH 113
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEI 240
ERG+++RD+K +N+L+D E +IKL+D+G CK G + TFCG+ Y +PEI
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGHIKLTDYGM------CKEGIRPGDTTSTFCGTPNYIAPEI 167
Query: 241 LKGVPYTPHYS-DVWSMGVVLYAMAFGRLPFD 271
L+G Y +S D W++GV+++ M GR PFD
Sbjct: 168 LRGEDYG--FSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 5e-31
Identities = 75/243 (30%), Positives = 125/243 (51%), Gaps = 9/243 (3%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
YV K IG GS+ L S G +K ++ + P ++ +E+ V+ ++HPN
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE-REESRKEVAVLSNMKHPN 60
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFI--QREGYIDEPRTKKWFRQLVDAIDYCHER 183
++++ ++ E +YI+M+Y E G L I QR E + WF Q+ A+ + H+R
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
++HRDIK +N+ + + IKL DFG AR L+ T G+ Y SPEI +
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIAR-----VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 244 VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303
PY + SD+W++G VLY M + F+ N L+ ++ P + S + + L+S
Sbjct: 176 RPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234
Query: 304 KIF 306
++F
Sbjct: 235 QLF 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-31
Identities = 66/271 (24%), Positives = 126/271 (46%), Gaps = 26/271 (9%)
Query: 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKK----FLPREIDVVKG 120
+ L +VIG G++ V + A+K ++K ++K + E +++
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ----KCVEKGSVRNVLNERRILQE 56
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
L HP L+ + + +Y++++ G L + ++ E + K W ++V A++Y
Sbjct: 57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H +G++HRDIK +N+L+D + ++ ++DF A L+ + G+ Y +PE+
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIAT--KV----TPDTLTTSTSGTPGYMAPEV 170
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-----DTNYIQLLKQVQTKVVFPTEPNVS 295
L Y+ D WS+GV Y G+ P+ + I KQ V++P S
Sbjct: 171 LCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI-RAKQETADVLYP--ATWS 226
Query: 296 AECKTLLSKIFSP-IKFRI--RLKDIKQDPW 323
E ++K+ + R+ LKD+K P+
Sbjct: 227 TEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKV------VSKVEAPPDYLKKFLPREIDVVKGLRHP 124
V+G G + V LA + G A+K +++ E +K R + RHP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK---RIFETANSERHP 62
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
L+ +T V +MEYA G L+ I + + EPR + +V + Y HE
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF-SEPRAVFYAACVVLGLQYLHENK 121
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
+V+RD+K +NLL+D E +K++DFG + M G S TFCG+ + +PE+L
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM----GFGDRTS-TFCGTPEFLAPEVLTET 176
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPF--DD 272
YT D W +GV++Y M G PF DD
Sbjct: 177 SYT-RAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 4e-30
Identities = 82/249 (32%), Positives = 129/249 (51%), Gaps = 21/249 (8%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHPNLIR 128
+VIG GSYA V L + A+KVV K D ++ E V + HP L+
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+T R++ ++EY G L+ +QR+ + E + + ++ A++Y HERG+++R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K +N+L+D E +IKL+D+G CK G + TFCG+ Y +PEIL+G Y
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFD--------DTNYIQLLKQV--QTKVVFPTEPNVSAE 297
D W++GV+++ M GR PFD D N L QV + ++ P +V A
Sbjct: 175 -FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 233
Query: 298 C--KTLLSK 304
K+ L+K
Sbjct: 234 SVLKSFLNK 242
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 5e-30
Identities = 76/228 (33%), Positives = 121/228 (53%), Gaps = 29/228 (12%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH------ 123
+VIG GSYA V L ++ A+KVV K D +ID V+ +H
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD-------EDIDWVQTEKHVFEQAS 53
Query: 124 --PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
P L+ +TT R+++++EY G L+ +QR+ + E + + ++ A+++ H
Sbjct: 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH 113
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEI 240
ERG+++RD+K +N+L+D + +IKL+D+G CK G + TFCG+ Y +PEI
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGM------CKEGLGPGDTTSTFCGTPNYIAPEI 167
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD------DTNYIQLLKQV 282
L+G Y D W++GV+++ M GR PFD D N L QV
Sbjct: 168 LRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 76/259 (29%), Positives = 130/259 (50%), Gaps = 26/259 (10%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP------DYLKK----FLPREI 115
+V G++IG G+Y V LA + G +AVK +VE P D +K L EI
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVK---QVELPATIAGRHDSRQKDMVKALRSEI 59
Query: 116 DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD 175
+ +K L H N++++L T + I +EY GS+ ++ G +E + + Q+++
Sbjct: 60 ETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE 119
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235
+ Y H +G++HRD+K +NLL+D + K+SDFG ++ K + + + + GS +
Sbjct: 120 GLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMSMQGSVFW 176
Query: 236 ASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP--- 289
+PE++ Y+ YS D+WS+G V+ M GR P+ D I + ++ K P
Sbjct: 177 MAPEVIHS--YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234
Query: 290 --TEPNVSAECKTLLSKIF 306
N+S L+ F
Sbjct: 235 PDVSMNLSPVALDFLNACF 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 74/260 (28%), Positives = 129/260 (49%), Gaps = 14/260 (5%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
+V+G G++ V L V +K + VE + E V+K L HPN+I +
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIP-VEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVH 187
+ + I+MEYA G+L ++IQ+ +DE +F Q++ A+ + H + ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124
Query: 188 RDIKCENLLIDGEYNI-KLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPY 246
RD+K +N+L+D + K+ DFG ++ + KS + T G+ Y SPE+ +G PY
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSK-----AYTVVGTPCYISPELCEGKPY 178
Query: 247 TPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF 306
SD+W++G VLY +A + F+ N L+ ++ + P S + + L+ +
Sbjct: 179 N-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML 237
Query: 307 S--PIKFRIRLKDIKQDPWV 324
+ P K R +L I P
Sbjct: 238 NLDPSK-RPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-29
Identities = 78/262 (29%), Positives = 132/262 (50%), Gaps = 16/262 (6%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK--VEAPPDYLKKFLPREIDVVKGLRHPNLI 127
K++G GS+ V LA A+K + K V D + + + + HP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLT 59
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
+T ++ +MEY G L+ IQ D PR + +++ + + H +G+V+
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYT 247
RD+K +N+L+D + +IK++DFG + +M + + TFCG+ Y +PEIL G Y
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-----TCTFCGTPDYIAPEILLGQKYN 174
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPN-VSAECKTLLSKIF 306
D WS GV+LY M G+ PF + +L + ++ P P ++ E K +L K+F
Sbjct: 175 -TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLF 231
Query: 307 --SPIKFRIRLK-DIKQDPWVK 325
P + R+ +K DI+Q P+ +
Sbjct: 232 VREPER-RLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 57/177 (32%), Positives = 99/177 (55%), Gaps = 9/177 (5%)
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ ++ ++Y+++ + G L +QREG D R + + +L+ A++ H+ V++RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS 251
EN+L+D + +I L DFG + +MK ++TFCG+ Y +PE+L G YT
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMK-----DDDKTNTFCGTPEYLAPELLLGHGYT-KAV 174
Query: 252 DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECKTLLSKIFS 307
D W++GV+LY M G PF D N ++ +++ Q + FP + K LL + S
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--GFDRDAKDLLIGLLS 229
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-29
Identities = 83/286 (29%), Positives = 144/286 (50%), Gaps = 26/286 (9%)
Query: 53 DVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP 112
D KKK T E IG G+ TV A G +VA+K ++ + P K+ +
Sbjct: 16 DPKKKYTRFEK--------IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---KELII 64
Query: 113 REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQ 172
EI V++ +HPN++ +L + ++++MEY GSL D + E +DE + R+
Sbjct: 65 NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRE 123
Query: 173 LVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK--SGHQSPLSDTFC 230
+ A+++ H V+HRDIK +N+L+ + ++KL+DFGF C + QS S T
Sbjct: 124 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF------CAQITPEQSKRS-TMV 176
Query: 231 GSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT--KVVF 288
G+ + +PE++ Y P D+WS+G++ M G P+ + N ++ L + T
Sbjct: 177 GTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 289 PTEPNVSAECKTLLSKIFS-PIKFRIRLKDIKQDPWVKTEANPAAS 333
+SA + L++ ++ R K++ Q P++K A P +S
Sbjct: 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI-AKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 60/196 (30%), Positives = 104/196 (53%), Gaps = 8/196 (4%)
Query: 113 REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI--QREGYIDEPRTKKWF 170
+E ++ ++HPN++ F ++ E +YI+MEY + G L+ I QR E +WF
Sbjct: 47 KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106
Query: 171 RQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFC 230
Q+ + + HE+ V+HRDIK +N+ + +KL DFG AR + T+
Sbjct: 107 VQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR-----LLTSPGAYACTYV 161
Query: 231 GSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT 290
G+ Y PEI + +PY + SD+WS+G +LY + + PF ++ L+ +V P
Sbjct: 162 GTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL 220
Query: 291 EPNVSAECKTLLSKIF 306
+ S E ++L+ ++F
Sbjct: 221 PSHYSYELRSLIKQMF 236
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 70 KVIGIGSYATVKLATST----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
K +G G + V+L G VAVK + + F REI++++ L H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDF-EREIEILRTLDHEN 67
Query: 126 LIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHE 182
++++ E + +IMEY GSL D++QR I+ R + Q+ +DY
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSYAYA 236
+ +HRD+ N+L++ E +K+SDFG A+ + K +SP+ + YA
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI-------FWYA 180
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAM 263
PE L+ ++ SDVWS GV LY +
Sbjct: 181 -PECLRTSKFS-SASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 68/205 (33%), Positives = 112/205 (54%), Gaps = 11/205 (5%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH---PNLI 127
+IG G+Y V G VA+K+++ ++ P D + + RE+ ++ LR PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIIN-LDTPDDDVSD-IQREVALLSQLRQSQPPNIT 65
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
++ + R++IIMEYAE GS+ + + G I E R+++ A+ Y H+ GV+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVALKYIHKVGVIH 124
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYT 247
RDIK N+L+ N+KL DFG A + S +S TF G+ + +PE++ Y
Sbjct: 125 RDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSKRS----TFVGTPYWMAPEVITEGKYY 179
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDD 272
+D+WS+G+ +Y MA G P+ D
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 22/280 (7%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
M+ + + KVIG G++ V+L A+K++SK E F E D++
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFR----QLVDA 176
+++ A + +Y++MEY G D + D P +KW R ++V A
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGG---DLVNLMSNYDIP--EKWARFYTAEVVLA 154
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
+D H G +HRD+K +N+L+D ++KL+DFG MK + DT G+ Y
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMDANGMV-RCDTAVGTPDYI 210
Query: 237 SPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV---QTKVVFPT 290
SPE+LK +Y D WS+GV LY M G PF + + ++ + + FP
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270
Query: 291 EPNVSAECKTLLSKIFSPIKFRI---RLKDIKQDPWVKTE 327
+ +S + K L+ + + R+ + +IK P+ K +
Sbjct: 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 89/294 (30%), Positives = 133/294 (45%), Gaps = 60/294 (20%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G+Y V A G VA+K + ++E + + REI ++K L HPN++R L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 132 AIETTHRVYIIMEYAEKG--SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+ + +++Y++ E+ + +D G +D P K + QL+ I YCH V+HRD
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA-------YASPEILK 242
+K +NLLID E +KL+DFG AR P+ +Y Y +PEIL
Sbjct: 125 LKPQNLLIDREGALKLADFGLAR-------AFGVPVR-----TYTHEVVTLWYRAPEILL 172
Query: 243 GVPYTPHYS---DVWSMGVVLYAMAFGRLPF-DDTNYIQLLKQVQT-------------- 284
G + YS D+WS+G + M R F D+ QL + +T
Sbjct: 173 G---SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229
Query: 285 ----KVVFP---------TEPNVSAECKTLLSK--IFSPIKFRIRLKDIKQDPW 323
K FP PN+ + LLSK ++ P K RI K Q P+
Sbjct: 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAK-RISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 16/212 (7%)
Query: 113 REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI--QREGYIDEPRTKKWF 170
E V+ L +IR+ ++ ++ I+MEYAE G L + QR + E + ++F
Sbjct: 48 DEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF 107
Query: 171 RQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFC 230
Q++ + + H + ++HRDIK NL +D N+K+ D G A+ + ++T
Sbjct: 108 IQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAK-----LLSDNTNFANTIV 162
Query: 231 GSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT 290
G+ Y SPE+ + PY SDVW++GVVLY G+ PFD N L+ ++ V P
Sbjct: 163 GTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV 221
Query: 291 EPNVSAECKTLLSKIFSPIKFRIRLKDIKQDP 322
S + L+ + + KD +Q P
Sbjct: 222 SQMYSQQLAQLIDQCLT--------KDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 73/240 (30%), Positives = 120/240 (50%), Gaps = 9/240 (3%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y+ +V+G G++ L T V K V+ + L EI ++ L+HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILSLLQHPN 60
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKW-FRQLVDAIDYCHER 183
+I + + + I MEYA G+L D I +++G + E W Q+V A+ Y H+
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
G++HRDIK N+ + IKL DFG ++ G + +++T G+ Y SPE+ +G
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISK-----ILGSEYSMAETVVGTPYYMSPELCQG 175
Query: 244 VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303
V Y SD+W++G VLY + + FD TN + L+ ++ P S+E +L+
Sbjct: 176 VKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 64/223 (28%), Positives = 117/223 (52%), Gaps = 10/223 (4%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
+G+ +G GS+ V++A G A+K + K E + + +E ++ L HP ++
Sbjct: 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
+ + + +RVY ++E+ G L +++ G K + +LV A +Y H + +++
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIY 141
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYT 247
RD+K ENLL+D + ++K++DFGFA+ + T CG+ Y +PE+++ +
Sbjct: 142 RDLKPENLLLDNKGHVKVTDFGFAK--------KVPDRTFTLCGTPEYLAPEVIQSKGHG 193
Query: 248 PHYSDVWSMGVVLYAMAFGRLPF-DDTNYIQLLKQVQTKVVFP 289
D W+MGV+LY G PF DDT + K + ++ FP
Sbjct: 194 KAV-DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP 235
|
Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 76/251 (30%), Positives = 127/251 (50%), Gaps = 10/251 (3%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF--LPREIDVVKGLRHPN 125
LGK++G G++ V L G ++AVK V P+ K+ L EI ++K L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 126 LIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
++++ + + I ME+ GS+ D ++ G + E T+K+ RQ+++ + Y H
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFA-RGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
+VHRDIK N+L D N+KL DFG + R C SG + G+ + SPE++
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG---MKSVTGTPYWMSPEVIS 182
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT-EPNVSAECKTL 301
G Y +D+WS+G + M + P+ + + + ++ T+ P P+VS C+
Sbjct: 183 GEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241
Query: 302 LSKIFSPIKFR 312
L +IF K R
Sbjct: 242 LKRIFVEAKLR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 74/255 (29%), Positives = 124/255 (48%), Gaps = 16/255 (6%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD-YLKKFLPREIDVVKGLRHPN 125
LG V G GSY V G VA+K +E+ D +KK REI ++K LRH N
Sbjct: 5 NLGLV-GEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
L+ ++ R+Y++ E+ + L D + +DE R +K+ Q++ I++CH +
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRDIK EN+L+ +KL DFGFAR + +D + + Y +PE+L G
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFAR----TLAAPGEVYTD-YVATRWYRAPELLVGDT 176
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305
D+W++G ++ M G F + I L + + N+ + + K
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL-----GNLIPRHQEIFQK- 230
Query: 306 FSPIKFRIRLKDIKQ 320
+P+ +RL ++K+
Sbjct: 231 -NPLFAGMRLPEVKE 244
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 72/238 (30%), Positives = 123/238 (51%), Gaps = 10/238 (4%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
V+G GS+ V LA A+K++ K V D ++ + + + + P L +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+T R+Y +MEY G L+ IQ+ G EP+ + ++ + + H RG+++RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
+K +N+++D E +IK++DFG + HM + TFCG+ Y +PEI+ PY
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKEHM-----VDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 250 YSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAE--CKTLLSK 304
D W+ GV+LY M G+ PFD + +L + + + V +P + A CK L++K
Sbjct: 182 V-DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 74/242 (30%), Positives = 126/242 (52%), Gaps = 16/242 (6%)
Query: 70 KVIGIGSYATVKLATSTRHGCD--VAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNL 126
V+G GS+ V LA R G D A+K++ K V D ++ + + + + P L
Sbjct: 6 MVLGKGSFGKVMLAE--RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVV 186
+ +T R+Y +MEY G L+ IQ+ G EP + ++ + + H +G++
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPY 246
+RD+K +N+++D E +IK++DFG + ++ + TFCG+ Y +PEI+ PY
Sbjct: 124 YRDLKLDNVMLDAEGHIKIADFGMCKENI-----FGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 247 TPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FP---TEPNVSAECKTLL 302
D W+ GV+LY M G+ PFD + +L + + V +P ++ VS CK LL
Sbjct: 179 GKSV-DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI-CKGLL 236
Query: 303 SK 304
+K
Sbjct: 237 TK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 79/263 (30%), Positives = 137/263 (52%), Gaps = 16/263 (6%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
KV+G GS+ V LA G AVK + K V D ++ + + + +P L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+T ++ +ME+ G L+ IQ +G D R + ++V + + H +G+++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTP 248
D+K +N+++D + +IK++DFG + ++ + + TFCG+ Y +PEIL+G+ YT
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNR-----ASTFCGTPDYIAPEILQGLKYT- 174
Query: 249 HYS-DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPN-VSAECKTLLSKIF 306
+S D WS GV+LY M G+ PF + +L + ++ P P ++ E K +L K+F
Sbjct: 175 -FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHYPRWITKESKDILEKLF 231
Query: 307 SPIKFRIRL---KDIKQDPWVKT 326
R RL +I+ P+ KT
Sbjct: 232 ERDPTR-RLGVVGNIRGHPFFKT 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 73/242 (30%), Positives = 124/242 (51%), Gaps = 16/242 (6%)
Query: 70 KVIGIGSYATVKLATSTRHGCD--VAVKVVSK--VEAPPDYLKKFLPREIDVVKGLRHPN 125
V+G GS+ V LA R G D A+K++ K V D + + + + G + P
Sbjct: 6 MVLGKGSFGKVMLAE--RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPF 62
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
L + +T R+Y +MEY G L+ IQ+ G EP + ++ + + H +G+
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
++RD+K +N+++D E +IK++DFG + +M + TFCG+ Y +PEI+ P
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENM-----WDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFP--TEPNVSAECKTLL 302
Y D W+ GV+LY M G+ PF+ + +L + + + V +P A CK L+
Sbjct: 178 YGKSV-DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 236
Query: 303 SK 304
+K
Sbjct: 237 TK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFL 130
+G GSY +V A G VA+KVV VE + K EI ++K P ++++
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIK----EISILKQCDSPYIVKYY 64
Query: 131 QAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+ ++I+MEY GS+ D ++ + E Q + ++Y H +HRD
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
IK N+L++ E KL+DFG + + +T G+ + +PE+++ + Y +
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSG-----QLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-N 178
Query: 250 YSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK 285
+D+WS+G+ MA G+ P+ D + ++ + + K
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK 214
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y L + IG G+Y V A G VA+KV+ K+E D+ + + +EI ++K RHPN
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDF--EIIQQEISMLKECRHPN 61
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERG 184
++ + + +++I+MEY GSL D Q G + E + R+ + + Y HE G
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 185 VVHRDIKCENLLI--DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL- 241
+HRDIK N+L+ DG+ +KL+DFG + + +F G+ + +PE+
Sbjct: 122 KIHRDIKGANILLTEDGD--VKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 242 --KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT 273
+ Y D+W++G+ +A + P D
Sbjct: 175 VERKGGYD-GKCDIWALGITAIELAELQPPMFDL 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 80/303 (26%), Positives = 128/303 (42%), Gaps = 54/303 (17%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y L K IG G+Y V A R G VA+K +S V K+ L REI +++ LRH N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHEN 60
Query: 126 LIRFL-----QAIETTHRVYIIMEYAEKGSLLDF---IQREGYIDEPRTKKWFRQLVDAI 177
+I L + E + VYI+ E E D I+ + + + + Q++ +
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 178 DYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS 237
Y H V+HRD+K N+L++ ++K+ DFG ARG + + L++ + Y +
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG-VDPDEDEKGFLTEYVVTRW-YRA 174
Query: 238 PEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE--- 291
PE+L Y+ D+WS+G + + + F +YI L + + P+E
Sbjct: 175 PELLLSS---SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231
Query: 292 ---------------------------PNVSAECKTLLSKI--FSPIKFRIRLKDIKQDP 322
P S E LL K+ F P K RI + P
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKK-RITADEALAHP 290
Query: 323 WVK 325
++
Sbjct: 291 YLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 78/251 (31%), Positives = 130/251 (51%), Gaps = 33/251 (13%)
Query: 70 KVIGIGSYATVKLATSTRHGCD----VAVKVVSK---VEAPPDYLKKFLPREIDVVKGLR 122
KV+G G Y V G D A+KV+ K V D R I ++ ++
Sbjct: 2 KVLGKGGYGKVFQVRKV-TGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI--LEAVK 58
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
HP ++ + A +T ++Y+I+EY G L ++REG E + ++ A+++ H+
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK-SGHQSPLSDTFCGSYAYASPEIL 241
+G+++RD+K EN+L+D + ++KL+DFG CK S H+ ++ TFCG+ Y +PEIL
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGL------CKESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 242 ------KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL-KQVQTKVVFPTEPNV 294
K V D WS+G ++Y M G PF N + + K ++ K+ P P +
Sbjct: 173 MRSGHGKAV-------DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP--PYL 223
Query: 295 SAECKTLLSKI 305
+ E + LL K+
Sbjct: 224 TPEARDLLKKL 234
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-28
Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 10/208 (4%)
Query: 69 GKVIGIGSYATVKLATSTRHGCDVAVKVV-----SKVEAPPDYLKKFLPREIDVVKGLRH 123
G+V+G G+Y TV T G +AVK V + + A +Y K L E+D++K L+H
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEK--LQEEVDLLKSLKH 61
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
N++++L + + I ME+ GS+ + R G + EP K+ +Q++D + Y H
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARG-HMKCKSGHQSPLSDTFCGSYAYASPEILK 242
VVHRDIK N+++ IKL DFG AR G S + + G+ + +PE++
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPF 270
Y SD+WS+G ++ MA G+ P
Sbjct: 182 ESGYG-RKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 77/263 (29%), Positives = 126/263 (47%), Gaps = 19/263 (7%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNLIRFL 130
+G G Y V LA G VA+K + K + + ++ L E D++ + L++ L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVL-TERDILTTTKSEWLVKLL 67
Query: 131 QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI 190
A + +Y+ MEY G + G + E + + ++ +A+D HE G +HRD+
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127
Query: 191 KCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHY 250
K EN LID +IKL+DFG ++G + +++ GS Y +PE+L+G Y
Sbjct: 128 KPENFLIDASGHIKLTDFGLSKGIVT--------YANSVVGSPDYMAPEVLRGKGYD-FT 178
Query: 251 SDVWSMGVVLYAMAFGRLPFDDTN----YIQLL---KQVQTKVVFPTEPNVSAECKTLLS 303
D WS+G +LY G PF + + L + +Q V N+S E L++
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238
Query: 304 KIFSPIKFRIR-LKDIKQDPWVK 325
K+ + R L+DIK P+ K
Sbjct: 239 KLINDPSRRFGSLEDIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 39/291 (13%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
K++G G V L G A+KV+ K E K + E +++ L HP L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
+ +T + ++M+Y G L +QR + E + + +++ A++Y H G+V+
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 188 RDIKCENLLIDGEYNIKLSDFGFA-----RGHMKCKSGH--------QSPLSDT------ 228
RD+K EN+L+ +I LSDF + K+ S S+T
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 229 -----FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ 283
F G+ Y +PE++ G + D W++G++LY M +G PF +N + +
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 284 TK-VVFPTEPNVSAECKTLLSKIF--SPIKFRIRL------KDIKQDPWVK 325
K V FP P VS+ + L+ K+ P K RL +IKQ P+ +
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSK---RLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 79/274 (28%), Positives = 130/274 (47%), Gaps = 38/274 (13%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
K +G G++ V L A+KV++ E ++ + E V+K + HP +IR
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+Y++MEY G L +++ G + ++V A++Y H + +V+RD
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD---TFCGSYAYASPEIL----- 241
+K EN+L+D E +IKL+DFGFA+ L D T CG+ Y +PE++
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAK-----------KLRDRTWTLCGTPEYLAPEVIQSKGH 175
Query: 242 -KGVPYTPHYSDVWSMGVVLYAMAFGRLPF-DDTNYIQLLKQVQTKVVFPTEPNVSAECK 299
K V D W++G+++Y M G PF DD + K + K+ FP ++ A K
Sbjct: 176 NKAV-------DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYA--K 226
Query: 300 TLLSKIFSPIKFRIRL-------KDIKQDPWVKT 326
L+ K+ + R RL D+K W K+
Sbjct: 227 DLIKKLLVVDRTR-RLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 77/278 (27%), Positives = 135/278 (48%), Gaps = 18/278 (6%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
M+ Y + KVIG G++ V+L A+K++SK E F E D++
Sbjct: 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
P +++ A + +Y++MEY G L++ + + E K + ++V A+D
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAI 158
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL--SDTFCGSYAYASP 238
H G++HRD+K +N+L+D ++KL+DFG C ++ + DT G+ Y SP
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFG------TCMKMDETGMVRCDTAVGTPDYISP 212
Query: 239 EILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV---QTKVVFPTEP 292
E+LK G Y D WS+GV L+ M G PF + + ++ + + FP +
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272
Query: 293 NVSAECKTLLSKIFSPIKFRI---RLKDIKQDPWVKTE 327
+S K L+ + + R+ +++IKQ P+ K +
Sbjct: 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 74/234 (31%), Positives = 123/234 (52%), Gaps = 22/234 (9%)
Query: 53 DVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP 112
D KKK T E IG G+ TV A G +VA+K ++ + P K+ +
Sbjct: 16 DPKKKYTRYEK--------IGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELII 64
Query: 113 REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQ 172
EI V+K L++PN++ FL + ++++MEY GSL D + E +DE + R+
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT-ETCMDEAQIAAVCRE 123
Query: 173 LVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK--SGHQSPLSDTFC 230
+ A+++ H V+HRDIK +N+L+ + ++KL+DFGF C + QS S T
Sbjct: 124 CLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF------CAQITPEQSKRS-TMV 176
Query: 231 GSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT 284
G+ + +PE++ Y P D+WS+G++ M G P+ + N ++ L + T
Sbjct: 177 GTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 65/237 (27%), Positives = 115/237 (48%), Gaps = 13/237 (5%)
Query: 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
+ + K +G GSY +V A+K V + + ++ EI ++ + HP
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHP 59
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTK----KWFRQLVDAIDYC 180
N+I + +A +++ I+MEYA G L I + + + + F QL+ +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
HE+ ++HRD+K N+L+ +K+ D G ++ +K ++ T G+ Y +PE+
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKV-LK------KNMAKTQIGTPHYMAPEV 172
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297
KG PY+ + SD+WS+G +LY MA PF+ + L +VQ P P S +
Sbjct: 173 WKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQD 228
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 65/270 (24%), Positives = 131/270 (48%), Gaps = 25/270 (9%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS V +AT G VAVK K++ ++ L E+ +++ +HPN++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ ++++ME+ E G+L D + ++E + ++ A+ + H +GV+HRDIK
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKC-KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHY 250
+++L+ + +KLSDFGF C + + P + G+ + +PE++ +PY
Sbjct: 143 SDSILLTSDGRVKLSDFGF------CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE- 195
Query: 251 SDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP-------NVSAECKTLLS 303
D+WS+G+++ M G P+ + +Q +K+++ P VS ++ L
Sbjct: 196 VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD-----NLPPKLKNLHKVSPRLRSFLD 250
Query: 304 K-IFSPIKFRIRLKDIKQDPWVKTEANPAA 332
+ + R ++ P++ P++
Sbjct: 251 RMLVRDPAQRATAAELLNHPFLAKAGPPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 9/207 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ L + IG GS+ V A R VA+KV+ EA + + + +EI + R P
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQCRSPY 60
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+ ++ + +++IIMEY GS LD + + G +DE R+++ ++Y HE G
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRDIK N+L+ E ++KL+DFG + G + +TF G+ + +PE++K
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVS-GQLT----STMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDD 272
Y +D+WS+G+ +A G P D
Sbjct: 175 YD-EKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 32/285 (11%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
M+ Y + KVIG G++ V+L A+K++SK E F E D++
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFR----QLVDA 176
P +++ A + +Y++MEY G L++ + D P +KW R ++V A
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVP--EKWARFYTAEVVLA 154
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA-----RGHMKCKSGHQSPLSDTFCG 231
+D H G +HRD+K +N+L+D ++KL+DFG G ++C DT G
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC---------DTAVG 205
Query: 232 SYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV---QTK 285
+ Y SPE+LK G Y D WS+GV LY M G PF + + ++ +
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265
Query: 286 VVFPTEPNVSAECKTLLSKIFSPIKFRI---RLKDIKQDPWVKTE 327
+ FP + ++S E K L+ + + R+ +++IK+ + K +
Sbjct: 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 45/287 (15%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G+Y V + + G VA+K + ++E+ + + REI ++K L+HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 132 AIETTHRVYIIMEY--AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+ R+Y+I E+ + LD + + Y+D K + Q++ I +CH R V+HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
+K +NLLID + IKL+DFG AR G + + Y +PE+L G +P
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAF-----GIPVRVYTHEVVTLWYRAPEVLLG---SPR 178
Query: 250 YS---DVWSMGVVLYAMAFGRLPFD-DTNYIQLLKQVQT------------------KVV 287
YS D+WS+G + MA + F D+ QL + + K
Sbjct: 179 YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238
Query: 288 FP---------TEPNVSAECKTLLSK--IFSPIKFRIRLKDIKQDPW 323
FP N+ + LL K I+ P K RI K P+
Sbjct: 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAK-RISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR--- 122
Y IG G+Y TV A G VA+K V +V + + REI ++K L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 123 HPNLIRFLQ--AIETTHR---VYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVD 175
HPN++R L T R + ++ E+ ++ L ++ + + + K RQL+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235
+D+ H +VHRD+K +N+L+ + +K++DFG AR + L + + Y
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR-----IYSFEMAL-TSVVVTLWY 172
Query: 236 ASPEILKGVPY-TPHYSDVWSMGVVLYAMAFGRLP-FDDTNYIQLLKQVQTKVVFPTE-- 291
+PE+L Y TP D+WS+G + + F R P F T+ L ++ + P+E
Sbjct: 173 RAPEVLLQSSYATP--VDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 292 -PNVSAECKTLLSKIFSPIKFRIRLKDIKQD 321
P + L + P K +
Sbjct: 230 WPRNVS-----LPRSSFPSYTPRSFKSFVPE 255
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 64/186 (34%), Positives = 100/186 (53%), Gaps = 20/186 (10%)
Query: 93 AVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI--ETTHRVYIIMEYAEKGS 150
A+K ++ P L+K + RE+++ K + P ++++ A E++ + I MEY E GS
Sbjct: 30 ALKTITTDPNPD--LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGS 87
Query: 151 LLDFI-----QREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKL 205
L D I +R G I E K ++ + Y H R ++HRDIK N+L+ + +KL
Sbjct: 88 L-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKL 146
Query: 206 SDFGFARGHMKCKSGHQ-SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA 264
DFG SG + L+ TF G+ Y +PE ++G PY+ SDVWS+G+ L +A
Sbjct: 147 CDFGV--------SGELVNSLAGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVA 197
Query: 265 FGRLPF 270
R PF
Sbjct: 198 QNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y L +VIG+G+ A V A + VA+K + + L +E+ + HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV--DELRKEVQAMSQCNHPN 60
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ---REGYIDEPRTKKWFRQLVDAIDYCHE 182
++++ + ++++M Y GSLLD ++ G +DE ++++ ++Y H
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFG-----FARGHMKCKSGHQSPLSDTFCGSYAYAS 237
G +HRDIK N+L+ + ++K++DFG G K TF G+ + +
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK------TFVGTPCWMA 174
Query: 238 PEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF 270
PE+++ V +D+WS G+ +A G P+
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 71/242 (29%), Positives = 129/242 (53%), Gaps = 15/242 (6%)
Query: 70 KVIGIGSYATVKLA---TSTRHGCDVAVKVVSKVEAP-PDYLKKFLPREIDVVKGLRHPN 125
KV+G GS+ V L T G A+KV+ K D ++ + R D++ + HP
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMER--DILAEVNHPF 59
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++ A +T ++Y+I+++ G L + +E E K + +L A+D+ H G+
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
++RD+K EN+L+D E +IKL+DFG ++ +S + +FCG+ Y +PE++
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK-----ESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECKTLLSK 304
+T +D WS GV+++ M G LPF + + + + + K+ P +S E ++LL
Sbjct: 175 HT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRA 231
Query: 305 IF 306
+F
Sbjct: 232 LF 233
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
L K IG GSY V + G VA+K + E P +KK REI ++K L+HPNL+
Sbjct: 6 LSK-IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLV 63
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
++ +++++ EY + L + + + E KK Q + A+++CH+ +H
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-VPY 246
RD+K EN+LI + IKL DFGFAR +G +D + + Y +PE+L G Y
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFAR----ILTGPGDDYTD-YVATRWYRAPELLVGDTQY 178
Query: 247 TPHYSDVWSMGVVLYAMAFG 266
P DVW++G V + G
Sbjct: 179 GPPV-DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 74/263 (28%), Positives = 131/263 (49%), Gaps = 10/263 (3%)
Query: 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF--LPREIDVVKGLRHPNL 126
GK++G G++ V L G ++A K V P+ K+ L EI ++K L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 127 IRFLQAIE--TTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
+++ + + I MEY GS+ D ++ G + E T+K+ RQ+++ + Y H
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFA-RGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
+VHRDIK N+L D N+KL DFG + R C SG + G+ + SPE++ G
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG---IRSVTGTPYWMSPEVISG 183
Query: 244 VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPN-VSAECKTLL 302
Y +DVWS+G + M + P+ + + + ++ T+ P P+ +S + L
Sbjct: 184 EGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 303 SKIFSPIKFRIRLKDIKQDPWVK 325
IF + R +++ + P+ +
Sbjct: 243 GCIFVEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 30/226 (13%)
Query: 48 AANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYL 107
A N +++K +T IG G + V L G VAVK +
Sbjct: 2 AINSKELKLGAT------------IGKGEFGDVMLGD--YRGQKVAVKCLKDDSTAAQ-- 45
Query: 108 KKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRT 166
FL E V+ LRHPNL++ L + + +YI+ EY KGSL+D+++ R +
Sbjct: 46 -AFLA-EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ 103
Query: 167 KKWF-RQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL 225
+ F + + ++Y E+ VHRD+ N+L+ + K+SDFG A+ + + + P+
Sbjct: 104 QLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV 163
Query: 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
T +PE L+ ++ SDVWS G++L+ + +FGR+P+
Sbjct: 164 KWT--------APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 77/301 (25%), Positives = 131/301 (43%), Gaps = 45/301 (14%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
K IGIG++ V L A+K + K + + E D++ + +++
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+ + +Y +M+Y G ++ + R G +E + + +L AI+ H+ G +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 190 IKCENLLIDGEYNIKLSDFGFARG--------------HMKCKS---------------- 219
IK +N+LID + +IKL+DFG G H + S
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 220 --------GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF- 270
HQ L+ + G+ Y +PE+L YT D WS+GV+LY M G+ PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFL 245
Query: 271 DDTNYIQLLKQV--QTKVVFPTEPNVSAECKTLLSKIFSPIKFRI---RLKDIKQDPWVK 325
DT LK + +T + P++ +S E L+ ++ + R+ +IK P+ K
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFK 305
Query: 326 T 326
Sbjct: 306 G 306
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 71/263 (26%), Positives = 141/263 (53%), Gaps = 20/263 (7%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
+G G++ V A G A K++ ++E+ + L+ F+ EID++ +HPN++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII-QIESE-EELEDFMV-EIDILSECKHPNIVGLYE 69
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI 190
A ++++I++E+ + G+L + E + EP+ + RQ+++A+++ H V+HRD+
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 191 KCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL-----KGVP 245
K N+L+ + ++KL+DFG + K KS Q DTF G+ + +PE++ K P
Sbjct: 130 KAGNILLTLDGDVKLADFGVS---AKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNP 184
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT--EPNV-SAECKTLL 302
Y + +D+WS+G+ L +A P + N +++L ++ K PT +P+ S+ L
Sbjct: 185 YD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPPTLDQPSKWSSSFNDFL 242
Query: 303 SK-IFSPIKFRIRLKDIKQDPWV 324
+ R ++ + P+V
Sbjct: 243 KSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-26
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 70 KVIGIGSYATVKLATSTRHGCD---VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
K +G GS+ V+ + G VAVK + K + D + FL +E ++ L H NL
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFL-KEAAIMHSLDHENL 58
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFI--QREGYIDEPRTKKWFRQLVDAIDYCHERG 184
IR L + TH + ++ E A GSLLD + G+ + Q+ + + Y +
Sbjct: 59 IR-LYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARG------HMKCKSGHQSPLSDTFCGSYAYASP 238
+HRD+ N+L+ + +K+ DFG R H + + P A+ +P
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF--------AWCAP 169
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQV 282
E L+ ++ H SDVW GV L+ M +G P+ + Q+LK++
Sbjct: 170 ESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 77/263 (29%), Positives = 131/263 (49%), Gaps = 10/263 (3%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF--LPREIDVVKGLRHPN 125
LGK++G G++ V L G ++AVK V + K+ L EI ++K LRH
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 126 LIRFLQAIE--TTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
++++ + ++ I +EY GS+ D ++ G + E T+++ RQ++ + Y H
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFA-RGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
+VHRDIK N+L D N+KL DFG + R C SG + G+ + SPE++
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG---IKSVTGTPYWMSPEVIS 182
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP-NVSAECKTL 301
G Y +DVWS+ + M + P+ + + + ++ T+ P P VS C+
Sbjct: 183 GEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241
Query: 302 LSKIFSPIKFRIRLKDIKQDPWV 324
L +IF K R + + + P+V
Sbjct: 242 LKQIFVEEKRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 74/230 (32%), Positives = 116/230 (50%), Gaps = 27/230 (11%)
Query: 108 KKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRT 166
K F E V + ++ +PN I+ ++ T +IM+Y + G L D +++EG + E
Sbjct: 52 KNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEV 111
Query: 167 KKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-EYNIKLSDFGFARGHMKCKSGHQSPL 225
KK RQLV+A++ H+ ++H DIK EN+L D + I L D+G CK
Sbjct: 112 KKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL------CKIIGTPSC 165
Query: 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN--YI---QLLK 280
D G+ Y SPE +KG Y + D W++GV+ Y + G+ PF + + LLK
Sbjct: 166 YD---GTLDYFSPEKIKGHNYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
Query: 281 QVQTKVVFPTEPNVSAECKTLLSKIFSPIKFRI--RL---KDIKQDPWVK 325
+ Q K+ F NVS K + S +K+ I RL +I + P++K
Sbjct: 222 RQQKKLPFI--KNVS---KNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 75/268 (27%), Positives = 129/268 (48%), Gaps = 28/268 (10%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP--REIDVVKGLRHPNLIR 128
V+G G+Y V A +A+K E P + P EI + L+H N+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHERGV 185
+L + I ME GSL ++ + +E + +Q+++ + Y H+ +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 186 VHRDIKCENLLIDGEYN--IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL-K 242
VHRDIK +N+L++ Y+ +K+SDFG ++ + +P ++TF G+ Y +PE++ K
Sbjct: 130 VHRDIKGDNVLVN-TYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDK 183
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-VFPTEPNV----SAE 297
G +D+WS+G + MA G+ PF + Q KV +F P + SAE
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKIHPEIPESLSAE 240
Query: 298 CKTLLSKIFSP-IKFRIRLKDIKQDPWV 324
K + + F P R D+ QDP++
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 58/195 (29%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 114 EIDVVK-GLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI----QREGYIDEPRTKK 168
E+ ++K LRHPN++R+ + R+YI+M+ E L + +++ E R
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 169 WFRQLVDAIDYCH-ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD 227
F Q+V A+ Y H E+ +VHRD+ N+++ + + ++DFG A+ + +S L+
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLT- 171
Query: 228 TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV 287
+ G+ Y+ PEI+K PY +DVW+ G +LY M + PF TN + L ++ V
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230
Query: 288 FPTEPNVSAECKTLL 302
P + +E T +
Sbjct: 231 EPLPEGMYSEDVTDV 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 1e-25
Identities = 83/286 (29%), Positives = 143/286 (50%), Gaps = 26/286 (9%)
Query: 53 DVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP 112
D KKK T E IG G+ TV A G +VA+K ++ + P K+ +
Sbjct: 16 DPKKKYTRFEK--------IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELII 64
Query: 113 REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQ 172
EI V++ ++PN++ +L + ++++MEY GSL D + E +DE + R+
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRE 123
Query: 173 LVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK--SGHQSPLSDTFC 230
+ A+D+ H V+HRDIK +N+L+ + ++KL+DFGF C + QS S T
Sbjct: 124 CLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF------CAQITPEQSKRS-TMV 176
Query: 231 GSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--F 288
G+ + +PE++ Y P D+WS+G++ M G P+ + N ++ L + T
Sbjct: 177 GTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 289 PTEPNVSAECKTLLSKIFS-PIKFRIRLKDIKQDPWVKTEANPAAS 333
+SA + L++ + R K++ Q P++K A P +S
Sbjct: 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL-AKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 73/231 (31%), Positives = 116/231 (50%), Gaps = 27/231 (11%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVV---SKVEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
+G G+YATV + G VA+K + ++ P + REI ++K L+H N++R
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-----REISLMKELKHENIVR 62
Query: 129 FLQAIETTHRVYIIMEYAEKG--SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVV 186
I T +++ ++ EY +K +D G +D K + QL+ I +CHE V+
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA---YASPEILKG 243
HRD+K +NLLI+ +KL+DFG AR P++ TF Y +P++L G
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR-------AFGIPVN-TFSNEVVTLWYRAPDVLLG 174
Query: 244 VPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE 291
+ YS D+WS+G ++ M GR F TN L ++ + PTE
Sbjct: 175 ---SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE 222
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 69/279 (24%), Positives = 133/279 (47%), Gaps = 37/279 (13%)
Query: 70 KVIGIGSYATVKLA---TSTRHGCDVAVKVVSKVEAPPDYLKK-----FLPREIDVVKGL 121
+V+G G+Y V L G A+KV+ K ++K E V++ +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEHTRTERQVLEAV 61
Query: 122 RH-PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
R P L+ A +T ++++I++Y G L + + + E + + ++V A+D+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H+ G+++RDIK EN+L+D E ++ L+DFG + K + + +FCG+ Y +PE+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLS----KEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 241 LKGVPYTPHYSDV---WSMGVVLYAMAFGRLPF----DDTNYIQLLKQVQTKVVFPTEPN 293
++G + WS+GV+ + + G PF + + ++ +++ P
Sbjct: 178 IRGGS--GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP-PFPKT 234
Query: 294 VSAECKTLLSKIF--SPIKFRIRL-----KDIKQDPWVK 325
+SAE + + K+ P K RL +IK P+ +
Sbjct: 235 MSAEARDFIQKLLEKDPKK---RLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 23/242 (9%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G++ V + +VAVK + PPD +KFL +E +++K HPN+++ +
Sbjct: 3 IGKGNFGDVYKGV-LKGNTEVAVKTC-RSTLPPDLKRKFL-QEAEILKQYDHPNIVKLIG 59
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA---IDYCHERGVVHR 188
+YI+ME GSLL F++++ + KK + +DA ++Y + +HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117
Query: 189 DIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSG-HQSPLSDTFCGSYAYASPEILKG 243
D+ N L+ +K+SDFG +R G G Q P+ T +PE L
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT--------APEALNY 169
Query: 244 VPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302
YT SDVWS G++L+ + G P+ + Q +++++ P E L+
Sbjct: 170 GRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM 228
Query: 303 SK 304
+
Sbjct: 229 LQ 230
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 70/223 (31%), Positives = 110/223 (49%), Gaps = 24/223 (10%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G+Y V A + G VA+K + +++ + + REI ++K L HPN+++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 132 AIETTHRVYIIMEYAEKG--SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
I T +++Y++ E+ + +D G I P K + QL+ + +CH V+HRD
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSG-IPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA-------YASPEILK 242
+K +NLLI+ E IKL+DFG AR P+ +Y Y +PEIL
Sbjct: 126 LKPQNLLINTEGAIKLADFGLAR-------AFGVPVR-----TYTHEVVTLWYRAPEILL 173
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPF-DDTNYIQLLKQVQT 284
G Y D+WS+G + M R F D+ QL + +T
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPN 125
+LGK IG G+++ V A S + G A+K + K + + REI ++ L HPN
Sbjct: 3 ILGK-IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQALRRLSPHPN 59
Query: 126 LIRFLQAI--ETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHE 182
++R ++ + T R+ ++ E + +L + I+ R+ + E R K + QL+ ++D+ H
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE-IL 241
G+ HRDIK EN+LI + +KL+DFG C+ + P + + Y +PE +L
Sbjct: 119 NGIFHRDIKPENILIKDD-ILKLADFG------SCRGIYSKPPYTEYISTRWYRAPECLL 171
Query: 242 KGVPYTPHYSDVWSMGVVLYAM 263
Y P D+W++G V + +
Sbjct: 172 TDGYYGPKM-DIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-25
Identities = 76/251 (30%), Positives = 125/251 (49%), Gaps = 15/251 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ + K IG G ++ V AT VA+K V E ++ +EID++K L HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFI----QREGYIDEPRTKKWFRQLVDAIDYCH 181
+I++L + + + I++E A+ G L I +++ I E K+F QL A+++ H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
R V+HRDIK N+ I +KL D G R ++ + + G+ Y SPE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERI 178
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPF--DDTNYIQLLKQVQTKVVFPTEP--NVSAE 297
Y SD+WS+G +LY MA + PF D N L ++++ + +P P + S +
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDYPPLPTEHYSEK 236
Query: 298 CKTLLSKIFSP 308
+ L+S P
Sbjct: 237 LRELVSMCIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVK--VVSKVEAPPDYLKKFLPREIDVVKGLRH 123
Y GK +G G+YA V A G VA+K + + + D + REI +++ L+H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYID--EPRTKKWFRQLVDAIDYCH 181
PN+I L + ++ E+ E + L+ + ++ I K + + ++Y H
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFAR--GHMKCKSGHQSPLSDTFCGSYAYASPE 239
++HRD+K NLLI + +KL+DFG AR G K HQ + Y +PE
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-------TRWYRAPE 172
Query: 240 ILKGVPYTPHYS---DVWSMGVVL 260
+L G HY D+WS+G +
Sbjct: 173 LLFG---ARHYGVGVDMWSVGCIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 16/231 (6%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G+Y TV A + VA+K V ++ + + REI ++K L+H N++R
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ + ++ ++ EY ++ F G ID K + QL+ + +CH V+HRD+K
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLK 126
Query: 192 CENLLIDGEYNIKLSDFGFARGH---MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTP 248
+NLLI+ +KL+DFG AR ++C S L Y P++L G
Sbjct: 127 PQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL--------WYRPPDVLFGAKLYS 178
Query: 249 HYSDVWSMGVVLYAMAFGRLP-FDDTNYIQLLKQVQTKVVFPTE---PNVS 295
D+WS G + +A P F + LK++ + PTE P VS
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 73/268 (27%), Positives = 116/268 (43%), Gaps = 34/268 (12%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVS--KVEA--PPDYLKKFLPREIDVVKGL 121
Y + IG G++ V A G VA+K V+ ++E P L REI ++
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQAL-----REIKALQAC 56
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYC 180
+HP +++ L ++MEY L + ++ E + E + K + R L+ + Y
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H G++HRD+K NLLI + +K++DFG AR S + L + Y +PE+
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLAR----LFSEEEPRLYSHQVATRWYRAPEL 171
Query: 241 LKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQVQTKVVFPT----EP 292
L G Y D+W++G + + G F N I QL VF T
Sbjct: 172 LYG---ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI------VFRTLGTPNE 222
Query: 293 NVSAECKTL--LSKIFSPIKFRIRLKDI 318
+L +KI P I L++I
Sbjct: 223 ETWPGLTSLPDYNKITFPESKPIPLEEI 250
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 71/226 (31%), Positives = 114/226 (50%), Gaps = 8/226 (3%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
VLG V+G G+Y V VA+K E + +K+ RE+ +++ L+ N+
Sbjct: 5 VLG-VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE-VKETTLRELKMLRTLKQENI 62
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVV 186
+ +A ++Y++ EY EK L + + + + + QL+ AI +CH+ +V
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPY 246
HRDIK ENLLI +KL DFGFAR G + ++ + + Y SPE+L G PY
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFAR---NLSEGSNANYTE-YVATRWYRSPELLLGAPY 178
Query: 247 TPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP 292
D+WS+G +L ++ G+ F + I L +Q KV+ P
Sbjct: 179 GKAV-DMWSVGCILGELSDGQPLFPGESEIDQLFTIQ-KVLGPLPA 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 76/251 (30%), Positives = 125/251 (49%), Gaps = 15/251 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ + K IG G ++ V AT G VA+K V + + +EID++K L HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFI----QREGYIDEPRTKKWFRQLVDAIDYCH 181
+I++ + + + I++E A+ G L I +++ I E K+F QL A+++ H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
R V+HRDIK N+ I +KL D G R ++ + + G+ Y SPE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERI 178
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPF--DDTNYIQLLKQVQTKVVFPTEPN--VSAE 297
Y SD+WS+G +LY MA + PF D N L K+++ + +P P+ S E
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPPLPSDHYSEE 236
Query: 298 CKTLLSKIFSP 308
+ L++ +P
Sbjct: 237 LRQLVNMCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 71/225 (31%), Positives = 116/225 (51%), Gaps = 15/225 (6%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVE--APPDYLKKFLPREIDVVKGLRH-PNLIR 128
IG G++ V A+KV+SK E A + R I V L P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+ +T +Y++ +Y G L +Q+EG E R K + +LV A+++ H+ +V+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL---KGVP 245
D+K EN+L+D +I L DFG ++ ++ + ++TFCG+ Y +PE+L KG
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLT-----DNKTTNTFCGTTEYLAPEVLLDEKG-- 173
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ-TKVVFP 289
YT H D WS+GV+++ M G PF + Q+ + + KV FP
Sbjct: 174 YTKHV-DFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP 217
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-24
Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 17/267 (6%)
Query: 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV--EAPPDYLKKFLPREIDVVKGLR 122
Y +V+G GSY V L RH D V+ K+ +K +E ++ L+
Sbjct: 1 AYCFVRVVGKGSYGEVSL---VRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57
Query: 123 HPNLIRFLQAIETTH-RVYIIMEYAEKGSLLDFI--QREGYIDEPRTKKWFRQLVDAIDY 179
HPN++ + ++ E +YI+M + E G L + Q+ + E + +WF Q+ A+ Y
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
HE+ ++HRD+K +N+ + IK+ D G AR +Q ++ T G+ Y SPE
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-----VLENQCDMASTLIGTPYYMSPE 172
Query: 240 ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299
+ PY + SDVW++G +Y MA + F+ + L+ ++ + P + S E
Sbjct: 173 LFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG 231
Query: 300 TLLSKIFS--PIKFRIRLKDIKQDPWV 324
L++ + S P K R +K I + P++
Sbjct: 232 ELIATMLSKRPEK-RPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-24
Identities = 71/243 (29%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
L + +G G + V + T VAVK + P+ FL +E ++K LRH L+
Sbjct: 10 LERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPE---AFL-QEAQIMKKLRHDKLV 64
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD-------AIDYC 180
+ +YI+ EY KGSLLDF++ K QLVD + Y
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLK-----SGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYA 236
R +HRD+ N+L+ K++DFG AR + G + P+ T
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT-------- 171
Query: 237 SPE-ILKGVPYTPHYSDVWSMGVVLYA-MAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294
+PE G +T SDVWS G++L + +GR+P+ ++L+QV+ P PN
Sbjct: 172 APEAANYGR-FTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNC 229
Query: 295 SAE 297
E
Sbjct: 230 PEE 232
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 9e-24
Identities = 69/234 (29%), Positives = 121/234 (51%), Gaps = 22/234 (9%)
Query: 53 DVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP 112
D KKK T E IG G+ TV A G +VA++ ++ + P K+ +
Sbjct: 17 DPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELII 65
Query: 113 REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQ 172
EI V++ ++PN++ +L + ++++MEY GSL D + E +DE + R+
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRE 124
Query: 173 LVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK--SGHQSPLSDTFC 230
+ A+++ H V+HRDIK +N+L+ + ++KL+DFGF C + QS S
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF------CAQITPEQSKRST-MV 177
Query: 231 GSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT 284
G+ + +PE++ Y P D+WS+G++ M G P+ + N ++ L + T
Sbjct: 178 GTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 78/305 (25%), Positives = 133/305 (43%), Gaps = 49/305 (16%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
K +GIG++ V LA A+K + K + + E D++ + ++R
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+ + +Y +M+Y G ++ + R G E + + +L A++ H+ G +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 190 IKCENLLIDGEYNIKLSDFGFARG--------------HMK---------------CKSG 220
IK +N+LID + +IKL+DFG G H++ C+ G
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 221 -------------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGR 267
HQ L+ + G+ Y +PE+L YT D WS+GV+LY M G+
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 268 LPFDDTNYIQLLKQV---QTKVVFPTEPNVSAECKTLLSKIFSPIKFRI---RLKDIKQD 321
PF ++ +V QT + P + +S E L+ K+ + R+ +IK
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAH 305
Query: 322 PWVKT 326
P+ KT
Sbjct: 306 PFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-23
Identities = 74/272 (27%), Positives = 131/272 (48%), Gaps = 26/272 (9%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA----PPDYLKKFLPREIDVVKGL 121
Y+L + +G GS+ TV L + + +KV+ ++ P + ++ E ++ L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSKL 59
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQRE-----GYIDEPRTKKWFRQLVDA 176
HP +++F + II EY E G LD E + E + +WF QL+
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCE-GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM-KCKSGHQSPLSDTFCGSYAY 235
+ Y H+R ++HRD+K +N+ + +K+ DFG +R M C L+ TF G+ Y
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD------LATTFTGTPYY 171
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQL-LKQVQTKVVFPTEPNV 294
SPE LK Y SD+WS+G +LY M F+ N++ + L+ V+ P+ P
Sbjct: 172 MSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT--PSLPET 228
Query: 295 -SAECKTLLSKIFSP-IKFRIRLKDIKQDPWV 324
S + +++ + + R +I ++P++
Sbjct: 229 YSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 62/194 (31%), Positives = 99/194 (51%), Gaps = 14/194 (7%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G+Y V A T G VA+K V +++ D + REI ++ LRHPN++ +
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 132 AIETTH--RVYIIMEYAEK--GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
+ H ++++MEY E+ SLLD + E + K QL+ + Y HE ++H
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFIIH 131
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARG-HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPY 246
RD+K NLL+ + +K++DFG AR + K +P T Y +PE+L G
Sbjct: 132 RDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLW----YRAPELLLGCTT 185
Query: 247 TPHYSDVWSMGVVL 260
D+W++G +L
Sbjct: 186 YTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-23
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 69 GKVIGIGSYATVKLATSTRHG----CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
KV+G G++ TV G VA+KV+ + E P K+ L E V+ + HP
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEIL-DEAYVMASVDHP 69
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHER 183
+++R L I + +V +I + G LLD++ + I W Q+ + Y E+
Sbjct: 70 HVVRLL-GICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSYAYAS 237
+VHRD+ N+L+ ++K++DFG A+ + G + P+ + +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG-KVPIK--------WMA 179
Query: 238 PEILKGVPYTPHYSDVWSMGVVLYA-MAFGRLPFDDTN 274
E + YT H SDVWS GV ++ M FG P++
Sbjct: 180 LESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-23
Identities = 57/212 (26%), Positives = 111/212 (52%), Gaps = 10/212 (4%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS V +AT G VAVK K++ ++ L E+ +++ H N++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ ++++ME+ E G+L D + ++E + ++ A+ Y H +GV+HRDIK
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS 251
+++L+ + IKLSDFGF + + P + G+ + +PE++ +PY
Sbjct: 146 SDSILLTSDGRIKLSDFGFC-----AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV- 199
Query: 252 DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ 283
D+WS+G+++ M G P+ + +Q +++++
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-23
Identities = 80/317 (25%), Positives = 140/317 (44%), Gaps = 44/317 (13%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
KVIG G++ V+L G A+K++ K + + E D++ +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+ + +Y+IME+ G ++ + ++ + E T+ + + V AID H+ G +HRD
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSG-------HQSPLSDTF------------- 229
IK +NLL+D + ++KLSDFG G K H P +F
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186
Query: 230 ----------CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
G+ Y +PE+ Y D WS+GV++Y M G PF +
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 280 KQV---QTKVVFPTEPNVSAECKTLLSKIFSPIKFRI---RLKDIKQDP------WVKTE 327
++V + +VFP E +S + K L+ + + + RI +++IK P W
Sbjct: 246 RKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIR 305
Query: 328 ANPAASAGVETKTLNQS 344
PAA +E K+++ +
Sbjct: 306 ERPAAIP-IEIKSIDDT 321
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-23
Identities = 61/223 (27%), Positives = 111/223 (49%), Gaps = 22/223 (9%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
L K +G G + V +AT +H KV K P + E +V+K L+H L+
Sbjct: 10 LEKKLGAGQFGEVWMATYNKH-----TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGV 185
+ L A+ T +YII E+ KGSLLDF++ + P+ + Q+ + + + +R
Sbjct: 65 K-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+HRD++ N+L+ K++DFG AR + G + P+ + +PE +
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAI 175
Query: 242 KGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQ 283
+T SDVWS G++L + +GR+P+ + ++++ ++
Sbjct: 176 NFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 217
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
+G G+ +V G +A KVV + A K+ L RE+ ++ R P ++ F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH-IGAKSSVRKQIL-RELQIMHECRSPYIVSFYG 70
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCH-ERGVVHRD 189
A + + + ME+ + GSL D I ++ G I K +V+ + Y + ++HRD
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ-SPLSDTFCGSYAYASPEILKGVPYTP 248
IK N+L++ IKL DFG SG + ++DTF G+ Y SPE ++G YT
Sbjct: 130 IKPSNILVNSRGQIKLCDFGV--------SGELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 249 HYSDVWSMGVVLYAMAFGRLPFDDTN 274
SDVWS+G+ + +A G+ PF +N
Sbjct: 182 K-SDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G+ TV G A+KV+ D +++ + REI++++ + HPN+++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+ + +++E+ + GSL EG DE RQ++ I Y H R +VHRD
Sbjct: 140 MFDHNGEIQVLLEFMDGGSL------EGTHIADEQFLADVARQILSGIAYLHRRHIVHRD 193
Query: 190 IKCENLLIDGEYNIKLSDFGFAR---GHMK-CKSGHQSPLSDTFCGSYAYASPEI----L 241
IK NLLI+ N+K++DFG +R M C S G+ AY SPE L
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---------VGTIAYMSPERINTDL 244
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPF 270
Y + D+WS+GV + GR PF
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 24/220 (10%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNL 126
L +VIG G+Y V A + G VA+K++ +E ++ + E ++++ HPN+
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNI 65
Query: 127 IRF----LQAIETTHR--VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF----RQLVDA 176
F ++ + ++++ME GS+ D ++ + ++W R+ +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
+ Y HE V+HRDIK +N+L+ +KL DFG + + G + +TF G+ +
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRR----NTFIGTPYWM 180
Query: 237 SPE-ILKGVPYTPHY---SDVWSMGVVLYAMAFGRLPFDD 272
+PE I Y SDVWS+G+ +A G+ P D
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-22
Identities = 76/269 (28%), Positives = 141/269 (52%), Gaps = 22/269 (8%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVV-SKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFL 130
+G G++ V A + G A KV+ +K E + L+ ++ EID++ HPN+++ L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE---EELEDYMV-EIDILASCDHPNIVKLL 68
Query: 131 QAIETTHRVYIIMEYAEKGSL-LDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
A + ++I++E+ G++ ++ E + EP+ + +Q ++A++Y HE ++HRD
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL-----KGV 244
+K N+L + +IKL+DFG + K+ D+F G+ + +PE++ K
Sbjct: 129 LKAGNILFTLDGDIKLADFG-----VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT--EPNV-SAECKTL 301
PY + +DVWS+G+ L MA P + N +++L ++ K PT +P+ S+E K
Sbjct: 184 PYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPPTLAQPSRWSSEFKDF 241
Query: 302 LSKIFSP-IKFRIRLKDIKQDPWVKTEAN 329
L K + R + Q P+V +N
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFVTVNSN 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-22
Identities = 54/212 (25%), Positives = 111/212 (52%), Gaps = 10/212 (4%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS V +A G VAVK++ + ++ L E+ +++ +H N++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ ++++ME+ + G+L D + + ++E + ++ A+ Y H +GV+HRDIK
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS 251
+++L+ + +KLSDFGF + P + G+ + +PE++ PY
Sbjct: 145 SDSILLTLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV- 198
Query: 252 DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ 283
D+WS+G+++ M G P+ + +Q +K+++
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 81/317 (25%), Positives = 140/317 (44%), Gaps = 44/317 (13%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
KVIG G++ V+L G A+K++ K + + E D++ +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+ + +Y+IME+ G ++ + ++ + E T+ + + V AID H+ G +HRD
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRD 126
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKS-------GHQSPLSDTF------------- 229
IK +NLL+D + ++KLSDFG G K H P TF
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186
Query: 230 ----------CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
G+ Y +PE+ Y D WS+GV++Y M G PF +
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 280 KQV---QTKVVFPTEPNVSAECKTLLSKIFSPIKFRI---RLKDIKQDP------WVKTE 327
K+V + ++FP E +S + K L+ + + RI +++IK +P W
Sbjct: 246 KKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIR 305
Query: 328 ANPAASAGVETKTLNQS 344
PAA +E K+++ +
Sbjct: 306 ERPAAIP-IEIKSIDDT 321
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 7e-22
Identities = 82/310 (26%), Positives = 133/310 (42%), Gaps = 56/310 (18%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + IG G+Y V A TR G VA+K + P K+ L RE+ +++ +H N
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDN 65
Query: 126 LIRFLQAIETTHR----VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFR----QLVDAI 177
+I + VY++M+ E L I + D+P T++ R QL+ +
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLME-SDLHHII----HSDQPLTEEHIRYFLYQLLRGL 120
Query: 178 DYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA--- 234
Y H V+HRD+K NLL++ + +++ DFG ARG + H+ F Y
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-----YFMTEYVATR 175
Query: 235 -YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI---------------QL 278
Y +PE+L +P D+WS+G + M R F NY+ ++
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235
Query: 279 LKQVQTKVV------FPTE---------PNVSAECKTLLSK--IFSPIKFRIRLKDIKQD 321
L ++ + V P + P S E LLS+ F P + RI ++ Q
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDP-EERITVEQALQH 294
Query: 322 PWVKTEANPA 331
P++ +P
Sbjct: 295 PFLAQYHDPD 304
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 56/212 (26%), Positives = 111/212 (52%), Gaps = 10/212 (4%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS V +AT G VAVK K++ ++ L E+ +++ +H N++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ ++++ME+ E G+L D + ++E + ++ A+ H +GV+HRDIK
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS 251
+++L+ + +KLSDFGF + + P + G+ + +PE++ +PY P
Sbjct: 144 SDSILLTHDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV- 197
Query: 252 DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ 283
D+WS+G+++ M G P+ + ++ +K ++
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 85/277 (30%), Positives = 134/277 (48%), Gaps = 38/277 (13%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF----LPREIDV-VKGLRHP 124
KVIG G++ V + G A+K+++K E LK+ E DV V G R
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM----LKRAETACFREERDVLVNGDRR- 61
Query: 125 NLIRFLQ-AIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHE 182
I L A + + +Y++M+Y G LL + + E + E + + ++V AID H+
Sbjct: 62 -WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
G VHRDIK +N+L+D +I+L+DFG + + S+ G+ Y SPEIL+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA----DGTVQSNVAVGTPDYISPEILQ 176
Query: 243 GVP-----YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-------FPT 290
+ Y P D WS+GV +Y M +G PF Y + L + K++ FP
Sbjct: 177 AMEDGKGRYGPE-CDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHKEHFQFPP 231
Query: 291 -EPNVSAECKTLLSKIFSPIKFRI---RLKDIKQDPW 323
+VS E K L+ ++ + R+ L+D K P+
Sbjct: 232 DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 9/208 (4%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS+ V R VA+K++ EA + + + +EI V+ P + R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYITRYYG 69
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ +++IIMEY GS LD + + G ++E R+++ +DY H +HRDIK
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS 251
N+L+ + ++KL+DFG A G + + +TF G+ + +PE++K Y +
Sbjct: 129 AANVLLSEQGDVKLADFGVA-GQLTDTQIKR----NTFVGTPFWMAPEVIKQSAYD-FKA 182
Query: 252 DVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
D+WS+G+ +A G P D + +++L
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVL 210
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVE---APPDYLKKFLPREIDVVKGLRHPNLI 127
+G GSYATV S G VA+K + AP + RE ++K L+H N++
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-----REASLLKDLKHANIV 66
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFR-QLVDAIDYCHERGVV 186
I T + ++ EY + L ++ G + F QL+ + YCH+R V+
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA---YASPEILKG 243
HRD+K +NLLI +KL+DFG AR +S S T+ Y P++L G
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARA--------KSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 244 VPYTPHYS---DVWSMGVVLYAMAFGRLPF 270
+ YS D+W +G + Y MA GR F
Sbjct: 178 ---STEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 79/300 (26%), Positives = 137/300 (45%), Gaps = 50/300 (16%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKK----FLPREIDVVKGLRHPN 125
KVIG G++ V+L G A+K + K + L+K + E D++ +P
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRK----SEMLEKEQVAHVRAERDILAEADNPW 62
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++ + + + +Y+IMEY G ++ + ++ E T+ + + + AID H+ G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMK----------------------CKSGHQS 223
+HRDIK +NLL+D + +IKLSDFG G K K
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 224 PLSDTF-----------CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF-- 270
++T+ G+ Y +PE+ Y D WS+GV++Y M G PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPFCS 241
Query: 271 DD--TNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFSPIKFRIR---LKDIKQDPWVK 325
D+ Y +++ +T + FP E +S E K L+ ++ + R+ + +IK P+ K
Sbjct: 242 DNPQETYRKIINWKET-LQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-21
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP----REIDVVKGLRHPNL 126
IG G+Y V A G VA+K V D K+ P REI +++ L H N+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRL-----DNEKEGFPITAIREIKILRQLNHRNI 68
Query: 127 IRFLQAI----------ETTHRVYIIMEYAE-------KGSLLDFIQREGYIDEPRTKKW 169
+ + + + Y++ EY + + L+ F E K +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF-------SEDHIKSF 121
Query: 170 FRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTF 229
+QL++ ++YCH++ +HRDIKC N+L++ + IKL+DFG AR + S P ++
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY---NSEESRPYTNKV 178
Query: 230 CGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLP 269
+ Y PE+L G Y P DVWS G +L + F + P
Sbjct: 179 ITLW-YRPPELLLGEERYGPAI-DVWSCGCILGEL-FTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 8e-21
Identities = 57/210 (27%), Positives = 110/210 (52%), Gaps = 9/210 (4%)
Query: 66 YVLGKVIGIGSYATVKL---ATSTRHGCDVAVKVVSKVE-APPDYLKKFLPREIDVVKGL 121
+ L KV+G G+Y V L T G A+KV+ K + E +V++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 122 RH-PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
R P L+ A +T ++++I++Y G + + + E + + +++ A+++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H+ G+V+RDIK EN+L+D E ++ L+DFG ++ + + + +FCG+ Y +PEI
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS----EEKERTYSFCGTIEYMAPEI 177
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPF 270
++G D WS+G++++ + G PF
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 16/212 (7%)
Query: 93 AVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLL 152
+ KV K P + E +++K L+H L+R + +YII EY KGSLL
Sbjct: 30 STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89
Query: 153 DFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210
DF++ + G + P+ + Q+ + + Y + +HRD++ N+L+ K++DFG
Sbjct: 90 DFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGL 149
Query: 211 AR----GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AF 265
AR + G + P+ + +PE + +T SDVWS G++LY + +
Sbjct: 150 ARVIEDNEYTAREGAKFPIK--------WTAPEAINFGSFTIK-SDVWSFGILLYEIVTY 200
Query: 266 GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297
G++P+ + ++ +Q P N E
Sbjct: 201 GKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-20
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 92 VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR-VYIIMEYAEKGS 150
VAVK + P K FL E ++K LRHP LI+ L A+ T +YI+ E + GS
Sbjct: 33 VAVKTLKPGTMDP---KDFL-AEAQIMKKLRHPKLIQ-LYAVCTLEEPIYIVTELMKYGS 87
Query: 151 LLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNI-KLSD 207
LL+++Q + P+ Q+ + Y + +HRD+ N+L+ GE NI K++D
Sbjct: 88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV-GENNICKVAD 146
Query: 208 FGFARGHMK----CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYA- 262
FG AR + + G + P+ T +PE ++ SDVWS G++L
Sbjct: 147 FGLARVIKEDIYEAREGAKFPIKWT--------APEAALYNRFSIK-SDVWSFGILLTEI 197
Query: 263 MAFGRLPFDDTNYIQLLKQVQTKVVFPTEPN 293
+ +GR+P+ ++L+QV P P
Sbjct: 198 VTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG 228
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 59/225 (26%), Positives = 112/225 (49%), Gaps = 24/225 (10%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNL 126
K +G G + V L R DVA+K++ + + D+++ E V+ L HPNL
Sbjct: 8 FLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIE-----EAKVMMKLSHPNL 61
Query: 127 IRFLQAIETTHR-VYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERG 184
++ L + T R ++I+ EY G LL++++ R+G + + +A++Y G
Sbjct: 62 VQ-LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEI 240
+HRD+ N L+ + +K+SDFG AR G + P+ +A PE+
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK--------WAPPEV 172
Query: 241 LKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQT 284
++ SDVWS GV+++ + + G++P++ + ++++ V
Sbjct: 173 FDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 81/315 (25%), Positives = 142/315 (45%), Gaps = 67/315 (21%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV----EAPPDYLKKFLPREIDVVKGL 121
Y + + +G G+Y V A R VA+K K+ D + F REI ++ L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALK---KIFDAFRNATDAQRTF--REIMFLQEL 63
Query: 122 R-HPNLIRFLQAI--ETTHRVYIIMEYAE-------KGSLLDFIQREGYIDEPRTKKWFR 171
HPN+++ L I E +Y++ EY E + ++L+ + + YI
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR-YI--------MY 114
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
QL+ A+ Y H V+HRD+K N+L++ + +KL+DFG AR + + ++P+ +
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 232 SYAYASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYI------------ 276
+ Y +PEIL G + Y+ D+WS+G +L M G+ F T+ +
Sbjct: 175 TRWYRAPEILLG---STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 277 ---------------QLLKQVQTKVVFPTE---PNVSAECKTLLSK--IFSPIKFRIRLK 316
+L + ++ P + P S + LL K +F+P K R+ +
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNK-RLTAE 290
Query: 317 DIKQDPWVKTEANPA 331
+ + P+V NP+
Sbjct: 291 EALEHPYVAQFHNPS 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 92 VAVKVVSKVEAPPDYLK-KFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGS 150
VA+K++ D LK + +E+ +K LRH +LI VYII E EKGS
Sbjct: 33 VAIKILKS----DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGS 88
Query: 151 LLDFIQR-EG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDF 208
LL F++ EG + Q+ + + Y E+ +HRD+ N+L+ + K++DF
Sbjct: 89 LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADF 148
Query: 209 GFAR---GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-A 264
G AR + S + P Y + +PE ++ SDVWS G++LY M
Sbjct: 149 GLARLIKEDVYLSSDKKIP--------YKWTAPEAASHGTFSTK-SDVWSFGILLYEMFT 199
Query: 265 FGRLPFDDTNYIQLLKQV 282
+G++P+ N ++ Q+
Sbjct: 200 YGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 74/240 (30%), Positives = 120/240 (50%), Gaps = 27/240 (11%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVE----APPDYLKKFLPREIDVVKGLRH 123
L K +G G+YATV S VA+K + ++E AP + RE+ ++K L+H
Sbjct: 10 LDK-LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAI-----REVSLLKNLKH 62
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFR-QLVDAIDYCHE 182
N++ I T + ++ EY + L ++ G + K F QL+ + YCH+
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
R ++HRD+K +NLLI+ + +KL+DFG AR KS S+ + Y P++L
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNEVVTLW-YRPPDVLL 176
Query: 243 GVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE---PNVSA 296
G + YS D+W +G +LY MA GR F + + L + + PTE P +++
Sbjct: 177 G---STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-20
Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 24/221 (10%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVS-KVEAPPDYLKKFLPREIDVVKGLRHPNL 126
LG++IG G + V T G VAVK + V A + FL E V+ L H NL
Sbjct: 10 LGEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTA-----QAFL-EETAVMTKLHHKNL 61
Query: 127 IRFLQAIETTHR-VYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHER 183
+R L I H +YI+ME KG+L++F++ G + + ++ + + ++Y +
Sbjct: 62 VRLLGVI--LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
+VHRD+ N+L+ + K+SDFG AR + P+ + +PE LK
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK--------WTAPEALKH 171
Query: 244 VPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQ 283
++ SDVWS GV+L+ + ++GR P+ + ++ + V+
Sbjct: 172 KKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 4e-20
Identities = 73/267 (27%), Positives = 129/267 (48%), Gaps = 18/267 (6%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
KVIG G++ V + A+K+++K E E DV+ + +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
A + + +Y++M+Y G LL + + E + E + + ++V AID H+ VHR
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR 126
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP--- 245
DIK +N+L+D +I+L+DFG M+ + S G+ Y SPEIL+ +
Sbjct: 127 DIKPDNILMDMNGHIRLADFGSCLKLME----DGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 246 --YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV---QTKVVFPTE-PNVSAECK 299
Y P D WS+GV +Y M +G PF + ++ ++ + + FP + +VS + K
Sbjct: 183 GKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAK 241
Query: 300 TLLSKIFSPIKFRI---RLKDIKQDPW 323
L+ ++ + R+ ++D KQ P+
Sbjct: 242 DLIRRLICSREHRLGQNGIEDFKQHPF 268
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-20
Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 27/222 (12%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
+G G Y V ++ VAVK + + +++FL +E V+K ++HPNL++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL-KEAAVMKEIKHPNLVQLLG 69
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF--RQLVDAIDYCHERGVVHRD 189
YII E+ G+LLD+++ + + Q+ A++Y ++ +HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 190 IKCENLLIDGEYNI-KLSDFGFARGHMK-----CKSGHQSPLSDTFCGSYAYASPEILKG 243
+ N L+ GE ++ K++DFG +R M +G + P+ T S AY I
Sbjct: 130 LAARNCLV-GENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI--- 184
Query: 244 VPYTPHYSDVWSMGVVLYAMA-FGRLPF---DDTNYIQLLKQ 281
SDVW+ GV+L+ +A +G P+ D + +LL++
Sbjct: 185 ------KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 220
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-20
Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 9/208 (4%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS+ V R VA+K++ EA + + + +EI V+ P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYVTKYYG 69
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ +++IIMEY GS LD + R G DE + ++++ +DY H +HRDIK
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS 251
N+L+ + ++KL+DFG A G + + +TF G+ + +PE+++ Y +
Sbjct: 129 AANVLLSEQGDVKLADFGVA-GQLTDTQIKR----NTFVGTPFWMAPEVIQQSAYDSK-A 182
Query: 252 DVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
D+WS+G+ +A G P D + +++L
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVL 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 6e-20
Identities = 71/238 (29%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVS-KVEAPPDYLKKFLPREIDVVKGLRHP 124
Y+ + +G GSYATV S +G VA+KV+S K E + RE ++KGL+H
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI---REASLLKGLKHA 63
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
N++ I T + + EY IQ G + + + QL+ + Y H +
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA---YASPEIL 241
++HRD+K +NLLI +KL+DFG AR +S S T+ Y P++L
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARA--------KSIPSQTYSSEVVTLWYRPPDVL 175
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQVQTKVVFPTE---PNVS 295
G D+W G + M G+ F + + L+++ T + PTE P VS
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-20
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS+ V R VA+K++ EA + + + +EI V+ P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYVTKYYG 69
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ +++IIMEY GS LD ++ G +DE + R+++ +DY H +HRDIK
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT------FCGSYAYASPEILKGVP 245
N+L+ +KL+DFG A L+DT F G+ + +PE++K
Sbjct: 129 AANVLLSEHGEVKLADFGVA-----------GQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
Y +D+WS+G+ +A G P + + +++L
Sbjct: 178 YDSK-ADIWSLGITAIELAKGEPPHSELHPMKVL 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-20
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
+G G+ V G +A K++ +E P + + RE+ V+ P ++ F
Sbjct: 7 GELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIRNQII-RELKVLHECNSPYIVGF 64
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHR 188
A + + I ME+ + GSL +++ G I E K ++ + Y E ++HR
Sbjct: 65 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHR 124
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG--HQSPLSDTFCGSYAYASPEILKGVPY 246
D+K N+L++ IKL DFG SG S ++++F G+ +Y SPE L+G Y
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGV--------SGQLIDS-MANSFVGTRSYMSPERLQGTHY 175
Query: 247 TPHYSDVWSMGVVLYAMAFGRLP 269
T SD+WS+G+ L MA GR P
Sbjct: 176 TVQ-SDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD---VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
LG+ IG G + V + VAVK K P +KFL +E +++ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFL-QEAYIMRQFDH 66
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF-RQLVDAIDYCHE 182
P++++ L + T + V+I+ME A G L ++Q Y + + + QL A+ Y
Sbjct: 67 PHIVK-LIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS----- 237
+ VHRDI N+L+ +KL DFG +R L D SY AS
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY-----------LEDE---SYYKASKGKLP 171
Query: 238 -----PEILKGVPYTPHYSDVWSMGVVLYA-MAFGRLPF 270
PE + +T SDVW GV ++ + G PF
Sbjct: 172 IKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
L K +G G + V + H VA+K + + P+ FL E +++K L+HP L+
Sbjct: 10 LVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSMSPE---AFL-AEANLMKQLQHPRLV 64
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTK--KWFRQLVDAIDYCHERGV 185
R L A+ T +YII EY E GSL+DF++ I K Q+ + + + +
Sbjct: 65 R-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+HRD++ N+L+ K++DFG AR + G + P+ + +PE +
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK--------WTAPEAI 175
Query: 242 KGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
+T SDVWS G++L + +GR+P+
Sbjct: 176 NYGTFTIK-SDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 21/191 (10%)
Query: 86 TRHG----CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141
T+HG V VK V+ + P REID++K + H +I + A V +
Sbjct: 112 TKHGDEQRKKVIVKAVTGGKTPG--------REIDILKTISHRAIINLIHAYRWKSTVCM 163
Query: 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201
+M K L ++ R G + + R+L++A+ Y H RG++HRD+K EN+ +D
Sbjct: 164 VMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE 222
Query: 202 NIKLSDFGFARGHMKCKSGHQ--SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVV 259
N L DFG A CK +P + G+ SPE+L PY +D+WS G+V
Sbjct: 223 NAVLGDFGAA-----CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLV 276
Query: 260 LYAMAFGRLPF 270
L+ M+ +
Sbjct: 277 LFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 70/261 (26%), Positives = 125/261 (47%), Gaps = 31/261 (11%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREID--------- 116
Y + +V+G G+ TV A G AVKVV +E + K E+
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFS 92
Query: 117 VVKGLRHPNLI-RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFR---- 171
+VK H + + + E + ++++YA G L R+ +T + FR
Sbjct: 93 IVKC--HEDFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTFREHEA 145
Query: 172 -----QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226
Q++ A+ + H + ++HRDIK N+L+ +KL DFGF++ + S +
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD---VG 202
Query: 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV 286
TFCG+ Y +PEI + PY+ +D++S+GV+LY + + PFD N +++ +
Sbjct: 203 RTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261
Query: 287 VFPTEPNVSAECKTLLSKIFS 307
P P++S E + +++ + S
Sbjct: 262 YDPLPPSISPEMQEIVTALLS 282
|
Length = 496 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 58/219 (26%), Positives = 116/219 (52%), Gaps = 19/219 (8%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVS--KVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
+G G++ V A + G A KV+ E DY+ EI+++ HP +++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-----EIEILATCNHPYIVKL 74
Query: 130 LQAIETTHRVYIIMEYAEKGSL-LDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
L A +++I++E+ G++ ++ + + EP+ + RQ+++A+ Y H ++HR
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR 134
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI-----LKG 243
D+K N+L+ + +IKL+DFG + ++K D+F G+ + +PE+ +K
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR-----DSFIGTPYWMAPEVVMCETMKD 189
Query: 244 VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
PY + +D+WS+G+ L MA P + N +++L ++
Sbjct: 190 TPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 227
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
L + IG G + V L G VAVK + D + E V+ LRH NL+
Sbjct: 10 LLQTIGKGEFGDVMLGD--YRGNKVAVKCIKN-----DATAQAFLAEASVMTQLRHSNLV 62
Query: 128 RFLQAI-ETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERG 184
+ L I E +YI+ EY KGSL+D+++ G + K+ + +A++Y
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
VHRD+ N+L+ + K+SDFG + S DT + +PE L+
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREK 174
Query: 245 PYTPHYSDVWSMGVVLYAM-AFGRLPF 270
++ SDVWS G++L+ + +FGR+P+
Sbjct: 175 KFSTK-SDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 28/223 (12%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD-----VAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
L + +G GS+ V + VA+K V++ + + ++ FL E V+K
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FL-NEASVMKEF 66
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI--------QREGYIDEPRTKK--WFR 171
+++R L + T ++ME KG L ++ G K
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG---HMKCKSGHQSPLSDT 228
++ D + Y + VHRD+ N ++ + +K+ DFG R + G + L
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL--- 183
Query: 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPF 270
+ +PE LK +T SDVWS GVVL+ MA P+
Sbjct: 184 ---PVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 54/289 (18%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+V K +GIG++ V LA A+K + K + + E D++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++ + + +Y +M+Y G ++ + R E + + +L AI+ H+ G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARG--------------HMK--------------- 216
+HRDIK +N+LID + +IKL+DFG G H++
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 217 CKSG-------------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM 263
C+ G HQ L+ + G+ Y +PE+L YT D WS+GV+L+ M
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEM 241
Query: 264 AFGRLPFDDTNYIQLLKQVQTKVV-------FPTEPNVSAECKTLLSKI 305
G+ PF + Q KV+ P + +S E L++K+
Sbjct: 242 LVGQPPF----LAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 66/247 (26%), Positives = 112/247 (45%), Gaps = 32/247 (12%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G++ V VAVK + PPD KFL +E ++K HPN++R +
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFL-QEARILKQYSHPNIVRLIG 60
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA---IDYCHERGVVHR 188
+YI+ME + G L F++ EG + K+ + + +A ++Y + +HR
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 189 DIKCENLLIDGEYNIKLSDFGFAR----------GHMKCKSGHQSPLSDTFCGSYAYASP 238
D+ N L+ + +K+SDFG +R G MK Q P+ + +P
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK-----QIPVK--------WTAP 165
Query: 239 EILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297
E L Y+ SDVWS G++L+ A + G +P+ + + Q + ++ V P
Sbjct: 166 EALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDA 224
Query: 298 CKTLLSK 304
L+ +
Sbjct: 225 VYRLMER 231
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 114 EIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQL 173
E D++ +P ++ + ET + ++MEY E G ++ G + + +F +
Sbjct: 51 ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET 110
Query: 174 VDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-GHMKCKS----GHQSPLSDT 228
V A++Y H G+VHRD+K +NLLI +IKL+DFG ++ G M + GH +
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 229 F-----CGSYAYASPE-ILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
F CG+ Y +PE IL+ G P D W+MG++LY G +PF +L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPV-----DWWAMGIILYEFLVGCVPFFGDTPEELF 225
Query: 280 KQVQT-KVVFPT-EPNVSAECKTLLSKI 305
QV + + +P + + A+ + L+S++
Sbjct: 226 GQVISDDIEWPEGDEALPADAQDLISRL 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 21/225 (9%)
Query: 70 KVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
KVIG G + V +L + DVA+K + K + FL E ++ HPN+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFL-TEASIMGQFDHPNI 67
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
IR + + V II EY E GSL F+ + +G + R + + Y E
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS-----GHQSPLSDTFCGSYAYASPEI 240
VHRD+ N+L++ K+SDFG +R ++ G + P+ + +PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR--------WTAPEA 179
Query: 241 LKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQT 284
+ +T SDVWS G+V++ M++G P+ D + ++K V+
Sbjct: 180 IAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 57/243 (23%), Positives = 106/243 (43%), Gaps = 22/243 (9%)
Query: 72 IGIGSYATVKLATSTRHGC---DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
+G G++ +V +VAVK + + KK RE V+ L HP ++R
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG--KKEFLREASVMAQLDHPCIVR 60
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
L + + ++ME A G LL ++++ I K+ Q+ + Y + VHR
Sbjct: 61 -LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 189 DIKCENLLIDGEYNIKLSDFGFARG------HMKCKSGHQSPLSDTFCGSYAYASPEILK 242
D+ N+L+ + K+SDFG +R + + + + PL YA PE +
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK-------WYA-PECIN 171
Query: 243 GVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301
++ SDVWS GV L+ ++G P+ + +++ +++ P E ++
Sbjct: 172 YGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSI 230
Query: 302 LSK 304
+
Sbjct: 231 MLS 233
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 52/138 (37%), Positives = 73/138 (52%), Gaps = 24/138 (17%)
Query: 171 RQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFG---FARGHMKCKSGHQSPLSD 227
RQL+ AIDY H G++HRDIK EN+L++G +I L DFG FARG S +P
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG---SWS---TPFHY 320
Query: 228 TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF------------GRLPFDDTNY 275
G+ +PE+L G PYTP D+WS G+V++ A R P+ D
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPY-DAQI 378
Query: 276 IQLLKQVQTKV-VFPTEP 292
+++++Q Q V FP
Sbjct: 379 LRIIRQAQVHVDEFPQHA 396
|
Length = 461 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y K IG G+ V A T G +VA+K +S+ + K+ RE+ ++K + H N
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKN 76
Query: 126 LIRFLQA------IETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
+I L +E VY++ME + +L IQ + +D R Q++ I +
Sbjct: 77 IIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKH 133
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
H G++HRD+K N+++ + +K+ DFG AR +G ++ Y Y +PE
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRY-YRAPE 187
Query: 240 ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI 276
++ G+ Y + D+WS+G ++ M G + F T++I
Sbjct: 188 VILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHI 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 48/180 (26%), Positives = 93/180 (51%), Gaps = 13/180 (7%)
Query: 89 GCDVAVKVVSKVEAPPD-YLKKFLPREIDVVKGLRHPNLIRFLQAIET-THRVYIIMEYA 146
G +VA+K++ + +AP + + + RE + L HPN++ L + E ++ + EY
Sbjct: 3 GHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 147 EKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNI 203
+L + + +G + T + Q++DA+ H +G+VHRD+K +N+++ +
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 204 KLSDFGFARGHMKCKSGHQSPLSDT----FCGSYAYASPEILKGVPYTPHYSDVWSMGVV 259
K+ DFG G + + T G+ Y +PE L+G P TP+ SD+++ G++
Sbjct: 122 KVLDFGI--GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN-SDLYAWGLI 178
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-19
Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 12/219 (5%)
Query: 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
H Y L + +G G+Y V A + G AVK++ K+E D+ + +EI +VK +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDF--SLIQQEIFMVKECKH 65
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
N++ + + + +++I MEY GSL D G + E + R+ + + Y H +
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL-- 241
G +HRDIK N+L+ ++KL+DFG A + +S F G+ + +PE+
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-----FIGTPYWMAPEVAAV 180
Query: 242 -KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
K Y D+W++G+ +A + P D + ++ L
Sbjct: 181 EKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 71/231 (30%), Positives = 113/231 (48%), Gaps = 17/231 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVE----APPDYLKKFLPREIDVVKGL 121
Y+ +G G+YATV S VA+K + ++E AP + RE+ ++K L
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAI-----REVSLLKDL 61
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYC 180
+H N++ I T + ++ EY +K L ++ G I+ K + QL+ ++YC
Sbjct: 62 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H R V+HRD+K +NLLI+ +KL+DFG AR KS S+ + Y P+I
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYSNEVVTLW-YRPPDI 175
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE 291
L G D+W +G + Y M+ GR F + + L + + PTE
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-19
Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 28/241 (11%)
Query: 72 IGIGSYATVKLAT---STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
+G G + V + T +TR VA+K + P+ FL +E V+K LRH L++
Sbjct: 14 LGQGCFGEVWMGTWNGTTR----VAIKTLKPGTMSPE---AFL-QEAQVMKKLRHEKLVQ 65
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVV 186
L A+ + +YI+ EY KGSLLDF++ E Y+ P+ Q+ + Y V
Sbjct: 66 -LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
HRD++ N+L+ K++DFG AR + G + P+ + +PE
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAAL 176
Query: 243 GVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301
+T SDVWS G++L + GR+P+ ++L QV+ P P L
Sbjct: 177 YGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235
Query: 302 L 302
+
Sbjct: 236 M 236
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 7e-19
Identities = 52/158 (32%), Positives = 85/158 (53%), Gaps = 9/158 (5%)
Query: 113 REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQ 172
RE+ V+ P ++ F A + + I ME+ + GSL +++ G I E K
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 111
Query: 173 LVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
++ + Y E+ ++HRD+K N+L++ IKL DFG + G + ++++F G
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS-GQLI------DSMANSFVG 164
Query: 232 SYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP 269
+ +Y SPE L+G Y+ SD+WSMG+ L MA GR P
Sbjct: 165 TRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 35/276 (12%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--PDYLKKFLPREIDVVKGLRHPNLI 127
K +G G+Y TV A R G VA+K K+ P + K RE+ ++K ++H N+I
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHMKHENVI 77
Query: 128 RFL------QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
L +++ H Y++M + G+ L + + + E R + Q++ + Y H
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH 135
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE-I 240
G++HRD+K NL ++ + +K+ DFG AR + + Y +PE I
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYVVTRWYRAPEVI 187
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNV----SA 296
L + YT D+WS+G ++ M G+ F +++ L ++ P++ V S
Sbjct: 188 LNWMHYT-QTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 297 ECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAA 332
+ K + K+ P R R KD + + ANP A
Sbjct: 247 DAKNYVKKL--P---RFRKKDFRS---LLPNANPLA 274
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 69/249 (27%), Positives = 120/249 (48%), Gaps = 21/249 (8%)
Query: 70 KVIGIGSY---ATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
KVIG G++ A VK+ + R A+K+++K E E +V+ +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTER---IYAMKILNKWEMLKRAETACFREERNVLVNGDCQWI 63
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGV 185
A + + +Y++M+Y G LL + + E + E + + ++V AI H+
Sbjct: 64 TTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY 123
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV- 244
VHRDIK +N+L+D +I+L+DFG + + S G+ Y SPEIL+ +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ----DGTVQSSVAVGTPDYISPEILQAME 179
Query: 245 ----PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV---QTKVVFPTE-PNVSA 296
Y P D WS+GV +Y M +G PF + ++ ++ + + FP+ +VS
Sbjct: 180 DGMGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238
Query: 297 ECKTLLSKI 305
E K L+ ++
Sbjct: 239 EAKDLIQRL 247
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 67 VLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
LGK +G G++ V A + VAVK++ K +A L + E++++K +
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLV-SEMEMMKMI 72
Query: 122 -RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-------EGYID--EPRTKKWFR 171
+H N+I L +Y+++EYA G+L DF++ D P +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 172 QLVD-------AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG------HMKCK 218
LV +++ + +HRD+ N+L+ ++ +K++DFG AR + K
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYA-MAFGRLPF 270
+G + +PE L YT H SDVWS GV+L+ G P+
Sbjct: 193 NGRL---------PVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 54/179 (30%), Positives = 95/179 (53%), Gaps = 21/179 (11%)
Query: 92 VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR--VYIIMEYAEKG 149
VAVK + + ++L+ F REI+++K L+H N++++ + R + ++MEY G
Sbjct: 36 VAVKKLQ--HSTAEHLRDF-EREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 150 SLLDFIQREGY-IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDF 208
SL D++Q+ +D + + Q+ ++Y + VHRD+ N+L++ E +K+ DF
Sbjct: 93 SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDF 152
Query: 209 GFA------RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLY 261
G + + K + +SP+ + YA PE L ++ SDVWS GVVLY
Sbjct: 153 GLTKVLPQDKEYYKVREPGESPI-------FWYA-PESLTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 70/236 (29%), Positives = 112/236 (47%), Gaps = 23/236 (9%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G+Y V A +A+K + ++E + + REI ++K ++H N++R
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPR-TKKWFRQLVDAIDYCHERGVVHRDI 190
+ + R+Y++ EY + + PR K + Q++ I YCH V+HRD+
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDL 128
Query: 191 KCENLLIDGEYN-IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA---YASPEILKGVPY 246
K +NLLID N +KL+DFG AR P+ TF Y +PEIL G
Sbjct: 129 KPQNLLIDRRTNALKLADFGLAR-------AFGIPVR-TFTHEVVTLWYRAPEILLG--- 177
Query: 247 TPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE---PNVSA 296
+ HYS D+WS+G + M + F + I L ++ + P E P V++
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233
|
Length = 294 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 71/249 (28%), Positives = 118/249 (47%), Gaps = 12/249 (4%)
Query: 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPR-EIDVVKGLR 122
H YVL ++G T +TR G D KVV+K D + R E+ +
Sbjct: 67 HMYVLTTLVG--RNPTTAAFVATR-GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD 123
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY----IDEPRTKKWFRQLVDAID 178
H +++ ++ ++ +IMEY G L I++ E F Q+V A+D
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
H R ++HRD+K N+ + IKL DFGF++ + S ++ +FCG+ Y +P
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS---LDVASSFCGTPYYLAP 240
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298
E+ + Y+ +D+WS+GV+LY + PF + ++++QV P VS+
Sbjct: 241 ELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299
Query: 299 KTLLSKIFS 307
K LL + S
Sbjct: 300 KALLDPLLS 308
|
Length = 478 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 45/151 (29%), Positives = 80/151 (52%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+V+ K I G++ V L + AVKVV K + + + E D + + P
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ ++++ + VY++MEY G + + GY DE K+ ++ A+DY H G+
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216
+HRD+K +N+LI E +IKL+DFG ++ +
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 71/230 (30%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y IG G+Y V AT G VA+K +S E + ++ L REI +++ +H N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-FCQRTL-REIKILRRFKHEN 64
Query: 126 LIRFL-----QAIETTHRVYIIMEYAE-------KGSLL--DFIQREGYIDEPRTKKWFR 171
+I L + E+ + VYI+ E E K L D IQ Y
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY----------- 113
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
Q++ + Y H V+HRD+K NLL++ ++K+ DFG AR + H L++ +
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP-EHDHTGFLTE-YVA 171
Query: 232 SYAYASPEI-LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-QLL 279
+ Y +PEI L YT D+WS+G +L M R F +Y+ QL
Sbjct: 172 TRWYRAPEIMLNSKGYTKAI-DIWSVGCILAEMLSNRPLFPGKDYLHQLN 220
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-18
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 13/209 (6%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
+G GSYATV S +G VA+KV+ E RE ++KGL+H N++
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI--REASLLKGLKHANIVLLHD 70
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
I T + ++ EY + G + K + QL+ + Y H+R ++HRD+K
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA---YASPEILKGVPYTP 248
+NLLI +KL+DFG AR +S S T+ Y P++L G
Sbjct: 131 PQNLLISDTGELKLADFGLARA--------KSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 249 HYSDVWSMGVVLYAMAFGRLPFDDTNYIQ 277
D+W +G + M G F IQ
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 63/227 (27%), Positives = 115/227 (50%), Gaps = 17/227 (7%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
K IG G+ V A T G +VAVK +S+ + K+ RE+ ++K + H N+I
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 130 L------QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
L +++E VY++ME + +L I E +D R Q++ I + H
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME--LDHERMSYLLYQMLCGIKHLHSA 142
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
G++HRD+K N+++ + +K+ DFG AR C + +P + + Y +PE++ G
Sbjct: 143 GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTP----YVVTRYYRAPEVILG 196
Query: 244 VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT 290
+ Y + D+WS+G ++ + G + F T++I +V ++ P+
Sbjct: 197 MGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 67/284 (23%), Positives = 127/284 (44%), Gaps = 21/284 (7%)
Query: 48 AANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCD-VAVKVVSKVEAPPDY 106
+ K +K E+ ++ + +G GS+ V LAT VA+K K +
Sbjct: 16 DSTKEPKRKNKMKYEDFNFI--RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQK 73
Query: 107 LKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRT 166
+ E ++ + HP + + + +Y+++E+ G F++R
Sbjct: 74 QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG 133
Query: 167 KKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226
+ Q+V +Y +V+RD+K ENLL+D + IK++DFGFA+ +
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRT 185
Query: 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV 286
T CG+ Y +PEIL V + +D W++G+ +Y + G PF + + +++ +
Sbjct: 186 YTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI 244
Query: 287 V-FPTEPNVSAECKTLLSKIFSPI------KFRIRLKDIKQDPW 323
+ FP + CK L+ K+ S + +++K+ PW
Sbjct: 245 IYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286
|
Length = 340 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVE----APPDYLKKFLPREIDVVKGL 121
Y+ + +G G+YATV S VA+K + ++E AP + RE+ ++K L
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAI-----REVSLLKDL 61
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF-RQLVDAIDYC 180
+H N++ + T + ++ EY +K L ++ G I K F Q++ + YC
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H R V+HRD+K +NLLI+ +KL+DFG AR KS S+ + Y P++
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARA----KSVPTKTYSNEVVTLW-YRPPDV 175
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPF 270
L G D+W +G + + MA GR F
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-18
Identities = 60/212 (28%), Positives = 109/212 (51%), Gaps = 12/212 (5%)
Query: 66 YVLGKVIGIGSYATVKLA---TSTRHGCDVAVKVVSKVEAPPDYLKKFLPR-EIDVVKGL 121
+ L KV+G G+Y V L + G A+KV+ K R E V++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 122 RH-PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
R P L+ A +T ++++I++Y G L + + E + + ++V A+++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H+ G+++RDIK EN+L+D ++ L+DFG ++ + + + +FCG+ Y +P+I
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE----DEVERAYSFCGTIEYMAPDI 177
Query: 241 LKGVPYTPHYS--DVWSMGVVLYAMAFGRLPF 270
++G H D WSMGV++Y + G PF
Sbjct: 178 VRGGD-GGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 9e-18
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 45/166 (27%)
Query: 113 REIDVVKGLRHPNLIRFLQAI---ETTHRVYIIMEYAE---KGSLLD-----FIQREGYI 161
REI+++ L+HPN++ ++ + ++Y++MEY E K SL++ F+Q E
Sbjct: 53 REINILLKLQHPNIVT-VKEVVVGSNLDKIYMVMEYVEHDLK-SLMETMKQPFLQSE--- 107
Query: 162 DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221
K QL+ + + H+ ++HRD+K NLL++ +K+ DFG AR +
Sbjct: 108 ----VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-------EY 156
Query: 222 QSPLSDTFCGSYA-------YASPEILKGVPYTPHYS---DVWSMG 257
SPL Y Y +PE+L G YS D+WS+G
Sbjct: 157 GSPL-----KPYTQLVVTLWYRAPELLLG---AKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVK-VVSKVEAPPDYLKKFLP----REIDVVKG 120
Y + +G G++ V A + G VA+K ++ E K P REI ++K
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE------KDGFPITALREIKILKK 63
Query: 121 LRHPNLIRFLQAI-----ETTHR---VYIIMEY--AEKGSLLD--FIQREGYIDEPRTKK 168
L+HPN++ + ++ + VY++ Y + LL+ ++ E + K
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT----ESQIKC 119
Query: 169 WFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK--SGHQSPLS 226
+ QL++ I+Y HE ++HRDIK N+LID + +K++DFG AR +
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 227 DTFCGSYA-------YASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGR 267
Y Y PE+L G YT D+W +G V M R
Sbjct: 180 TR---KYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDY---LKKFLPREIDVVKGLRHPNLI 127
++G G+ TV A +AVKV+ P D L+K + E++++ P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVI-----PLDITVELQKQIMSELEILYKCDSPYII 62
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
F A +R+ I E+ + GSL D ++ I E + +V + Y ++H
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSL-DVYRK---IPEHVLGRIAVAVVKGLTYLWSLKILH 118
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYT 247
RD+K N+L++ +KL DFG + + + ++ T+ G+ AY +PE + G Y
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLV-------NSIAKTYVGTNAYMAPERISGEQYG 171
Query: 248 PHYSDVWSMGVVLYAMAFGRLPF 270
H SDVWS+G+ +A GR P+
Sbjct: 172 IH-SDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 66/326 (20%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPR---EIDVVKGLRHPNL 126
KVIG G++ V+L G A+K + K E + K L E DV+ P +
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM---FKKDQLAHVKAERDVLAESDSPWV 63
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVV 186
+ + + +Y+IME+ G L+ + + E T+ + + V AI+ H+ G +
Sbjct: 64 VSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMK------------------CKSGHQSPLSDT 228
HRDIK +N+LID +IKLSDFG + G K S D+
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 229 F------------------------CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA 264
G+ Y +PEI Y D WS+G +++
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMFECL 242
Query: 265 FGRLPFDDTN----YIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFSPIKFRI---RLKD 317
G PF N Y +++ +T + FP + ++S E + L+ ++ + + R+ +
Sbjct: 243 IGWPPFCSENSHETYRKIINWRET-LYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHE 301
Query: 318 IKQDPWVKTEANPAASAGVETKTLNQ 343
IK P+ GV+ T+ Q
Sbjct: 302 IKSHPFF---------RGVDWDTIRQ 318
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 22/229 (9%)
Query: 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
++GK V LA VAVK ++ +++ K L +EI + L+HP
Sbjct: 3 LTLIGK--CFEDLMIVHLAKHKPTNTLVAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR---EGYIDEPRTKKWFRQLVDAIDYCH 181
N++ ++ + +Y++ GS D ++ EG E + +++A+DY H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL-PELAIAFILKDVLNALDYIH 118
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM-----KCKSGHQSPLSDTFCGSYAYA 236
+G +HR +K ++L+ G+ + LS ++ M + + H P S + +
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSV-SMIKHGKRQRVVHDFPKSSVK--NLPWL 175
Query: 237 SPEILK----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ 281
SPE+L+ G Y SD++S+G+ +A G +PF D Q+L +
Sbjct: 176 SPEVLQQNLQG--YNEK-SDIYSVGITACELANGHVPFKDMPATQMLLE 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 57/217 (26%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFL- 130
+G G+Y +V A T+ G VAVK +S+ + K+ RE+ ++K ++H N+I L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 131 -----QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++E + VY++ G+ L+ I + + + + Q++ + Y H +
Sbjct: 84 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 141
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRD+K NL ++ + +K+ DFG AR H + + Y +PEI+
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMTGYVATRWYRAPEIMLNWM 193
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
+ D+WS+G ++ + GR F T++I LK +
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 24/223 (10%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
+++G G++ V T + VAVK K + P + KFL E ++K HPN+++
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTC-KEDLPQELKIKFL-SEARILKQYDHPNIVKL 57
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA---IDYCHERGVV 186
+ +YI+ME G L F++++ DE +TK+ + +DA + Y + +
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 187 HRDIKCENLLIDGEYNI-KLSDFGFAR---GHMKCKSG-HQSPLSDTFCGSYAYASPEIL 241
HRD+ N L+ GE N+ K+SDFG +R + SG Q P+ + +PE L
Sbjct: 116 HRDLAARNCLV-GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK--------WTAPEAL 166
Query: 242 KGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
Y+ SDVWS G++L+ + G P+ Q +QV+
Sbjct: 167 NYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE 208
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 22/223 (9%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
L K +G G + V + T + VAVK + P+ FL E ++K LRH L+
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPE---SFL-EEAQIMKKLRHDKLV 64
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQR-EG-YIDEPRTKKWFRQLVDAIDYCHERGV 185
+ L A+ + +YI+ EY KGSLLDF++ EG + P Q+ + Y
Sbjct: 65 Q-LYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+HRD++ N+L+ K++DFG AR + G + P+ + +PE
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAA 175
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQ 283
+T SDVWS G++L + GR+P+ N ++L+QV+
Sbjct: 176 LYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-17
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 95 KVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDF 154
KV K P + + +E ++K LRH L+ L A+ + +YI+ E+ KGSLLDF
Sbjct: 32 KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP-LYAVVSEEPIYIVTEFMGKGSLLDF 90
Query: 155 IQREG---YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211
+ +EG Y+ P+ Q+ D + Y +HRD++ N+L+ K++DFG A
Sbjct: 91 L-KEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLA 149
Query: 212 R----GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-G 266
R + G + P+ + +PE +T SDVWS G++L + G
Sbjct: 150 RLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIK-SDVWSFGILLTELVTKG 200
Query: 267 RLPFDDTNYIQLLKQVQTKVVFP 289
R+P+ ++L+QV+ P
Sbjct: 201 RVPYPGMVNREVLEQVERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-17
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 12/211 (5%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G+Y V A + G A+KV+ K+E D+ + +EI ++K +H N++ +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDF--AVVQQEIIMMKDCKHSNIVAYFG 73
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191
+ +++I ME+ GSL D G + E + R+ + + Y H +G +HRDIK
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIK 133
Query: 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS 251
N+L+ ++KL+DFG + + +S F G+ + +PE+ V Y+
Sbjct: 134 GANILLTDNGHVKLADFGVSAQITATIAKRKS-----FIGTPYWMAPEV-AAVERKGGYN 187
Query: 252 ---DVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
D+W++G+ +A + P D + ++ L
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 9e-17
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 30/206 (14%)
Query: 72 IGIGSYATVKLATS--TRHGCDVAVKVVSKVEAPPDYLKKFLP---REIDVVKGLRHPNL 126
IG G+Y V A + G + A+K K + + REI +++ L+H N+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIK---KFKGDKEQYTGISQSACREIALLRELKHENV 64
Query: 127 IRFLQAI--ETTHRVYIIMEYAEKGSLLDFIQ-----REGYIDEPRTKKWFRQLVDAIDY 179
+ ++ VY++ +YAE L I+ + I K Q+++ + Y
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 180 CHERGVVHRDIKCENLLIDGEYN----IKLSDFGFARGHMKCKSGHQSPLS-DTFCGSYA 234
H V+HRD+K N+L+ GE +K+ D G AR + + D +
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR---LFNAPLKPLADLDPVVVTIW 180
Query: 235 YASPEILKGVPYTPHYS---DVWSMG 257
Y +PE+L G HY+ D+W++G
Sbjct: 181 YRAPELLLG---ARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 30/230 (13%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
+G GS V A + VAVK + + P +K L REI +++ L H N+++ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHAL-REIKIIRRLDHDNIVKVYE 69
Query: 132 AIETTHR--------------VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAI 177
+ + VYI+ EY E L + +G + E + + QL+ +
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLRGL 127
Query: 178 DYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
Y H V+HRD+K N+ I+ E +K+ DFG AR + H+ LS+ + Y
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGYLSEGLVTKW-YR 185
Query: 237 SPEILKGVPYTP-HYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
SP +L +P +Y+ D+W+ G + M G+ F + ++ ++ +
Sbjct: 186 SPRLL----LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 62/226 (27%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
K IG G+ V A +VA+K +S+ + K+ RE+ ++K + H N+I
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 130 L------QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
L +++E VYI+ME + +L IQ E +D R Q++ I + H
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA 145
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
G++HRD+K N+++ + +K+ DFG AR + S + + + Y +PE++ G
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 244 VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP 289
+ Y + D+WS+G ++ M G + F T++I +V ++ P
Sbjct: 200 MGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 113 REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQ 172
RE+ V+ P ++ F A + + I ME+ + GSL ++ I E K
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA 111
Query: 173 LVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
++ + Y E+ ++HRD+K N+L++ IKL DFG + G + ++++F G
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS-GQLI------DSMANSFVG 164
Query: 232 SYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP 269
+ +Y SPE L+G Y+ SD+WSMG+ L +A GR P
Sbjct: 165 TRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 80/308 (25%), Positives = 126/308 (40%), Gaps = 79/308 (25%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEA-----PPDYLKKFLPREIDVVKGLRHPNL 126
IG G+Y V A G VA+K +++E PP L REI +++ L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTAL-----REISLLQMLSESIY 62
Query: 127 IRFLQAIETTHR------VYIIMEYAEKGSLLDFIQREGY-----IDEPRTKKWFRQLVD 175
I L +E +Y++ EY + L F+ G + K + QL+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYN-IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
+ +CH+ GV+HRD+K +NLL+D + +K++D G R P+ SY
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-------AFSIPV-----KSYT 169
Query: 235 -------YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT 284
Y +PE+L G + HYS D+WS+G + M+ + F + +Q L +
Sbjct: 170 HEIVTLWYRAPEVLLG---STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226
Query: 285 KVVFPTE---------------------------PNVSAECKTLLSKI--FSPIKFRIRL 315
+ PTE P++S E LL K+ + P K RI
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAK-RISA 285
Query: 316 KDIKQDPW 323
K P+
Sbjct: 286 KAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 75/311 (24%), Positives = 139/311 (44%), Gaps = 61/311 (19%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
K IG G+ V A +VA+K +S+ + K+ RE+ ++K + H N+I
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 81
Query: 130 L------QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
L +++E VY++ME + +L IQ E +D R Q++ I + H
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA 138
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
G++HRD+K N+++ + +K+ DFG AR + S + + + Y +PE++ G
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 244 VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI---------------QLLKQVQTKV-- 286
+ Y + D+WS+G ++ M ++ F +YI + +K++Q V
Sbjct: 193 MGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 287 --------------------VFPTEPN----VSAECKTLLSK--IFSPIKFRIRLKDIKQ 320
+FP + +++ + LLSK + P K RI + + Q
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK-RISVDEALQ 310
Query: 321 DPWVKTEANPA 331
P++ +PA
Sbjct: 311 HPYINVWYDPA 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 75/253 (29%), Positives = 116/253 (45%), Gaps = 44/253 (17%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHPNLIRFL 130
IG G+ V + G +AVK + + + K+ L ++DVV K P +++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRIL-MDLDVVLKSHDCPYIVKCY 80
Query: 131 QAIETTHRVYIIMEY----AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER-GV 185
T V+I ME +K LL IQ G I E K +V A+ Y E+ GV
Sbjct: 81 GYFITDSDVFICMELMSTCLDK--LLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHM-----KCKSGHQSPLSDTFCGSYAYASPEI 240
+HRD+K N+L+D N+KL DFG + G + K +S G AY +PE
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGIS-GRLVDSKAKTRSA----------GCAAYMAPER 185
Query: 241 LKGVPYTPHY---SDVWSMGVVLYAMAFGRLPFD--DTNYIQLLKQVQTKVVFPTEPNVS 295
+ P Y +DVWS+G+ L +A G+ P+ T + +V TK++ P++
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEEPPSLP 240
Query: 296 AECKTLLSKIFSP 308
++ FSP
Sbjct: 241 ------PNEGFSP 247
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 55/221 (24%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
K +G G + VK R DVA+K++ + D +F+ E V+ L H L++
Sbjct: 10 KELGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMSED---EFI-EEAKVMMKLSHEKLVQL 64
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEP-RTKKWFRQLVDAIDYCHERGVVHR 188
+YI+ EY G LL++++ G +P + + + + + + Y + +HR
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA------YASPEILK 242
D+ N L+D + +K+SDFG +R L D + S ++ PE+L
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR----------YVLDDEYTSSVGSKFPVRWSPPEVLL 174
Query: 243 GVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQV 282
++ SDVW+ GV+++ + + G++P++ N + +++V
Sbjct: 175 YSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 26/274 (9%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
+G G+Y +V G +A+K + ++E + + E+D++ P ++ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQII-MELDILHKAVSPYIVDFYG 66
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGY----IDEPRTKKWFRQLVDAIDYCHER-GVV 186
A VY+ MEY + GSL D + G I E ++ +V + + E ++
Sbjct: 67 AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH-QSPLSDTFCGSYAYASPEILK--G 243
HRD+K N+L++G +KL DFG SG+ + L+ T G +Y +PE +K G
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGV--------SGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 244 VPYTPHY---SDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--VFPTEP-NVSAE 297
P Y SDVWS+G+ + MA GR P+ Y + Q+ V PT P S +
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 298 CKTLLSKIFSPI-KFRIRLKDIKQDPWVKTEANP 330
+ ++K + I R + + PW+ N
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 22/244 (9%)
Query: 70 KVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
KVIG G + V +L + VA+K + K + FL E ++ HPN+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFL-SEASIMGQFDHPNI 67
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGV 185
I + + V I+ EY E GSL F+++ +G + R + + Y + G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSYAYASPE 239
VHRD+ N+L++ K+SDFG +R G + P+ + +PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR--------WTAPE 179
Query: 240 ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298
+ +T SDVWS G+V++ M++G P+ + + ++K ++ P + A
Sbjct: 180 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAAL 238
Query: 299 KTLL 302
L+
Sbjct: 239 HQLM 242
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 22/210 (10%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR---HPNLIR 128
IG+G+Y TV A G VA+K V +V+ D L RE+ ++K L HPN++R
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 129 FLQAIETTH-----RVYIIMEYAEKG--SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
+ T+ +V ++ E+ ++ + LD + G E K RQ + +D+ H
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE-TIKDLMRQFLRGLDFLH 125
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+VHRD+K EN+L+ +KL+DFG AR + C+ +P+ T Y +PE+L
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLARIY-SCQMA-LTPVVVTLW----YRAPEVL 179
Query: 242 KGVPY-TPHYSDVWSMGVVLYAMAFGRLPF 270
Y TP D+WS+G + +A F R P
Sbjct: 180 LQSTYATP--VDMWSVGCI-FAEMFRRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 64/249 (25%), Positives = 115/249 (46%), Gaps = 35/249 (14%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
+G G+Y V A T+ G VA+K +S+ + K+ RE+ ++K + H N+I
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGL 79
Query: 130 L------QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
L ++E VY++ G+ L+ I + + + + Q++ + Y H
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA 137
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL-- 241
G++HRD+K N+ ++ + +K+ DFG AR H + + Y +PEI+
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLAR--------HTDDEMTGYVATRWYRAPEIMLN 189
Query: 242 KGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298
HY+ D+WS+G ++ + G+ F +++I LK++ V P E
Sbjct: 190 WM-----HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE------- 237
Query: 299 KTLLSKIFS 307
LL KI S
Sbjct: 238 -ELLQKISS 245
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 17/219 (7%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G++ V T R G VA+K + V K+ RE+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66
Query: 132 AIETTH-----RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVV 186
++ H +Y++ E + L I + K + Q++ + Y H G++
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGIL 125
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPY 246
HRDIK NLL++ +K+ DFG AR +S H + T Y Y +PEIL G
Sbjct: 126 HRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT---QY-YRAPEILMG--- 178
Query: 247 TPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
+ HY+ D+WS+G + + R+ F + IQ L +
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-16
Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 11/144 (7%)
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
A ET + ++M G L I G E R + Q++ +++ H+R +V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
+K EN+L+D N+++SD G A K G+ Y +PE+L+G Y
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR------AGTPGYMAPEVLQGEVYD-- 172
Query: 250 YS-DVWSMGVVLYAMAFGRLPFDD 272
+S D +++G LY M GR PF
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
YV + +G+G++ V A G +VA+K + K + P L K RE+ ++K LRH N
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHEN 70
Query: 126 LIR----FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
+I F+ +E +Y + E G+ L + +++ + + Q++ + Y H
Sbjct: 71 IISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
GVVHRD+K N+LI+ ++K+ DFG AR Q P + + Y +PEI+
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLAR--------IQDPQMTGYVSTRYYRAPEIM 177
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI 276
D+WS G + M G+ F +++
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 22/225 (9%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y K +G G+Y +V A R G VA+K +S+ + K+ RE+ ++K ++H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHEN 75
Query: 126 LIRFLQAIETT------HRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAID 178
+I L + Y++M Y + D + G+ + E + + Q++ +
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
Y H G++HRD+K NL ++ + +K+ DFG AR H + + Y +P
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRWYRAP 183
Query: 239 E-ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
E IL + Y D+WS+G ++ M G+ F +Y+ L Q+
Sbjct: 184 EVILNWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 8e-16
Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 51/234 (21%)
Query: 67 VLGKVIGIGSYATVKLATSTRHG-----CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
VLGK +G G + V AT+ R VAVK++ + + + L E +++K +
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD--LLSEFNLLKQV 60
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ----------------REGYIDEPR 165
HP++I+ A + +I+EYA+ GSL F++ Y+D P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 166 TK----------KWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR--- 212
+ W Q+ + Y E +VHRD+ N+L+ +K+SDFG +R
Sbjct: 121 ERALTMGDLISFAW--QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 213 ---GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM 263
++K +S + P+ + + E L YT SDVWS GV+L+ +
Sbjct: 179 EEDSYVK-RSKGRIPVK--------WMAIESLFDHIYTTQ-SDVWSFGVLLWEI 222
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-16
Identities = 53/220 (24%), Positives = 104/220 (47%), Gaps = 22/220 (10%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
K +G G + V L VA+K +++ + D+++ E V+ L HP L++
Sbjct: 10 KELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAMSEEDFIE-----EAKVMMKLSHPKLVQ 63
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
+YI+ E+ E G LL+++ QR+G + + + + + ++Y +H
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 188 RDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
RD+ N L+ +K+SDFG R SG + P+ ++ PE+
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK--------WSPPEVFNF 175
Query: 244 VPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQV 282
Y+ SDVWS GV+++ + G++PF+ + ++++ +
Sbjct: 176 SKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKV--EAPPDYLKKFLPREIDVVKGLRHPNLI 127
KV+G G++ TV G V + V K EA K + E V+ + +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERGVV 186
R L I T V +I + G LLD++ + + I W Q+ ++Y ER +V
Sbjct: 73 RLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLV 131
Query: 187 HRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
HRD+ N+L+ ++K++DFG A+ G + P+ + + E +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK--------WMALESI 183
Query: 242 KGVPYTPHYSDVWSMGVVLYA-MAFGRLPFD 271
YT H SDVWS GV ++ M FG P+D
Sbjct: 184 LHRIYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 60/230 (26%), Positives = 110/230 (47%), Gaps = 27/230 (11%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSK-----VEAPPDYLKKFLPREIDVVKGLRHPNL 126
+G G+Y +V A TR VAVK +S+ + A Y RE+ ++K ++H N+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY------RELRLLKHMKHENV 76
Query: 127 IRFLQ------AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
I L +IE + VY++ G+ L+ I + + + + QL+ + Y
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H G++HRD+K N+ ++ + +++ DFG AR +G + + Y +PEI
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTG--------YVATRWYRAPEI 186
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT 290
+ + D+WS+G ++ + G+ F +YI LK++ V P+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 84/330 (25%), Positives = 137/330 (41%), Gaps = 48/330 (14%)
Query: 14 IKTDTIAQSSKENKRPKSSSNKLDLDA----------SSRSTLIAANKRDVKKKSTVMEN 63
I D K +K K S K +++ ++ + ++ + N
Sbjct: 6 IDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPN 65
Query: 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
Y LG +IG GS+ V A VA+K KV P Y RE+ ++K L H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK---KVLQDPQYKN----RELLIMKNLNH 118
Query: 124 PNLIRFLQAIETTHRVY---------IIMEYAEKG--SLLDFIQREGY-IDEPRTKKWFR 171
N+I FL+ T ++ME+ + + R + + K +
Sbjct: 119 INII-FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLID-GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFC 230
QL A+ Y H + + HRD+K +NLLID + +KL DFG A+ + Q +S +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL----AGQRSVS--YI 231
Query: 231 GSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP 289
S Y +PE++ G YT H D+WS+G ++ M G F + + L ++ + P
Sbjct: 232 CSRFYRAPELMLGATNYTTHI-DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290
Query: 290 TEPNVSAECKTLLSKIFSPIKFRIRLKDIK 319
TE + K +P I+ D+K
Sbjct: 291 TEDQL---------KEMNPNYADIKFPDVK 311
|
Length = 440 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 72 IGIGSYATVK--LATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
+G G++ TVK + + VAVK++ K + LK L RE +V++ L +P ++R
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+ E + ++ME AE G L F+Q+ ++ E + Q+ + Y E VHRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 190 IKCENLLIDGEYNIKLSDFGFARG------HMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
+ N+L+ ++ K+SDFG ++ + K K+ + P+ + +PE +
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK--------WYAPECMNY 172
Query: 244 VPYTPHYSDVWSMGVVLY-AMAFGRLPF 270
++ SDVWS GV+++ A ++G+ P+
Sbjct: 173 YKFSSK-SDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 90 CDVAVKVVSKVEAPPDYLKKFLPR---------EIDVVKGLRHPNLIRFLQAIETTHRVY 140
C V VK K+ A KK L + E ++++ + P ++ A E+ +
Sbjct: 10 CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLC 69
Query: 141 IIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID 198
++M G L I G ++ R + Q+ I + H +V+RD+K EN+L+D
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD 129
Query: 199 GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGV 258
+ N +LSD G A K+ Q G+ Y +PEILK PY+ + D ++MG
Sbjct: 130 DQGNCRLSDLGLAVELKDGKTITQR------AGTNGYMAPEILKEEPYS-YPVDWFAMGC 182
Query: 259 VLYAMAFGRLPFDD 272
+Y M GR PF D
Sbjct: 183 SIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-PNLIRFL 130
IG G++ TV G +AVK + + +K L ++DVV P +++F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE--QKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 131 QAIETTHRVYIIMEYA----EKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER-GV 185
A+ +I ME +K + + I E K V A++Y E +
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKI 129
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFC-----GSYAYASPEI 240
+HRD+K N+L+D NIKL DFG SG L D+ G Y +PE
Sbjct: 130 IHRDVKPSNILLDRNGNIKLCDFGI--------SGQ---LVDSIAKTRDAGCRPYMAPER 178
Query: 241 LKGVPYTPH--YSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV 286
+ + SDVWS+G+ LY +A G+ P+ N + Q+ V
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVV 224
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 36/239 (15%)
Query: 70 KVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKK----FLPREIDVVKGLR 122
KVIG G + V L R VA+K + P Y +K FL E ++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-----PGYTEKQRQDFL-SEASIMGQFS 64
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCH 181
H N+IR + II EY E G+L +++ +G + R + + Y
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA------- 234
+ VHRD+ N+L++ K+SDFG +R L D G+Y
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSR-----------VLEDDPEGTYTTSGGKIP 173
Query: 235 --YASPEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQTKVVFPT 290
+ +PE + +T SDVWS G+V++ M+FG P+ D + +++K + P
Sbjct: 174 IRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 70 KVIGIGSYATVKL----ATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+V+G G + V L + G VAVK + K E + +EI+++K L H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWK-KEINILKTLYHEN 67
Query: 126 LIRFLQAIETT--HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
++++ + +IMEY GSL D++ + ++ + + +Q+ + + Y H +
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQ 126
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFAR----GHM--KCKSGHQSPLSDTFCGSYAYAS 237
+HRD+ N+L+D + +K+ DFG A+ GH + + SP+ + YA
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------FWYA- 178
Query: 238 PEILKGVPYTPHYSDVWSMGVVLYAM 263
E LK ++ + SDVWS GV LY +
Sbjct: 179 VECLKENKFS-YASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 63/247 (25%), Positives = 108/247 (43%), Gaps = 24/247 (9%)
Query: 70 KVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+VIG G + V +L + VA+K + K + FL E ++ HPN+
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLS-EASIMGQFDHPNI 67
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
I + + V II E+ E G+L F+ Q +G + R + + Y E
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA------YASPE 239
VHRD+ N+L++ K+SDFG +R + P T+ S + +PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSR---FLEDDTSDP---TYTSSLGGKIPIRWTAPE 181
Query: 240 ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298
+ +T SDVWS G+V++ M++G P+ D + ++ ++ P +C
Sbjct: 182 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM----DC 236
Query: 299 KTLLSKI 305
T L ++
Sbjct: 237 PTALHQL 243
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 60/249 (24%), Positives = 110/249 (44%), Gaps = 32/249 (12%)
Query: 92 VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151
VA+K + K A P ++F +E +++ L+HPN++ L ++ EY G L
Sbjct: 38 VAIKTL-KENAEPKVQQEFR-QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL 95
Query: 152 LDFIQREGYIDEPRTKKWFR----------------QLVDAIDYCHERGVVHRDIKCENL 195
+F+ R + + Q+ ++Y VHRD+ N
Sbjct: 96 HEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC 155
Query: 196 LIDGEYNIKLSDFGFAR---GHMKCKSGHQSPLSDTFCGSYAYASPE-ILKGVPYTPHYS 251
L+ +K+SDFG +R + +S L + PE IL G +T S
Sbjct: 156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL------PVRWMPPEAILYG-KFTTE-S 207
Query: 252 DVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFSPIK 310
D+WS GVVL+ + ++G P+ + ++++ ++++ + P + A L+ + ++ I
Sbjct: 208 DIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIP 267
Query: 311 F-RIRLKDI 318
R R KDI
Sbjct: 268 ARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 55/251 (21%), Positives = 101/251 (40%), Gaps = 31/251 (12%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF-----------LPREID 116
G +G G+Y V+ A T G VA+K V +E D K RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 117 VVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
++ ++H N++ + + ++M+ L + R+ + E + K Q+++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA-- 234
++ H+ +HRD+ N+ I+ + K++DFG AR + G+
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR-----RYGYPPYSDTLSKDETMQR 186
Query: 235 ------------YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
Y +PE+L G D+WS+G + + G+ F N I L ++
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 283 QTKVVFPTEPN 293
+ P E N
Sbjct: 247 FELLGTPNEDN 257
|
Length = 335 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-15
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 40/205 (19%)
Query: 90 CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA-IETTHRVYIIMEYAEK 148
+V VK V K A + L +E ++ GL H N++ L IE +++ Y
Sbjct: 36 EEVFVKTV-KDHASEIQVTLLL-QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNW 93
Query: 149 GSLLDFIQ--REGYIDEPRTKKWFRQLVD-------AIDYCHERGVVHRDIKCENLLIDG 199
G+L F+Q R G + P+ +QLV + Y H+RGV+H+DI N +ID
Sbjct: 94 GNLKLFLQQCRLGEANNPQALST-QQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE 152
Query: 200 EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY-----------AYASPEILKGVPYTP 248
E +K++D +R D F Y + + E L Y+
Sbjct: 153 ELQVKITDNALSR--------------DLFPMDYHCLGDNENRPVKWMALESLVNKEYS- 197
Query: 249 HYSDVWSMGVVLYA-MAFGRLPFDD 272
SDVWS GV+L+ M G+ P+ +
Sbjct: 198 SASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 8e-15
Identities = 58/244 (23%), Positives = 100/244 (40%), Gaps = 41/244 (16%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD------VAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
VL + +G G++ V L H VAVK + E + +K RE +++
Sbjct: 8 VLKRELGEGAFGKVFLGE-CYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELLTN 64
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG----YIDEPRTKK-------- 168
+H N+++F ++ EY E G L F++ G ++ P +
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 169 -WFR-QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK----SGHQ 222
Q+ + Y + VHRD+ N L+ + +K+ DFG +R GH
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 223 S-PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF---DDTNYIQ 277
P+ + PE + +T SDVWS GVVL+ + +G+ P+ + I+
Sbjct: 185 MLPIR--------WMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235
Query: 278 LLKQ 281
+ Q
Sbjct: 236 CITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 41/266 (15%)
Query: 67 VLGKVIGIGSYATVKLATS-------TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVK 119
VLGK +G G + V A + VAVK++ D L E++++K
Sbjct: 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD--LISEMELMK 72
Query: 120 GL-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR------EGYIDEPRTKK---W 169
+ +H N+I L +Y+I+EYA KG+L +F++ + D + +
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 170 FRQLVD-------AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG-----HMKC 217
F+ LV ++Y R +HRD+ N+L+ + +K++DFG ARG + K
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYI 276
S + P+ + +PE L YT H SDVWS G++++ + G P+
Sbjct: 193 TSNGRLPVK--------WMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVE 243
Query: 277 QLLKQVQTKVVFPTEPNVSAECKTLL 302
+L K ++ N + E L+
Sbjct: 244 ELFKLLREGHRMDKPSNCTHELYMLM 269
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 14/222 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV-EAPPDYLKKFLPREIDVVKGLRHP 124
Y + +VIG GSY V A T G VA+K ++ V E D + + REI +++ LRHP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 59
Query: 125 NLIRFLQAIETTHR-----VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
+++ + R +Y++ E E L I+ + + + QL+ A+ Y
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
H V HRD+K +N+L + + +K+ DFG AR + +D + + Y +PE
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN-DTPTAIFWTD-YVATRWYRAPE 176
Query: 240 ILKGV--PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
+ YTP D+WS+G + + G+ F N + L
Sbjct: 177 LCGSFFSKYTPAI-DIWSIGCIFAEVLTGKPLFPGKNVVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 67/277 (24%), Positives = 128/277 (46%), Gaps = 38/277 (13%)
Query: 72 IGIGSYATVKLA----TSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
+G G + V+L G VAVK + K E+ +++ L +EI++++ L H N++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIAD-LKKEIEILRNLYHENIV 69
Query: 128 RF--LQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERG 184
++ + + + + +IME+ GSL +++ R + I+ + K+ Q+ +DY R
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
VHRD+ N+L++ E+ +K+ DFG + ++ + + D + YA +++
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-------------------IQLLKQVQTK 285
Y SDVWS GV LY + L + D+ +L++ ++
Sbjct: 189 FYIA--SDVWSFGVTLYEL----LTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242
Query: 286 VVFPTEPNVSAECKTLLSK--IFSPIKFRIRLKDIKQ 320
P PN E L+ K F P K R +++ +
Sbjct: 243 KRLPRPPNCPEEVYQLMRKCWEFQPSK-RTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 70 KVIGIGSYATVKLATSTRHG----CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
KV+G G++ TV G VA+K++++ P ++ F+ + ++ + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEAL-IMASMDHPH 70
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERG 184
L+R L + + + ++ + G LLD++ + + I W Q+ + Y ER
Sbjct: 71 LVRLL-GVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFAR---GHMK--CKSGHQSPLSDTFCGSYAYASPE 239
+VHRD+ N+L+ ++K++DFG AR G K G + P+ + + E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK--------WMALE 181
Query: 240 ILKGVPYTPHYSDVWSMGVVLYA-MAFGRLPFD 271
+ +T H SDVWS GV ++ M FG P+D
Sbjct: 182 CIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 35/223 (15%)
Query: 71 VIGIGSYATVKLATSTRHGC--DVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLI 127
VIG G++ V A + G D A+K + + + D+ + E++V+ L HPN+I
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 59
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQR-------------EGYIDEPRTKKWFRQLV 174
L A E +Y+ +EYA G+LLDF+++ +++
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 175 DA---IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG---HMKCKSGHQSPLSDT 228
D +DY ++ +HRD+ N+L+ Y K++DFG +RG ++K K+ + P+
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPVR-- 176
Query: 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
+ + E L YT + SDVWS GV+L+ + + G P+
Sbjct: 177 ------WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 67/230 (29%), Positives = 107/230 (46%), Gaps = 20/230 (8%)
Query: 65 GYVLGKVIGIGSYATVKLAT--STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
Y L K +G G+Y V A T VA+K ++ V + K+ L RE+ +++ R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFR 59
Query: 123 -HPNL-------IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLV 174
H N+ I F + +Y+ E E L I+ + + + + Q++
Sbjct: 60 GHKNITCLYDMDIVFPGNF---NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 175 DAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
+ Y H V+HRD+K NLL++ + +K+ DFG ARG + G + + +
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVATRW 174
Query: 235 YASPEI-LKGVPYTPHYSDVWSMGVVLYAMAFGRLP-FDDTNYIQLLKQV 282
Y +PEI L YT DVWS+G +L A GR P F +Y+ L Q+
Sbjct: 175 YRAPEIMLSFQSYTKAI-DVWSVGCIL-AELLGRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 35/223 (15%)
Query: 71 VIGIGSYATVKLATSTRHG--CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLI 127
VIG G++ V A + G + A+K++ + + D+ + E++V+ L HPN+I
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKLGHHPNII 66
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQR-------------EGYIDEPRTKKWFRQLV 174
L A E +YI +EYA G+LLDF+++ G +++ +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 175 DA---IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG---HMKCKSGHQSPLSDT 228
D + Y E+ +HRD+ N+L+ K++DFG +RG ++K K+ + P+
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK-KTMGRLPVR-- 183
Query: 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
+ + E L YT SDVWS GV+L+ + + G P+
Sbjct: 184 ------WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 54/170 (31%), Positives = 76/170 (44%), Gaps = 20/170 (11%)
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDF----IQREGYIDEPRTKKWFRQLVDAIDY 179
P + F A+ V+I ME + SL F + I E K +V A++Y
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 180 CHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH--QSPLSDTFCGSYAYA 236
H + V+HRD+K N+LI+ +KL DFG SG+ S G Y
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI--------SGYLVDSVAKTIDAGCKPYM 170
Query: 237 SPEILKGVPYTPHY---SDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQV 282
+PE + Y SDVWS+G+ + +A GR P+D Q LKQV
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV 220
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 62/229 (27%), Positives = 113/229 (49%), Gaps = 45/229 (19%)
Query: 114 EIDVVKGLRHPNLIRFLQAI--ETTHRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTK 167
E++V++ L+H N++R++ + ++YI+ME+ + G L IQ+ G I+E
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 168 KWFRQLVDAIDYCH--------ERGVVHRDIKCENLLI-----------------DGEYN 202
RQL+ A+ YCH ER V+HRD+K +N+ + +G
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 203 IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHY---SDVWSMGVV 259
K+ DFG ++ G +S ++ + G+ Y SPE+L + T Y SD+W++G +
Sbjct: 181 AKIGDFGLSK-----NIGIES-MAHSCVGTPYYWSPELL--LHETKSYDDKSDMWALGCI 232
Query: 260 LYAMAFGRLPFDDT-NYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFS 307
+Y + G+ PF N+ QL+ +++ P + S E L+ + +
Sbjct: 233 IYELCSGKTPFHKANNFSQLISELKRGPDLPIKGK-SKELNILIKNLLN 280
|
Length = 1021 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 82/325 (25%), Positives = 134/325 (41%), Gaps = 50/325 (15%)
Query: 73 GIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA 132
G + +V LA T G V V++ + +E + K L E+ + RHPN++
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRI-TDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTV 67
Query: 133 IETTHRVYII---MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
T +++I M Y SLL EG + E + ++Y H+ G +HR+
Sbjct: 68 FTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYIHRN 126
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTF----CGSYAYASPEILKGVP 245
IK ++LI G+ + LS G + + ++G ++ + F + SPE+L+
Sbjct: 127 IKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDL 184
Query: 246 YTPHY-SDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--------VFP------- 289
Y + SD++S+G+ +A GR+PF D Q+L Q FP
Sbjct: 185 YGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMK 244
Query: 290 -------------------TEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANP 330
T+ S +T SK FSP + ++QDP E P
Sbjct: 245 NSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDP----EKRP 300
Query: 331 AASAGVETKTLNQSKIDTQANSNSL 355
+AS+ + Q K TQ + SL
Sbjct: 301 SASSLLSHAFFKQVKEQTQGSILSL 325
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 26/227 (11%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV-EAPPDYLKKFLPREIDVVKGLRHP 124
YV K IG G+Y V A ++ VA+K ++ + D + REI +++ L H
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL--REIKLLRHLDHE 64
Query: 125 NLIRFLQAIETTHR-----VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
N+I + HR VYI+ E + L I+ + + + + QL+ + Y
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA----Y 235
H V+HRD+K NLL++ ++K+ DFG AR + F Y Y
Sbjct: 124 IHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---------TTSEKGDFMTEYVVTRWY 174
Query: 236 ASPE-ILKGVPYTPHYSDVWSMGVVLYAMAFGRLP-FDDTNYIQLLK 280
+PE +L YT DVWS+G + A GR P F +Y+ LK
Sbjct: 175 RAPELLLNCSEYTTAI-DVWSVGCIF-AELLGRKPLFPGKDYVHQLK 219
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 9e-14
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 53/256 (20%)
Query: 92 VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151
VAVK + K A K+FL +E ++ HPN+++ L YIIME E G L
Sbjct: 29 VAVKTLRK-GATDQEKKEFL-KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDL 86
Query: 152 LDFIQREGYIDEPRTKKWFRQLVD-AID------YCHERGVVHRDIKCENLLI-----DG 199
L +++ ++L+D +D Y + +HRD+ N L+ D
Sbjct: 87 LSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDA 146
Query: 200 EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY-----------AYASPEILKGVPYTP 248
+ +K+ DFG AR D + Y + +PE L +T
Sbjct: 147 DRVVKIGDFGLAR--------------DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTT 192
Query: 249 HYSDVWSMGVVLYA-MAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFS 307
SDVWS GV+++ + G+ P+ N ++L+ V N + L++ +
Sbjct: 193 Q-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCW- 250
Query: 308 PIKFRIRLKDIKQDPW 323
QDP
Sbjct: 251 -----------AQDPS 255
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS+ V AT++ VAVK +S + + + +E+ ++ L+HPN I +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI 190
H +++MEY GS D ++ + + E + + Y H ++HRDI
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 191 KCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHY 250
K N+L+ +KL+DFG S +S +++F G+ + +PE++ + +
Sbjct: 148 KAGNILLTEPGQVKLADFG---------SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 251 S--DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
DVWS+G+ +A + P + N + L +
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 53/216 (24%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
P ++ A T ++ I++ G L + + G E + + +++ +++ H R
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL-K 242
VV+RD+K N+L+D ++++SD G A K K H S G++ Y +PE+L K
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS------VGTHGYMAPEVLQK 169
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPF-----DDTNYIQLLKQVQTKVVFPTEPN-VSA 296
GV Y +D +S+G +L+ + G PF D + I + T + P+ S
Sbjct: 170 GVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TLTMAVELPDSFSP 224
Query: 297 ECKTLLSKIFS-PIKFRI-----RLKDIKQDPWVKT 326
E ++LL + + R+ +++K+ P+ ++
Sbjct: 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 36/110 (32%), Positives = 66/110 (60%), Gaps = 8/110 (7%)
Query: 162 DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221
EPR + Q++ +++ H+R +++RD+K EN+L+D + N+++SD G A ++ K G
Sbjct: 95 PEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA---VELKDGQ 151
Query: 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYS-DVWSMGVVLYAMAFGRLPF 270
+ + G+ + +PE+L+G Y +S D +++GV LY M R PF
Sbjct: 152 SK--TKGYAGTPGFMAPELLQGEEYD--FSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVS-----KVEAPPDYLKKFLPREIDVVKGLRHPNL 126
IG GS+ V A R VA+K +S E D +K E+ ++ LRHPN
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-----EVRFLQQLRHPNT 77
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGV 185
I + H +++MEY GS D ++ + + E + + Y H
Sbjct: 78 IEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRDIK N+L+ +KL+DFG A + +++F G+ + +PE++ +
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSAS--LVSP-------ANSFVGTPYWMAPEVILAMD 187
Query: 246 YTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
Y DVWS+G+ +A + P + N + L
Sbjct: 188 -EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 31/170 (18%)
Query: 117 VVKGLRH----------------PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY 160
++KGLR PN++ + I + V++++++AE G L I +
Sbjct: 22 ILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN 81
Query: 161 IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220
I E K+W ++V A+D H G+V RD+ N+L+D +I+L+ F
Sbjct: 82 IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYF-----------S 130
Query: 221 HQSPLSDTFCG---SYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGR 267
S + D+ G Y +PE+ G+ D WS+G +L+ + G+
Sbjct: 131 RWSEVEDSCDGEAVENMYCAPEV-GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS+ V A R+ VA+K +S + + + +E+ ++ LRHPN I++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI 190
H +++MEY GS D ++ + + E + + Y H ++HRD+
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141
Query: 191 KCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHY 250
K N+L+ +KL DFG A +P ++ F G+ + +PE++ + +
Sbjct: 142 KAGNILLSEPGLVKLGDFGSA--------SIMAP-ANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 251 S--DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
DVWS+G+ +A + P + N + L +
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 65/223 (29%), Positives = 113/223 (50%), Gaps = 35/223 (15%)
Query: 71 VIGIGSYATVKLATSTRHGC--DVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLI 127
VIG G++ V A + G D A+K + + + D+ + E++V+ L HPN+I
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 71
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYID-EP------RTKKWF--RQLVD--- 175
L A E +Y+ +EYA G+LLDF+++ ++ +P T +QL+
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 176 ----AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG---HMKCKSGHQSPLSDT 228
+DY ++ +HRD+ N+L+ Y K++DFG +RG ++K K+ + P+
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPVR-- 188
Query: 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
+ + E L YT + SDVWS GV+L+ + + G P+
Sbjct: 189 ------WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 19/225 (8%)
Query: 81 KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140
+ ST G ++++K L EI + L H N+++ + + + Y
Sbjct: 180 RGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTY 239
Query: 141 IIMEYAEKGSLLDFIQREG--YIDEP---RTKKWFRQLVDAIDYCHERGVVHRDIKCENL 195
+I + + L F+ E + D P +T+ +QL+ A++Y H++ ++HRDIK EN+
Sbjct: 240 MITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298
Query: 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWS 255
++ + I L DFG A K + + G+ A SPEIL G Y +D+WS
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEK----EREAFDYGWVGTVATNSPEILAGDGYC-EITDIWS 353
Query: 256 MGVVLYAM-AFGRLPFDDTN---YIQLLKQVQTKVV----FPTEP 292
G++L M + P D QLLK + + V FP P
Sbjct: 354 CGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 64/243 (26%), Positives = 109/243 (44%), Gaps = 41/243 (16%)
Query: 68 LGKVIGIGSYATVKLATST-------RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
LGK +G G + V +A + + VAVK++ D L E++++K
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMKM 76
Query: 121 L-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYI------------DEPRTK 167
+ +H N+I L A +Y+I+EYA KG+L ++++ DE T
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 168 KWF----RQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKCK 218
K Q+ ++Y + +HRD+ N+L+ +K++DFG AR + K
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQ 277
+ + P+ + +PE L YT H SDVWS GV+++ + G P+ +
Sbjct: 197 TNGRLPVK--------WMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 278 LLK 280
L K
Sbjct: 248 LFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 69/246 (28%), Positives = 118/246 (47%), Gaps = 45/246 (18%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD---------VAVKVVSKVEAPPDYLKKFLPREIDV 117
VLGK +G G + V +A + G D VAVK++ K +A L + E+++
Sbjct: 21 VLGKPLGEGCFGQVVMAEAI--GLDKEKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEM 76
Query: 118 VKGL-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--REGYID-------EPRTK 167
+K + +H N+I L A +Y+I+EYA KG+L ++++ R ++ P +
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 168 KWFRQLVD-------AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-----GHM 215
F+ LV ++Y + +HRD+ N+L+ + +K++DFG AR +
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTN 274
K + + P+ + +PE L YT H SDVWS GV+L+ + G P+
Sbjct: 197 KKTTNGRLPVK--------WMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVP 247
Query: 275 YIQLLK 280
+L K
Sbjct: 248 VEELFK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 28/168 (16%)
Query: 113 REIDVVKGLRHPNLIRFLQAIETTH---RVYIIMEYAEKG--SLLDFIQREGYIDEP--- 164
REI +++ L+HPN+I LQ + +H +V+++ +YAE ++ F + +P
Sbjct: 47 REIALLRELKHPNVIS-LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 105
Query: 165 ---RTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE----YNIKLSDFGFARGHMKC 217
K Q++D I Y H V+HRD+K N+L+ GE +K++D GFAR
Sbjct: 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR----- 160
Query: 218 KSGHQSPLS-----DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVL 260
SPL D ++ Y +PE+L G + D+W++G +
Sbjct: 161 --LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF--LPREIDVVKGLRHPNL 126
K++G G + TV G + + V K + F + + + L H +
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+R L I + ++ + + GSLLD + Q +D R W Q+ + Y E +
Sbjct: 72 VRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKCKSGHQSPLSDTFCGSYAYASPEI 240
VHR++ N+L+ + ++++DFG A S H++P+ A I
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK-------WMALESI 183
Query: 241 LKGVPYTPHYSDVWSMGVVLYA-MAFGRLPF 270
L G YT H SDVWS GV ++ M++G P+
Sbjct: 184 LFG-RYT-HQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 7e-13
Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS+ V A R VA+K +S + + + +E+ ++ ++HPN I +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI 190
H +++MEY GS D ++ + + E + + Y H ++HRDI
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 151
Query: 191 KCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHY 250
K N+L+ +KL+DFG A SP +++F G+ + +PE++ + +
Sbjct: 152 KAGNILLTEPGQVKLADFGSA--------SIASP-ANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 251 S--DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
DVWS+G+ +A + P + N + L +
Sbjct: 203 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 22/227 (9%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ L +V+G G+Y V + G A+KV+ E + +K EI+++K H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL----EINMLKKYSHHR 73
Query: 126 LIR-----FLQAIETTH--RVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDA 176
I F++ H +++++ME+ GS+ D ++ + + E R+++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
+ + H V+HRDIK +N+L+ +KL DFG + + G + +TF G+ +
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRR----NTFIGTPYWM 188
Query: 237 SPEIL---KGVPYTPHY-SDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
+PE++ + T Y SD+WS+G+ MA G P D + ++ L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 8e-13
Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 28/168 (16%)
Query: 113 REIDVVKGLRHPNLIRFLQAIETTH---RVYIIMEYAEKG--SLLDFIQREGYIDEPR-- 165
REI +++ L+HPN+I LQ + +H +V+++ +YAE ++ F + +P
Sbjct: 47 REIALLRELKHPNVIA-LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQL 105
Query: 166 ----TKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE----YNIKLSDFGFARGHMKC 217
K Q++D I Y H V+HRD+K N+L+ GE +K++D GFAR
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR----- 160
Query: 218 KSGHQSPLS-----DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVL 260
SPL D ++ Y +PE+L G + D+W++G +
Sbjct: 161 --LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 72 IGIGSYATVKLATSTRHGCD-VAVKVVSKVEAPPDYLKKFLPREIDVVKGLR---HPNLI 127
IG G+Y V A ++G VA+K V +V+ + + RE+ V++ L HPN++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 128 RFLQAIETTH-----RVYIIMEYAEKG--SLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
R + ++ ++ E+ ++ + LD + G E K QL+ +D+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKDMMFQLLRGLDFL 126
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H VVHRD+K +N+L+ IKL+DFG AR + Q L+ + Y +PE+
Sbjct: 127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-----SFQMALTSVVVTLW-YRAPEV 180
Query: 241 LKGVPY-TPHYSDVWSMGVVLYAMAFGRLPF 270
L Y TP D+WS+G + +A F R P
Sbjct: 181 LLQSSYATP--VDLWSVGCI-FAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 60/270 (22%), Positives = 120/270 (44%), Gaps = 31/270 (11%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIR 128
+ IG G+Y V + ++G AVK++ P + + + E +++K L HPN+++
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILD----PIHDIDEEIEAEYNILKALSDHPNVVK 79
Query: 129 FL-----QAIETTHRVYIIMEYAEKGSLLD----FIQREGYIDEPRTKKWFRQLVDAIDY 179
F + ++ ++++++E GS+ D F++R ++EP + + + +
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
H +HRD+K N+L+ E +KL DFG + + + + F + +PE
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-----WMAPE 194
Query: 240 ILK-----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294
++ Y DVWS+G+ + G P D + ++ L ++ P P
Sbjct: 195 VIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKI------PRNPPP 247
Query: 295 SAECKTLLSKIFSPIKFRIRLKDIKQDPWV 324
+ L S F+ + KD ++ P V
Sbjct: 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTV 277
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 64/245 (26%), Positives = 107/245 (43%), Gaps = 21/245 (8%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKV---EAPPDYLKKFLPREIDVVKGLRHPNL 126
KV+G G++ TV G +V + V KV P K+ L E V+ G+ P +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVGSPYV 71
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
R L I T V ++ + G LLD++ + + I W Q+ + Y E +
Sbjct: 72 CRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKCKSGHQSPLSDTFCGSYAYASPEI 240
VHRD+ N+L+ ++K++DFG AR G + P+ + + E
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK--------WMALES 182
Query: 241 LKGVPYTPHYSDVWSMGVVLYA-MAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299
+ +T H SDVWS GV ++ M FG P+D ++ ++ P P + +
Sbjct: 183 ILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241
Query: 300 TLLSK 304
++ K
Sbjct: 242 MIMVK 246
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 9e-13
Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 31/233 (13%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGC---DVAVKVVSKVEAPPDYL--KKFLPREIDVVKGL 121
GK +G G++ V AT+ +G D +KV K+ P + ++ L E+ ++ L
Sbjct: 38 SFGKTLGAGAFGKVVEATA--YGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 122 -RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAID 178
H N++ L A + +I EY G LL+F++R E ++ + Q+ +
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK-----CKSGHQSPLSDTFCGSY 233
+ + +HRD+ N+L+ +K+ DFG AR M K + P+
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK------- 208
Query: 234 AYASPE-ILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFD----DTNYIQLLK 280
+ +PE I V YT SDVWS G++L+ + + G P+ D+ + +L+K
Sbjct: 209 -WMAPESIFNCV-YTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK 258
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-13
Identities = 49/221 (22%), Positives = 95/221 (42%), Gaps = 24/221 (10%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G + V L VA+K + + + + E V+ L HP L++
Sbjct: 12 IGSGQFGLVWLG-YWLEKRKVAIKTIREGAMSEEDFIE----EAQVMMKLSHPKLVQLYG 66
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI 190
+ ++ E+ E G L D+++ + G + + + + Y V+HRD+
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 191 KCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA------YASPEILKGV 244
N L+ +K+SDFG R L D + S ++SPE+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTR----------FVLDDQYTSSTGTKFPVKWSSPEVFSFS 176
Query: 245 PYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQT 284
Y+ SDVWS GV+++ + + G+ P+++ + ++++ +
Sbjct: 177 KYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA 216
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 92 VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY-IIMEYAEKGS 150
VAVKV+ + +A + + FL +E+ ++ L PN+ R L + T +IMEY E G
Sbjct: 49 VAVKVL-RPDASDNAREDFL-KEVKILSRLSDPNIARLL-GVCTVDPPLCMIMEYMENGD 105
Query: 151 LLDFIQREGYIDEPRTKKWFR-------------QLVDAIDYCHERGVVHRDIKCENLLI 197
L F+Q+ ++ E Q+ + Y VHRD+ N L+
Sbjct: 106 LNQFLQK--HVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
Query: 198 DGEYNIKLSDFGFARGHMKC---KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVW 254
Y IK++DFG +R + ++PL + + E + +T SDVW
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPL------PIRWMAWESVLLGKFTTK-SDVW 216
Query: 255 SMGVVLYA-MAFGRL-PFDD-------TNYIQLLKQVQTKVVFPTEPNVSAEC 298
+ GV L+ + R P++ N + ++ P PN +
Sbjct: 217 AFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDI 269
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 40/225 (17%)
Query: 68 LGKVIGIGSYATVKLATS-------TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
LGK +G G + V +A + VAVK++ D L E++++K
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD--LVSEMEMMKM 73
Query: 121 L-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDE-------PRTKKWF 170
+ +H N+I L A +Y+++EYA KG+L ++++ R +D P + F
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 171 RQLVD-------AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKCK 218
+ LV ++Y + +HRD+ N+L+ + +K++DFG AR + K
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM 263
+ + P+ + +PE L YT H SDVWS GV+L+ +
Sbjct: 194 TNGRLPVK--------WMAPEALFDRVYT-HQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 56/228 (24%), Positives = 109/228 (47%), Gaps = 24/228 (10%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHP 124
+ L +++G G+Y V + G A+KV+ + +K+ EI+++K H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSHHR 63
Query: 125 NLIRFLQAIETTH------RVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDA 176
N+ + A + +++++ME+ GS+ D I+ + + E R+++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
+ + H+ V+HRDIK +N+L+ +KL DFG + + G + +TF G+ +
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRR----NTFIGTPYWM 178
Query: 237 SPEILKGVPYTPHY-----SDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
+PE++ P SD+WS+G+ MA G P D + ++ L
Sbjct: 179 APEVI-ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 70 KVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+VIG G + V L S AVK ++++ + +++FL +E ++K HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFL-KEGIIMKDFSHPNV 58
Query: 127 IRFLQ-AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFR---QLVDAIDYCHE 182
+ L + + +++ Y + G L +FI+ E + P K Q+ ++Y
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLAS 116
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARG-------HMKCKSGHQSPLSDTFCGSYAY 235
+ VHRD+ N ++D + +K++DFG AR + +G + P+ +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK--------W 168
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYA-MAFGRLP------FDDTNYI 276
+ E L+ +T SDVWS GV+L+ M G P FD T Y+
Sbjct: 169 MALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 59/260 (22%), Positives = 110/260 (42%), Gaps = 45/260 (17%)
Query: 88 HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAE 147
H VA+K + + P + + +E ++ L HPN++ L + V ++ EY
Sbjct: 33 HAQLVAIKTLKDINNPQQWGE--FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90
Query: 148 KGSLLDF-IQREGYID------EPRTKK----------WFRQLVDAIDYCHERGVVHRDI 190
+G L +F I R + D E T K Q+ ++Y VH+D+
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDL 150
Query: 191 KCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHY 250
N+LI + ++K+SD G +R + + Y P+ L + + P
Sbjct: 151 AARNILIGEQLHVKISDLGLSR--------------EIYSADYYRVQPKSLLPIRWMPPE 196
Query: 251 ----------SDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299
SD+WS GVVL+ + +FG P+ + ++++ V+ + + P +
Sbjct: 197 AIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMY 256
Query: 300 TLLSKIFSPI-KFRIRLKDI 318
+L+++ + R R KDI
Sbjct: 257 SLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 22/185 (11%)
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
A ET + +++ G L I G +E R + ++ ++ H+ +V+RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTF---CGSYAYASPEILKGVPY 246
+K EN+L+D +I++SD G A P T G+ Y +PE++K Y
Sbjct: 128 LKPENILLDDHGHIRISDLGLAV---------HVPEGQTIKGRVGTVGYMAPEVVKNERY 178
Query: 247 TPHYSDVWSMGVVLYAMAFGRLPFDD-------TNYIQLLKQVQTKVVFPTEPNVSAECK 299
T D W++G +LY M G+ PF +L+K+VQ + P+ + CK
Sbjct: 179 T-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237
Query: 300 TLLSK 304
LL K
Sbjct: 238 MLLCK 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 49/227 (21%), Positives = 101/227 (44%), Gaps = 23/227 (10%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIR 128
+ IG G+Y V T+ + G AVK++ P + + + E ++++ L HPN+++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILD----PISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 129 FLQAIETTHR-----VYIIMEYAEKGSLLDFIQ----REGYIDEPRTKKWFRQLVDAIDY 179
F + +++++E GS+ + ++ +DE + + +
Sbjct: 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
H ++HRD+K N+L+ E +KL DFG + + + + F + +PE
Sbjct: 144 LHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-----WMAPE 198
Query: 240 ILK-GVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
++ Y Y DVWS+G+ + G P D + ++ L ++
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 47/187 (25%), Positives = 86/187 (45%), Gaps = 15/187 (8%)
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCH 181
H N++R I + + I+ EY G+L F+++ EG + + L + Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA--YASPE 239
E G VH+ + +L++ + K+S GF R + + T G +A+PE
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKIS--GFRRL----QEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 240 ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298
++ ++ SDVWS G+V++ M++G P+ D + ++K V+ P N C
Sbjct: 179 AIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRN----C 233
Query: 299 KTLLSKI 305
LL ++
Sbjct: 234 PNLLHQL 240
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 39/148 (26%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
P ++ A T ++ I++ G L + + G E + + +++ +++ H R
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL-K 242
VV+RD+K N+L+D ++++SD G A C + P + G++ Y +PE+L K
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASV--GTHGYMAPEVLQK 169
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPF 270
G Y +D +S+G +L+ + G PF
Sbjct: 170 GTAYDSS-ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 17/103 (16%)
Query: 171 RQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT-- 228
R ++ AI Y HE ++HRDIK EN+ I+ ++ L DFG A C P+
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA-----C-----FPVDINAN 238
Query: 229 ----FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGR 267
+ G+ A +PE+L PY P D+WS G+VL+ MA
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAV-DIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP----REIDVVKGL 121
Y IG G++ V A + VA+K V K+ P REI +++ L
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-----KEGFPITALREIKILQLL 68
Query: 122 RHPNLIRFLQAIETTHR--------VYIIMEYAEK--GSLLDFIQREGYIDEPRTKKWFR 171
+H N++ ++ T Y++ E+ E LL + KK +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK--FTLSEIKKVMK 126
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
L++ + Y H ++HRD+K N+LI + +KL+DFG AR K+ +
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS-KPNRYTNRVV 185
Query: 232 SYAYASPEILKGVPYTPHYS---DVWSMGVVLYAM 263
+ Y PE+L G Y D+W G ++ M
Sbjct: 186 TLWYRPPELLLG---ERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 72 IGIGSYATVK--LATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
+G G++ VK + + DVA+KV+ + + RE +++ L +P ++R
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV--RDEMMREAEIMHQLDNPYIVRM 60
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+ E + ++ME A G L F+ ++ I + Q+ + Y + VHR
Sbjct: 61 IGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 189 DIKCENLLIDGEYNIKLSDFGFARG------HMKCKSGHQSPLSDTFCGSYAYASPEILK 242
D+ N+L+ ++ K+SDFG ++ + K +S + PL + +PE +
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK--------WYAPECIN 171
Query: 243 GVPYTPHYSDVWSMGVVLY-AMAFGRLPF 270
++ SDVWS G+ ++ A ++G+ P+
Sbjct: 172 FRKFSSR-SDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 57/254 (22%), Positives = 112/254 (44%), Gaps = 33/254 (12%)
Query: 55 KKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPRE 114
+K V+ + GY + K + GS V +AT V +K+ K ++ L +
Sbjct: 57 QKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQN 113
Query: 115 IDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQL 173
++ HP++IR + + +++ + L ++ +R + + +Q+
Sbjct: 114 VN------HPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQI 166
Query: 174 VDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
++ + Y H + ++HRD+K EN+ I+ + + D G A+ + +P G+
Sbjct: 167 LEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV------VAPAFLGLAGTV 220
Query: 234 AYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDD----------TNYIQLLKQV 282
+PE+L Y +D+WS G+VL+ M A+ F+D + + LLK +
Sbjct: 221 ETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 283 QTKVV----FPTEP 292
T V FP +P
Sbjct: 280 STLKVHPEEFPRDP 293
|
Length = 357 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 92 VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151
VA+K V++ + + ++ FL E V+K +++R L + +IME +G L
Sbjct: 39 VAIKTVNEAASMRERIE-FL-NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 96
Query: 152 LDFI-------QREGYIDEPRTKKWFR---QLVDAIDYCHERGVVHRDIKCENLLIDGEY 201
++ + P KK + ++ D + Y + VHRD+ N ++ ++
Sbjct: 97 KSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 156
Query: 202 NIKLSDFGFARGHMKC---KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGV 258
+K+ DFG R + + G + L + SPE LK +T + SDVWS GV
Sbjct: 157 TVKIGDFGMTRDIYETDYYRKGGKGLL------PVRWMSPESLKDGVFTTY-SDVWSFGV 209
Query: 259 VLYAMA-FGRLPFDDTNYIQLLKQV 282
VL+ +A P+ + Q+L+ V
Sbjct: 210 VLWEIATLAEQPYQGMSNEQVLRFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 54/196 (27%), Positives = 80/196 (40%), Gaps = 42/196 (21%)
Query: 92 VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151
VAVK++ + + FL +EI ++ L++PN+IR L + + +I EY E G L
Sbjct: 47 VAVKML-RADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 152 LDFI-QREGY-----------IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG 199
F+ QRE + Q+ + Y VHRD+ N L+
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 200 EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA------------YASPEILKGVPYT 247
Y IK++DFG +R + + G Y A IL G T
Sbjct: 165 HYTIKIADFGMSR--------------NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT 210
Query: 248 PHYSDVWSMGVVLYAM 263
SDVW+ GV L+ M
Sbjct: 211 A--SDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 56/185 (30%), Positives = 81/185 (43%), Gaps = 25/185 (13%)
Query: 92 VAVKVV---SKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148
VAVK++ + A D+LK EI ++ L+ PN+IR L T+ + +I EY E
Sbjct: 49 VAVKMLREDANKNARNDFLK-----EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 149 GSLLDFIQR-----EGYIDEPRTKKWFR------QLVDAIDYCHERGVVHRDIKCENLLI 197
G L F+ R + T + Q+ + Y VHRD+ N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 198 DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE-ILKGVPYTPHYSDVWSM 256
Y IK++DFG +R SG + + S E IL G T SDVW+
Sbjct: 164 GKNYTIKIADFGMSR---NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA--SDVWAF 218
Query: 257 GVVLY 261
GV L+
Sbjct: 219 GVTLW 223
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 18/183 (9%)
Query: 132 AIETTHRVYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
A ET + +++ G L I G +E R + +++ ++ H V+RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
+K EN+L+D +I++SD G A +K G G+ Y +PE+L YT
Sbjct: 128 LKPENILLDDYGHIRISDLGLA---VKIPEGE---SIRGRVGTVGYMAPEVLNNQRYT-L 180
Query: 250 YSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE--------CKTL 301
D W +G ++Y M G+ PF ++V +V+ TE SA+ CK L
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL-ETEEVYSAKFSEEAKSICKML 239
Query: 302 LSK 304
L+K
Sbjct: 240 LTK 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 56/227 (24%), Positives = 89/227 (39%), Gaps = 34/227 (14%)
Query: 72 IGIGSYATVKLAT-----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
IG G++ V A VAVK++ K EA D F RE ++ HPN+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQ-REAALMAEFDHPNI 70
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFI----------------------QREGYIDEP 164
++ L + ++ EY G L +F+ +
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 165 RTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224
+Q+ + Y ER VHRD+ N L+ +K++DFG +R S
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR---NIYSADYYK 187
Query: 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
S+ + PE + YT SDVW+ GVVL+ + ++G P+
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 92 VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151
VAVK V++ + + ++ FL E V+KG +++R L + ++ME G L
Sbjct: 39 VAVKTVNESASLRERIE-FL-NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 96
Query: 152 LDFIQ--REGYIDEP-RTKKWFRQLV-------DAIDYCHERGVVHRDIKCENLLIDGEY 201
+++ R + P R ++++ D + Y + + VHRD+ N ++ ++
Sbjct: 97 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 156
Query: 202 NIKLSDFGFARGHMKC---KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGV 258
+K+ DFG R + + G + L + +PE LK +T SD+WS GV
Sbjct: 157 TVKIGDFGMTRDIYETDYYRKGGKGLL------PVRWMAPESLKDGVFTT-SSDMWSFGV 209
Query: 259 VLYAM-AFGRLPFDDTNYIQLLKQV 282
VL+ + + P+ + Q+LK V
Sbjct: 210 VLWEITSLAEQPYQGLSNEQVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 33/233 (14%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + ++IG G V LA VA+K + + + LKK RE + L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFI----QREGYIDEPRTK-------KWFRQLV 174
++ VY M Y E +L + Q+E E K F ++
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 175 DAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT------ 228
I+Y H +GV+HRD+K +N+L+ + + D+G A K + L D
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA----IFKKLEEEDLLDIDVDERN 179
Query: 229 -----------FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF 270
G+ Y +PE L GVP + +D++++GV+LY M P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 59/251 (23%), Positives = 110/251 (43%), Gaps = 36/251 (14%)
Query: 92 VAVKVVS-KVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGS 150
VA+K + K E P L++ E + L+HPN++ L + + +I Y
Sbjct: 38 VAIKTLKDKAEGP---LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD 94
Query: 151 LLDFIQRE------GYIDEPRTKK----------WFRQLVDAIDYCHERGVVHRDIKCEN 194
L +F+ G D+ +T K Q+ +++ VVH+D+ N
Sbjct: 95 LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154
Query: 195 LLIDGEYNIKLSDFG-----FARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
+L+ + N+K+SD G +A + K P+ + SPE + ++
Sbjct: 155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR--------WMSPEAIMYGKFSID 206
Query: 250 YSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFSP 308
SD+WS GVVL+ + ++G P+ + +++ ++ + V P + A TL+ + ++
Sbjct: 207 -SDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNE 265
Query: 309 I-KFRIRLKDI 318
R R KDI
Sbjct: 266 FPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 12/220 (5%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
V+G+ G TV LA G V V+ ++ +EA + + FL E+ V K HPN+
Sbjct: 5 VIGR--GFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHPNI 61
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFI--QREGYIDEPRTKKWFRQLVDAIDYCHERG 184
+ + + ++++ + GS D I + E + ++ A+DY H G
Sbjct: 62 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA----YASPEI 240
VHR +K ++LI + + LS G G + + F + SPE+
Sbjct: 122 YVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEV 179
Query: 241 L-KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
L + + SD++S+G+ +A G +PF D Q+L
Sbjct: 180 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGC---DVAVKVVSKVEAPPDYLKKFLPREIDV 117
++ H VL + +G G++ V LA + C D + V ++ D +K RE ++
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLA-ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 60
Query: 118 VKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG-------------YIDEP 164
+ L+H ++++F + ++ EY + G L F++ G + +
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 165 RTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK----SG 220
+ +Q+ + Y + VHRD+ N L+ +K+ DFG +R G
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 221 HQS-PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
H P+ + PE + +T SDVWS+GVVL+ + +G+ P+
Sbjct: 181 HTMLPIR--------WMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 37/229 (16%)
Query: 66 YVLGKVIGIGSYATVK---LATSTRHGCDVAVKVV-SKVEAPPDYLKKFLPREIDVVKGL 121
+ LG+++G G + +V+ L + VAVK++ + + + D +++FL RE +K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFL-REAACMKEF 58
Query: 122 RHPNLIRFLQAIETTHRV-------YIIMEYAEKGSLLDFIQREGYIDEPRT---KKWFR 171
HPN+I+ L + R +I+ + + G L F+ +EP T + R
Sbjct: 59 DHPNVIK-LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 172 QLVD---AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228
++D ++Y + +HRD+ N +++ + ++DFG ++ K SG D
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK---KIYSG------DY 168
Query: 229 F---CGS---YAYASPEILKGVPYTPHYSDVWSMGVVLYA-MAFGRLPF 270
+ C S + + E L YT H SDVW+ GV ++ M G+ P+
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 15/113 (13%)
Query: 162 DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221
DE R + ++ ++ H +V+RD+K EN+L+D +I++SD G A
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAV--------- 150
Query: 222 QSPLSDTF---CGSYAYASPEILKGVPYTPHYS-DVWSMGVVLYAMAFGRLPF 270
+ P +T G+ Y +PE++K YT +S D W +G ++Y M G+ PF
Sbjct: 151 EIPEGETIRGRVGTVGYMAPEVVKNERYT--FSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 50/222 (22%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 68 LGKVIGIGSYATVKLATSTRHGC---DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
LGK++G G + +V ++ VAVK + +++FL E +K HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHP 61
Query: 125 NLIRFL------QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPR---TKKWFRQLVD 175
N+++ + +++ + +I+ + + G L F+ P + + +VD
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 176 ---AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG---HQSPLSDTF 229
++Y R +HRD+ N ++ + + ++DFG ++ K SG Q ++
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK---KIYSGDYYRQGRIAKM- 177
Query: 230 CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPF 270
+ + E L YT SDVW+ GV ++ +A G+ P+
Sbjct: 178 --PVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 13/112 (11%)
Query: 162 DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221
DE R + +L ++ +V+RD+K EN+L+D +I++SD G A
Sbjct: 100 DEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV--------- 150
Query: 222 QSPLSDTF---CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF 270
Q P +T G+ Y +PE++ YT D W +G ++Y M G+ PF
Sbjct: 151 QIPEGETVRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 39/231 (16%)
Query: 67 VLGKVIGIGSYATVKLA-----TSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
VL + +G G++ V LA + T+ VAVK + P +K RE +++ L
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---PTLAARKDFQREAELLTNL 64
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG-----YID-EPRTKKW------ 169
+H ++++F + ++ EY + G L F++ G +D +PR K
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 170 ----FRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK----SGH 221
Q+ + Y + VHRD+ N L+ +K+ DFG +R GH
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 222 QS-PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
P+ + PE + +T SDVWS GV+L+ + +G+ P+
Sbjct: 185 TMLPIR--------WMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 66/288 (22%), Positives = 119/288 (41%), Gaps = 53/288 (18%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--PDYLKKFLPREIDVVKGLRHPNLI 127
IG G + V L + R G A VV ++ A PD FL +E+ + L HPN++
Sbjct: 1 DEIGNGWFGKVLLGEAHR-GMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVL 58
Query: 128 RFL-QAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDAID---YCH 181
+ L Q IE+ + +++E+ G L ++++ R + R + + H
Sbjct: 59 QCLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFA-----RGHMKCKSGHQSPLSDTFCGSYAYA 236
+ +H D+ N + + ++K+ D+G A + K H PL +
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--------WL 169
Query: 237 SPEI-------LKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQV----QT 284
+PE+ L T S++WS+GV ++ + P+ D + Q+LKQV
Sbjct: 170 APELVEIRGQDLLPKDQT-KKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228
Query: 285 KVVFPTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAA 332
K+ +P + +K+ R ++ Q W+ E P A
Sbjct: 229 KL---PKPQLD-------------LKYSDRWYEVMQFCWLDPETRPTA 260
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 20/218 (9%)
Query: 68 LGKVIGIGSYATVK--LATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
LGK +G G + +V VAVK + ++ FL E +K HPN
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHPN 61
Query: 126 LIRFLQA-IETTHR-----VYIIMEYAEKGSLLDFIQREGYIDEPR------TKKWFRQL 173
++R + ++T +I+ + + G L F+ D P+ K+ +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 174 VDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
++Y + +HRD+ N +++ N+ ++DFG ++ Q ++
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM---PV 178
Query: 234 AYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPF 270
+ + E L YT SDVWS GV ++ +A G+ P+
Sbjct: 179 KWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 57/235 (24%), Positives = 91/235 (38%), Gaps = 54/235 (22%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCD-----VAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
L + +G G++ V D VAVK + + + D FL E ++
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-FL-MEALIMSKFN 67
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF-----------R 171
H N++R + +I++E G L F+ RE PR ++ R
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-REN---RPRPERPSSLTMKDLLFCAR 123
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLID--GEYNI-KLSDFGFARGHMKCKSGHQSPLSDT 228
+ Y E +HRDI N L+ G + K++DFG AR D
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--------------DI 169
Query: 229 FCGSY-----------AYASPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPF 270
+ SY + PE L G+ + +DVWS GV+L+ + G +P+
Sbjct: 170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK--TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 30/235 (12%)
Query: 70 KVIGIGSYATVKLATSTRHGCD-----VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
+G G + V LA + + V VK + K + L+ RE+D+ + L H
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHK 68
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFR---------QLVD 175
N++R L Y+I+EY + G L F++ DE Q+
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK---CK-SGHQSPLSDTFCG 231
+D+ VHRD+ N L+ + +K+S ++ K PL
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR----- 183
Query: 232 SYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTK 285
+ +PE ++ ++ SDVWS GV+++ + G LPF + ++L ++Q
Sbjct: 184 ---WLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 50/203 (24%), Positives = 77/203 (37%), Gaps = 49/203 (24%)
Query: 92 VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151
VAVK++ + +A + FL +E+ ++ L+ PN+IR L + +I EY E G L
Sbjct: 49 VAVKIL-RPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 152 LDFIQREGYIDE-------------------PRTKKWFRQLVDAIDYCHERGVVHRDIKC 192
F+ D+ Q+ + Y VHRD+
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLAT 166
Query: 193 ENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA------------YASPEI 240
N L+ IK++DFG +R + + G Y A I
Sbjct: 167 RNCLVGENLTIKIADFGMSR--------------NLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 241 LKGVPYTPHYSDVWSMGVVLYAM 263
L G T SDVW+ GV L+ +
Sbjct: 213 LMGKFTTA--SDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 42/196 (21%), Positives = 79/196 (40%), Gaps = 32/196 (16%)
Query: 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWF----RQLVDAIDYCHERGVVHRDIKCENLL 196
++ EY + G L F+ RE + W +QL A+ Y ++ +VH ++ +N+L
Sbjct: 77 MVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNIL 133
Query: 197 I-----DGEYN--IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
+ + Y IKLSD G + + + +PE ++ +
Sbjct: 134 VARYGLNEGYVPFIKLSDPGIPI----TVLSREERVERI-----PWIAPECIRNGQASLT 184
Query: 250 -YSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFS 307
+D WS G L + G P + + + Q + P P+ AE L+++ ++
Sbjct: 185 IAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM-PD-CAELANLINQCWT 242
Query: 308 P-----IKFRIRLKDI 318
FR L+D+
Sbjct: 243 YDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 67/278 (24%), Positives = 117/278 (42%), Gaps = 33/278 (11%)
Query: 70 KVIGIGSYATVKLA--TSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
K IG G + V L S V VK + +V A KFL E + L+H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFL-EEAQPYRSLQHSNLL 58
Query: 128 RFL-QAIETTHRVYIIMEYAEKGSLLDFIQR----EGYIDEPRT-KKWFRQLVDAIDYCH 181
+ L Q E T + ++ME+ G L +++ E +P T ++ ++ + + H
Sbjct: 59 QCLGQCTEVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+ +H D+ N L+ + +K+ D+G + H K K + D + +PE++
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLS--HNKYKEDYYVT-PDQLWVPLRWIAPELV 174
Query: 242 KGVPYT------PHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294
V S+VWS+GV ++ + G P+ + +QV T V
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD----EQVLTYTV------- 223
Query: 295 SAECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAA 332
E + L K + R ++ Q W++ E P+A
Sbjct: 224 -REQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSA 260
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 54/242 (22%), Positives = 99/242 (40%), Gaps = 37/242 (15%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD-----VAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
VL +G G++ V LA + VAVK + + + ++ RE +++ L
Sbjct: 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVL 64
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG----YIDE-----------PRT 166
+H +++RF + ++ EY G L F++ G + +
Sbjct: 65 QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 167 KKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC---KSGHQS 223
Q+ + Y VHRD+ N L+ +K+ DFG +R + G ++
Sbjct: 125 LAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF---DDTNYIQLL 279
L + PE + +T SD+WS GVVL+ + +G+ P+ +T I+ +
Sbjct: 185 ML------PIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
Query: 280 KQ 281
Q
Sbjct: 238 TQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 64/277 (23%), Positives = 104/277 (37%), Gaps = 78/277 (28%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK-------VE---------APPDYLKK 109
+VLGK +G G++ V A+ K V K VE A P+
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193
Query: 110 FLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-------EGYI- 161
F+ ++ V + +++ Y + +L D +Q E Y+
Sbjct: 194 FVYGFLEPVSSKKEDEY-------------WLVWRYEGESTLADLMQSKEFPYNVEPYLL 240
Query: 162 ----DEPR--------TKKWFRQLVDAIDYCHERGVVHRDIKCENLLID-GEYNIKLSDF 208
D P+ + RQ++ A+D H G+VHRD+K +N++ G + K+ D
Sbjct: 241 GKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDL 300
Query: 209 GFARGHMKCKSG-HQSPLSDTFCGSYAYASPE--ILK----GVPYT-------------- 247
G A + G + P F YA+PE I+ P
Sbjct: 301 GAA---ADLRVGINYIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355
Query: 248 -PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ 283
P D++S G++ MAF L D N IQ +Q++
Sbjct: 356 LPDRFDIYSAGLIFLQMAFPNLRSDS-NLIQFNRQLK 391
|
Length = 566 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 37/178 (20%), Positives = 79/178 (44%), Gaps = 34/178 (19%)
Query: 114 EIDVVKGLRHPNLIR----FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKW 169
EI ++ + N+++ + ++ R+ +I+EY +G L + + +E +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLS------- 120
Query: 170 FRQLVD-AIDYCHERGVV---------HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219
F+ +D AID C +G+ ++++ + L+ Y +K+ H K
Sbjct: 121 FKTKLDMAIDCC--KGLYNLYKYTNKPYKNLTSVSFLVTENYKLKII------CHGLEKI 172
Query: 220 GHQSPLSDTFCGSYAYASPEILKGV--PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY 275
P + Y S ++L + YT D++S+GVVL+ + G++PF++
Sbjct: 173 LSSPPFKNV--NFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTT 227
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
Q+ + +++ + VHRD+ N+LI +K+ DFG AR M+ S + S S TF
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGS-TFL- 303
Query: 232 SYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDD 272
+ +PE + YT SDVWS G++L+ + G P+ +
Sbjct: 304 PLKWMAPESIFNNLYTT-LSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 40/204 (19%)
Query: 93 AVKVVSKVEAPPDYLK------KFLP--REIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144
AVK+V V P Y + +F+ R+ D + R+ Q ET H ++ +
Sbjct: 158 AVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-ETGHMCIVMPK 213
Query: 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH-ERGVVHRDIKCENLL------- 196
Y LLD+I + G + Q A+DY H E ++H D+K EN+L
Sbjct: 214 YGP--CLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV 271
Query: 197 IDGEYN---------IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYT 247
+D N +++ D G C H + Y SPE++ G+ +
Sbjct: 272 VDPVTNRALPPDPCRVRICDLGGC-----CDERHSR---TAIVSTRHYRSPEVVLGLGWM 323
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFD 271
+ +D+WSMG ++Y + G+L +D
Sbjct: 324 -YSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK-----CKSGHQSPLS 226
Q+ +++ R +HRD+ N+L+ +K+ DFG AR K K + PL
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
+ +PE + YT SDVWS GV+L+ + + G P+
Sbjct: 242 --------WMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK-----CKSGHQSPLS 226
Q+ +++ R +HRD+ N+L+ +K+ DFG AR K K + PL
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
+ +PE + YT SDVWS GV+L+ + + G P+
Sbjct: 247 --------WMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK-----CKSGHQSPLS 226
Q+ +D+ + +HRD+ N+L+ K+ DFG AR M K + P+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
+ +PE + YT SDVWS G++L+ + + G+ P+
Sbjct: 280 --------WMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 24/236 (10%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVS--KVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
IG G + V L + VA VV K A +FL ++ D + L+HPN+++
Sbjct: 3 IGNGWFGKV-LLSEIYTDTGVARVVVKELKANASSKEQNEFL-QQGDPYRILQHPNILQC 60
Query: 130 L-QAIETTHRVYIIMEYAEKGSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCHERG 184
L Q +E ++ EY E G L ++ +E ++ ++ + + H+
Sbjct: 61 LGQCVEAI-PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI---L 241
+H D+ N + + +K+ D+G G + K + D C + +PE+
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGI--GPSRYKEDYIET-EDDKCVPLRWLAPELVGEF 176
Query: 242 KGVPYTPH---YSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQV----QTKVVFP 289
G T S+VW++GV L+ + P+ + ++L V Q K+ P
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 20/45 (44%), Positives = 28/45 (62%)
Query: 167 KKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211
K RQ++ + H G+VHRDIK ENLL+ + +K+ DFG A
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
Q+ +++ + VHRD+ N+L+ +K+ DFG AR M S + S S TF
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH-DSNYVSKGS-TFL- 301
Query: 232 SYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPF 270
+ +PE + YT SDVWS G++L+ + + G P+
Sbjct: 302 PVKWMAPESIFDNLYTT-LSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 39/150 (26%), Positives = 65/150 (43%), Gaps = 26/150 (17%)
Query: 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKW----FRQLVDAIDYCHERGVVHRDIKCENLL 196
++ E+ E G L F+ R+ + T W +QL A+ Y ++ +VH ++ +N+L
Sbjct: 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNIL 137
Query: 197 -----IDGEYN--IKLSDFGFARGHMKCKSGHQSPLSDTFC-GSYAYASPEILKGVPYTP 248
IDGE IKLSD G + LS C + +PE ++
Sbjct: 138 LAREGIDGECGPFIKLSDPGIP----------ITVLSRQECVERIPWIAPECVEDSKNLS 187
Query: 249 HYSDVWSMGVVLYAMAF-GRLPFDDTNYIQ 277
+D WS G L+ + + G +P D +
Sbjct: 188 IAADKWSFGTTLWEICYNGEIPLKDKTLAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 16/49 (32%), Positives = 28/49 (57%)
Query: 163 EPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211
+ K + ++ ++Y HE G+ H DIK EN+++DG + D+G A
Sbjct: 125 KKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 16/96 (16%)
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNI-KLSDFGFARGHMK----CKSGH-QSPL 225
Q+ +++ R +HRD+ N+L+ E N+ K+ DFG AR K + G + PL
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLY 261
+ +PE + YT SDVWS GV+L+
Sbjct: 240 K--------WMAPESIFDKVYTTQ-SDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 12/99 (12%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD-------VAVKVVSKVEAPPDYLKKFLPREIDVVK 119
VLG+ +G G++ V AT+ HG VAVK++ + K+ L E+ ++
Sbjct: 40 VLGRTLGSGAFGRVVEATA--HGLSHSQSTMKVAVKMLKSTARSSE--KQALMSELKIMS 95
Query: 120 GL-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR 157
L H N++ L A +YII EY G L+D++ R
Sbjct: 96 HLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCD-----VAVKVVSKVEAPPDYLKKFLPREIDVVKGL- 121
GK +G G++ V AT+ G + VAVK++ K A D ++ L E+ ++ L
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTDE-REALMSELKILSHLG 99
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQRE 158
+H N++ L A V +I EY G LL+F++++
Sbjct: 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFL 130
VI G S ++G VK ++ V + P EI + L+HPN+++ +
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIVKLI 749
Query: 131 QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER---GVVH 187
+ Y+I EY E +L + ++ + R +K + A+ + H R VV
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRNLSW---ERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG-SYAYASPEILKGVPY 246
++ E ++IDG+ L S +DT C S AY +PE +
Sbjct: 807 GNLSPEKIIIDGKDEPHL-----------RLSLPGLLCTDTKCFISSAYVAPETRETKDI 855
Query: 247 TPHYSDVWSMGVVLYAMAFGRLPFD 271
T SD++ G++L + G+ P D
Sbjct: 856 TEK-SDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 29/120 (24%), Positives = 56/120 (46%), Gaps = 19/120 (15%)
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKCKSGHQSPLS 226
Q+ + + + +HRD+ N+L+ K+ DFG AR + K + P+
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFD----DTNYIQLLKQ 281
+ +PE + YT SDVWS G++L+ + + G P+ D+ + +++K+
Sbjct: 282 --------WMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE 332
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 357 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| KOG0579|consensus | 1187 | 100.0 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152|consensus | 772 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG2052|consensus | 513 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| KOG1024|consensus | 563 | 100.0 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1345|consensus | 378 | 99.98 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| KOG0590|consensus | 601 | 99.97 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1164|consensus | 322 | 99.96 | ||
| KOG1163|consensus | 341 | 99.96 | ||
| KOG1165|consensus | 449 | 99.96 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0603|consensus | 612 | 99.95 | ||
| KOG1240|consensus | 1431 | 99.93 | ||
| KOG0195|consensus | 448 | 99.93 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| KOG0606|consensus | 1205 | 99.92 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1166|consensus | 974 | 99.9 | ||
| KOG4158|consensus | 598 | 99.89 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1033|consensus | 516 | 99.87 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1023|consensus | 484 | 99.85 | ||
| KOG0590|consensus | 601 | 99.83 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| KOG0601|consensus | 524 | 99.72 | ||
| KOG0606|consensus | 1205 | 99.69 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.63 | |
| KOG1266|consensus | 458 | 99.61 | ||
| KOG1243|consensus | 690 | 99.59 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| KOG0601|consensus | 524 | 99.52 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.49 | |
| KOG3087|consensus | 229 | 99.46 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.36 | |
| KOG3741|consensus | 655 | 99.34 | ||
| KOG2137|consensus | 700 | 99.29 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.28 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.28 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.26 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.15 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.06 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.06 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.97 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.86 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.8 | |
| KOG0576|consensus | 829 | 98.7 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.7 | |
| KOG1035|consensus | 1351 | 98.65 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.63 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.57 | |
| KOG1235|consensus | 538 | 98.43 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.38 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.37 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.32 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.16 | |
| KOG2268|consensus | 465 | 98.13 | ||
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.1 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.05 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.04 | |
| KOG2270|consensus | 520 | 98.0 | ||
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.95 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.94 | |
| KOG1826|consensus | 2724 | 97.88 | ||
| PRK05231 | 319 | homoserine kinase; Provisional | 97.75 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.74 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.73 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.42 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.37 | |
| KOG1093|consensus | 725 | 97.35 | ||
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.29 | |
| PLN02236 | 344 | choline kinase | 97.25 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.13 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.02 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.95 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.67 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.63 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.56 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.55 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.54 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.48 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.42 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.37 | |
| KOG1236|consensus | 565 | 95.86 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-63 Score=431.73 Aligned_cols=265 Identities=30% Similarity=0.540 Sum_probs=230.3
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchH----HhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDY----LKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
..+..|.+.+.||+|+||.|-+|..+.+|+.||||++.+....... ....+++|+++|++|+|||||+++++|+..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3566799999999999999999999999999999999875444321 223467999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcEEEeecCCCcc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE---YNIKLSDFGFARG 213 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~---~~~kl~Dfg~~~~ 213 (357)
+..|+||||++||.|.+++-.++.+.+...+.+++||+.|+.|||++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999876 7799999999974
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCC--CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhhc---cc
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGV--PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ-LLKQVQTK---VV 287 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~---~~ 287 (357)
.. ......+.||||.|.|||++.+. .+++.++|+|||||++|-+++|.+||.+..... +.++|..+ +.
T Consensus 329 ~g------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 329 SG------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred cc------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 32 33445688999999999999654 455555899999999999999999998765555 66666543 33
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
.+.+..++++..+||.+|| .||++||++.++|+||||+..+..+
T Consensus 403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 4556789999999999999 9999999999999999999877554
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-61 Score=438.67 Aligned_cols=261 Identities=31% Similarity=0.598 Sum_probs=240.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.+|..+++||+|||+.||.+++..+|+.||+|++.+.........+.+.+|+++.+.|+|||||+++++|++..++|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46999999999999999999999999999999999877777777888999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|+|..++|..+++++.+++|.+++.++.||+.||.|||+++|+|||||..|+|++++.+|||+|||+|..+.. ..
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~-----~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY-----DG 172 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC-----cc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999975422 23
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCCCCCCCCHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li 302 (357)
....+.||||.|.|||++....++.. +||||+|||||-||+|++||+..+..+++.+|.. .+.+|. .++.++++||
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~~A~dLI 249 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSAEAKDLI 249 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCHHHHHHH
Confidence 44678999999999999998888888 9999999999999999999999999999999865 444555 7999999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
++|| .+|.+||++++||.|+||+....++.
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 9999 89999999999999999976655543
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-61 Score=416.78 Aligned_cols=264 Identities=28% Similarity=0.531 Sum_probs=241.1
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
....++|+++++||+|+||.||+++.+.+++.||+|++++.........+....|..+|..++||.||+++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 34567899999999999999999999999999999999887666655567788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+|+||+.||.|..+|++++.|++..++.++..|+.||.|||++|||||||||+|||+|.+|+++|+|||+++..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~----- 175 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED----- 175 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999733
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
........++|||+.|||||++.+..|+.. +|+||||+++|+|++|..||.+.+...+.++|........+..++.+++
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEAR 254 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHH
Confidence 223344567899999999999999999988 9999999999999999999999999999999887764555556999999
Q ss_pred HHHHHhc-CCCCCCC----CHHHHhcCCCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRI----RLKDIKQDPWVKTEAN 329 (357)
Q Consensus 300 ~li~~~L-~~p~~Rp----s~~~ll~hp~~~~~~~ 329 (357)
+||+++| .+|++|. ++.+|.+||||.+-.+
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 9999999 9999995 8999999999998644
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-60 Score=410.00 Aligned_cols=260 Identities=30% Similarity=0.484 Sum_probs=235.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-eE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH-RV 139 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 139 (357)
+...+.+.++.||+|..|+||+++++.+++.+|+|++. ...+....+.+.+|+++++.++|||||+++|+|..+. .+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~--~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL--LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec--ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 44557888999999999999999999999999999983 2334556777889999999999999999999999999 49
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+++||||+||+|.+++...++++|..+..++.++++||.|||+ .+||||||||+||||+..|.+||||||.++.+...
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999999998999999999999999999999996 99999999999999999999999999999755322
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhhcccCCCCCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-----NYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~ 293 (357)
...+++||..|||||.+.+..|+.+ +||||||++++||++|+.||... +..+++..|........+..
T Consensus 233 ------~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 233 ------IANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG 305 (364)
T ss_pred ------hcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 5678899999999999999999999 99999999999999999999874 78888888887666555555
Q ss_pred -CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 294 -VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 294 -~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
+|+++++||..|| +||.+||+++|+++|||+++....
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 9999999999999 999999999999999999986543
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-58 Score=416.86 Aligned_cols=268 Identities=30% Similarity=0.571 Sum_probs=241.6
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 138 (357)
.-..++|..++.||+|+|++|++|+.+.+++.||||++.+.....+.....+..|-..|.+| .||+|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567899999999999999999999999999999999887777776778888999999999 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+|+||+++|+|.++|++.+.|++..++.++.+|+.||+|||++|||||||||+|||+|.+|+++|+|||.++.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998765433
Q ss_pred CCC--------CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC
Q psy7825 219 SGH--------QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT 290 (357)
Q Consensus 219 ~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 290 (357)
... .......++||..|.+||++.....+.. +|+|+||||+|+|+.|.+||.+.+...++++|+.. .+..
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-~y~f 306 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-DYEF 306 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-cccC
Confidence 321 1111256899999999999999988888 99999999999999999999999999999988753 3444
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
++++++.+++||+++| .||.+|+++.||.+||||.+-.+
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 5579999999999999 99999999999999999987643
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-58 Score=413.90 Aligned_cols=275 Identities=29% Similarity=0.499 Sum_probs=245.4
Q ss_pred ccccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 55 KKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 55 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
+.+...+..++|.++++||+|+||.||+|+.+.+|..||+|++++.........+.++.|-.+|...++|.||+++..|+
T Consensus 132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 34455667789999999999999999999999999999999999887777666788889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
+..++||||||++||++..+|.+.+.|++..++.++.+++.|++.||..|+|||||||+|+|||..|++||+|||++..+
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999643
Q ss_pred cccc------------------CCCCCC------------------------CCCcccCCccccccceecCCCCCCCccc
Q psy7825 215 MKCK------------------SGHQSP------------------------LSDTFCGSYAYASPEILKGVPYTPHYSD 252 (357)
Q Consensus 215 ~~~~------------------~~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~D 252 (357)
.... .....+ .....+|||.|+|||++.+..|+.. +|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cD 370 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CD 370 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-cc
Confidence 2200 000001 0123579999999999999999888 99
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh---hcccCCCCCCCCHHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCC
Q psy7825 253 VWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ---TKVVFPTEPNVSAECKTLLSKIFSPIKFRIR---LKDIKQDPWVKT 326 (357)
Q Consensus 253 iwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~s~~~~~li~~~L~~p~~Rps---~~~ll~hp~~~~ 326 (357)
+||||||+||||.|.+||.+.++.+++.+|. ..+.+|....++.+++|||.+||.||++|.. ++||.+||||++
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCcccc
Confidence 9999999999999999999999999999874 4678888889999999999999999999975 999999999998
Q ss_pred CCCC
Q psy7825 327 EANP 330 (357)
Q Consensus 327 ~~~~ 330 (357)
..+.
T Consensus 451 v~W~ 454 (550)
T KOG0605|consen 451 VDWD 454 (550)
T ss_pred CCcc
Confidence 7554
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-57 Score=380.19 Aligned_cols=260 Identities=32% Similarity=0.571 Sum_probs=238.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
...++|++.+.||.|+||.|.+++.+.+|..||+|++.+.....-...+...+|..+|+.+.||.++++++.|.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 66678999999999999999999999999999999998876666555677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
+||||++||.|+.++++.++|++..++.++.||+.||+|||+++|++|||||+|||+|.+|++||+|||+++..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v------ 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV------ 194 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999743
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCCCCCCCCHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECK 299 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~ 299 (357)
...+.+.||||.|+|||++...++... +|+||||+++|||+.|.+||.+.+...+.++|.. .+.+|. .++.+++
T Consensus 195 --~~rT~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~--~fs~~~k 269 (355)
T KOG0616|consen 195 --SGRTWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS--YFSSDAK 269 (355)
T ss_pred --cCcEEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc--ccCHHHH
Confidence 223678899999999999999999877 9999999999999999999999999999999865 455555 6999999
Q ss_pred HHHHHhc-CCCCCC-----CCHHHHhcCCCCCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFR-----IRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 300 ~li~~~L-~~p~~R-----ps~~~ll~hp~~~~~~~~~ 331 (357)
+||+.+| .|-.+| ....+|..||||+...+.+
T Consensus 270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred HHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 9999999 898777 5678999999999876654
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-56 Score=390.23 Aligned_cols=260 Identities=32% Similarity=0.602 Sum_probs=233.1
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
..+|.+.+.||+|+||+||+|+++.++..||||.+.+... ....++.+..|+.+|+.++|||||.+++++..++++|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3569999999999999999999999999999999977654 344567788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC------CcEEEeecCCCccccc
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE------YNIKLSDFGFARGHMK 216 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~------~~~kl~Dfg~~~~~~~ 216 (357)
||||.||+|.+++++.+.+++..++.++.||+.||++||+++||||||||.|||++.. -.+||+|||+++.+.
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~- 166 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ- 166 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC-
Confidence 9999999999999999999999999999999999999999999999999999999865 458999999998653
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNV 294 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~ 294 (357)
...+..+.||++.|||||++....|+.+ +|+||+|+|+|+|++|+.||...+..+++..+...-. ...+..+
T Consensus 167 -----~~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 167 -----PGSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred -----chhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 3345567899999999999999999988 9999999999999999999999999999887765432 2233467
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
++.+.+|+..+| .+|..|.+..+-+.|+++...+..
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~ 277 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQD 277 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCccc
Confidence 888889999999 899999999999999999987633
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-56 Score=411.73 Aligned_cols=262 Identities=38% Similarity=0.658 Sum_probs=241.6
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
-|++++.||.|+-|.|.+|++..+|+.+|||++.+.....+.....+.+|+.+|+.+.||||++++++|+...++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 39999999999999999999999999999999987655455556678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|++||.|++++-++|++++.++.+++.||+.|+.|+|..+|+||||||+|+|++..+++||+|||+|... ....
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe------~~gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE------VPGK 166 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc------cCCc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999632 2344
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSK 304 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 304 (357)
...+.||+|.|.|||++.|.+|...++||||.|+|||.||+|+.||++.+...++.+++.+. |..+.++|.++.+||++
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-FEMPSNISSEAQDLLRR 245 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-ccCCCcCCHHHHHHHHH
Confidence 56688999999999999999999999999999999999999999999999999999988754 45556899999999999
Q ss_pred hc-CCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy7825 305 IF-SPIKFRIRLKDIKQDPWVKTEANPAAS 333 (357)
Q Consensus 305 ~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 333 (357)
|| .||.+|++.+||++|||++.......+
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred HhccCccccccHHHHhhCchhhcCCCCChh
Confidence 99 999999999999999999998766555
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-55 Score=401.45 Aligned_cols=259 Identities=42% Similarity=0.808 Sum_probs=231.7
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCc--hHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCC
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP--DYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTH 137 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 137 (357)
....+|.+++.||+|+||.|++|.+..+|..||+|++.+..... ....+.+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34567999999999999999999999999999999876642221 234566779999999999 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEEeecCCCccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMK 216 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~ 216 (357)
.+|+||||+.||+|.+++...+++.+..++.++.||+.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999997442
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc-ccCCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-VVFPTEPNV 294 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~ 294 (357)
.......+.|||+.|+|||++.+.. |...++||||+|++||.|++|+.||.+.+...+...|... +.+|. .+
T Consensus 173 ----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~--~~ 246 (370)
T KOG0583|consen 173 ----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS--YL 246 (370)
T ss_pred ----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC--Cc
Confidence 1234456889999999999999988 9888899999999999999999999999988888886544 44454 46
Q ss_pred -CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 295 -SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 295 -s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
|.++++||++|| .+|..|+++.+|+.||||+.
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999 89999999999999999998
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-54 Score=377.38 Aligned_cols=273 Identities=28% Similarity=0.447 Sum_probs=241.8
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
+...+....|++++.||.|.-|+||+|+...++..+|+|++.+............+.|.++|..++||.++.++..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 44556677899999999999999999999999999999999887776666666788899999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
...|+|||||+||+|..+++++ +.|++..++.++.+++-||+|||-+|||+|||||+||||.++|++-|+||.++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999875 57999999999999999999999999999999999999999999999999987522
Q ss_pred ccc------------------------------c-C-C-------------------CCCCCCCcccCCccccccceecC
Q psy7825 215 MKC------------------------------K-S-G-------------------HQSPLSDTFCGSYAYASPEILKG 243 (357)
Q Consensus 215 ~~~------------------------------~-~-~-------------------~~~~~~~~~~gt~~y~aPE~~~~ 243 (357)
... . . . ........++||-.|.|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 110 0 0 0 00122345789999999999999
Q ss_pred CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-hhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCC----HHH
Q psy7825 244 VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIR----LKD 317 (357)
Q Consensus 244 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps----~~~ 317 (357)
..++.. +|+|+||+++|||++|..||.+.+..+++.+| ...+.+|..+.++..++|||+++| +||.+|.. +.+
T Consensus 310 ~GHgsA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 310 EGHGSA-VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CCCCch-hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 999988 99999999999999999999999998888776 567788888899999999999999 99999999 999
Q ss_pred HhcCCCCCCCCCC
Q psy7825 318 IKQDPWVKTEANP 330 (357)
Q Consensus 318 ll~hp~~~~~~~~ 330 (357)
|.+||||++..+.
T Consensus 389 IK~HpFF~gVnWa 401 (459)
T KOG0610|consen 389 IKRHPFFEGVNWA 401 (459)
T ss_pred hhcCccccCCChh
Confidence 9999999998654
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-55 Score=370.75 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=220.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
+.|+.+.++|+|+||.||+++++.+|+.||||.+-..+ .+...++...+|+.+|++|+|+|+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46889999999999999999999999999999985543 34556677789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|||+. ++.+-+.+. ..++...+..++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+.. .
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-----p 154 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-----P 154 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-----C
Confidence 99988 666666553 4589999999999999999999999999999999999999999999999999986643 2
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc-----------------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK----------------- 285 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------------- 285 (357)
....+..+.|.+|+|||.+.|...+.+.+||||+||++.||++|.+.|.+.+..+.+..|...
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 233456678999999999988544444499999999999999999999998877776665432
Q ss_pred ---ccCCCC----------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 286 ---VVFPTE----------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 286 ---~~~~~~----------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+.+|.+ +.++..+.+|++.|| .||.+|++.+|+|.||||.+-.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 222221 578899999999999 8999999999999999996543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-55 Score=389.52 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=227.3
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCC-e
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTH-R 138 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~ 138 (357)
+..++|.+.+.||.|.||.||+|+.+.+|..||||.+++....-++.. -.||+..|++|+ ||||+++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~--nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM--NLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH--HHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 445689999999999999999999999999999999876555443322 238999999998 999999999998877 9
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
+|+|||||+. +|+++++.+ ..|++..++.|+.||++||+|+|.+|++|||+||+||||.....+||+|||+|+...
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-- 161 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR-- 161 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--
Confidence 9999999977 999999865 679999999999999999999999999999999999999988899999999998542
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC------
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE------ 291 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 291 (357)
..+..+..+.|..|+|||++....+++.+.|||++|||++|+.+-++.|.+.+..+.+.+|...+..|..
T Consensus 162 ----SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 162 ----SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ----cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 3344566789999999999987777766699999999999999999999999988888877654444332
Q ss_pred -----------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 292 -----------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 292 -----------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
+..+.++.+||.+|| +||.+||+|.|+|+||||+....
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 568999999999999 99999999999999999998643
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=384.31 Aligned_cols=268 Identities=31% Similarity=0.601 Sum_probs=227.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHH-----------hhhHHHHHHHHHcCCCCCccee
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYL-----------KKFLPREIDVVKGLRHPNLIRF 129 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~ 129 (357)
...++|++.+.||+|.||.|-+|++..+++.||||++.+........ .+.+.+|+.+|++|.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34567999999999999999999999999999999997654332211 2468899999999999999999
Q ss_pred eEEEEe--CCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7825 130 LQAIET--THRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLS 206 (357)
Q Consensus 130 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~ 206 (357)
+++..+ .+.+|||+|||..|.+...- ...+ +++.++++|+.+++.||+|||.+|||||||||+|+||+.+|++||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 999865 56899999999988765432 2334 8999999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCCCCCCCcccCCccccccceecC---CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Q psy7825 207 DFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG---VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ 283 (357)
Q Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 283 (357)
|||.+..................+|||.|+|||...+ ..+...+.||||||++||.|+.|+.||-+....++..+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 9999875432211111111223689999999999977 5566777899999999999999999999999999999875
Q ss_pred -hcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 284 -TKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 284 -~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
..+.+|..+.+.+.+++||.+|| +||+.|+++.+|..|||......
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 46678888889999999999999 99999999999999999998743
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-56 Score=372.19 Aligned_cols=245 Identities=28% Similarity=0.433 Sum_probs=217.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeE-EEEeCCe-EEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ-AIETTHR-VYI 141 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~-~~l 141 (357)
.+|.|+++||+|+||.||++++..+|..+|.|.+.- ..-+....+.+..|+.+|++|+|||||++++ .|..+.. ++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f-~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF-GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch-hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 359999999999999999999999999999999873 3344555677789999999999999999998 5554444 899
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 142 IMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHE--RG--VVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~--~~--ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
|||+|.+|+|..+++. +..+++..+|+++.|++.||.++|+ .. |+||||||.||+++.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999975 4579999999999999999999999 44 99999999999999999999999999986
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC-C
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE-P 292 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~ 292 (357)
+.... ....+.+|||+||+||.+.+.+|+.+ +|||||||++|||+.-+.||.+.+..++..+|..+...|.+ .
T Consensus 178 l~s~~-----tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 178 LSSKT-----TFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDE 251 (375)
T ss_pred hcchh-----HHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHH
Confidence 53322 22346789999999999999999988 99999999999999999999999999999999888665565 6
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCH
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRL 315 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~ 315 (357)
.+|.++..||..|+ .||+.||+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCc
Confidence 89999999999999 999999986
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-54 Score=379.58 Aligned_cols=261 Identities=31% Similarity=0.540 Sum_probs=219.5
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC--eEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH--RVYI 141 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 141 (357)
.+|..++.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|..++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 45888999999999999999999999999999986652222 566889999999999999999999754443 6999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeecCCCcccccccC
Q psy7825 142 IMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-EYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~ 219 (357)
+|||+++|+|.+++.+.+ .+++..++.+..||++||+|||++||+|+||||+|||++. ++.+||+|||++..... .
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~--~ 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES--K 171 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc--c
Confidence 999999999999999876 7999999999999999999999999999999999999999 79999999999875432 1
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHH-hhcccCCCCCCCCHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQV-QTKVVFPTEPNVSAE 297 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i-~~~~~~~~~~~~s~~ 297 (357)
...........||+.|||||++.++.....++|||||||++.||+||..||.. ......+-.+ ......+.+..+|.+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE 251 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence 22233344678999999999999643333349999999999999999999987 3444433333 333334556679999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
+++||..|+ .+|+.||||.++|.|||+++...
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999 99999999999999999998765
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=392.57 Aligned_cols=259 Identities=28% Similarity=0.507 Sum_probs=235.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+......+ .+.+.+|+++++.++||||+.++++|+...++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~-l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE-LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH-HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 5799999999999999999999999999999999876655443 455789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+.| +|..++...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++.+|++|+||||+++... ...
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~-----~~t 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS-----TNT 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc-----cCc
Confidence 99987 999999999999999999999999999999999999999999999999999999999999998432 233
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
.......|||.|||||++.+.+|+.. +|+||||||+|||+.|++||......++.+.|......+.. ..+..+.+|+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~-~~S~~f~nfl~ 232 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS-TASSSFVNFLQ 232 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc-cccHHHHHHHH
Confidence 44556679999999999999999988 99999999999999999999999999999998776554433 79999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 304 KIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
.+| +||..|.+..+++.|||.+.....+
T Consensus 233 gLL~kdP~~RltW~~Ll~HpF~k~~~~~~ 261 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGHPFWKGKINIA 261 (808)
T ss_pred HHhhcChhhcccHHHHhcChHHhhhhhhh
Confidence 999 9999999999999999999875543
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-54 Score=376.35 Aligned_cols=258 Identities=35% Similarity=0.670 Sum_probs=239.2
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|++.+.||+|.||.|-+|.....|+.||||.+++.....+.-.-.+++|+++|..|+||||+.++.+|++.+.+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 35789999999999999999999989999999999988777666666678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||..+|.|++++.+.+.+++.+++.++.||++|+.|+|.++++|||||.+|||+|.++++||+|||++..+ .
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly------~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY------A 204 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh------c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998643 2
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
......++||+|.|.+||++.|.+|....+|.||||++||-|+.|.+||++.+...++.+|..+..+.. .-+.++.-|
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP--~~PSdA~gL 282 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP--ETPSDASGL 282 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC--CCCchHHHH
Confidence 344567899999999999999999998879999999999999999999999999999999988876654 478899999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
|++|| .+|++|.++++|-.|.|+.=.
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheeecc
Confidence 99999 999999999999999998643
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-53 Score=391.64 Aligned_cols=261 Identities=27% Similarity=0.496 Sum_probs=235.6
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCC
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTH 137 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 137 (357)
..+..++|.++++||+|+||+|+++..+.+++.||||++++.....+...+..+.|..++.... ||.++.++.+|+...
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3567788999999999999999999999999999999999887777777888889999999886 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
++|+||||+.||++.. ++..+.|++..++.|+..|+.||.|||++|||+||||.+|||+|.+|++||+|||+++..
T Consensus 443 ~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--- 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--- 518 (694)
T ss_pred eEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc---
Confidence 9999999999999443 344567999999999999999999999999999999999999999999999999999733
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCCCCCCCCH
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSA 296 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~ 296 (357)
......+.++||||.|||||++.+..|+.. +|+||||++|||||.|..||.+.+.+++.+.|.. ...+|. .+|.
T Consensus 519 --m~~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~--~ls~ 593 (694)
T KOG0694|consen 519 --MGQGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSK 593 (694)
T ss_pred --CCCCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--cccH
Confidence 223446789999999999999999999988 9999999999999999999999999999999865 455666 4999
Q ss_pred HHHHHHHHhc-CCCCCCCCH-----HHHhcCCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRL-----KDIKQDPWVKTEA 328 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~-----~~ll~hp~~~~~~ 328 (357)
+..++++++| .+|++|.-. .+|..||||+.-.
T Consensus 594 ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 9999999999 999999764 8999999999753
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-53 Score=350.38 Aligned_cols=267 Identities=25% Similarity=0.402 Sum_probs=229.0
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.+|...++||+|.||.||+|++..+|+.||||.+......+. ......+|+..|+.++|+||+.++++|.....+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 468899999999999999999999999999999976644433 3344559999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||++. +|+..++.. ..++..+++.++.++++||+|||.+.|+||||||.|+||+.+|.+||+|||+++.+....
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~---- 155 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN---- 155 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC----
Confidence 99987 999999764 579999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC-----------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE----------- 291 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 291 (357)
......+-|..|+|||.+.|...+...+||||.|||+.||+-|.+-|.+.+..+.+..|-..+..|.+
T Consensus 156 -~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 -RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred -cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 22233378999999999988776666699999999999999999999999988888877654444332
Q ss_pred ----------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcccccc
Q psy7825 292 ----------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAGVE 337 (357)
Q Consensus 292 ----------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~~~ 337 (357)
+..++++.+|+..|| .||.+|+++.|+|+|+||+..+.+.....+-
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp 297 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLP 297 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCc
Confidence 356788999999999 9999999999999999999876665544443
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-53 Score=387.48 Aligned_cols=263 Identities=28% Similarity=0.513 Sum_probs=235.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
..|...+.||+|+.|.||.|....+++.||||.+....... ++.+.+|+.+|+..+|+|||.+++.|...+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 45888999999999999999999999999999997655444 566789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++||+|.+.+.... ++|.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+.. ..
T Consensus 350 Eym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~-----~~ 423 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE-----EQ 423 (550)
T ss_pred eecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc-----cc
Confidence 9999999999996644 99999999999999999999999999999999999999999999999999875432 22
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--cCCCCCCCCHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--VFPTEPNVSAECKTL 301 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~l 301 (357)
..+.+.+|||+|||||++....|+.+ +||||||++++||+-|.+||-..++...+..|.... ....+..+|..+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 35678899999999999999999999 999999999999999999999888888877776543 344467899999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCccccc
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAGV 336 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~~ 336 (357)
+.+|| .|+++|+++.+||+||||+.+....+...+
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pL 538 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMAKPESSLNPL 538 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHHH
Confidence 99999 999999999999999999887776655443
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=369.80 Aligned_cols=270 Identities=26% Similarity=0.465 Sum_probs=232.6
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
....+...+|++.++||.|..++||+|+....+..||||++.......+ .+.+++|+..|+.++||||++++..|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3445566789999999999999999999999999999999976655544 67788999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
..+|+||.|+.+|++.+++... ..++|..+..|++++++||.|||.+|.||||||+.||||+.+|.|+|+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999874 34999999999999999999999999999999999999999999999999998766
Q ss_pred ccccCCCCCCCC-CcccCCccccccceec--CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHhhcccCC-
Q psy7825 215 MKCKSGHQSPLS-DTFCGSYAYASPEILK--GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL-KQVQTKVVFP- 289 (357)
Q Consensus 215 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~- 289 (357)
.. .+...... .+++||++|||||++. ...|+.+ +||||||++..||.+|..||....+.+++ ..++.....+
T Consensus 177 ~~--~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 177 FD--SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred cc--cCceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence 54 23333333 7789999999999953 3456666 99999999999999999999999887765 4455444322
Q ss_pred -------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 290 -------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 290 -------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
....++..++++|..|| +||.+||+++++|+|+||+..+.+.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 12457889999999999 9999999999999999999987663
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=350.03 Aligned_cols=259 Identities=31% Similarity=0.603 Sum_probs=236.7
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
....++|.+++.||+|.||.||+|+.+.++..||+|++.+...........+++|+++...|+||||++++++|.+...+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 34556799999999999999999999999999999999887776666778899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
|+++||..+|+|+..++ ...++++...+.++.|++.||.|+|..+|+||||||+|+|++..+.+||+|||-+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--- 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--- 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec---
Confidence 99999999999999999 5577999999999999999999999999999999999999999999999999987532
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCCCCCCCCH
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSA 296 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~ 296 (357)
....+.+.|||..|.|||+..+..++.. +|+|++|++.||++.|..||+.....++...|.. .+.+| ..++.
T Consensus 175 ----p~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p--~~is~ 247 (281)
T KOG0580|consen 175 ----PSNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP--STISG 247 (281)
T ss_pred ----CCCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC--cccCh
Confidence 1445678899999999999999999988 9999999999999999999999998888888764 33444 68999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
++++||.+|| .+|.+|....|++.|||+....
T Consensus 248 ~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~~ 280 (281)
T KOG0580|consen 248 GAADLISRLLVKNPIERLALTEVMDHPWIVANG 280 (281)
T ss_pred hHHHHHHHHhccCccccccHHHHhhhHHHHhcC
Confidence 9999999999 9999999999999999998653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=382.36 Aligned_cols=263 Identities=27% Similarity=0.465 Sum_probs=224.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36999999999999999999999999999999997644333334566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC---
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG--- 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--- 220 (357)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998744211100
Q ss_pred ---------------------------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Q psy7825 221 ---------------------------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT 273 (357)
Q Consensus 221 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 273 (357)
.........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCCCC
Confidence 00011134579999999999998888877 99999999999999999999998
Q ss_pred CHHHHHHHHhh---cccCCCCCCCCHHHHHHHHHhcCC---CCCCCCHHHHhcCCCCCCC
Q psy7825 274 NYIQLLKQVQT---KVVFPTEPNVSAECKTLLSKIFSP---IKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 274 ~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~L~~---p~~Rps~~~ll~hp~~~~~ 327 (357)
+..+....+.. ...+|....+++++++||.+|+.+ +..||++++|++||||++.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 88887777653 344555456899999999998733 3357999999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-52 Score=378.79 Aligned_cols=256 Identities=25% Similarity=0.488 Sum_probs=225.6
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+|.+.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.++..++||||+++++.+..++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 44679999999999999999999999999999999976433333334567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~----- 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----- 170 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-----
Confidence 999999999999999888899999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
.....+|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+.....+.+.... .+.+..++..+++|
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~l 245 (329)
T PTZ00263 171 ---RTFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDL 245 (329)
T ss_pred ---CcceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHH
Confidence 1224579999999999998888776 999999999999999999999988888777775442 33344689999999
Q ss_pred HHHhc-CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 302 LSKIF-SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 302 i~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
|++|| .||.+||+ +++|+.||||.+.
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999 89999997 7999999999874
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=373.84 Aligned_cols=262 Identities=28% Similarity=0.445 Sum_probs=224.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC--CeEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT--HRVY 140 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 140 (357)
.+.|+.++.||+|.||.||+|++..+|+.||+|.++....... ......+|+.+|++|+||||+++.+...+. ..+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 4569999999999999999999999999999999976554433 344556999999999999999999987665 6899
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 141 IIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
+|+|||+. +|..++... -.|++.+++.++.||+.||+|+|++||+|||||.+|||||.+|.+||+|||+|+.+...
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~-- 271 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS-- 271 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC--
Confidence 99999988 999999774 47999999999999999999999999999999999999999999999999999855332
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC--------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE-------- 291 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------- 291 (357)
.....+..+-|..|+|||.+.|...+..++|+||.||||.||++|++.|.+.+..+.++.|.....-|.+
T Consensus 272 --~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 --GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred --CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 2222456678999999999998876666699999999999999999999999988888877542221111
Q ss_pred --------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 292 --------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 292 --------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
..++..+.+|+..|| -||.+|.||.++|.++||...+.+
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~ 409 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLP 409 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCC
Confidence 367899999999999 899999999999999999655444
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=356.83 Aligned_cols=272 Identities=29% Similarity=0.527 Sum_probs=234.9
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
-.+.|.+.++||+|.|+.||++.+..+|+.+|+|+++....... ..+.+.+|+.+.+.|+||||+++.+.+.+....|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34569999999999999999999999999999999865443332 35668899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcEEEeecCCCccccccc
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG---EYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~---~~~~kl~Dfg~~~~~~~~~ 218 (357)
|+|++.|++|..-+-.+..+++..+-.++.||+++|.|+|.+||||||+||+|+|+-. .--+||+|||++..+.
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--- 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--- 164 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence 9999999999776666667899999999999999999999999999999999999953 3458999999997553
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCCCCCCCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFPTEPNVS 295 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~s 295 (357)
.......++|||.|||||++...+|+.. +|||+.|+|+|-|+.|.+||.+.+...++++|..+ +..|.+++++
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 3344567889999999999999999988 99999999999999999999999999999998654 3344578999
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCccccccccccc
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLN 342 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~~~~~~~~ 342 (357)
+++++||++|| .||.+|+|+.+.|+|||+++ .+...+......++.
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~-r~~~As~~H~~dtvd 287 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICN-RERVASAIHRQDTVD 287 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcc-hHHHHHHhhhHHHHH
Confidence 99999999999 89999999999999999998 444555544444433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=371.41 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=223.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36999999999999999999999999999999987543333333456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~------- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------- 153 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-------
Confidence 9999999999999888899999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
.....+|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+.... ...+..++..+++||+
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 230 (291)
T cd05612 154 -RTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIK 230 (291)
T ss_pred -CcccccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHH
Confidence 1224569999999999988888766 999999999999999999999988877777765432 2233457999999999
Q ss_pred Hhc-CCCCCCCC-----HHHHhcCCCCCCCCC
Q psy7825 304 KIF-SPIKFRIR-----LKDIKQDPWVKTEAN 329 (357)
Q Consensus 304 ~~L-~~p~~Rps-----~~~ll~hp~~~~~~~ 329 (357)
+|| .||.+||+ ++++++||||+....
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 999 89999995 999999999986443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-54 Score=380.49 Aligned_cols=275 Identities=24% Similarity=0.402 Sum_probs=243.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
..|...++||+|+||.||+|.+..+++.||+|++.......+ .+.+++|+.+|.+++++||.++++.+..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 448888999999999999999999999999999976555443 566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|||.||++.++++..+.+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+..+.. ..
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~-----~~ 165 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN-----TV 165 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec-----hh
Confidence 9999999999999888889999999999999999999999999999999999999999999999999875432 22
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
..+.+++|||.|||||++.+..|+.+ +||||||+++|||++|.+||.+..+...+..|.+.........++..+++||.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred hccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHH
Confidence 33478899999999999998899988 99999999999999999999998886666556555444445589999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCCCCCCCCCccccccccccccchh
Q psy7825 304 KIF-SPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKI 346 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~ 346 (357)
.|| ++|+.||+|.+||+|+|++.....+....++.+...+...
T Consensus 245 ~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~~ 288 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRVK 288 (467)
T ss_pred HHhhcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhhc
Confidence 999 9999999999999999999988777777777776666554
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=375.54 Aligned_cols=251 Identities=30% Similarity=0.507 Sum_probs=218.3
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKG 149 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 149 (357)
++||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++..++||||+++++.+...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997643333333445668999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcc
Q psy7825 150 SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTF 229 (357)
Q Consensus 150 ~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 229 (357)
+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||+++.... ........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-----~~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-----DGATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-----CCCcccce
Confidence 9999999888899999999999999999999999999999999999999999999999999863211 11223356
Q ss_pred cCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CC
Q psy7825 230 CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SP 308 (357)
Q Consensus 230 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~ 308 (357)
+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+.... ...+..++.++.+||++|| .|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred ecCccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCC
Confidence 79999999999998888877 999999999999999999999888877777664332 2333469999999999999 89
Q ss_pred CCCCC-----CHHHHhcCCCCCCC
Q psy7825 309 IKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 309 p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
|++|| ++.++++||||...
T Consensus 234 P~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 234 PKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=381.57 Aligned_cols=263 Identities=29% Similarity=0.496 Sum_probs=224.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|++..+|+.||||++.............+.+|+.++..++||||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36999999999999999999999999999999997643333334556778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC-
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ- 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~- 222 (357)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999864322110000
Q ss_pred --------------------------------CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCC
Q psy7825 223 --------------------------------SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF 270 (357)
Q Consensus 223 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 270 (357)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCCCC
Confidence 001123579999999999988888877 99999999999999999999
Q ss_pred CCCCHHHHHHHHhh---cccCCCCCCCCHHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCC
Q psy7825 271 DDTNYIQLLKQVQT---KVVFPTEPNVSAECKTLLSKIFSPIKFRIR---LKDIKQDPWVKTE 327 (357)
Q Consensus 271 ~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~L~~p~~Rps---~~~ll~hp~~~~~ 327 (357)
.+.+..+....+.. ...++....+++++++||++||.+|.+|++ +++++.||||++.
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCC
Confidence 99888777766543 234444456899999999999988888887 9999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-52 Score=358.55 Aligned_cols=266 Identities=27% Similarity=0.457 Sum_probs=224.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-----CCe
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET-----THR 138 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 138 (357)
..|...+.||+|+||.|+.|.++.+|+.||||.+.......-. .+...+|+.+|+.++|+||+.+++.+.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~-akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQID-AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHH-HHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4466689999999999999999999999999988644333333 3344599999999999999999998854 457
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+|+|+++. +|...++.+..+++..+..++.||++||+|+|+.+|+||||||.|+|++.+..+||+|||+|+.....
T Consensus 101 vYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 9999999955 99999998888999999999999999999999999999999999999999999999999999866432
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC-------
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE------- 291 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 291 (357)
......+..+-|..|+|||++.....++++.||||+|||+.||++|+..|.+.+..+.+..|......|.+
T Consensus 179 --~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 179 --FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred --CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 22333456678999999999977666656699999999999999999999998877777766554443322
Q ss_pred -----------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCccc
Q psy7825 292 -----------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASA 334 (357)
Q Consensus 292 -----------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~ 334 (357)
++.++.+.+|+.+|| .||.+|+|++|+|+||||..--.+...+
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 678999999999999 9999999999999999998875554433
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=370.99 Aligned_cols=252 Identities=28% Similarity=0.515 Sum_probs=218.0
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcE-EEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCD-VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH- 137 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 137 (357)
.+......+.+.||.|+||+||+|.+. |.. ||||++......... .+.|.+|+.+|..++|||||+|+|++....
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 444455677778999999999999987 566 999999776655554 678999999999999999999999999887
Q ss_pred eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEEEcCCC-cEEEeecCCCcc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERG-VVHRDIKCENLLIDGEY-NIKLSDFGFARG 213 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~-ivH~dlkp~Nili~~~~-~~kl~Dfg~~~~ 213 (357)
.+++||||+++|+|.+++.. .+.++...+..++.||++||.|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999988 678999999999999999999999999 99999999999999998 999999999975
Q ss_pred cccccCCCCCCCCCcccCCccccccceec--CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-hcccCCC
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILK--GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ-TKVVFPT 290 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~ 290 (357)
..... .......||+.|||||++. ...|+.+ +||||||+++|||+||+.||.+....+....+. ...+.+.
T Consensus 194 ~~~~~-----~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 194 KVISK-----TSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI 267 (362)
T ss_pred ecccc-----ccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 43221 1222367999999999999 5578877 999999999999999999999998877666665 4444444
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+..+++.+..||.+|| .||..||++.+|+.
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 5569999999999999 89999999999875
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-51 Score=372.01 Aligned_cols=258 Identities=32% Similarity=0.537 Sum_probs=232.0
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 140 (357)
....|.+.+.||+|.||.||+++.+.+|+.+|+|++.+...........+.+|+.+|+++. ||||+.++++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456999999999999999999999999999999998876655444567889999999998 999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC----CcEEEeecCCCccccc
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE----YNIKLSDFGFARGHMK 216 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~----~~~kl~Dfg~~~~~~~ 216 (357)
+|||++.||.|.+.+.+. .+++..+..++.|++.++.|||+.||+||||||+|+|+... +.++++|||++.....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999887 49999999999999999999999999999999999999643 5799999999974422
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFPTEPN 293 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~ 293 (357)
.......+||+.|+|||++.+..|+.. +||||+|+++|.|++|..||.+.+.......+... +..+.++.
T Consensus 192 ------~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 192 ------GERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred ------CceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 334567889999999999999999988 99999999999999999999999888887777554 44556788
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
++..+++||+.|| .||..|+++.++|+|||++..
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999 999999999999999999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-51 Score=373.59 Aligned_cols=254 Identities=29% Similarity=0.480 Sum_probs=222.5
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++..++||||+++++++.....+|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 69999999999999999999999999999999976433332334557789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-------- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-------- 153 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--------
Confidence 999999999999888899999999999999999999999999999999999999999999999999864321
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCCCC----CCCCHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFPTE----PNVSAE 297 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~----~~~s~~ 297 (357)
.....+|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+....+... ...+.. ..++.+
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 2345579999999999998888877 99999999999999999999998887776665432 222222 256999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+.+||.+|| .+|.+||++.++++||||.+.
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999999999 889999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-51 Score=379.73 Aligned_cols=262 Identities=28% Similarity=0.479 Sum_probs=223.7
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58999999999999999999999999999999876443333445668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC----
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG---- 220 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---- 220 (357)
|++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999997533111000
Q ss_pred --------------------------------------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHH
Q psy7825 221 --------------------------------------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYA 262 (357)
Q Consensus 221 --------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 262 (357)
.........+||+.|+|||++.+..++.+ +|||||||++||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHHHHH
Confidence 00011124579999999999998888877 999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHhh---cccCCCCCCCCHHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCC
Q psy7825 263 MAFGRLPFDDTNYIQLLKQVQT---KVVFPTEPNVSAECKTLLSKIFSPIKFRIR---LKDIKQDPWVKTE 327 (357)
Q Consensus 263 ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~L~~p~~Rps---~~~ll~hp~~~~~ 327 (357)
|++|+.||...+..+....+.. ....|....+++++.+||.+|+.+|.+|++ +.+++.||||+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999998877766655532 344555567899999999998888999987 9999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=351.57 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=221.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE--eCCeEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE--TTHRVYI 141 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~l 141 (357)
+.|+.+..|++|.||.||+|+++.+++.||+|.++........... -.+|+.+|.+++|||||.+..+.. +-+.+|+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIt-sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPIT-SLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcch-hHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3599999999999999999999999999999999765533332233 348999999999999999988764 4457999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|||||+. +|..++...+ +|...+++.++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+...
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--- 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--- 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC---
Confidence 9999988 9999998754 8999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC---------
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE--------- 291 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------- 291 (357)
.......+-|..|+|||.+.+.+-++.+.|+||+|||+.||+++++.|.+....+.+.+|-..+..|..
T Consensus 231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 122345567999999999988876666699999999999999999999999888888887654444432
Q ss_pred --------------------C--CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 292 --------------------P--NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 292 --------------------~--~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
+ .+++...+|++.+| .||.+|.|+.|.|+|+||.+.+.+
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 1 25699999999999 999999999999999999996554
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=377.23 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=221.4
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|.+++.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++++.....+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58999999999999999999999999999999976544444445668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC----
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG---- 220 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---- 220 (357)
|++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+||||+.+++++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999997533110000
Q ss_pred --------------------------------------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHH
Q psy7825 221 --------------------------------------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYA 262 (357)
Q Consensus 221 --------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 262 (357)
.........+||+.|+|||++.+..++.+ +|||||||++||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHHHH
Confidence 00001124579999999999988888877 999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHhh---cccCCCCCCCCHHHHHHHHHhc-C--CCCCCCCHHHHhcCCCCCCC
Q psy7825 263 MAFGRLPFDDTNYIQLLKQVQT---KVVFPTEPNVSAECKTLLSKIF-S--PIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 263 ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~L-~--~p~~Rps~~~ll~hp~~~~~ 327 (357)
|++|..||...+.......+.. ....+....++.++++||.+|+ . ++..|+++.+|++||||++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999988777666555432 3344545568999999999976 3 45559999999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-51 Score=380.35 Aligned_cols=262 Identities=27% Similarity=0.477 Sum_probs=222.4
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.++..++||||+++++.+..++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 69999999999999999999999999999999865433233334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC----
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG---- 220 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---- 220 (357)
|++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~ 161 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999997532110000
Q ss_pred ----------------------------------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcC
Q psy7825 221 ----------------------------------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFG 266 (357)
Q Consensus 221 ----------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 266 (357)
.........+||+.|+|||++.+..++.+ +|||||||++|+|++|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyell~G 240 (376)
T cd05598 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVG 240 (376)
T ss_pred cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeehhhC
Confidence 00011124579999999999998888877 9999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhh---cccCCCCCCCCHHHHHHHHHhcCCCCCCC---CHHHHhcCCCCCCC
Q psy7825 267 RLPFDDTNYIQLLKQVQT---KVVFPTEPNVSAECKTLLSKIFSPIKFRI---RLKDIKQDPWVKTE 327 (357)
Q Consensus 267 ~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~L~~p~~Rp---s~~~ll~hp~~~~~ 327 (357)
+.||.+.+..+....+.. ....+....++.++.+||.+|+.+|.+|+ ++.++++||||++.
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999998887766655532 23344445789999999999888999999 99999999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=372.28 Aligned_cols=259 Identities=24% Similarity=0.443 Sum_probs=224.5
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCC-cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHG-CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
.+..++|.+.+.||+|+||.||+|.+..++ ..||+|++.............+.+|+.++..++||||+++++++.....
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 345567999999999999999999876554 7899999875443333334567789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+||||++||+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 999999999999999999888899999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~ 298 (357)
.....+||+.|+|||++.+..++.. +|||||||++|+|++|..||.+.+.......+..... ..++.+++.+
T Consensus 184 ------~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~ 255 (340)
T PTZ00426 184 ------RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNC 255 (340)
T ss_pred ------CcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHH
Confidence 1234579999999999988888776 9999999999999999999999888777777665432 2345689999
Q ss_pred HHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCCC
Q psy7825 299 KTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTEA 328 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~~ 328 (357)
++||++|| .+|.+|+ +++++++||||++..
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999 8999995 999999999998753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=378.25 Aligned_cols=263 Identities=27% Similarity=0.452 Sum_probs=221.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++..++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36999999999999999999999999999999986543333333456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC---
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG--- 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--- 220 (357)
||++||+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+|||++.++.++|+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998632110000
Q ss_pred --------CC-------------------------------CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHH
Q psy7825 221 --------HQ-------------------------------SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLY 261 (357)
Q Consensus 221 --------~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 261 (357)
.. .......+||+.|+|||++.+..++.+ +|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchhhh
Confidence 00 000113579999999999998888877 99999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhh---cccCCCCCCCCHHHHHHHHHhcCCCCC---CCCHHHHhcCCCCCCC
Q psy7825 262 AMAFGRLPFDDTNYIQLLKQVQT---KVVFPTEPNVSAECKTLLSKIFSPIKF---RIRLKDIKQDPWVKTE 327 (357)
Q Consensus 262 ell~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~L~~p~~---Rps~~~ll~hp~~~~~ 327 (357)
||++|..||.+.+..+....+.. ...+|....++.++++||.+||.+|.+ |+++.+++.||||++.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999998887777666543 344455556899999999999954443 6799999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-51 Score=375.81 Aligned_cols=263 Identities=29% Similarity=0.546 Sum_probs=227.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.++..++||||+++++++..+..+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36999999999999999999999999999999997644333233556788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC----
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS---- 219 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---- 219 (357)
||+++++|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999875432210
Q ss_pred --------------------CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q psy7825 220 --------------------GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279 (357)
Q Consensus 220 --------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 279 (357)
...........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 000112334579999999999999888877 99999999999999999999988877776
Q ss_pred HHHhh---cccCCCCCCCCHHHHHHHHHhcCCCCCCCC-HHHHhcCCCCCCC
Q psy7825 280 KQVQT---KVVFPTEPNVSAECKTLLSKIFSPIKFRIR-LKDIKQDPWVKTE 327 (357)
Q Consensus 280 ~~i~~---~~~~~~~~~~s~~~~~li~~~L~~p~~Rps-~~~ll~hp~~~~~ 327 (357)
..+.. ...+|....+++++++||.+||.+|.+||+ ++++++||||++.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCC
Confidence 66644 445555556899999999999988999999 9999999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=366.91 Aligned_cols=249 Identities=27% Similarity=0.473 Sum_probs=216.7
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCCh
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 151 (357)
||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++.+......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999998754333333345567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccC
Q psy7825 152 LDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231 (357)
Q Consensus 152 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~g 231 (357)
.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... ........+|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~g 155 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK-----DDDKTNTFCG 155 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc-----CCCccccccC
Confidence 99999888899999999999999999999999999999999999999999999999999864211 1122335679
Q ss_pred CccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCC
Q psy7825 232 SYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIK 310 (357)
Q Consensus 232 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~ 310 (357)
|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+... ....+..++.++++||.+|| .||.
T Consensus 156 t~~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~ 233 (312)
T cd05585 156 TPEYLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPT 233 (312)
T ss_pred CcccCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCHH
Confidence 999999999998888877 99999999999999999999988888777766543 22334569999999999999 8999
Q ss_pred CCC---CHHHHhcCCCCCCC
Q psy7825 311 FRI---RLKDIKQDPWVKTE 327 (357)
Q Consensus 311 ~Rp---s~~~ll~hp~~~~~ 327 (357)
+|| ++.++|.||||.+.
T Consensus 234 ~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 234 RRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HcCCCCCHHHHHcCCCcCCC
Confidence 997 58999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=374.62 Aligned_cols=264 Identities=27% Similarity=0.491 Sum_probs=225.0
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++.+.....+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36899999999999999999999999999999997544333334566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC---
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG--- 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--- 220 (357)
||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998644211100
Q ss_pred ---------------------------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Q psy7825 221 ---------------------------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT 273 (357)
Q Consensus 221 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 273 (357)
.........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCCCC
Confidence 00011224579999999999998888877 99999999999999999999998
Q ss_pred CHHHHHHHHhh---cccCCCCCCCCHHHHHHHHHhcCCCCCCC---CHHHHhcCCCCCCCC
Q psy7825 274 NYIQLLKQVQT---KVVFPTEPNVSAECKTLLSKIFSPIKFRI---RLKDIKQDPWVKTEA 328 (357)
Q Consensus 274 ~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~L~~p~~Rp---s~~~ll~hp~~~~~~ 328 (357)
+.......+.. ...+|....+++++++||.+|+.+|.+|+ ++.++++||||++..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCC
Confidence 88877777653 23344444589999999999888888887 589999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=367.32 Aligned_cols=251 Identities=31% Similarity=0.514 Sum_probs=217.6
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKG 149 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 149 (357)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997644333333456678999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcc
Q psy7825 150 SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTF 229 (357)
Q Consensus 150 ~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 229 (357)
+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... ........
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~-----~~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-----DAATMKTF 155 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC-----cccccccc
Confidence 9999998888899999999999999999999999999999999999999999999999999863211 11122345
Q ss_pred cCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CC
Q psy7825 230 CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SP 308 (357)
Q Consensus 230 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~ 308 (357)
+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+... ....+..++.++.+||++|| .|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred cCCcCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-CccCCCCCCHHHHHHHHHHcCCC
Confidence 79999999999988888777 99999999999999999999988877776665432 22334568999999999999 99
Q ss_pred CCCCC-----CHHHHhcCCCCCCC
Q psy7825 309 IKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 309 p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
|.+|+ ++.++++||||.+.
T Consensus 234 P~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99997 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-50 Score=366.03 Aligned_cols=252 Identities=31% Similarity=0.518 Sum_probs=217.4
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKG 149 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 149 (357)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||++++++|.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997643333333455668999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcc
Q psy7825 150 SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTF 229 (357)
Q Consensus 150 ~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 229 (357)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... ........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~-----~~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-----DGATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-----CCCccccc
Confidence 9999998888899999999999999999999999999999999999999999999999998863211 11112345
Q ss_pred cCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CC
Q psy7825 230 CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SP 308 (357)
Q Consensus 230 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~ 308 (357)
.|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+.... ...+..+++++++||++|| .|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred cCCcCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCC
Confidence 69999999999998888877 999999999999999999999888877776654322 2223468999999999999 89
Q ss_pred CCCCC-----CHHHHhcCCCCCCCC
Q psy7825 309 IKFRI-----RLKDIKQDPWVKTEA 328 (357)
Q Consensus 309 p~~Rp-----s~~~ll~hp~~~~~~ 328 (357)
|.+|| ++.++++||||....
T Consensus 234 P~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 234 PKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 99998 999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=357.82 Aligned_cols=253 Identities=28% Similarity=0.460 Sum_probs=210.1
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||.|+||.||+|.+..++..||+|++....... ....+.+|+.+++.++||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 456999999999999999999999999999999986433221 133456899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|||+++ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~---- 156 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP---- 156 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC----
Confidence 999976 9999887643 5789999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-------------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV------------- 287 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------- 287 (357)
........|++.|+|||++.+.. ++.+ +|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 -TKTYSNEVVTLWYRPPDVLLGSTEYSTP-IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred -CccccCceecccccChHHhcCCcccCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 11223456899999999987644 5544 9999999999999999999988776665554432111
Q ss_pred -------CCC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 288 -------FPT---------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 288 -------~~~---------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
++. .+.++.++++||++|| .||.+|||++|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 111 1356889999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-50 Score=371.84 Aligned_cols=263 Identities=28% Similarity=0.447 Sum_probs=223.4
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..+..+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34566799999999999999999999999999999999754333333345577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~-- 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-- 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC--
Confidence 9999999999999998654 5899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCcccCCccccccceecCCC----CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCCCCC
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVP----YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFPTEP 292 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~ 292 (357)
........+||+.|+|||++.+.. ++.+ +|||||||++|+|++|+.||.+.+.......+... ..++...
T Consensus 196 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 196 --GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred --CcccCCCCCCCcCeECHHHhccCCCCCCCCCc-eeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 111223567999999999986543 4445 99999999999999999999998888777777542 3455555
Q ss_pred CCCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKF--RIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~~ 328 (357)
.+|.++++||++|| .+|.+ |+++++++.||||++..
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 78999999999999 78887 99999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=367.85 Aligned_cols=259 Identities=29% Similarity=0.464 Sum_probs=223.4
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++..++||||+++++.+.....+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36999999999999999999999999999999997654433344566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+++++|.+++.+. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~----~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN----K 156 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC----C
Confidence 999999999999876 67999999999999999999999999999999999999999999999999998744211 1
Q ss_pred CCCCCcccCCccccccceec------CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCCCCCC
Q psy7825 223 SPLSDTFCGSYAYASPEILK------GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFPTEPN 293 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~ 293 (357)
........||+.|+|||++. +..++.+ +|||||||++|+|++|..||...+.......+... ..++..+.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE-CDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCc-ceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence 11223456899999999986 3445555 99999999999999999999988877777766432 34555567
Q ss_pred CCHHHHHHHHHhcCCCCCCCCHHHHhcCCCCCCC
Q psy7825 294 VSAECKTLLSKIFSPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 294 ~s~~~~~li~~~L~~p~~Rps~~~ll~hp~~~~~ 327 (357)
++.++.+||+.||.+|.+||++.+++.||||...
T Consensus 236 ~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 236 VSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCC
Confidence 8999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=358.03 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=214.5
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.++..++|+||+++++.+..++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 78899999999999999999999999999998754433333344567899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 146 AEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 146 ~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..... .
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~------~ 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------G 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC------C
Confidence 9999999888643 3589999999999999999999999999999999999999999999999999864321 1
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---hhcccCCCCCCCCHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV---QTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~s~~~~~ 300 (357)
.......|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...........+ ...........++.++.+
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 234 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS 234 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence 11234568999999999998888877 99999999999999999999875433222222 122223334568999999
Q ss_pred HHHHhc-CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 301 LLSKIF-SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 301 li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
||++|| .||.+||+ ++++++||||++.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999 89999997 8999999999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=364.57 Aligned_cols=251 Identities=30% Similarity=0.511 Sum_probs=216.4
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
+.||+|+||.||+|.++.+++.||||++.+.........+.+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998754322222344556788888776 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~-----~~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-----NGKTTST 155 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-----CCCcccc
Confidence 99999999888899999999999999999999999999999999999999999999999999863211 1122334
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..++...+..... ..+..++.++++||++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cccCccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHccc
Confidence 579999999999998888877 9999999999999999999999988888877765332 233468999999999999 8
Q ss_pred CCCCCCCH------HHHhcCCCCCCC
Q psy7825 308 PIKFRIRL------KDIKQDPWVKTE 327 (357)
Q Consensus 308 ~p~~Rps~------~~ll~hp~~~~~ 327 (357)
||.+||++ ++++.||||+..
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 99999998 999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=370.05 Aligned_cols=263 Identities=29% Similarity=0.464 Sum_probs=221.9
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..+..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34567899999999999999999999999999999999754333333345577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~-- 195 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-- 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC--
Confidence 9999999999999999754 5899999999999999999999999999999999999999999999999998743211
Q ss_pred CCCCCCCCcccCCccccccceecCCC----CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCCCCC
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVP----YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFPTEP 292 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~ 292 (357)
........+||+.|+|||++.+.. ++.+ +|||||||++|+|++|+.||.+.+.......+... ..+|...
T Consensus 196 --~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~-~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 196 --GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred --CceecccCCCCcccCCHHHHhccCCCCCCCcc-cCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 111223567999999999997543 4445 99999999999999999999988887777776542 3445545
Q ss_pred CCCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKF--RIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~~ 328 (357)
.++..+++||..|| .++.+ |+++.++++||||+...
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 68999999999999 55543 89999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=357.02 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=212.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++..++.+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 3699999999999999999999999999999998754332 223455778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~ 155 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS----N 155 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc----c
Confidence 999987776665555679999999999999999999999999999999999999999999999999987542111 1
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-----------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV----------------- 286 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------- 286 (357)
.......|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 11224568999999999988888776 999999999999999999998876554433322110
Q ss_pred ---cCCC-----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 287 ---VFPT-----------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 287 ---~~~~-----------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
..+. ...+|.++.+||++|| .||++||+++++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0111 1237889999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=361.87 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=220.2
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCC-CcceeeEEEEeCCeEEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP-NLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 143 (357)
+|.+.+.||+|+||.||+|.+..+++.||||++.+.........+.+..|+.++..+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 489999999999999999999999999999999764332233345567899999999765 5888999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-----~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-----GG 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-----CC
Confidence 9999999999999888899999999999999999999999999999999999999999999999999863211 11
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+.... ...+..++.++.+||+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 233 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICK 233 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Confidence 12234579999999999998888877 999999999999999999999988888777765432 2334468999999999
Q ss_pred Hhc-CCCCCCCCH-----HHHhcCCCCCCC
Q psy7825 304 KIF-SPIKFRIRL-----KDIKQDPWVKTE 327 (357)
Q Consensus 304 ~~L-~~p~~Rps~-----~~ll~hp~~~~~ 327 (357)
+|| .+|.+|++. +++++||||...
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999 899999987 899999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=358.10 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=208.2
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++........ ...+.+|+.+++.++||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3579999999999999999999999999999999865432221 23456899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|||+.+ +|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 155 (303)
T cd07869 82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV----- 155 (303)
T ss_pred EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC-----
Confidence 999964 888877654 5689999999999999999999999999999999999999999999999999863211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhhcccCC-----------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQVQTKVVFP----------- 289 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~----------- 289 (357)
.........|++.|+|||++.+......++|||||||++|+|++|..||.+... .+.+..+......+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 111223456899999999987654333449999999999999999999987533 23333221111000
Q ss_pred -----------C---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 290 -----------T---------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 290 -----------~---------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
. ....+.++.+||.+|| .||++|||+.++|+||||++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 0 0124578999999999 89999999999999999988543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=363.24 Aligned_cols=252 Identities=31% Similarity=0.534 Sum_probs=211.7
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
++||+|+||.||+|.+..+++.||+|++.+...........+.+|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999765444444455677899999988 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... .......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-----~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-----PGDTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-----CCCcccc
Confidence 99999998888899999999999999999999999999999999999999999999999999863211 1122335
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT--------NYIQLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
.+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||... ...+...+.........+..++..+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 679999999999998888877 99999999999999999999631 111222222222233344568999999
Q ss_pred HHHHhc-CCCCCCCC------HHHHhcCCCCCCC
Q psy7825 301 LLSKIF-SPIKFRIR------LKDIKQDPWVKTE 327 (357)
Q Consensus 301 li~~~L-~~p~~Rps------~~~ll~hp~~~~~ 327 (357)
||++|| .||.+|++ ++++++||||...
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999 99999997 7899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=364.13 Aligned_cols=251 Identities=32% Similarity=0.524 Sum_probs=216.2
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKG 149 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 149 (357)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.++..++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997643333333445668999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 150 SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 150 ~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
+|..++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~-----~~~~~~~ 155 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-----DGATMKT 155 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC-----CCccccc
Confidence 999999888889999999999999999999997 7999999999999999999999999999863211 1112234
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
..||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+.......+... ....+..++.++.+||++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred ccCCcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHhhc
Confidence 569999999999988888877 99999999999999999999988877776665432 22233468999999999999 9
Q ss_pred CCCCCC-----CHHHHhcCCCCCCC
Q psy7825 308 PIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 308 ~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
||.+|+ ++.++++||||.+.
T Consensus 234 dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 999997 99999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=366.94 Aligned_cols=264 Identities=28% Similarity=0.459 Sum_probs=223.3
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..+..++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+..+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34556789999999999999999999999999999999875433333334557789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+++||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~- 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE- 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-
Confidence 99999999999999999764 4899999999999999999999999999999999999999999999999998744211
Q ss_pred CCCCCCCCCcccCCccccccceecCCC----CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCCCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVP----YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFPTE 291 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~ 291 (357)
........+||+.|+|||++.+.. ++.+ +|||||||++|+|++|..||.+.+.......+... ..++..
T Consensus 196 ---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 196 ---GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred ---CcccccCcccCccccCHHHHhccCCCccCCCc-cceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence 111223567999999999997543 4445 99999999999999999999998888877777543 345555
Q ss_pred CCCCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCCCCCC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKF--RIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~~ 328 (357)
..++..+++||..|| .++.+ |+++++|++||||++..
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 679999999999999 44443 88999999999998854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=360.46 Aligned_cols=254 Identities=28% Similarity=0.482 Sum_probs=215.8
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHH---HcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV---KGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++ ..++||||+++++++.....+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999999999999999999754322222234555666554 566799999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|||++|++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~-----~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG-----F 154 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC-----C
Confidence 999999999988865 4699999999999999999999999999999999999999999999999998863211 1
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
.......+|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+..... ..+..++..+.+||
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li 232 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIM 232 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHH
Confidence 122345679999999999998888777 9999999999999999999999888887777654322 23346899999999
Q ss_pred HHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 303 SKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 303 ~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
++|| .||.+|| ++.++++||||++.
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999 8999999 79999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=360.89 Aligned_cols=257 Identities=36% Similarity=0.640 Sum_probs=228.6
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.+.+.||+|.|+.|-+|++.-+|..||||++.+.....-. ...+.+|+..|+.++|||||++|++......+|+|+|.
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 88999999999999999999999999999999887665433 44566999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE-cCCCcEEEeecCCCcccccccCCCCC
Q psy7825 146 AEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI-DGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 146 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili-~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
-++|+|+++|.+. ..+.+..+++++.||+.|+.|+|...+|||||||+||++ ..-|-+||.|||++..+ ...
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf------~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF------QPG 172 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC------CCc
Confidence 9999999999764 459999999999999999999999999999999999866 45689999999998633 223
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
....+.||+..|.|||++.|..|+..++||||||+|||.|++|+.||+..+..+.+..|+... +..+..++.+|++||.
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-YtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-YTVPSHVSKECRDLIQ 251 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-ccCchhhhHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999999988888876432 3334479999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 304 KIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.|| .||++|.+.++|..++|+|..-++
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHhcCchhhccHHHHhccccccCCCCC
Confidence 999 999999999999999999986544
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=361.43 Aligned_cols=251 Identities=31% Similarity=0.498 Sum_probs=216.7
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
++||+|+||.||+|++..+++.||||++.+...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999764333333344566788888866 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~-----~~~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL-----NGVTTTT 155 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc-----CCccccc
Confidence 99999998888899999999999999999999999999999999999999999999999999863211 1122334
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
.+|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+..... ..+..++.++.+||++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cccCccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhcc
Confidence 579999999999998888877 9999999999999999999999988888877765432 223458999999999999 8
Q ss_pred CCCCCC-------CHHHHhcCCCCCCC
Q psy7825 308 PIKFRI-------RLKDIKQDPWVKTE 327 (357)
Q Consensus 308 ~p~~Rp-------s~~~ll~hp~~~~~ 327 (357)
||.+|| ++.++++||||...
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 999999 99999999999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-51 Score=340.40 Aligned_cols=256 Identities=28% Similarity=0.521 Sum_probs=223.1
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCC-----CchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA-----PPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHR 138 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 138 (357)
.|...+.||.|..+.|-++..+.+|..+|+|++..... ......+.-.+|+.+|+++. ||+|+++.++|+.+.+
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 48888999999999999999999999999999854321 23334455668999999985 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+++|+|.++.|.|+|++.+.-.+++...+.|+.|+++|++|||.++||||||||+|||++++.+++|+|||++..+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~--- 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE--- 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC---
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCCCCCcccCCccccccceec-----CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILK-----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFPT 290 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~ 290 (357)
........||||+|+|||.+. +.+.+...+|+|++|+|+|-|+.|..||-.....-++..|+.+ +.-|.
T Consensus 175 ---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 175 ---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 223345678999999999983 3333333499999999999999999999988888888888664 34456
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
+.+++...++||.+|| .||.+|.|++++|+||||.+
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 7889999999999999 99999999999999999943
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=357.98 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=218.5
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|++.+.||+|+||.||+|++..+|..||+|++.... .......+.+|+.+++.++||||+++++++..++.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 34578999999999999999999999999999999986532 2334566889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
+||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 9999999999999999888899999999999999999999986 699999999999999999999999999864321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh---------------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT--------------- 284 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--------------- 284 (357)
.......|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+..++...+..
T Consensus 157 ----~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 157 ----SMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ----cccccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence 12234568999999999998888877 9999999999999999999977655444322211
Q ss_pred -------------------------------cccCC-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 285 -------------------------------KVVFP-TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 285 -------------------------------~~~~~-~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
..... ....++.++++||++|| .||++||++++|++||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 00000 11247899999999999 8999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-51 Score=346.61 Aligned_cols=267 Identities=31% Similarity=0.519 Sum_probs=239.8
Q ss_pred cccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.....+..++|..+++||+|.||.|.+++.+.+|+.||||++++.-.........-..|-.+|+..+||.+..+...|+.
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 33445567789999999999999999999999999999999987666555555556689999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
.+++|+||||..||.|+-++.+...|++..++.+...|+.||.|||+.+||+||||.+|+|+|.+|++||+|||+++...
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999997432
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-hcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ-TKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~ 294 (357)
.......++||||.|+|||++....|... +|+|.+|+++|||++|+.||...+...+++.|. ..+.+|. .+
T Consensus 320 -----~~g~t~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr--~l 391 (516)
T KOG0690|consen 320 -----KYGDTTKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR--TL 391 (516)
T ss_pred -----cccceeccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc--cC
Confidence 23445678999999999999999999987 999999999999999999999999999998874 5666776 59
Q ss_pred CHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTEANP 330 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~~~~ 330 (357)
+++++.|+..+| +||.+|. ++.+|.+|+||....+.
T Consensus 392 s~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 392 SPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred CHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 999999999999 9999996 68999999999987554
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=358.96 Aligned_cols=251 Identities=30% Similarity=0.502 Sum_probs=213.6
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
++||+|+||.||+|.+..+|+.||+|++.+.....+.....+..|..++..+ +||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999754322122234455677777754 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.... .......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-----GDNRAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-----CCCceec
Confidence 99999998888899999999999999999999999999999999999999999999999999863211 1122335
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+...+.+.+.... ...+..++.++++||++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-PHYPRWITKESKDILEKLFER 233 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHccC
Confidence 679999999999998888877 999999999999999999999888887777765432 2223468999999999999 8
Q ss_pred CCCCCCCH-HHHhcCCCCCCC
Q psy7825 308 PIKFRIRL-KDIKQDPWVKTE 327 (357)
Q Consensus 308 ~p~~Rps~-~~ll~hp~~~~~ 327 (357)
||.+||++ ++++.||||+..
T Consensus 234 dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CHHHcCCChHHHHcCCCcCCC
Confidence 99999998 589999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=359.55 Aligned_cols=252 Identities=27% Similarity=0.510 Sum_probs=215.8
Q ss_pred ceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCC-chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 69 GKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAP-PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
++.||+|+||.||+|... .+++.||+|++...... .......+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999863 46899999998753221 11223456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~ 155 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-----EGT 155 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc-----CCC
Confidence 999999999999888899999999999999999999999999999999999999999999999999863211 112
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSK 304 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 304 (357)
......|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+... ....++.++..+.+||++
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-KLNLPPYLTPEARDLLKK 233 (323)
T ss_pred cccccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHH
Confidence 2334579999999999988887766 99999999999999999999998887777766543 234455789999999999
Q ss_pred hc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 305 IF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 305 ~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
|| .+|.+|| ++.+++.||||...
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99 8999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-49 Score=358.76 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=220.1
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
+|.+.+.||+|+||.||+|.+..+++.||||++.+...........+..|..++..+ .|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 488999999999999999999999999999999764333333344456788888777 4889999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++|+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~-----~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-----DG 155 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC-----CC
Confidence 9999999999998888899999999999999999999999999999999999999999999999999863211 11
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+...+...+.... ...+..++.++.+||.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 233 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICK 233 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHH
Confidence 22335679999999999999888877 999999999999999999999988888877765432 2233468999999999
Q ss_pred Hhc-CCCCCCCCH-----HHHhcCCCCCCC
Q psy7825 304 KIF-SPIKFRIRL-----KDIKQDPWVKTE 327 (357)
Q Consensus 304 ~~L-~~p~~Rps~-----~~ll~hp~~~~~ 327 (357)
+|| .+|.+|++. .++++||||+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 999 899999984 899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=357.98 Aligned_cols=251 Identities=31% Similarity=0.525 Sum_probs=213.0
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHc-CCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG-LRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
++||+|+||.||+|.+..+++.||||++...........+.+..|..++.. .+||||+++++++.....+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975432222223334456666665 4799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~-----~~~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN-----GEGKAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC-----CCCcccc
Confidence 99999998888899999999999999999999999999999999999999999999999999864321 1122345
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..++...+.... ...+..++.++.+||.+|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-PHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred ccCCccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccC
Confidence 679999999999998888877 999999999999999999999988888777765432 2334568999999999999 8
Q ss_pred CCCCCCCH-HHHhcCCCCCCC
Q psy7825 308 PIKFRIRL-KDIKQDPWVKTE 327 (357)
Q Consensus 308 ~p~~Rps~-~~ll~hp~~~~~ 327 (357)
+|.+||++ .+++.||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CHHHcCCChHHHHcCcccCCC
Confidence 99999986 488899999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=359.81 Aligned_cols=251 Identities=30% Similarity=0.557 Sum_probs=213.3
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHH-HHHHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREI-DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|. .+++.++||||+++++.+.....+++||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999999999999999998754322222223333444 456889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-----~~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-----HSKTTST 155 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-----CCCcccc
Confidence 99999999888899999999999999999999999999999999999999999999999999863211 1122334
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+..++...+.... ....+.++..+.+||++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred ccCChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence 579999999999998888877 999999999999999999999988888777765432 2334568999999999999 8
Q ss_pred CCCCCCCH----HHHhcCCCCCCC
Q psy7825 308 PIKFRIRL----KDIKQDPWVKTE 327 (357)
Q Consensus 308 ~p~~Rps~----~~ll~hp~~~~~ 327 (357)
||.+||++ .+++.||||...
T Consensus 234 ~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 234 DRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CHHhCCCCCCCHHHHHcCCCcCCC
Confidence 99999988 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=359.37 Aligned_cols=260 Identities=27% Similarity=0.457 Sum_probs=210.2
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC-----CeE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT-----HRV 139 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 139 (357)
+|.+.+.||+|+||.||+|.+..+|..||||.+........ ....+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccch-hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 58999999999999999999999999999999864322222 233467899999999999999999987543 358
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 59999998888899999999999999999999999999999999999999999999999999874322111
Q ss_pred CCCCCCCCcccCCccccccceecC--CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-----------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKG--VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV----------- 286 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------- 286 (357)
........+|++.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+.......+....
T Consensus 159 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 159 --TAIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred --ccccccCCCCCCCcCCHHHHhccccccCch-hHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 1112234579999999999865 456665 999999999999999999998766543332221100
Q ss_pred ----------------cCC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 287 ----------------VFP---TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 287 ----------------~~~---~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
..+ ..+.++..+.+||.+|| .+|.+||+++++|+||||++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000 11357889999999999 89999999999999999987554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=359.83 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=212.5
Q ss_pred CeEEceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCC-chHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeE
Q psy7825 65 GYVLGKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAP-PDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRV 139 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 139 (357)
+|++.+.||+|+||.||+|... .+|+.||+|++.+.... .....+.+..|+.++..+. ||||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999863 46899999998753221 2223455778999999995 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-- 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-- 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhhcccCCCCCCCC
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT----NYIQLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~s 295 (357)
........+||+.|+|||++.+......++|||||||++|+|++|..||... ........+. ....+.+..++
T Consensus 159 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (332)
T cd05614 159 --EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFPSFIG 235 (332)
T ss_pred --CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCC
Confidence 1112234579999999999987653334499999999999999999999643 2223333332 22334445789
Q ss_pred HHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 296 AECKTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
..+++||.+|| .||.+|| +++++++||||++.
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999 8999999 88999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=358.73 Aligned_cols=251 Identities=30% Similarity=0.534 Sum_probs=210.5
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999765444433455677888888776 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... .......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~-----~~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-----PGDTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC-----CCCcccc
Confidence 99999998888899999999999999999999999999999999999999999999999999863211 1112334
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT---------NYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||... ........+. ......+..++..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~~~~~~~ 233 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKAA 233 (329)
T ss_pred ccCCccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCCCCCCHHHH
Confidence 679999999999998888877 99999999999999999999521 1112222222 222333456899999
Q ss_pred HHHHHhc-CCCCCCCC------HHHHhcCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIR------LKDIKQDPWVKTE 327 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps------~~~ll~hp~~~~~ 327 (357)
+||++|| .||.+||+ +.+++.||||++.
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999 89999998 5899999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=357.63 Aligned_cols=252 Identities=33% Similarity=0.551 Sum_probs=216.9
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
+.||+|+||.||+|.+..+++.||||++.+...........+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999764333333345566888888888 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-----~~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL-----GGVTTST 155 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc-----CCCcccc
Confidence 99999999888899999999999999999999999999999999999999999999999999863211 1112234
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
.+|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+..... ..+..++..+.+||++|| .
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred eecCccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHccC
Confidence 579999999999999888877 9999999999999999999998888777776654322 233468999999999999 9
Q ss_pred CCCCCCCH-----HHHhcCCCCCCCC
Q psy7825 308 PIKFRIRL-----KDIKQDPWVKTEA 328 (357)
Q Consensus 308 ~p~~Rps~-----~~ll~hp~~~~~~ 328 (357)
||.+||++ .+++.||||+...
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999 9999999998853
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-50 Score=361.98 Aligned_cols=258 Identities=27% Similarity=0.505 Sum_probs=235.5
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe-EEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR-VYI 141 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l 141 (357)
.++|..++++|+|+||.+++++++.+++.|++|.+......... ++...+|+.+++++.|||||.+.+.|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 35699999999999999999999999999999999766554443 3356699999999999999999999988887 999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 142 IMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
||+||+||+|.+.+.+. ..|+++.+..++.||+.|+.|||+++|+|||||+.|||++.++.++|+|||+++.+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 99999999999999764 46999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
.....+.+||+.||+||++.+.+|..+ +|||||||++|||++-+++|.+.+...+..+|......|.+..++.+++
T Consensus 160 ---~~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~ 235 (426)
T KOG0589|consen 160 ---DSLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELR 235 (426)
T ss_pred ---hhhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHH
Confidence 124557789999999999999999999 9999999999999999999999999999999999888999999999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.||+.|| .+|..||++.+||.+|.++..
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 9999999 999999999999999998854
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=342.02 Aligned_cols=265 Identities=27% Similarity=0.405 Sum_probs=222.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC-cceeeEEEEeCC-----
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN-LIRFLQAIETTH----- 137 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~----- 137 (357)
..|..++.||+|+||+||+|+.+.+|+.||+|.++..... +..-....+|+.+|+.++|+| |+.+++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3477888899999999999999999999999999765442 122344559999999999999 999999998877
Q ss_pred -eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 138 -RVYIIMEYAEKGSLLDFIQREG----YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 138 -~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.+++|+||++. +|..++.... .++...++.++.||+.||.|||+++|+||||||.||||++.|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 89999999976 9999998754 47788999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC-
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE- 291 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~- 291 (357)
.... ........++|..|+|||++.+...+....||||+|||++||++++..|.+....+.+..|-.....|..
T Consensus 169 a~~i-----p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 169 AFSI-----PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HhcC-----CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 4422 2222456678999999999999855555599999999999999999999999888877777554433321
Q ss_pred ----------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcccc
Q psy7825 292 ----------------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAG 335 (357)
Q Consensus 292 ----------------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~ 335 (357)
+..+.+..+++.+|| .+|.+|.|++.+|.||||+....+.+...
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~~~ 316 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQLL 316 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhhhh
Confidence 234469999999999 89999999999999999999866655433
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=355.63 Aligned_cols=252 Identities=30% Similarity=0.498 Sum_probs=213.7
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHc-CCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG-LRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
+.||+|+||.||+|++..+++.||||++.......+.....+..|..++.. ++||||+++++++...+.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975432211223344567777775 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML-----GDAKTCT 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC-----CCCceee
Confidence 99999998888899999999999999999999999999999999999999999999999999863211 1112234
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
..||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..++...+..... ..+..++.++++||.+|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP-CYPRWLTREAKDILVKLFVR 233 (316)
T ss_pred ecCCccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHhcc
Confidence 579999999999998888877 9999999999999999999998888877777654322 223468999999999999 8
Q ss_pred CCCCCCCHH-HHhcCCCCCCCC
Q psy7825 308 PIKFRIRLK-DIKQDPWVKTEA 328 (357)
Q Consensus 308 ~p~~Rps~~-~ll~hp~~~~~~ 328 (357)
+|.+||++. +++.||||+...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred CHhhcCCChHHHHcCcccCCCC
Confidence 999999996 999999998853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=343.90 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=215.6
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----eE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH-----RV 139 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 139 (357)
.|.-.+++|.|+||.||+|....+++.||||.+-..... -.+|+.+|+.++|||||+++.+|.... +.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 488899999999999999999999999999987443222 227999999999999999999885422 45
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEEeecCCCccc
Q psy7825 140 YIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGH 214 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-~~~kl~Dfg~~~~~ 214 (357)
.+||||++. +|...++. +..++...++-+..||++||.|||+.||+||||||.|+|||.+ |.+||||||.|+.+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 689999976 99999985 5679999999999999999999999999999999999999987 89999999999866
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC---
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE--- 291 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--- 291 (357)
.... ...+...|..|+|||.+.|...++.+.||||.||++.||+.|++.|.+.+..+++..|...+..|..
T Consensus 177 ~~~e------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGE------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCC------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4322 2244557889999999998876666699999999999999999999998888877776554443332
Q ss_pred -------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 292 -------------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 292 -------------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
...+++..+|+.++| .+|.+|.++.|++.||||+.-..+..
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~ 317 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNT 317 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCc
Confidence 357899999999999 89999999999999999998766643
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=359.83 Aligned_cols=255 Identities=25% Similarity=0.463 Sum_probs=222.7
Q ss_pred cccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.....+....+.+.+.||+|.||.||.|.++. ...||+|.+....... +.|.+|+.+|++|+|++||++++++..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 34445556667788899999999999999874 3489999987654432 445699999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
+..+||||||++.|+|.++|+. +..+...+.+.++.||++||+||+++++|||||...||||+++..+||+|||+++.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 8899999999999999999987 46799999999999999999999999999999999999999999999999999983
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCC
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEP 292 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 292 (357)
... .........--...|.|||.+....++.+ +||||||++||||+| |+.||.+.+..++++.+..+++.|.++
T Consensus 353 ~~d----~~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~ 427 (468)
T KOG0197|consen 353 IGD----DEYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE 427 (468)
T ss_pred cCC----CceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC
Confidence 211 11112222234568999999999999988 999999999999996 999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.||+++.+++..|| .+|++|||++.+..
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 99999999999999 89999999997753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=356.67 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=212.8
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++|+||+++++++...+.+++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3456889999999999999999999999999999985432 23345668899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~---- 221 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT---- 221 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc----
Confidence 9999999998653 23577888999999999999999999999999999999999999999999998754211
Q ss_pred CCCCCCcccCCccccccceecC----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhhcccCCCCCCC
Q psy7825 222 QSPLSDTFCGSYAYASPEILKG----VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN---YIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~ 294 (357)
........|+..|+|||++.. ..+...++|||||||++|+|++|+.||.... .......+...........+
T Consensus 222 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (353)
T PLN00034 222 -MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300 (353)
T ss_pred -cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence 111234569999999999843 2333334999999999999999999997432 23333333333333444578
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
+.++++||.+|| .||.+||++.+||+||||.....+..
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~~ 339 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQG 339 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcccc
Confidence 999999999999 89999999999999999999876643
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=355.35 Aligned_cols=259 Identities=30% Similarity=0.493 Sum_probs=215.5
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..++|+||+++++++..+..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36999999999999999999999999999999997543333333456778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD----G 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC----C
Confidence 99999999999976 457999999999999999999999999999999999999999999999999998643211 1
Q ss_pred CCCCCcccCCccccccceecC-----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCC-CCCC
Q psy7825 223 SPLSDTFCGSYAYASPEILKG-----VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFP-TEPN 293 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~-~~~~ 293 (357)
.......+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+..+....+... ..++ ..+.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD 235 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCc-ceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence 111223469999999999863 234445 99999999999999999999988877776666432 2222 2235
Q ss_pred CCHHHHHHHHHhc-CCCC--CCCCHHHHhcCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIK--FRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~--~Rps~~~ll~hp~~~~~ 327 (357)
++..+++||++|| .++. .|+++.+++.||||.+.
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 8999999999999 4433 38999999999999774
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=354.14 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=218.6
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 143 (357)
+|...+.||+|+||.||+|.+..+|+.||+|++.+.........+.+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3788899999999999999999999999999997543322333445667888888886 577888999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~-----~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-----DG 155 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC-----CC
Confidence 9999999999999888899999999999999999999999999999999999999999999999999863211 11
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+.... ...+..++.++.+|+.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~ 233 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICK 233 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHH
Confidence 12234569999999999998888877 999999999999999999999988877777765432 2233468999999999
Q ss_pred Hhc-CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 304 KIF-SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 304 ~~L-~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
+|| .+|.+|++ .+++++||||+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999 89999997 5799999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=360.54 Aligned_cols=250 Identities=27% Similarity=0.467 Sum_probs=209.7
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC---CCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL---RHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
||+|+||.||+|.+..+|+.||||++.+..............|..++..+ .||||+++++.+.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998654332222222334566666554 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~-----~~~~~~~ 155 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT-----DNKTTNT 155 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC-----CCCCccC
Confidence 99999999888899999999999999999999999999999999999999999999999999863211 1122335
Q ss_pred ccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-
Q psy7825 229 FCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF- 306 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L- 306 (357)
.+||+.|+|||++.+.. ++.+ +|||||||++|+|++|..||...+..+....+...........++.++++||++||
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~-~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKH-VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLN 234 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCc-cceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence 67999999999997654 5555 99999999999999999999998888877776544332223458999999999999
Q ss_pred CCCCCCC----CHHHHhcCCCCCCC
Q psy7825 307 SPIKFRI----RLKDIKQDPWVKTE 327 (357)
Q Consensus 307 ~~p~~Rp----s~~~ll~hp~~~~~ 327 (357)
.||.+|| ++.++++||||...
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCC
Confidence 8999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=357.18 Aligned_cols=251 Identities=30% Similarity=0.548 Sum_probs=213.3
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHH-HHHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREID-VVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++.+...+.+++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997543322222333445544 57789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-----~~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-----QSDTTTT 155 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC-----CCCCccc
Confidence 99999998888899999999999999999999999999999999999999999999999999863211 1122345
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
.+|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..++...+.... ....+..+..+.++|++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLEK 233 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhcc
Confidence 679999999999998888877 999999999999999999999988888777765432 2334568999999999999 8
Q ss_pred CCCCCCCH----HHHhcCCCCCCC
Q psy7825 308 PIKFRIRL----KDIKQDPWVKTE 327 (357)
Q Consensus 308 ~p~~Rps~----~~ll~hp~~~~~ 327 (357)
+|.+||++ .+++.||||...
T Consensus 234 ~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 234 DRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CHHhcCCCCCCHHHHhcCCCcCCC
Confidence 99999877 599999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=355.03 Aligned_cols=253 Identities=30% Similarity=0.514 Sum_probs=212.4
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999765444444456677899999888 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-----~~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG-----PGDTTST 155 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC-----CCCceec
Confidence 99999998888899999999999999999999999999999999999999999999999999863211 1122335
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT------NYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||... ...+...........+.+..++..+.++|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred ccCCcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 679999999999998888877 99999999999999999999531 22222222222223344456899999999
Q ss_pred HHhc-CCCCCCCC------HHHHhcCCCCCCCC
Q psy7825 303 SKIF-SPIKFRIR------LKDIKQDPWVKTEA 328 (357)
Q Consensus 303 ~~~L-~~p~~Rps------~~~ll~hp~~~~~~ 328 (357)
++|| .||.+|++ +.+++.||||....
T Consensus 235 ~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 235 KGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 9999 89999998 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=360.99 Aligned_cols=255 Identities=21% Similarity=0.315 Sum_probs=208.7
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+...+|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++||||++++++|......+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 45567999999999999999999999999999999643 123568999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
+|+|++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~--- 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI--- 235 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc---
Confidence 9999995 589999988888999999999999999999999999999999999999999999999999998632111
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHhhc--------
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN-------YIQLLKQVQTK-------- 285 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~-------- 285 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.... ....+..+...
T Consensus 236 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 236 -NANKYYGWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred -cccccccccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 1112234679999999999988888877 999999999999999998874321 11111111100
Q ss_pred -------------------ccCCC-------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 286 -------------------VVFPT-------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 286 -------------------~~~~~-------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
...+. ...++.++.+||.+|| .||.+|||++++|+||||+....+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 00000 0135678999999999 999999999999999999986544
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=364.46 Aligned_cols=253 Identities=27% Similarity=0.426 Sum_probs=204.8
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC-----
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT----- 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 136 (357)
...+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 4467999999999999999999999999999999885421 2234799999999999999998876432
Q ss_pred ---CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeec
Q psy7825 137 ---HRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-NIKLSDF 208 (357)
Q Consensus 137 ---~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-~~kl~Df 208 (357)
..+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 257799999976 78777653 46799999999999999999999999999999999999998665 6999999
Q ss_pred CCCcccccccCCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc
Q psy7825 209 GFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV 287 (357)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 287 (357)
|+++..... .......||+.|+|||++.+. .++.+ +|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 216 Gla~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 216 GSAKNLLAG------QRSVSYICSRFYRAPELMLGATNYTTH-IDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred ccchhccCC------CCcccCCCCcCccCHHHhcCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999744211 112345689999999998765 45555 9999999999999999999998776655544432111
Q ss_pred ------------------CC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 288 ------------------FP----------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 288 ------------------~~----------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
++ .+...+.++++||.+|| .||.+||++.|+|+||||.+...
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 11 11246889999999999 89999999999999999987543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=354.31 Aligned_cols=251 Identities=29% Similarity=0.521 Sum_probs=212.5
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHH-HHHHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREI-DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
++||+|+||.||+|++..+|+.||+|++.+...........+..|. .+++.++||||+++++.+...+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999998754332222233344454 467889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..... .......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-----~~~~~~~ 155 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE-----PEETTST 155 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC-----CCCcccc
Confidence 99999998888899999999999999999999999999999999999999999999999999863211 1122334
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
.+|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+.......+.... ...++..+..+.++|.+|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccC
Confidence 579999999999988888877 999999999999999999999988877777765432 3344578999999999999 8
Q ss_pred CCCCCCCH----HHHhcCCCCCCC
Q psy7825 308 PIKFRIRL----KDIKQDPWVKTE 327 (357)
Q Consensus 308 ~p~~Rps~----~~ll~hp~~~~~ 327 (357)
+|.+||++ .++++||||...
T Consensus 234 ~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 234 DQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred CHhhcCCCCCCHHHHhCCCCcCCC
Confidence 99999876 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=345.41 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=215.7
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+..+..+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 38899999999999999999998999999999875443333334556689999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 145 YAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 145 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE------ 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 99999999988653 4589999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh---cccCCCCCCCCHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT---KVVFPTEPNVSAECK 299 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~ 299 (357)
.......+|++.|+|||++.+..++.. +||||+||++|+|++|..||.+.+.....+.+.. ......+..++..++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 155 GETIRGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred CCccccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 111224468999999999988888877 9999999999999999999987665443333221 222223346899999
Q ss_pred HHHHHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 300 ~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
+||.+|| .||.+|| ++++++.||||...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 9999999 9999999 99999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=353.68 Aligned_cols=251 Identities=31% Similarity=0.548 Sum_probs=212.4
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHH-HHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPRE-IDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E-~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
+.||+|+||.||+|.+..+++.||+|++.+...........+..| ..+++.++||||+++++.+...+.+++||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999875432222122223334 4467889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.... .......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~-----~~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-----HNGTTST 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc-----CCCCccc
Confidence 99999999888899999999999999999999999999999999999999999999999999864321 1122345
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
.+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... ....+.++..+.+||.+|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred ccCCccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-cCCCCCCCHHHHHHHHHHccc
Confidence 679999999999998888877 999999999999999999999888887777765432 2334579999999999999 8
Q ss_pred CCCCCCCHH----HHhcCCCCCCC
Q psy7825 308 PIKFRIRLK----DIKQDPWVKTE 327 (357)
Q Consensus 308 ~p~~Rps~~----~ll~hp~~~~~ 327 (357)
+|.+||++. ++++|+||...
T Consensus 234 ~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 234 DRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CHHHCCCCCCCHHHHhcCcccCCC
Confidence 999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=345.54 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=208.7
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCCh
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 151 (357)
||+|+||.||+|.+..+|+.||+|.+...........+.+..|+.+++.++||||+++.+++......++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998754433332334566899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCC
Q psy7825 152 LDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD 227 (357)
Q Consensus 152 ~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 227 (357)
.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-----QSKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC-----Ccccc
Confidence 988743 356899999999999999999999999999999999999999999999999998643221 11123
Q ss_pred cccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 228 TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI----QLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 228 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
...|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .....+... ....++.++..+.+|+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 233 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCE 233 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHH
Confidence 4568999999999998888877 99999999999999999999765432 222222211 22233468999999999
Q ss_pred Hhc-CCCCCCC-----CHHHHhcCCCCCCCCCC
Q psy7825 304 KIF-SPIKFRI-----RLKDIKQDPWVKTEANP 330 (357)
Q Consensus 304 ~~L-~~p~~Rp-----s~~~ll~hp~~~~~~~~ 330 (357)
+|| .||.+|| +++++++||||++..+.
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred HHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 999 8999999 88999999999885433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-50 Score=387.00 Aligned_cols=266 Identities=27% Similarity=0.453 Sum_probs=236.9
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..+..++|.|+++||+|+||.|.+++.+.+++.||+|++++...........|..|-.+|...+.+=|+.++.+|+++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 34566789999999999999999999999999999999987444433335678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+||||++||+|..++.+.+++++..++.|+..|+.||..||+.|+|||||||+|||+|..|+++|+|||.+-...
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~--- 226 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD--- 226 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC---
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999885432
Q ss_pred CCCCCCCCCcccCCccccccceec----C-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh---cccCCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILK----G-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT---KVVFPT 290 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~ 290 (357)
.+........+|||.|.+||++. + +.|+.. +|+||||+++|||++|..||...+..+++.+|.. .+.||.
T Consensus 227 -~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~e-cDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 227 -ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRE-CDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred -CCCcEEeccccCCCCccCHHHHHhhcCCccccCCc-cchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 12333456778999999999993 3 456666 9999999999999999999999999999999854 577886
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCC
Q psy7825 291 EPNVSAECKTLLSKIFSPIKFRIR---LKDIKQDPWVKTEAN 329 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L~~p~~Rps---~~~ll~hp~~~~~~~ 329 (357)
...+|+++++||++++.+|+.|.. ++++..||||.+-.+
T Consensus 305 ~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCCh
Confidence 678999999999999999998888 999999999999876
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=358.87 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=212.6
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-C-----CCcceeeEEEEeCCe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-H-----PNLIRFLQAIETTHR 138 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~~~~~~~~~~~ 138 (357)
+|.+.++||+|+||.|.+|.+..+++.||||+++.... ....-..|+.+|..|+ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 68999999999999999999999999999999975322 2334457999999997 3 489999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC--cEEEeecCCCccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY--NIKLSDFGFARGH 214 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~--~~kl~Dfg~~~~~ 214 (357)
+|||+|.+.. +|+++++.+ ..|+...++.++.||+.||..||..||||+||||+|||+.+-+ .+||+|||.+...
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999965 999999875 3588999999999999999999999999999999999997553 6999999998632
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC---
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE--- 291 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--- 291 (357)
.....+.+-+..|+|||++.|.+|+.. .||||||||++||++|.+.|.+.+..+.+..|...+..|..
T Consensus 342 --------~q~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 342 --------SQRVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred --------CCcceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 122236678889999999999999998 99999999999999999999998888877776543322211
Q ss_pred -----------------------------------------------C------------CCCHHHHHHHHHhc-CCCCC
Q psy7825 292 -----------------------------------------------P------------NVSAECKTLLSKIF-SPIKF 311 (357)
Q Consensus 292 -----------------------------------------------~------------~~s~~~~~li~~~L-~~p~~ 311 (357)
| .....+.+||++|| .||..
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 1 23467899999999 99999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy7825 312 RIRLKDIKQDPWVKTE 327 (357)
Q Consensus 312 Rps~~~ll~hp~~~~~ 327 (357)
|+++.++|+||||.+.
T Consensus 493 R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 493 RITPAQALNHPFLTGT 508 (586)
T ss_pred cCCHHHHhcCcccccc
Confidence 9999999999999944
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=334.76 Aligned_cols=260 Identities=28% Similarity=0.510 Sum_probs=221.9
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEEEeccC
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYIIMEYAE 147 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 147 (357)
.+.||+|+|+.|..+....+|.+||||++.+.. ...+..+.+|++++.+++ |+||++++++|+++..+|+|||.+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 568999999999999999999999999998763 334566779999999996 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc---EEEeecCCCcccccc--cCCCC
Q psy7825 148 KGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN---IKLSDFGFARGHMKC--KSGHQ 222 (357)
Q Consensus 148 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~---~kl~Dfg~~~~~~~~--~~~~~ 222 (357)
||+|..+|+++..|++.++..+..+|+.||.+||.+||.||||||+|||...-.+ +|||||.+....... .....
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9999999999999999999999999999999999999999999999999976544 799999887643322 22333
Q ss_pred CCCCCcccCCccccccceec----CCCCCCCcccHHHHHHHHHHHHcCCCCCCCC---------------CHHHHHHHHh
Q psy7825 223 SPLSDTFCGSYAYASPEILK----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT---------------NYIQLLKQVQ 283 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~---------------~~~~~~~~i~ 283 (357)
.+...+++|+..|||||+.. ...++.+++|.||||+|+|-||.|..||.+. -...+++.|+
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 44556789999999999873 3345555599999999999999999999653 2556777777
Q ss_pred hcc-cCCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 284 TKV-VFPT--EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 284 ~~~-~~~~--~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
.+. .||. +..+|.+.++||..+| .|+.+|.++.+++.|||++...+..
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 654 3444 4679999999999999 9999999999999999999986663
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=344.76 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=205.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECC-CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC---CCCCcceeeEEEE-----
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTR-HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL---RHPNLIRFLQAIE----- 134 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~----- 134 (357)
.+|++.+.||+|+||.||+|.+.. +|+.||+|++........ ....+.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 478899999865433222 122344677776665 6999999999885
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
....+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 34568999999964 999999763 458999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC--
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT-- 290 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-- 290 (357)
..... .......|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 159 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 159 IYSFQ------MALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred eccCC------cccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 43211 22345568999999999988888877 9999999999999999999998887776666543221111
Q ss_pred ------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 291 ------------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 291 ------------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.+.++..+++||.+|| .||++||++.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1357889999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=347.99 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=212.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+........ ...+.+|+.+++.++||||+++++++..++..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 3569999999999999999999999999999999865432221 23456899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 157 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP---- 157 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC----
Confidence 999976 888888654 45889999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--------------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-------------- 287 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------- 287 (357)
........+++.|+|||++.+......++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 158 -TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred -ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 11122346789999999987654333449999999999999999999988776655544432111
Q ss_pred ------CC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 288 ------FP---------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 288 ------~~---------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
++ ..+.++.++++||.+|| .||.+||++.++|+||||+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 11 11357899999999999 89999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=354.52 Aligned_cols=250 Identities=28% Similarity=0.505 Sum_probs=214.3
Q ss_pred eeeeecCCeEEEEEEE---CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEecc
Q psy7825 70 KVIGIGSYATVKLATS---TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYA 146 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 146 (357)
+.||+|+||.||++.+ ..+|+.||+|++........ ....+.+|+.++..++||||+++++++..+..+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999976 35789999999975432221 1334568999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCC
Q psy7825 147 EKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226 (357)
Q Consensus 147 ~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 226 (357)
++++|.+++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..... .....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~-----~~~~~ 155 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-----HEKKA 155 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC-----CCCce
Confidence 9999999998888899999999999999999999999999999999999999999999999999864321 11223
Q ss_pred CcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc
Q psy7825 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF 306 (357)
Q Consensus 227 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L 306 (357)
...+|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+..+....+.... ...+..++..+++||++||
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l 233 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALF 233 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHh
Confidence 34679999999999988877766 999999999999999999999888877777665432 2334468999999999999
Q ss_pred -CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 307 -SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 307 -~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
.||.+||+ +.+++.||||+..
T Consensus 234 ~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 234 KRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=352.77 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=216.7
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||++.++.+++.||+|++.+...........+..|+.++..++|+||+++++.+.....+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999986533323333455778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~----~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED----G 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC----C
Confidence 99999999999987 467899999999999999999999999999999999999999999999999998643211 1
Q ss_pred CCCCCcccCCccccccceecC-----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc---cCCC-CCC
Q psy7825 223 SPLSDTFCGSYAYASPEILKG-----VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV---VFPT-EPN 293 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~-~~~ 293 (357)
.......+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||...+..+....+.... .+|. ...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCc-CCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence 112234579999999999862 345555 999999999999999999999988888777765432 2222 235
Q ss_pred CCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKF--RIRLKDIKQDPWVKTE 327 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~ 327 (357)
++.++++||++|| .++.+ |++++++++||||++.
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 7999999999999 54443 7899999999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=352.12 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=216.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||++++..+++.||+|++.+...........+.+|..++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999987543333333455778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||++||+|.+++.+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD----G 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC----C
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998643211 1
Q ss_pred CCCCCcccCCccccccceecC-----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc---cCCC-CCC
Q psy7825 223 SPLSDTFCGSYAYASPEILKG-----VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV---VFPT-EPN 293 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~-~~~ 293 (357)
.......+|++.|+|||++.+ ..++.+ +|||||||++|+|++|+.||...+..+....+.... .++. ...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD 235 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCc-ccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence 111233569999999999875 345555 999999999999999999999888877777665432 2222 235
Q ss_pred CCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKF--RIRLKDIKQDPWVKTE 327 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~ 327 (357)
+++++++||.+|| .++.+ |++++++++||||++.
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 7899999999999 54443 6799999999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=351.01 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=216.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||++++++|..++.++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34578999999999999999999999999999999886532 2333556789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
+||||+++++|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+|||++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence 9999999999999999888899999999999999999999975 799999999999999999999999999864321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----------------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ---------------- 283 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---------------- 283 (357)
.......|+..|+|||++.+..++.+ +|||||||++|+|++|+.||......+....+.
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 157 ----SMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred ----hccccCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence 11234468999999999988877777 999999999999999999997655433322110
Q ss_pred ----------------------------hcccCC-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 284 ----------------------------TKVVFP-TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 284 ----------------------------~~~~~~-~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
...... ....++.++++||.+|| .||.+||++.+++.||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 000000 01136789999999999 9999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=366.64 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=224.6
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC---
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH--- 137 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 137 (357)
....+|.+.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34568999999999999999999999999999999987654433 33455778999999999999999988765332
Q ss_pred -----eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7825 138 -----RVYIIMEYAEKGSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDF 208 (357)
Q Consensus 138 -----~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Df 208 (357)
.+++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 478999999999999998652 46899999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC
Q psy7825 209 GFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF 288 (357)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 288 (357)
|+++...... ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+......
T Consensus 188 Gls~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~ 263 (496)
T PTZ00283 188 GFSKMYAATV---SDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263 (496)
T ss_pred ccCeeccccc---cccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 9987542211 1122345679999999999998888877 99999999999999999999998888888877766665
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 289 PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 289 ~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+.++.+++++.+||.+|| .+|.+||++.+++.|||++..
T Consensus 264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 666789999999999999 899999999999999998753
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=352.49 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=207.1
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH----- 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 137 (357)
.++|.+.+.||+|+||.||+|.+..+|..||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357999999999999999999999999999999986543322 22445668999999999999999999886443
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 138 -RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 138 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
.+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 57999999976 67776643 488999999999999999999999999999999999999999999999999863211
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc---------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--------- 287 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------- 287 (357)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+.....
T Consensus 176 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 176 ------NFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ------CccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 122234568999999999999888877 9999999999999999999987765443322211110
Q ss_pred --------------CC------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 288 --------------FP------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 288 --------------~~------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.+ .....+..+++||.+|| .||++||++.|+|.||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 00 01124678999999999 8999999999999999998543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=356.94 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=212.6
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----eE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH-----RV 139 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 139 (357)
+|.+.+.||+|+||.||+|.+..+|+.||||.+....... .....+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL-VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch-HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999999999999999885432222 22345678999999999999999999998776 78
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+|+||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-- 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-- 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC--
Confidence 99999996 489998888888999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc------------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV------------ 287 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------ 287 (357)
.........+++.|+|||++.+......++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 157 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 157 --ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred --ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 111223346889999999998755433449999999999999999999988876665554432111
Q ss_pred ------------C-------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 288 ------------F-------PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 288 ------------~-------~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
. ......++++.+||.+|| .||.+||++.++|.||||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0 112346889999999999 8999999999999999999853
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=364.91 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=221.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCC-CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRH-GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
..|.+.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.++..++||||+++++.+...+.+|+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3499999999999999999998777 788999976432 223345677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 143 MEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
|||++||+|.+++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~- 222 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS- 222 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc-
Confidence 999999999988754 356899999999999999999999999999999999999999999999999998754221
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~ 298 (357)
.........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..++...+......+.+..++.++
T Consensus 223 --~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 223 --VSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred --cccccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence 11122345679999999999998888877 999999999999999999999988888887776655545556789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
++||.+|| .+|..||++.+++.|||++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999 89999999999999999874
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=364.41 Aligned_cols=254 Identities=21% Similarity=0.352 Sum_probs=203.8
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC------CCcceeeEEEEe
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH------PNLIRFLQAIET 135 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~ 135 (357)
..++|++.+.||+|+||.||+|.+..+++.||||+++.... ....+..|+.++..+.| +++++++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 35789999999999999999999999999999999864221 12334467777776654 458888888875
Q ss_pred C-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCC------------
Q psy7825 136 T-HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEY------------ 201 (357)
Q Consensus 136 ~-~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~------------ 201 (357)
. ..+|+||+++ |++|.+++.+.+.+++..++.++.||+.||.|||. .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5789999988 67999999888889999999999999999999998 5999999999999998765
Q ss_pred ----cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy7825 202 ----NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ 277 (357)
Q Consensus 202 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 277 (357)
.+||+|||.+... .......+||+.|+|||++.+..++.+ +|||||||++|||++|+.||.+.+..+
T Consensus 282 ~~~~~vkl~DfG~~~~~--------~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDE--------RHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCceEEECCCCccccC--------ccccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999987421 112335679999999999999888877 999999999999999999998877655
Q ss_pred HHHHHhhcccC-C------------------------C----------------CCCCCHHHHHHHHHhc-CCCCCCCCH
Q psy7825 278 LLKQVQTKVVF-P------------------------T----------------EPNVSAECKTLLSKIF-SPIKFRIRL 315 (357)
Q Consensus 278 ~~~~i~~~~~~-~------------------------~----------------~~~~s~~~~~li~~~L-~~p~~Rps~ 315 (357)
.+..+...... | . ....+..+.+||.+|| .||++||++
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 54433221100 0 0 0012456789999999 999999999
Q ss_pred HHHhcCCCCCCCCC
Q psy7825 316 KDIKQDPWVKTEAN 329 (357)
Q Consensus 316 ~~ll~hp~~~~~~~ 329 (357)
+|+|+||||+....
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999998533
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=334.74 Aligned_cols=259 Identities=28% Similarity=0.517 Sum_probs=219.6
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch------HHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD------YLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
+|.+...||+|+||.||+|.+..+++.||+|.+........ ...+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47888999999999999999988899999998865433221 233567899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
.++|+||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987553211
Q ss_pred CC-CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SG-HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
.. ..........|+..|+|||.+.+..++.. +|+|||||++|+|++|+.||.+.+.......+........+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 11 11111223468899999999988887777 99999999999999999999887666655555444443444568999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
+.++|++|| .+|.+||++.+|++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999 899999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=339.34 Aligned_cols=257 Identities=29% Similarity=0.519 Sum_probs=224.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.....+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36999999999999999999999999999999987644433334566779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|.|||++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999998888999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
.....|++.|+|||.+.+...+.+ +||||||+++|+|++|..||...+.......+... ..+.+..++..++++|+
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 230 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIR 230 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHH
Confidence 234568999999999988777766 99999999999999999999888876666665432 23344568999999999
Q ss_pred Hhc-CCCCCCC-----CHHHHhcCCCCCCCCCC
Q psy7825 304 KIF-SPIKFRI-----RLKDIKQDPWVKTEANP 330 (357)
Q Consensus 304 ~~L-~~p~~Rp-----s~~~ll~hp~~~~~~~~ 330 (357)
+|| .+|.+|+ ++++++.||||+.....
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 999 8999999 99999999999886543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=332.92 Aligned_cols=258 Identities=27% Similarity=0.458 Sum_probs=218.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch--HHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD--YLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
++|.+.+.||+|++|.||.|.+..+++.||+|.+........ .....+.+|+.+++.++||||+++++++.....+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 459999999999999999999998999999999865433222 123457789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|+||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~- 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS- 160 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998644221111
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCCCCCCCCHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECKT 300 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~ 300 (357)
........|+..|+|||++.+..++.+ +||||||+++|+|++|+.||...+.......+.. ......+..++..+.+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 161 -GTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred -cccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111123457889999999998887766 9999999999999999999987766555444432 2333344578999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
||++|| .+|.+||++.++++||||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999 899999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=339.25 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=213.2
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|++|+.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 78889999999999999999999999999998765444333345566899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 146 AEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 146 ~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
++|++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~------ 155 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG------ 155 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC------
Confidence 9999999998653 35899999999999999999999999999999999999999999999999988633111
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI---QLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
.......|+..|+|||++.+..++.+ +||||||+++|+|++|+.||...... .....+...........++.++++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARS 234 (285)
T ss_pred ccccCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHH
Confidence 11123468999999999988888877 99999999999999999999865321 222222222222233468999999
Q ss_pred HHHHhc-CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 301 LLSKIF-SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 301 li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
||++|| .||.+||+ ++++++||||+..
T Consensus 235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 999999 89999999 9999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=338.87 Aligned_cols=249 Identities=25% Similarity=0.348 Sum_probs=205.0
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCCh
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 151 (357)
||+|+||.||++....+|+.||+|.+.............+..|+++++.++||||+++++.+..+..+++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998654333222234455799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcc
Q psy7825 152 LDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTF 229 (357)
Q Consensus 152 ~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 229 (357)
.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++..... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~------~~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD------GKTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC------Cceeecc
Confidence 99886543 588899999999999999999999999999999999999999999999999864321 1112234
Q ss_pred cCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhhcccCCCCCCCCHHHHHHHHHh
Q psy7825 230 CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY----IQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305 (357)
Q Consensus 230 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 305 (357)
.|+..|+|||++.+..++.+ +|||||||++|+|++|+.||..... ..................++.++++||++|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHH
Confidence 68999999999988887777 9999999999999999999976432 222222222111122246899999999999
Q ss_pred c-CCCCCCCCH----HHHhcCCCCCCC
Q psy7825 306 F-SPIKFRIRL----KDIKQDPWVKTE 327 (357)
Q Consensus 306 L-~~p~~Rps~----~~ll~hp~~~~~ 327 (357)
| .||.+||++ ++++.||||+..
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCC
Confidence 9 899999999 778899999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=349.19 Aligned_cols=254 Identities=27% Similarity=0.414 Sum_probs=209.1
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT------ 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 136 (357)
.++|.+.+.||+|+||.||+|.+..+++.||||++........ ....+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT-HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCch-hHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4579999999999999999999999999999999865433222 234566899999999999999999987543
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
..+|+||||+++ +|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 357999999976 78887754 378999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT------ 290 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------ 290 (357)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 179 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 179 ------SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ------CCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 112234568999999999998888877 9999999999999999999988776665555432211110
Q ss_pred -----------------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 291 -----------------------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 291 -----------------------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
....+..+++||.+|| .||.+|||+.++|+||||...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0123568899999999 899999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=339.47 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=212.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||.|+||.||+|.+..+++.||+|.+........ ...+.+|+.+++.++||||+++++++.....+++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 3569999999999999999999999999999999864432221 23456899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++......
T Consensus 83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---- 157 (301)
T cd07873 83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---- 157 (301)
T ss_pred Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC----
Confidence 999975 898888763 56899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--------------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-------------- 287 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------- 287 (357)
........+++.|+|||++.+......++|||||||++|+|++|+.||...+..+....+.....
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 158 -TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 11122345788999999987654333449999999999999999999988776655544332111
Q ss_pred ------CCC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 288 ------FPT---------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 288 ------~~~---------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+. .+.+++.+++||.+|| .||.+||+++++|.||||+.-.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 110 1357889999999999 899999999999999999876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=348.55 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=207.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT------ 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 136 (357)
.++|.+.+.||+|+||.||+|.+..+++.||||.+........ ....+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH-HHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4579999999999999999999998999999999865433322 234566899999999999999999988543
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
...++||||+++ +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 357999999976 77777754 488999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC--------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF-------- 288 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------- 288 (357)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+......
T Consensus 172 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 172 ------SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ------ccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 122234578999999999998888877 99999999999999999999887655443332111100
Q ss_pred -----------------------------C----CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 289 -----------------------------P----TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 289 -----------------------------~----~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+ .....+.++++||.+|| .||.+|||+.|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 0 01224678899999999 8999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=338.40 Aligned_cols=252 Identities=33% Similarity=0.624 Sum_probs=211.0
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|++.+.||+|+||.||++.+..+++.||+|++......... .....+|+.+++.++||||+++++++......++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999765443322 22334699999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCC
Q psy7825 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL 225 (357)
Q Consensus 146 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 225 (357)
+.+++|.+++...+.+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+... ......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-----~~~~~~ 154 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-----SENNEN 154 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES-----TSTTSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccc
Confidence 999999999998888999999999999999999999999999999999999999999999999998632 112223
Q ss_pred CCcccCCccccccceec-CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHhh-cccC--CCCCCCCHHH
Q psy7825 226 SDTFCGSYAYASPEILK-GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ---LLKQVQT-KVVF--PTEPNVSAEC 298 (357)
Q Consensus 226 ~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~-~~~~--~~~~~~s~~~ 298 (357)
.....++..|+|||++. +...+.+ +||||||+++|+|++|..||......+ ....... .... ......+..+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRK-SDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTH-HHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccc-ccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 34567899999999998 6666655 999999999999999999999874333 3332221 1111 1111234899
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.++|++|| .+|.+||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999 899999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=337.11 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=204.2
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC---CCCCcceeeEEEEe-----C
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL---RHPNLIRFLQAIET-----T 136 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~ 136 (357)
+|++.+.||+|+||.||+|.+..+|+.||+|.+........ ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 48999999999999999999999999999999865332221 122344677766655 69999999998754 3
Q ss_pred CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
..+++|+||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 468999999975 899988764 34899999999999999999999999999999999999999999999999998643
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-----
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP----- 289 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----- 289 (357)
.. ........|+..|+|||++.+..++.+ +|||||||++|+|++|+.||.+....+....+......+
T Consensus 159 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 159 SC------QMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cC------cccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 21 111233468899999999988888777 999999999999999999998877666555443211100
Q ss_pred ---------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 290 ---------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 290 ---------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
..+.++..+++||.+|| .||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11357889999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=340.78 Aligned_cols=266 Identities=27% Similarity=0.442 Sum_probs=225.1
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.............+..|+.++..++||||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 69999999999999999999999999999999976554443445667899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC-
Q psy7825 145 YAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH- 221 (357)
Q Consensus 145 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~- 221 (357)
|+.|++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 99999999999764 568999999999999999999999999999999999999999999999999986432211100
Q ss_pred -----------------------CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy7825 222 -----------------------QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQL 278 (357)
Q Consensus 222 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 278 (357)
.........|+..|+|||++.+..++.+ +||||||+++|+|++|..||...+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 0011223568999999999988877766 9999999999999999999988877766
Q ss_pred HHHHh-hcccCCCCCCCCHHHHHHHHHhc-CCCCCCCC----HHHHhcCCCCCCCCCCC
Q psy7825 279 LKQVQ-TKVVFPTEPNVSAECKTLLSKIF-SPIKFRIR----LKDIKQDPWVKTEANPA 331 (357)
Q Consensus 279 ~~~i~-~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps----~~~ll~hp~~~~~~~~~ 331 (357)
...+. ....++....++..+++||++|| .+|++||+ ++++|.||||++.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 65544 34444444457999999999999 89999999 99999999999865443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=348.74 Aligned_cols=257 Identities=24% Similarity=0.411 Sum_probs=208.5
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT------ 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 136 (357)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 356999999999999999999999999999999986533222 1234466899999999999999999887533
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
...|++++++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 4578999988 6799888754 5699999999999999999999999999999999999999999999999999874321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------ 289 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------ 289 (357)
......|++.|+|||++.+. .++.+ +|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 171 --------~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 171 --------EMTGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred --------CcCCccccccccCchHhcCCccCCch-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 12345689999999999774 44544 999999999999999999998877655554443211100
Q ss_pred ------------------C------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 290 ------------------T------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 290 ------------------~------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
. ....++.+.+||.+|| .||.+||++.++|.||||.+...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~ 308 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence 0 1235677899999999 8999999999999999999865543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=328.66 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=220.0
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|++|.||+|.+..+++.|++|.+....... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 4888999999999999999999999999999986544333 334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 145 YAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 145 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|++|++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~----- 154 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----- 154 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-----
Confidence 99999999999774 56899999999999999999999999999999999999999999999999998744321
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
........|++.|+|||++.+..++.+ +|+||||+++|+|++|+.||...+.......+......+....++..+.++|
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLI 233 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHH
Confidence 111234468899999999998888777 9999999999999999999998887777766665544444447899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.+|| .+|++||++.++++|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 9999 899999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=346.73 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=206.0
Q ss_pred cccccCeEEceeeeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAI 133 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 133 (357)
.+..++|++.+.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45667899999999999999999975 23457899999864322 22245577999999999 899999999988
Q ss_pred EeC-CeEEEEEeccCCCChHHHHHhc------------------------------------------------------
Q psy7825 134 ETT-HRVYIIMEYAEKGSLLDFIQRE------------------------------------------------------ 158 (357)
Q Consensus 134 ~~~-~~~~lv~e~~~~~~L~~~l~~~------------------------------------------------------ 158 (357)
... ..+++||||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 654 4689999999999999999752
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCccc
Q psy7825 159 --------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFC 230 (357)
Q Consensus 159 --------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 230 (357)
.++++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++...... .........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~~ 237 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP---DYVRKGSAR 237 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc---chhcccCCC
Confidence 237788889999999999999999999999999999999999999999999987442211 111122344
Q ss_pred CCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 231 GSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQ-LLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 231 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
+++.|+|||++.+..++.+ +|||||||++|||++ |..||.+..... ....+........+..+++.+.+||.+|| .
T Consensus 238 ~~~~y~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred CCccccCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 6788999999988888877 999999999999996 999998765433 33444444444445678999999999999 8
Q ss_pred CCCCCCCHHHHhc
Q psy7825 308 PIKFRIRLKDIKQ 320 (357)
Q Consensus 308 ~p~~Rps~~~ll~ 320 (357)
||.+||++.+|++
T Consensus 317 dp~~RPs~~el~~ 329 (338)
T cd05102 317 DPKERPTFSALVE 329 (338)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=328.30 Aligned_cols=253 Identities=27% Similarity=0.510 Sum_probs=216.5
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-CCeEEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET-THRVYIIM 143 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 143 (357)
+|++.+.||+|++|.||++.+..+++.||+|.+....... ...+.+.+|+.+++.++|+|++++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 4899999999999999999999899999999986543332 234557789999999999999999998764 45689999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 144 EYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 144 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||+++++|.+++... ..+++..++.++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~---- 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ---- 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc----
Confidence 999999999999763 45899999999999999999999999999999999999999999999999998644211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
........|++.|+|||++.+..++.+ +|+||||+++|+|++|+.||...+.......+......+....++..+.+|
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd08223 156 -CDMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGEL 233 (257)
T ss_pred -CCccccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHH
Confidence 112334568999999999998888877 999999999999999999999888777666655544434445789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
|.+|| .+|.+||++.++++||||
T Consensus 234 i~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 234 IATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 99999 899999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=334.47 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=216.7
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|+..+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+.+.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 78889999999999999999999999999998765443333345567899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 146 AEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 146 ~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~------~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE------G 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC------C
Confidence 9999999988653 3699999999999999999999999999999999999999999999999998853311 1
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc---cCCCCCCCCHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV---VFPTEPNVSAECKT 300 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~~~~ 300 (357)
.......|+..|+|||++.+..++.+ +|+|||||++|+|++|..||.+.........+.... .......++.++.+
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHH
Confidence 11234468999999999988888877 999999999999999999998776554443332211 12233468999999
Q ss_pred HHHHhc-CCCCCCCC-----HHHHhcCCCCCCCCC
Q psy7825 301 LLSKIF-SPIKFRIR-----LKDIKQDPWVKTEAN 329 (357)
Q Consensus 301 li~~~L-~~p~~Rps-----~~~ll~hp~~~~~~~ 329 (357)
|+..|| .+|.+||+ +.+++.|+||+....
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 999999 89999999 899999999998633
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=337.67 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=214.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||++.+..+|..+|+|.+.... .......+.+|++++..++||||+++++++..++.+++|+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999886432 2333556778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||+|+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 152 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------ 152 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc------
Confidence 999999999999988889999999999999999999997 5999999999999999999999999998864311
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc---------------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--------------- 287 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------- 287 (357)
.......|+..|+|||++.+..++.+ +|+||||+++|+|++|+.||...+.......+.....
T Consensus 153 -~~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 153 -SMANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred -cccccCCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 11234578999999999988777766 9999999999999999999976554333322211100
Q ss_pred --------------------CCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 288 --------------------FPT--EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 288 --------------------~~~--~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+. ...++.++++||.+|| .+|.+||++.+|+.||||.+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 000 1136889999999999 899999999999999999875433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=332.44 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=221.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||.|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++|+||+++++.+..+..+++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch--HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36889999999999999999999999999999986543222 2345778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++++|.+++... ++++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM----- 152 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-----
Confidence 999999999999875 78999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCC-CCHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPN-VSAECKTLL 302 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~s~~~~~li 302 (357)
.......|++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.......+........... ++.++.++|
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cccccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 12234568889999999988887777 9999999999999999999988776666655554443333333 899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+|| .+|.+||+++++++||||+.....
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 9999 899999999999999999886544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=336.18 Aligned_cols=259 Identities=22% Similarity=0.392 Sum_probs=225.3
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.+++.||+|+||.||+|.++.+|..+|||.+..... .+.+-+|+.+|.+++.|+||+++|.+.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 7788899999999999999999999999998754221 34456899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 146 AEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 146 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|..|++.++++. +.++++.++..++...+.||+|||...-+|||||..|||++.+|+.||+|||.+..+.. ...
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-----TMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-----TMA 184 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh-----hHH
Confidence 999999999975 56799999999999999999999999999999999999999999999999999975422 223
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--cCCCCCCCCHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--VFPTEPNVSAECKTLL 302 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~li 302 (357)
.+++..|||.|||||++..-.|+.. +||||||++..||..|++||.+..+...+..|-... .|..+...|.++.+||
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred hhCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 3567789999999999999999988 999999999999999999999887766555543322 2333456899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcccc
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAG 335 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~ 335 (357)
+.|| +.|++|.++.++++|||+++++.......
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~ 297 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQL 297 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHH
Confidence 9999 99999999999999999999887654443
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=355.49 Aligned_cols=257 Identities=21% Similarity=0.395 Sum_probs=223.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.+.|.|+..||.|+||.||+|..+.++-..|.|++... .....+.+.-|+++|..++||+|+++++.|..++.++++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 44588999999999999999999988888899987532 222245566899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
.|||.||-+..++-+ ...+++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.. ...
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAK-----n~~ 182 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAK-----NKS 182 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccccc-----chh
Confidence 999999999988876 46799999999999999999999999999999999999999999999999998752 222
Q ss_pred CCCCCCcccCCcccccccee-----cCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCC
Q psy7825 222 QSPLSDTFCGSYAYASPEIL-----KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNV 294 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~ 294 (357)
....+.++.|||+|||||++ ...+|+.. +||||||++|.||..+.+|-...++...+-+|..... ...+...
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~W 261 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHW 261 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchh
Confidence 33446688999999999997 46677777 9999999999999999999999999888888765432 2335679
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+..+.+|+++|| ++|..||++.+||+||||++..
T Consensus 262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred hhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 999999999999 9999999999999999999754
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=346.51 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=207.0
Q ss_pred ccCeEEceeeeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATST--RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
..+|.+.+.||+|+||.||+|... .++..||+|.+... ....+|+.+++.++||||+++++.+.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 457999999999999999999754 35688999987542 22458999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
+|||++. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~--- 238 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH--- 238 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc---
Confidence 9999996 589999977788999999999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhhcc-----cC----
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY---IQLLKQVQTKV-----VF---- 288 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~-----~~---- 288 (357)
..........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... ...+..+.... .+
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 11222335679999999999998888877 9999999999999999999965432 11111111100 00
Q ss_pred -------------------CC-----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 289 -------------------PT-----EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 289 -------------------~~-----~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
.. ...++.++.+||++|| .||.+||++.++|.||||+....
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00 1235778999999999 89999999999999999987544
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=334.23 Aligned_cols=262 Identities=25% Similarity=0.387 Sum_probs=216.4
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC--chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
+|.+.+.||+|+||.||+|.+..+|+.||||.+...... .......+..|+.+++.++|+||+++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999989999999998754433 122345566899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|||+ +++|.+++.... .+++..++.++.||++||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--- 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence 9999 889999998765 79999999999999999999999999999999999999999999999999987542211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC------------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------------ 289 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------------ 289 (357)
.......+++.|+|||.+.+......++|+|||||++|+|++|..||.+.+..+....+......+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 --RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred --ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 112233567889999998664443444999999999999999988888776655554443221111
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 290 ---------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 290 ---------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
.....+..+.+||.+|| .+|.+||++.+++.||||++...+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 01345789999999999 89999999999999999999877764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=333.28 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=221.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||++.+..+++.|++|.+.............+.+|+.+++.++||||+++++.+..+..+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999987654333333456778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC---
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG--- 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--- 220 (357)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999988632110000
Q ss_pred -------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-cCCC-C
Q psy7825 221 -------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-VFPT-E 291 (357)
Q Consensus 221 -------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~-~ 291 (357)
..........|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||.+.+..+....+.... ..+. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 00011123457889999999988888777 999999999999999999999888777776655432 2232 2
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCC---HHHHhcCCCCCCCC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIR---LKDIKQDPWVKTEA 328 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps---~~~ll~hp~~~~~~ 328 (357)
+.++.++++||++|| .+|.+||+ +.++|+||||....
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 368999999999999 89999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=329.15 Aligned_cols=253 Identities=19% Similarity=0.353 Sum_probs=215.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
++..+|.+.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+..+..++||||+++++++..+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 45667999999999999999999864 4467899998865322 233456779999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.|++||||||+|||++.++.++++|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999999774 5789999999999999999999999999999999999999999999999998753211
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhhcccCCCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s 295 (357)
..........++..|+|||.+.+..++.+ +|||||||++|+|+ +|..||.+.+..+....+......+.+..++
T Consensus 160 ----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd05064 160 ----EAIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCP 234 (266)
T ss_pred ----cchhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCC
Confidence 01111112335678999999988888877 99999999999977 4999999998888888887776667777899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+.+++.+|| .+|..||++++|++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=331.54 Aligned_cols=262 Identities=27% Similarity=0.477 Sum_probs=221.4
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.+|.+.+.||.|+||.||+|.+..+|+.|++|.+...... ..+.+.+|+.+++.++||||+++++.+.....+++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 4599999999999999999999999999999998653322 2455778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++++|..++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~-----~ 169 (296)
T cd06655 96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-----Q 169 (296)
T ss_pred EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc-----c
Confidence 999999999988654 5899999999999999999999999999999999999999999999999988643211 1
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--cCCCCCCCCHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--VFPTEPNVSAECKTL 301 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~l 301 (357)
.......|+..|+|||.+.+..++.+ +|+|||||++|+|++|+.||...+.......+.... ....+..++..+.+|
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 11234468899999999988888777 999999999999999999998877665554443222 222344689999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcccc
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAG 335 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~ 335 (357)
|++|| .+|.+||++.+|+.||||+..........
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~~~ 283 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTP 283 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhccccccCCc
Confidence 99999 89999999999999999998775444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=331.07 Aligned_cols=253 Identities=28% Similarity=0.444 Sum_probs=205.7
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|++|.||+|.+..+|..||+|.+...... ......+.+|+.+++.++||||+++++.+..+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 488999999999999999999989999999998653322 2223456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 145 YAEKGSLLDFIQRE---GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 145 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|++ ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---- 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC----
Confidence 997 4898888653 46899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc---------------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--------------- 286 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------- 286 (357)
........+++.|+|||++.+......++|||||||++|+|++|+.||.+.........+....
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1122334578899999998765433334999999999999999999998765443322211100
Q ss_pred -------------cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 287 -------------VFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 287 -------------~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.......+++++++||++|| .||.+||++.+|+.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00012357899999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.59 Aligned_cols=261 Identities=23% Similarity=0.419 Sum_probs=217.1
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
.++.|++.+.||.|+||.||+|.+..++..|++|++... .......+.+|+.+++.++||||+++++.+..+..+++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 345699999999999999999999999999999998643 22234557789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||||+++++|..++.+ ...+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---- 162 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK---- 162 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc----
Confidence 9999999999988765 45689999999999999999999999999999999999999999999999998753211
Q ss_pred CCCCCCCcccCCccccccceecC-----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCC
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKG-----VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPN 293 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~ 293 (357)
.........+++.|+|||++.+ ..++.+ +|+|||||++|+|++|..||...+......++..... ...+..
T Consensus 163 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06644 163 -TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240 (292)
T ss_pred -cccccceecCCccccCceeeccccccCCCCCch-hhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence 1111234458889999999853 334545 9999999999999999999988776665555543322 223446
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
++.++.+||++|| .+|.+||++.++++||||..-....
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 8899999999999 8999999999999999998755444
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=325.04 Aligned_cols=259 Identities=27% Similarity=0.461 Sum_probs=214.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC--chHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--CCeE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--PDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--THRV 139 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 139 (357)
.+|.+.+.||+|+||.||.|.+..+|..||||.+...... .....+.+.+|+.+++.+.||||+++++++.. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4699999999999999999999999999999988643222 22234567889999999999999999998876 3568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++||||+++++|.+++.....+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998877899999999999999999999999999999999999999999999999999874322111
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CCCCCCCCHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPTEPNVSAEC 298 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~ 298 (357)
. ........|+..|+|||++.+..++.+ +|+|||||++|+|++|+.||...........+..... ...+...+..+
T Consensus 162 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 162 S--GTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred c--ccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 1 111223458899999999988777766 9999999999999999999987765555544433222 22344678899
Q ss_pred HHHHHHhcCCCCCCCCHHHHhcCCCCC
Q psy7825 299 KTLLSKIFSPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 299 ~~li~~~L~~p~~Rps~~~ll~hp~~~ 325 (357)
.++|++|+.+|..||++++|++|||+.
T Consensus 239 ~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 239 RDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 999999998899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=334.17 Aligned_cols=256 Identities=23% Similarity=0.413 Sum_probs=217.0
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||.|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++.+..+...++||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 4699999999999999999999888999999998643 2223455778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+++++|.+++... ..+++..++.++.|++.+|.|||+.||+|+||+|+||+++.++.++|+|||++..... .
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~-----~ 156 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS-----T 156 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc-----c
Confidence 999999999999764 5699999999999999999999999999999999999999999999999998753321 1
Q ss_pred CCCCCcccCCccccccceecC-----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCC
Q psy7825 223 SPLSDTFCGSYAYASPEILKG-----VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVS 295 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s 295 (357)
........|++.|+|||++.. ..++.+ +|+||||+++|+|++|+.||...+.......+..... ...+..++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~-sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS 235 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCcc-ccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCC
Confidence 112234568999999999752 334445 9999999999999999999998877776666554322 22345689
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.++.+||..|| .+|.+||++.++++||||.+..
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 99999999999 8999999999999999998863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=365.66 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=213.9
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--CCe
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--THR 138 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 138 (357)
...++|.+++.||+|+||.||+|.+..++..||+|++....... .....+..|+.++..|+||||++++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34467999999999999999999999999999999987544333 234567789999999999999999998854 457
Q ss_pred EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCCEEEcC--------
Q psy7825 139 VYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHER-------GVVHRDIKCENLLIDG-------- 199 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~-------~ivH~dlkp~Nili~~-------- 199 (357)
+|+||||+++++|.++|.. .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 9999999999999999975 35799999999999999999999985 4999999999999964
Q ss_pred ---------CCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecC--CCCCCCcccHHHHHHHHHHHHcCCC
Q psy7825 200 ---------EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG--VPYTPHYSDVWSMGVVLYAMAFGRL 268 (357)
Q Consensus 200 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~ 268 (357)
.+.++|+|||++..... ........||+.|+|||++.+ ..++.+ +||||||||+|+|++|..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~------~s~~~s~vGTp~YmAPEvL~ge~~~~s~K-SDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGI------ESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccCCCCceEEccCCccccccc------cccccccCCCccccCHHHHhccCCCCCch-hHHHHHHHHHHHHHHCCC
Confidence 23489999999874321 112234579999999999864 335555 999999999999999999
Q ss_pred CCCCCCH-HHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 269 PFDDTNY-IQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 269 pf~~~~~-~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
||...+. ..++..+......+. ...+.++.+||..|| .+|.+||++.|+|.||||+....+
T Consensus 242 PF~~~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 9976544 344444444433332 357899999999999 899999999999999999977655
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=326.53 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=214.7
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC---chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP---PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
+|.+.+.||+|+||.||+|.. .+|+.+|+|.+...... .......+.+|+.+++.++|+||+++++++......++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 488999999999999999986 46889999988643322 12223557889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC-C
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS-G 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 220 (357)
|+||++|++|.+++.+.+++++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999864321111 1
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc--ccCCCCCCCCHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK--VVFPTEPNVSAEC 298 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~s~~~ 298 (357)
..........|+..|+|||++.+..++.+ +|+||||+++|+|++|..||...+.......+... ...+.+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11122234568999999999988888777 99999999999999999999876655444333322 2223445689999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.+||++|| .+|.+||++.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999 899999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=326.21 Aligned_cols=258 Identities=25% Similarity=0.442 Sum_probs=213.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC--chHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--CCeE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--PDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--THRV 139 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 139 (357)
.+|.+.+.||+|+||.||+|.+..++..|++|.+...... .......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4699999999999999999999999999999988654322 22234567889999999999999999998865 4678
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++++||+++++|.+++...+.+++...+.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999864422111
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-CCCCCCHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP-TEPNVSAEC 298 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~~ 298 (357)
. ........++..|+|||.+.+..++.. +|||||||++|+|++|+.||...........+......+ .+..+++.+
T Consensus 162 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 162 S--GTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred c--CCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 1 111123458889999999988877776 999999999999999999998776655554443322222 234578999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
++|| .|| .+|.+||++++|++||||+
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 9999 566 8999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=331.43 Aligned_cols=256 Identities=26% Similarity=0.467 Sum_probs=216.4
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.+|.+.+.||+|+||.||+|.+..++..|++|.+....... ...+.+|+.+++.+.||||+++++.+......++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 46999999999999999999999899999999986544332 355778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...... .
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~-----~ 170 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----Q 170 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc-----c
Confidence 99999999999865 45899999999999999999999999999999999999999999999999988643211 1
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--cCCCCCCCCHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--VFPTEPNVSAECKTL 301 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~l 301 (357)
.......|++.|+|||.+.+..++.+ +|||||||++|+|++|+.||...+.......+.... ..+.+..++..+.+|
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 11233468899999999988777776 999999999999999999998776654443332222 122344688999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
|.+|| .+|.+||++.+|+.||||.....
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 99999 89999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=328.82 Aligned_cols=252 Identities=24% Similarity=0.416 Sum_probs=218.2
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48999999999999999999999999999999976554443445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|+.|++|.+++....++++..+..++.||+++|.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------ 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------
Confidence 99999999999888789999999999999999999999999999999999999999999999999986442211
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY---IQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
......|+..|+|||++.+..++.+ +|+||||+++|+|++|..||...+. ......... .....++.++..+.++
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDA 232 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHH
Confidence 2234558889999999988877777 9999999999999999999987763 333333332 3334445789999999
Q ss_pred HHHhc-CCCCCCCCH--HHHhcCCCC
Q psy7825 302 LSKIF-SPIKFRIRL--KDIKQDPWV 324 (357)
Q Consensus 302 i~~~L-~~p~~Rps~--~~ll~hp~~ 324 (357)
|.+|| .||.+||++ ++++.||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 99999 999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=331.12 Aligned_cols=240 Identities=16% Similarity=0.235 Sum_probs=206.9
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe----CCeEEEEEec
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET----THRVYIIMEY 145 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~ 145 (357)
..||+|++|.||+|.+ +|+.||||.+...........+.+.+|+.+|.+++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999987 488999999976655555555678899999999999999999999876 4578999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 146 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
+++|+|.+++.....+++.....++.+++.||.|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-------- 175 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-------- 175 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc--------
Confidence 99999999999888899999999999999999999984 999999999999999999999999999864321
Q ss_pred CCCcccCCccccccceecC--CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCCCCCCCCHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKG--VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECKTL 301 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~l 301 (357)
......|+..|+|||++.+ ..++.+ +|||||||++|||++|+.||.+.+..++...+.. ....+.+..++..+++|
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 254 (283)
T PHA02988 176 PPFKNVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCI 254 (283)
T ss_pred ccccccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHH
Confidence 1123468899999999976 566666 9999999999999999999999888887777643 33344444789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhc
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~ 320 (357)
|.+|| .||.+||++.+|+.
T Consensus 255 i~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 255 VEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHhcCCcccCcCHHHHHH
Confidence 99999 89999999999985
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=351.24 Aligned_cols=249 Identities=31% Similarity=0.504 Sum_probs=215.1
Q ss_pred eeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCC
Q psy7825 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGS 150 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 150 (357)
+||+|.||+||.|++..+....|||.+..... ...+-+..|+.+-++|+|.|||+++|.+..++++-|+||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 79999999999999999999999998854322 225567899999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeecCCCcccccccCCCCCCCC
Q psy7825 151 LLDFIQRE-GYI--DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-EYNIKLSDFGFARGHMKCKSGHQSPLS 226 (357)
Q Consensus 151 L~~~l~~~-~~l--~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 226 (357)
|.++++.. |++ .+..+-.+.+||++||+|||++.|||||||-+||||+. .|.+||+|||.++.+. .-.+.+
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-----ginP~T 733 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-----GINPCT 733 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc-----cCCccc
Confidence 99999874 777 88899999999999999999999999999999999975 5889999999987542 234556
Q ss_pred CcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 227 DTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDT--NYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 227 ~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
.++.||..|||||++..++ .+.+++|||||||++.||.||++||-.. ....+++.-.-....|.+..++.++++||.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil 813 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL 813 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence 7888999999999996543 3344599999999999999999999654 334444444555667777789999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 304 KIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+|+ .+|..||++.++|.+||++.+
T Consensus 814 rcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 814 RCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHcCCCcccCccHHHhccCcccccC
Confidence 999 899999999999999999998
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=328.04 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=209.3
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|++.++||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++..++||||+++++.+......++|+|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 5888999999999999999999999999999986532 22234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..... .
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~-------~ 148 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-------S 148 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-------c
Confidence 9999998654 3478999999999999999999999999999999999999999999999999864321 1
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHhhcc-cCCCCCCCCH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-------IQLLKQVQTKV-VFPTEPNVSA 296 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~-~~~~~~~~s~ 296 (357)
.....+|+..|+|||++.+..++.+ +|+|||||++|+|++|+.||..... ......+.... ........+.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE 227 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH
Confidence 2234578999999999998888777 9999999999999999999965321 12222222111 1112235789
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
++++||.+|| .+|.+||++++++.||||+.....
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~ 262 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG 262 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence 9999999999 899999999999999999886443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=328.92 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=212.3
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||.|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.....+++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 4899999999999999999999899999999987654322 234567799999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 145 YAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 145 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|+ +++|.+++.. ...+++..++.++.||+.+|.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999999865 45689999999999999999999999999999999999999999999999999874422111
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC--------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP-------------- 289 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------- 289 (357)
.......|+..|+|||++.+......++||||||+++|+|++|..||.+.........+......+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 122345689999999998765543444999999999999999999998776655554443321111
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 290 ---------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 290 ---------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
..+..+..+.+||++|| .+|.+||+++++|.||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01356799999999999 8999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.17 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=201.3
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.....+|.+.+.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++||||+++++++......
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 34456799999999999999999999999999999975322 123699999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++|+|++.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 133 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~--- 208 (357)
T PHA03209 133 CMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV--- 208 (357)
T ss_pred EEEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc---
Confidence 999999965 88888865 4679999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCCH----------HHHHHHHhh---
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF-DDTNY----------IQLLKQVQT--- 284 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~----------~~~~~~i~~--- 284 (357)
.........||+.|+|||++.+..++.+ +|||||||++|+|+++..|+ ..... ..+...+..
T Consensus 209 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~ 284 (357)
T PHA03209 209 ---VAPAFLGLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV 284 (357)
T ss_pred ---cCcccccccccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence 1122234568999999999998888877 99999999999999865544 33211 111111110
Q ss_pred -cccCC----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 285 -KVVFP----------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 285 -~~~~~----------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
...++ ....++.++.+||.+|| .||.+|||+.|||+||||++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 285 HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00011 01246778889999999 99999999999999999986
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=329.26 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=210.6
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|.+.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++.+.....+++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 345699999999999999999999999999999998654221 23456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|+||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~----- 158 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA----- 158 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC-----
Confidence 999999999999998888899999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCcccCCccccccceec---CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-hcccCCC---CCCC
Q psy7825 222 QSPLSDTFCGSYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ-TKVVFPT---EPNV 294 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~---~~~~ 294 (357)
.........|+..|+|||++. ...++.+ +|+|||||++|+|++|..||............. .....+. ...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQL-CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCch-hhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence 111223456899999999974 3445555 999999999999999999997665444333322 2222111 2257
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPW 323 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~ 323 (357)
+..+.+||.+|| .+|++||++++|+.|||
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 889999999999 89999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=333.02 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=205.4
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.....+++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 488999999999999999999999999999998654322 2223456689999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 145 YAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 145 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|+.+ +|.+++.. .+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-----~ 153 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-----V 153 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-----C
Confidence 9975 88888765 567999999999999999999999999999999999999999999999999998643211 1
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhhccc---------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF-DDTNYIQLLKQVQTKVV--------------- 287 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~--------------- 287 (357)
.......+++.|+|||++.+......++|||||||++|+|++|..|| .+.+....+..+.....
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 11223457889999999877654334499999999999999998885 44444444333321110
Q ss_pred ---C----------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 288 ---F----------PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 288 ---~----------~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
+ ...+.+++++++||++|| .||.+|||+++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 011357899999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=328.62 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=210.5
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 3699999999999999999999989999999998654322 222345678999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++++.|..++.....+++..++.++.||+.+|.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---- 155 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence 9999988888887777799999999999999999999999999999999999999999999999999875422111
Q ss_pred CCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc----------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV---------------- 286 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------------- 286 (357)
......++..|+|||++.+.. ++.+ +||||||+++|+|++|..||.+....+....+....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~-~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPP-VDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCch-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 122345788999999987644 4555 999999999999999999998776555443332110
Q ss_pred ----cCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 287 ----VFPT----------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 287 ----~~~~----------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
..+. .+.++..+.+||.+|| .+|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0111 1356889999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=323.69 Aligned_cols=253 Identities=30% Similarity=0.527 Sum_probs=219.6
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|+||.||.+....+|+.||+|.+........ ....+.+|+.+++.++||||+++++++......++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999865433322 24467789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 145 YAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 145 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|+.+++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 99999999999764 35789999999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
........|++.|+|||++.+..++.+ +|+|||||++|+|++|..||...+..+....+......+....++.++.++|
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLV 233 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence 111223458889999999988877776 9999999999999999999998888887777766555555567899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.+|| .+|.+||++.++++||||
T Consensus 234 ~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 234 SQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHhhCChhhCcCHHHHhhCcCC
Confidence 9999 899999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=321.70 Aligned_cols=253 Identities=29% Similarity=0.450 Sum_probs=221.2
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|++.++||.|+||.||.++...+++.+++|.+......... ...+.+|+.++++++|+||+++++++......+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH-HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 489999999999999999999999999999998655433332 4456799999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 145 YAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 145 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|+++++|.+++.+. ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999775 4689999999999999999999999999999999999999999999999999864422211
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
......|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+..+....+......+....++.++.++|
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHH
Confidence 2234568999999999988877766 9999999999999999999998888887777765544455567899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.+|| .+|.+||++.++++|||+
T Consensus 234 ~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 234 HSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHcccCcccCCCHHHHhhCcCC
Confidence 9999 899999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=345.58 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=217.8
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
....+..+...+++.||+|.||+||+|.+.. .||||+++......+ ..+.|++|+.++++-+|-||+-|.|++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 4556666778899999999999999999875 499999977666555 577899999999999999999999999987
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
.. .||+.+|+|.+|+.+++- ...|.....+.|+.||++||.|||.++|||||||..|||+.++++|||+|||++....
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 77 999999999999999975 3569999999999999999999999999999999999999999999999999997544
Q ss_pred cccCCCCCCCCCcccCCccccccceec---CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC--
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT-- 290 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-- 290 (357)
..... .......|...|||||+++ ..+|+.. +||||||+++|||++|..||...+.++++-.+-.++..+.
T Consensus 540 ~w~g~---~q~~qp~gsilwmAPEvIRmqd~nPfS~q-SDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 540 RWSGE---QQLEQPHGSLLWMAPEVIRMQDDNPFSFQ-SDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eeccc---cccCCCccchhhhcHHHHhhcccCCCCcc-cchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence 33211 1223445888999999985 3456666 9999999999999999999998787887777766654443
Q ss_pred --CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 291 --EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 291 --~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
...++.++++|+..|| .++++||.+.+||.
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 3468889999999999 89999999999997
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=337.94 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=206.6
Q ss_pred Eceeeeec--CCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 68 LGKVIGIG--SYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 68 ~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
++++||+| +|++||++.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 788999999999999999999865433 233456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC--
Q psy7825 146 AEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH-- 221 (357)
Q Consensus 146 ~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~-- 221 (357)
+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+............
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999999753 458999999999999999999999999999999999999999999999998654322111000
Q ss_pred CCCCCCcccCCccccccceecCC--CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc-cc-----------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGV--PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-VV----------- 287 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~----------- 287 (357)
.........++..|+|||++.+. .++.+ +|||||||++|+|++|+.||............... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 00111233567889999999763 46666 99999999999999999999875544333221110 00
Q ss_pred ---------------------------------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 288 ---------------------------------FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 288 ---------------------------------~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
.+....+++.+.+||++|| .||++||++++|++||||++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~ 315 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence 0011235789999999999 89999999999999999987543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=320.74 Aligned_cols=249 Identities=28% Similarity=0.460 Sum_probs=211.4
Q ss_pred cCeEE-ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEe----CC
Q psy7825 64 HGYVL-GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIET----TH 137 (357)
Q Consensus 64 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----~~ 137 (357)
++|.+ .++||-|-.|.|..+..+.+|+.+|+|++... ...++|+++-.... |||||.++++|++ ..
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 34666 46899999999999999999999999998542 22458888877774 9999999998754 56
Q ss_pred eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcEEEeecCCCc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE---YNIKLSDFGFAR 212 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~---~~~kl~Dfg~~~ 212 (357)
++.+|||.++||.|+..++.++. |+|.++..|+.||..|+.|||+.+|.||||||+|+|+... -.+||+|||+++
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 78899999999999999998764 9999999999999999999999999999999999999754 468999999997
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhhc---
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY----IQLLKQVQTK--- 285 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~--- 285 (357)
.. .......+.|-||+|.|||++...+|+.. +|+||+|+++|-|++|.+||..+.. ..+..+|..+
T Consensus 213 ~t------~~~~~L~TPc~TPyYvaPevlg~eKydks-cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 213 ET------QEPGDLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred cc------CCCccccCCcccccccCHHHhCchhcCCC-CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 43 22344567889999999999999998877 9999999999999999999976542 3344555433
Q ss_pred ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 286 VVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 286 ~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+.-|.+..+|++.+++|+.|| .+|.+|.++.+++.|||+.+.
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 333446789999999999999 899999999999999999986
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=327.11 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=209.8
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.++..++||||+++++.+.....+++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3456999999999999999999999999999999986432221 3457789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|+||+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~---- 159 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT---- 159 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc----
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998644211
Q ss_pred CCCCCCcccCCccccccceec---CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCC---CCCCC
Q psy7825 222 QSPLSDTFCGSYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFP---TEPNV 294 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~---~~~~~ 294 (357)
........|++.|+|||.+. ...++.+ +|+|||||++|+|++|..||...........+.. ....+ ....+
T Consensus 160 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~-~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06646 160 -IAKRKSFIGTPYWMAPEVAAVEKNGGYNQL-CDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237 (267)
T ss_pred -ccccCccccCccccCHhHcccccCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccccc
Confidence 11123346889999999984 3334545 9999999999999999999976654433322211 11211 12357
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPW 323 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~ 323 (357)
+..+.+||++|| .+|.+||++++||+|+|
T Consensus 238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 238 SSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 899999999999 89999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=327.29 Aligned_cols=259 Identities=25% Similarity=0.454 Sum_probs=214.1
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---hHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP---DYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
+|.+.+.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++|+||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999986543221 2235668899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-NIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~ 220 (357)
|+||++|++|.+++.+.+++++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 5899999998754322111
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHhh-cccCCCCCCCCH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK---QVQT-KVVFPTEPNVSA 296 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~-~~~~~~~~~~s~ 296 (357)
.........|+..|+|||++.+..++.+ +|+||||+++|+|++|..||.......... .+.. ......++.++.
T Consensus 161 -~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 161 -AGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred -CCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 1112234568899999999988777766 999999999999999999997544322222 2211 222333446889
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
++.+++.+|| .+|..||++.+++.||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999 8999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=330.00 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=214.8
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
-|++.+.||.|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++.+......++|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3788899999999999999999999999999885432 2224556789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 145 YAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 145 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|+++++|..++.+ ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-----~ 157 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-----I 157 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-----c
Confidence 9999999998865 467999999999999999999999999999999999999999999999999998643211 1
Q ss_pred CCCCcccCCccccccceec-----CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--cCCCCCCCCH
Q psy7825 224 PLSDTFCGSYAYASPEILK-----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--VFPTEPNVSA 296 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~ 296 (357)
.......|+..|+|||++. +..++.+ +|||||||++|+|++|+.||...+..+....+.... ..+.+..++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCcc-chhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCH
Confidence 1223456899999999984 3345545 999999999999999999998877666555543322 2223446899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
++++||.+|| .+|.+||++.++++||||+.....
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence 9999999999 899999999999999999976443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=332.32 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=217.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+....... .+.+.+|+.+++.++|+||+++++.+..+...++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 56999999999999999999998899999999986533322 355778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++++|.+++.+ ..+++..+..++.|++.+|.|||+.|++|+||+|+|||++.++.++|+|||++...... .
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~-----~ 169 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----Q 169 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC-----c
Confidence 99999999999865 45899999999999999999999999999999999999999999999999998643211 1
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--cCCCCCCCCHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--VFPTEPNVSAECKTL 301 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~l 301 (357)
.......|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||...+.......+.... ....+..++..+++|
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence 11234468899999999988887776 999999999999999999998766544332222211 112234688999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
|.+|| .+|.+||++++++.||||+.......
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 99999 89999999999999999998765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=348.80 Aligned_cols=266 Identities=23% Similarity=0.342 Sum_probs=233.5
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.-++.||.|+||-||.|++..+.+.||||.+...........+.+.+|+.+|.++.|||++.+.|+|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66788899999999999999999999999999877777777778888999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 146 AEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 146 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|-| +-.|++.- ..++-+.++..|..+.+.||.|||+.+.||||||..|||+++.|.|||+|||.+... .
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---------~ 177 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---------A 177 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---------C
Confidence 965 88888864 457899999999999999999999999999999999999999999999999987522 2
Q ss_pred CCCcccCCcccccccee---cCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-cCCCCCCCCHHHHH
Q psy7825 225 LSDTFCGSYAYASPEIL---KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-VFPTEPNVSAECKT 300 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~ 300 (357)
...+++|||+|||||++ ..+.|+.+ +||||||++..||.-.++|+-.++....+-.|.... +.-..+..|..+++
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~ 256 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 256 (948)
T ss_pred chhcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHH
Confidence 34578999999999998 45678888 999999999999999999988888777766664433 33334578999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCccccccccccc
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLN 342 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~~~~~~~~ 342 (357)
||..|| +.|..|||.+++|+|+|+....++..-.++++++.+
T Consensus 257 Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTKd 299 (948)
T KOG0577|consen 257 FVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTKD 299 (948)
T ss_pred HHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHHH
Confidence 999999 889999999999999999998888777777766543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=325.04 Aligned_cols=250 Identities=27% Similarity=0.531 Sum_probs=216.0
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCCh
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 151 (357)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+..+..+++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999989999999999765554444456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccC
Q psy7825 152 LDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231 (357)
Q Consensus 152 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~g 231 (357)
.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ......|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------~~~~~~~ 154 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------KTWTFCG 154 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc------ccccccC
Confidence 9999888889999999999999999999999999999999999999999999999999987442211 1233468
Q ss_pred CccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHhh-cccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 232 SYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN--YIQLLKQVQT-KVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 232 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.... .......+.. ......+...+.+++++|.+|| .
T Consensus 155 ~~~~~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 155 TPEYVAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CcCccChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence 899999999988777777 999999999999999999998766 5555555543 2233334456899999999999 8
Q ss_pred CCCCCCC-----HHHHhcCCCCCCCC
Q psy7825 308 PIKFRIR-----LKDIKQDPWVKTEA 328 (357)
Q Consensus 308 ~p~~Rps-----~~~ll~hp~~~~~~ 328 (357)
+|.+||+ ++++++||||++-.
T Consensus 234 ~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 234 NPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred ChhhCcCCcccCHHHHhcChhhhCCC
Confidence 9999999 99999999998753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=320.91 Aligned_cols=252 Identities=28% Similarity=0.478 Sum_probs=218.5
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|+||.||+|.+..+++.+|+|.+........ ....+.+|+.+++.++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccH-HHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 48999999999999999999999999999999876543333 35567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecCCCcccccccCCC
Q psy7825 145 YAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-NIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 145 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|+++++|.+++... ..+++..+..++.+++.+|.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 99999999999764 3589999999999999999999999999999999999998654 5799999998744221
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
.......|+..|+|||.+.+..++.+ +||||||+++|+|++|+.||...+.......+......+....++..++++
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 232 (256)
T cd08220 156 --SKAYTVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQL 232 (256)
T ss_pred --ccccccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHH
Confidence 11223568889999999988777766 999999999999999999999888777777766655555556789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
|.+|| .+|.+||++.++++||||
T Consensus 233 i~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 233 ILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHccCChhhCCCHHHHhhCCCC
Confidence 99999 899999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=335.46 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=190.7
Q ss_pred ceeeeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--CCeEEEEEe
Q psy7825 69 GKVIGIGSYATVKLATST--RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--THRVYIIME 144 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 144 (357)
++.||+|+||.||+|.+. .+++.||+|.+..... ...+.+|+.+++.++||||+++++.+.. +..+++|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 457999999999999965 4678999998864332 2335689999999999999999998854 567899999
Q ss_pred ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCcEEEeecCCC
Q psy7825 145 YAEKGSLLDFIQRE---------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI----DGEYNIKLSDFGFA 211 (357)
Q Consensus 145 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili----~~~~~~kl~Dfg~~ 211 (357)
|+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +..+.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 888887532 258999999999999999999999999999999999999 45678999999999
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH---------HHHHHHH
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY---------IQLLKQV 282 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~i 282 (357)
+...... ..........||+.|+|||++.+......++|||||||++|+|++|+.||..... ...+..+
T Consensus 160 ~~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 160 RLFNSPL--KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eccCCCC--ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 7542211 1111223457899999999998755433449999999999999999999964321 1111111
Q ss_pred hhcccCC-------------------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 283 QTKVVFP-------------------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 283 ~~~~~~~-------------------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
......+ .....+..+.+||++|| .||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1100000 01124567899999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=344.45 Aligned_cols=259 Identities=40% Similarity=0.718 Sum_probs=234.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
...|.+.+.||+|.|+.|.+|++..+|..||||++.+.......... +.+|+.+|..++|||||+++.+.+....+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k-~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQK-LGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHH-HHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34599999999999999999999999999999999887776665445 77999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|||+.+|.+++++.+.+...+..++.++.|+++|++|||+++|||||||++|||++.+.++||+|||++..+. .
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~------~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD------Y 207 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec------c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999997543 3
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-hhcccCCCCCCCCHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~~~~l 301 (357)
.....++||++.|.|||++.+..|....+|+||||+++|-|+.|.+||++.+...+...+ ...++.|. .++.+|++|
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~--~ms~dce~l 285 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF--YMSCDCEDL 285 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc--eeechhHHH
Confidence 455678899999999999999999988899999999999999999999998887776654 33444554 489999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
|+++| .+|.+|++.+++.+|.|.......
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 99999 899999999999999999876554
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=324.02 Aligned_cols=257 Identities=23% Similarity=0.446 Sum_probs=215.4
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||.|+||.||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+......++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 36999999999999999999998889999999986543322 3456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQRE---GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999998755332221
Q ss_pred CCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCC---CCC
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTE---PNV 294 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~---~~~ 294 (357)
. ........|+..|+|||++... .++.+ +|+||||+++|+|++|+.||...+.......+..... .+.. ..+
T Consensus 159 ~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 159 T-RKVRKTFVGTPCWMAPEVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred c-ccccccccCChhhcChHHHccccCcCcc-cchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence 1 1223445689999999998776 45555 9999999999999999999988776655554433221 1111 257
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
++.+.+||.+|| .+|.+||++.+|+.||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 899999999999 899999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=329.32 Aligned_cols=253 Identities=22% Similarity=0.382 Sum_probs=216.6
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCC-----cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHG-----CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
..+|++.+.||+|+||.||+|.....+ ..||+|.+.... .......+.+|+.++..++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 456999999999999999999876554 679999875432 2334566889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7825 138 RVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~ 201 (357)
..+++|||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 999999999999999999764 4578899999999999999999999999999999999999999
Q ss_pred cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy7825 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLK 280 (357)
Q Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~ 280 (357)
.++|+|||++...... ..........+++.|+|||.+.+..++.+ +|||||||++|||++ |..||.+....+...
T Consensus 162 ~~~L~dfg~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSA---DYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEECCCcceeecccc---ccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999998643211 11122234457889999999988888877 999999999999997 999999988888888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+......+.+..++.++.+|+.+|| .+|.+||++.+|+++
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88776666666789999999999999 899999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=346.50 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=203.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+++.++|+||+++++++...+..++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 4567999999999999999999999999999999532 1234589999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||+++.....
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~--- 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS--- 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc---
Confidence 999995 5888888664 56999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHhhcc----cC
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT--------NYIQLLKQVQTKV----VF 288 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~----~~ 288 (357)
..........||+.|+|||++.+..++.+ +|||||||++|||++|..|+... ...++...+.... .+
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 11122234679999999999999888877 99999999999999987654221 1222222222110 00
Q ss_pred C--------------------------CC---CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 289 P--------------------------TE---PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 289 ~--------------------------~~---~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
+ .+ ..++.++.+||.+|| .||.+||++.|||+||||+.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 00 135678999999999 89999999999999999976
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=322.77 Aligned_cols=256 Identities=28% Similarity=0.476 Sum_probs=222.5
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|++|.||+|.+..+++.|++|++...... .....+.+|+..+..++|+||+++++.+......++|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3589999999999999999999999999999998654432 33566789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+++++|.+++.....+++..++.++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--- 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--- 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---
Confidence 999999999999888889999999999999999999999 9999999999999999999999999999874422111
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhhcccCCCCCC-CCHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT---NYIQLLKQVQTKVVFPTEPN-VSAEC 298 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~-~s~~~ 298 (357)
......++..|+|||.+.+..++.+ +|+||||+++|+|++|..||... ...+....+........... ++..+
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 156 --QCNTFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred --cccceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 1124468889999999988877776 99999999999999999999776 55666666665544444555 89999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.++|.+|| .+|..||++.++++||||+..
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999 899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=344.96 Aligned_cols=235 Identities=27% Similarity=0.485 Sum_probs=210.6
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
++-||.|+.|-||+|+.. ++.||||.++.. -..++.-|++|+||||+.|.|+|.....+|||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 567999999999999876 789999987432 22678899999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
|.|...|+...+++......|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||.++.... ......
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~------~STkMS 270 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD------KSTKMS 270 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh------hhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999874322 234567
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-hhcccCCCCCCCCHHHHHHHHHhc-
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECKTLLSKIF- 306 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~~~~li~~~L- 306 (357)
++||..|||||++.+.+.+.+ +||||||++|||||||..||.+.+...++-.+ ...+..|.+..+++.++=||++||
T Consensus 271 FaGTVaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 899999999999999999988 99999999999999999999988776665444 344567778899999999999999
Q ss_pred CCCCCCCCHHHHhcCC
Q psy7825 307 SPIKFRIRLKDIKQDP 322 (357)
Q Consensus 307 ~~p~~Rps~~~ll~hp 322 (357)
..|..||++.|||.|-
T Consensus 350 sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHL 365 (904)
T ss_pred cCCCCCccHHHHHHHH
Confidence 8899999999999984
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=325.40 Aligned_cols=252 Identities=23% Similarity=0.403 Sum_probs=208.2
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeC-----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETT----- 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----- 136 (357)
.+.|.+.+.||+|+||.||+|.+..+++.||+|++...... ...+.+|+.++..+ +|+||+++++.+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 34588999999999999999999999999999998654322 24466899999998 699999999998653
Q ss_pred -CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 137 -HRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 137 -~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999999863 4689999999999999999999999999999999999999999999999999864
Q ss_pred cccccCCCCCCCCCcccCCccccccceecC-----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc-cc
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKG-----VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-VV 287 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~ 287 (357)
.... ........|++.|+|||++.+ ..++.+ +|||||||++|+|++|..||...........+... ..
T Consensus 161 ~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06637 161 LDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234 (272)
T ss_pred cccc-----cccCCcccccccccCHhHhccccCcCCCCCch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC
Confidence 3211 112334568999999999863 345555 99999999999999999999876655544443322 22
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
......++.++.+||.+|| .+|.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 2233468899999999999 899999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=357.00 Aligned_cols=267 Identities=26% Similarity=0.454 Sum_probs=219.6
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEE-EE
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQA-IE 134 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-~~ 134 (357)
....++.++++|.++|.+|||+.||+|++...|..||+|++-.. ++...+.+.+|+.+|+.|. |+|||.+++. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 45567788899999999999999999999988899999987543 4455778899999999997 9999999993 21
Q ss_pred e------CCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCCcEE
Q psy7825 135 T------THRVYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLIDGEYNIK 204 (357)
Q Consensus 135 ~------~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~~~~~~k 204 (357)
. ...++|+||||+||.|-|++.. ...|++.++++|+.|+++|+.+||..+ |||||||-|||||+.+|+.|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 1357899999999999999985 356999999999999999999999998 99999999999999999999
Q ss_pred EeecCCCcccccccCCCCCC----CCCcccCCcccccccee---cCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH
Q psy7825 205 LSDFGFARGHMKCKSGHQSP----LSDTFCGSYAYASPEIL---KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ 277 (357)
Q Consensus 205 l~Dfg~~~~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 277 (357)
|||||.+............. ..-...-|+.|+|||++ .+...+.+ +|||+|||+||.|++...||++.....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~la 265 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGKLA 265 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCccee
Confidence 99999986433222110000 00123468999999997 57778887 999999999999999999999875433
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 278 LLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 278 ~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
+ +...+.+|..+.++..+++||+.|| .+|.+||++.|++.+-+.-.+.+.
T Consensus 266 I---lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 266 I---LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred E---EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 3 3456778888899999999999999 899999999999986555444433
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=321.75 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=213.5
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||.|+||.||+|.+..+++.+++|++...... ..+.+.+|+.+++.++||||+++++.+.....++++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5699999999999999999999888999999998654332 2456779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~----- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT----- 154 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh-----
Confidence 999999999999876 78999999999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCcccCCccccccceecCC---CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc-ccC---CCCCCCC
Q psy7825 223 SPLSDTFCGSYAYASPEILKGV---PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-VVF---PTEPNVS 295 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~---~~~~~~s 295 (357)
........++..|+|||.+.+. .++.. +|+||||+++|+|++|..||.+.+.......+... +.. .....++
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~-~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence 1112345688899999999776 66665 99999999999999999999887765555444332 111 1223467
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQDPW 323 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~hp~ 323 (357)
.++.+||++|| .+|..||++.+|+.|+|
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 89999999999 89999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=320.25 Aligned_cols=253 Identities=28% Similarity=0.505 Sum_probs=215.1
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC--chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
+|+..+.||+|+||.||+|.+..++..|++|.+...... .......+.+|+.+++.++|+||+++++++.....+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 478889999999999999999888999999998654322 223345678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
+||+++++|.+++.+...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999986432211
Q ss_pred CCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCCCCCCCCHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECKT 300 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~ 300 (357)
......|+..|+|||.+.... ++.+ +|+||||+++|+|++|+.||...........+.. ......++.++..+.+
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~-~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLA-ADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence 123456889999999987766 5655 9999999999999999999987765555544443 2222334568999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
||++|| .+|.+||++.+++.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999 899999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=326.18 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=201.9
Q ss_pred eeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHH---HcCCCCCcceeeEEEEeCCeEEEEEeccC
Q psy7825 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV---KGLRHPNLIRFLQAIETTHRVYIIMEYAE 147 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 147 (357)
+||+|+||.||++.+..+++.||+|++.+...........+.+|..++ ....||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998765433222223333444433 34479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCC
Q psy7825 148 KGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD 227 (357)
Q Consensus 148 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 227 (357)
+++|.+++...+.+++..+..++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++...... ...
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------~~~ 153 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------KPH 153 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-------Ccc
Confidence 9999999988888999999999999999999999999999999999999999999999999998643211 122
Q ss_pred cccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q psy7825 228 TFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY--IQLLKQVQTKVVFPTEPNVSAECKTLLSK 304 (357)
Q Consensus 228 ~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 304 (357)
...|+..|+|||.+.+ ..++.+ +|+|||||++|+|++|..||..... ...............++.++.++++||++
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH
Confidence 3468999999999864 445555 9999999999999999999975432 11222222222333345689999999999
Q ss_pred hc-CCCCCCC-----CHHHHhcCCCCCCCC
Q psy7825 305 IF-SPIKFRI-----RLKDIKQDPWVKTEA 328 (357)
Q Consensus 305 ~L-~~p~~Rp-----s~~~ll~hp~~~~~~ 328 (357)
|| .||.+|| ++.++++||||++..
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 99 9999999 699999999999844
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=329.01 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=210.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++..+...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 36999999999999999999999889999999886543332 33455778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++++|..+......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~----- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----- 154 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence 999999998888776679999999999999999999999999999999999999999999999999986432211
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc------------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK------------------ 285 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------------ 285 (357)
.......++..|+|||++.+......++||||||+++|+|++|+.||......+....+...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 11233467889999999876543334499999999999999999999876654433332210
Q ss_pred --ccCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 286 --VVFP----------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 286 --~~~~----------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
...+ ..+.++..+.+||.+|| .+|.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0011 12467899999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=328.31 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=214.2
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++..++||||+++++.+...+.+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 5889999999999999999999899999999886432 22234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 145 YAEKGSLLDFIQRE---GYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 145 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|+++++|..++... ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 155 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---- 155 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC----
Confidence 99999999998763 368999999999999999999997 5999999999999999999999999999864311
Q ss_pred CCCCCCCcccCCccccccceecCCCC------CCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HhhcccCCCC
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPY------TPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ---VQTKVVFPTE 291 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~ 291 (357)
.......|++.|+|||++.+... +.+ +|+|||||++|+|++|+.||........... +........+
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd06622 156 ---SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ-SDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP 231 (286)
T ss_pred ---CccccCCCccCccCcchhcCCCCCccCCCCcc-cchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC
Confidence 12234458889999999855432 444 9999999999999999999976655444333 3333333445
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
+.++.++.+||.+|| .+|.+||++.+++.||||......
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 568999999999999 899999999999999999887544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.22 Aligned_cols=253 Identities=29% Similarity=0.502 Sum_probs=218.3
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--CCeEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--THRVYII 142 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 142 (357)
+|.+.+.||.|+||.||+|.+..+|..||+|++...... ....+.+..|+.+++.++||||+++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 488999999999999999999999999999998654443 3334567789999999999999999997753 4578999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 143 MEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCH-----ERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH-----~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
+||+++++|.+++.. ..++++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999976 367899999999999999999999 89999999999999999999999999999875
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
..... .......|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+.......+........+..
T Consensus 160 ~~~~~-----~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd08217 160 LGHDS-----SFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYR 233 (265)
T ss_pred ccCCc-----ccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccc
Confidence 42211 11234468999999999988887766 9999999999999999999998887777777766655555667
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
++..+.+++.+|| .+|.+||++.+|++|||+
T Consensus 234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 234 YSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 8999999999999 899999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=328.93 Aligned_cols=262 Identities=25% Similarity=0.348 Sum_probs=212.6
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC--CeEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT--HRVY 140 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 140 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++|+||+++++++... +.++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 456999999999999999999999999999999986543222 1122345799999999999999999998754 5689
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 141 IIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~- 162 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA- 162 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-
Confidence 99999975 89888876 3678999999999999999999999999999999999999999999999999987542211
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC----------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP---------- 289 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------- 289 (357)
.......+++.|+|||++.+......++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 163 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 163 ----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred ----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 111223457889999998764433344999999999999999999999888777766554321110
Q ss_pred ----------C---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 290 ----------T---------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 290 ----------~---------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
. ....+..+.+||.+|| .||++||++.+++.||||++.+-+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 0 0235889999999999 8999999999999999999765553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=326.12 Aligned_cols=253 Identities=30% Similarity=0.464 Sum_probs=207.3
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|++.+.||.|++|.||+|.+..+|+.||||.+...... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 488999999999999999999999999999988643322 2223457789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 145 YAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 145 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|+. ++|..++.. ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~----- 153 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP----- 153 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-----
Confidence 996 589998865 356899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-------------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------------- 289 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------------- 289 (357)
........++..|+|||++.+......++||||||+++|+|+||+.||...+.......+......+
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1112233578899999998776543444999999999999999999998776554443332211110
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 290 ---------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 290 ---------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
..+.++.+++++|.+|| .||.+||++++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01357899999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=326.97 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=216.8
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++.+.....+++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 45679999999999999999999999999999998864322 2335667899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|+||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---- 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---- 156 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence 99999999999999888889999999999999999999997 5999999999999999999999999998753311
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHhhcccCC
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-----------QLLKQVQTKVVFP 289 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----------~~~~~i~~~~~~~ 289 (357)
.......|+..|+|||++.+..++.+ +|+|||||++|+|++|..||...... .....+.......
T Consensus 157 ---~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd06620 157 ---SIADTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232 (284)
T ss_pred ---hccCccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC
Confidence 11224568999999999988777777 99999999999999999999865432 2222222221111
Q ss_pred C-CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 290 T-EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 290 ~-~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
. ...++.++.+||.+|| .||.+||++.++++||||......
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~ 275 (284)
T cd06620 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275 (284)
T ss_pred CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 1 2237889999999999 899999999999999999886543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=322.33 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=211.8
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC-------chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP-------PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 488999999999999999999888999999988542211 1112345778999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
..++|+||+++++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998643211
Q ss_pred cCCCCCCCCCcccCCccccccceecCCC--CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-c--CC--C
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVP--YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-V--FP--T 290 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~--~~--~ 290 (357)
. .........|+..|+|||++.... ++.+ +|+||||+++|+|++|..||...+.......+.... . ++ .
T Consensus 162 ~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 162 Y---DNDQNMSMQGSVFWMAPEVIHSYSQGYSAK-VDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred c---cccccccccCCccccCHHHhccccCCCCcc-chhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 1 111223456889999999987654 5555 999999999999999999998766554443332211 1 11 1
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.+.++..+++||.+|| .+|..||+++++|+||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2357899999999999 899999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=325.91 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=219.7
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|...+.||.|+||.||+|.+..++..||+|++...... .....+.+|+.+++.+.||||+++++.+..+...++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 478889999999999999999989999999998654322 234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|++|++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-----~~ 156 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-----QI 156 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC-----cc
Confidence 9999999999865 56899999999999999999999999999999999999999999999999998643211 11
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSK 304 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 304 (357)
......++..|+|||++.+..++.+ +|+|||||++|+|++|..||...........+...........++..+.+||.+
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred ccccccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHH
Confidence 1223457889999999988877777 999999999999999999998887766665554443333344678999999999
Q ss_pred hc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 305 IF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 305 ~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
|| .+|.+||++.+++.||||......
T Consensus 236 ~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 236 CLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred HcccCcccCcCHHHHHhChHhhhcchh
Confidence 99 899999999999999999887654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=325.05 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=213.8
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|++.+.||.|+||.||+|.+..+++.+|+|.+...... .....+.+|+.+++.+.||||+++++.+.....+++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 588899999999999999999999999999998654332 334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 145 YAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 145 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|+++++|.+++... ..+++..+..++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---- 155 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---- 155 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----
Confidence 99999999999876 789999999999999999999999 999999999999999999999999999886432111
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhhcccCCCCCC-CCH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-----NYIQLLKQVQTKVVFPTEPN-VSA 296 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~-~s~ 296 (357)
.....++..|+|||.+.+..++.+ +||||||+++|+|++|..||... ...+..+.+........... ++.
T Consensus 156 ---~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06605 156 ---AKTFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSP 231 (265)
T ss_pred ---hhcccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 112568889999999988887777 99999999999999999999754 23333333333222222222 789
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
++++||.+|| .+|.+||++.+++.||||+..
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999 899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=321.32 Aligned_cols=250 Identities=25% Similarity=0.436 Sum_probs=213.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||.|+||.||+|....+++.|++|.+..... ...+.+|+.+++.++||||+++++.+.....+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 569999999999999999999998899999999864321 456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~----- 152 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT----- 152 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC-----
Confidence 99999999999975 456899999999999999999999999999999999999999999999999998744221
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--cCCCCCCCCHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--VFPTEPNVSAECKT 300 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~ 300 (357)
........|+..|+|||++.+..++.+ +||||||+++|+|++|+.||...........+.... ....+..++.++.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND 231 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHH
Confidence 111233457889999999988877766 999999999999999999998776655444433221 12233467899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
+|.+|| .+|.+||++.++|.||||
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999 899999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=319.61 Aligned_cols=249 Identities=27% Similarity=0.491 Sum_probs=216.1
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|+||.||++.+..++..||+|.+...... ...+.+.+|+.+++.++|+||+++++.+..+..+++|+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 488999999999999999999999999999998654322 234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 145 YAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 145 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+..... .
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~-----~ 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-----P 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc-----c
Confidence 99999999998653 4589999999999999999999999999999999999999999999999999864321 1
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
........|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+.......+......+.+..++..+++||
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLI 232 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHH
Confidence 112234568899999999988887777 9999999999999999999998888777777766655555567899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~h 321 (357)
++|| .+|.+||++.+|+.-
T Consensus 233 ~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 233 KQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHhCCcccCCCHHHHhhc
Confidence 9999 899999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=333.75 Aligned_cols=263 Identities=22% Similarity=0.352 Sum_probs=223.1
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..+..+.|+.-++||+||||.||-++...+|+.||.|.+.+..............|-.+|..++.+.||.+-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34556779999999999999999999999999999998876555444445566789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+|+|+..|.||+|.-+|...+ .|++..++.++.+|+-||++||+.+||+|||||+|||+|+.|++.|+|+|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999999997654 699999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHh-hcccCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI----QLLKQVQ-TKVVFPTE 291 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~-~~~~~~~~ 291 (357)
.......+||.+|||||++.+..|+.. .|+|||||++|||+.|+.||...... ++-..+. ....++
T Consensus 340 ------g~~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~-- 410 (591)
T KOG0986|consen 340 ------GKPIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS-- 410 (591)
T ss_pred ------CCccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--
Confidence 222334589999999999999999888 99999999999999999999654322 2222222 223333
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCCCCC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTEANP 330 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~~~~ 330 (357)
..+|+++++|.+.+| +||.+|. .+.++.+||||++-..+
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 579999999999999 9999886 46699999999986443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=339.07 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=209.0
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQA 132 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 132 (357)
..+..++|.+.+.||+|+||.||+|++ ..++..||||++...... ...+.+.+|+.++..+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 345566799999999999999999974 345678999998643322 2245677899999999 79999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcC-----------------------------------------------------
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQREG----------------------------------------------------- 159 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------- 159 (357)
+......++||||+++|+|.+++.+..
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999996531
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 160 ----------------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 160 ----------------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 4678889999999999999999999999999999999999999999999998744221
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhhcccCCCCCCCC
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYI-QLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s 295 (357)
.. ........++..|+|||++.+..++.+ +|||||||++|+|++ |..||...... .....+........+...+
T Consensus 268 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (375)
T cd05104 268 SN---YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAP 343 (375)
T ss_pred cc---ccccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCC
Confidence 11 111223345678999999998888877 999999999999997 89999876543 3444445444444455678
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.++++||.+|| .||++||++.+|++.
T Consensus 344 ~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=323.53 Aligned_cols=257 Identities=25% Similarity=0.471 Sum_probs=218.5
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|...+.||+|++|.||++.+..+++.+++|.+..... ...+.+.+|+.+++.+.||||+++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 35556799999999999999988899999998754322 224456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|++|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++..... ...
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~-----~~~ 170 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-----EVP 170 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc-----CCc
Confidence 9999999999977 6689999999999999999999999999999999999999999999999998763321 111
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC--CCCCCCHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP--TEPNVSAECKTLL 302 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~~~~li 302 (357)
......|++.|+|||.+.+..++.+ +||||||+++|+|++|+.||...+.......+....... ....++..+.+||
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence 2234568999999999988887777 999999999999999999998888777766665543222 1234889999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
++|| .+|.+||++.++++||||+...++.
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 279 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAGPPS 279 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCCCcc
Confidence 9999 8999999999999999999977654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=328.97 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=205.1
Q ss_pred cccCeEEceeeeecCCeEEEEEEECC----------------CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTR----------------HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 125 (357)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45679999999999999999998532 34579999886432 2333556789999999999999
Q ss_pred cceeeEEEEeCCeEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7825 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG-------------------YIDEPRTKKWFRQLVDAIDYCHERGVV 186 (357)
Q Consensus 126 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~l~~~~~~~i~~~i~~~l~~LH~~~iv 186 (357)
|+++++++......++||||+++++|.+++.... .++...++.++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 367788999999999999999999999
Q ss_pred ecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-
Q psy7825 187 HRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF- 265 (357)
Q Consensus 187 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~- 265 (357)
||||||+|||++.++.++|+|||+++..... ..........++..|+|||++.+..++.+ +||||||+++|+|++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~ 236 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAG---DYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILML 236 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccC---ceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHc
Confidence 9999999999999999999999998643211 11112233456789999999988888877 999999999999986
Q ss_pred -CCCCCCCCCHHHHHHHHhhc-------ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 266 -GRLPFDDTNYIQLLKQVQTK-------VVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 266 -g~~pf~~~~~~~~~~~i~~~-------~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+..||...+..+....+... .....++.++..+.+||.+|| .+|.+||++.+|.+
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 67889887766665544321 112233568999999999999 89999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=317.75 Aligned_cols=257 Identities=30% Similarity=0.485 Sum_probs=214.8
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|+||.||+|.+..+++.|++|++...... ....+.+..|+.+++.++|+||+++++.+.....+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 589999999999999999999888999999998765443 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|+++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~-~~~ 158 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT-MGE 158 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc-ccc
Confidence 9999999999988877999999999999999999999999999999999999999999999999998754322211 111
Q ss_pred CCCcccCCccccccceecCCC---CCCCcccHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhhc--ccCCCCCCCCHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVP---YTPHYSDVWSMGVVLYAMAFGRLPFDDTN-YIQLLKQVQTK--VVFPTEPNVSAEC 298 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~--~~~~~~~~~s~~~ 298 (357)
......++..|+|||++.+.. .+.+ +||||||+++|+|++|..||...+ .......+... ...|....++..+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~-~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcc-cchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 022356788999999997765 5555 999999999999999999997653 33333333322 2233344569999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.+||++|| .+|.+||++.+++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999 899999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=330.04 Aligned_cols=258 Identities=25% Similarity=0.468 Sum_probs=218.5
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3555678999999999999998899999999875432 2234557799999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++..... ...
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~-----~~~ 173 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-----EVP 173 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc-----ccc
Confidence 9999999998854 4589999999999999999999999999999999999999999999999998864321 111
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCCHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAECKTLL 302 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li 302 (357)
......|+..|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+.......+..... .+....++..+.+||
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred cCceeecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 2234568899999999988787776 9999999999999999999988877666655544332 222335789999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
.+|| .+|.+||+++++++||||.....+..
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 9999 89999999999999999998877764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=354.13 Aligned_cols=264 Identities=22% Similarity=0.387 Sum_probs=229.2
Q ss_pred ccccccccccccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC
Q psy7825 51 KRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125 (357)
Q Consensus 51 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 125 (357)
+.........+...+.+..+.||+|+||.||+|+.. .....||||.++... ....+..|++|++++..|+|||
T Consensus 473 ~~~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 473 QLNPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPN 550 (774)
T ss_pred CCCCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCC
Confidence 344456666778888999999999999999999853 234679999886432 3335788999999999999999
Q ss_pred cceeeEEEEeCCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7825 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQRE--------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191 (357)
Q Consensus 126 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlk 191 (357)
||+++|+|..++..|+|+||+..|+|.+||... .+++..+.+.|+.||+.||+||-++.+|||||.
T Consensus 551 IVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLA 630 (774)
T KOG1026|consen 551 IVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLA 630 (774)
T ss_pred eEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchh
Confidence 999999999999999999999999999999752 138889999999999999999999999999999
Q ss_pred CCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCC
Q psy7825 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPF 270 (357)
Q Consensus 192 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf 270 (357)
++|+||.++..|||+|||+++..-. .+.........-..+|||||.+..+++++. +||||+|++|||+++ |+.||
T Consensus 631 TRNCLVge~l~VKIsDfGLsRdiYs---sDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy 706 (774)
T KOG1026|consen 631 TRNCLVGENLVVKISDFGLSRDIYS---SDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPY 706 (774)
T ss_pred hhhceeccceEEEecccccchhhhh---hhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcc
Confidence 9999999999999999999985422 112222223345679999999999999999 999999999999995 99999
Q ss_pred CCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 271 DDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 271 ~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+....+.++.|+.+-..+.+.++|.++.+|+..|| ..|.+||+++||-.
T Consensus 707 ~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 707 YGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred cccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999999988889999999999999999999 89999999999853
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=324.49 Aligned_cols=259 Identities=30% Similarity=0.587 Sum_probs=221.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 142 (357)
++|.+.+.||+|+||.||+|.+..+|..||+|++.+...........+.+|+.++..+. ||||+++++.+......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46999999999999999999999999999999987654444444566778999999998 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||++++++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999875432221100
Q ss_pred ---------------CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc
Q psy7825 223 ---------------SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV 287 (357)
Q Consensus 223 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 287 (357)
........|+..|+|||++.+..++.. +|+||||+++|+|++|..||...........+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~ 238 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK-LE 238 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-cC
Confidence 122234567899999999988777766 9999999999999999999998776665555442 22
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCH----HHHhcCCCC
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRL----KDIKQDPWV 324 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~----~~ll~hp~~ 324 (357)
...+..+++.+.+||.+|| .+|.+||++ +++++||||
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 3334468999999999999 899999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=322.17 Aligned_cols=253 Identities=21% Similarity=0.403 Sum_probs=209.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeC-----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETT----- 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----- 136 (357)
.++|.+.+.||+|+||.||+|....+++.+|+|++..... ....+.+|+.++..+ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 5679999999999999999999999999999999865322 134466899999998 799999999998643
Q ss_pred CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
...++|+||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 468999999999999998863 4568999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCC-----CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP-----YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV 287 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 287 (357)
...... .......|+..|+|||++.... ++.+ +|||||||++|+|++|+.||........+..+.....
T Consensus 177 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 177 QLTSTR-----LRRNTSVGTPFWMAPEVIACEQQYDYSYDAR-CDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred hccccc-----ccccCccCCccccChhhhcCCCCcccccCCc-cchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 432211 1122346889999999985433 4455 9999999999999999999988776665555543322
Q ss_pred C--CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 288 F--PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 288 ~--~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
. ......+..+.+||.+|| .+|..||++.+|+.||||+
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2 223457789999999999 8999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=322.51 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=212.7
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC---CCCcceeeEEEEeCCeEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR---HPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~l 141 (357)
.|.+.+.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.+. |||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch--hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4788899999999999999999999999999986532222 2345678999999986 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||+++++|.+++.. +.+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--- 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence 9999999999999866 478999999999999999999999999999999999999999999999999986443211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC-CCCCHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE-PNVSAECKT 300 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~s~~~~~ 300 (357)
.......|+..|+|||.+.+......++|+||||+++|+|++|..||.+.........+......... ..++.++.+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence 11234468899999999876543333499999999999999999999887766555444332221111 237899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
+|.+|| .||.+||++.+++.||||++...
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 999999 89999999999999999987553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=323.58 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=207.8
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCCh
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 151 (357)
||+|+||.||+|.+..+|+.||+|++.............+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999998754333333344566899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcc
Q psy7825 152 LDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTF 229 (357)
Q Consensus 152 ~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 229 (357)
.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc------CCccccc
Confidence 99998765 699999999999999999999999999999999999999999999999998864321 1112234
Q ss_pred cCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhhcccCCCCCCCCHHHHHHHHHh
Q psy7825 230 CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY----IQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305 (357)
Q Consensus 230 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 305 (357)
.++..|+|||++.+..++.+ +||||||+++|+|++|+.||..... ..+...+. ......++.+++.+.++|++|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccCCccCCHHHHHHHHHH
Confidence 57889999999988777766 9999999999999999999976543 22222221 222333456899999999999
Q ss_pred c-CCCCCCC-----CHHHHhcCCCCCCCC
Q psy7825 306 F-SPIKFRI-----RLKDIKQDPWVKTEA 328 (357)
Q Consensus 306 L-~~p~~Rp-----s~~~ll~hp~~~~~~ 328 (357)
| .+|.+|| ++.+++.||||.+-.
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 9 8999999 888899999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=338.26 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=207.7
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRH-----GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAI 133 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 133 (357)
.+..++|.+.+.||+|+||.||+|.+... +..||+|++...... .....+.+|+.+++.+ +|+||+++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 45667899999999999999999986433 357999998653322 2245677899999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhc-------------------------------------------------------
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQRE------------------------------------------------------- 158 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------------------- 158 (357)
.....+++||||+++|+|.+++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 9999999999999999999998642
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 159 ---------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 159 ---------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
.++++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ..
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~---~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS---NY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc---ce
Confidence 246788899999999999999999999999999999999999999999999987442211 11
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHhhcccCCCCCCCCHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLL-KQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~s~~~~~l 301 (357)
.......++..|+|||++.+..++.+ +|||||||++|+|++ |+.||......... ..+......+.+..++.++.++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence 11223345678999999988888877 999999999999997 99999876554433 3334444444455679999999
Q ss_pred HHHhc-CCCCCCCCHHHHhc
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~ 320 (357)
|.+|| .+|.+||++.+|++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=322.53 Aligned_cols=252 Identities=28% Similarity=0.448 Sum_probs=203.0
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|++|.||+|.+..+++.||||.+....... ....+.+|+.+++.++|+||+++++++......++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 56999999999999999999999899999999986533221 1233558999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+.+ +|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----- 156 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP----- 156 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC-----
Confidence 99975 999988764 46899999999999999999999999999999999999999999999999998633111
Q ss_pred CCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhhcccCC-----------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTN-YIQLLKQVQTKVVFP----------- 289 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~----------- 289 (357)
........++..|+|||++.+.. ++.+ +||||||+++|+|++|+.||.+.. ..+....+......+
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcH-HHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11112234688999999987644 5555 999999999999999999997655 333332221110000
Q ss_pred ------------------CCCCCC--HHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 290 ------------------TEPNVS--AECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 290 ------------------~~~~~s--~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
..+.++ ..+.++|.+|| .+|++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 001234 88999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=323.71 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=204.5
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCe----
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHR---- 138 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~---- 138 (357)
++|.+.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 36999999999999999999999999999999876533221 12345668999999995 6999999999877665
Q ss_pred -EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeecCCC
Q psy7825 139 -VYIIMEYAEKGSLLDFIQRE-----GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-EYNIKLSDFGFA 211 (357)
Q Consensus 139 -~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-~~~~kl~Dfg~~ 211 (357)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++||||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 898888652 35799999999999999999999999999999999999998 889999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP- 289 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~- 289 (357)
....... .......+++.|+|||++.+.. ++.+ +|+||||+++|+|++|..||.+.+.......+......+
T Consensus 159 ~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 159 RAFSIPV-----KSYTHEIVTLWYRAPEVLLGSTHYSTP-VDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred eecCCCc-----cccCCcccccCCCChHHhhCCCCCCch-HHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 6432211 1112335688899999886644 4545 999999999999999999998776655444332211100
Q ss_pred --------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 290 --------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 290 --------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
..+.++..+.+||.+|| .+|.+||++.+++.||||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01358899999999999 8999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=317.98 Aligned_cols=253 Identities=30% Similarity=0.561 Sum_probs=217.2
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|+||.||+|.++.+|..+|+|.+........ ..+.+.+|+.+++.++|+||+++++.+......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 48899999999999999999999999999999865433222 24556789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc-EEEeecCCCcccccccCCC
Q psy7825 145 YAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN-IKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~~ 221 (357)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||++++++. ++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---- 155 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC----
Confidence 999999999997643 4789999999999999999999999999999999999998864 699999988644211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
........|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+..+....+......+..+.++.++.++
T Consensus 156 -~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (257)
T cd08225 156 -MELAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSL 233 (257)
T ss_pred -cccccccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHH
Confidence 111223468899999999988777776 999999999999999999999887777776665555455556789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
|.+|| .+|++||++.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 99999 899999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=319.09 Aligned_cols=250 Identities=28% Similarity=0.486 Sum_probs=208.2
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHH-HHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV-VKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
+.||.|+||.||+|.+..+|+.||+|++.+...........+..|..+ ....+|+|++++++.+..++.+++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 569999999999999998999999999865433222222233345444 4456899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------~~~ 152 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------NKK 152 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---------ccc
Confidence 99999999888899999999999999999999999999999999999999999999999998863211 234
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-cCC--CCCCCCHHHHHHHHHh
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-VFP--TEPNVSAECKTLLSKI 305 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~--~~~~~s~~~~~li~~~ 305 (357)
..|+..|+|||.+.+..++.+ +||||||+++|+|++|..||...+.......+.... ..+ ....++..+.++|.+|
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred CCCCcCccChhhhcCCCCcch-hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 458889999999988776666 999999999999999999999888777766654322 222 2336899999999999
Q ss_pred c-CCCCCCC---CHHHHhcCCCCCCCCC
Q psy7825 306 F-SPIKFRI---RLKDIKQDPWVKTEAN 329 (357)
Q Consensus 306 L-~~p~~Rp---s~~~ll~hp~~~~~~~ 329 (357)
| .+|.+|| +++|++.||||.+.++
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 9 8999999 5579999999987543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=321.41 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=204.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHH-HHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREID-VVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+........ ... +..|+. .++.++||||+++++++..+...++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~-~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKR-LLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHH-HHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 369999999999999999999999999999999865433222 223 334555 46677899999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 143 MEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
|||++ ++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99997 488888764 34689999999999999999999997 999999999999999999999999999864321
Q ss_pred cCCCCCCCCCcccCCccccccceecC----CCCCCCcccHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhhcccCCC-C
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKG----VPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQVQTKVVFPT-E 291 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~-~ 291 (357)
........|+..|+|||++.+ ..++.+ +|+|||||++|+|++|+.||... ...+....+........ .
T Consensus 157 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd06617 157 -----SVAKTIDAGCKPYMAPERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA 230 (283)
T ss_pred -----ccccccccCCccccChhhcCCcccccccCcc-ccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc
Confidence 111223468889999999865 334555 99999999999999999999753 22222333322222211 2
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
..+|.++.+||.+|| .+|.+||++.+++.||||+.....
T Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 358999999999999 899999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=315.82 Aligned_cols=258 Identities=27% Similarity=0.450 Sum_probs=215.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCC--CchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC--CeE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA--PPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT--HRV 139 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 139 (357)
.+|.+.+.||+|+||.||+|.+..++..||+|.+..... ........+.+|+.+++.++|+||+++++.+... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 469999999999999999999999999999998754321 1223345688999999999999999999998663 568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++|+||+++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 89999999999999998877899999999999999999999999999999999999999999999999999875422111
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc-ccCCCCCCCCHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-VVFPTEPNVSAEC 298 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~~ 298 (357)
.........|+..|+|||++.+..++.+ +|+|||||++|+|++|+.||.+........++... .....+..+++.+
T Consensus 162 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 162 --SGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred --cCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 1111223568899999999988777766 99999999999999999999887666655554432 2233356789999
Q ss_pred HHHHHHhcCCCCCCCCHHHHhcCCCC
Q psy7825 299 KTLLSKIFSPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 299 ~~li~~~L~~p~~Rps~~~ll~hp~~ 324 (357)
.++|.+||.+|.+||++.+++.|||+
T Consensus 239 ~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 239 RDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHhcCcccCccHHHHhcCCCC
Confidence 99999999778999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=330.41 Aligned_cols=260 Identities=28% Similarity=0.463 Sum_probs=207.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC-----Ce
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT-----HR 138 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 138 (357)
++|.+.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 579999999999999999999999999999999854222 22244566899999999999999999876543 35
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
.++|+||+.+ +|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 8999999965 88888754 468999999999999999999999999999999999999999999999999987542211
Q ss_pred CCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC---------
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF--------- 288 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------- 288 (357)
. .........|++.|+|||.+.+. .++.+ +|||||||++|+|++|+.||.+.+.......+...+..
T Consensus 161 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 161 D--HTGFLTEYVATRWYRAPEIMLNSKGYTKA-IDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred c--ccCCcCCcCcCCCccChHHhhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 1 11122345689999999987654 45544 99999999999999999999876654433322111100
Q ss_pred ------------------C---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 289 ------------------P---TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 289 ------------------~---~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
+ ..+..+.++.+||.+|| .+|.+||++.+++.||||......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 0 01356889999999999 899999999999999999987554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=326.89 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=209.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEE--EEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCC
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDV--AVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTH 137 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 137 (357)
+.-++|.+.+.||+|+||.||+|.+..++..+ ++|.+.. .........+.+|+.++.++ +||||+++++++..++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 45567999999999999999999988777654 6665532 22333455677899999999 8999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~ 201 (357)
.+++||||+++++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999997543 478899999999999999999999999999999999999999
Q ss_pred cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy7825 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLK 280 (357)
Q Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~ 280 (357)
.++|+|||++..... ........++..|+|||++.+..++.+ +|||||||++|+|++ |..||...+..+...
T Consensus 162 ~~kl~dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 162 VAKIADFGLSRGQEV------YVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred cEEeCccccCcccch------hhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 999999999852211 111112234668999999988777766 999999999999998 999999888877777
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+......+.+..++.++.+||.+|| .+|..||++.++|.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 235 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 76655444445568899999999999 899999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=320.34 Aligned_cols=252 Identities=25% Similarity=0.453 Sum_probs=209.1
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCC----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTH---- 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~---- 137 (357)
.++|.+.+.||.|++|.||+|.+..+++.+++|++..... ....+.+|+.+++.+ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4679999999999999999999988899999999865432 235577999999999 6999999999996544
Q ss_pred --eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 138 --RVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 138 --~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
.+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999999875 357899999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCC-----CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV-----PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV 286 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 286 (357)
...... ........|+..|+|||++... .++.+ +||||||+++|+|++|..||...........+....
T Consensus 161 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 234 (275)
T cd06608 161 AQLDST-----LGRRNTFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234 (275)
T ss_pred eecccc-----hhhhcCccccccccCHhHhcccccccCCcccc-ccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC
Confidence 643211 1122345688999999988542 34445 999999999999999999998766655555544332
Q ss_pred c--CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 287 V--FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 287 ~--~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
. ......++.++++||.+|| .||.+||++.++++|||+
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2 1222347889999999999 899999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=321.22 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=218.2
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.+.+.||+|+||.||+|.+..++..||+|++...... .....+.+|+.++..++||||+++++.+..+...++||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 77889999999999999999889999999987543322 2345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCC
Q psy7825 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL 225 (357)
Q Consensus 146 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 225 (357)
+++++|.+++.. +.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-----~~~ 157 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-----QIK 157 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-----hhh
Confidence 999999999864 46899999999999999999999999999999999999999999999999988643211 111
Q ss_pred CCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHh
Q psy7825 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305 (357)
Q Consensus 226 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 305 (357)
.....|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||...........+...........++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 236 (277)
T ss_pred hccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 223468889999999988777766 9999999999999999999988777666666554433334456899999999999
Q ss_pred c-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 306 F-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 306 L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
| .+|..||++.++++||||.+....
T Consensus 237 l~~~p~~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 237 LNKEPSFRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred ccCChhhCcCHHHHHhCHHHhhhhhc
Confidence 9 899999999999999999986443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=321.29 Aligned_cols=249 Identities=21% Similarity=0.368 Sum_probs=203.2
Q ss_pred eeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHH---HHHHcCCCCCcceeeEEEEeCCeEEEEEeccC
Q psy7825 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREI---DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAE 147 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 147 (357)
+||+|+||.||+|.+..+++.||+|++.+...........+..|. ..+....||+|+++++.+......++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999989999999998765433222122223333 34455679999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCC
Q psy7825 148 KGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD 227 (357)
Q Consensus 148 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 227 (357)
|++|.+++...+.+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~-------~~~~ 153 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-------KKPH 153 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc-------cCCc
Confidence 999999998888899999999999999999999999999999999999999999999999999864321 1123
Q ss_pred cccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 228 TFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDT---NYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 228 ~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
...|+..|+|||++.+. .++.+ +||||+|+++|+|++|+.||.+. ........ ........+..++..+.++|.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~-~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~ 231 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFSPELRSLLE 231 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcc-cchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-hhccCCCCCCcCCHHHHHHHH
Confidence 45689999999999755 45655 99999999999999999999766 32222222 222233344467999999999
Q ss_pred Hhc-CCCCCCC-----CHHHHhcCCCCCCCC
Q psy7825 304 KIF-SPIKFRI-----RLKDIKQDPWVKTEA 328 (357)
Q Consensus 304 ~~L-~~p~~Rp-----s~~~ll~hp~~~~~~ 328 (357)
+|| .+|.+|| ++.++++||||++..
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 999 8999999 999999999998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=317.97 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=214.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++..+..+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 44569999999999999999999999999999998864321 23456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 142 IMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
+|||+++++|.+++... ..+++..++.++.|++.+|+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~- 158 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 158 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce-
Confidence 99999999999999764 358899999999999999999999999999999999999999999999999986442211
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~ 298 (357)
........++..|+|||.+.+..++.. +|||||||++|+|++ |..||.+.+..+....+......+.+..++.++
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (263)
T cd05052 159 ---YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKV 234 (263)
T ss_pred ---eeccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 111112234568999999988888877 999999999999998 999999988888877777766666667899999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.++|.+|| .+|.+||++.++++
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 99999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=323.89 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=214.4
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
..|.+.+.||+|+||.||+|....+|+.||+|++.............+.+|+.+++.++||||+++++++......++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45999999999999999999998899999999986554444444456779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+.| +|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------- 166 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------- 166 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC-------
Confidence 99975 77777754 4578999999999999999999999999999999999999999999999999886321
Q ss_pred CCCCCcccCCccccccceec---CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-CCCCCCHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP-TEPNVSAEC 298 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~~ 298 (357)
......|++.|+|||++. ...++.+ +||||||+++|+|++|..||...+.......+....... ....++..+
T Consensus 167 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 167 --PANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred --CCCCccCCccccCceeeeccCCCCCCcc-cchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 112346788999999984 3445555 999999999999999999998877766555544322211 123578899
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
++||.+|| .+|.+||++.+|+.||||.....+
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 276 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP 276 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence 99999999 899999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=321.89 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=207.5
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||.|++|.||+|.+..+|..||||++....... ....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4899999999999999999999999999999986543221 13445689999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 145 YAEKGSLLDFIQRE---GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 145 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|+++ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---- 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----
Confidence 9986 899888754 35899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC------------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------------ 289 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------------ 289 (357)
........++..|+|||++.+......++||||||+++|+|++|+.||.+.+..+....+......+
T Consensus 154 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 154 -VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 1112234578899999998765443344999999999999999999998877665554432211100
Q ss_pred ----------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 290 ----------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 290 ----------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
..+.++..++++|.+|| .+|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 01346889999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=325.89 Aligned_cols=266 Identities=26% Similarity=0.463 Sum_probs=223.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.+|.+.+.||+|+||.||++.+..++..||+|.+...... ..+.+.+|+.+++.++||||+++++.+......++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 5699999999999999999998888999999998543222 2455778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~-----~ 169 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----Q 169 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc-----c
Confidence 999999999999754 4789999999999999999999999999999999999999999999999987643211 1
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc--ccCCCCCCCCHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK--VVFPTEPNVSAECKTL 301 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~s~~~~~l 301 (357)
.......|++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+.......+... ..++....++..+++|
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 11233468889999999988877776 99999999999999999999877655443333221 1222334578899999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcccccccc
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAGVETK 339 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~~~~~ 339 (357)
|++|| .+|.+||++.+++.||||+...+.+..+.+.+.
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~~~~ 287 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAA 287 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCcccccccchHHH
Confidence 99999 899999999999999999999888887776654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=314.41 Aligned_cols=253 Identities=30% Similarity=0.522 Sum_probs=221.0
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||.|+||.||++.+..++..|++|++...... ......+.+|+++++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 488999999999999999999989999999998654432 2334557789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 145 YAEKGSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 145 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
++++++|.+++.+. ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999764 679999999999999999999999999999999999999999999999999986432211
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
.......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...+..............+.+..++..+.+
T Consensus 158 ---~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd08215 158 ---DLAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRN 233 (258)
T ss_pred ---ceecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 12334568899999999988887777 99999999999999999999988877777776555444555578999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
+|++|| .+|.+||++.++|.||||
T Consensus 234 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 234 LVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999 899999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=328.11 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=213.4
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcE----EEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCD----VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.+...+|++.+.||+|+||.||+|.+..+|.. ||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 45667899999999999999999998666654 8999885422 22334567789999999999999999999876
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
. ..++|+||+++|+|.+++... ..++...++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||+++..
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 4 567999999999999999874 46889999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
..... ........++..|+|||++.+..++.+ +||||||+++|+|++ |..||.+....+....+......+.++.
T Consensus 160 ~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd05108 160 GADEK---EYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 235 (316)
T ss_pred cCCCc---ceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCC
Confidence 32111 111122334678999999988888877 999999999999997 9999998887777666666666676778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
++.++.++|.+|| .+|..||++.+++.+
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999 899999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=327.12 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=216.0
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|.+.+.||+|+||.||+|.+..++..||+|++...... ...+.+.+|+.+++.++||||+++++.+..+...++|+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 377788999999999999999988999999988643322 234567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|+++++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-----~~ 156 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-----QI 156 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc-----ch
Confidence 9999999998865 56899999999999999999999999999999999999999999999999998644211 11
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSK 304 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 304 (357)
......|+..|+|||++.+..++.+ +|+|||||++|+|++|..||...........+...........++.++.++|.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHH
Confidence 1223458889999999988887777 999999999999999999998776665555444433333334678999999999
Q ss_pred hc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 305 IF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 305 ~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
|| .+|.+||++.++++||||....
T Consensus 236 ~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 236 CLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HccCCcccCcCHHHHHHhHHHHHHh
Confidence 99 8999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=321.02 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=201.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.+|.+.+.||+|+||.||+|.+..+|..||+|++....... ....+.+|+.+++.++|+||+++++++..+...++|+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 56999999999999999999999999999999986543221 1234568999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP----- 156 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC-----
Confidence 9996 577777654 356788999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhhcccCCC----------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQVQTKVVFPT---------- 290 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~---------- 290 (357)
........+++.|+|||++.+.. ++.. +||||||+++|+|++|..||.+.+. .+.+..+......|.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 11123345788999999987654 4555 9999999999999999999976543 222222211100000
Q ss_pred ---------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 291 ---------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 291 ---------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.-..+..+.+||.+|| .||.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0123678999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=321.41 Aligned_cols=253 Identities=20% Similarity=0.360 Sum_probs=213.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATS----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..+|++.+.||+|+||.||+|.. ..++..|++|.+..... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 35689999999999999999985 33567899998864322 2234567789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE-----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~ 201 (357)
.|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999998532 2377888999999999999999999999999999999999999
Q ss_pred cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy7825 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLK 280 (357)
Q Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~ 280 (357)
.++|+|||+++...... .........++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+.....+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSAD---YYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEeccccccccccCCc---ceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999987442211 1112233446778999999988888777 999999999999998 999998888877777
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+......+.+..++..++++|.+|| .+|.+||++.+|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 77766666666789999999999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=322.28 Aligned_cols=253 Identities=22% Similarity=0.385 Sum_probs=214.4
Q ss_pred cccCeEEceeeeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTR-----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
...+|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34568999999999999999998643 368899999864332 22356788999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREG--------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN 202 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~ 202 (357)
...++||||+++++|.+++...+ .+++..+..++.||+.||.|||++|++|+||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997643 3788899999999999999999999999999999999999999
Q ss_pred EEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q psy7825 203 IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQ 281 (357)
Q Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~ 281 (357)
++|+|||++....... .........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+..+....
T Consensus 161 ~kl~d~g~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTD---YYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred EEECCcccceecccCc---ceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999999986432111 1111223346788999999998888877 999999999999998 9999998888888887
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 282 VQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 282 i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+......+.+..++..+++||.+|| .+|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7766555555679999999999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=315.53 Aligned_cols=248 Identities=20% Similarity=0.395 Sum_probs=210.2
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
..+|.+.+.||+|+||.||+|..+. +..+|+|.+...... ...+.+|+.+++.++||||+++++++......++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 3568999999999999999998754 568999987643322 34467899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|||+++|+|.+++.. .+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~--- 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc---
Confidence 999999999999975 3568999999999999999999999999999999999999999999999999886432111
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
........++..|+|||++.+..++.+ +|+||||+++|+|++ |+.||...+..+....+........+...+..+.+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05114 155 -YTSSSGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE 232 (256)
T ss_pred -eeccCCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 111122235668999999988877776 999999999999999 99999998888888887766555555568899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhc
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~ 320 (357)
|+.+|| .+|.+||++.++++
T Consensus 233 li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=321.33 Aligned_cols=261 Identities=21% Similarity=0.332 Sum_probs=214.7
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTR-----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
+..++|.+.+.||+|+||.||+|..+. .+..||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 455679999999999999999997542 3568999987543322 223346789999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE----------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKL 205 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl 205 (357)
....++||||+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999999753 23456788999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhh
Q psy7825 206 SDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQT 284 (357)
Q Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~ 284 (357)
+|||+++....... ........++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+....+....+..
T Consensus 161 ~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 161 GDFGMTRDIYETDY---YRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred CcCCcccccccccc---ccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999874322111 111122345678999999988888877 999999999999998 7899998888887776655
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc------CCCCCCC
Q psy7825 285 KVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ------DPWVKTE 327 (357)
Q Consensus 285 ~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~------hp~~~~~ 327 (357)
....+.+..++..++++|.+|| .+|.+||++.++++ ||||.+.
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 5444445567899999999999 89999999999997 9999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=329.32 Aligned_cols=266 Identities=26% Similarity=0.406 Sum_probs=209.9
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeC
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETT 136 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 136 (357)
...+.+..|++++.||+||.+.||++...+. ..||+|.+..... +.....-+..|+.+|.+|+ |.+|++++++-..+
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 3455677799999999999999999986654 5566665533333 3445666889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
+.+|+|||+-+. +|..+|++... ++...++.+..||+.|+.++|..||||.||||.|+|+-. |.+||+|||.|....
T Consensus 433 ~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 999999999865 99999988654 333588999999999999999999999999999999874 689999999997553
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCC----------CCcccHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhh
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYT----------PHYSDVWSMGVVLYAMAFGRLPFDDTN-YIQLLKQVQT 284 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~ 284 (357)
...........+||+.||+||.+....++ .+++||||||||||+|+.|+.||.... ...-+..|..
T Consensus 511 ---~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~ 587 (677)
T KOG0596|consen 511 ---PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD 587 (677)
T ss_pred ---ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence 23344556678999999999998543332 223899999999999999999998654 3333344433
Q ss_pred c---ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 285 K---VVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 285 ~---~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
. +.||..+.. .++.++++.|| .||++||++.+||+|||++.-..+.
T Consensus 588 P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~ 637 (677)
T KOG0596|consen 588 PNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPV 637 (677)
T ss_pred CCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccc
Confidence 2 234433222 23999999999 9999999999999999999855543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=320.29 Aligned_cols=249 Identities=30% Similarity=0.458 Sum_probs=202.5
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeC--CeEEEE
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETT--HRVYII 142 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv 142 (357)
|.+.+.||+|+||.||+|.+..+++.||+|.+......... . ...+|+..+.++. |+||+++++++... +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-V-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-h-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 67889999999999999999999999999998654332221 2 2347888898885 99999999999887 899999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
+||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++. +.++|+|||++......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---- 152 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---- 152 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC----
Confidence 999975 88888876 356899999999999999999999999999999999999999 99999999998744211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--------------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-------------- 287 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------- 287 (357)
.......++..|+|||++........++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 153 --PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred --CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1112345788999999875544433449999999999999999999988776665544432111
Q ss_pred -----CCC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 288 -----FPT---------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 288 -----~~~---------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
++. .+.++..+.+||.+|| .+|.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 110 1357899999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.31 Aligned_cols=253 Identities=31% Similarity=0.536 Sum_probs=219.4
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|++++..++|||++++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 488999999999999999999988999999999765443 2335668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|+++++|.+++...+.+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-----~ 154 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-----K 154 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc-----c
Confidence 99999999999888889999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSK 304 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 304 (357)
......++..|+|||...+...+.+ +|||+||+++|+|++|..||...+..............+.++.++..+.++|.+
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 1234568889999999987776666 999999999999999999998776655555544444444556789999999999
Q ss_pred hc-CCCCCCCCHHHHhcCCCC
Q psy7825 305 IF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 305 ~L-~~p~~Rps~~~ll~hp~~ 324 (357)
|| .+|++||++.+++.||||
T Consensus 234 ~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcCHHHHhcCCCC
Confidence 99 899999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=331.06 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=207.2
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT------ 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 136 (357)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.+...... ....+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT-HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChh-HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4679999999999999999999999999999999865333222 234456899999999999999999988643
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
...|+||||+.+ +|.+.+... +++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 357999999965 888888654 89999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------- 289 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------- 289 (357)
........|+..|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+...+..+
T Consensus 171 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 171 ------SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred ------CCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 111234468899999999998888877 999999999999999999998776544443332211110
Q ss_pred ------------------------------C-----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 290 ------------------------------T-----EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 290 ------------------------------~-----~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
. ....+..+++||.+|| .||.+||++.++|.||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0 1134678999999999 99999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=322.20 Aligned_cols=253 Identities=23% Similarity=0.419 Sum_probs=213.5
Q ss_pred ccccCeEEceeeeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
++.++|.+.+.||+|+||.||++.. ..++..+|+|.+... .......+.+|+.++..++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4567799999999999999999985 234567899987543 23335567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREG-------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN 202 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~ 202 (357)
...+++||||+++++|.+++...+ .+++..++.++.||+.||+|||+.|++||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999997543 3899999999999999999999999999999999999999999
Q ss_pred EEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q psy7825 203 IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQ 281 (357)
Q Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~ 281 (357)
++|+|||++....... .........++..|+|||++.+..++.+ +|||||||++|+|++ |..||...........
T Consensus 159 ~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 159 VKIGDFGMSRDVYSTD---YYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred EEeccCCccccccCCc---eeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999986432111 1111223446778999999988887777 999999999999998 9999998888888888
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 282 VQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 282 i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+......+....++.++.+|+.+|| .+|.+||++.++++
T Consensus 235 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 235 ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7766555555678999999999999 89999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=324.46 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=208.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC--CeEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT--HRVYI 141 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 141 (357)
++|.+.+.||.|+||.||+|.+..+++.+|+|.+...... +.....+.+|+.++..++||||+++++++... ...|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4699999999999999999999999999999998654333 22233456899999999999999999998877 89999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|+||+.+ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-- 160 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--
Confidence 9999975 999998764 358999999999999999999999999999999999999999999999999987443211
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-----------
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP----------- 289 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------- 289 (357)
.......+++.|+|||.+.+......++|+||||+++|+|++|..||...........+......+
T Consensus 161 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 161 ---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred ---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 112234578899999998765543344999999999999999999998877665555443211100
Q ss_pred -------------------CCCC-CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 290 -------------------TEPN-VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 290 -------------------~~~~-~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.... +++.+.+||++|| .+|++||++.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0111 5889999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=321.59 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=207.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEE------e
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIE------T 135 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~------~ 135 (357)
.+.|++.+.||.|+||.||+|.+..+++.||+|++..... ....+..|+.++..+ +|+||+++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 3569999999999999999999999999999999854321 234567899999998 6999999999885 3
Q ss_pred CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
...++++|||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 56789999999999999999763 4588889999999999999999999999999999999999999999999999864
Q ss_pred cccccCCCCCCCCCcccCCccccccceec-----CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILK-----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV- 287 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~- 287 (357)
.... ........|++.|+|||++. +..++.+ +|+|||||++|+|++|..||...........+.....
T Consensus 171 ~~~~-----~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd06636 171 LDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 244 (282)
T ss_pred hhcc-----ccCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC
Confidence 3211 11223456899999999985 3345555 9999999999999999999987665554444333222
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
......++.++.+||++|| .||.+||++.+||.||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 1223358999999999999 899999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=317.02 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=214.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.++|.+.+.||+|+||.||+|.+... ...||||.+.... .......+.+|+.++..++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 45799999999999999999998644 4579999875432 233345677899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++||||+++++|.+++... +.+++..++.++.|++.||.|||++||+|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999999764 478999999999999999999999999999999999999999999999999987543111
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
.........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...........+......+....++..
T Consensus 161 ---~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd05033 161 ---ATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSA 236 (266)
T ss_pred ---cceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 1111112335678999999988888877 999999999999997 99999888888888777766666666678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+.+|+.+|| .+|.+||++.+|+++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=321.09 Aligned_cols=253 Identities=22% Similarity=0.416 Sum_probs=207.0
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEE-----e
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIE-----T 135 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~ 135 (357)
..++|.+.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.++..+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 45679999999999999999999999999999998754322 134466899999999 6999999999873 4
Q ss_pred CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
+...++||||++|++|.+++.. ...+++..++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 4678999999999999998753 356889999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecC-----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-----VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV 286 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 286 (357)
...... ........|++.|+|||++.. ..++.+ +|||||||++|+|++|+.||...........+....
T Consensus 172 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 172 AQLTST-----RLRRNTSVGTPFWMAPEVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred eecccC-----CCccccccCCCcccChhhhchhhhccccccch-hhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 644211 112234468999999999853 335555 999999999999999999998776655444433221
Q ss_pred --cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 287 --VFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 287 --~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
....+..++..+.+||.+|| .+|.+||++.+|++|+||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 11223457889999999999 899999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=326.39 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=189.5
Q ss_pred ceeeeecCCeEEEEEEECC--CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE--eCCeEEEEEe
Q psy7825 69 GKVIGIGSYATVKLATSTR--HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE--TTHRVYIIME 144 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 144 (357)
+..||+|+||.||+|.... ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+++|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3579999999999999654 568899998864322 233568999999999999999999885 3567899999
Q ss_pred ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCcEEEeecCCC
Q psy7825 145 YAEKGSLLDFIQRE---------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI----DGEYNIKLSDFGFA 211 (357)
Q Consensus 145 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili----~~~~~~kl~Dfg~~ 211 (357)
|+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9965 888887531 248899999999999999999999999999999999999 45678999999999
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHH
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI---------QLLKQV 282 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~~i 282 (357)
+....... .........||+.|+|||++.+......++|||||||++|+|++|+.||...... .....+
T Consensus 160 ~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 160 RLFNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eccCCCcc--cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 75422111 1112234568999999999977553334499999999999999999999643211 111111
Q ss_pred hhcccC-------------------------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 283 QTKVVF-------------------------------------PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 283 ~~~~~~-------------------------------------~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
...... ......+..+.+||.+|| .||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000 001234677899999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=321.30 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=210.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|+||+++++++...+..++|+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 3699999999999999999999999999999988654332 223456779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++++.+..+..+...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 9999877777776667799999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc----------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV---------------- 286 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------------- 286 (357)
.......++..|+|||++.+. .++.+ +|+||||+++|+|++|+.||.+....+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKP-VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 122345678899999999887 55555 999999999999999999998765544333322100
Q ss_pred ----cCC-----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 287 ----VFP-----------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 287 ----~~~-----------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.++ .+..++.++++||++|| .+|.+||+++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000 11235899999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=316.06 Aligned_cols=252 Identities=29% Similarity=0.423 Sum_probs=210.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++.+...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46999999999999999999999999999999887655444455566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 144 EYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 144 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 99999999998863 3458899999999999999999999999999999999999999999999999886432111
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHhhcccCCC-CCCCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN--YIQLLKQVQTKVVFPT-EPNVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~-~~~~s~ 296 (357)
.......|++.|+|||.+.+..++.+ +|+||||+++|+|++|+.||.... .......+......+. ...++.
T Consensus 161 ----~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 161 ----TAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred ----HHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 11223468889999999988777766 999999999999999999996543 3444444443332222 235789
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+.+||.+|| .+|.+||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999 899999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=319.62 Aligned_cols=251 Identities=31% Similarity=0.488 Sum_probs=206.5
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.+.+.||.|++|.||+|.+..+|..||+|++....... .....+.+|+.+++.++|||++++++++......++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678889999999999999999999999999986543222 2234566899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 146 AEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 146 ~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
+. ++|.+++.... .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...... .
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-----~ 153 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP-----V 153 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-----c
Confidence 95 59999998765 6899999999999999999999999999999999999999999999999998643211 1
Q ss_pred CCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc---------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--------------- 287 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------- 287 (357)
.......++..|+|||++.+.. ++.+ +|+||||+++|+|++|..||...+.......+.....
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTP-VDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1112335688999999887654 4444 9999999999999999999987765444333221100
Q ss_pred ----C---------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 288 ----F---------PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 288 ----~---------~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
+ ...+.++..+.++|.+|| .+|.+||++++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 112467899999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=314.43 Aligned_cols=245 Identities=23% Similarity=0.394 Sum_probs=206.5
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKG 149 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 149 (357)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.....+++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999899999999875432 2334566789999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 150 SLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 150 ~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
+|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~ 155 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG---VYASTGGM 155 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccc---cccccCCC
Confidence 999999764 45899999999999999999999999999999999999999999999999998643211 00000111
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF- 306 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L- 306 (357)
..++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...........+......+.+..++..+.+|+.+||
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred CCCceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence 123457999999988888777 999999999999997 99999887777776666665555666678999999999999
Q ss_pred CCCCCCCCHHHHhc
Q psy7825 307 SPIKFRIRLKDIKQ 320 (357)
Q Consensus 307 ~~p~~Rps~~~ll~ 320 (357)
.+|.+||++.++++
T Consensus 235 ~~p~~Rps~~~~~~ 248 (252)
T cd05084 235 YDPGQRPSFSTVHQ 248 (252)
T ss_pred CChhhCcCHHHHHH
Confidence 89999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=321.09 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=207.5
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|++|.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++......++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46999999999999999999999899999999886543222 22345678999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-EYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||+++ +|.+++.... .+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||++......
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--- 156 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--- 156 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC---
Confidence 99965 8888886543 3578889999999999999999999999999999999985 457999999998643211
Q ss_pred CCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC----------
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP---------- 289 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------- 289 (357)
........+++.|+|||++.+.. ++.+ +||||||+++|+|++|..||...+..+...++......+
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~-~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 157 --VRTFTHEVVTLWYRAPEILLGSRHYSTP-VDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred --ccccccCceeecccCHHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 11122345788999999987654 4444 999999999999999999998776655544432211100
Q ss_pred ------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 290 ------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 290 ------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
..+.+++.++++|.+|| .+|++||++.+++.||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 12457899999999999 899999999999999999874
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=319.07 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=210.5
Q ss_pred ccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
+..++|++.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34567999999999999999999864 2357899998754322 1223456789999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREG----------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKL 205 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl 205 (357)
+...++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999997532 3567788999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhh
Q psy7825 206 SDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQT 284 (357)
Q Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~ 284 (357)
+|||++........ ........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.........+..
T Consensus 161 ~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCCccccCCcce---eecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999864322111 111122345788999999988888877 999999999999998 7899998888877777665
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 285 KVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 285 ~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
....+....++..+.+||.+|| .+|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5444555678999999999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=319.35 Aligned_cols=254 Identities=19% Similarity=0.281 Sum_probs=211.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTR-----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45679999999999999999999876 67889999875432 222345577899999999999999999999988
Q ss_pred CeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---cEEEe
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREG-------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY---NIKLS 206 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~---~~kl~ 206 (357)
...++||||++|++|.+++...+ .+++..+..++.||+.||.|||+++++|+||+|+||+++.++ .++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999999997653 488999999999999999999999999999999999998765 58999
Q ss_pred ecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhc
Q psy7825 207 DFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTK 285 (357)
Q Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 285 (357)
|||+++...... .........++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+.......+...
T Consensus 162 dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 162 DFGMARDIYRAS---YYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred cCccccccCCcc---ceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999987542111 0111112234568999999988888877 999999999999996 99999988887777776655
Q ss_pred ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 286 VVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 286 ~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.....+..++..+.+|+.+|| .+|..||++.+|++|
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 444555678999999999999 899999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=329.87 Aligned_cols=265 Identities=28% Similarity=0.490 Sum_probs=213.0
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe----CCeE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET----THRV 139 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 139 (357)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 56999999999999999999999999999999986533222 224456689999999999999999988753 4578
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++|+||+. ++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 59999998888899999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-----------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV----------- 287 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------- 287 (357)
. .........|+..|+|||++.+. .++.+ +|||||||++|+|++|+.||.+.+.......+.....
T Consensus 163 ~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~-~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 163 E-HKYFMTEYVATRWYRAPELLLSLPEYTTA-IDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred C-CCcccccccccccccChHHhcCCcccccc-cchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 1 11222345789999999998664 34545 9999999999999999999987665443332221100
Q ss_pred ----------CC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 288 ----------FP---------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 288 ----------~~---------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
++ ..+..+.++.++|++|| .+|.+||++.+++.||||.+.+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 00 01357899999999999 89999999999999999987655543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=316.91 Aligned_cols=255 Identities=27% Similarity=0.506 Sum_probs=216.0
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCCh
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 151 (357)
||.|+||.||+|.+..+|+.|++|++.............+.+|+.+++.++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999998765443344456688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC---CCCCCCCc
Q psy7825 152 LDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG---HQSPLSDT 228 (357)
Q Consensus 152 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~ 228 (357)
.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999988778999999999999999999999999999999999999999999999999998643221110 00112234
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCCCCCCCCHHHHHHHHHhc-
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECKTLLSKIF- 306 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~L- 306 (357)
..++..|+|||.+.+...+.. +|+||||+++|+|++|..||...........+.. ....+....++..+.+||++||
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 567889999999988776666 9999999999999999999998888877777654 2333333334999999999999
Q ss_pred CCCCCCCCH---HHHhcCCCCCCC
Q psy7825 307 SPIKFRIRL---KDIKQDPWVKTE 327 (357)
Q Consensus 307 ~~p~~Rps~---~~ll~hp~~~~~ 327 (357)
.+|.+||++ .++|+||||..-
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCC
Confidence 899999999 999999999853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=336.93 Aligned_cols=262 Identities=28% Similarity=0.496 Sum_probs=223.6
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
.++||+|.||+||-|++.++|+.||||++.+....... ...+++|+.+|..+.||+||.+.-.|+..+.+++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 67999999999999999999999999999887665543 36688999999999999999999999999999999999966
Q ss_pred CChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcEEEeecCCCcccccccCCCCC
Q psy7825 149 GSLLDFIQ--REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE---YNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 149 ~~L~~~l~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
+..++|- +.+++++.....++.||+.||.|||.++|+|+||||+|||+... -++||||||+++.+.+ .
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE------k 720 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE------K 720 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch------h
Confidence 6666553 46889999999999999999999999999999999999999644 4799999999986643 2
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
..+...+|||.|+|||++.+..|... -|+||+|+|+|--+.|..||... +..+.+++..-.+....+..++.++.+||
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHH
Confidence 34567789999999999999999988 89999999999999999999643 44444444444444455678999999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcccccccc
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAGVETK 339 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~~~~~ 339 (357)
..+| ..-++|.+.++.|.|||+|+...=...+.+|.+
T Consensus 800 n~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~ 837 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVR 837 (888)
T ss_pred HHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHh
Confidence 9999 788899999999999999998766555555443
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=317.15 Aligned_cols=256 Identities=29% Similarity=0.475 Sum_probs=209.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--CCeEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--THRVYI 141 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 141 (357)
++|...+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+++++.++||||+++++++.. ...+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 3689999999999999999999989999999998654332 234557789999999999999999998854 347899
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 142 IMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999988754 35589999999999999999999999999999999999999999999999999764321
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhhccc--CCC
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-----NYIQLLKQVQTKVV--FPT 290 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~--~~~ 290 (357)
.......++..|+|||.+.+..++.+ +|||||||++|+|++|..||... ...+....+..... .+.
T Consensus 158 ------~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd06621 158 ------SLAGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230 (287)
T ss_pred ------cccccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc
Confidence 11123457889999999988888877 99999999999999999999765 23334433332111 111
Q ss_pred ----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 291 ----EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 291 ----~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
....++.+++||.+|| .+|.+||++.|++.||||++...
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 1235689999999999 89999999999999999977544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.93 Aligned_cols=250 Identities=28% Similarity=0.471 Sum_probs=202.6
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
......||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 444468999999999999999899999999875432 22245678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeecCCCcccccccCCC
Q psy7825 146 AEKGSLLDFIQRE-GYI--DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-EYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 146 ~~~~~L~~~l~~~-~~l--~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
+++++|.+++... ..+ ++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||.+......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---- 162 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI---- 162 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC----
Confidence 9999999999864 455 78889999999999999999999999999999999976 678999999998643211
Q ss_pred CCCCCCcccCCccccccceecCCC--CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHhhcccCCCCCCCCHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVP--YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ--LLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~s~~ 297 (357)
........|++.|+|||++.+.. ++.+ +|+||||+++|+|++|+.||....... .............+..++++
T Consensus 163 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~-~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 163 -NPCTETFTGTLQYMAPEVIDKGPRGYGAP-ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240 (268)
T ss_pred -CCccccCCCCccccChhhhccccccCCch-hhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence 11122345789999999986543 4555 999999999999999999997643222 11111112222334568999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
+++|+++|| .+|.+||++.+++.||||
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999 899999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=323.68 Aligned_cols=257 Identities=23% Similarity=0.462 Sum_probs=217.0
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.....||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++..+.||||+++++.+..+...++|+||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 55566899999999999999888999999998653322 234567899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCC
Q psy7825 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL 225 (357)
Q Consensus 146 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 225 (357)
+++++|..++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~-----~~~~ 173 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-----DVPK 173 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc-----cccc
Confidence 999999998755 4589999999999999999999999999999999999999999999999998863321 1112
Q ss_pred CCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCCHHHHHHHH
Q psy7825 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAECKTLLS 303 (357)
Q Consensus 226 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~ 303 (357)
.....|+..|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+..... ......++..+.++|+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred ccceecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence 234568999999999988887776 9999999999999999999988777666655543221 2223467899999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 304 KIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
+|| .+|.+||++.++++||||.+...+.+
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence 999 89999999999999999998866555
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=326.48 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=214.0
Q ss_pred CeE-EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchH-----------HhhhHHHHHHHHHcCCCCCcceeeEE
Q psy7825 65 GYV-LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDY-----------LKKFLPREIDVVKGLRHPNLIRFLQA 132 (357)
Q Consensus 65 ~y~-~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~ 132 (357)
+|. +.+.||.|+||.||+|.+..+++.||||++......... ....+.+|+.+++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 455 467899999999999999999999999998654332210 01236689999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
+...+..++||||+. ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcccee
Confidence 999999999999997 4999999888889999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCC---------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Q psy7825 213 GHMKCKSG---------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ 283 (357)
Q Consensus 213 ~~~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 283 (357)
........ ..........+++.|+|||.+.+......++|+|||||++|+|++|..||.+.+..+....+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 44311000 001111233568899999999775543444999999999999999999999887766655543
Q ss_pred hcccCCC---------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 284 TKVVFPT---------------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 284 ~~~~~~~---------------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
.....+. .+..+..+.+||.+|| .+|.+||+++++|.||||+....+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence 2111000 1346889999999999 8999999999999999999886663
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=324.99 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=202.8
Q ss_pred CeEEceeeeecCCeEEEEEEECC--CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC--CeEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTR--HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT--HRVY 140 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 140 (357)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.............+.+|+.++..++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999998764322233344566899999999999999999999888 8899
Q ss_pred EEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC----CCcEEEeecCCC
Q psy7825 141 IIMEYAEKGSLLDFIQRE-----GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG----EYNIKLSDFGFA 211 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~----~~~~kl~Dfg~~ 211 (357)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++||||+|+||+++. ++.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 787777532 36899999999999999999999999999999999999999 899999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHH
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ---------LLKQ 281 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------~~~~ 281 (357)
........ .........++..|+|||++.+.. ++.+ +|||||||++|+|++|+.||.+..... .+..
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 160 RLFNAPLK--PLADLDPVVVTIWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccCCCcc--cccccCCccccccccCHHHHhCCCCCCcH-HHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 75432211 112223456889999999887654 4544 999999999999999999997543221 1111
Q ss_pred Hhh------------------------cccCCCC------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 282 VQT------------------------KVVFPTE------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 282 i~~------------------------~~~~~~~------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
+.. ....... ...+..+.++|.+|| .||++||++.+++.||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 100 0000001 156788999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=313.36 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=212.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|.+.+.||+|++|.||+|.+.. ++.||+|.+...... .+.+.+|+.+++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 445679999999999999999998654 578999998654322 344678999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+||||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997654 68999999999999999999999999999999999999999999999999987543111
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
........++..|+|||++.+..++.+ +||||||+++|+|++ |+.||.+.........+......+....++..
T Consensus 158 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05068 158 ----YEAREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE 232 (261)
T ss_pred ----ccccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 011111223457999999988888877 999999999999998 99999998888888777766666666678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+++.+|| .+|.+||++.+|+.
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=321.43 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=204.5
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH----- 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 137 (357)
.++|.+.+.||+|+||.||+|.+..+++.||||.+........ ....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-chhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3469999999999999999999999999999998865432221 2233557999999999999999999886543
Q ss_pred ---eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 138 ---RVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 138 ---~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
..++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 45999999965 888888654 3689999999999999999999999999999999999999999999999999875
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc------
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV------ 286 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------ 286 (357)
........ ........++..|+|||.+.+.. ++.+ +||||||+++|+|++|..||.+.+.......+....
T Consensus 169 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 169 FSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPP-IDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccCCcccC-CCCccCcccCccccCcHHhcCCcccCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 43222111 11223456788999999987654 4444 999999999999999999998877655443332210
Q ss_pred --------------cCCC-----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 287 --------------VFPT-----------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 287 --------------~~~~-----------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
..+. ....+..+.+||.+|| .+|.+||+++++|+||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0000 0124678889999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=314.98 Aligned_cols=250 Identities=24% Similarity=0.441 Sum_probs=213.5
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|++.+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 44567999999999999999999865 467899998754322 2456778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++|||+++++|.+++.+. ..++...++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999999753 468889999999999999999999999999999999999999999999999987542211
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
........++..|+|||++.+..++.+ +|||||||++|+|++ |..||...........+......+....++.+
T Consensus 158 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05072 158 ----YTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232 (261)
T ss_pred ----eeccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 111122345678999999988887776 999999999999998 99999988888888887777666666789999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+||.+|| .+|++||+++++++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=316.53 Aligned_cols=244 Identities=27% Similarity=0.475 Sum_probs=199.6
Q ss_pred CeEEceee--eecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEE
Q psy7825 65 GYVLGKVI--GIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 65 ~y~~~~~l--G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 141 (357)
.|.+.+.+ |+|+||.||++....++..+|+|++....... .|+.....+ +||||+++++.+...+.+++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 35665555 99999999999999999999999986543221 122222222 69999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-NIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~ 220 (357)
||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~---- 162 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT---- 162 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC----
Confidence 999999999999998887899999999999999999999999999999999999999998 999999998864321
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHhh--cccCCCCCCCCHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQL-LKQVQT--KVVFPTEPNVSAE 297 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~--~~~~~~~~~~s~~ 297 (357)
.....|+..|+|||++.+..++.+ +||||||+++|+|++|..||........ ...+.. ....+..+.++..
T Consensus 163 -----~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 163 -----PSCYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred -----CccCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 123458899999999988888776 9999999999999999999975543221 111111 2222334469999
Q ss_pred HHHHHHHhc-CCCCCCCC-HHHHhcCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIR-LKDIKQDPWVKT 326 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps-~~~ll~hp~~~~ 326 (357)
+.+||.+|| .+|.+||+ ++++|+||||++
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999 89999996 699999999974
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.77 Aligned_cols=246 Identities=24% Similarity=0.408 Sum_probs=214.7
Q ss_pred eeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEecc
Q psy7825 70 KVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYA 146 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 146 (357)
+.||+|+||.||+|.+... +..|++|++....... ....+.+|+.++..++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999998866 8999999986544332 3566789999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 147 EKGSLLDFIQRE---------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 147 ~~~~L~~~l~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 77999999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCH
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSA 296 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 296 (357)
.. ........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+....+......+.+..++.
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd00192 159 DY---YRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234 (262)
T ss_pred cc---cccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCCh
Confidence 11 122334557889999999988877776 999999999999998 6999999988888888877666666678899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
++.+++.+|| .+|.+||++.+++++
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHh
Confidence 9999999999 899999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=318.89 Aligned_cols=256 Identities=29% Similarity=0.493 Sum_probs=219.1
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.+.|.+.+.||+|++|.||+|.+..++..|++|++..... ....+.+|+.+++.++|+||+++++.+......++|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3458899999999999999999998899999999865433 245567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
+||++|++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--- 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--- 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch---
Confidence 99999999999998876 79999999999999999999999999999999999999999999999999876432211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCCHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAECK 299 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~ 299 (357)
.......++..|+|||++.+..++.+ +|+||||+++|+|++|..||...+.......+..... .+....++..+.
T Consensus 171 --~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 171 --SKRNSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred --hhhccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 11223457889999999988888777 9999999999999999999988777665555443322 222334889999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+||.+|| .+|..||++.+++.||||++.-
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 9999999 8999999999999999999943
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=319.85 Aligned_cols=249 Identities=25% Similarity=0.422 Sum_probs=208.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCc--EEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGC--DVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 140 (357)
++|.+.++||+|+||.||+|....++. .+++|.+.... .....+.+.+|+.++.++ +||||+++++++.....++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 469999999999999999999877664 46888765322 222345577899999999 6999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7825 141 IIMEYAEKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIK 204 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~k 204 (357)
+|+||+++++|.+++.... .+++..++.++.||+.||+|||+.|++||||||+|||++.++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997532 478899999999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q psy7825 205 LSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQ 283 (357)
Q Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~ 283 (357)
|+|||++..... .........+..|+|||++.+..++.+ +|||||||++|+|++ |..||.+....+....+.
T Consensus 160 l~dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~ 232 (297)
T cd05089 160 IADFGLSRGEEV------YVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232 (297)
T ss_pred ECCcCCCccccc------eeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 999999853211 111111223457999999988887777 999999999999997 999999988888888877
Q ss_pred hcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 284 TKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.....+.+..++..+++||.+|| .+|.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 233 QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66665556679999999999999 899999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.74 Aligned_cols=248 Identities=23% Similarity=0.416 Sum_probs=211.0
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.+|.+.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 45889999999999999999876 4678999988643332 234668999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||++|++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||+++..... .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~----~ 154 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----Q 154 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc----c
Confidence 999999999999763 46899999999999999999999999999999999999999999999999998643211 0
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..+....+......+.+..++..+.++
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTI 233 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 011112224457999999988888877 999999999999998 899999888888888877776666667799999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~h 321 (357)
+.+|| .+|++||++.++++.
T Consensus 234 i~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 234 MYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHH
Confidence 99999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=304.95 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=209.2
Q ss_pred cccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.....+++.+|++.+.||+|||+.||+++...++..||+|.+..... ...+..++|++..++++||||++++++...
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 34556788899999999999999999999999999999998865442 225567799999999999999999876533
Q ss_pred -----CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCCcEE
Q psy7825 136 -----THRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLIDGEYNIK 204 (357)
Q Consensus 136 -----~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~~~~~~k 204 (357)
....|++++|...|+|.+.+.. +..+++.+++.|+.+|++||++||+.. ++||||||.|||+.+.+.++
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence 3459999999999999999975 347999999999999999999999998 99999999999999999999
Q ss_pred EeecCCCcccccccCCC----CCCCCCcccCCccccccceec---CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH-
Q psy7825 205 LSDFGFARGHMKCKSGH----QSPLSDTFCGSYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI- 276 (357)
Q Consensus 205 l~Dfg~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~- 276 (357)
|.|||.+......-.+. .-........|..|+|||.+. +...+.+ +|||||||++|.|+.|..||+..-..
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 99999886321110000 000011223578899999984 4556666 99999999999999999999642110
Q ss_pred -H-HHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 277 -Q-LLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 277 -~-~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
. .+......+.+|....+|+.+.+||++|| .||.+||++.+++.+
T Consensus 249 gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 01111235667777779999999999999 999999999999864
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=312.94 Aligned_cols=249 Identities=20% Similarity=0.383 Sum_probs=210.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
..+|.+.+.||+|+||.||+|.+.. +..+|+|.+...... ...+.+|+.++..++||||+++++++.....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4569999999999999999998754 456999987643322 34467899999999999999999999988999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence 9999999999999764 4689999999999999999999999999999999999999999999999999864422111
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
.......++..|+|||++.+..++.+ +||||||+++|+|++ |..||...+..+....+......+.....+..+++
T Consensus 156 --~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05113 156 --TSSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYA 232 (256)
T ss_pred --eecCCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 11112335678999999988887777 999999999999998 99999988887777777666555555668999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~h 321 (357)
++.+|| .+|.+||++.+|+.+
T Consensus 233 li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 233 IMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHcCCCcccCCCHHHHHHh
Confidence 999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=319.52 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=214.4
Q ss_pred cccCeEEceeeeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTR-----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
...+|++.+.||+|+||.||+|.+.. .+..||+|++.... .....+.+.+|+.++..++||||+++++.+...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 34458899999999999999998754 35789999986432 233456688999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE 200 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~ 200 (357)
...++++||+.+++|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 347888899999999999999999999999999999999999
Q ss_pred CcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q psy7825 201 YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLL 279 (357)
Q Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~ 279 (357)
+.++|+|||+++...... .........+++.|+|||++.+..++.+ +|||||||++|||++ |..||.+....+..
T Consensus 161 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 161 LNVKISDLGLFREVYAAD---YYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred CceEecccccccccccch---heeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999987442211 1111233446789999999988888777 999999999999998 88999998888888
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 280 KQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 280 ~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+.+......+.+..++..+.+|+.+|| .+|.+||++.+|+..
T Consensus 237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 237 EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 888776666666789999999999999 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=326.64 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=209.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC-----Ce
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT-----HR 138 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 138 (357)
.+|.+.+.||+|+||.||+|.+..+|+.||||.+......... ...+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch-hHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4699999999999999999999999999999998653322222 33456899999999999999999987643 35
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+|+||+. ++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 899999996 5999999888889999999999999999999999999999999999999999999999999987432111
Q ss_pred CCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-----------
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV----------- 286 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------- 286 (357)
.......++..|+|||++.+. .++.+ +|||||||++|+|++|+.||.+.+.......+....
T Consensus 163 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 163 -----DFMTEYVVTRWYRAPELLLNCSEYTTA-IDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred -----ccccccccccCccChHHHhcCCCCCCc-ccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 112344578899999998753 45555 999999999999999999998765433332221100
Q ss_pred ------------c-------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 287 ------------V-------FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 287 ------------~-------~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
. ....+.++.++.+||++|| .+|.+||+++++++||||......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 0 0012468899999999999 899999999999999999875444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=321.04 Aligned_cols=262 Identities=27% Similarity=0.474 Sum_probs=230.9
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 138 (357)
.+...+|..+.+||+|+||.|.+|..+.+.+.||||++++.-...+.-.+.-+.|-.+|.... -|.+++++.+|+.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 455567999999999999999999999999999999998765554444555556778888775 6788999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+||||+.||+|-..+++-+++-+..+..++..|+.||-+||++||++||||.+|||++.+|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn---- 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN---- 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998732
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~ 297 (357)
......+.++||||.|+|||++...+|... +|+||+|++||||+.|+.||++.+..+++..|.. ...+|. .+|.+
T Consensus 501 -i~~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK--slSkE 576 (683)
T KOG0696|consen 501 -IFDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK--SLSKE 576 (683)
T ss_pred -ccCCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc--cccHH
Confidence 233445668999999999999999999988 9999999999999999999999999999998865 455555 59999
Q ss_pred HHHHHHHhc-CCCCCCCCH-----HHHhcCCCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRL-----KDIKQDPWVKTEAN 329 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~-----~~ll~hp~~~~~~~ 329 (357)
+.++++.+| +.|.+|... .+|-.||||+.--+
T Consensus 577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred HHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 999999999 899988643 68899999987644
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=308.47 Aligned_cols=249 Identities=27% Similarity=0.508 Sum_probs=212.9
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++|+||+++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48889999999999999999998899999999865433 234567799999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 145 YAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 145 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999999876 6799999999999999999999999999999999999999999999999999864422110
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCCHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAECKTL 301 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~l 301 (357)
.....|+..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+.......+..... .+....++..+.++
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDF 230 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHH
Confidence 345568899999999988777766 9999999999999999999988755555444433222 22222348999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPW 323 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~ 323 (357)
|.+|| .||.+||++.+++.|||
T Consensus 231 i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 231 LKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHccCChhhCCCHHHHhcCCC
Confidence 99999 89999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=349.27 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=207.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++..++||||+++++++...+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47999999999999999999999999999999987654444455667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 144 EYAEKGSLLDFIQRE-----------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
||++|++|.+++... ..++...+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998641 234566788999999999999999999999999999999999999999999997
Q ss_pred ccccccCC-------------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q psy7825 213 GHMKCKSG-------------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279 (357)
Q Consensus 213 ~~~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 279 (357)
........ .........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.....
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 54211100 00111223579999999999998888777 99999999999999999999876554433
Q ss_pred HHH--hhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 280 KQV--QTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 280 ~~i--~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
... ...........++..+.+++.+|| .||++||+..+.+.
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 221 111112222468899999999999 89999987666554
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=285.39 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=217.2
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|.-.+.||+|.||+||+|++..+++.||+|.++..+.... .-....+|+-+++.++|.|||++++....+..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 36667899999999999999999999999999976544332 23345589999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 145 YAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 145 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||.. +|..+... ++.++...++.++.|+++||.++|++++.|||+||.|+||+.+|.+||+|||+++.+...-
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv----- 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV----- 155 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-----
Confidence 9965 88888866 5789999999999999999999999999999999999999999999999999998542211
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhhcccCCCC-----------
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVVFPTE----------- 291 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 291 (357)
.-....+-|..|.+|.++.+.+.+....|+||.|||+.|+. .|++.|.+.+..+.+..|-..+..|..
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 11122346889999999999887766689999999999999 588889999998888887554333321
Q ss_pred -----------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 292 -----------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 292 -----------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
|..+..-++|++.+| .+|..|++++..++||||.+..
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 455678899999999 8999999999999999998753
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=309.64 Aligned_cols=255 Identities=29% Similarity=0.526 Sum_probs=215.9
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC--CeEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT--HRVYII 142 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 142 (357)
+|.+.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 488899999999999999999989999999998655432 33356678999999999999999999999988 899999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
+||+++++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988878999999999999999999999999999999999999999999999999998754322110
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhh-cccCCCCCCCCHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN-YIQLLKQVQT-KVVFPTEPNVSAECKT 300 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~-~~~~~~~~~~s~~~~~ 300 (357)
.......++..|+|||.+.+...+.+ +||||||+++|+|++|..||.... .......+.. ......+..++..+.+
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred -ccccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence 11234568889999999988877766 999999999999999999998765 3333333322 2223334567999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
||.+|| .+|.+||++.+++.||||
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999 899999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=311.70 Aligned_cols=251 Identities=30% Similarity=0.441 Sum_probs=211.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46999999999999999999999899999999987544444444566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 144 EYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 144 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
||+++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999999864 345899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhhcccCCCCC-CCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT--NYIQLLKQVQTKVVFPTEP-NVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~-~~s~ 296 (357)
........|++.|+|||.+.+..++.. +|+||||+++|+|++|+.||... +..+....+......+.+. .++.
T Consensus 160 ---~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08224 160 ---TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235 (267)
T ss_pred ---CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCH
Confidence 111223468889999999988888777 99999999999999999999654 3344555554443333333 6889
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+.++|.+|| .+|..||++.+|++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999 89999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=315.77 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=212.4
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCc----EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGC----DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.+...+|++.+.||+|+||.||+|.+..+|. .||+|++.... .......+.+|+.++..+.||||+++++.+..
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 4566789999999999999999999877665 48999885432 22334567789999999999999999998875
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
...++++||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||+++..
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4577999999999999999774 56899999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
...... .......+++.|+|||.+.+..++.+ +|||||||++|||++ |..||...........+......+.+..
T Consensus 160 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05109 160 DIDETE---YHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPI 235 (279)
T ss_pred ccccce---eecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCcc
Confidence 221110 11112235678999999988888877 999999999999998 9999988887777776766666666678
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++.++.++|.+|| .||..||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999 89999999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=314.55 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=213.5
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCc---EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGC---DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
..+|.+.+.||+|+||.||+|.+..+++ .||||++.... .......+..|+.+++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3469999999999999999999876664 69999885432 233356688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++||||+++++|.+++... +.++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999999763 568999999999999999999999999999999999999999999999999986442211
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
.............+..|+|||.+.+..++.+ +|||||||++|||++ |..||...+..+....+......+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 1111000111112457999999988888777 999999999999886 99999988888888887766666666788999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+++.+|| .+|.+||++.+|+.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=335.73 Aligned_cols=272 Identities=28% Similarity=0.469 Sum_probs=232.1
Q ss_pred ccccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 55 KKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 55 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
+.+...+...-|..++.||-|+||.|.++...++...||+|.+++.+.........++.|-.||...+++-||+++..|+
T Consensus 620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 34445556677999999999999999999999999999999998877766666677889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
+.+.+|+||+|++||++-.+|-+.+-|.|..++.++..+..|+++.|..|+|||||||+|||||.+|++||+|||++..+
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999743
Q ss_pred ccccC------CC-------------------------------CCCCCCcccCCccccccceecCCCCCCCcccHHHHH
Q psy7825 215 MKCKS------GH-------------------------------QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMG 257 (357)
Q Consensus 215 ~~~~~------~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 257 (357)
....+ +. ........+||+.|+|||++....|+.. +|+||.|
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~g 858 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVG 858 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhh
Confidence 21110 00 0111123579999999999999998887 9999999
Q ss_pred HHHHHHHcCCCCCCCCCHHHHHHHH---hhcccCCCCCCCCHHHHHHHHHhcCCCCCCC---CHHHHhcCCCCCCC
Q psy7825 258 VVLYAMAFGRLPFDDTNYIQLLKQV---QTKVVFPTEPNVSAECKTLLSKIFSPIKFRI---RLKDIKQDPWVKTE 327 (357)
Q Consensus 258 ~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~s~~~~~li~~~L~~p~~Rp---s~~~ll~hp~~~~~ 327 (357)
+|||||+.|+.||-+..+.+...++ ...+.++.-.+++.++.+||.+|..+++.|. -++||..||||+.-
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCcccccc
Confidence 9999999999999877665554433 4455666666899999999999997777664 57889999999984
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=331.36 Aligned_cols=262 Identities=22% Similarity=0.368 Sum_probs=225.8
Q ss_pred cccccccccccccCeEEceeeeecCCeEEEEEEECCCCc---E-EEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcc
Q psy7825 52 RDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGC---D-VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127 (357)
Q Consensus 52 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 127 (357)
....+....+..++..+.+.||+|+||.||+|..+..+. . ||||...-...........+.+|+++|+.++|||||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 344455566677778888999999999999999765422 3 899988653434455567788999999999999999
Q ss_pred eeeEEEEeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7825 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLS 206 (357)
Q Consensus 128 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~ 206 (357)
+++|+......+++|||+|.||+|.++|++.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeC
Confidence 99999999999999999999999999999876 49999999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCCCCCCC-cccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH-h
Q psy7825 207 DFGFARGHMKCKSGHQSPLSD-TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQV-Q 283 (357)
Q Consensus 207 Dfg~~~~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i-~ 283 (357)
|||+++... ...... ...-...|+|||.+....++.+ +|||||||++||+++ |..||.+....++..+| .
T Consensus 305 DFGLs~~~~------~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 305 DFGLSRAGS------QYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred ccccccCCc------ceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 999986332 111111 1124579999999999988888 999999999999997 88899999999999998 7
Q ss_pred hcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 284 TKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+...+.+...+.++..++.+|+ .+|+.||++.++.+
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 78888888899999999999999 99999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=330.72 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=210.1
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeE
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRH-----GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQ 131 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~ 131 (357)
...+..++|++++.||+|+||.||+|.+... +..||||++..... ....+.+.+|+.++..+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3455677899999999999999999986432 35799999864322 223456789999999996 999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHhc-----------------------------------------------------
Q psy7825 132 AIETTHRVYIIMEYAEKGSLLDFIQRE----------------------------------------------------- 158 (357)
Q Consensus 132 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------- 158 (357)
++.....+|+||||+++|+|.+++..+
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988642
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7825 159 -------------------------------------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENL 195 (357)
Q Consensus 159 -------------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Ni 195 (357)
..+++..+..++.||+.||.|||+.||+|+||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367788899999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCC
Q psy7825 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTN 274 (357)
Q Consensus 196 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~ 274 (357)
|++.++.++|+|||+++...... .........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||....
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDS---NYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccc---cccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCcccc
Confidence 99999999999999987442211 1112233457788999999988888877 999999999999996 999998764
Q ss_pred HH-HHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 275 YI-QLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 275 ~~-~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.. .....+......+.+..++.++.++|.+|| .+|++||++.+|.+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 43 344455555555556679999999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.30 Aligned_cols=252 Identities=21% Similarity=0.378 Sum_probs=211.4
Q ss_pred cccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
...+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 3456999999999999999999853 345668888874322 22245577999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE 200 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~ 200 (357)
...++||||+++++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997643 37889999999999999999999999999999999999999
Q ss_pred CcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q psy7825 201 YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLL 279 (357)
Q Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~ 279 (357)
+.++|+|||++....... .........++..|+|||++.+..++.+ +|||||||++|+|++ |..||...+.....
T Consensus 160 ~~~~l~dfg~a~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~ 235 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTD---YYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235 (291)
T ss_pred CcEEECCCCcccccCCCc---eeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999986432111 1112234456789999999988888777 999999999999998 99999888888777
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 280 KQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 280 ~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+...........++..+.+|+.+|| .+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 236 ECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 777665554455568999999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=319.32 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=216.0
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeE
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRH-----GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQ 131 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 131 (357)
...+..++|.+.+.||+|+||.||++..... ...+|+|.+..... . .....+.+|+.++..+ +|+||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~-~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-E-KDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-H-HHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3456677899999999999999999987643 37899998864322 2 2234577899999999 7999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7825 132 AIETTHRVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENL 195 (357)
Q Consensus 132 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Ni 195 (357)
++..+..++++|||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999642 4588999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCC
Q psy7825 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTN 274 (357)
Q Consensus 196 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~ 274 (357)
|++.++.++|+|||+++....... ........++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+..
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDY---YRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred EEcCCCeEEeCccccccccccccc---eeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999999999875422111 111122234678999999988888877 999999999999997 999999988
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 275 YIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 275 ~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
..+....+......+.+..++..+.+|+.+|| .+|.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 240 VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 88888877776665666678999999999999 899999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.46 Aligned_cols=261 Identities=29% Similarity=0.471 Sum_probs=217.5
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----eE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH-----RV 139 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 139 (357)
+|.+.+.||.|++|.||+|.+..+|+.||||.+..... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 58999999999999999999998899999999865432 1223455778999999999999999999987765 78
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||+.+ +|.+++.+.+.+++..++.++.||+.||.+||+.||+|+||||.|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999975 8999998878899999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC--------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT-------- 290 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------- 290 (357)
. ........++..|+|||++.+. .++.+ +|+||||+++|+|++|..||.+.+..+....+......+.
T Consensus 159 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~-sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 159 E--KGFLTEYVVTRWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred c--cccccccccccCcCCceeeecccCCCcc-hhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 0 0112344678899999999887 55555 9999999999999999999998887766665544322111
Q ss_pred ----------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 291 ----------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 291 ----------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+.++..+.+||.+|| .+|.+||++.+++.||||++...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 1346889999999999 899999999999999999887555
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=315.22 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=213.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRH-----GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
+..++|.+.+.||+|+||.||+|.+... +..||+|.+..... ......+.+|+.++..++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4556799999999999999999987643 48899999754322 2224457789999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREG----------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKL 205 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl 205 (357)
....++||||+++++|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+|||++.++.++|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999999997532 3677889999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhh
Q psy7825 206 SDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQT 284 (357)
Q Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~ 284 (357)
+|||+++...... .........++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.+.......+..
T Consensus 161 ~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 161 GDFGMTRDIYETD---YYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred CCcccchhhccCc---ccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 9999986442211 1111233456789999999988887777 999999999999998 9999998888888877776
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 285 KVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 285 ~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
....+.+..++..+.+||.+|| .+|.+||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5555556678999999999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=324.68 Aligned_cols=263 Identities=27% Similarity=0.449 Sum_probs=210.0
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeC--CeEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETT--HRVY 140 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~ 140 (357)
++|.+.+.||+|+||.||+|.+..+|+.+|+|.+......... ...+.+|+.++.++ +||||+++++++... ...+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~-~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD-AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh-hhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4699999999999999999999988999999988543222222 34466899999999 999999999988643 4689
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
+||||+.+ +|..++... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||.+.........
T Consensus 86 lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999975 999998766 7899999999999999999999999999999999999999999999999998755332211
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC------------
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF------------ 288 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------ 288 (357)
..........|+..|+|||++.+......++|+||||+++|+|++|+.||.+....+....+......
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 11123334568999999999866544334499999999999999999999876655443332211100
Q ss_pred ------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 289 ------------------PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 289 ------------------~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
...+.++.++.+||.+|| .+|.+||++.++++||||++-..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 011347899999999999 89999999999999999987533
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=315.11 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=214.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
..+|.+.+.||.|+||.||+|.+.. +..+|+|++...... ....+.+|+.+++.++||||+++++++......++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3459999999999999999999887 889999998654321 244577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 143 MEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--- 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--- 157 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc---
Confidence 9999999999999753 46899999999999999999999999999999999999999999999999998644211
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
........++..|+|||++.+..++.+ +||||||+++|+|++ |+.||...+..+....+......+.+..+++.+.
T Consensus 158 --~~~~~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05148 158 --VYLSSDKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY 234 (261)
T ss_pred --cccccCCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHH
Confidence 111123345678999999988877777 999999999999998 8999999888888888877777777778999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhc
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++|.+|| .+|.+||++.+|++
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 235 KIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 9999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.67 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=195.6
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCC-cEEEEEE--------------eecCCCCchHHhhhHHHHHHHHHcCCCCCcc
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHG-CDVAVKV--------------VSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 127 (357)
..+|++++.||+|+||.||+|..+... ..+++|. +.+...........+.+|+.+|..++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 457999999999999999998764332 2222221 1111111222345578999999999999999
Q ss_pred eeeEEEEeCCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7825 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQRE-----GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN 202 (357)
Q Consensus 128 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~ 202 (357)
++++++...+..|+|++++.+ +|..++... .......++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999954 788777542 22346678889999999999999999999999999999999999
Q ss_pred EEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCC-CCCC--CH-HHH
Q psy7825 203 IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP-FDDT--NY-IQL 278 (357)
Q Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~--~~-~~~ 278 (357)
+||+|||++..+... ........+||+.|+|||++.+..++.+ +|||||||++|||++|..+ |... .. .++
T Consensus 306 vkL~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 306 IVLGDFGTAMPFEKE----REAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred EEEEeCCCceecCcc----cccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999998754211 1122334679999999999998888877 9999999999999998754 4322 12 222
Q ss_pred HHHHhhc----ccCCC--------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 279 LKQVQTK----VVFPT--------------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 279 ~~~i~~~----~~~~~--------------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.+.+... ..++. ...++.++.++|.+|| .||.+||++.|+|.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 2211100 00000 1235678889999999 999999999999999999876
Q ss_pred CC
Q psy7825 328 AN 329 (357)
Q Consensus 328 ~~ 329 (357)
..
T Consensus 461 ~~ 462 (501)
T PHA03210 461 EE 462 (501)
T ss_pred Cc
Confidence 43
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=317.11 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=207.0
Q ss_pred EEceeeeecCCeEEEEEEEC----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 67 VLGKVIGIGSYATVKLATST----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 67 ~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.+.+.||.|.||.||+|.+. ..+..|+||.+... ......+.+.+|+..++.++||||++++|++......++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 44688999998442 2333356677999999999999999999999988889999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 143 MEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
+||+++|+|.+++... ..++......++.||+.||.|||+++++|+||+++|||++.++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~--- 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK--- 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 9999999999999886 67999999999999999999999999999999999999999999999999998644111
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
..........+...|+|||.+.+..++.+ +||||||+++|||++ |+.||.+.+..+....+......+.+..++..+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccceeccchhHHHH
Confidence 11112223446779999999988887766 999999999999999 7899999999998888877777777778999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhc
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++|..|| .+|++||++.+|++
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHh
Confidence 9999999 89999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=309.97 Aligned_cols=246 Identities=30% Similarity=0.537 Sum_probs=214.6
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCCh
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 151 (357)
||.|+||.||++.+..+++.||+|++.............+..|+.+++.++||||+++++.+..+..+++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999998766554444456678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccC
Q psy7825 152 LDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231 (357)
Q Consensus 152 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~g 231 (357)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-----SRTNTFCG 155 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----CcccCCcC
Confidence 9999988789999999999999999999999999999999999999999999999999986432211 12334568
Q ss_pred CccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCC
Q psy7825 232 SYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIK 310 (357)
Q Consensus 232 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~ 310 (357)
+..|+|||.+.+...+.. +|+||||+++|+|++|..||...+.......+.. ...+.+...+..+.++|++|| .||.
T Consensus 156 ~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~ 233 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPT 233 (250)
T ss_pred CccccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 889999999988777766 9999999999999999999988877666666544 334455567999999999999 8999
Q ss_pred CCCCH---HHHhcCCCC
Q psy7825 311 FRIRL---KDIKQDPWV 324 (357)
Q Consensus 311 ~Rps~---~~ll~hp~~ 324 (357)
+||++ ++++.||||
T Consensus 234 ~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 234 KRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hCCCcccHHHHHhCCCC
Confidence 99999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=320.02 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=211.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTR-------HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQ 131 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 131 (357)
.+..++|.+.+.||+|+||.||+|.+.. ++..+|+|.+..... . .....+.+|+.++..+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~-~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-E-KDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-h-HHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4445679999999999999999998643 235799998865322 2 2234566899999999 7999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7825 132 AIETTHRVYIIMEYAEKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENL 195 (357)
Q Consensus 132 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Ni 195 (357)
++......++||||+++++|.+++.... .++...++.++.||+.||+|||++|++|+||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997642 478899999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCC
Q psy7825 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTN 274 (357)
Q Consensus 196 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~ 274 (357)
|++.++.++|+|||.+........ ........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred EEcCCCcEEECCCcccccccccch---hhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999999999999864421110 011112234568999999988887777 999999999999998 899999888
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 275 YIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 275 ~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
..+....+......+.+..++.++.+||.+|| .+|.+||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 88877777666555556678999999999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=310.95 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=205.9
Q ss_pred eeeecCCeEEEEEEE--CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 71 VIGIGSYATVKLATS--TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
.||+|+||.||+|.+ ..++..+|+|++.... ......+.+..|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999964 4567899999886433 23344566789999999999999999999875 4567899999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
++|.+++.....+++..+..++.|++.||+|||++|++|+||||.||+++.++.++|+|||++......... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~ 157 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY--YKAKTH 157 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe--eeecCC
Confidence 999999988888999999999999999999999999999999999999999999999999998754221110 011122
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF- 306 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L- 306 (357)
..++..|+|||.+.+..++.+ +|+|||||++|||++ |..||.+....+....+......+.+..++.++.+||.+||
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence 234678999999987777766 999999999999997 99999988888888888776666666679999999999999
Q ss_pred CCCCCCCCHHHHhc
Q psy7825 307 SPIKFRIRLKDIKQ 320 (357)
Q Consensus 307 ~~p~~Rps~~~ll~ 320 (357)
.+|.+||++.+|..
T Consensus 237 ~~p~~Rp~~~~i~~ 250 (257)
T cd05116 237 YGVDERPGFAVVEL 250 (257)
T ss_pred cCchhCcCHHHHHH
Confidence 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=313.04 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=213.2
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCC---cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHG---CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
...+|++.+.||+|+||.||+|.+..++ ..+|+|.+.... .......+.+|+.++..++||||+++++++..++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3457999999999999999999876444 379999875432 22334567889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.++||||+++++|.+++... +.++...+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999765 46899999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCH
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSA 296 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 296 (357)
.. .........++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.+....+....+......+....++.
T Consensus 160 ~~--~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd05066 160 PE--AAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPA 236 (267)
T ss_pred cc--eeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCH
Confidence 11 1111112233568999999988888777 999999999999886 9999998887777777777666666667899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+.+++.+|| .+|.+||++.++++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHH
Confidence 9999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=311.07 Aligned_cols=249 Identities=25% Similarity=0.427 Sum_probs=209.3
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|++.+.||+|+||.||+|.+..+ ..||+|++...... .+.+.+|+.+++.++||||+++++.+. ....+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 3456799999999999999999988765 46999998653332 245678999999999999999999875 45679
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999999763 357899999999999999999999999999999999999999999999999986442211
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
........++..|+|||++.+..++.. +|||||||++|+|++ |..||.+.........+......+....++..
T Consensus 157 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd05071 157 ----YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 231 (262)
T ss_pred ----cccccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHH
Confidence 111123346678999999988888777 999999999999999 88999988887777777666555666679999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+||.+|| .+|.+||++.++++
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=299.94 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=210.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 142 (357)
++.+++..||.|..|.|++++...+|...|||.+.+..... ....+...+.++... ++|+||+.+|+|..+..+++.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke--e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH--HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 44667788999999999999999999999999987644322 234455666666655 499999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 143 MEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||.+.. .+..++.+ .++++|..+-++...+++||.||..+ ||+|||+||+|||+|+.|++||||||.+..+..+
T Consensus 170 MelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--- 245 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--- 245 (391)
T ss_pred HHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc---
Confidence 999854 77777765 57899999999999999999999965 8999999999999999999999999998755432
Q ss_pred CCCCCCCcccCCccccccceecC---CCCCCCcccHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhhccc--CCCCCCC
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKG---VPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQVQTKVV--FPTEPNV 294 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~--~~~~~~~ 294 (357)
.......|-+.|||||.+.. ..|+.+ +||||||++++||.||..||.+. ...+++.++..... .+....+
T Consensus 246 ---kAhtrsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF 321 (391)
T KOG0983|consen 246 ---KAHTRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF 321 (391)
T ss_pred ---cccccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence 23344568899999999953 456766 99999999999999999999874 44566666655433 2333458
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
|+++.+|+..|| +|+.+||...++|+|||+.....
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 999999999999 99999999999999999988643
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=309.59 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=219.2
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+|.+.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++|+||+++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 4889999999999999999999999999999987544333 234556689999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 145 YAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 145 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|+++++|.+++.+ ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999876 356899999999999999999999999999999999999999999999999998644221
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
......|++.|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+.......+......+....++.++++
T Consensus 157 ----~~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQN 231 (256)
T ss_pred ----CcccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHH
Confidence 2223458889999999988888777 99999999999999999999988887777776655555555578999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
+|.+|| .+|.+||++.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 999999 899999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=309.66 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=206.1
Q ss_pred eeeeecCCeEEEEEEECCCC---cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEecc
Q psy7825 70 KVIGIGSYATVKLATSTRHG---CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYA 146 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 146 (357)
+.||+|+||.||+|.+...+ ..+|+|.+...... .....+.+|+.+++.+.||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999875544 78999998654432 23456778999999999999999999876 45689999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCC
Q psy7825 147 EKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226 (357)
Q Consensus 147 ~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 226 (357)
.+++|.+++.....+++..+..++.|++.+|+|||+.|++|+||||+|||++.++.++|+|||+++........ ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~--~~~~ 155 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--YRAT 155 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc--cccc
Confidence 99999999988878999999999999999999999999999999999999999999999999998754321111 1111
Q ss_pred CcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHh
Q psy7825 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305 (357)
Q Consensus 227 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 305 (357)
....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..+....+......+.+..++..++++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 12224568999999988888877 999999999999997 9999998888777777766666666678999999999999
Q ss_pred c-CCCCCCCCHHHHhc
Q psy7825 306 F-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 306 L-~~p~~Rps~~~ll~ 320 (357)
| .+|.+||++.+|++
T Consensus 235 l~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 235 WKYRPEDRPTFSELES 250 (257)
T ss_pred hcCChhhCcCHHHHHH
Confidence 9 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=315.10 Aligned_cols=252 Identities=29% Similarity=0.477 Sum_probs=208.3
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC--CeEEEEE
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT--HRVYIIM 143 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 143 (357)
|.+.+.||.|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.+.|||++++++++... ...++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999999999999999997654 2222345567899999999999999999999887 8999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+++ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--- 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--- 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc---
Confidence 99975 899988765 5799999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC-----------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT----------- 290 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----------- 290 (357)
.......++..|+|||.+.+.. ++.+ +||||||+++|+|++|+.||...+.......+......+.
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~-~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 1122345678899999886644 4444 9999999999999999999988877666555443211110
Q ss_pred -------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 291 -------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 291 -------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
...++..+.++|++|| .+|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0113889999999999 899999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.25 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=211.7
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|...+.||+|+||.||+|.+..+|..|++|++.............+.+|+.+++.++|||++++++++......|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 67778899999999999999989999999998765444443445677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 146 AEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 146 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
+.+ +|.+++.. ..++++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++... .
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~---------~ 172 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---------S 172 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc---------C
Confidence 965 78777765 456899999999999999999999999999999999999999999999999987521 1
Q ss_pred CCCcccCCccccccceec---CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc-ccCCCCCCCCHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-VVFPTEPNVSAECKT 300 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~ 300 (357)
......|+..|+|||++. +..++.+ +||||||+++|+|++|..||...+.......+... ......+.++..+++
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 122456889999999984 3445555 99999999999999999999887766655554332 222223457889999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
||.+|| .+|.+||++.+++.||||+....
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 999999 89999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=323.15 Aligned_cols=259 Identities=24% Similarity=0.384 Sum_probs=204.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC-------
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT------- 136 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------- 136 (357)
.+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 5799999999999999999999999999999998654432 245567899999999999999999776543
Q ss_pred -------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeec
Q psy7825 137 -------HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-EYNIKLSDF 208 (357)
Q Consensus 137 -------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-~~~~kl~Df 208 (357)
...++|+||+++ +|.+++.. +.+++..++.++.||+.||.|||+.|++||||||+||+++. ++.++|+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 357999999975 89888864 46899999999999999999999999999999999999974 567899999
Q ss_pred CCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC
Q psy7825 209 GFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF 288 (357)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 288 (357)
|.+......... ........|+..|+|||++.+......++|||||||++|+|++|+.||.+.+.......+......
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 160 GLARIVDPHYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred ccceecCCcccc--ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 998643211111 111123357889999998765443334499999999999999999999877655544433221110
Q ss_pred -----------------------C------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 289 -----------------------P------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 289 -----------------------~------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
+ ..+.++.++.+||.+|| .||.+||++.++|.||||+.-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~ 308 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC 308 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence 0 01357899999999999 89999999999999999985433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=318.39 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=216.6
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|...+.||+|+||.||+|.+..+|..||+|++.............+.+|+.+++.++|||++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 78889999999999999999989999999998765444444455677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 146 AEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 146 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
+.| +|.+++.. ..++++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~--------- 176 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS--------- 176 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC---------
Confidence 976 77777754 5678999999999999999999999999999999999999999999999999875321
Q ss_pred CCCcccCCccccccceec---CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CCCCCCCCHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPTEPNVSAECKT 300 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~ 300 (357)
......|++.|+|||++. ...++.+ +|||||||++|+|++|..||...+.......+..... ......++..+++
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 177 PANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred CcccccCCccccChhhhhcCCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 122346888999999974 3445555 9999999999999999999988776666655544332 2334468899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAAS 333 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 333 (357)
||.+|| .+|.+||++.++++|+|+.........
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~ 289 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERPETVL 289 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhccCcccch
Confidence 999999 899999999999999999887665544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=313.42 Aligned_cols=253 Identities=19% Similarity=0.316 Sum_probs=208.5
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcE----EEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCD----VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
+...+|++.+.||+|+||.||+|.+..+|.. +++|.+... ........+..|+..+..+.||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 4556799999999999999999998777764 666665322 11222345667888999999999999999875 4
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
...++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.|++|+||||+|||++.++.++|+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 567889999999999999976 4578999999999999999999999999999999999999999999999999987442
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
... .........++..|+|||++.+..++.+ +||||||+++|||++ |..||.+.........+......+.+..+
T Consensus 161 ~~~---~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T cd05111 161 PDD---KKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQIC 236 (279)
T ss_pred CCC---cccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCC
Confidence 111 1112233456778999999988888877 999999999999998 99999988877766666655555555678
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.++.+++.+|| .+|..||++.++++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 899999999999 89999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=325.11 Aligned_cols=255 Identities=21% Similarity=0.344 Sum_probs=205.6
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTR-----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIE 134 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 134 (357)
+..++|++.+.||+|+||.||+|.... +++.||+|++..... . .....+.+|+.++..+ +|+||+++++++.
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~-~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-A-SEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-H-HHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 445679999999999999999997533 457899998864322 2 2234566899999999 7999999999876
Q ss_pred e-CCeEEEEEeccCCCChHHHHHhc-------------------------------------------------------
Q psy7825 135 T-THRVYIIMEYAEKGSLLDFIQRE------------------------------------------------------- 158 (357)
Q Consensus 135 ~-~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------------------- 158 (357)
. +..+++++||+++++|.+++...
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 46788999999999999998642
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCC
Q psy7825 159 ------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGS 232 (357)
Q Consensus 159 ------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt 232 (357)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.... .........++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~---~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP---DYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc---chhhccCCCCC
Confidence 257889999999999999999999999999999999999999999999999987542211 11112234467
Q ss_pred ccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCC
Q psy7825 233 YAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQ-LLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPI 309 (357)
Q Consensus 233 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p 309 (357)
..|+|||++.+..++.+ +|||||||++|+|++ |..||.+....+ ....+........+..++.++.+++.+|| .+|
T Consensus 239 ~~y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 239 LKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred ccccCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCCh
Confidence 78999999999888888 999999999999997 999998755433 33344444444445568899999999999 899
Q ss_pred CCCCCHHHHhcC
Q psy7825 310 KFRIRLKDIKQD 321 (357)
Q Consensus 310 ~~Rps~~~ll~h 321 (357)
++||++.+|++|
T Consensus 318 ~~RPs~~ell~~ 329 (337)
T cd05054 318 EDRPTFSELVEI 329 (337)
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=313.05 Aligned_cols=251 Identities=29% Similarity=0.431 Sum_probs=209.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|..+|||.+.............+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 35889999999999999999999899999999887654444444566779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 144 EYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 144 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999999864 356899999999999999999999999999999999999999999999999988643211
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHhhcccCCC-CCCCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY--IQLLKQVQTKVVFPT-EPNVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~-~~~~s~ 296 (357)
........|+..|+|||.+.+..++.+ +|+||||+++|+|++|..||.+... ......+......+. ...++.
T Consensus 160 ---~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 160 ---TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred ---CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence 111234468899999999988887776 9999999999999999999965432 333444433222222 235889
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+++||.+|| .+|.+||++.+|++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999 89999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=307.08 Aligned_cols=270 Identities=30% Similarity=0.482 Sum_probs=234.8
Q ss_pred cccccccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceee
Q psy7825 52 RDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFL 130 (357)
Q Consensus 52 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 130 (357)
.+..+....+..++|.++.+||+|+|+.|.+++.+++.+.||+|++++.-...++-.+.++.|-.+..+. +||.+|.++
T Consensus 238 m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglh 317 (593)
T KOG0695|consen 238 MDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLH 317 (593)
T ss_pred ccccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehh
Confidence 3334455567778999999999999999999999999999999999888777777778888999999887 599999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 131 QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 131 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
.+|+.+..+++|.||++||+|--+++++++++++.++.+...|+.||.|||+.|||+||||.+|+|++..|++||+|+|+
T Consensus 318 scfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 318 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred hhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHh
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-------DTNYIQLLKQVQ 283 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-------~~~~~~~~~~i~ 283 (357)
++.- -.....+.++||||.|.|||++.+..|... +|+|+||++++||+.|+.||+ +.+.++.+.++.
T Consensus 398 cke~-----l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi 471 (593)
T KOG0695|consen 398 CKEG-----LGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI 471 (593)
T ss_pred hhcC-----CCCCcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH
Confidence 8732 223455778999999999999999999988 999999999999999999995 334445554543
Q ss_pred hcccCCCCCCCCHHHHHHHHHhc-CCCCCCC------CHHHHhcCCCCCCC
Q psy7825 284 TKVVFPTEPNVSAECKTLLSKIF-SPIKFRI------RLKDIKQDPWVKTE 327 (357)
Q Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rp------s~~~ll~hp~~~~~ 327 (357)
-..+...+..+|-.+..+++..| +||++|. .+.++..|+||+.-
T Consensus 472 lekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 472 LEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred hhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 33333444468888999999999 9999885 47899999999864
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=316.74 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=214.1
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEEC-------CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceee
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATST-------RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFL 130 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 130 (357)
..+...+|.+.+.||+|+||.||+|+.. ..+..||+|.+..... ......+.+|+.++..+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3466778999999999999999999752 2345799998754321 22245577999999999 799999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7825 131 QAIETTHRVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194 (357)
Q Consensus 131 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~N 194 (357)
+++......++||||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999999764 236778899999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCC
Q psy7825 195 LLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDT 273 (357)
Q Consensus 195 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~ 273 (357)
||++.++.++|+|||+++....... ........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EEEcCCCcEEECCCccceecccccc---cccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999874422111 111222345678999999988888777 999999999999998 88999998
Q ss_pred CHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 274 NYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 274 ~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+..++...+........+..++..+++||.+|| .+|..||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 888888888766655556678999999999999 899999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=314.88 Aligned_cols=253 Identities=21% Similarity=0.371 Sum_probs=211.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
+...+|.+.+.||+|+||.||+|... .++..+|+|.+... .......+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 34567899999999999999999742 34678899986532 23335568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREG---------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE 200 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~ 200 (357)
....+++|||+++++|.+++.... .+++..++.++.||+.||+|||+.|++|+||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999997643 47889999999999999999999999999999999999999
Q ss_pred CcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q psy7825 201 YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLL 279 (357)
Q Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~ 279 (357)
+.++|+|||++....... .........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||......+..
T Consensus 159 ~~~kL~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTD---YYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CCEEECCCCceeEcCCCc---eeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 999999999986432111 1111223345678999999988888877 999999999999998 99999888877777
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 280 KQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 280 ~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+........+..++..+.+||.+|| .||.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 777665555555679999999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=312.31 Aligned_cols=251 Identities=20% Similarity=0.356 Sum_probs=206.7
Q ss_pred eEEceeeeecCCeEEEEEEECCCCc--EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe------CC
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGC--DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------TH 137 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~ 137 (357)
|.+.+.||+|+||.||+|.+..++. .+|+|.+..... .....+.+.+|+.+++.++||||+++++.+.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999877665 689998865433 23334567789999999999999999997643 22
Q ss_pred eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 138 RVYIIMEYAEKGSLLDFIQR------EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
..++++||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999998843 234789999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCC
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPT 290 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~ 290 (357)
+....... ........+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||......+....+......+.
T Consensus 160 ~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd05075 160 KKIYNGDY---YRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ 235 (272)
T ss_pred cccCcccc---eecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 75422111 111122346678999999998888777 999999999999999 8999998888887777776665566
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+.++..+.++|.+|| .+|.+||++.+|+++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6689999999999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=316.39 Aligned_cols=256 Identities=25% Similarity=0.453 Sum_probs=215.9
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.....||+|+||.||++....+|..||||.+.... ......+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 334568999999999999999999999999875322 22345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCC
Q psy7825 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL 225 (357)
Q Consensus 146 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 225 (357)
+++++|.+++.. +.+++..++.++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~-----~~~ 172 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-----VPR 172 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc-----ccc
Confidence 999999998754 46899999999999999999999999999999999999999999999999987643211 111
Q ss_pred CCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCCHHHHHHHH
Q psy7825 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAECKTLLS 303 (357)
Q Consensus 226 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~ 303 (357)
.....|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...........+..... ......++..+.++|.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccccCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHH
Confidence 233568899999999988777766 9999999999999999999988777666655543332 2233468999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 304 KIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
+|| .+|.+||++.+++.||||.....++
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 999 8999999999999999999987655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=323.82 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=211.6
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR---- 138 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 138 (357)
.++|.+.+.||+|++|.||+|.+..++..||+|++....... .....+.+|+.+++.+.||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 456999999999999999999999999999999886532222 223456689999999999999999988765554
Q ss_pred --EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 139 --VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 139 --~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999999 5699999875 4699999999999999999999999999999999999999999999999999874321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC-----
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT----- 290 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----- 290 (357)
. .....++..|+|||.+.+. .++.+ +||||||+++|+|++|+.||.+.+....+..+......+.
T Consensus 171 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~-~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 171 E--------MTGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred c--------ccCCcccccccCHHHHhCCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 1 2234578899999998664 34444 9999999999999999999988777665555433221110
Q ss_pred -------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 291 -------------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 291 -------------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
...++..+.+||++|| .+|.+||++.+|+.||||++...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 1246899999999999 8999999999999999999876654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=308.44 Aligned_cols=250 Identities=25% Similarity=0.426 Sum_probs=214.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|.+.+.||+|+||.||+|.+. ++..||||.+...... .+.+.+|+.+++.++|+||+++++++......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 45678999999999999999999975 4578999988654332 345678999999999999999999999989999
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+||||+++++|.+++... ..++...+..++.+|+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD- 156 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch-
Confidence 999999999999999764 36899999999999999999999999999999999999999999999999998644211
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
.........++..|+|||.+.+..++.+ +|+||||+++|+|++ |+.||.+.+.......+......+.+...+.+
T Consensus 157 ---~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05034 157 ---EYTAREGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE 232 (261)
T ss_pred ---hhhhhhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 0111112234568999999988887777 999999999999998 99999998888888888777666666778999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+++.+|| .+|.+||+++++++
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=316.88 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=210.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEEC-------CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATST-------RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQ 131 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 131 (357)
.+...+|.+.+.||+|+||.||+|+.. ..+..+|+|.+..... ......+.+|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 445567999999999999999999753 2345799998764322 22244577899999999 5999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7825 132 AIETTHRVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENL 195 (357)
Q Consensus 132 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Ni 195 (357)
++.....+++||||+++|+|.+++... ..++...+..++.||+.||.|||++|++|+||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999753 2478889999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCC
Q psy7825 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTN 274 (357)
Q Consensus 196 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~ 274 (357)
|++.++.++|+|||+++........ .......++..|+|||++.+..++.+ +||||||+++|+|++ |..||...+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYY---KKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEcCCCcEEEccccccccccccccc---cccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999998744221110 11112224567999999988877776 999999999999998 899999988
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 275 YIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 275 ~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+....+........+..++.++++||.+|| .+|..||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 88888777666554555678999999999999 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=310.58 Aligned_cols=251 Identities=18% Similarity=0.315 Sum_probs=208.0
Q ss_pred eEEceeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe----
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR---- 138 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 138 (357)
|.+.+.||+|+||.||+|....+ +..||+|.+...... ......+.+|+..++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56788999999999999987543 478999998653332 2234567799999999999999999998765443
Q ss_pred --EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 139 --VYIIMEYAEKGSLLDFIQRE------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 139 --~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
.++++||+++++|..++... ..+++..++.++.|++.||.|||+.|++|+||||+||++++++.++|+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999998542 3589999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCC
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFP 289 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 289 (357)
++....... ........++..|+|||.+.+..++.+ +|||||||++|||++ |..||.+....+....+.......
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 160 SKKIYSGDY---YRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred eeecccccc---ccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 874422111 111112234678999999988877777 999999999999998 999999888888887777666666
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 290 TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 290 ~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+..++..+.++|.+|| .||.+||++.+++++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66789999999999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=362.15 Aligned_cols=267 Identities=28% Similarity=0.447 Sum_probs=226.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
-+|.....||.|.||.||.|.+..+|...|+|.+.-.... ......+.+|..++..++|||+|+++|+-...+.++|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3588889999999999999999999999999988654433 444566789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|||+||+|.++++..+..++.....+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|..+...... ..
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~-~~ 1392 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT-MP 1392 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc-CC
Confidence 99999999999999888899999999999999999999999999999999999999999999999999865433211 12
Q ss_pred CCCCcccCCccccccceecCCC--CCCCcccHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVP--YTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
......+||+.|||||++.+.+ ....++|||||||++.||+||+.||... +..++.-.+..+-..+.+..+|.+.++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 2334678999999999996644 2233489999999999999999999754 345566666555555555569999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
||..|| .||++|.++.|||+|-|-+.+...-.
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~s 1505 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKSCTDEDS 1505 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhccccccccch
Confidence 999999 99999999999999999988766543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=308.38 Aligned_cols=249 Identities=22% Similarity=0.407 Sum_probs=210.7
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++|+||+++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 44567999999999999999999855 5788999998654432 345678999999999999999998874 45789
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++|||+.+++|.+++... ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~- 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN- 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC-
Confidence 999999999999998753 46889999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
.........++..|+|||++.+..++.+ +||||||+++|+|++ |+.||.+.+..+....+......+....++.+
T Consensus 156 ---~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05067 156 ---EYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE 231 (260)
T ss_pred ---CcccccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHH
Confidence 1111123345678999999988887776 999999999999998 99999988888887777766666666778999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.++|.+|| .+|++||++++++.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=319.36 Aligned_cols=262 Identities=25% Similarity=0.421 Sum_probs=208.7
Q ss_pred CeEEceeeeecCCeEEEEEEECCC--CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEe----CC
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRH--GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIET----TH 137 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~ 137 (357)
+|.+.+.||+|+||.||+|.+..+ +..||+|.+...... ......+.+|+.++..+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999887 899999998643222 22244566899999999 59999999987543 24
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.++++++++. ++|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5788999986 599999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC--------
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF-------- 288 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------- 288 (357)
... .........|+..|+|||++.+. .++.+ +||||||+++|+|++|..||...+....+..+......
T Consensus 159 ~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~-~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 159 PGE-NAGFMTEYVATRWYRAPEIMLSFQSYTKA-IDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred ccc-ccccccCcccCccccCcHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 211 11122345789999999988664 45555 99999999999999999999877655544433221110
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 289 ----------------------PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 289 ----------------------~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
...+.++..+.+||.+|| .+|.+||++.+++.||||.....+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 012346889999999999 899999999999999999755443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.60 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=219.3
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCC-Cc----EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRH-GC----DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
+........+.||+|+||.||.|..... |. .||||.+.+.. .......|.+|..+|+.++||||++++|++..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 4566788999999999999999987543 32 38888775533 33446678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE-------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDF 208 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Df 208 (357)
....++++|||+||+|..+|++. ..++..+...++.||++|+.||+++++|||||..+|+|++....+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999875 35889999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhccc
Q psy7825 209 GFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVV 287 (357)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~ 287 (357)
|+|+.+-.. ..........-...|||||.+..+.++++ +||||||+++||+++ |..||.+.+..+++..+..+.+
T Consensus 847 GlArDiy~~---~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 847 GLARDIYDK---DYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR 922 (1025)
T ss_pred chhHhhhhc---hheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc
Confidence 999843211 11111111233568999999999999998 999999999999996 8999999999999998777778
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+.+..|++.+.++|..|| .+|+.||++..|++
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 8889999999999999999 89999999999997
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.46 Aligned_cols=254 Identities=23% Similarity=0.367 Sum_probs=213.1
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCc---EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGC---DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..++|...+.||+|+||.||+|....++. .+|+|.+..... ....+.+..|+.++..++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45578999999999999999999876554 689998754322 2234567789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.++||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999764 57899999999999999999999999999999999999999999999999998644221
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCH
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSA 296 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 296 (357)
... .........+..|+|||++.+..++.+ +|||||||++|+|++ |..||...+..+....+......+....++.
T Consensus 161 ~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 237 (268)
T cd05063 161 PEG--TYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPS 237 (268)
T ss_pred ccc--ceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCH
Confidence 111 111111223457999999988887776 999999999999997 9999988888888888776666666667899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++.+|+.+|| .+|..||++.+|++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=317.35 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=207.0
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH----- 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 137 (357)
.++|.+.+.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 456999999999999999999999999999999986543222 22345668999999999999999999887654
Q ss_pred -----eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 138 -----RVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 138 -----~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
.+++|+||+++ +|..++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 79999999976 777777654 46899999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP- 289 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~- 289 (357)
........ .......++..|+|||++.+.. ++.. +|||||||++|+|++|+.||...+....+..+......+
T Consensus 164 ~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~-~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 164 RLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPA-IDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccCCcc----cccccceeccCccChHHhcCCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 74422111 1112234677899999886543 4444 999999999999999999998877666655544321111
Q ss_pred ----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 290 ----------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 290 ----------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
....++..+.+||.+|| .+|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 11246899999999999 899999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=330.61 Aligned_cols=262 Identities=23% Similarity=0.427 Sum_probs=235.9
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+...++.++..||-|+||.|-++..+.....+|+|++++.........+.+..|-.+|..++.|.||+++..|.++.++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34456788889999999999999987666679999998877766666777889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
++||-|-||.|+..++.++.|++..++.++..+++|++|||.+|||+|||||+|++++.+|-+||.|||+++.+.
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~----- 571 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG----- 571 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998553
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC-CCCCCCCHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF-PTEPNVSAECK 299 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~ 299 (357)
....+.++||||.|.|||++.+..++.. +|.||||+++|||++|.+||.+.++..++..|..++.. ..+..++....
T Consensus 572 -~g~KTwTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~ 649 (732)
T KOG0614|consen 572 -SGRKTWTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTAT 649 (732)
T ss_pred -cCCceeeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHH
Confidence 3345678999999999999999999988 99999999999999999999999999999998776542 23357999999
Q ss_pred HHHHHhc-CCCCCCCC-----HHHHhcCCCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIR-----LKDIKQDPWVKTEAN 329 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~~~ 329 (357)
+||+++. .+|.+|.. +.+|.+|.||.+-.+
T Consensus 650 ~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 650 DLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred HHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 9999999 78998876 899999999998644
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.64 Aligned_cols=149 Identities=30% Similarity=0.536 Sum_probs=139.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++.+.....+|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997665555555677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
||+.|++|.+++...+.+++..++.++.||+.||.|||..||+||||||+||||+.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999888889999999999999999999999999999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=321.49 Aligned_cols=254 Identities=25% Similarity=0.466 Sum_probs=206.7
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC------C
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT------H 137 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 137 (357)
.+|.+.+.||+|+||.||+|.+..+|+.||||++...... +.....+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 4799999999999999999999889999999998653322 22234567899999999999999999988654 3
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.+++|+||+.. +|..++. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 56999999964 7777653 3589999999999999999999999999999999999999999999999999864311
Q ss_pred cCCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC--------
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF-------- 288 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------- 288 (357)
......++..|+|||++.+. .++.+ +|||||||++|+|++|+.||.+.+....+..+......
T Consensus 170 -------~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 170 -------EMTGYVVTRWYRAPEVILNWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred -------CCCCceeeecccChhhhcCccccCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 12234678899999998764 45545 99999999999999999999987765555443321110
Q ss_pred ----------------CC------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 289 ----------------PT------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 289 ----------------~~------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
+. .+..+..+.+||.+|| .||.+||++.+++.||||+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00 1357788999999999 899999999999999999987553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=308.58 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=209.9
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|++.+.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.+++.++|+|++++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 34567999999999999999999866 4667999998654332 234778999999999999999999875 45688
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999999763 458999999999999999999999999999999999999999999999999986432111
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
........++..|+|||++.+..++.+ +|+||||+++|+|++ |..||.+.+..+....+......+.+...+..
T Consensus 157 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05070 157 ----YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231 (260)
T ss_pred ----cccccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 111122335668999999988887777 999999999999999 89999988888888887766666666778999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+|+.+|| .+|.+||++.++++
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=314.29 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=209.2
Q ss_pred CeEEceeeeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTR-----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
+|++.+.||+|+||.||+|.... ....+++|.+..... ......+.+|+.+++.++||||+++++.+......
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998643 235688888754322 22235577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7825 140 YIIMEYAEKGSLLDFIQRE------------------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENL 195 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Ni 195 (357)
++++||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||+|+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2478889999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCC
Q psy7825 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTN 274 (357)
Q Consensus 196 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~ 274 (357)
|+++++.++|+|||+++....... ........++..|+|||++.+..++.+ +||||||+++|+|++ |..||.+..
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDS---YVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEcCCCcEEeccccccccccCccc---hhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999864322111 111223345678999999988877776 999999999999998 999999888
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 275 YIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 275 ~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
...+.+.+......+.+..++.++.+||.+|| .+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 88888777766666666679999999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.53 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=210.4
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQA 132 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 132 (357)
..+..++|.+.+.||+|+||.||+|.+ ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 345667899999999999999999975 23456899998764322 22345678999999999 79999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
+...+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997643 389999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHhhcccC
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLL-KQVQTKVVF 288 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~-~~i~~~~~~ 288 (357)
+........ ........++..|+|||++.+..++.+ +|||||||++|+|++ |..||......... ..+......
T Consensus 188 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 263 (302)
T cd05055 188 ARDIMNDSN---YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM 263 (302)
T ss_pred cccccCCCc---eeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence 874432111 111223346788999999988888777 999999999999998 99999877655444 333444444
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 289 PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 289 ~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+...+..+.+|+.+|| .+|++||++.+|++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 445568999999999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=306.03 Aligned_cols=245 Identities=26% Similarity=0.492 Sum_probs=211.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|++.+.||.|+||.||+|... |+.||+|.+..... ....+.+|+.++..++|+||+++++.+......+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 34567999999999999999999865 78999999864332 2455778999999999999999999999899999
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999998765 68999999999999999999999999999999999999999999999999987442111
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
....++..|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+........+..+++.
T Consensus 157 --------~~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05039 157 --------DSGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPE 227 (256)
T ss_pred --------ccCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHH
Confidence 12234567999999988777766 999999999999997 99999988888877777666555555678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+||.+|| .+|.+||++.++++
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=317.32 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=205.2
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------- 135 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 135 (357)
.++|.+.+.||+|+||.||+|.+..+++.||||++........ ....+.+|+.+++.++||||+++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 3579999999999999999999999999999999865433221 12345689999999999999999987743
Q ss_pred -CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 136 -THRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 136 -~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
...+++|+||+.+ +|...+.. ...+++..++.++.||++||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 3357999999965 77777764 45799999999999999999999999999999999999999999999999999875
Q ss_pred cccccCCCC------CCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc
Q psy7825 214 HMKCKSGHQ------SPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV 286 (357)
Q Consensus 214 ~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 286 (357)
......... ........|++.|+|||.+.+.. ++.+ +|||||||++|+|++|+.||.+.+.....+.+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch-hHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 432221111 11122345788999999987654 4555 999999999999999999998877766555543211
Q ss_pred cCCC-----------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 287 VFPT-----------------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 287 ~~~~-----------------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
..+. ...++..+.+||.+|| .+|.+||++.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 1000 0235578999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=312.76 Aligned_cols=258 Identities=26% Similarity=0.464 Sum_probs=210.9
Q ss_pred CeEEceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCC-chHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeE
Q psy7825 65 GYVLGKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAP-PDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 139 (357)
+|++.+.||.|+||.||+|.+. .+|..||+|++...... .....+.+.+|+.++..+ +|+||+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 47899999998653221 122235567899999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-- 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCcccCCccccccceecCC--CCCCCcccHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhhcccCCCCCC
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGV--PYTPHYSDVWSMGVVLYAMAFGRLPFDDTN----YIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 293 (357)
.........|+..|+|||.+.+. .++.. +||||||+++|+|++|..||.... ...+...+.. ...+.++.
T Consensus 159 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (290)
T cd05613 159 --EVERAYSFCGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQE 234 (290)
T ss_pred --cccccccccCCcccCChhhccCCCCCCCcc-ccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCcc
Confidence 11122345688999999998753 34444 999999999999999999996432 2233333222 22334456
Q ss_pred CCHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTEA 328 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~~ 328 (357)
++..+.+|+++|| .+|.+|| ++++++.||||+...
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 8999999999999 8999997 899999999998865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.96 Aligned_cols=254 Identities=21% Similarity=0.337 Sum_probs=212.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECC----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTR----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET- 135 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 135 (357)
+..++|.+.+.||+|+||.||+|.+.. .+..|++|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999865 35889999875322 23335667789999999999999999998765
Q ss_pred CCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE--------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSD 207 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~D 207 (357)
....+++++|+++++|.+++... ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56789999999999999999753 4588999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcc
Q psy7825 208 FGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKV 286 (357)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 286 (357)
||+++.+..... ........++..|+|||++.+..++.+ +|||||||++|++++ |+.||...+..+....+....
T Consensus 161 ~g~~~~~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 161 NALSRDLFPMDY---HCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred CCCcccccCCce---EEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 999875422111 111122346778999999988888777 999999999999998 999999888888777777666
Q ss_pred cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 287 VFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 287 ~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+....+++++.+++.+|| .+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 65555678999999999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=323.51 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=204.0
Q ss_pred eeeeec--CCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccC
Q psy7825 70 KVIGIG--SYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAE 147 (357)
Q Consensus 70 ~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 147 (357)
..||+| +||+||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||++++++|..+...++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 99999999999999999999986544333 334678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC--
Q psy7825 148 KGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS-- 223 (357)
Q Consensus 148 ~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~-- 223 (357)
+++|.+++.+. ..+++..+..++.||+.||+|||+.|++||||||+|||++.++.++++||+.+............
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999999864 34899999999999999999999999999999999999999999999999865322111110000
Q ss_pred CCCCcccCCccccccceecCC--CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc---------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGV--PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--------------- 286 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------- 286 (357)
.......++..|+|||++.+. .++.. +|||||||++|+|++|..||.+..............
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVK-SDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 001122356679999999764 34555 999999999999999999998765544332221110
Q ss_pred -------------------------------cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 287 -------------------------------VFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 287 -------------------------------~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
..+....++..+.+||++|| .||.+||+++++|+||||.+..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 01112346788999999999 899999999999999999886654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=330.49 Aligned_cols=253 Identities=25% Similarity=0.482 Sum_probs=215.6
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCC-CchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe--EEEE
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA-PPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR--VYII 142 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 142 (357)
.+...+||+|+|-+||+|.+..+|..||--.++..+. ......+.|..|+.+|+.|+||||++++.+|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 4567899999999999999999999998654432222 122224678899999999999999999999977554 8899
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCC-CcEEEeecCCCcccccccC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~ 219 (357)
+|.+..|+|..++.+.+.++...++.|++||++||.|||++. |||||||.+||||+.+ |.|||+|+|+|.....+.
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 999999999999999999999999999999999999999984 9999999999999865 899999999997653322
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHhhcccCCC-CCCCCHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-DTNYIQLLKQVQTKVVFPT-EPNVSAE 297 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~-~~~~s~~ 297 (357)
....+|||.|||||++. ..|+.. +||||||+.+.||+|+..||. -.++.++++++..+..... ...-+++
T Consensus 201 ------aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 201 ------AKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred ------cceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 23468999999999998 677777 999999999999999999996 4678888888887765433 2334799
Q ss_pred HHHHHHHhcCCCCCCCCHHHHhcCCCCCCC
Q psy7825 298 CKTLLSKIFSPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 298 ~~~li~~~L~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+++||.+||.....||++.+||.||||...
T Consensus 273 vr~fIekCl~~~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLATKSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcCchhccCHHHHhhChhhccc
Confidence 999999999558889999999999999986
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.64 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=209.2
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCC----------------cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHG----------------CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 125 (357)
...+|++.+.||+|+||.||+|.+...+ ..||+|.+..... ......+.+|+.++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3457999999999999999999876533 5689998764332 233566789999999999999
Q ss_pred cceeeEEEEeCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7825 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG-----------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194 (357)
Q Consensus 126 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~N 194 (357)
|+++++++..+...++++|++++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998765 68999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc--CCCCCCC
Q psy7825 195 LLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF--GRLPFDD 272 (357)
Q Consensus 195 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~ 272 (357)
|+++.++.++|+|||++...... ..........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSS---DYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccC---cceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999998643211 11122234456789999999988777777 999999999999997 7889988
Q ss_pred CCHHHHHHHHhhc-------ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 273 TNYIQLLKQVQTK-------VVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 273 ~~~~~~~~~i~~~-------~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+..+.+..+... ...+.++.++.++.+||.+|| .+|.+||++.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 7766666555332 122334567899999999999 89999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=308.71 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=214.2
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCc----EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGC----DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.+...+|++.+.||+|+||.||+|.+..+|. .+|+|.+..... ......+.+|+.++..++||||+++++++..
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 3456679999999999999999999876664 589998754432 3334567789999999999999999999887
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
...++|+||+++|+|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.++..
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 7889999999999999999874 56899999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
...... .......++..|+|||.+....++.+ +|+||||+++|+|++ |..||.+....++...+......+.+..
T Consensus 160 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05057 160 DVDEKE---YHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235 (279)
T ss_pred cCcccc---eecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCC
Confidence 321111 11112224568999999988777776 999999999999998 9999999888888877777666666677
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++..+.+++.+|| .+|..||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8999999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=306.35 Aligned_cols=244 Identities=25% Similarity=0.456 Sum_probs=207.6
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE-EeCCeE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI-ETTHRV 139 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 139 (357)
+...+|.+.+.||+|+||.||++... |..||+|.+.... ..+.+.+|+.+++.++|+|++++++++ ..+...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 34557999999999999999999765 7889999875322 134567899999999999999999975 455678
Q ss_pred EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
++|+||+++++|.+++.... .+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999997643 4789999999999999999999999999999999999999999999999998633211
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCH
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSA 296 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 296 (357)
.....++..|+|||++.+..++.+ +|||||||++|+|++ |+.||...+..+....+.........+.++.
T Consensus 156 --------~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05082 156 --------QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226 (256)
T ss_pred --------CCCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCH
Confidence 122334568999999988877776 999999999999997 9999998888888777766655555667999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+.++|.+|| .+|.+||++.++++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=318.41 Aligned_cols=282 Identities=26% Similarity=0.423 Sum_probs=232.5
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHH----hhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYL----KKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
...-+++|.++.+||+|||+.||+|.+....+.||+|+-.....+.++. .+...+|..+-+.|+||.||+++++|.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 3344678999999999999999999999999999999875444443332 344668999999999999999999985
Q ss_pred -eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEEcCC---CcEEEeec
Q psy7825 135 -TTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER--GVVHRDIKCENLLIDGE---YNIKLSDF 208 (357)
Q Consensus 135 -~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~ivH~dlkp~Nili~~~---~~~kl~Df 208 (357)
+.+.+|-|+|||+|.+|.-++..+..+++.+++.|+.||+.||.||... .|||.||||.|||+..+ |.+||+||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 5667899999999999999999999999999999999999999999977 59999999999999644 77999999
Q ss_pred CCCcccccccCC--CCCCCCCcccCCccccccceecCC----CCCCCcccHHHHHHHHHHHHcCCCCCCCCCH-HHHHHH
Q psy7825 209 GFARGHMKCKSG--HQSPLSDTFCGSYAYASPEILKGV----PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQ 281 (357)
Q Consensus 209 g~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~ 281 (357)
|+++.......+ .....+....||.+|+|||.+.-+ +.+.+ +||||+|+|+|.++.|+.||..+.. .++++.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnK-VDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNK-VDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccc-eeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 999865433322 233445567899999999998433 34444 9999999999999999999987643 333332
Q ss_pred --H--hhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcccccccccc
Q psy7825 282 --V--QTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTL 341 (357)
Q Consensus 282 --i--~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~~~~~~~ 341 (357)
| ...+.||..|.++.++++||++|| ..-++|.+..+|..||+|.....++.+.+--...-
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~gs~~~a~ 761 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTGSPAGAA 761 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccCCCcccc
Confidence 2 346789999999999999999999 88889999999999999999888887776544433
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.93 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=213.6
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCC-------CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCccee
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRH-------GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRF 129 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 129 (357)
...+...+|.+++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.++.++ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3345556799999999999999999986432 2368999875422 222345677899999999 79999999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7825 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCE 193 (357)
Q Consensus 130 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~ 193 (357)
++++.....+++++||+++|+|.+++.+.. .++...+..++.||+.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999997532 3677888999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCC
Q psy7825 194 NLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDD 272 (357)
Q Consensus 194 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~ 272 (357)
|||++.++.++|+|||+++...... .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||.+
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNID---YYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred eEEEcCCCcEEECCcccceeccccc---ccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999986432111 0111122234568999999988888877 999999999999998 8999999
Q ss_pred CCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy7825 273 TNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDP 322 (357)
Q Consensus 273 ~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp 322 (357)
.+..+....+......+.+..++.++.+||.+|| .+|.+||++.+++.+-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 240 IPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 8888888877766665666678999999999999 8999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=319.28 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=208.7
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH----- 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 137 (357)
.++|.+.+.||+|+||.||+|.+..+|..||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456999999999999999999999999999999985432 22333445678999999999999999999986543
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 138 -RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 138 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
.+++|+||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 468999999 6799888864 5689999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-------- 287 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------- 287 (357)
......+++.|+|||++.+.. ++.+ +|+||||+++|+|++|..||.+.+.......+.....
T Consensus 171 --------~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 171 --------EMTGYVVTRWYRAPEVILNWMHYTQT-VDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred --------CccccccCCcccCHHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 122345788999999987643 4444 9999999999999999999987765444333221100
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 288 ----------------------FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 288 ----------------------~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
....+.++..+.++|.+|| .||.+||++.+++.||||+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 0012467889999999999 899999999999999999986444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=306.07 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=207.6
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|.+.+.||+|+||.||+|.+..+ ..+|+|.+...... .+.+.+|+.+++.++|||++++++++. ....++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 345699999999999999999987654 46999987543322 345678999999999999999998875 456789
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 142 IMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-
Confidence 99999999999999764 347899999999999999999999999999999999999999999999999986432111
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~ 298 (357)
........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+....+....+......+.+..++..+
T Consensus 157 ---~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05069 157 ---YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL 232 (260)
T ss_pred ---ccccCCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 111122345678999999988877776 999999999999999 999999888888777777666666666789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+||++|| .+|.+||+++++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=305.59 Aligned_cols=244 Identities=20% Similarity=0.357 Sum_probs=203.4
Q ss_pred eeeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 71 VIGIGSYATVKLATST--RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999764 445679999886432 2334566889999999999999999999886 4578999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCC
Q psy7825 149 GSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD 227 (357)
Q Consensus 149 ~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 227 (357)
++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~ 156 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY--YKARS 156 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc--eeccC
Confidence 999999975 457899999999999999999999999999999999999999999999999998643221111 11111
Q ss_pred cccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc
Q psy7825 228 TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF 306 (357)
Q Consensus 228 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L 306 (357)
...++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+....+....+......+.++.+++++.++|.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 2224578999999988777776 999999999999996 99999998888887777776666666788999999999999
Q ss_pred -CCCCCCCCHHHHhc
Q psy7825 307 -SPIKFRIRLKDIKQ 320 (357)
Q Consensus 307 -~~p~~Rps~~~ll~ 320 (357)
.+|++||++.+|++
T Consensus 236 ~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 236 IYKWEDRPNFAKVEE 250 (257)
T ss_pred CCChhhCcCHHHHHH
Confidence 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=314.69 Aligned_cols=255 Identities=27% Similarity=0.387 Sum_probs=204.0
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 142 (357)
++|...+.||+|+||.||++.+..+|+.||+|.+...... .....+.+|+.++.++. |+||+++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 3567788999999999999999999999999998654332 23455778999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 143 MEYAEKGSLLDFIQ-----REGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 143 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
|||+.+ +|.++.. ....+++..+..++.+++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 6655442 235699999999999999999999975 999999999999999999999999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCC---CCCCCcccHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhhccc--C--
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGV---PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQVQTKVV--F-- 288 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~--~-- 288 (357)
. .......|+..|+|||++.+. .++.+ +|||||||++|+|++|+.||..... .+....+..... .
T Consensus 161 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd06616 161 S------IAKTRDAGCRPYMAPERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN 233 (288)
T ss_pred C------CccccccCccCccCHHHhccccccCCcch-hhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCC
Confidence 1 112234588899999999776 45655 9999999999999999999976542 122222221111 1
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 289 PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 289 ~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.....++.++.+||.+|| .+|.+||++++|++||||+...
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 112348899999999999 8999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=308.99 Aligned_cols=253 Identities=26% Similarity=0.478 Sum_probs=211.0
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC--chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
+|.+.+.||+|+||.||++.+...+..+++|++...... .......+..|+.+++.++||||+++++.+......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 589999999999999999998887777878776543221 111123455789999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 143 MEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999998864 356899999999999999999999999999999999999975 57999999988643211
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~ 298 (357)
........|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...........+........+..++.++
T Consensus 159 ----~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd08222 159 ----CDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQL 233 (260)
T ss_pred ----cccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHH
Confidence 112234457889999999988777777 999999999999999999998877776666665544444455789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.++|.+|| .+|.+||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999 899999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.22 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=213.5
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|...+.||+|+||.||+|.+..++..+|+|.+.............+.+|+.+++.++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 47778899999999999999998999999999865433333334556789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 145 YAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 145 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|+.| +|.+++.. ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 96 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~-------- 166 (308)
T cd06634 96 YCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------- 166 (308)
T ss_pred ccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec--------
Confidence 9964 88777754 4568999999999999999999999999999999999999999999999999886431
Q ss_pred CCCCcccCCccccccceecC---CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CCCCCCCCHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKG---VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPTEPNVSAECK 299 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~ 299 (357)
......|++.|+|||.+.+ ..++.+ +|||||||++|+|++|..||...+.......+..... ......++..++
T Consensus 167 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 167 -PANXFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244 (308)
T ss_pred -CcccccCCccccCHHHHhhcccCCCCcc-cchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence 1223468889999999742 345555 9999999999999999999987766555544443322 222346889999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAAS 333 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 333 (357)
+||++|| .+|.+||++.+++.|||+.....+...
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~~ 279 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 279 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCccccccCChhHH
Confidence 9999999 899999999999999999997555433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=311.90 Aligned_cols=251 Identities=29% Similarity=0.499 Sum_probs=208.5
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.+.+.||+|++|.||+|....+++.||+|++..... .+.....+..|+.+++.++|+||+++++++......++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 5677899999999999999999999999999876542 222345566899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 146 AEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 146 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
+++ +|.+++.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----- 153 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR----- 153 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-----
Confidence 975 999999876 5799999999999999999999999999999999999999999999999999864422111
Q ss_pred CCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc----------------
Q psy7825 225 LSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---------------- 287 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------------- 287 (357)
......++..|+|||.+.+. .++.+ +||||||+++|+|++|..||...+....+..+.....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCcc-ccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12233467789999998776 55555 9999999999999999999988776655544432111
Q ss_pred ---CC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 288 ---FP---------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 288 ---~~---------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
++ ..+..+..+.++|++|| .+|++||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00 01245789999999999 899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=307.84 Aligned_cols=242 Identities=26% Similarity=0.428 Sum_probs=201.8
Q ss_pred eeeeecCCeEEEEEEECCCCcE--EEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEEEecc
Q psy7825 70 KVIGIGSYATVKLATSTRHGCD--VAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIMEYA 146 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 146 (357)
+.||+|+||.||+|.+..++.. +++|.+... ........+.+|+.++..+ +||||+++++++.....+++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3699999999999998877754 577776532 2223345677899999999 7999999999999999999999999
Q ss_pred CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 147 EKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 147 ~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||||+|||++.++.++|+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997543 478899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCC
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFP 289 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 289 (357)
+..... .........+..|+|||++.+..++.+ +||||||+++|+|++ |..||.+.+..+....+......+
T Consensus 159 ~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (270)
T cd05047 159 SRGQEV------YVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231 (270)
T ss_pred ccccch------hhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCC
Confidence 752211 111112224567999999988777776 999999999999996 999999888888777776655555
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 290 TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 290 ~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+..++.++.+|+.+|| .+|..||++.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 55578999999999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=312.11 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=211.4
Q ss_pred cccCeEEceeeeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTR-----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.+.||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45679999999999999999998743 57899999885432 223345678899999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE----------------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~N 194 (357)
...++|+||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||+|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 9999999999999999999743 236788899999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCC
Q psy7825 195 LLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDT 273 (357)
Q Consensus 195 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~ 273 (357)
|+++.++.++|+|||++........ ........++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY---YKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCcc---ccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999864321111 111122234667999999988888877 999999999999997 88999888
Q ss_pred CHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 274 NYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 274 ~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
...+....+......+.+..++.++.+||.+|| .+|.+||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 237 AHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 888887777666555555678999999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=313.30 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=205.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCC--------------CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRH--------------GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 126 (357)
+..++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|++++..++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3456799999999999999999986532 2358999886432 23335568899999999999999
Q ss_pred ceeeEEEEeCCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7825 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194 (357)
Q Consensus 127 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~N 194 (357)
+++++++......++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999999999999999999999999999996532 36788899999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc--CCCCCCC
Q psy7825 195 LLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF--GRLPFDD 272 (357)
Q Consensus 195 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~ 272 (357)
|+++.++.++|+|||++...... ..........++..|+|||++.+..++.+ +|||||||++|+|++ |..||..
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSG---DYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEEcCCCcEEecccccccccccC---cceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999998643211 11112223345778999999988888777 999999999999987 6789988
Q ss_pred CCHHHHHHHHhh-------cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 273 TNYIQLLKQVQT-------KVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 273 ~~~~~~~~~i~~-------~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+..+....+.. ......++.+++.+.+||.+|| .+|.+||++++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 776665554322 1112234568899999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=308.98 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=205.5
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC---CCCCcceeeEEEEeCCe----
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL---RHPNLIRFLQAIETTHR---- 138 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~---- 138 (357)
|.+.+.||+|+||.||+|.+..+++.||+|.+...... +.....+.+|+.++..+ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 67889999999999999999888999999998654332 22234455777777665 59999999999988776
Q ss_pred -EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 139 -VYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 139 -~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
++++|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887643 58999999999999999999999999999999999999999999999999986542
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC-----
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT----- 290 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----- 290 (357)
.. .......++..|+|||++.+..++.+ +|+|||||++|+|++|..||.+....+....+......+.
T Consensus 159 ~~------~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 159 FE------MALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred CC------cccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 21 11123347889999999988888777 9999999999999999999998877666655543221110
Q ss_pred ---------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 291 ---------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 291 ---------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.+.++..+.+||.+|| .||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 1245688899999999 899999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=323.60 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=209.7
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQA 132 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 132 (357)
..+..++|.+.+.||+|+||.||+|++. .++..||+|++...... ...+.+.+|+.+|..+. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4455667999999999999999999853 34578999999653322 22345779999999997 9999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcC-----------------------------------------------------
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQREG----------------------------------------------------- 159 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------- 159 (357)
+.....+++|+||+++|+|.+++.+.+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999996532
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7825 160 ---------------------------------------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194 (357)
Q Consensus 160 ---------------------------------------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~N 194 (357)
.++...++.++.||+.||.|||+.|++||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25667788999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCC
Q psy7825 195 LLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDT 273 (357)
Q Consensus 195 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~ 273 (357)
||++.++.++|+|||+++....... ........+++.|+|||.+.+..++.+ +||||||+++|||++ |..||...
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSN---YISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccc---cccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999874322111 111223457889999999988887776 999999999999998 89999876
Q ss_pred CHHHH-HHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 274 NYIQL-LKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 274 ~~~~~-~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
...+. ...+......+.+..++.++.+||.+|| .+|..||++++|+..
T Consensus 346 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 346 PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55444 3444555555555678999999999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=318.08 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=207.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT------ 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 136 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.++..++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 467999999999999999999999999999999886532222 2234566899999999999999999987543
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
...+++++++ |++|.+++... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3478888887 77998888654 589999999999999999999999999999999999999999999999999864311
Q ss_pred ccCCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-------- 287 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------- 287 (357)
......|+..|+|||.+.+. .++.+ +|||||||++|+|++|+.||...+.......+.....
T Consensus 173 --------~~~~~~~~~~y~aPE~~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 173 --------EMTGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred --------cccccccCCCccCHHHHhCccCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 12234678899999998763 45555 9999999999999999999987665554433321110
Q ss_pred ----------------CCC------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 288 ----------------FPT------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 288 ----------------~~~------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
.+. ....+.++.+||.+|| .||.+||++.+++.||||++...+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~ 311 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 311 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence 000 1136889999999999 89999999999999999997655543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=303.27 Aligned_cols=249 Identities=20% Similarity=0.356 Sum_probs=210.6
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
..+|.+.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 346899999999999999999875 4678999988644332 23467899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
+||+++++|.+++... +.+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc---
Confidence 9999999999999764 568999999999999999999999999999999999999999999999999986432110
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.........+.+........+...+..+.+
T Consensus 155 -~~~~~~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05112 155 -YTSSTGTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYE 232 (256)
T ss_pred -ccccCCCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 011112335678999999988777766 999999999999998 99999988888888877665555445568999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~h 321 (357)
|+.+|| .+|.+||++.+++++
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHh
Confidence 999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.61 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=203.5
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEEEe
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 144 (357)
|.+.+.||+|++|.||+|....+++.|+||.+.......+ .....+|+..+..+. |+||+++++.+..+...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999988899999998865433221 223347899999999 9999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 145 YAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|+ +++|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~------ 151 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS------ 151 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC------
Confidence 99 779999987754 789999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC------------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------------ 289 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------------ 289 (357)
........++..|+|||++.+.. ++.. +|+||||+++|+|++|+.||......+....+......+
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~-~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSP-VDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCc-cchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 11122345788999999886544 4444 999999999999999999998776555443332211110
Q ss_pred -----------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 290 -----------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 290 -----------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
..+..+..+.+||++|| .+|.+||++++++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 01234789999999999 899999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=302.00 Aligned_cols=243 Identities=22% Similarity=0.391 Sum_probs=205.2
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKG 149 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 149 (357)
++||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46999999999999854 68899999876432 2333445778999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 150 SLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 150 ~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
+|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~----~~~~~~~ 153 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG----IYSSSGL 153 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc----ccccCCC
Confidence 999998754 46889999999999999999999999999999999999999999999999998632111 0111112
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF- 306 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L- 306 (357)
..++..|+|||++.+..++.+ +||||||+++|+|++ |..||.+.........+........+..++..+.+|+.+||
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD 232 (250)
T ss_pred CCCcccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 234568999999988877777 999999999999998 99999988888777777766655556678999999999999
Q ss_pred CCCCCCCCHHHHhc
Q psy7825 307 SPIKFRIRLKDIKQ 320 (357)
Q Consensus 307 ~~p~~Rps~~~ll~ 320 (357)
.+|.+||++.++++
T Consensus 233 ~~p~~Rp~~~~l~~ 246 (250)
T cd05085 233 YKPENRPKFSELQK 246 (250)
T ss_pred cCcccCCCHHHHHH
Confidence 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=313.06 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=210.9
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-CCeEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET-THRVY 140 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 140 (357)
..++|.+.+.||.|+||.||+|.+..+|+.||+|++.+..... .....+.+|+.++..++||||++++++|.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4567999999999999999999999999999999886433222 223456689999999999999999998865 56789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
+++||+ +++|..++.. ..+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||.+.....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 999998 5589888864 4588999999999999999999999999999999999999999999999999863211
Q ss_pred CCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc--------------
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-------------- 285 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------- 285 (357)
......++..|+|||.+.+. .++.+ +||||||+++|+|++|+.||...........+...
T Consensus 161 ----~~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 161 ----QMTGYVSTRYYRAPEIMLTWQKYDVE-VDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred ----CcCCCcccccccCceeeeccCCcCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 11234578899999998663 45555 99999999999999999999876653322211110
Q ss_pred -------------ccCC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcccc
Q psy7825 286 -------------VVFP---TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAG 335 (357)
Q Consensus 286 -------------~~~~---~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~ 335 (357)
...+ ..+.++..++++|++|| .+|++||++.+++.||||.....+.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~ 302 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV 302 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccC
Confidence 0011 11357899999999999 89999999999999999998777765544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.27 Aligned_cols=252 Identities=21% Similarity=0.374 Sum_probs=206.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC--CC----CcceeeEEEEeC
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR--HP----NLIRFLQAIETT 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~----~iv~~~~~~~~~ 136 (357)
.++|.+...+|+|.||.|-.+.+..++..||||+++.... ..+..+-|+++|.++. -| -++.+.++|+..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 6789999999999999999999999999999999865332 3444557999999994 22 267788899999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---------------
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG--------------- 199 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~--------------- 199 (357)
++.|+|+|.+ |.++++++..++ +++...++.++.|+++++++||+++++|.||||+|||+..
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999998 669999998864 6889999999999999999999999999999999999931
Q ss_pred -----CCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Q psy7825 200 -----EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN 274 (357)
Q Consensus 200 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 274 (357)
+..++|+|||.|+.. .......+.|..|+|||++.+-.++.. +||||+||||+||.+|...|+..+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~--------~e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFD--------HEHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred eccCCCcceEEEecCCccee--------ccCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCC
Confidence 335899999998632 122356678999999999999999998 999999999999999999998877
Q ss_pred HHH---HHHHHhhcccC-------------------CC-----------------------CCCCCHHHHHHHHHhc-CC
Q psy7825 275 YIQ---LLKQVQTKVVF-------------------PT-----------------------EPNVSAECKTLLSKIF-SP 308 (357)
Q Consensus 275 ~~~---~~~~i~~~~~~-------------------~~-----------------------~~~~s~~~~~li~~~L-~~ 308 (357)
..+ +.+.|...++. +. .+..-.++.+||++|| .|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 555 33333221100 00 0112357889999999 99
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q psy7825 309 IKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 309 p~~Rps~~~ll~hp~~~~~~ 328 (357)
|.+|+|+.|+|.||||....
T Consensus 394 P~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 394 PARRITLREALSHPFFARLT 413 (415)
T ss_pred ccccccHHHHhcCHHhhcCC
Confidence 99999999999999998753
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=304.78 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=209.9
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
+...+|.+.+.||+|+||.||+|.+... ...|+||....... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3456799999999999999999987543 35689998754322 2335567899999999999999999998875 4
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 578999999999999999764 3589999999999999999999999999999999999999999999999999864322
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s 295 (357)
.. ........++..|+|||.+.+..++.. +||||||+++|+|++ |..||.+....+....+......+.++.++
T Consensus 160 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05056 160 ES----YYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCP 234 (270)
T ss_pred cc----ceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCC
Confidence 11 111112234568999999988777776 999999999999985 999999888777777776666666667899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
..+.+||.+|| .+|.+||++.+++..
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 899999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=302.69 Aligned_cols=245 Identities=23% Similarity=0.402 Sum_probs=205.2
Q ss_pred eeeeecCCeEEEEEEECC-CCc--EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEecc
Q psy7825 70 KVIGIGSYATVKLATSTR-HGC--DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYA 146 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 146 (357)
+.||+|++|.||+|.+.. +++ .||||.+...... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999765 333 6999998664443 345668899999999999999999999988 8899999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 147 EKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 147 ~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~ 155 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED--HYV 155 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc--cee
Confidence 9999999998754 689999999999999999999999999999999999999999999999999875532111 111
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhh-cccCCCCCCCCHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li 302 (357)
......++..|+|||++.+..++.+ +|||||||++|+|++ |..||...+..+....+.. ....+....++..+.+++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence 1223457789999999988888877 999999999999998 9999988887777766653 233334456889999999
Q ss_pred HHhc-CCCCCCCCHHHHhc
Q psy7825 303 SKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~ 320 (357)
.+|| .+|.+||++.++++
T Consensus 235 ~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 235 LQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHCCCCcccCCCHHHHHH
Confidence 9999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=310.17 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=205.1
Q ss_pred cccCeEEceeeeecCCeEEEEEEECC----------------CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTR----------------HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 125 (357)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++|+|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence 34579999999999999999986432 34578999886432 2333556789999999999999
Q ss_pred cceeeEEEEeCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7825 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG-----------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194 (357)
Q Consensus 126 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~N 194 (357)
|+++++++...+..++||||+++++|.+++.... .+++..++.++.||+.||+|||+.|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999997642 36677899999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc--CCCCCCC
Q psy7825 195 LLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF--GRLPFDD 272 (357)
Q Consensus 195 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~ 272 (357)
||++.++.++|+|||++....... .........++..|+|||+..+..++.+ +|+|||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGD---YYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCc---ceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999986432111 1111223345678999999888888777 999999999999998 7899987
Q ss_pred CCHHHHHHHHhh-------cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 273 TNYIQLLKQVQT-------KVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 273 ~~~~~~~~~i~~-------~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+..+....... ....+.+..++..+.+||.+|| .||.+||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 766665543321 2233445578899999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=309.24 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=204.0
Q ss_pred ccCeEEceeeeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC--
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATS----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT-- 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 136 (357)
+.-|.+.+.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+.||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 34588999999999999999974 4568899999985432 222345688999999999999999999998775
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
...++||||++|++|.+++.+. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..+.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 5789999999999999999765 358999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC---------------CHHHHHH
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT---------------NYIQLLK 280 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---------------~~~~~~~ 280 (357)
..... ........++..|+|||++.+..++.+ +|||||||++|+|+++..|+... .......
T Consensus 161 ~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 161 TDKEY--YTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cCccc--eeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 21111 111223457778999999988887777 99999999999999987664221 1112222
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+......+.+..++..+.+||.+|| .+|.+||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 23333444555678999999999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=317.70 Aligned_cols=255 Identities=20% Similarity=0.342 Sum_probs=203.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIE 134 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 134 (357)
+..++|++.+.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4556899999999999999999984 34578999999864322 22244577899999999 6899999999875
Q ss_pred e-CCeEEEEEeccCCCChHHHHHhc-------------------------------------------------------
Q psy7825 135 T-THRVYIIMEYAEKGSLLDFIQRE------------------------------------------------------- 158 (357)
Q Consensus 135 ~-~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------------------- 158 (357)
. +..+++||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45688999999999999998653
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCC
Q psy7825 159 ------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226 (357)
Q Consensus 159 ------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 226 (357)
..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP---DYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc---chhhc
Confidence 135777888999999999999999999999999999999999999999999986432111 11111
Q ss_pred CcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhhcccCCCCCCCCHHHHHHHHH
Q psy7825 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYI-QLLKQVQTKVVFPTEPNVSAECKTLLSK 304 (357)
Q Consensus 227 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~~~~li~~ 304 (357)
....++..|+|||++.+..++.+ +||||||+++|+|++ |..||...... .....+......+.+..+++++.+++..
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 317 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 22345678999999988888777 999999999999996 99999775433 3334444444444455688999999999
Q ss_pred hc-CCCCCCCCHHHHhcC
Q psy7825 305 IF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 305 ~L-~~p~~Rps~~~ll~h 321 (357)
|| .+|.+||++.+|++|
T Consensus 318 cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 318 CWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 99 899999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=301.70 Aligned_cols=247 Identities=25% Similarity=0.424 Sum_probs=211.4
Q ss_pred EEceeeeecCCeEEEEEEECCCC----cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 67 VLGKVIGIGSYATVKLATSTRHG----CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 67 ~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.+.+.||.|+||.||++.+...+ ..||+|++...... .....+..|+.++..++|+||+++++.+...+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 56789999999999999988766 89999998543322 1345677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 143 MEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|||+++++|.+++..... +++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY- 158 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc-
Confidence 999999999999986544 89999999999999999999999999999999999999999999999999874432211
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
.......+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+.......+......+....++.++.
T Consensus 159 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T smart00219 159 ---YKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIY 234 (258)
T ss_pred ---cccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence 11112236789999999977777766 999999999999998 8999998888888888777666666667999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhc
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+++.+|| .+|.+||++.++++
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 235 KLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHCcCChhhCcCHHHHHh
Confidence 9999999 89999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=308.25 Aligned_cols=259 Identities=26% Similarity=0.472 Sum_probs=210.2
Q ss_pred CeEEceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCC-chHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeE
Q psy7825 65 GYVLGKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAP-PDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 139 (357)
+|.+.+.||+|+||.||++.+. .+++.||||++.+.... .......+.+|+.++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999853 46789999998653322 122234567899999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++||||+++++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|.||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-- 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998654221
Q ss_pred CCCCCCCCcccCCccccccceecCCC--CCCCcccHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhhcccCCCCCC
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVP--YTPHYSDVWSMGVVLYAMAFGRLPFDDTN----YIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 293 (357)
.........|+..|+|||.+.+.. .+.+ +|+||||+++|+|++|..||.... .......+.. ...+.+..
T Consensus 159 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (288)
T cd05583 159 --EEERAYSFCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKT 234 (288)
T ss_pred --cccccccccCCccccCHHHhcCCCCCCcch-hhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCCCcc
Confidence 111123356889999999987654 4555 999999999999999999996432 2222222222 22344556
Q ss_pred CCHHHHHHHHHhc-CCCCCCCC---HHHHhcCCCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIR---LKDIKQDPWVKTEAN 329 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps---~~~ll~hp~~~~~~~ 329 (357)
++..+.++|.+|| .+|+.||+ +.++|+||||+...+
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 8999999999999 89999998 567799999988644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=308.42 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=207.3
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 138 (357)
.+..++|.+.+.||+|+||.||+|.+..+++.||||.+....... ....+..|+.++..+. ||||+++++++.....
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 455677999999999999999999999889999999987543222 2333446776666664 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
.++||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.++|+|||++.....
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9999999854 78887765 4578999999999999999999997 5999999999999999999999999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCC----CCCCcccHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhhcc--cCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVP----YTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQVQTKV--VFP 289 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~--~~~ 289 (357)
. .......++..|+|||.+.+.. ++.+ +||||||+++|+|++|+.||..... .+.+..+.... ..+
T Consensus 168 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06618 168 S------KAKTRSAGCAAYMAPERIDPPDPNPKYDIR-ADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP 240 (296)
T ss_pred C------CcccCCCCCccccCHhhcCCCCCccccccc-hhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC
Confidence 1 1112335788999999987653 5555 9999999999999999999976432 33343433222 122
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 290 TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 290 ~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
....++.++.+||.+|| .+|..||++.+++.||||+...
T Consensus 241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 22357899999999999 8999999999999999999743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=309.30 Aligned_cols=251 Identities=29% Similarity=0.463 Sum_probs=208.7
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.+.+.||.|++|.||+|.+..+|+.+++|.+....... .....+.+|+.+++.++|+||+++++.+..+..+++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 567889999999999999999899999999986544332 2345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 146 AEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 146 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
+++ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-----~ 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-----R 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----c
Confidence 976 888888763 578999999999999999999999999999999999999999999999999886442211 1
Q ss_pred CCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC--------------
Q psy7825 225 LSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP-------------- 289 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------- 289 (357)
......++..|+|||.+.+. .++.+ +|+||||+++|+|++|+.||...+..+....+......+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~-~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTP-VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 12234578899999999876 45555 999999999999999999998877666554443221111
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 290 ---------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 290 ---------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
..+.++.++++||.+|| .||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11347899999999999 899999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=300.55 Aligned_cols=244 Identities=23% Similarity=0.396 Sum_probs=206.5
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKG 149 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 149 (357)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++|+||+++++++......++|+||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999887 999999988654332 23556789999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCc
Q psy7825 150 SLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228 (357)
Q Consensus 150 ~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 228 (357)
+|.+++... ..++...+..++.+++.+|.|||++|++|+||+|+|||++.++.++|+|||++...... ........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~---~~~~~~~~ 154 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG---IYTVSDGL 154 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCC---cceecccc
Confidence 999999763 56889999999999999999999999999999999999999999999999998643211 01111112
Q ss_pred ccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-
Q psy7825 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF- 306 (357)
Q Consensus 229 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L- 306 (357)
..++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...........+......+.+..++..+.+||.+||
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred CcceeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhc
Confidence 234567999999988887777 999999999999998 89999888877777777665555556678999999999999
Q ss_pred CCCCCCCCHHHHhc
Q psy7825 307 SPIKFRIRLKDIKQ 320 (357)
Q Consensus 307 ~~p~~Rps~~~ll~ 320 (357)
.+|.+||++.++++
T Consensus 234 ~~p~~Rp~~~ell~ 247 (251)
T cd05041 234 YDPENRPSFSEIYN 247 (251)
T ss_pred cChhhCcCHHHHHH
Confidence 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=310.40 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=210.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCc----EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGC----DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
+...+|++.+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456679999999999999999999877776 468887754322 22234577899999999999999999988754
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
..++++||+++|+|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 467899999999999999765 368999999999999999999999999999999999999999999999999987542
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
... .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||.+.........+......+.++.+
T Consensus 161 ~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd05110 161 GDE---KEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPIC 236 (303)
T ss_pred Ccc---cccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence 211 1111223345678999999988888777 999999999999997 99999887777766666666666666778
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+..+.+++..|| .+|++||+++++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999 899999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=305.75 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=210.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTR-----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
...+|.+.+.||+|+||.||+|+.+. ..+.|++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34579999999999999999999653 34679999875432 222455678999999999999999999999998
Q ss_pred CeEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREG---------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSD 207 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~D 207 (357)
...++||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999999998755 689999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhh-c
Q psy7825 208 FGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQT-K 285 (357)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~-~ 285 (357)
||++...... .........++..|+|||.+.+.....+ +||||||+++|+|++ |..||.+.........+.. .
T Consensus 161 ~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 161 LSLSKDVYNS----EYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred cccccccCcc----cccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 9998643211 1111223346778999999988777766 999999999999998 8899988777776666553 3
Q ss_pred ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 286 VVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 286 ~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
...+....++..+.++|.+|| .+|.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 334445578999999999999 899999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.68 Aligned_cols=249 Identities=24% Similarity=0.438 Sum_probs=209.6
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+...+|.+.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 34567999999999999999999865 45679999875422 124557789999999999999999999887 7789
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++|||+++++|.+++.+. ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999763 457888899999999999999999999999999999999999999999999986442111
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
........++..|+|||++.+..++.+ +|+|||||++|+|++ |..||.+.+..+....+......+.....+.+
T Consensus 157 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05073 157 ----YTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE 231 (260)
T ss_pred ----cccccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHH
Confidence 111122335678999999988777776 999999999999998 99999988888888777777666666789999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+++.+|| .+|.+||++.++++
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999 89999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=305.93 Aligned_cols=249 Identities=23% Similarity=0.378 Sum_probs=198.3
Q ss_pred eEEceeeeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--CCeE
Q psy7825 66 YVLGKVIGIGSYATVKLATS----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--THRV 139 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 139 (357)
|.+.+.||+|+||.||++.. ..++..||+|++..... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 48999999999999988653 45688999999864322 2234557789999999999999999998765 3468
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++||||+++++|.+++... .+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999999764 489999999999999999999999999999999999999999999999999874422111
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH--H-------------HHHHHHhh
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY--I-------------QLLKQVQT 284 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~-------------~~~~~i~~ 284 (357)
.........++..|+|||.+.+..++.+ +||||||+++|+|++|..||..... . .....+..
T Consensus 163 --~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 163 --YYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred --hhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 0111122345678999999988888777 9999999999999999999864321 1 11111222
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 285 KVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 285 ~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
....+.+..++..+.+|+.+|| .+|..||++++|+.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2333445578999999999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=299.52 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=210.7
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCC----cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-CCe
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHG----CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET-THR 138 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 138 (357)
..|++...||+|.||.||+|..+.++ +.+|||.++-.... ..+....-+|+.+++.++||||+.+..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 35999999999999999999654443 37999988644332 2233445589999999999999999999877 889
Q ss_pred EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC----CcEEEeecC
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE-----GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE----YNIKLSDFG 209 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~----~~~kl~Dfg 209 (357)
+++++||.+. +|+.+|+-. ..++...++.|+.||+.|+.|||++=|+||||||.||||..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999988 999999642 458999999999999999999999999999999999999888 899999999
Q ss_pred CCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC---------HHHHHH
Q psy7825 210 FARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN---------YIQLLK 280 (357)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---------~~~~~~ 280 (357)
+++.+...-.. .......+-|..|+|||.+.|...++++.|||++|||+.||++-.+.|.+.. ..+.+.
T Consensus 182 laR~~~~plkp--l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 182 LARLFNNPLKP--LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred HHHHhhccccc--cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99876432221 1123345678999999999999988888999999999999999988885421 122333
Q ss_pred HHhhcccCCCC------------------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy7825 281 QVQTKVVFPTE------------------------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPW 323 (357)
Q Consensus 281 ~i~~~~~~~~~------------------------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~ 323 (357)
.|...+.+|.. ..-++...+|+.+|| .||.+|++++|+|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 44333333321 234566899999999 99999999999999999
Q ss_pred CCCCCCC
Q psy7825 324 VKTEANP 330 (357)
Q Consensus 324 ~~~~~~~ 330 (357)
|...+.+
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 9998655
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=305.04 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=204.1
Q ss_pred eeeeecCCeEEEEEEECCCC------cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 70 KVIGIGSYATVKLATSTRHG------CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
+.||+|+||.||+|+....+ ..+|+|.+...... .....+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36999999999999876443 68999987543221 22445778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-----cEEEeecCCC
Q psy7825 144 EYAEKGSLLDFIQRE-------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-----NIKLSDFGFA 211 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-----~~kl~Dfg~~ 211 (357)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999742 3478899999999999999999999999999999999999887 8999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCC
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPT 290 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~ 290 (357)
....... .........++..|+|||++.+..++.+ +|||||||++|+|++ |..||...+..+....+........
T Consensus 159 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05044 159 RDIYKSD---YYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK 234 (269)
T ss_pred ccccccc---ccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC
Confidence 6442211 1111223346788999999998888777 999999999999998 9999988887777777766555556
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
...++..+.+||.+|| .+|.+||++++|++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6678999999999999 89999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=311.51 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=199.7
Q ss_pred EEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEecc
Q psy7825 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYA 146 (357)
Q Consensus 67 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 146 (357)
.+++.+|.| |.||.++...+++.||||++....... .....+.+|+.+++.++|+||+++++++......+++|||+
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 344444444 555666666689999999987643322 23556889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC--CC
Q psy7825 147 EKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG--HQ 222 (357)
Q Consensus 147 ~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~ 222 (357)
++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999999763 45899999999999999999999999999999999999999999999999988644221111 01
Q ss_pred CCCCCcccCCccccccceecCC--CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHhhccc------------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGV--PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL-KQVQTKVV------------ 287 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~------------ 287 (357)
........++..|+|||++.+. .++.+ +|+|||||++|+|++|..||......... +.+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1112234577889999998663 45555 99999999999999999999876544332 22221100
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 288 --------------------FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 288 --------------------~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.+....++.++.+||.+|| .||.+||+++++|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0001234578999999999 8999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.14 Aligned_cols=252 Identities=23% Similarity=0.388 Sum_probs=200.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--C
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATS----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--T 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 136 (357)
..+|++.+.||+|+||.||+|.. ..++..||+|.+.... ....+.+.+|+.++..++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 45799999999999999999974 4568899999875432 2234567899999999999999999998743 3
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
..+++|+||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 4689999999999999999764 468999999999999999999999999999999999999999999999999987542
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH----------------HHHH
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY----------------IQLL 279 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------------~~~~ 279 (357)
..... ........++..|+|||++.+..++.+ +||||||+++|||++|..|+..... ..+.
T Consensus 160 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 160 QDKEY--YKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCCcc--eeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 21110 011111224456999999988877776 9999999999999998777643221 1112
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 280 KQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 280 ~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+......+....++.++.+||.+|| .+|+.||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 223333444555678999999999999 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=313.94 Aligned_cols=249 Identities=28% Similarity=0.411 Sum_probs=195.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-eEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH-RVY 140 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 140 (357)
..++|.-...||+|+||.||+|.... |..||||.+....... ...|.+|+.++.+++|||+|+++|+|.+.+ ..+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 45678888999999999999999765 4899999775543321 233889999999999999999999999888 599
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 141 IIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERG---VVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
||+||++.|+|.+++.... ++++....+|+.++++||+|||... ||||||||+|||+|+++.+||+|||+++...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999998754 8999999999999999999999854 9999999999999999999999999996432
Q ss_pred cccCCCCCCCCCcc-cCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC---HHHHHH----HHhh---
Q psy7825 216 KCKSGHQSPLSDTF-CGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN---YIQLLK----QVQT--- 284 (357)
Q Consensus 216 ~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~----~i~~--- 284 (357)
.. ... .... .||.+|+|||.+..+..+.+ +||||||+++.||++|+.+.+... ...+.. .+..
T Consensus 229 ~~----~~~-~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~ 302 (361)
T KOG1187|consen 229 EG----DTS-VSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL 302 (361)
T ss_pred cc----ccc-eeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence 10 111 1111 79999999999998888888 999999999999999998887432 111111 1111
Q ss_pred --cccCCCC-CCCC--HH---HHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 285 --KVVFPTE-PNVS--AE---CKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 285 --~~~~~~~-~~~s--~~---~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+..... ...+ .. +..+..+|+ .+|..||+..|+++
T Consensus 303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111111 1233 23 455667899 88999999999754
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=322.14 Aligned_cols=242 Identities=31% Similarity=0.525 Sum_probs=208.0
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 141 (357)
.+.|.+...+|.|+|+.|-.+.+..+++.+++|++.+..... .+|+.++... +||||+++.+.+.+....|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~-------~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN-------QDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccccc-------ccccchhhhhcCCCcceeecceecCCceeee
Confidence 456999999999999999999999999999999997763322 2567555555 69999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE-cCCCcEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI-DGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili-~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|||.+.|+-|.+.+.....+. ..+..|+.+|+.|+.|||++|||||||||+|||+ +..|+++|+|||+++.....
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 999999999999888776555 7888899999999999999999999999999999 58899999999998754221
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhhcccCCCCCCCCHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
..+.+-|..|.|||++....|+.. +||||||++||+||+|+.||...... ++...+... +....+|..++
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~s~~vS~~AK 540 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KFSECVSDEAK 540 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---ccccccCHHHH
Confidence 445667899999999999999988 99999999999999999999876554 444444332 12257999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
+||++|| .||.+||++.+++.||||
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 9999999 899999999999999999
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=300.03 Aligned_cols=241 Identities=27% Similarity=0.448 Sum_probs=204.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
..+|.+.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++..++||||+++++++..+ ..++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 35699999999999999999864 58899999875421 134577899999999999999999998754 47899
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 143 MEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999999999997643 5789999999999999999999999999999999999999999999999998632111
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
......+..|+|||.+.+..++.+ +|+||||+++|+|++ |+.||...+..+....+......+....++..+.
T Consensus 154 -----~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (254)
T cd05083 154 -----VDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227 (254)
T ss_pred -----CCCCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHH
Confidence 112234568999999988887777 999999999999997 9999999888887777766655555567899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhc
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+||.+|| .+|..||++++|+.
T Consensus 228 ~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 228 VLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=299.84 Aligned_cols=247 Identities=20% Similarity=0.321 Sum_probs=198.4
Q ss_pred eeeeecCCeEEEEEEECC---CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE-eCCeEEEEEec
Q psy7825 70 KVIGIGSYATVKLATSTR---HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE-TTHRVYIIMEY 145 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 145 (357)
+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++.+. .+...++|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998643 34679999874322 2222456778999999999999999999765 45668899999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 146 AEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 146 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
+.+++|.+++... ..++...+..++.|++.||.|||+.+++|+||+|+|||++.++.++|+|||++......... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~ 157 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY-SVH 157 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce-eec
Confidence 9999999999764 34677888899999999999999999999999999999999999999999998643211100 001
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...+..+....+......+.+..++..+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 1123345778999999988887777 999999999999999 56778887777777766655555555568999999999
Q ss_pred Hhc-CCCCCCCCHHHHhc
Q psy7825 304 KIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~ll~ 320 (357)
+|| .+|++||++.+|+.
T Consensus 237 ~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 237 SCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHcCCChhhCCCHHHHHH
Confidence 999 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=300.69 Aligned_cols=237 Identities=19% Similarity=0.290 Sum_probs=189.3
Q ss_pred eeeeecCCeEEEEEEECCC------------CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 70 KVIGIGSYATVKLATSTRH------------GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
+.||+|+||.||+|+.... ...+++|++.... ......+.+|+.++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999985322 2358888765432 223455778899999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc-------EEEeecC
Q psy7825 138 RVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN-------IKLSDFG 209 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~-------~kl~Dfg 209 (357)
..++||||+++++|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999998875 456899999999999999999999999999999999999987664 8999999
Q ss_pred CCcccccccCCCCCCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhhccc
Q psy7825 210 FARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVV 287 (357)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~ 287 (357)
++.... ......++..|+|||.+.+ ..++.+ +|||||||++|+|+ .|..||......+.........
T Consensus 158 ~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~- 226 (262)
T cd05077 158 IPITVL---------SRQECVERIPWIAPECVEDSKNLSIA-ADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC- 226 (262)
T ss_pred CCcccc---------CcccccccccccChhhhcCCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc-
Confidence 875331 1123457889999999874 445555 99999999999998 6889988766544433222222
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
......+.++.+||.+|| .||.+||++.+|+++
T Consensus 227 -~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 -MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 222235688999999999 899999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=303.17 Aligned_cols=237 Identities=20% Similarity=0.334 Sum_probs=191.9
Q ss_pred eeeeecCCeEEEEEEECCCCc-------EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 70 KVIGIGSYATVKLATSTRHGC-------DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
+.||+|+||.||+|.+...+. .+|+|.+.... ....+.+.+|+.+++.+.||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999998765443 48888764322 22345677899999999999999999999998999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc--------EEEeecCCCcc
Q psy7825 143 MEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN--------IKLSDFGFARG 213 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~--------~kl~Dfg~~~~ 213 (357)
|||+++|+|.+++..++ .+++..+..++.||+.||+|||+.||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 69999998753
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhhcccCCCC
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFG-RLPFDDTNYIQLLKQVQTKVVFPTE 291 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~ 291 (357)
.. ......++..|+|||++.+.. ++.. +||||||+++|+|++| ..||...+..............|
T Consensus 158 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 225 (258)
T cd05078 158 VL---------PKEILLERIPWVPPECIENPQNLSLA-ADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP-- 225 (258)
T ss_pred cC---------CchhccccCCccCchhccCCCCCCch-hhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCC--
Confidence 21 122345788999999998754 4545 9999999999999998 57777666555444333333333
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
...+.++.+||.+|| .+|.+||++++|++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 347789999999999 899999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.81 Aligned_cols=228 Identities=25% Similarity=0.347 Sum_probs=191.0
Q ss_pred cCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCChHHH
Q psy7825 75 GSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDF 154 (357)
Q Consensus 75 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 154 (357)
|.+|.||+|.+..+|+.||+|.+..... ..+|...+....||||+++++++......++||||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8899999999999999999999865321 22455555666799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCcc
Q psy7825 155 IQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234 (357)
Q Consensus 155 l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~ 234 (357)
+.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|||.+..... ......++..
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~--------~~~~~~~~~~ 147 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--------SCDGEAVENM 147 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc--------ccccCCcCcc
Confidence 98877899999999999999999999999999999999999999999999999998753321 1123345678
Q ss_pred ccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q psy7825 235 YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRI 313 (357)
Q Consensus 235 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rp 313 (357)
|+|||.+.+..++.+ +|+||+|+++|+|++|..||...... +........++.++..+++||.+|| .||.+||
T Consensus 148 y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 148 YCAPEVGGISEETEA-CDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred ccCCcccCCCCCCch-hhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 999999988777776 99999999999999999887643221 1111222334568999999999999 8999999
Q ss_pred CH-----HHHhcCCCC
Q psy7825 314 RL-----KDIKQDPWV 324 (357)
Q Consensus 314 s~-----~~ll~hp~~ 324 (357)
++ ++++.||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.98 Aligned_cols=236 Identities=19% Similarity=0.271 Sum_probs=189.5
Q ss_pred eeeecCCeEEEEEEECCC------------------------CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc
Q psy7825 71 VIGIGSYATVKLATSTRH------------------------GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 126 (357)
.||+|+||.||+|....+ ...|++|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 599999999999974321 2458888875321 2223456688999999999999
Q ss_pred ceeeEEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----
Q psy7825 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY---- 201 (357)
Q Consensus 127 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~---- 201 (357)
+++++++......++||||+++++|..++.+ .+.+++..+..++.||+.||+|||+.||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999975 46789999999999999999999999999999999999997654
Q ss_pred ---cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHH-cCCCCCCCCCHH
Q psy7825 202 ---NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYI 276 (357)
Q Consensus 202 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~ 276 (357)
.++++|||++..... .....++..|+|||.+.+. .++.+ +||||||+++|||+ +|..||......
T Consensus 159 ~~~~~kl~d~g~~~~~~~---------~~~~~~~~~~~aPe~~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS---------REERVERIPWIAPECVPGGNSLSTA-ADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred ccceeeecCCcccccccc---------ccccccCCcccCchhhcCCCCCCcH-HHHHHHHHHHHHHHhCCCCCccccChH
Confidence 379999998753211 1223477889999998764 45555 99999999999985 799999887665
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 277 QLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 277 ~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+...........+. ..+..+.+||.+|| .+|.+||++.+||++
T Consensus 229 ~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 229 EKERFYEKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHhccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 55444443333332 35678999999999 899999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=299.37 Aligned_cols=245 Identities=19% Similarity=0.311 Sum_probs=191.8
Q ss_pred eeeeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccC
Q psy7825 70 KVIGIGSYATVKLATST--RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAE 147 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 147 (357)
+.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||+++++.+.....+++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36999999999999864 34567999987654322 223457789999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 148 KGSLLDFIQREG-----YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 148 ~~~L~~~l~~~~-----~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
+|+|.+++.... ..+...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~---~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE---DY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCc---ce
Confidence 999999997532 3566788899999999999999999999999999999999999999999998632111 11
Q ss_pred CCCCCcccCCccccccceecCCC-------CCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhc--ccCCC--
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVP-------YTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTK--VVFPT-- 290 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~-- 290 (357)
........|+..|+|||++.+.. ++.+ +||||||+++|+|++ |..||......+........ ...+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKE-SNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCcc-chhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 11122345788899999986432 3444 999999999999996 99999877665544332221 11111
Q ss_pred -CCCCCHHHHHHHHHhcCCCCCCCCHHHHhc
Q psy7825 291 -EPNVSAECKTLLSKIFSPIKFRIRLKDIKQ 320 (357)
Q Consensus 291 -~~~~s~~~~~li~~~L~~p~~Rps~~~ll~ 320 (357)
....++.+.+++..|+.+|.+||++++|+.
T Consensus 235 ~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 124688999999999977999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=299.57 Aligned_cols=245 Identities=18% Similarity=0.322 Sum_probs=191.8
Q ss_pred eeeecCCeEEEEEEECC--CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 71 VIGIGSYATVKLATSTR--HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
.||+|+||.||+|.... ....+|+|.+.... .......+.+|+..++.++||||+++++.+.....+++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 59999999999997532 34568888764322 233345577899999999999999999999999999999999999
Q ss_pred CChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 149 GSLLDFIQREG-----YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 149 ~~L~~~l~~~~-----~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED---YY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch---he
Confidence 99999997642 24677889999999999999999999999999999999999999999999986321110 00
Q ss_pred CCCCcccCCccccccceecC-------CCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhccc--CC---C
Q psy7825 224 PLSDTFCGSYAYASPEILKG-------VPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVV--FP---T 290 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~--~~---~ 290 (357)
.......++..|+|||++.. ..++.+ +|||||||++|+|++ |..||......+....+..... .+ .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~-~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK-SNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchh-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence 11123345678999999743 233444 999999999999998 8899988777666555433222 11 1
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCHHHHhcC
Q psy7825 291 EPNVSAECKTLLSKIFSPIKFRIRLKDIKQD 321 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L~~p~~Rps~~~ll~h 321 (357)
...++..+.+++..|+.||.+||++++|++-
T Consensus 236 ~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 236 DLKYSDRWYEVMQFCWLDPETRPTAEEVHEL 266 (269)
T ss_pred cccCCHHHHHHHHHHhcCcccccCHHHHHHH
Confidence 2368899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=301.03 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=205.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECC----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--C
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTR----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--T 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 136 (357)
..+|.+.+.||+|+||.||+|.... ++..||||++...... .....+.+|+.+++.+.||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3468889999999999999998643 4789999998654432 335668899999999999999999999877 5
Q ss_pred CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
...++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 68999999999999999997654 58999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC---------------HHHHHH
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN---------------YIQLLK 280 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---------------~~~~~~ 280 (357)
..... ........++..|+|||.+.+..++.. +||||||+++|+|++|..||.... ......
T Consensus 161 ~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 161 EDKDY--YYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred cCCcc--eeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 11110 111112234567999999988877777 999999999999999999986532 122233
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+......+.+..++.++.+|+.+|| .+|.+||++.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 34444455555678899999999999 89999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=336.07 Aligned_cols=255 Identities=25% Similarity=0.486 Sum_probs=201.7
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC--------
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT-------- 136 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-------- 136 (357)
+|+.+++||+||||.||+|+++-+|+.||||.+.... .+.....+.+|+.+|.+|+|||||+++..|...
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 5888999999999999999999999999999986544 334455577999999999999999998322000
Q ss_pred --------------------------------------------------------------------------------
Q psy7825 137 -------------------------------------------------------------------------------- 136 (357)
Q Consensus 137 -------------------------------------------------------------------------------- 136 (357)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q psy7825 137 -------------------------------HRVYIIMEYAEKGSLLDFIQREGYI-DEPRTKKWFRQLVDAIDYCHERG 184 (357)
Q Consensus 137 -------------------------------~~~~lv~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~~i~~~l~~LH~~~ 184 (357)
..+||-||||+..+|.+++.++... ....+|.++.+|++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 1268889999997777777766544 47889999999999999999999
Q ss_pred ceecCCCCCCEEEcCCCcEEEeecCCCcccc-------------cccCCCCCCCCCcccCCccccccceecCCC---CCC
Q psy7825 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHM-------------KCKSGHQSPLSDTFCGSYAYASPEILKGVP---YTP 248 (357)
Q Consensus 185 ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~-------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ 248 (357)
||||||||.||+++.++.|||+|||++.... ....+......+..+||.-|+|||++.+.. |+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998521 011112222445678999999999997765 666
Q ss_pred CcccHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhhcccCCCC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy7825 249 HYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTKVVFPTE----PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDP 322 (357)
Q Consensus 249 ~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~----~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp 322 (357)
+ +||||||+|++||+. ||.. +.-..++..++ ....|.+ ..--+.-+.+|++|| .||.+||||.|||.+.
T Consensus 798 K-iDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 798 K-IDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred h-hhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 6 999999999999994 5653 33444555555 3333333 223356788999999 8999999999999999
Q ss_pred CCCC
Q psy7825 323 WVKT 326 (357)
Q Consensus 323 ~~~~ 326 (357)
||..
T Consensus 873 llpp 876 (1351)
T KOG1035|consen 873 LLPP 876 (1351)
T ss_pred CCCc
Confidence 9986
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.41 Aligned_cols=250 Identities=25% Similarity=0.447 Sum_probs=207.8
Q ss_pred CeEEceeeeecCCeEEEEEEECC-CCcEEEEEEeecCCC-------CchHHhhhHHHHHHHHHc-CCCCCcceeeEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTR-HGCDVAVKVVSKVEA-------PPDYLKKFLPREIDVVKG-LRHPNLIRFLQAIET 135 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~ 135 (357)
+|.+.+.||+|+||.||+|.+.. .++.+|+|.+..... ........+.+|+.++.. ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999887 678999998854321 122223445578887765 789999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
++..++||||++|++|.+++.. ...+++..++.++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998853 3468999999999999999999996 7899999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT 290 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 290 (357)
+....... ......|+..|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+.......+......+.
T Consensus 161 ~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd08528 161 AKQKQPES------KLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233 (269)
T ss_pred eeeccccc------ccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence 86432211 2234568899999999988877766 9999999999999999999988887777766655544443
Q ss_pred C-CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 291 E-PNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 291 ~-~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
. ..++..+.+||.+|| .||.+||++.++.++
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 3 268899999999999 899999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=296.63 Aligned_cols=251 Identities=18% Similarity=0.349 Sum_probs=204.0
Q ss_pred eEEceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----
Q psy7825 66 YVLGKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH----- 137 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 137 (357)
|.+.+.||+|+||.||+|.+. .++..||||++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567889999999999999864 35789999998654333 223455778999999999999999999885432
Q ss_pred -eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 138 -RVYIIMEYAEKGSLLDFIQRE------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 138 -~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
..+++++|+.+|+|.+++... ..++...++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347889999999999887532 2478899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCC
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFP 289 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 289 (357)
++...... .........+++.|++||.+.+..++.+ +|||||||++|+|++ |..||.+.+..+....+.......
T Consensus 160 ~~~~~~~~---~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 160 SKKIYSGD---YYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccCCc---ceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 87442211 1111122345678999999988877776 999999999999998 899998888777777666554455
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 290 TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 290 ~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
..+.++..+.+++.+|| .+|..||++.+++..
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55678899999999999 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=295.78 Aligned_cols=234 Identities=20% Similarity=0.292 Sum_probs=190.8
Q ss_pred eeeeecCCeEEEEEEECCCC----------cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 70 KVIGIGSYATVKLATSTRHG----------CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
+.||+|+||.||+|.+..++ ..+++|++...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999987766 35777876433221 4557789999999999999999999887 778
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-------cEEEeecCCC
Q psy7825 140 YIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-------NIKLSDFGFA 211 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-------~~kl~Dfg~~ 211 (357)
++||||+++++|.+++.... .++...+..++.||+.||.|||+.||+|+||||+|||++.++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998765 789999999999999999999999999999999999999887 7999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCC--CCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccC
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV--PYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVF 288 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~ 288 (357)
..... .....++..|+|||++.+. .++.+ +||||||+++|+|++ |..||...+..............
T Consensus 156 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~-~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 225 (259)
T cd05037 156 ITVLS---------REERVERIPWIAPECIRNGQASLTIA-ADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL 225 (259)
T ss_pred ccccc---------ccccccCCCccChhhhcCCCCCcchh-hHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCC
Confidence 74321 2234467789999999776 55555 999999999999999 68888776544433333322222
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 289 PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 289 ~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.+ ....+.+||.+|| .+|.+||++.++++
T Consensus 226 ~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 226 PMP--DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCC--CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222 3489999999999 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=296.21 Aligned_cols=256 Identities=16% Similarity=0.242 Sum_probs=191.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCc--hHH------hhhHHHHHHHHHcCCCCCccee
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPP--DYL------KKFLPREIDVVKGLRHPNLIRF 129 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~--~~~------~~~~~~E~~~l~~l~h~~iv~~ 129 (357)
+...+|.+.+.||+|+||.||+|.+..+ +..+|+|+........ +.. ......+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4456799999999999999999998777 6677888643222111 000 0011133345566789999999
Q ss_pred eEEEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEE
Q psy7825 130 LQAIETTH----RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKL 205 (357)
Q Consensus 130 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl 205 (357)
++++.... ..+++++++.. ++.+.+......++..++.++.|++.||.|||+.+|+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765543 45778888744 78887776666789999999999999999999999999999999999999999999
Q ss_pred eecCCCcccccccCCC--CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-HHHHH---
Q psy7825 206 SDFGFARGHMKCKSGH--QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN-YIQLL--- 279 (357)
Q Consensus 206 ~Dfg~~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~--- 279 (357)
+|||+++.+....... .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.. .....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999997553211110 1111233469999999999998888877 999999999999999999998763 22222
Q ss_pred -----HHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 280 -----KQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 280 -----~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+..... ..+.++..+.++++.|+ .+|++||++.+|++
T Consensus 247 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22221111 12357899999999999 89999999999975
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=291.34 Aligned_cols=244 Identities=19% Similarity=0.296 Sum_probs=190.2
Q ss_pred eeeecCCeEEEEEEECCC--CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 71 VIGIGSYATVKLATSTRH--GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
.||+|+||.||+|..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 599999999999975432 23466666543322 22355677999999999999999999999999999999999999
Q ss_pred CChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 149 GSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 149 ~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|+|.+++.+. ..++...++.++.||+.||.|||+.+++|+||||+|||++.++.++|+|||++...... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~---~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE---DYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc---hhhh
Confidence 9999999764 23567778899999999999999999999999999999999999999999987532110 0111
Q ss_pred CCCcccCCccccccceecCC-------CCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhccc-----CCCC
Q psy7825 225 LSDTFCGSYAYASPEILKGV-------PYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVV-----FPTE 291 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~-----~~~~ 291 (357)
.....+|+..|+|||++... .++.+ +||||||+++|+|++ |..||...+..+....+..... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~-~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKP-SNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCc-chhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 12345688899999998532 23344 999999999999996 5779987777666665432211 1122
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCHHHHhc
Q psy7825 292 PNVSAECKTLLSKIFSPIKFRIRLKDIKQ 320 (357)
Q Consensus 292 ~~~s~~~~~li~~~L~~p~~Rps~~~ll~ 320 (357)
..+++.+.+++..||.+|.+||++.+|++
T Consensus 236 ~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 236 LPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred CCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 35789999999999977999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.07 Aligned_cols=254 Identities=23% Similarity=0.409 Sum_probs=219.1
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEe-----C
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIET-----T 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-----~ 136 (357)
.+-|++.++||.|.+|.||+++.+.+|+.+|+|+.......+ +.++.|.++|+.+ .|||++.++|+|.. +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 345999999999999999999999999999999987655443 3455788899888 49999999999853 5
Q ss_pred CeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
+.+|||||||.||+..|+++. ...+.|..+..|+..++.||.+||.+.++|||||-.|||++.++.|||+|||.+..+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 689999999999999999975 467999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCCCCCCCcccCCccccccceec-----CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILK-----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP 289 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 289 (357)
.. ....+.+++|||.|||||++. ...|+.+ +|+||||++..||.-|.+|+-+..+...+-.|-......
T Consensus 174 ds-----T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 174 DS-----TVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred ec-----ccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 32 233466889999999999994 3456666 999999999999999999999988887777765443322
Q ss_pred --CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 290 --TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 290 --~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
.+...++++.+||..|| +|.++||+..++|.|||++.
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 24578999999999999 99999999999999999994
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=321.15 Aligned_cols=262 Identities=23% Similarity=0.380 Sum_probs=228.7
Q ss_pred cccccccccccCeEEceeeeecCCeEEEEEEECCCC---cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceee
Q psy7825 54 VKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHG---CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFL 130 (357)
Q Consensus 54 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 130 (357)
+......++.....|.++||.|.||.|++|+.+..| ..||||.++... .+..+..|..|+.+|-+++||||+++.
T Consensus 619 vreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 619 VREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred HHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 344455667778899999999999999999987766 559999886433 333466688999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecC
Q psy7825 131 QAIETTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFG 209 (357)
Q Consensus 131 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg 209 (357)
|+......+.||.|||++|+|..||+.+ +.|+..++..+++.|+.||+||-++|+|||||...||||+.+..+|++|||
T Consensus 697 GVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 697 GVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred EEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccc
Confidence 9999999999999999999999999875 679999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhhcccC
Q psy7825 210 FARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVVF 288 (357)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~ 288 (357)
+++.+.... ..........-..+|.|||.+...++++. +||||+|++|||.+ .|..||=+....+.++.|..+++.
T Consensus 777 LSRvledd~--~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL 853 (996)
T KOG0196|consen 777 LSRVLEDDP--EAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL 853 (996)
T ss_pred ceeecccCC--CccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHHHHhccCC
Confidence 998653322 11111111223579999999999999988 99999999999977 699999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 289 PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 289 ~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
|.+..||..+.+|+..|| +|-.+||.+.||+.
T Consensus 854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 999999999999999999 89999999999986
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=287.34 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=214.9
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe------
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------ 135 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 135 (357)
....|+-...||+|.||.||+|+.+.+|+.||+|++-........... ..+|+.+|..|+|+|++.+++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpit-alreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPIT-ALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHH-HHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 344588888999999999999999999999999876432222222223 3489999999999999999887632
Q ss_pred --CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 136 --THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 136 --~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
...+|+||.+|+. +|..++... .+++..++.+++.+++.||.|+|.+.|+|||+|+.|+||+.+|.++|+|||+++
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 3458999999987 999999754 679999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh---cccCC
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT---KVVFP 289 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~ 289 (357)
.+......... .....+-|..|++||.+.|..-+....|||+.|||+.||+|+.+-|.++...+.+..|.. .....
T Consensus 173 ~fs~~~n~~kp-rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 173 AFSTSKNVVKP-RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred ceecccccCCC-CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 77554444333 344566799999999998876555559999999999999999999999887776665532 11111
Q ss_pred CC-------------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 290 TE-------------------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 290 ~~-------------------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+ -.-+++..+|+..|| .||.+|++++++|.|.||...+-+
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 11 122568899999999 899999999999999999987666
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=306.29 Aligned_cols=254 Identities=22% Similarity=0.375 Sum_probs=217.5
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+......+.+.||+|.||.|.+++... +..||||.++... .......|.+|+.+|.+|+||||+.++|+|..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 4455678899999999999999998553 6999999986533 233367788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
++|+||++.|+|.+|+.++. .+.......++.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l--- 687 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL--- 687 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc---
Confidence 99999999999999998863 3455667789999999999999999999999999999999999999999999844
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHH--cCCCCCCCCCHHHHHHHHhhcc-------cC
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA--FGRLPFDDTNYIQLLKQVQTKV-------VF 288 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~i~~~~-------~~ 288 (357)
..+.........+-..+|||||.+..++++.+ +|+|+||+++||++ +...||.....++..+.....+ ..
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 23334444556667889999999999999988 99999999999987 5789999999988888765432 33
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 289 PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 289 ~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+.++-++..+.+||.+|| .+-++||++++|-.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 445689999999999999 89999999999854
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=286.05 Aligned_cols=267 Identities=27% Similarity=0.363 Sum_probs=210.8
Q ss_pred ccccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHH-HHcCCCCCcceeeEEE
Q psy7825 55 KKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV-VKGLRHPNLIRFLQAI 133 (357)
Q Consensus 55 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~ 133 (357)
......+...+.+-+..||.|+||+|++..++.+|+..|||.++...... ....+..|.+. ++.-++||||+++|++
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k--eq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK--EQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH--HHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 34444566666777889999999999999999999999999997654422 24445566664 4455799999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEee
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQR-----EGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSD 207 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~D 207 (357)
..++.+|+.||.+.- +|..+-.. +..++|..+-.|....+.||.||-. ..|||||+||+|||++..|.+||||
T Consensus 133 F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 133 FSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred hcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence 999999999999965 77665542 4569999999999999999999985 4899999999999999999999999
Q ss_pred cCCCcccccccCCCCCCCCCcccCCccccccceecC--CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhh
Q psy7825 208 FGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG--VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQVQT 284 (357)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~ 284 (357)
||.+..+. .+.......|-..|||||.+.. ..|+.+ +|+||||++|||+.||..||.+-+. .+.+.++..
T Consensus 212 FGIcGqLv------~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 212 FGICGQLV------DSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI 284 (361)
T ss_pred ccchHhHH------HHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence 99986543 2233445568889999999954 346666 9999999999999999999986432 333333322
Q ss_pred -ccc---CCCC-CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 285 -KVV---FPTE-PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 285 -~~~---~~~~-~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
... ++.. -.++..+..||..|| +|-..||...+++++||++......
T Consensus 285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~ 337 (361)
T KOG1006|consen 285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG 337 (361)
T ss_pred CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence 111 1111 258999999999999 9999999999999999999875543
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=310.13 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=229.6
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCC-C--cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRH-G--CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
+|..++..+.+.||+|.||.|++|.++.- | ..||||+++...... ....|.+|+.+|..|+|+|++++||+..+
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 45566788899999999999999998653 3 558999997654443 46678899999999999999999999887
Q ss_pred CeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
....+|+|++++|+|.+.|++ ...|....+..|+.||+.||.||..+++|||||...|+|+-....+||+|||+.+.+
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 778899999999999999987 356888899999999999999999999999999999999999999999999999876
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
...... ..+.....-...|.|||.+...+++.. +|||++|+++|||++ |..||.+....++++.|..+...+.++.
T Consensus 263 g~ned~--Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~ 339 (1039)
T KOG0199|consen 263 GENEDM--YVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKY 339 (1039)
T ss_pred CCCCcc--eEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCC
Confidence 543332 222233334568999999999999988 999999999999996 8999999999999999999999999999
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
|++++.+++..|| .+|.+||++..|.+.-++.....-
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~ 377 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPA 377 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCc
Confidence 9999999999999 899999999999887777765544
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=302.58 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=216.1
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCC----CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRH----GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
-.+..+...+.++||.|.||.||.|.+..- .-.||||..+.....++ .+.|..|..+|+.++||||++++|+|.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeee
Confidence 344455566678999999999999987432 34588998865443333 667889999999999999999999997
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
+ ...|+|||.++.|.|..+++.+ ..++......++.||+.||.|||+..+|||||...||||...-.+||+|||+++.
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 5 5689999999999999999875 5689999999999999999999999999999999999999999999999999986
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhhcccCCCCC
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVVFPTEP 292 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 292 (357)
....... ......-...|||||.+.-..++.. +|||.||+.+||++ .|..||.+....+.+-.+..+.+.|.++
T Consensus 541 ~ed~~yY----kaS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~ 615 (974)
T KOG4257|consen 541 LEDDAYY----KASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP 615 (974)
T ss_pred ccccchh----hccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC
Confidence 5322111 1112224568999999998888887 99999999999988 6999999998888888888999999999
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+||+.+..|+.+|| .+|.+||.+.+|..
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 99999999999999 99999999988764
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=301.64 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=220.4
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..++..+..+.+.||-|.||.||.|.+++..-.||||.++.... ..+.|..|+.+|+.++|||+|+++|+|..+..
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 34455567788899999999999999999999999998854322 25667799999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+|||+|||..|+|.++|++.. -++...++.++.||..||+||..+++|||||...|+||.++..+|++|||+++....
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999999998754 367778889999999999999999999999999999999999999999999985532
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s 295 (357)
... -.....--...|.|||.+....++.+ +|||+||++|||+.| |-.||.+.+..+.+..+..+++...+.+|+
T Consensus 418 DTY----TAHAGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 418 DTY----TAHAGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred Cce----ecccCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCC
Confidence 211 11122223568999999999999988 999999999999996 889999999999999999999988889999
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHh
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIK 319 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll 319 (357)
+.+.+|++.|| +.|.+||++.++-
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHH
Confidence 99999999999 9999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=313.70 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=179.5
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCC----CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEE---
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRH----GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA--- 132 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~--- 132 (357)
.+..++|.+.+.||+|+||.||+|.+..+ +..||+|.+....... ....+ .+....+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhc
Confidence 44567899999999999999999999988 8999999875422111 11111 1122222222222221
Q ss_pred ---EEeCCeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7825 133 ---IETTHRVYIIMEYAEKGSLLDFIQREGY--------------------IDEPRTKKWFRQLVDAIDYCHERGVVHRD 189 (357)
Q Consensus 133 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~i~~~i~~~l~~LH~~~ivH~d 189 (357)
......+++|+||+.+++|.+++..... .....+..++.||+.||.|||+.||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2456689999999999999999975421 11334668999999999999999999999
Q ss_pred CCCCCEEEcC-CCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCC----------------------C
Q psy7825 190 IKCENLLIDG-EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP----------------------Y 246 (357)
Q Consensus 190 lkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~ 246 (357)
|||+|||++. ++.+||+|||+++..... ........+|++.|+|||.+.... +
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~----~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVG----INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccc----cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999986 579999999999744221 112234567899999999764322 2
Q ss_pred CCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc----------cc----------CCCCCCCCHHHHHHHHHhc
Q psy7825 247 TPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK----------VV----------FPTEPNVSAECKTLLSKIF 306 (357)
Q Consensus 247 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------~~----------~~~~~~~s~~~~~li~~~L 306 (357)
..+ +|||||||++|||+++..|+... .......+... .. +...+..+...++||.+||
T Consensus 357 ~~k-~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 357 PDR-FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCC-cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 223 69999999999999987775432 11111111100 00 0011123445679999999
Q ss_pred -CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 307 -SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 307 -~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.||++||++.++|+||||++....
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCcc
Confidence 999999999999999999986553
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=278.91 Aligned_cols=240 Identities=34% Similarity=0.655 Sum_probs=205.8
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCChHHHH
Q psy7825 76 SYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI 155 (357)
Q Consensus 76 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 155 (357)
+||.||+|....+|+.+|+|++........ ...+.+|+..++.++|+||+++++.+......++++|++++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998899999999865443322 456789999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccc
Q psy7825 156 QREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235 (357)
Q Consensus 156 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y 235 (357)
.....++...++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... ......++..|
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~ 152 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------LLTTFVGTPEY 152 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc------ccccccCCcCC
Confidence 887668999999999999999999999999999999999999999999999999987542211 23345688899
Q ss_pred cccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhhcccCCCCCC--CCHHHHHHHHHhc-CCCCC
Q psy7825 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTKVVFPTEPN--VSAECKTLLSKIF-SPIKF 311 (357)
Q Consensus 236 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~--~s~~~~~li~~~L-~~p~~ 311 (357)
+|||.+.+..++.+ +|+|+||+++|+|++|..||.. .+.......+........... ++.++.+++.+|| .+|.+
T Consensus 153 ~~pE~~~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 231 (244)
T smart00220 153 MAPEVLLGKGYGKA-VDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEK 231 (244)
T ss_pred CCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchh
Confidence 99999988888876 9999999999999999999987 555555555544433332222 8899999999999 89999
Q ss_pred CCCHHHHhcCCCC
Q psy7825 312 RIRLKDIKQDPWV 324 (357)
Q Consensus 312 Rps~~~ll~hp~~ 324 (357)
||++.++++||||
T Consensus 232 Rp~~~~~~~~~~~ 244 (244)
T smart00220 232 RLTAEEALQHPFF 244 (244)
T ss_pred ccCHHHHhhCCCC
Confidence 9999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=300.62 Aligned_cols=263 Identities=19% Similarity=0.191 Sum_probs=189.6
Q ss_pred ccccCeEEceeeeecCCeEEEEEEEC----------------CCCcEEEEEEeecCCCCch-----------HHhhhHHH
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATST----------------RHGCDVAVKVVSKVEAPPD-----------YLKKFLPR 113 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~-----------~~~~~~~~ 113 (357)
...++|.+.++||+|+||.||+|... ..++.||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45778999999999999999999742 2356899999854321100 01122335
Q ss_pred HHHHHHcCCCCCc-----ceeeEEEEe--------CCeEEEEEeccCCCChHHHHHhc----------------------
Q psy7825 114 EIDVVKGLRHPNL-----IRFLQAIET--------THRVYIIMEYAEKGSLLDFIQRE---------------------- 158 (357)
Q Consensus 114 E~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~---------------------- 158 (357)
|+.++..++|.++ ++++++|.. ....++||||+++++|.+++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777788876554 566676642 35689999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCcccc
Q psy7825 159 --GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236 (357)
Q Consensus 159 --~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~ 236 (357)
..++...++.++.|++.+|.|||+.+|+||||||+|||++.++.++|+|||++....... ........+++.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~----~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI----NFNPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC----ccCccccCCCccee
Confidence 123556788899999999999999999999999999999999999999999986432111 11111233578999
Q ss_pred ccceecCCCCC---------------------CCcccHHHHHHHHHHHHcCCC-CCCCCCHHH-H----------HHH-H
Q psy7825 237 SPEILKGVPYT---------------------PHYSDVWSMGVVLYAMAFGRL-PFDDTNYIQ-L----------LKQ-V 282 (357)
Q Consensus 237 aPE~~~~~~~~---------------------~~~~DiwslG~il~ell~g~~-pf~~~~~~~-~----------~~~-i 282 (357)
|||++...... ....||||+||++|+|++|.. ||.+..... . ... .
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 99998543211 112699999999999999975 775422111 0 111 1
Q ss_pred hhcccCCCCCCCCHHHHHHHHHhc-CCC---CCCCCHHHHhcCCCCCCC
Q psy7825 283 QTKVVFPTEPNVSAECKTLLSKIF-SPI---KFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 283 ~~~~~~~~~~~~s~~~~~li~~~L-~~p---~~Rps~~~ll~hp~~~~~ 327 (357)
.....++..+.+++..++|+.+|| .+| .+|+|++|+|+||||.+.
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 123345555678999999999999 654 679999999999999764
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=306.02 Aligned_cols=202 Identities=32% Similarity=0.500 Sum_probs=171.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe------C
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------T 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 136 (357)
+.-|...+.||+|+||.||+++++.+|+.||||.+++...... .+...+|+++|++++|+|||+++++-+. .
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~--~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP--RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccch--HHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 3558899999999999999999999999999999976543332 4556689999999999999999987544 3
Q ss_pred CeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCc--EEEeecC
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE---GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG--EYN--IKLSDFG 209 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~--~~~--~kl~Dfg 209 (357)
+...+|||||.||+|...+++- ..+++.+.+.++.+++.||.|||++||+||||||.||++-. +|+ -||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 3568999999999999999762 34999999999999999999999999999999999999843 343 5999999
Q ss_pred CCcccccccCCCCCCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Q psy7825 210 FARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDT 273 (357)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~ 273 (357)
.|+.+.. .......+||+.|.+||++.. ..|+.. +|.|||||++|+++||..||...
T Consensus 170 ~Arel~d------~s~~~S~vGT~~YLhPel~E~q~~y~~t-VDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 170 AARELDD------NSLFTSLVGTEEYLHPELYERQKKYTAT-VDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccccCCC------CCeeeeecCchhhcChHHHhhccCcCce-eehhhhhhHHHHHhccCCCCCcC
Confidence 9985532 235667889999999999985 566665 99999999999999999999643
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=311.48 Aligned_cols=254 Identities=27% Similarity=0.384 Sum_probs=200.4
Q ss_pred ccCeEEceeeeecCCeE-EEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEE
Q psy7825 63 NHGYVLGKVIGIGSYAT-VKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 140 (357)
..-|...+++|.|+.|+ ||+|... |+.||||.+-. .......+|+..|+..+ ||||+++++.-.++.+.|
T Consensus 508 k~~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y 579 (903)
T KOG1027|consen 508 KLFFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY 579 (903)
T ss_pred eeeeccHHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence 33466778899999886 7999876 88999997632 22455679999999995 999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---C--CcEEEeecCCC
Q psy7825 141 IIMEYAEKGSLLDFIQREG----YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG---E--YNIKLSDFGFA 211 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~---~--~~~kl~Dfg~~ 211 (357)
|..|.|.. +|.+++...+ .......+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||++
T Consensus 580 IalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 580 IALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99999977 9999998631 1122456889999999999999999999999999999976 3 45899999999
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcC-CCCCCCCCHHHH--HHHHhhcccC
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFG-RLPFDDTNYIQL--LKQVQTKVVF 288 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~--~~~i~~~~~~ 288 (357)
+.+....... ....+..||.+|+|||++........ +|||||||++|+.++| .+||.+.-..+. +.........
T Consensus 659 Kkl~~~~sS~--~r~s~~sGt~GW~APE~L~~~~~~~a-vDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 659 KKLAGGKSSF--SRLSGGSGTSGWQAPEQLREDRKTQA-VDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHL 735 (903)
T ss_pred cccCCCcchh--hcccCCCCcccccCHHHHhccccCcc-cchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeee
Confidence 8765443332 22567789999999999988777665 9999999999999986 899987543321 1111122222
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 289 PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 289 ~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
... -..++++||.+|+ .+|..||+|.+||.||+|=+...+
T Consensus 736 ~~~--~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 736 EPL--PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR 776 (903)
T ss_pred ccC--chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence 222 2229999999999 899999999999999999876544
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=280.04 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=211.4
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe----
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET---- 135 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 135 (357)
.....+|.-+..+|.|.- .|..|.+.-.+++||+|.+......... .....+|..++..+.|+||++++.+|.-
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~-akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH-AKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc-chhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 344567999999999999 8888999999999999988655333222 3445589999999999999999998843
Q ss_pred --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 136 --THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 136 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
...+|+|||++.. +|...+... ++...+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+++.
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~~e--lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVILME--LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHHHh--cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 3468999999965 999988743 78899999999999999999999999999999999999999999999999973
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC--
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE-- 291 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-- 291 (357)
. . ........+.|..|.|||++.+..+... +||||+||++.||++|+..|.+.+..+...++...+..|.+
T Consensus 168 e-----~-~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 168 E-----D-TDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred c-----C-cccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 2 1 2234456678999999999999998888 99999999999999999999988776666655443322221
Q ss_pred ---------------------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 292 ---------------------------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 292 ---------------------------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
+.-+..+++|+.+|| .+|++|.+++++|+|||++
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 234578999999999 8999999999999999997
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=278.64 Aligned_cols=136 Identities=26% Similarity=0.425 Sum_probs=117.0
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-----C---CCcce
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-----H---PNLIR 128 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~ 128 (357)
....+...+|.+.++||+|.|++||+|.+..+.+.||+|+++.. +...+....|+.+|++++ | ..||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 34556678999999999999999999999999999999998653 334455668999999884 2 36999
Q ss_pred eeEEEEe----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEE
Q psy7825 129 FLQAIET----THRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLI 197 (357)
Q Consensus 129 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili 197 (357)
+++.|.. +.++|+|+|++ |.+|..+|... ..++...++.|+.||+.||.|||.. ||||.||||+|||+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 9999964 56899999999 66999999874 3489999999999999999999965 99999999999999
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=276.90 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=210.0
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----eE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH-----RV 139 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 139 (357)
+.+..+.||.|+||.||.+++..+|+.||+|.+......-.. .+.+-+|+.+|..++|.|++..++..+-.. .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s-~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLAS-CKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHH-HHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 345567999999999999999999999999987554333222 233458999999999999999887764332 46
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+++|.+.. +|..++-.-.+++...++-+++||++||+|||+.+|.||||||.|+|++.+..+||||||+++...
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee---- 207 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD---- 207 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc----
Confidence 778888865 888888888889999999999999999999999999999999999999999999999999998432
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC--------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE-------- 291 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------- 291 (357)
..........+-|.+|+|||+++|...++.+.||||+|||+.||+..+..|...++.+.++.|...+..|.-
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 222223334456889999999999888878799999999999999999999988888777766543333321
Q ss_pred -------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 292 -------------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 292 -------------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
..-..+...++..+| .||..|.+..+.+.|+++....
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 133457778888888 8999999999999999998754
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=287.96 Aligned_cols=251 Identities=25% Similarity=0.442 Sum_probs=206.5
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC------CCCcceeeEEEEeC
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR------HPNLIRFLQAIETT 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 136 (357)
..+|.+....|+|-|++|..|.+..-|..||||++...+. ....=..|+++|++|+ .-++++++..|...
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 4678999999999999999999999999999999976332 2334448999999995 34789999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecCCCc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-NIKLSDFGFAR 212 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-~~kl~Dfg~~~ 212 (357)
+++|||||.+. .+|.+++.+.| .|....++.++.|++.||..|-..||+|.||||.||||++.. .+||||||.|.
T Consensus 507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 99999999985 49999998754 478889999999999999999999999999999999998774 57999999985
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc-ccCCCC
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-VVFPTE 291 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~ 291 (357)
.... .. ...+.-+..|.|||++.|.+|+.. .|+||+||+||||.||+..|.+....+++...+.. ..+|..
T Consensus 586 ~~~e------ne-itPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 586 FASE------NE-ITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred cccc------cc-ccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 3211 11 112223557999999999999988 99999999999999999999998888877654321 111110
Q ss_pred ----------------------------------------------------------CCCCHHHHHHHHHhc-CCCCCC
Q psy7825 292 ----------------------------------------------------------PNVSAECKTLLSKIF-SPIKFR 312 (357)
Q Consensus 292 ----------------------------------------------------------~~~s~~~~~li~~~L-~~p~~R 312 (357)
+.+-..+++|+..|| -||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 112357899999999 899999
Q ss_pred CCHHHHhcCCCCCC
Q psy7825 313 IRLKDIKQDPWVKT 326 (357)
Q Consensus 313 ps~~~ll~hp~~~~ 326 (357)
.+..|+|.||||+.
T Consensus 738 it~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 738 ITVNQALKHPFITE 751 (752)
T ss_pred CCHHHHhcCCcccC
Confidence 99999999999985
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=259.41 Aligned_cols=252 Identities=25% Similarity=0.446 Sum_probs=200.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEe--CCe
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIET--THR 138 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~ 138 (357)
..++|++.+.+|+|.|+.||.|....+++.++||+++.- .++.+.+|+.+|..|. ||||+++++...+ ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 356799999999999999999999999999999998642 2566889999999997 9999999998865 446
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~ 217 (357)
..+|+||+.+.+...+.. .++...++.++.+++.||.|+|++||+|||+||.|++|+.. ..++|+|||+|..+.
T Consensus 110 paLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-- 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-- 184 (338)
T ss_pred chhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC--
Confidence 789999998866666553 48899999999999999999999999999999999999865 579999999996432
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHhhc-----------
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-DTNYIQLLKQVQTK----------- 285 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~----------- 285 (357)
.....+..+.+..|--||.+.......-.-|+|||||++..|+..+.||- +.+..+.+-+|...
T Consensus 185 ----p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 ----PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred ----CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 22223455678899999999776555444899999999999999999983 33322222222110
Q ss_pred ---ccCC---------------------C-CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 286 ---VVFP---------------------T-EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 286 ---~~~~---------------------~-~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
...+ . ....++++.+|+..+| .|-.+|+|+++++.||||....
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 0000 0 0235799999999999 8999999999999999998743
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=295.61 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=214.8
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEEC---C----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCccee
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATST---R----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRF 129 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~---~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~ 129 (357)
...+..++..+.+.||+|.||.|++|... . ....||||........ ...+.+..|+.+|+.+. |+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 34455556677889999999999999743 1 1467999988654443 33677889999999995 9999999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7825 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCE 193 (357)
Q Consensus 130 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~ 193 (357)
+|++...+.+++|.||+..|+|.++++..+ .++..+.+.++.||+.|++||++.+++||||...
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998765 4889999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeecCCCcccccccCCCCCCCCCccc--CCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCC
Q psy7825 194 NLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFC--GSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPF 270 (357)
Q Consensus 194 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf 270 (357)
|||+..+..+||+|||+++....... ....... -...|||||.+....++.+ +||||+|+++||+++ |..||
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~----y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDY----YRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCc----eEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCC
Confidence 99999999999999999974321111 1001111 2346999999999888888 999999999999996 88999
Q ss_pred CCCC-HHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 271 DDTN-YIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 271 ~~~~-~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+.. ..++.+.+..+.+...+..+++++.++++.|| .+|++||++.++..
T Consensus 523 p~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 9866 67777888888888888899999999999999 89999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.77 Aligned_cols=236 Identities=21% Similarity=0.296 Sum_probs=186.1
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|...++||+|+||.||+|.+..+|..||||.+...... ...|+..+++++||||+++++++......++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 356677899999999999999889999999988643221 1256889999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH---ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|+++|+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 9999999999963 789999999999999999999 6699999999999999998888775 66543211
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHhhc-----c---cC
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN-----YIQLLKQVQTK-----V---VF 288 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~-----~---~~ 288 (357)
......|++.|+|||++.+..++.+ +|||||||++|||++|+.||.... ..+........ . ..
T Consensus 834 ---~~~~~~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 834 ---TDTKCFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ---cCCCccccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence 1123368899999999998888877 999999999999999999985321 11111110000 0 00
Q ss_pred ----CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 289 ----PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 289 ----~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+.......++.+++.+|| .+|.+||++.++++.
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 001112236778999999 899999999999875
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.96 Aligned_cols=202 Identities=34% Similarity=0.583 Sum_probs=179.7
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHh-----hhHHHHHHHHHcCC---CCCcceeeEEEEe
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLK-----KFLPREIDVVKGLR---HPNLIRFLQAIET 135 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~---h~~iv~~~~~~~~ 135 (357)
.+|...+.+|.|+||.|++|.++.+...|+||.+.+...-.+... -.+..|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 359999999999999999999999999999999977544333222 23567999999997 9999999999999
Q ss_pred CCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEY-AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
++++|++||- -+|.+|+++|..+..++|.++..|++|++.|+++||+.||||||||-+|+.++.+|.+||+|||.+...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 9999999995 456799999999999999999999999999999999999999999999999999999999999987533
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD 272 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 272 (357)
.......++||..|.|||++.|.+|-.+.-|||+||+++|-++...-||..
T Consensus 721 -------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 -------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred -------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 233456788999999999999999998889999999999999999988864
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=286.68 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=213.0
Q ss_pred eEEceeeeecCCeEEEEEEECCCC----cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHG----CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
.+..++||+|+||+||+|.+-..| -+||||++...... .....+..|+.+|..++|||++++++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 455779999999999999986555 46888887543332 22455779999999999999999999998765 789
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|++|+++|+|.++++.+ +.+.....+.|..||++||.|||.++++||||-..||||..-.++||.|||+++.+......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999999864 67889999999999999999999999999999999999999999999999999866433222
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
... ....-.+.|||-|.+....|+.. +||||+|+++||++| |..|+.+....++-..+..+.+.+.++.++.++.
T Consensus 855 y~~---~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 855 YSA---PGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred ccc---cccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHH
Confidence 111 12223568999999999999988 999999999999996 9999999999999999998999999999999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhc
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.++.+|| .|+..||+++++..
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHH
Confidence 9999999 99999999998864
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=266.73 Aligned_cols=246 Identities=25% Similarity=0.415 Sum_probs=187.5
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHH--cCCCCCcceeeEEEEeCC----e
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVK--GLRHPNLIRFLQAIETTH----R 138 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~~iv~~~~~~~~~~----~ 138 (357)
+..+.+.||+|.||.||+|.+. |+.||||++...+.. ...+|.+++. .|+|+||+.|++.-..+. .
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~------SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDER------SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEecccchh------hhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 4788999999999999999887 899999999654322 1225555554 569999999998754332 6
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER--------GVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
++||.+|.+.|+|+|+|.+ ..++.+...+++..++.||+|||.. .|.|||||..||||..+|.+.|+|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 8999999999999999988 5599999999999999999999943 399999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCCCC-----CCCcccHHHHHHHHHHHHc----------CCCCCCC---
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPY-----TPHYSDVWSMGVVLYAMAF----------GRLPFDD--- 272 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~ell~----------g~~pf~~--- 272 (357)
|......... -....+..+||.+|||||++...-. +.+.+||||||.|+||++. -+.||.+
T Consensus 363 Av~h~~~t~~-idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 363 AVRHDSDTDT-IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eEEecccCCc-ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9866544322 2233456789999999999954211 1223899999999999974 2568854
Q ss_pred --CCHHHHHHHHhhcccCCCCCC---CC---HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 273 --TNYIQLLKQVQTKVVFPTEPN---VS---AECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 273 --~~~~~~~~~i~~~~~~~~~~~---~s---~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+.+++.+.+...-..|..|+ -. ..+.++|+.|| .+|.-|.++--|.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 345555554433333333221 12 35667899999 89999999877653
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=289.05 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=220.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.++.++|.|.||.||+++++.+++..|+|+++...... ...+++|+-+++.++||||+.+++.+.....+++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 456999999999999999999999999999999996543322 45567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||||.||+|.+.-+--+++++.++....+..+++|+|||+.|-+|||||-.|||+++.|.+|+.|||.+..+. ..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit-----at 165 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT-----AT 165 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh-----hh
Confidence 9999999999999888999999999999999999999999999999999999999999999999999986432 22
Q ss_pred CCCCCcccCCcccccccee---cCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-hhcccCCC---CCCCC
Q psy7825 223 SPLSDTFCGSYAYASPEIL---KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPT---EPNVS 295 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~~---~~~~s 295 (357)
...+..+.||++|||||+- ..+.|... +|||++|+...|+---+.|--+..+.+.+... ...+..|. ....+
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 2334567899999999987 45556666 99999999999999888887666665555444 33333332 34689
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+.+.+|++.+| ++|++||+++.+|.|||+....
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~l 278 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL 278 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccch
Confidence 99999999999 9999999999999999998873
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=269.44 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=190.7
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHc--CCCCCcceeeEEEEeCC-
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG--LRHPNLIRFLQAIETTH- 137 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~- 137 (357)
.+.....+.++||+|.||.||+|+.. ++.||||++... .++.+..|-++.+. ++|+||++|++.-+...
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 34455778899999999999999876 689999998542 24556677777765 57999999999876555
Q ss_pred ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEEEcCCCcEEE
Q psy7825 138 ---RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER---------GVVHRDIKCENLLIDGEYNIKL 205 (357)
Q Consensus 138 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~ivH~dlkp~Nili~~~~~~kl 205 (357)
.++||++|.+.|+|.++|..+. +++....+++..|++||+|||+- .|+|||||..||||..|++..|
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 8999999999999999997764 89999999999999999999953 5999999999999999999999
Q ss_pred eecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCC-----CcccHHHHHHHHHHHHcCC------------C
Q psy7825 206 SDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTP-----HYSDVWSMGVVLYAMAFGR------------L 268 (357)
Q Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~ell~g~------------~ 268 (357)
+|||+|..+.. +.........+||.+|||||++.+...-. ++.||||+|.++|||++.. .
T Consensus 358 aDFGLAl~~~p---~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql 434 (534)
T KOG3653|consen 358 ADFGLALRLEP---GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL 434 (534)
T ss_pred eccceeEEecC---CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence 99999986642 22222233478999999999997654333 3379999999999998632 2
Q ss_pred CCC-----CCCHHHHHHHHhhcccCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHH
Q psy7825 269 PFD-----DTNYIQLLKQVQTKVVFPTEP------NVSAECKTLLSKIF-SPIKFRIRLKDI 318 (357)
Q Consensus 269 pf~-----~~~~~~~~~~i~~~~~~~~~~------~~s~~~~~li~~~L-~~p~~Rps~~~l 318 (357)
||+ ....+++.+.+......|..+ .--..+++.+..|| .||+-|.|+.=+
T Consensus 435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 332 123445555544333333321 23467899999999 899999998643
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=240.06 Aligned_cols=217 Identities=29% Similarity=0.427 Sum_probs=175.3
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCC
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTH 137 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 137 (357)
..+..++...+..||+|++|.|-+.++..+|...|+|.+...-.. + ..+.+.+|+.+..+. .+|.+|.|+|......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-Q-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-H-HHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 344455566778899999999999999999999999998654432 2 244455788776665 6999999999999999
Q ss_pred eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQ----REGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.+++.||.+.. +|..+-. +.+.++|..+-+|+..++.||.|||++ .++|||+||+||||+.+|++|+||||.+.
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999966 8877664 367899999999999999999999976 89999999999999999999999999987
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecC----CCCCCCcccHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhhc
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKG----VPYTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTK 285 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~ 285 (357)
.+.. +.......|-..|||||.+.. ..|+.+ +||||||+++.||.+++.||+. ..+.+++.++...
T Consensus 198 ~L~d------SiAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 198 YLVD------SIAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred eehh------hhHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 5422 111222447778999999843 356666 9999999999999999999975 4566666665443
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=260.26 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=202.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECC---CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCe
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTR---HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHR 138 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 138 (357)
.+.|.+.++||+|.|++||++.+.. .++.||+|.+...... ..+..|+++|..+. +.||+++.+++..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4459999999999999999999876 6899999988654443 34678999999996 8999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~ 217 (357)
+++|+||++.....++... ++...++.++..++.||.++|.+|||||||||.|+|.+.. +.-.|+|||++......
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999888888865 6789999999999999999999999999999999999865 56799999999721100
Q ss_pred c------C---------------------------------CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHH
Q psy7825 218 K------S---------------------------------GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGV 258 (357)
Q Consensus 218 ~------~---------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 258 (357)
. . ...........||++|+|||++...+--+.++||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0 000111224569999999999987776666699999999
Q ss_pred HHHHHHcCCCCCCCC--CHHHHHHH--------------------------------Hhhcc-----------------c
Q psy7825 259 VLYAMAFGRLPFDDT--NYIQLLKQ--------------------------------VQTKV-----------------V 287 (357)
Q Consensus 259 il~ell~g~~pf~~~--~~~~~~~~--------------------------------i~~~~-----------------~ 287 (357)
|+..+++++.||-.. +...+.+. +...+ .
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 999999999999321 10000000 00000 0
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
....+.++..+.+|+.+|| .||.+|.+++++|+||||.+..
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 0011345679999999999 8999999999999999999653
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=249.46 Aligned_cols=259 Identities=21% Similarity=0.304 Sum_probs=214.7
Q ss_pred cccccccccCeEEceeeeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceee
Q psy7825 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRH-----GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFL 130 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 130 (357)
.+...+...+++...++-+|.||.||.|.+... .+.|.+|.++.... +-....+..|..++..+.|||+..+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--QIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--HHHHHHHHHHHHHHhcCcCCCcccee
Confidence 344456677899999999999999999976543 24456665543221 22245677899999999999999999
Q ss_pred EEEE-eCCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7825 131 QAIE-TTHRVYIIMEYAEKGSLLDFIQRE--------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201 (357)
Q Consensus 131 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~ 201 (357)
+++. +....++++.+..-|+|..|+... ..++..+...++.|++.|++|||+.||||.||...|++|++..
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe
Confidence 9874 455677888888889999999831 2477888899999999999999999999999999999999999
Q ss_pred cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy7825 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLK 280 (357)
Q Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~ 280 (357)
++||+|=.+++.+.... ......+.-....||+||.+.+..|++. +|+||||+++|||+| |+.||.+.++.++..
T Consensus 434 qVkltDsaLSRDLFP~D---YhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm~~ 509 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGD---YHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEMEH 509 (563)
T ss_pred eEEeccchhccccCccc---ccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence 99999999998664322 2222233334678999999999999988 999999999999996 999999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.++.+++...+-+||+++..++.-|| -.|++||+++|+..
T Consensus 510 ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 510 YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 99999998888899999999999999 89999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=234.05 Aligned_cols=211 Identities=36% Similarity=0.675 Sum_probs=183.6
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCCh
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSL 151 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 151 (357)
||+|++|.||++....+|+.+++|++....... ....+.+|+..++.+.|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999986543321 245677999999999999999999999999999999999998999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeecCCCcccccccCCCCCCCCCcc
Q psy7825 152 LDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-EYNIKLSDFGFARGHMKCKSGHQSPLSDTF 229 (357)
Q Consensus 152 ~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 229 (357)
.+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~ 153 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-----LLKTI 153 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-----hhhcc
Confidence 9999876 56899999999999999999999999999999999999999 89999999999864422111 12334
Q ss_pred cCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-C
Q psy7825 230 CGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-S 307 (357)
Q Consensus 230 ~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~ 307 (357)
.+...|++||.+... ..+.. +|+|+||+++++| ..+.+++..|+ .
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~-~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEK-SDIWSLGVILYEL--------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred cCCCCccChhHhcccCCCCch-hhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhC
Confidence 578899999999876 55555 9999999999999 88999999999 8
Q ss_pred CCCCCCCHHHHhcCC
Q psy7825 308 PIKFRIRLKDIKQDP 322 (357)
Q Consensus 308 ~p~~Rps~~~ll~hp 322 (357)
+|..||++.++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=233.98 Aligned_cols=214 Identities=36% Similarity=0.629 Sum_probs=181.3
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.+.+.||.|++|.||+|....+++.+|+|.+...... ...+.+.+|+..+..++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999888999999998754433 2356778999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 146 AEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 146 ~~~~~L~~~l~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
+++++|.+++..... +++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+........ .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~----~ 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA----A 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc----c
Confidence 999999999988766 89999999999999999999999999999999999999999999999999875432210 1
Q ss_pred CCCcccCCcccccccee-cCCCCCCCcccHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHhhcc
Q psy7825 225 LSDTFCGSYAYASPEIL-KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD--TNYIQLLKQVQTKV 286 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~ell~g~~pf~~--~~~~~~~~~i~~~~ 286 (357)
......++..|++||.+ ....++.. +|+|+||+++|+|++|+.||.. .+...+.+.+..+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~-~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEA-VDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCch-hhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 22345678899999998 66666665 9999999999999999999977 34445666665554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=231.68 Aligned_cols=250 Identities=26% Similarity=0.459 Sum_probs=188.7
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeE-EEEeCCeEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQ-AIETTHRVYI 141 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~-~~~~~~~~~l 141 (357)
+.|.|.+.||+|.||.+-+++++.+++.+++|.+...... ...|.+|...--.|. |.||+..++ .|+..+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 3599999999999999999999999999999998664433 455778887766675 899998776 5788889999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc--CCCcEEEeecCCCcccccccC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID--GEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~--~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++||++.|+|..-+...| +.|.....++.|+++||.|||+.++||||||.+||||- +...+||||||..+....
T Consensus 100 ~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--- 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--- 175 (378)
T ss_pred eeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc---
Confidence 999999999999887765 78999999999999999999999999999999999994 334799999999752210
Q ss_pred CCCCCCCCcccCCccccccceecCC-----CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhhcc--cC
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGV-----PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ----LLKQVQTKV--VF 288 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~--~~ 288 (357)
.-...--+..|.|||+.... ...+. +|+|.||+|+|.++||..||+.....+ -..+..... ..
T Consensus 176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps-~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPS-TDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred -----eehhhhhhcccCCcHHHhhccccceEeccc-ccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 00111134578999987422 23344 899999999999999999997432111 112222211 22
Q ss_pred CC-CCCCCHHHHHHHHHhc-CCCCCC---CCHHHHhcCCCCCCC
Q psy7825 289 PT-EPNVSAECKTLLSKIF-SPIKFR---IRLKDIKQDPWVKTE 327 (357)
Q Consensus 289 ~~-~~~~s~~~~~li~~~L-~~p~~R---ps~~~ll~hp~~~~~ 327 (357)
|. ...+++.+..+.++-| .++++| -+++.....-|....
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 21 2347888888999999 889988 455555566676543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=279.63 Aligned_cols=204 Identities=16% Similarity=0.215 Sum_probs=146.9
Q ss_pred cCCC-CCcceeeEEE-------EeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7825 120 GLRH-PNLIRFLQAI-------ETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI 190 (357)
Q Consensus 120 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dl 190 (357)
.+.| +||..+++.| .....+++++|++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3444 5777777776 2334677888988 5599999975 356999999999999999999999999999999
Q ss_pred CCCCEEEcCCCcE-------------------EEeecCCCcccccccCC-----------CCCCCCCcccCCccccccce
Q psy7825 191 KCENLLIDGEYNI-------------------KLSDFGFARGHMKCKSG-----------HQSPLSDTFCGSYAYASPEI 240 (357)
Q Consensus 191 kp~Nili~~~~~~-------------------kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~ 240 (357)
||+||||+..+.+ |++|||+++........ .........+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999655444 55555554421100000 00001112468999999999
Q ss_pred ecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy7825 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIK 319 (357)
Q Consensus 241 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll 319 (357)
+.+..++.+ +|||||||++|||++|..|+.... .....+......+..........+++.+|| .+|.+||++.++|
T Consensus 187 ~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSSNCA-SDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCCCch-hhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 999888776 999999999999999988875422 122222222211211123566789999999 8999999999999
Q ss_pred cCCCCCCC
Q psy7825 320 QDPWVKTE 327 (357)
Q Consensus 320 ~hp~~~~~ 327 (357)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999874
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=257.76 Aligned_cols=261 Identities=25% Similarity=0.405 Sum_probs=206.1
Q ss_pred EEceeeeecCCeEEEEEEECCCCcEEEEEEeecC---CCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV---EAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 67 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
....++|.|++|.|+.+......+.++.|.+... ..........+..|+.+-..+.|||++..+..+.......-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4577899999998888887766666776655421 1111111222667888888899999988777666655555569
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|||++ +|+.++.+.+.+...++..++.|++.|++|||+.||.|||+|++|++++.+|.+||+|||.+..+...... ..
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~-~~ 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK-NI 478 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch-hh
Confidence 99999 99999998888999999999999999999999999999999999999999999999999998755433222 23
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHhh-------cccCCCCCCCC
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL-KQVQT-------KVVFPTEPNVS 295 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~-------~~~~~~~~~~s 295 (357)
......+|+..|+|||++.+..|+++..||||.|++++.|++|+.||......+.. ..... .........++
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp 558 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP 558 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence 55667889999999999999999999999999999999999999999654332221 11110 01111223578
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
...+.+|.+|| .+|.+|.++++|++.+||+...-
T Consensus 559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred hhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 99999999999 89999999999999999998643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=212.40 Aligned_cols=159 Identities=19% Similarity=0.195 Sum_probs=127.6
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCC
Q psy7825 149 GSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD 227 (357)
Q Consensus 149 ~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 227 (357)
|+|.+++.. ...+++..++.++.||+.||.|||+.+ ||+|||++.++.+++ ||++..... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~----------~ 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP----------E 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------c
Confidence 689999987 456999999999999999999999999 999999999999999 998864321 1
Q ss_pred cccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhhcccCC------CCCCCCH--HH
Q psy7825 228 TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQVQTKVVFP------TEPNVSA--EC 298 (357)
Q Consensus 228 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~------~~~~~s~--~~ 298 (357)
...|++.|+|||++.+..++.+ +|||||||++|||++|+.||..... ......+....... ....++. .+
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF 141 (176)
T ss_pred cCCCcccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence 1258899999999999888877 9999999999999999999976533 22333332221111 1122333 69
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
++||.+|| .+|.+||++.+++.|+|+..
T Consensus 142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 142 ADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999 89999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=217.90 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=195.9
Q ss_pred CeEEceeeeecCCeEEEEEEECCCC-cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC----CCcceeeEEE-EeCCe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHG-CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH----PNLIRFLQAI-ETTHR 138 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~~~~~~-~~~~~ 138 (357)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++.+ ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7999999999999999999987764 6799998765433221 146678888888863 6899999999 57888
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-----CcEEEeecCCC
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-----YNIKLSDFGFA 211 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-----~~~kl~Dfg~~ 211 (357)
.++||+.+ |.+|.++.... +.++...+..++.|++.+|++||+.|++||||||.|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 77999988654 579999999999999999999999999999999999999865 36899999999
Q ss_pred cccc--cccCCC-C-CCC-CCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHh
Q psy7825 212 RGHM--KCKSGH-Q-SPL-SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI---QLLKQVQ 283 (357)
Q Consensus 212 ~~~~--~~~~~~-~-~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~ 283 (357)
+... ...... . ... ...+.||..|.++.++.+...+.+ .|+||+++++.+|+.|..||...... .......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8332 222211 1 111 234569999999999999999988 99999999999999999999765532 2222222
Q ss_pred hcccCC-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 284 TKVVFP-TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 284 ~~~~~~-~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
...... .....+.++.++...+- .+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 222222 22345677777777776 678889999888765
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=200.06 Aligned_cols=240 Identities=25% Similarity=0.316 Sum_probs=189.5
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 138 (357)
.+....|.+++.||.|+||.+|+|....+|..||||+-..... ...+..|..+...|+ ...|+.+..++.+..+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 3455679999999999999999999999999999998654322 233557999999997 5788888888888999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcEEEeecCCCccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE---YNIKLSDFGFARGH 214 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~---~~~kl~Dfg~~~~~ 214 (357)
-.+||+.+ |.+|.++..- ...|+...++-++-||+.-++|+|.++++||||||+|+|..-+ ..+.|+|||+++.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999 7799998864 3569999999999999999999999999999999999999654 45899999999877
Q ss_pred ccccCCCCCCCC--CcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhhc-ccC
Q psy7825 215 MKCKSGHQSPLS--DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY---IQLLKQVQTK-VVF 288 (357)
Q Consensus 215 ~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~-~~~ 288 (357)
.........+.+ ....||.+|.+-..+.+...+.+ .|+-|+|.++.++..|..||++... .+-.++|.+. ...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 655554443332 34679999999988888777777 9999999999999999999987643 3333444322 111
Q ss_pred CCC---CCCCHHHHHHHHHhc
Q psy7825 289 PTE---PNVSAECKTLLSKIF 306 (357)
Q Consensus 289 ~~~---~~~s~~~~~li~~~L 306 (357)
+.. .++|.++...+.-|-
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCR 264 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHh
Confidence 211 356677776666654
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=207.06 Aligned_cols=207 Identities=23% Similarity=0.316 Sum_probs=177.4
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 138 (357)
.+-.-.|++++.||+|+||.++.|.+.-++++||||.-..... .-.++.|....+.|. .++|...+.+...+.+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY 98 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence 3445569999999999999999999999999999997543222 123667888888885 7999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-----CcEEEeecCCCc
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-----YNIKLSDFGFAR 212 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-----~~~kl~Dfg~~~ 212 (357)
-.||+|.+ |.+|+|+..=. +.|+...+..++.||+.-++|+|++.+|.|||||+|+||..- ..+.|+|||+++
T Consensus 99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99999999 77988888643 569999999999999999999999999999999999999643 348999999999
Q ss_pred ccccccCCCCCCCC--CcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Q psy7825 213 GHMKCKSGHQSPLS--DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT 273 (357)
Q Consensus 213 ~~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 273 (357)
.+..+......+.+ ....||.+||+-....|...+.+ .|+-|||-+++++|.|..||.+.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccc
Confidence 88777666555444 35679999999999999998888 99999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-26 Score=209.80 Aligned_cols=261 Identities=30% Similarity=0.479 Sum_probs=209.3
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCC-CcceeeEEEEeCCeEEEEEe
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP-NLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e 144 (357)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.++..+.|+ +|+++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788899999999999999987 78999998765555443466688999999999988 79999999988888899999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecCCCcccccccCC
Q psy7825 145 YAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-NIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~ 220 (357)
++.++++.+++.... .++......++.|++.++.|+|..+++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887764 799999999999999999999999999999999999999998 7999999998743222211
Q ss_pred CCC-CCCCcccCCccccccceecCC---CCCCCcccHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhhcccC----
Q psy7825 221 HQS-PLSDTFCGSYAYASPEILKGV---PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY----IQLLKQVQTKVVF---- 288 (357)
Q Consensus 221 ~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~---- 288 (357)
... .......|+..|+|||.+.+. ..... .|+|++|++++++++|..||..... ......+......
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~-~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSS-SDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 110 134567899999999999884 44444 9999999999999999999877653 4444444433321
Q ss_pred CCCCCC----CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 289 PTEPNV----SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 289 ~~~~~~----s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
...... ...+.+++..++ .+|..|.+..+...++|.......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~ 284 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK 284 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence 111111 258999999999 899999999999999777665333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=217.04 Aligned_cols=171 Identities=19% Similarity=0.204 Sum_probs=130.6
Q ss_pred ccCeEEceeeeecCCeEEEEEEECC-CCcEEEEEEeecCCC--CchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTR-HGCDVAVKVVSKVEA--PPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.++|.+.+.||+|+||.||+|.+.. +++.||||++..... ........+.+|+.+|..++|+|+++.+.. ....
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 4569999999999999999999876 678889998653211 123345668899999999999999853322 2457
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI-KCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dl-kp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
|+||||++|++|.. +.. .. ...++.+++.+|.|||+.||+|||| ||+|||++.++.++|+|||+++.+....
T Consensus 94 ~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 94 GLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred EEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence 99999999999973 211 11 1467899999999999999999999 9999999999999999999998654322
Q ss_pred CCCCC---CCCCcccCCccccccceecC
Q psy7825 219 SGHQS---PLSDTFCGSYAYASPEILKG 243 (357)
Q Consensus 219 ~~~~~---~~~~~~~gt~~y~aPE~~~~ 243 (357)
..... ..-.+..++..|+|||.+..
T Consensus 167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 167 ALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred chhhhhhhhhhhhhhccCccCCcccCCh
Confidence 11110 11135678889999999853
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=230.85 Aligned_cols=239 Identities=29% Similarity=0.495 Sum_probs=200.3
Q ss_pred eeeecCCeEEEEEEE---CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEEEecc
Q psy7825 71 VIGIGSYATVKLATS---TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYIIMEYA 146 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 146 (357)
++|.|+||.|+++.. .+.|..||+|+..+......... ....|..++..++ ||.++++...|+.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998752 44578899999876544333222 4446888888887 999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCC
Q psy7825 147 EKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226 (357)
Q Consensus 147 ~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 226 (357)
.||.|...+.....+.+.....+...++-+++++|..+++|||+|++||+++.+|++++.|||+++......
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------- 151 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence 999999999988889999999999999999999999999999999999999999999999999987543211
Q ss_pred CcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-cccCCCCCCCCHHHHHHHHHh
Q psy7825 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECKTLLSKI 305 (357)
Q Consensus 227 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~ 305 (357)
..|||..|||||++. .+... +|.||+|+++++|++|..||.. ++...|.. .+.. +...+..+++++..+
T Consensus 152 -~~cgt~eymApEI~~--gh~~a-~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~--p~~l~~~a~~~~~~l 221 (612)
T KOG0603|consen 152 -IACGTYEYRAPEIIN--GHLSA-ADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEM--PRELSAEARSLFRQL 221 (612)
T ss_pred -hcccchhhhhhHhhh--ccCCc-ccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCC--chhhhHHHHHHHHHH
Confidence 118999999999998 34444 8999999999999999999988 44555443 3433 446999999999999
Q ss_pred c-CCCCCCCCH-----HHHhcCCCCCCCC
Q psy7825 306 F-SPIKFRIRL-----KDIKQDPWVKTEA 328 (357)
Q Consensus 306 L-~~p~~Rps~-----~~ll~hp~~~~~~ 328 (357)
+ .+|..|.-. .++++|+||+.--
T Consensus 222 ~~r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 222 FKRNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred HhhCHHHHhccCcchhHHHhccchheeee
Confidence 9 899988654 7999999998753
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-27 Score=229.71 Aligned_cols=240 Identities=26% Similarity=0.351 Sum_probs=184.0
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC--chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.|...+.||.+.|=+|.+|++.. |. |+||++-+.... -....+.+ .|+. ...+++||.+++..+...+...|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 48889999999999999998653 44 999998665422 22333333 3444 6667899999999888888888999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC--
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-- 220 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-- 220 (357)
-+|+.. +|+|.+..++.+..-+.+.|+.|++.||..+|..||+|||||.+||||+.-..+.|+||...+-.....+.
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 999976 99999999888999999999999999999999999999999999999999999999999987532222111
Q ss_pred CCCCCCCcccCCccccccceecCC----------C-CCCCcccHHHHHHHHHHHHc-CCCCCCC-----------CCHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGV----------P-YTPHYSDVWSMGVVLYAMAF-GRLPFDD-----------TNYIQ 277 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~~DiwslG~il~ell~-g~~pf~~-----------~~~~~ 277 (357)
.......+...-.+|.|||.+... . ..+ +.||||+||++.||++ |++||.- .+.+.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~p-aMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTP-AMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccCh-hhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 111112223345689999988431 1 233 3899999999999996 6888842 12222
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 278 LLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 278 ~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+++| -+..+++||..|+ .||..|.++++.|+-
T Consensus 258 ~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 22222 3458999999999 899999999999975
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=191.70 Aligned_cols=241 Identities=18% Similarity=0.288 Sum_probs=196.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.+..+..+|.+...|..|+|++. |..+++|++...+.. ..+.+.|..|.-.|+.+.||||+.+++.|.....+.++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 34556667889999999999987 567888888654443 334566778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCCcEEEe--ecCCCcccccc
Q psy7825 144 EYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLIDGEYNIKLS--DFGFARGHMKC 217 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~~~~~~kl~--Dfg~~~~~~~~ 217 (357)
.|++.|+|+..+++.. .++..++.+++.+|++|++|||+.. |.-..|....++||++.+.+|. |--++-
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----- 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----- 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----
Confidence 9999999999998754 3678899999999999999999985 5555689999999999876663 322221
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCC--CCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HhhcccCCCCCCC
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYT--PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNV 294 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~ 294 (357)
......-.|.||+||.+...+-+ .+++|+|||++++|||.|...||.+..+.+.--+ ..++++...+|++
T Consensus 342 -------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi 414 (448)
T KOG0195|consen 342 -------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI 414 (448)
T ss_pred -------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence 11222346899999999765543 3458999999999999999999999887765444 4677888889999
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIK 319 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll 319 (357)
+..+..|+.-|+ .||.+||.++.|+
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999 8999999998875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=189.59 Aligned_cols=175 Identities=18% Similarity=0.156 Sum_probs=134.1
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhh------HHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF------LPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
+-.++|++.++||.|+||.||++.. ++..+|||++.......+..... +.+|+..+.++.|++|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3467899999999999999999755 46789999997655544433333 679999999999999999988765
Q ss_pred eC--------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7825 135 TT--------HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLS 206 (357)
Q Consensus 135 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~ 206 (357)
.. ...++||||++|.+|.++.. +++ ....+++.+|..||..|++|||++|+||+++.+| ++|+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 33 35789999999999988742 333 2466999999999999999999999999999998 9999
Q ss_pred ecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHH
Q psy7825 207 DFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA 264 (357)
Q Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 264 (357)
|||.......... .........+... +|+|+||+++..+.
T Consensus 177 Dfg~~~~~~e~~a-----------------~d~~vler~y~~~-~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKA-----------------KDRIDLERHYGIK-NEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhh-----------------HHHHHHHhHhccc-ccccceeEeehHHH
Confidence 9998753311100 0113334445544 99999999876554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=186.07 Aligned_cols=140 Identities=16% Similarity=0.215 Sum_probs=110.7
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchH-----------------------HhhhHHHHHHHHHcCCCCC
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDY-----------------------LKKFLPREIDVVKGLRHPN 125 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~ 125 (357)
...||+|+||.||+|.+. +|+.||||+++........ .......|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999754221110 0123345999999998877
Q ss_pred cceeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCEEEcCCCcEE
Q psy7825 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC-HERGVVHRDIKCENLLIDGEYNIK 204 (357)
Q Consensus 126 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~ivH~dlkp~Nili~~~~~~k 204 (357)
+......... ..++||||++|+++...+...+.++...+..++.|++.+|.+| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6443332222 2389999999987776655566799999999999999999999 799999999999999998 47899
Q ss_pred EeecCCCc
Q psy7825 205 LSDFGFAR 212 (357)
Q Consensus 205 l~Dfg~~~ 212 (357)
|+|||++.
T Consensus 158 LiDFG~a~ 165 (190)
T cd05147 158 IIDVSQSV 165 (190)
T ss_pred EEEccccc
Confidence 99999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=217.92 Aligned_cols=228 Identities=25% Similarity=0.421 Sum_probs=174.2
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+|..++.|..|+||-||.++++.+.+.+|+|+- +... +.+. ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l--------ilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL--------ILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccc-ccch--------hhhc--cccccCCccee--------------
Confidence 446799999999999999999999999999999643 2111 1111 22233344333
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC-
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG- 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 220 (357)
|+=..++..-++++... +.+++|||+.||+|||+||+|++|+.-|++|++|||+++........
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444454445554433 78999999999999999999999999999999999998643221111
Q ss_pred ---------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-cCCC
Q psy7825 221 ---------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-VFPT 290 (357)
Q Consensus 221 ---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~ 290 (357)
.........|||+.|.|||++....|... +|+|+||+|+|+++-|..||.+..+++++.++.... .++.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 01122234689999999999999888877 999999999999999999999999999998865443 3333
Q ss_pred -CCCCCHHHHHHHHHhc-CCCCCC---CCHHHHhcCCCCCCCCCC
Q psy7825 291 -EPNVSAECKTLLSKIF-SPIKFR---IRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 291 -~~~~s~~~~~li~~~L-~~p~~R---ps~~~ll~hp~~~~~~~~ 330 (357)
....+.+++++|.+|| .+|..| +.+-++.+|+||+.--+.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 4568999999999999 888877 578889999999987665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=193.76 Aligned_cols=232 Identities=23% Similarity=0.306 Sum_probs=148.6
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC----------CCcceeeEEE--
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH----------PNLIRFLQAI-- 133 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~~iv~~~~~~-- 133 (357)
+...+.||.|+++.||.+++..+|+.+|||++...........+.+++|.-....+.+ -.++..++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 6778899999999999999999999999999876654444445556666554444322 1122222211
Q ss_pred -------EeC---C-----eEEEEEeccCCCChHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7825 134 -------ETT---H-----RVYIIMEYAEKGSLLDFIQR---EGY----IDEPRTKKWFRQLVDAIDYCHERGVVHRDIK 191 (357)
Q Consensus 134 -------~~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~----l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlk 191 (357)
... . ..+++|+.+.+ +|.+++.. ... +.......+..|+++.+++||..|++|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 111 1 23678887755 88888652 221 2223334566899999999999999999999
Q ss_pred CCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCC--------CCCCCcccHHHHHHHHHHH
Q psy7825 192 CENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV--------PYTPHYSDVWSMGVVLYAM 263 (357)
Q Consensus 192 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el 263 (357)
|+|++++.+|.++|+||+....... ... ....+..|.|||..... .++.. .|.|+||+++|.|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~-~DaW~LG~~ly~l 243 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT-----RYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFA-TDAWQLGITLYSL 243 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE-----EEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HH-HHHHHHHHHHHHH
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc-----eee---ccCCCcccCChhhhhhhcccCcccceeeec-cCHHHHHHHHHHH
Confidence 9999999999999999987753211 110 02345789999977332 33444 7999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCC
Q psy7825 264 AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFR 312 (357)
Q Consensus 264 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~R 312 (357)
++|..||........... .+. .+. .+|+.++.||+.+| .+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~---~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW---DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG---GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc---cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999986533221111 111 223 68999999999999 899877
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=179.64 Aligned_cols=142 Identities=18% Similarity=0.201 Sum_probs=112.7
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch-----------------------HHhhhHHHHHHHHHcCCCC
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD-----------------------YLKKFLPREIDVVKGLRHP 124 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~ 124 (357)
+.+.||+|+||.||+|.+. +|+.||||+++....... .....+.+|...+..+.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3568999999999999987 899999999976432100 0122346789999999999
Q ss_pred CcceeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcE
Q psy7825 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNI 203 (357)
Q Consensus 125 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~ 203 (357)
++.....+.... .++||||++|+++.........++...+..++.|++.++.+||. .||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 875444333322 47999999987655443345668899999999999999999999 9999999999999999 7899
Q ss_pred EEeecCCCcc
Q psy7825 204 KLSDFGFARG 213 (357)
Q Consensus 204 kl~Dfg~~~~ 213 (357)
+|+|||++..
T Consensus 157 ~liDFG~a~~ 166 (190)
T cd05145 157 YIIDVSQAVE 166 (190)
T ss_pred EEEEccccee
Confidence 9999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=174.26 Aligned_cols=193 Identities=15% Similarity=0.089 Sum_probs=138.6
Q ss_pred EEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchH-HhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEEEe
Q psy7825 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDY-LKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 67 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.+...|++|+||+||++.. .+.+++.+.+......... ....+.+|+++|++|. +++|++++++ ...+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998865 4778887776543332221 1235789999999996 5889999885 34689999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEEcCCCcEEEeecCCCcccccccCC---
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI-KCENLLIDGEYNIKLSDFGFARGHMKCKSG--- 220 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dl-kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--- 220 (357)
|+.|.+|...+.. . ...++.|++.+|.++|+.||+|||| ||+|||++.++.++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9999988764422 1 2357889999999999999999999 799999999999999999999733211000
Q ss_pred -CCCC----CCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCC
Q psy7825 221 -HQSP----LSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDD 272 (357)
Q Consensus 221 -~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~ 272 (357)
.... .......++.|+.|+...-- ..+-.+.++++.|+-+|.++|+..++-+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0000 00112256778888765332 2221226999999999999999988643
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=207.41 Aligned_cols=200 Identities=25% Similarity=0.362 Sum_probs=164.8
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC---CCCcceeeEEEE
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR---HPNLIRFLQAIE 134 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~ 134 (357)
...+.+..|.|.+.||+|+||.||+|.... |+.||+|+-.....+.-++...+ +.+|+ -+.|+.+..++.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~------~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQV------MERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHH------HHhhchhhhcchHHHHHHHc
Confidence 344567789999999999999999999776 99999999877666654444333 33333 345667777777
Q ss_pred eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-------CCcEEEee
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-------EYNIKLSD 207 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-------~~~~kl~D 207 (357)
..+..++|+||.+.|+|.++++..+.+++..+..+..||+..+++||..+|||+||||+|+||.. ..-++|+|
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred cCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 77888999999999999999998888999999999999999999999999999999999999943 23489999
Q ss_pred cCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCC
Q psy7825 208 FGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRL 268 (357)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 268 (357)
||.+-.......+ ......++|-.+-.+|+..|.+++.. .|.|+|+.++|-||.|+.
T Consensus 845 fG~siDm~lfp~~---~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDG---TKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCC---cEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 9998755443333 12234568899999999999999999 999999999999999864
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=181.29 Aligned_cols=253 Identities=22% Similarity=0.363 Sum_probs=172.9
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCc-----------------------------------EEEEEEeecCCCC-
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGC-----------------------------------DVAVKVVSKVEAP- 103 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----------------------------------~vavK~~~~~~~~- 103 (357)
.+..++|+|++.||+|..+.||.|+...+|. +.|||.+-..+..
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 4556789999999999999999987544221 2455554322221
Q ss_pred -chHHhhhHHHHH------HH--------HH-------c-CCCCCcceeeEEEEe-------------------------
Q psy7825 104 -PDYLKKFLPREI------DV--------VK-------G-LRHPNLIRFLQAIET------------------------- 135 (357)
Q Consensus 104 -~~~~~~~~~~E~------~~--------l~-------~-l~h~~iv~~~~~~~~------------------------- 135 (357)
...+.+..-+|. .+ .+ + -+|||||+++++|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 111222222221 01 11 1 259999999887732
Q ss_pred --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc--CCC--cEEEeecC
Q psy7825 136 --THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID--GEY--NIKLSDFG 209 (357)
Q Consensus 136 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~--~~~--~~kl~Dfg 209 (357)
...+|+||...+. +|..++-.+. .+.....-++.|+++|+.|||.+||.|||+|.+|||+. +++ .++|+|||
T Consensus 313 g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 313 GEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred CCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence 2357999998866 9999997765 57888889999999999999999999999999999994 343 47999999
Q ss_pred CCcccccccCCCCC---CCCCcccCCccccccceecCCC-----CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHH-H
Q psy7825 210 FARGHMKCKSGHQS---PLSDTFCGSYAYASPEILKGVP-----YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL-K 280 (357)
Q Consensus 210 ~~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~ 280 (357)
++..-.. .+..- .......|....||||+....+ .+..++|.|+.|.+.||++...-||.......+- .
T Consensus 391 CcLAd~~--hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r 468 (598)
T KOG4158|consen 391 CCLADDN--HGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR 468 (598)
T ss_pred eeeeccc--cccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh
Confidence 8752111 00111 1112345888999999985432 2222389999999999999999999873322111 1
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHH
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLK 316 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~ 316 (357)
..++....+.+..++..+++||..+| .||.+|++..
T Consensus 469 ~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 469 TYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 12223334445679999999999999 8999999854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=165.73 Aligned_cols=134 Identities=20% Similarity=0.258 Sum_probs=105.9
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-----CCCCcceeeEEEEeCC---eEE
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-----RHPNLIRFLQAIETTH---RVY 140 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~~~ 140 (357)
.+.||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ .||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 5656555 69988653222 245578999999999 5799999999998874 434
Q ss_pred -EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCCEEEcC----CCcEEEeecCCC
Q psy7825 141 -IIMEY--AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAI-DYCHERGVVHRDIKCENLLIDG----EYNIKLSDFGFA 211 (357)
Q Consensus 141 -lv~e~--~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~ivH~dlkp~Nili~~----~~~~kl~Dfg~~ 211 (357)
+|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 5578999999764 46665 35678888777 9999999999999999999974 347999995544
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-23 Score=191.68 Aligned_cols=180 Identities=23% Similarity=0.438 Sum_probs=136.1
Q ss_pred EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
+|+.|++|.-.+|.+|+.++. ..+....+.++.|++.+++| +|.+|+|+||.||+...+..++|+|||+.....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence 567888888889999997543 35667888999999999999 999999999999999999999999999987543
Q ss_pred cccCCC-CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 216 KCKSGH-QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 216 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
...... ..-.....+||..||+||.+.+..|+.+ +||||||+|++||++ -..+|+. ......+..+...|..-.
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~~ 483 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFLQ 483 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHhh
Confidence 333111 1112345679999999999999999988 999999999999996 3333322 122333333333322222
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
--+.-..|+.+|| ..|..||++...-.|+|++
T Consensus 484 d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 484 DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 3355668999999 8899999888888888864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=171.46 Aligned_cols=143 Identities=17% Similarity=0.205 Sum_probs=114.4
Q ss_pred CeEEceeeeecCCeEEEEEE-ECCCCcEEEEEEeecCCCCc---------------------hHHhhhHHHHHHHHHcCC
Q psy7825 65 GYVLGKVIGIGSYATVKLAT-STRHGCDVAVKVVSKVEAPP---------------------DYLKKFLPREIDVVKGLR 122 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 122 (357)
.|.+.+.||+|+||.||+|. +..+|+.||||++....... ......+.+|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 66789999999987543210 011234668999999997
Q ss_pred CCC--cceeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEEEcC
Q psy7825 123 HPN--LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG-VVHRDIKCENLLIDG 199 (357)
Q Consensus 123 h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-ivH~dlkp~Nili~~ 199 (357)
+.+ ++++++. . ..++||||++|.+|.........+....+..++.||+.+|.+||+.| ++|+||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 3444432 2 34899999999888776645556677778899999999999999999 99999999999999
Q ss_pred CCcEEEeecCCCc
Q psy7825 200 EYNIKLSDFGFAR 212 (357)
Q Consensus 200 ~~~~kl~Dfg~~~ 212 (357)
++.++|+|||.+.
T Consensus 184 ~~~i~LiDFg~a~ 196 (237)
T smart00090 184 DGKVVIIDVSQSV 196 (237)
T ss_pred CCCEEEEEChhhh
Confidence 8899999999875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-20 Score=159.28 Aligned_cols=136 Identities=23% Similarity=0.298 Sum_probs=113.8
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchH-----HhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDY-----LKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
+.||+|++|.||+|.+ .|..+++|+.......... ....+.+|+.++..+.|++|.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 5788999986543222111 12346789999999999998877777777778899999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
|++|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+.
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 9999999999876432 8889999999999999999999999999999999 7899999999875
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-21 Score=177.07 Aligned_cols=200 Identities=24% Similarity=0.434 Sum_probs=156.2
Q ss_pred HHcCCCCCcceeeEEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCCE
Q psy7825 118 VKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGV-VHRDIKCENL 195 (357)
Q Consensus 118 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i-vH~dlkp~Ni 195 (357)
|+.+.|.|+.+|+|.+.++...++|.+||..|+|.+.+.. ...++......++++|+.||.|||+..| .|+.++..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4578899999999999999999999999999999999976 4568888889999999999999999876 9999999999
Q ss_pred EEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCC------CCCcccHHHHHHHHHHHHcCCCC
Q psy7825 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPY------TPHYSDVWSMGVVLYAMAFGRLP 269 (357)
Q Consensus 196 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~ell~g~~p 269 (357)
+++..+.+||+|||+....... ..........-..-|.|||.+.+... ..++.|+||+|+++||+++...|
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~---~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEET---AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeeeeEEEEechhhhccccccc---ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999997644220 00011111123457999999976421 23448999999999999999999
Q ss_pred CCCC----CHHHHHHHHhhcccCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 270 FDDT----NYIQLLKQVQTKVVFPTEP------NVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 270 f~~~----~~~~~~~~i~~~~~~~~~~------~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
|... +..++...+......+..| ...+++..+++.|| .+|..||+++++-.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9752 3345555555422222221 34567999999999 89999999999864
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-22 Score=192.87 Aligned_cols=260 Identities=28% Similarity=0.462 Sum_probs=208.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECC-CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTR-HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 141 (357)
..|.+.+.||+|+|+.|-.+.... ....+|+|.+.... ...........|..+-..+. |+|++.+++.....+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 347888889999999999987643 34556777665433 22222344556888888887 9999999999999999999
Q ss_pred EEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEcCCC-cEEEeecCCCcccccc
Q psy7825 142 IMEYAEKGSLLDFI-QREG-YIDEPRTKKWFRQLVDAIDYCH-ERGVVHRDIKCENLLIDGEY-NIKLSDFGFARGHMKC 217 (357)
Q Consensus 142 v~e~~~~~~L~~~l-~~~~-~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~ 217 (357)
++++..|+++.+.+ .... ..+...+..++.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.|||++..+...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999999 5443 5788899999999999999999 99999999999999999999 9999999999866432
Q ss_pred cCCCCCCCCCcccC-CccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHh--hcccCCCCC
Q psy7825 218 KSGHQSPLSDTFCG-SYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL--KQVQ--TKVVFPTEP 292 (357)
Q Consensus 218 ~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~i~--~~~~~~~~~ 292 (357)
..........+| ++.|+|||...+..+.....|+||.|+++..+++|..||......... ..+. .......+.
T Consensus 179 --~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 179 --NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred --CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 222334445678 999999999998766666699999999999999999999754433311 1111 122244456
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
.++....+++.+++ .+|..|.+.+++..+||+..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccccccc
Confidence 78999999999999 89999999999999999999
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=154.41 Aligned_cols=132 Identities=20% Similarity=0.289 Sum_probs=106.5
Q ss_pred eeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch-----HHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD-----YLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
.||+|+||.||+|.. +|..+++|+......... .....+.+|+.++..+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 478899998643222111 1124567899999999988765555555566677899999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 146 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++.
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 999999998865321 8899999999999999999999999999999 7899999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.2e-20 Score=154.94 Aligned_cols=136 Identities=21% Similarity=0.284 Sum_probs=107.6
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch-------------------HHhhhHHHHHHHHHcCCCCC-
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD-------------------YLKKFLPREIDVVKGLRHPN- 125 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~~- 125 (357)
|.+.+.||+|+||.||++... +|+.||||++........ .......+|+.++..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999864 799999998764321100 01123567888999887774
Q ss_pred -cceeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7825 126 -LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIK 204 (357)
Q Consensus 126 -iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~k 204 (357)
++..++ ....++||||++|++|..+... .....++.+++.++.++|..||+|+||+|+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 2345899999999998775431 34567889999999999999999999999999999999999
Q ss_pred EeecCCCc
Q psy7825 205 LSDFGFAR 212 (357)
Q Consensus 205 l~Dfg~~~ 212 (357)
|+|||++.
T Consensus 166 liDfg~~~ 173 (198)
T cd05144 166 IIDWPQMV 173 (198)
T ss_pred EEECCccc
Confidence 99999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-19 Score=170.31 Aligned_cols=137 Identities=19% Similarity=0.261 Sum_probs=110.9
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP-----PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.|...+.||+|+||.||+|.+.. ..+++|+....... .....+.+.+|+.++..++|++++....++......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 35678899999999999998753 34555543221111 112235577999999999999998877777777778
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999999886 356789999999999999999999999999999 57799999999986
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=146.68 Aligned_cols=136 Identities=22% Similarity=0.305 Sum_probs=98.6
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhh---------------------HHHHHHHHHcCCCCC--
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF---------------------LPREIDVVKGLRHPN-- 125 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~~-- 125 (357)
.+.||+|+||.||+|.+. +|+.||||++............. ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999876 79999999986543221111111 135666666664432
Q ss_pred cceeeEEEEeCCeEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcE
Q psy7825 126 LIRFLQAIETTHRVYIIMEYAEKGSLLD-FIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNI 203 (357)
Q Consensus 126 iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~ 203 (357)
+.+.++. ...++||||++|+.+.. .+.... . ...+..++.+++.++.++|. .||+|+||+|+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444443 23589999999854322 121111 1 16788999999999999999 9999999999999999 8899
Q ss_pred EEeecCCCc
Q psy7825 204 KLSDFGFAR 212 (357)
Q Consensus 204 kl~Dfg~~~ 212 (357)
+|+|||.+.
T Consensus 154 ~liDfg~a~ 162 (187)
T cd05119 154 YIIDVPQAV 162 (187)
T ss_pred EEEECcccc
Confidence 999999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=145.16 Aligned_cols=136 Identities=20% Similarity=0.265 Sum_probs=103.9
Q ss_pred eeee-ecCCeEEEEEEECCCCcEEEEEEeecCCC----------CchHHhhhHHHHHHHHHcCCCCCc--ceeeEEEEeC
Q psy7825 70 KVIG-IGSYATVKLATSTRHGCDVAVKVVSKVEA----------PPDYLKKFLPREIDVVKGLRHPNL--IRFLQAIETT 136 (357)
Q Consensus 70 ~~lG-~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~ 136 (357)
..|| .||.|+||.+... +..++||.+..... ........+.+|+.++..|.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888888888764 77899998854221 011223457789999999998775 6677664332
Q ss_pred -Ce---EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 137 -HR---VYIIMEYAEK-GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 137 -~~---~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
.. .++|+|+++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+|+||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 2599999997 689988865 3455543 568999999999999999999999999999999999999987
Q ss_pred c
Q psy7825 212 R 212 (357)
Q Consensus 212 ~ 212 (357)
.
T Consensus 190 ~ 190 (239)
T PRK01723 190 E 190 (239)
T ss_pred c
Confidence 5
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=133.83 Aligned_cols=131 Identities=21% Similarity=0.261 Sum_probs=110.8
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC--CCcceeeEEEEeCCeEEEEEec
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH--PNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
+.+.||.|.++.||++... +..+++|....... ...+.+|+.++..+.+ .++++++..+...+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4567999999999999875 37899998754332 3456789999999976 5889999888887889999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER---GVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 146 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
++|+.+..+ +......++.+++.+|++||.. +++|+|++|.||+++..+.++++|||.+.
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 998777654 5566778899999999999985 69999999999999998999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.3e-18 Score=156.62 Aligned_cols=257 Identities=21% Similarity=0.235 Sum_probs=194.0
Q ss_pred ccCeEEceeeee--cCCeEEEEEEE--CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCC
Q psy7825 63 NHGYVLGKVIGI--GSYATVKLATS--TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTH 137 (357)
Q Consensus 63 ~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 137 (357)
...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-......... ...=.+|+.....++ |++.++.+..++..+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCC
Confidence 455778889999 99999999998 788999999974322221111 112226676667775 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCCEEEcCC-CcEEEeecCCC
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVD----AIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFA 211 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~i~~----~l~~LH~~~ivH~dlkp~Nili~~~-~~~kl~Dfg~~ 211 (357)
..++-+|++. .+|..+...... ++...++..+.+... ||.++|..+++|-|++|.||+...+ ...+++|||+.
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 9999999995 688888876544 899999999999999 9999999999999999999999999 78899999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhhcccCC
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT--NYIQLLKQVQTKVVFP 289 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~ 289 (357)
..+................|...|++||...+-. +.. .|+|+||.++.+-.+|-.++... +....+++.. +...
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~-~~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~e 346 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA-TFA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--IPLE 346 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcccc-chH-hhhcchhhhhHhhHhhcccccCCCCCCcccccccc--Cchh
Confidence 7554333222222223335788999999887643 334 89999999999999887665433 2222222211 1111
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 290 TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 290 ~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
.-...+.++...+..|+ .+|..|+++..++.|+++.
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 11246777788999999 8899999999999999998
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-17 Score=163.14 Aligned_cols=272 Identities=20% Similarity=0.292 Sum_probs=207.5
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
...+++.+.+-+-+|.++.++.+.-..+|...++|+............+....+-.++-...+|-++.....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34556888889999999999999877777666766653322211111111222222222234465665555555677899
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc---
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC--- 217 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~--- 217 (357)
++++|..|++|...++..++.+.+-++.++..+..++++||...+.|+|++|.|+|+..+|+.++.|||........
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999843211000
Q ss_pred ------------------c-----CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Q psy7825 218 ------------------K-----SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN 274 (357)
Q Consensus 218 ------------------~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 274 (357)
. ............||+.|.+||...+...... +|+|++|+++++.++|..||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0001122345679999999999999998888 999999999999999999999999
Q ss_pred HHHHHHHHhhccc-CCC-CCCCCHHHHHHHHHhc-CCCCCCCCHH---HHhcCCCCCCCCCCCcc
Q psy7825 275 YIQLLKQVQTKVV-FPT-EPNVSAECKTLLSKIF-SPIKFRIRLK---DIKQDPWVKTEANPAAS 333 (357)
Q Consensus 275 ~~~~~~~i~~~~~-~~~-~~~~s~~~~~li~~~L-~~p~~Rps~~---~ll~hp~~~~~~~~~~~ 333 (357)
..+.++.+..... .+. +...+.+..+++..+| .+|.+|..+. ++..|+||++..+.+..
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence 9999988765433 222 3467899999999999 8999999988 99999999998776443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-15 Score=143.94 Aligned_cols=139 Identities=23% Similarity=0.345 Sum_probs=92.6
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC---------------------------c----hHHhhh----
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP---------------------------P----DYLKKF---- 110 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------------~----~~~~~~---- 110 (357)
|.. +.||+|++|+||+|+.+.+|+.||||++++.... . ++..+.
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 555 7899999999999999888999999999643110 0 011222
Q ss_pred --HHHHHHHHHcCC----CCCcceeeEEE-EeCCeEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHHHHHH
Q psy7825 111 --LPREIDVVKGLR----HPNLIRFLQAI-ETTHRVYIIMEYAEKGSLLDF--IQREG----YIDEPRTKKWFRQLVDAI 177 (357)
Q Consensus 111 --~~~E~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~--l~~~~----~l~~~~~~~i~~~i~~~l 177 (357)
+.+|+..+.++. +.+.+.+-.++ +.....++||||++|+++.++ +...+ .+.+..+..++.|+
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---- 276 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---- 276 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH----
Confidence 334444444442 22222222222 224456799999999999875 33333 23334444444444
Q ss_pred HHHHhCCceecCCCCCCEEEcCCC----cEEEeecCCCc
Q psy7825 178 DYCHERGVVHRDIKCENLLIDGEY----NIKLSDFGFAR 212 (357)
Q Consensus 178 ~~LH~~~ivH~dlkp~Nili~~~~----~~kl~Dfg~~~ 212 (357)
...|++|+|++|.||+++.+| .++++|||+..
T Consensus 277 ---f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg 312 (537)
T PRK04750 277 ---FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVG 312 (537)
T ss_pred ---HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEE
Confidence 459999999999999999988 99999999975
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.2e-17 Score=139.22 Aligned_cols=206 Identities=20% Similarity=0.298 Sum_probs=144.4
Q ss_pred HHHHcCCCCCcceeeEEEEe-----CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--
Q psy7825 116 DVVKGLRHPNLIRFLQAIET-----THRVYIIMEYAEKGSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCHERG-- 184 (357)
Q Consensus 116 ~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~-- 184 (357)
..|-++.|.|+++++.++.+ .....++.||+..|+|..+|++- ..+......+|+.||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 45566779999999988754 34688999999999999999863 45888999999999999999999884
Q ss_pred ceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHH
Q psy7825 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA 264 (357)
Q Consensus 185 ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 264 (357)
|+|+++..+.|++..+|-+|++--............ .........+-++|.+||.=...+.+.. +|||++|+...+|.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~-~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlema 276 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNST-REAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEMA 276 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhh-hHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHHH
Confidence 999999999999999998887543221111000000 0011122346788999996555444444 99999999999999
Q ss_pred cCCCCCC-CCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 265 FGRLPFD-DTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 265 ~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.|..--. .......-..+...... .-...-+++|..|| ..|..||++.++|.||-+-+.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~----len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIG----LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred HheeccCCCcceeehhhhhhhheee----ccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 8765422 22211111222221111 12234567899999 789999999999999987553
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-14 Score=136.28 Aligned_cols=184 Identities=18% Similarity=0.329 Sum_probs=137.4
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
|.+ +..+-++.+..-.|..+.++.+|.|.+...... .......+.+..|+.++||||++++..++.++.+|+|+|.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 444 333344443332466778899999998865443 2244566888999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH-ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 146 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
+. .|...+.+.+ ...+..-+.||+.||.+|| +.+++|++|.-..|+|+..|..||++|-++...... ..
T Consensus 91 V~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~----~~- 160 (690)
T KOG1243|consen 91 VR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGF----NA- 160 (690)
T ss_pred cc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccC----Cc-
Confidence 84 7888887744 7778888999999999998 568999999999999999999999999877422111 10
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcC
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFG 266 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 266 (357)
......-.-.|..|+.+....++ .|.|.|||++++++.|
T Consensus 161 ~~~~~~~~~s~~~P~~~~~s~~s---~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 PAKSLYLIESFDDPEEIDPSEWS---IDSWGLGCLIEELFNG 199 (690)
T ss_pred ccccchhhhcccChhhcCccccc---hhhhhHHHHHHHHhCc
Confidence 11111122346677766544432 7999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.4e-14 Score=119.25 Aligned_cols=139 Identities=14% Similarity=0.178 Sum_probs=101.6
Q ss_pred ceeeeecCCeEEEEEEECC------CCcEEEEEEeecCCCC----------c---------hHHhhh----HHHHHHHHH
Q psy7825 69 GKVIGIGSYATVKLATSTR------HGCDVAVKVVSKVEAP----------P---------DYLKKF----LPREIDVVK 119 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~----------~---------~~~~~~----~~~E~~~l~ 119 (357)
..+||.|.=+.||.|.... .+..+|||+.+..... + ...... .++|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998553 3579999998532110 0 011222 338999999
Q ss_pred cCCC--CCcceeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCEE
Q psy7825 120 GLRH--PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC-HERGVVHRDIKCENLL 196 (357)
Q Consensus 120 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~ivH~dlkp~Nil 196 (357)
++.. -+++..+++ ..-++||||+.+..+..-.-+...++...+..+..+++.+|..| |..|+||+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9963 456677764 45679999997654432222233456667788899999999998 8999999999999999
Q ss_pred EcCCCcEEEeecCCCc
Q psy7825 197 IDGEYNIKLSDFGFAR 212 (357)
Q Consensus 197 i~~~~~~kl~Dfg~~~ 212 (357)
+. ++.+.|+|||.+.
T Consensus 158 ~~-~~~v~iIDF~qav 172 (197)
T cd05146 158 WH-DGKVWFIDVSQSV 172 (197)
T ss_pred EE-CCcEEEEECCCce
Confidence 97 4689999999886
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=137.00 Aligned_cols=141 Identities=22% Similarity=0.230 Sum_probs=97.4
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---------------------------h----HHh------hhH
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP---------------------------D----YLK------KFL 111 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------------------------~----~~~------~~~ 111 (357)
.+.||.|++|.||+|+.. +|+.||||+.+...... . ... -.+
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 357999999999999865 68999999985421100 0 000 024
Q ss_pred HHHHHHHHcCC-----CCCcceeeEE-EEeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q psy7825 112 PREIDVVKGLR-----HPNLIRFLQA-IETTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVD-AIDYCHER 183 (357)
Q Consensus 112 ~~E~~~l~~l~-----h~~iv~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~-~l~~LH~~ 183 (357)
.+|+..+..+. +++| .+-.. .......++||||++|++|.++.... ... ....++..++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 45666555552 3332 22222 22344568999999999999887532 112 23456666665 47889999
Q ss_pred CceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 184 ~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
|++|+|++|.||+++.++.++++|||++..+
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999998644
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.2e-14 Score=116.19 Aligned_cols=127 Identities=14% Similarity=0.104 Sum_probs=95.2
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-ceeeEEEEeCCeEEEEEeccC
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-IRFLQAIETTHRVYIIMEYAE 147 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~ 147 (357)
.+.|+.|.++.||+++.. +..|++|+....... ...+.+|+.+++.+.+.++ ++++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 356889999999999865 788999987543211 2235689999998865554 44554432 23479999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 148 KGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV-----VHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 148 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i-----vH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
|.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887653 01123457889999999999985 9999999999999 6689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=136.00 Aligned_cols=250 Identities=20% Similarity=0.182 Sum_probs=184.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEEC-CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATST-RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 140 (357)
..+|..+..||.|.|+.|+.+... .++..|++|...+....... ..+-..|+.+...+. |.+++.+...|...+..|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-DIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-hhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 456888999999999999998755 67889999987554333322 222336777777775 888999888888888888
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEEeecCCCcccccccC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~ 219 (357)
+-.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..+++|||....+..
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--- 419 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF--- 419 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce---
Confidence 999999999887777555558889999999999999999999999999999999999886 7779999998753211
Q ss_pred CCCCCCCCcccCCcccc--ccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 220 GHQSPLSDTFCGSYAYA--SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
......+..+++ +++......+... .|+++||..+++.++|...-...+.. ..+.. ...+..+....+
T Consensus 420 -----~~~~~~~~~r~~p~~~~~~e~~~~~~~-~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~-~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 420 -----SSGVFHHIDRLYPIAEILLEDYPHLSK-ADIFSLGLSVDEAITGSPLSESGVQS---LTIRS-GDTPNLPGLKLQ 489 (524)
T ss_pred -----ecccccccccccccchhhccccccccc-cccccccccccccccCcccCcccccc---eeeec-ccccCCCchHHh
Confidence 111222333444 4555566667766 99999999999999986533222111 11122 223444456688
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
+..+.+.++ .++..||.+.++..|.=|..
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 888888888 89999999999998875543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.3e-13 Score=107.21 Aligned_cols=133 Identities=23% Similarity=0.293 Sum_probs=99.1
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHH-----hhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYL-----KKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
..+++|+=+.+|.+.+. |..+++|.-.+.....+.. ...-.+|+.++..+.--.|....-++.+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 46789999999999764 5567777543322222222 2345579999999876565544444455666779999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
|++|..|.+.+... ...++..+-..+.-||..||+|+||.++||++..++ +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99999999999765 245666777777789999999999999999998764 9999999985
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.9e-13 Score=105.88 Aligned_cols=143 Identities=19% Similarity=0.219 Sum_probs=107.8
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEe-----ecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVV-----SKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~-----~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
....|-+|+-+.|+++.+. |+.++||.- +.......-.+....+|+..|.++.--+|.-..-+|.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678899999999999765 888888853 222222333455677899999998755665544455566666789
Q ss_pred EeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---cEEEeecCCCc
Q psy7825 143 MEYAEK-GSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY---NIKLSDFGFAR 212 (357)
Q Consensus 143 ~e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~---~~kl~Dfg~~~ 212 (357)
|||++| .++.+++... ..........++..|-+.+.-||.+++||+||.++||++..++ .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999987 5788888764 2233344478899999999999999999999999999997654 36899999975
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=6.2e-12 Score=108.33 Aligned_cols=139 Identities=19% Similarity=0.229 Sum_probs=103.6
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC--CCcceeeEEEEeC---CeEEEEEe
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH--PNLIRFLQAIETT---HRVYIIME 144 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e 144 (357)
+.||.|..+.||++.... |..+++|+....... .....+.+|+.++..+.+ .++++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998643 689999987543321 123457789999999975 3456777766553 25689999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE------------------------------------------ 182 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~------------------------------------------ 182 (357)
|++|.++.+.+.. ..++......++.+++++|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888775532 346666666777777777777763
Q ss_pred --------------CCceecCCCCCCEEEcC--CCcEEEeecCCCc
Q psy7825 183 --------------RGVVHRDIKCENLLIDG--EYNIKLSDFGFAR 212 (357)
Q Consensus 183 --------------~~ivH~dlkp~Nili~~--~~~~kl~Dfg~~~ 212 (357)
..++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 6678999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.8e-11 Score=109.86 Aligned_cols=211 Identities=17% Similarity=0.203 Sum_probs=152.2
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE----eCCeEEEEEeccCC-CC
Q psy7825 76 SYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE----TTHRVYIIMEYAEK-GS 150 (357)
Q Consensus 76 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-~~ 150 (357)
--.+.|++....+|..|++|.+.-..... ......-+++++++.|+|||+|.++|. .+..+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 45678999999999999999983211111 112235688999999999999999886 35578999999887 57
Q ss_pred hHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 151 LLDFIQR---------------EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 151 L~~~l~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
|.++--. +...++..+|.++.|+..||.++|+.|+.-+-|.|.+||++.+..++|...|....+.
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7776532 2347889999999999999999999999999999999999998888887776653321
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCC-CCCCCHHHH-HHHHhhcccCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP-FDDTNYIQL-LKQVQTKVVFPTEPN 293 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~-~~~i~~~~~~~~~~~ 293 (357)
... + |.+.+. +.-|.=.||.++..|.||..- +........ ++.|. +.
T Consensus 445 ~d~------------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~--------~~ 493 (655)
T KOG3741|consen 445 EDP------------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT--------TT 493 (655)
T ss_pred CCC------------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh--------hh
Confidence 111 0 111111 127999999999999999643 222222222 22222 25
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
++.+++++|.-+. ..+++ -++.+++.+
T Consensus 494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 494 YSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 8899999999988 56665 788888754
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.2e-12 Score=122.42 Aligned_cols=158 Identities=22% Similarity=0.345 Sum_probs=114.8
Q ss_pred HHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCcccccccC----CCCCCCCCcccCCccccccceecCC
Q psy7825 170 FRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS----GHQSPLSDTFCGSYAYASPEILKGV 244 (357)
Q Consensus 170 ~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~ 244 (357)
+.+++.|+.++|.. ++||++|.|++|.++.+|..||+.|+++........ ........-..-...|.|||.+.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 33444899999976 899999999999999999999999998763322111 1111111223356799999999986
Q ss_pred CCCCCcccHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhh---cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy7825 245 PYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQT---KVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIK 319 (357)
Q Consensus 245 ~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll 319 (357)
..+.. +|+||||+++|.+. .|+.-+.............. ...+-....+++++++-+.++| .++.-||++..++
T Consensus 185 ~~~~~-sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPA-SDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccc-ccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 66666 99999999999998 56666655433332222111 1122223579999999999999 8888899999999
Q ss_pred cCCCCCCCC
Q psy7825 320 QDPWVKTEA 328 (357)
Q Consensus 320 ~hp~~~~~~ 328 (357)
..|||++..
T Consensus 264 ~~~ff~D~~ 272 (700)
T KOG2137|consen 264 SIPFFSDPG 272 (700)
T ss_pred cccccCCch
Confidence 999999964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.4e-11 Score=100.08 Aligned_cols=126 Identities=24% Similarity=0.330 Sum_probs=83.8
Q ss_pred EEEEEEECCCCcEEEEEEeecCCC-----------------------CchHHhhhHHHHHHHHHcCCCC--CcceeeEEE
Q psy7825 79 TVKLATSTRHGCDVAVKVVSKVEA-----------------------PPDYLKKFLPREIDVVKGLRHP--NLIRFLQAI 133 (357)
Q Consensus 79 ~V~~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~ 133 (357)
.||.|... +|..+|||+.+.... .........++|...|..+..- ++++.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999864 578999999754211 1112234577899999999865 466666442
Q ss_pred EeCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 134 ETTHRVYIIMEYAE--KGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY-CHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 134 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
.-++||||++ |..+..+.... ++......++.+++..+.. +|..|++|+||++.|||++++ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2369999998 65565544322 2255667788888885444 689999999999999999987 999999998
Q ss_pred Cc
Q psy7825 211 AR 212 (357)
Q Consensus 211 ~~ 212 (357)
+.
T Consensus 153 av 154 (188)
T PF01163_consen 153 AV 154 (188)
T ss_dssp EE
T ss_pred ce
Confidence 75
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.9e-10 Score=101.33 Aligned_cols=139 Identities=17% Similarity=0.112 Sum_probs=98.0
Q ss_pred eeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHh---------hhHHHHHHHHHcCCCCC--cceeeEEEEe----
Q psy7825 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLK---------KFLPREIDVVKGLRHPN--LIRFLQAIET---- 135 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~~~~E~~~l~~l~h~~--iv~~~~~~~~---- 135 (357)
.+-......|+++.. .|+.|.||........ ...+ ..+.+|...+..|..-+ ++..+++++.
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 333333444666654 4778999976332211 0011 13568888888885333 3445555543
Q ss_pred -CCeEEEEEeccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-------CCcEE
Q psy7825 136 -THRVYIIMEYAEKG-SLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-------EYNIK 204 (357)
Q Consensus 136 -~~~~~lv~e~~~~~-~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-------~~~~k 204 (357)
....++|+|++++. +|.+++.. ....+......++.+++..+..||..||+|+|+++.|||++. ++.+.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 23578999999885 79999864 344567788899999999999999999999999999999975 46799
Q ss_pred EeecCCCc
Q psy7825 205 LSDFGFAR 212 (357)
Q Consensus 205 l~Dfg~~~ 212 (357)
|+||+.+.
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.9e-10 Score=102.46 Aligned_cols=234 Identities=16% Similarity=0.206 Sum_probs=152.5
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcce--------eeEEEEeCCe
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIR--------FLQAIETTHR 138 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~--------~~~~~~~~~~ 138 (357)
.+..||+|+-+.+|-.-.- ...+.|++........ . +-+..|... .||-+-. ++|- .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 4667999999999976432 2346677755433221 1 223334443 3553322 1111 12233
Q ss_pred EEEEEeccCCC-ChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 139 VYIIMEYAEKG-SLLDFIQ------REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 139 ~~lv~e~~~~~-~L~~~l~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
+.++|..+.|. .+..+.. ....+.+..+...+..++.+.+.||+.|.+-+|+.++|+||++++.+.|.|=...
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 67888888774 3333332 1234777889999999999999999999999999999999999999999986544
Q ss_pred cccccccCCCCCCCCCcccCCccccccceec-----CCCCCCCcccHHHHHHHHHHHHcC-CCCCCCCC-------HHH-
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILK-----GVPYTPHYSDVWSMGVVLYAMAFG-RLPFDDTN-------YIQ- 277 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~-------~~~- 277 (357)
... .........+|...|.+||... +..-+.. .|.|.||+++++|+.| ++||.+.. +.+
T Consensus 165 qi~------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 165 QIN------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred eec------cCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 321 1222334567999999999764 4444555 8999999999999986 99996532 111
Q ss_pred HHH--------HHhhcccCC----CCCCCCHHHHHHHHHhcC---CCCCCCCHHHH
Q psy7825 278 LLK--------QVQTKVVFP----TEPNVSAECKTLLSKIFS---PIKFRIRLKDI 318 (357)
Q Consensus 278 ~~~--------~i~~~~~~~----~~~~~s~~~~~li~~~L~---~p~~Rps~~~l 318 (357)
.+. +...+...+ ...-+++++..|..+|+. .+.-||+++..
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 111 101111111 113578999999999993 26689998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.4e-10 Score=96.92 Aligned_cols=137 Identities=23% Similarity=0.311 Sum_probs=103.8
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecC-------CCCc------------hHHhhhHHHHHHHHHcCCCC--
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV-------EAPP------------DYLKKFLPREIDVVKGLRHP-- 124 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~------------~~~~~~~~~E~~~l~~l~h~-- 124 (357)
+.++..||-|.=+.||.|.+. .|.++|||.=+.. .... .......++|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456788999999999999966 5899999974221 0011 11234466899999999744
Q ss_pred CcceeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7825 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIK 204 (357)
Q Consensus 125 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~k 204 (357)
.|++.+++ +..++|||+++|..|...- ++.+....++..|+.-+..+-..|+||+|+++-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67777763 5668999999996665533 24555666777777777777799999999999999999999999
Q ss_pred EeecCCCc
Q psy7825 205 LSDFGFAR 212 (357)
Q Consensus 205 l~Dfg~~~ 212 (357)
++||-.+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.2e-09 Score=88.13 Aligned_cols=139 Identities=14% Similarity=0.143 Sum_probs=101.4
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---hHHhhhHHHHHHHHHcCCCC--CcceeeEEEEe----CCeEEEE
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP---DYLKKFLPREIDVVKGLRHP--NLIRFLQAIET----THRVYII 142 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~----~~~~~lv 142 (357)
-|+||-+.|+..... |+.+-+|......... ......|.+|...|..|..- .+++....... .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 467899999998755 4578888764111100 22355678999999988532 24555422211 2246799
Q ss_pred EeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc--EEEeecCCCc
Q psy7825 143 MEYAEK-GSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN--IKLSDFGFAR 212 (357)
Q Consensus 143 ~e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~--~kl~Dfg~~~ 212 (357)
+|-+.| .+|.+++... .+.+......++.+++.++.-||+.|+.|+|+.+.|||++.+|. +.++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998764 5899988663 34577778899999999999999999999999999999987777 9999998664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.8e-09 Score=90.77 Aligned_cols=103 Identities=25% Similarity=0.324 Sum_probs=83.6
Q ss_pred hHHHHHHHHHcCCCCC--cceeeEEEEeC----CeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7825 110 FLPREIDVVKGLRHPN--LIRFLQAIETT----HRVYIIMEYAEKG-SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182 (357)
Q Consensus 110 ~~~~E~~~l~~l~h~~--iv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~ 182 (357)
...+|...+..|..-+ +++.+++.+.. ...++|+|++++. +|.+++......+......++.+++..+.-||.
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 4567888777775333 45566665542 2458999999884 799999875557788889999999999999999
Q ss_pred CCceecCCCCCCEEEcCCC---cEEEeecCCCc
Q psy7825 183 RGVVHRDIKCENLLIDGEY---NIKLSDFGFAR 212 (357)
Q Consensus 183 ~~ivH~dlkp~Nili~~~~---~~kl~Dfg~~~ 212 (357)
.||+|+|+++.|||++.++ .+.|+||+-++
T Consensus 137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred CcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 9999999999999999887 89999999765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.97 E-value=8.4e-09 Score=86.69 Aligned_cols=141 Identities=25% Similarity=0.267 Sum_probs=93.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhh------hHHHHHHHHHcCCC---CCcceeeE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKK------FLPREIDVVKGLRH---PNLIRFLQ 131 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~------~~~~E~~~l~~l~h---~~iv~~~~ 131 (357)
+..++|.+.+++-......|.+..- +|..+++|..+......+.... ...+++..+..+.. .....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3456789999998888777777654 4889999987653322221111 12234444444422 22223222
Q ss_pred EE-----EeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEe
Q psy7825 132 AI-----ETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLS 206 (357)
Q Consensus 132 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~ 206 (357)
+. ......+++|||++|..|.++.. +++ .+...|..++.-||..|++|+|.+|.|++++++ .++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence 22 22345678999999988877543 333 245667788999999999999999999999965 49999
Q ss_pred ecCCCc
Q psy7825 207 DFGFAR 212 (357)
Q Consensus 207 Dfg~~~ 212 (357)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.6e-08 Score=84.62 Aligned_cols=136 Identities=18% Similarity=0.181 Sum_probs=94.6
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch---------------------HHhhhHHHHHHHHHcCC--CCCc
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD---------------------YLKKFLPREIDVVKGLR--HPNL 126 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l~--h~~i 126 (357)
.+|+.|.-+.||+|.. .++..+|+|++......-. .......+|...|.++. +=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677888889999974 5589999999854322111 11233557888888875 3344
Q ss_pred ceeeEEEEeCCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEE
Q psy7825 127 IRFLQAIETTHRVYIIMEYAEKG-SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIK 204 (357)
Q Consensus 127 v~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~k 204 (357)
++-+++. ...|||||+... .-.-.|.. -.+...++..+..++++.+.-|-. .++||+||+.-|||+. ++.+.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 5555543 346999998553 11111111 123344688888889998888877 8999999999999999 78999
Q ss_pred EeecCCCc
Q psy7825 205 LSDFGFAR 212 (357)
Q Consensus 205 l~Dfg~~~ 212 (357)
++|||.+.
T Consensus 207 iID~~QaV 214 (268)
T COG1718 207 IIDVSQAV 214 (268)
T ss_pred EEECcccc
Confidence 99999986
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.6e-08 Score=96.39 Aligned_cols=140 Identities=27% Similarity=0.261 Sum_probs=92.5
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC---------------------------ch----HHhh------hHH
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP---------------------------PD----YLKK------FLP 112 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------------~~----~~~~------~~~ 112 (357)
+.|+.++-|+||+|+... |+.||||+.+..-.. .. +..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999775 999999997542110 00 0111 134
Q ss_pred HHHHHHHcCC-----CCCcceeeEEEEeCCeEEEEEeccCCCChHHHH--HhcCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q psy7825 113 REIDVVKGLR-----HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI--QREGYIDEPRTKKWFRQLVDA-IDYCHERG 184 (357)
Q Consensus 113 ~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~l~~~~~~~i~~~i~~~-l~~LH~~~ 184 (357)
+|...+.++. .++|.--.=+++....-.++|||++|..+.+.. ...+ ++... ++..++.+ +..+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g-~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG-IDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC-CCHHH---HHHHHHHHHHHHHHhcC
Confidence 5665555552 333322222334456678999999999888884 4433 45333 22222222 33344589
Q ss_pred ceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 185 ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
++|.|.+|.||+++.+|.+.+.|||+...+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 999999999999999999999999998643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.80 E-value=1e-07 Score=82.20 Aligned_cols=133 Identities=17% Similarity=0.127 Sum_probs=83.4
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC--cceeeEEEEeCCeEEEEEeccC
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN--LIRFLQAIETTHRVYIIMEYAE 147 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~ 147 (357)
..||+|..+.||+. .|..+++|...... . ...+.+|.+++..+..-+ +++.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-D----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-C----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999984 25568899875322 1 233578999999886433 4677888877888899999999
Q ss_pred CCC-hHHHH--------------Hh------c---CCCCHHHH-HHHHH----------HHHH-HHHHHHh----CCcee
Q psy7825 148 KGS-LLDFI--------------QR------E---GYIDEPRT-KKWFR----------QLVD-AIDYCHE----RGVVH 187 (357)
Q Consensus 148 ~~~-L~~~l--------------~~------~---~~l~~~~~-~~i~~----------~i~~-~l~~LH~----~~ivH 187 (357)
|.+ +...+ .+ . ........ ..+.. .+.. ...+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11111 10 0 00111110 01100 1111 1222221 24789
Q ss_pred cCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 188 RDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 188 ~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.3e-09 Score=101.29 Aligned_cols=245 Identities=16% Similarity=0.082 Sum_probs=167.1
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC-cceeeEEEEeCCeEEEEEe
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN-LIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 144 (357)
|...+-+++|+++.+++.+...+...+ .+++... ....-++++|.+++||| .+..++.++.+...+++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 555667899999999999876654444 6666433 22335889999999999 7777888888889999999
Q ss_pred ccCCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 145 YAEKG-SLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 145 ~~~~~-~L~~~l-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
++.++ +....+ ...-.+.+.+...+...-.+++++||+..-+|+| ||+..+ +..+..||+....+...
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~----- 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT----- 384 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc-----
Confidence 99886 222111 1111233444555666677889999999878998 777654 67899999987644221
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC----CCCCCHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT----EPNVSAEC 298 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~s~~~ 298 (357)
.......+++.|+|||+.....+... .|.|++|.-..+|.-|-.|-.. +......+-.....+. ...-+..-
T Consensus 385 -~~~~t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~ 460 (829)
T KOG0576|consen 385 -MKPRTAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFH 460 (829)
T ss_pred -cccccCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccc
Confidence 13456779999999999999998888 9999999887788777766432 1000000000000000 00011111
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAAS 333 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 333 (357)
+++...|+ .-|.-|+....++.|.+|.+++-+..+
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~ 496 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHC 496 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhccCccccee
Confidence 24777888 678889999999999999999877443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.1e-07 Score=80.63 Aligned_cols=137 Identities=20% Similarity=0.201 Sum_probs=81.7
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCC--CcceeeEEE---EeCCeEEEEE
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP--NLIRFLQAI---ETTHRVYIIM 143 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~---~~~~~~~lv~ 143 (357)
++.|+.|..+.||++.... ..+++|+.... .....+.+|..++..+... .+++++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999998664 58999986432 2345677888888888533 355666644 3344678999
Q ss_pred eccCCCChHH----------------HHHh---c----CCCCHHH------HHHH---------------HHHHHH-HHH
Q psy7825 144 EYAEKGSLLD----------------FIQR---E----GYIDEPR------TKKW---------------FRQLVD-AID 178 (357)
Q Consensus 144 e~~~~~~L~~----------------~l~~---~----~~l~~~~------~~~i---------------~~~i~~-~l~ 178 (357)
++++|..+.. .+.+ . ..+.... ...+ ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 1111 1 0011000 0000 111222 333
Q ss_pred HHHh-------CCceecCCCCCCEEEc-CCCcEEEeecCCCc
Q psy7825 179 YCHE-------RGVVHRDIKCENLLID-GEYNIKLSDFGFAR 212 (357)
Q Consensus 179 ~LH~-------~~ivH~dlkp~Nili~-~~~~~kl~Dfg~~~ 212 (357)
.++. ..++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 3599999999999999 56667899999763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.1e-07 Score=91.82 Aligned_cols=203 Identities=17% Similarity=0.202 Sum_probs=143.1
Q ss_pred HHHHHHHHHcCCCCCcceeeEEEEeCCeEE----EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7825 111 LPREIDVVKGLRHPNLIRFLQAIETTHRVY----IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVV 186 (357)
Q Consensus 111 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iv 186 (357)
...|...+..+.|+|++.++.+........ +..+++.+.++...++.-+.++....+.+..++..||.|+|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 445677788889999999998875544333 4467888899999999999999999999999999999999999666
Q ss_pred ecCCCCC---CEEEcCCCcEEEe--ecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCC-cccHHHHHHHH
Q psy7825 187 HRDIKCE---NLLIDGEYNIKLS--DFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH-YSDVWSMGVVL 260 (357)
Q Consensus 187 H~dlkp~---Nili~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il 260 (357)
|.-+... +.-++.++.+.++ ||+..+.+.... ......-...|.++|.......... ..|+|.+|...
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~------~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE------KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcc------cchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 6555555 4444566666666 888775332111 1112234556788888766555433 26999999999
Q ss_pred HHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 261 YAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 261 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
..+..|..+-.... ....+. .........+++.+|+ .++++|+++.+++.|+|.+....
T Consensus 383 ~~~~~~~~i~~~~~---~~~~~l-------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA---VPVSLL-------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred hhhhhcCccccccc---chhhhh-------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence 99998765432111 000000 0012227888889999 88999999999999999987543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.3e-07 Score=73.85 Aligned_cols=129 Identities=19% Similarity=0.239 Sum_probs=93.5
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcce-eeEEEEeCCeEEEEEe
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIR-FLQAIETTHRVYIIME 144 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e 144 (357)
-...+.||+|.+|.||++.+. |..+|+|+-+... .+..+..|+++|..++.-++.+ ++.+.++ ++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 445678999999999999876 6799999865322 2566789999999998776654 4444332 34599
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCCEEEcCCCcEEEeecCCCc
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIK-CENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlk-p~Nili~~~~~~kl~Dfg~~~ 212 (357)
|+.|.+|.++.... + ++-+..+++.-.-|-..||-|+.|+ |...+|..++.+.|+||..|+
T Consensus 93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 99998887766432 2 2334555666566788899999987 555555555699999999875
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.7e-07 Score=77.55 Aligned_cols=133 Identities=16% Similarity=0.096 Sum_probs=82.6
Q ss_pred eeecCC-eEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEEEeccCCC
Q psy7825 72 IGIGSY-ATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYIIMEYAEKG 149 (357)
Q Consensus 72 lG~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~ 149 (357)
|-.|.+ ..||++... +..++||+..... ...+.+|+.++..+. +--+++++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 445555 789998643 4688999865432 223557888888884 444667888777767788999999997
Q ss_pred ChHHHHH----------------h--c-C----CCCHH--HHHHHHH--------------------HHHHHHHHHH---
Q psy7825 150 SLLDFIQ----------------R--E-G----YIDEP--RTKKWFR--------------------QLVDAIDYCH--- 181 (357)
Q Consensus 150 ~L~~~l~----------------~--~-~----~l~~~--~~~~i~~--------------------~i~~~l~~LH--- 181 (357)
+|..... + . . ++... ....... .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 7664320 0 0 0 11100 0000000 0111122221
Q ss_pred ----hCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 182 ----ERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 182 ----~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1248999999999999998778899999763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.4e-06 Score=83.20 Aligned_cols=139 Identities=24% Similarity=0.300 Sum_probs=88.5
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC----------------------------chHHhhh------HHHH
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP----------------------------PDYLKKF------LPRE 114 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~~~------~~~E 114 (357)
.+.||.-+.|.||+|+.+. |+.||||+.+..-.. -++..+. |.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3579999999999999776 999999997542111 0111111 2234
Q ss_pred HHHHHcC----CCCC------cceeeEEEEeCCeEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHH-HHHHH
Q psy7825 115 IDVVKGL----RHPN------LIRFLQAIETTHRVYIIMEYAEKGSLLDF--IQREGYIDEPRTKKWFRQLVDA-IDYCH 181 (357)
Q Consensus 115 ~~~l~~l----~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~l~~~~~~~i~~~i~~~-l~~LH 181 (357)
++...++ .|-+ |++++. .......|+|||++|..+.|. |.+.+ ++...+. ..+.++ ++.|=
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~---~~l~~~~~~qIf 318 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDIL---NKLVEAYLEQIF 318 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHH---HHHHHHHHHHHH
Confidence 4333332 2434 333333 234456899999999876654 33443 5555433 333333 22344
Q ss_pred hCCceecCCCCCCEEEcC----CCcEEEeecCCCccc
Q psy7825 182 ERGVVHRDIKCENLLIDG----EYNIKLSDFGFARGH 214 (357)
Q Consensus 182 ~~~ivH~dlkp~Nili~~----~~~~kl~Dfg~~~~~ 214 (357)
..|++|+|-+|.||++.. ++.+.+.|||+...+
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 678999999999999984 567999999998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.40 E-value=7.9e-06 Score=68.10 Aligned_cols=128 Identities=19% Similarity=0.176 Sum_probs=89.0
Q ss_pred cCeEEceeeeecCC-eEEEEEEECCCCcEEEEEEeecCCCCc-----------h-------HHhhhHHHHHHHHHcCC--
Q psy7825 64 HGYVLGKVIGIGSY-ATVKLATSTRHGCDVAVKVVSKVEAPP-----------D-------YLKKFLPREIDVVKGLR-- 122 (357)
Q Consensus 64 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~-------~~~~~~~~E~~~l~~l~-- 122 (357)
.+++.++.||.|.- |.||+++.. |+.||+|++..-.... + ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57999999999999 999999765 7899999943211000 0 12234667777777664
Q ss_pred -CCCc--ceeeEEEEeC------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy7825 123 -HPNL--IRFLQAIETT------------------HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181 (357)
Q Consensus 123 -h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH 181 (357)
+.++ ++.+|+..-. ....||.||++... .+... -+.+|.+-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 4556 8888887322 12457777776533 23333 3456666777799
Q ss_pred hCCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 182 ~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999997 4588999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.3e-06 Score=85.74 Aligned_cols=80 Identities=18% Similarity=0.194 Sum_probs=56.1
Q ss_pred ceeeeecCCeEEEEEEECCCC--cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCc--ceeeEEEEeC---CeEE
Q psy7825 69 GKVIGIGSYATVKLATSTRHG--CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNL--IRFLQAIETT---HRVY 140 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~ 140 (357)
.+.|+.|.+..+|+......+ ..+++|+......... ...+.+|+.+|+.+. |+++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~--~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS--AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc--HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 567899999999998765432 4688887543221111 245779999999995 6654 7777777653 4678
Q ss_pred EEEeccCCCC
Q psy7825 141 IIMEYAEKGS 150 (357)
Q Consensus 141 lv~e~~~~~~ 150 (357)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.37 E-value=9.5e-06 Score=68.11 Aligned_cols=134 Identities=20% Similarity=0.299 Sum_probs=93.5
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC-------------chHHhhhHHHHHHHHHcCC------CCCccee
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP-------------PDYLKKFLPREIDVVKGLR------HPNLIRF 129 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~------h~~iv~~ 129 (357)
...||+|+.-.||.-- .....+||+....... .........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3479999999999542 3456899998765400 0011233446666555554 7889999
Q ss_pred eEEEEeCCeEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC--C
Q psy7825 130 LQAIETTHRVYIIMEYAEK------GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE--Y 201 (357)
Q Consensus 130 ~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~--~ 201 (357)
+|+.+++....+|+|.+.. .+|.+++.+.. +++ .+...+-+-..||-+++|+.+|++|.||++... +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999997643 36888885543 555 344444556678899999999999999999643 2
Q ss_pred --cEEEee-cCC
Q psy7825 202 --NIKLSD-FGF 210 (357)
Q Consensus 202 --~~kl~D-fg~ 210 (357)
.+.|+| ||.
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 577887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.9e-06 Score=73.04 Aligned_cols=73 Identities=14% Similarity=0.082 Sum_probs=45.6
Q ss_pred eeeeecCCe-EEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCC---CcceeeEEEEeC---CeEEEE
Q psy7825 70 KVIGIGSYA-TVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP---NLIRFLQAIETT---HRVYII 142 (357)
Q Consensus 70 ~~lG~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv 142 (357)
+.|+.|+.. .||+. +..+++|+..... ....+.+|+.++..+... .+.++++..... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 467777776 48876 2357888754311 133577899999888532 344555444322 245789
Q ss_pred EeccCCCChH
Q psy7825 143 MEYAEKGSLL 152 (357)
Q Consensus 143 ~e~~~~~~L~ 152 (357)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.7e-05 Score=68.62 Aligned_cols=77 Identities=10% Similarity=0.028 Sum_probs=55.4
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC---CCcceeeEEEEe---CCeEEE
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH---PNLIRFLQAIET---THRVYI 141 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~---~~~~~l 141 (357)
-.+.||.|..+.||...... + .+++|..+. ... ...+..|...|+.|.. -.++++++.+.. .+..++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPLMARS-FST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEEEecc-ccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 35579999999999986432 3 577787432 111 2457789999998853 367888887754 366899
Q ss_pred EEeccCCCCh
Q psy7825 142 IMEYAEKGSL 151 (357)
Q Consensus 142 v~e~~~~~~L 151 (357)
|||+++|.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998765
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=98.13 E-value=4e-06 Score=74.08 Aligned_cols=136 Identities=18% Similarity=0.276 Sum_probs=96.7
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCC-------CCchH------------HhhhHHHHHHHHHcCCC--C
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVE-------APPDY------------LKKFLPREIDVVKGLRH--P 124 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~------------~~~~~~~E~~~l~~l~h--~ 124 (357)
+.++..||-|.-+.||.+-+. .|++.++|+-+... ...++ .+-...+|...|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 566788999999999999855 48899999632111 11111 11224578888888852 2
Q ss_pred CcceeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7825 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIK 204 (357)
Q Consensus 125 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~k 204 (357)
-|++.+++ +..++|||++.|-+|...-+-. .+..+...+...+.-|..+|+||+|+.--||+|++++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 35555543 4568999999997776654322 2344556666677778999999999999999999999999
Q ss_pred EeecCCCc
Q psy7825 205 LSDFGFAR 212 (357)
Q Consensus 205 l~Dfg~~~ 212 (357)
++||-...
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99997654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.2e-05 Score=66.43 Aligned_cols=75 Identities=16% Similarity=0.096 Sum_probs=47.7
Q ss_pred ceeeeecCCeEEEEEEECC-CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC-cceeeEEEEeCCeEEEEEecc
Q psy7825 69 GKVIGIGSYATVKLATSTR-HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN-LIRFLQAIETTHRVYIIMEYA 146 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~ 146 (357)
.+.|..|-...+|++.... .+..|++|+....... .-...+|+.++..+...+ .+++++.+. + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 3567778888999997443 3578999976532111 112347888888885433 344544432 2 3799999
Q ss_pred CCCCh
Q psy7825 147 EKGSL 151 (357)
Q Consensus 147 ~~~~L 151 (357)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.7e-05 Score=66.28 Aligned_cols=96 Identities=17% Similarity=0.164 Sum_probs=77.6
Q ss_pred HHHHHHHcCCC-CCcceeeEEEEeCCeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q psy7825 113 REIDVVKGLRH-PNLIRFLQAIETTHRVYIIMEYAEKGSLLDF---IQREGYIDEPRTKKWFRQLVDAIDYCHE---RGV 185 (357)
Q Consensus 113 ~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i 185 (357)
.|.-++..+++ +++++++|+|-. ++|.||...+++... +..-...++....+|+.++++.+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999975 689999999832 568899987665421 1122235889999999999999999998 358
Q ss_pred eecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 186 VHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 186 vH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.-.|++++|+-|+++|.+|++|...+.
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcc
Confidence 889999999999999999999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.05 E-value=3e-05 Score=68.37 Aligned_cols=131 Identities=17% Similarity=0.210 Sum_probs=76.1
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-ceeeEEEEeCCeEEEEEeccCCCC
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-IRFLQAIETTHRVYIIMEYAEKGS 150 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~ 150 (357)
+..|-...+|+.. .++..+++|+....... ..-...+|..+++.+...++ ++++.... -++|+||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 5567788899886 34678999975432111 10124578889998864433 34444432 268999999865
Q ss_pred hHH--------------HHHh---c----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceecCCC
Q psy7825 151 LLD--------------FIQR---E----GYIDE-PRTKKWFRQL---------VDAIDYCHE--------RGVVHRDIK 191 (357)
Q Consensus 151 L~~--------------~l~~---~----~~l~~-~~~~~i~~~i---------~~~l~~LH~--------~~ivH~dlk 191 (357)
+.. .+.+ . .+++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 432 1111 0 11111 1112221111 122222222 248999999
Q ss_pred CCCEEEcCCCcEEEeecCCCc
Q psy7825 192 CENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 192 p~Nili~~~~~~kl~Dfg~~~ 212 (357)
|.||++++++ +.|+||..+.
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cCcEEEeCCC-CEEEeccccC
Confidence 9999999877 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.00013 Score=67.80 Aligned_cols=79 Identities=16% Similarity=0.047 Sum_probs=52.7
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC--c--hHHhhhHHHHHHHHHcCC---CCCcceeeEEEEeCCeEEE
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--P--DYLKKFLPREIDVVKGLR---HPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~--~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~l 141 (357)
.+.||.|.+..||++.....++.++||.-...... . ....+....|.+.|..+. ..++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 45799999999999998654468999975321110 0 112344567888888763 2456677766 3355789
Q ss_pred EEeccCCC
Q psy7825 142 IMEYAEKG 149 (357)
Q Consensus 142 v~e~~~~~ 149 (357)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999764
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=98.00 E-value=9.7e-05 Score=66.63 Aligned_cols=141 Identities=18% Similarity=0.265 Sum_probs=96.4
Q ss_pred EEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCC-----------------------CchHHhhhHHHHHHHHHcCCC
Q psy7825 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA-----------------------PPDYLKKFLPREIDVVKGLRH 123 (357)
Q Consensus 67 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~h 123 (357)
.|..+|..|.-+.||.|. ..+|..+|||+++..-. .....+-....|+..|.+|..
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 455688899999999998 45688899999743210 111223345678888888876
Q ss_pred CCcceeeEEEEeCCeEEEEEeccCCCC-hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEcCCC
Q psy7825 124 PNLIRFLQAIETTHRVYIIMEYAEKGS-LLDFIQREGYIDEPRTKKWFRQLVDAIDYCH-ERGVVHRDIKCENLLIDGEY 201 (357)
Q Consensus 124 ~~iv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~dlkp~Nili~~~~ 201 (357)
.+|+..--... ....|||+++.+.. -.-.| +.-.++...+..+-.+++.-|.-|- ..++||.||+--|+|+- +|
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG 301 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC
Confidence 65443222222 13468999985321 11112 2334777788888888888777765 56999999999999986 56
Q ss_pred cEEEeecCCCc
Q psy7825 202 NIKLSDFGFAR 212 (357)
Q Consensus 202 ~~kl~Dfg~~~ 212 (357)
.+.|+|.+.+.
T Consensus 302 ~lyiIDVSQSV 312 (520)
T KOG2270|consen 302 KLYIIDVSQSV 312 (520)
T ss_pred EEEEEEccccc
Confidence 99999999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00012 Score=66.00 Aligned_cols=136 Identities=21% Similarity=0.219 Sum_probs=81.5
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC--cceeeEE------EEeCCeEE
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN--LIRFLQA------IETTHRVY 140 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~------~~~~~~~~ 140 (357)
.+.|..|....+|++... +..+++|+... .. ...+..|+.++..+.+.+ +++++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VS----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CC----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 456777888899998643 45799998754 11 233556777777774322 4444431 23355678
Q ss_pred EEEeccCCCChHH----HHH-------h----cCCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q psy7825 141 IIMEYAEKGSLLD----FIQ-------R----EGYIDE--------PRTK------------KWFRQLVDAIDYCHE--- 182 (357)
Q Consensus 141 lv~e~~~~~~L~~----~l~-------~----~~~l~~--------~~~~------------~i~~~i~~~l~~LH~--- 182 (357)
+|+++++|..+.. .+. + ...+.. .... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 111 0 000000 0000 011112334444443
Q ss_pred ----CCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 183 ----RGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 183 ----~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999988777899999864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=66.62 Aligned_cols=140 Identities=19% Similarity=0.153 Sum_probs=81.4
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC--cceeeEE------EEeCC
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN--LIRFLQA------IETTH 137 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~------~~~~~ 137 (357)
....+.++.|....+|++... +..+++|+...... ...+..|..++..|...+ +++++.. ....+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~-----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVK-----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCCCC-----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 344667788888899998643 34688998754211 122345667777764222 3444432 12346
Q ss_pred eEEEEEeccCCCChH----HHHH----------h-cCCC--------CHHHHHH---------------HHHHHHHHHHH
Q psy7825 138 RVYIIMEYAEKGSLL----DFIQ----------R-EGYI--------DEPRTKK---------------WFRQLVDAIDY 179 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~----~~l~----------~-~~~l--------~~~~~~~---------------i~~~i~~~l~~ 179 (357)
..+++++|++|..+. ..+. . ...+ ....... ....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999985431 1111 0 0001 0010000 01112334555
Q ss_pred HHh-------CCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 180 CHE-------RGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 180 LH~-------~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
+.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 542 579999999999999998877899999863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.88 E-value=6.6e-07 Score=92.48 Aligned_cols=219 Identities=17% Similarity=0.087 Sum_probs=144.9
Q ss_pred hhhHHHHHHHHHcCCCCCcceeeEEEE--eCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH
Q psy7825 108 KKFLPREIDVVKGLRHPNLIRFLQAIE--TTHRVYIIMEYAEKGSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCH 181 (357)
Q Consensus 108 ~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~LH 181 (357)
++....|..-++...|+++.....-.. .....+.+++++.+|.+++.+-++ .++....+.....+.+....-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 344445666666678888777655442 233567889999999999999653 33444444444444466666666
Q ss_pred hC---C--ceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHH
Q psy7825 182 ER---G--VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSM 256 (357)
Q Consensus 182 ~~---~--ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 256 (357)
.. | .+|+++++-|.+|..+..++++++|+.+.. .+.....+...+++.|+.|++...-.++.+ +|+|..
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-----np~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~ 1426 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-----NPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRR 1426 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCccccccccccccc-----CchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHH
Confidence 44 1 789999999999999999999999998722 112223445678889999999988888877 999999
Q ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 257 GVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 257 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
|+.+|.+..|..+|-......+...+.....+..+.-.|.+.-.....+| ..-..||.-..++..+.|-...-.-+
T Consensus 1427 s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~~~d~~ 1503 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVGLRDIC 1503 (2724)
T ss_pred HHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccccccCcc
Confidence 99999999998887543333333333333333333333344444444444 55555888888887777655444433
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0015 Score=59.54 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=74.3
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC--cceeeE------EEEeCCeEE
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN--LIRFLQ------AIETTHRVY 140 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~------~~~~~~~~~ 140 (357)
.+.|+.|....+|++... +..+++|++.. ... ..+..|+.++..|...+ +++.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~--~~~----~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER--LTA----EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEecc--CCh----HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 345777887899998743 33799998751 111 22234555555553111 333332 123356678
Q ss_pred EEEeccCCCChH-----------HHHHh----cCCC--------CH---HHH-HH-----------HHHH-HHHHHHHHH
Q psy7825 141 IIMEYAEKGSLL-----------DFIQR----EGYI--------DE---PRT-KK-----------WFRQ-LVDAIDYCH 181 (357)
Q Consensus 141 lv~e~~~~~~L~-----------~~l~~----~~~l--------~~---~~~-~~-----------i~~~-i~~~l~~LH 181 (357)
++++|++|..+. ..+.+ ...+ .. ... .. .+.+ +...+..+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999986431 11111 0000 00 000 00 1111 111223332
Q ss_pred -------hCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 182 -------ERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 182 -------~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
..++||+|+.|.||+++.+....|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2379999999999999976556899999874
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00029 Score=63.32 Aligned_cols=138 Identities=19% Similarity=0.178 Sum_probs=80.8
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC--CCcceeeEEEEeCC--eEEE
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH--PNLIRFLQAIETTH--RVYI 141 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~--~~~l 141 (357)
..+.+.+..|-.-.+|..... ++.++++ ... ....-.......+|+.+++.+.- --+...++.|..+. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 344445534444445555443 7788888 322 11122223445578888888753 23445566665554 6789
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHH-HHHHHHHHHH---------------------------------------
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFR-QLVDAIDYCH--------------------------------------- 181 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~-~i~~~l~~LH--------------------------------------- 181 (357)
||+|++|..+.+.+... .....++. .++..|..||
T Consensus 103 v~~~veGe~~~~~~~~~-----~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 103 VMEWVEGEVVWSALPPE-----SLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEEEecceeccCcCCcc-----cchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 99999985322222110 00011111 3333333333
Q ss_pred -----------hC--------CceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 182 -----------ER--------GVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 182 -----------~~--------~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.+ .++|+|+.+.|++|++++-+-|.||+++.
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 22 48999999999999999999999999985
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00034 Score=63.26 Aligned_cols=75 Identities=19% Similarity=0.092 Sum_probs=47.0
Q ss_pred eeeeecCCeEEEEEEECC------CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-ceeeEEEEeCCeEEEE
Q psy7825 70 KVIGIGSYATVKLATSTR------HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-IRFLQAIETTHRVYII 142 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv 142 (357)
+.|..|-...+|++.... .++.|++|+....... .....+|..++..+...++ +++++.+. + .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 446667777889887543 2578999986543211 1224578888888853333 45555553 2 358
Q ss_pred EeccCCCChH
Q psy7825 143 MEYAEKGSLL 152 (357)
Q Consensus 143 ~e~~~~~~L~ 152 (357)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0026 Score=58.13 Aligned_cols=76 Identities=14% Similarity=0.021 Sum_probs=46.1
Q ss_pred eeeecCCeEEEEEEECCCCcEEEEEEeecCCC----CchHHhhhHHHHHHHHHcCC--CCC-cceeeEEEEeCCeEEEEE
Q psy7825 71 VIGIGSYATVKLATSTRHGCDVAVKVVSKVEA----PPDYLKKFLPREIDVVKGLR--HPN-LIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 71 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv~ 143 (357)
.||.|....||++.....++.|+||.-...-. .-........-|...|+... .|. +++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47999999999999754446899996422111 10111233446777777764 353 4444432 344556899
Q ss_pred eccCC
Q psy7825 144 EYAEK 148 (357)
Q Consensus 144 e~~~~ 148 (357)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0025 Score=59.31 Aligned_cols=77 Identities=16% Similarity=0.051 Sum_probs=49.4
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCC-Cch---HHhhhHHHHHHHHHcCC---CCCcceeeEEEEeCCeEE
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA-PPD---YLKKFLPREIDVVKGLR---HPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~ 140 (357)
..+.||.|....||++.+. +..++||.-..... ..+ .....-..|+..|..+. ..++++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3567899999999999863 45799997542111 000 11222335666676654 246788888776 3457
Q ss_pred EEEeccCC
Q psy7825 141 IIMEYAEK 148 (357)
Q Consensus 141 lv~e~~~~ 148 (357)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999977
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00094 Score=62.91 Aligned_cols=158 Identities=22% Similarity=0.279 Sum_probs=102.8
Q ss_pred HHHHHHHHcCCCCCcceeeEEEEe-CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7825 112 PREIDVVKGLRHPNLIRFLQAIET-THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI 190 (357)
Q Consensus 112 ~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dl 190 (357)
.-...+++.+.|+|...++++... -....+|+|++ +.+|++.+..+. +-..... .+|+.|-
T Consensus 30 lgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~~-- 91 (725)
T KOG1093|consen 30 LGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLHL-- 91 (725)
T ss_pred hhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cccccee--
Confidence 356778999999999999987654 23578899999 459999997654 2211111 2222221
Q ss_pred CCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCC
Q psy7825 191 KCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF 270 (357)
Q Consensus 191 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 270 (357)
|+ ++.+| -+.. .. ....| ++ +|||++|.++.++.-|...+
T Consensus 92 ---~~-------~~~td-~~~t------~~------~~~~~----------------pK-sdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 92 ---NI-------IYITD-HFLT------KY------PSPIG----------------PK-SDVWSLGFIILELYLGISLE 131 (725)
T ss_pred ---hh-------hhccc-cccc------cC------CCCCC----------------cc-hhhhhHHHHHHHHHHhhHHH
Confidence 22 22223 0000 00 11111 24 99999999999999998888
Q ss_pred CCCCHHHHHHHHhhcccCCCC-----------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 271 DDTNYIQLLKQVQTKVVFPTE-----------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 271 ~~~~~~~~~~~i~~~~~~~~~-----------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
......+....+..-+..+.. -.++....++...|+ ..|..||...++.+++-|...
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 766665555555443322221 136778888889999 789999999999999988764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0017 Score=57.84 Aligned_cols=29 Identities=31% Similarity=0.423 Sum_probs=24.7
Q ss_pred CceecCCCCCCEEEcCCCc-EEEeecCCCc
Q psy7825 184 GVVHRDIKCENLLIDGEYN-IKLSDFGFAR 212 (357)
Q Consensus 184 ~ivH~dlkp~Nili~~~~~-~kl~Dfg~~~ 212 (357)
.++|+|++|.|||+++++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 3899999999999997555 5799999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0032 Score=57.99 Aligned_cols=136 Identities=18% Similarity=0.229 Sum_probs=78.7
Q ss_pred ceeeeecCCeEEEEEEECC----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-ceeeEEEEeCCeEEEEE
Q psy7825 69 GKVIGIGSYATVKLATSTR----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-IRFLQAIETTHRVYIIM 143 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 143 (357)
...|-.|-.-.+|++.... .++.|++|+..... +...+ ..+|..+++.+..-++ .++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3345457788899987432 24689999875432 11122 2478888888865444 3566665432 578
Q ss_pred eccCCCChHHH-------H-------Hh---cC------CCCHHHHHHHHHHH-----------------HHHHHHHH--
Q psy7825 144 EYAEKGSLLDF-------I-------QR---EG------YIDEPRTKKWFRQL-----------------VDAIDYCH-- 181 (357)
Q Consensus 144 e~~~~~~L~~~-------l-------~~---~~------~l~~~~~~~i~~~i-----------------~~~l~~LH-- 181 (357)
+|++|.+|... + .+ .. ......+..++.++ ...+..|.
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 88877665321 1 10 00 01112222332111 11122221
Q ss_pred ------hCCceecCCCCCCEEEcC-CCcEEEeecCCCc
Q psy7825 182 ------ERGVVHRDIKCENLLIDG-EYNIKLSDFGFAR 212 (357)
Q Consensus 182 ------~~~ivH~dlkp~Nili~~-~~~~kl~Dfg~~~ 212 (357)
...++|+|+++.|||+++ ++.+.++||..+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 225899999999999986 4689999999874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0046 Score=56.65 Aligned_cols=138 Identities=17% Similarity=0.244 Sum_probs=77.3
Q ss_pred eEEceeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-ceeeEEEEeCCeEEE
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-IRFLQAIETTHRVYI 141 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~l 141 (357)
..+.. |..|-...+|++..... +..|++|+...... ...+ -.+|..+++.+..-++ +++++++. ++ +
T Consensus 17 i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G---~ 87 (330)
T PLN02421 17 FSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFG-NG---M 87 (330)
T ss_pred eEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc---E
Confidence 34444 44477778898865432 34799998754221 1111 2478888888875555 35565553 22 5
Q ss_pred EEeccCCCChHH-------HH-------Hh--cCC------C-CHHHHHHHHHHH----------------------HHH
Q psy7825 142 IMEYAEKGSLLD-------FI-------QR--EGY------I-DEPRTKKWFRQL----------------------VDA 176 (357)
Q Consensus 142 v~e~~~~~~L~~-------~l-------~~--~~~------l-~~~~~~~i~~~i----------------------~~~ 176 (357)
|.+|++|..|.. .+ .+ ... . ....+..+..++ ..-
T Consensus 88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 167 (330)
T PLN02421 88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE 167 (330)
T ss_pred eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence 889988765421 11 11 001 1 112222222221 111
Q ss_pred HHHHH----hCC----ceecCCCCCCEEEcC-CCcEEEeecCCCc
Q psy7825 177 IDYCH----ERG----VVHRDIKCENLLIDG-EYNIKLSDFGFAR 212 (357)
Q Consensus 177 l~~LH----~~~----ivH~dlkp~Nili~~-~~~~kl~Dfg~~~ 212 (357)
+..+. ..+ ++|.|+.+.|||+++ ++.++++||..+.
T Consensus 168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 22221 112 799999999999975 4789999999874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.024 Score=51.34 Aligned_cols=28 Identities=29% Similarity=0.647 Sum_probs=25.1
Q ss_pred CCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 183 ~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
.+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999987 67899999975
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0068 Score=54.17 Aligned_cols=74 Identities=18% Similarity=0.184 Sum_probs=48.5
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC---CCCcceeeEEEEeCCeEEEEEe
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR---HPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e 144 (357)
-.+.|+.|....+|+.. .+++.+.||+-.. .....+..|..-|+.|. .-.+++++++....+..++|+|
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 45578889999999986 5688999998652 12456778888888883 3457789998888777899999
Q ss_pred ccCCC
Q psy7825 145 YAEKG 149 (357)
Q Consensus 145 ~~~~~ 149 (357)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 98776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.065 Score=56.54 Aligned_cols=30 Identities=40% Similarity=0.538 Sum_probs=25.5
Q ss_pred CCceecCCCCCCEEEcCCC--cE-EEeecCCCc
Q psy7825 183 RGVVHRDIKCENLLIDGEY--NI-KLSDFGFAR 212 (357)
Q Consensus 183 ~~ivH~dlkp~Nili~~~~--~~-kl~Dfg~~~ 212 (357)
.++||+|+.+.|||++.++ .+ -|+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999875 45 599999864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.008 Score=55.74 Aligned_cols=78 Identities=18% Similarity=0.092 Sum_probs=48.5
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCC---CchHHhhhHHHHHHHHHcCC--CCC-cceeeEEEEeCCeEEEE
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA---PPDYLKKFLPREIDVVKGLR--HPN-LIRFLQAIETTHRVYII 142 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv 142 (357)
.+.||.|.-..||++.+...++.|+||.-...-. .-.-..+...-|.+.|+... .|. +++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6678999999999999754456899996422111 11112344456778888764 454 4455543 34455688
Q ss_pred EeccCC
Q psy7825 143 MEYAEK 148 (357)
Q Consensus 143 ~e~~~~ 148 (357)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.064 Score=48.61 Aligned_cols=29 Identities=21% Similarity=0.218 Sum_probs=26.9
Q ss_pred CceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 184 GVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 184 ~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
++||+|+.+.|||+++++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999999864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.021 Score=53.27 Aligned_cols=79 Identities=16% Similarity=0.111 Sum_probs=45.6
Q ss_pred CeEEceeeeecCCeEEEEEEECCC-CcE-----EEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-ceeeEEEEeCC
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRH-GCD-----VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-IRFLQAIETTH 137 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~-~~~-----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~ 137 (357)
...+. .|..|-...+|++..... +.. |.+++... ......+ -.+|+.+++.+...++ .++++.+..
T Consensus 52 ~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~-- 124 (383)
T PTZ00384 52 FIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD-- 124 (383)
T ss_pred cEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEec-cHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence 34444 455588889999975432 222 44443211 1111111 2368999999976555 456666542
Q ss_pred eEEEEEeccCCCChH
Q psy7825 138 RVYIIMEYAEKGSLL 152 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~ 152 (357)
++|.||++|.+|.
T Consensus 125 --g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 --FTIQEWVEGNTMG 137 (383)
T ss_pred --EEEEEEeccccCC
Confidence 5899999987653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.03 Score=51.04 Aligned_cols=133 Identities=17% Similarity=0.221 Sum_probs=77.3
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc---ce---eeEEE--EeC--CeEEE
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL---IR---FLQAI--ETT--HRVYI 141 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i---v~---~~~~~--~~~--~~~~l 141 (357)
|.+ .-..||+..... | .+++|+.... .. ...+..|...+..|.-.+| ++ .=|.. .-. .+.+-
T Consensus 34 l~s-~eN~~f~~~~~~-g-~~iLki~~~~-~~----~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 34 LNS-EENSNFRVQTED-G-RYILKIYRPG-WT----RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccc-ccCceEEEEecC-C-CeEEEEecCC-CC----HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 444 445788887543 3 4499988664 22 3345567888887742221 12 11211 123 37788
Q ss_pred EEeccCCCChHH-----HHH-------h------cCC---------CCHH----HH---------HHHHHHHHHHHHHHH
Q psy7825 142 IMEYAEKGSLLD-----FIQ-------R------EGY---------IDEP----RT---------KKWFRQLVDAIDYCH 181 (357)
Q Consensus 142 v~e~~~~~~L~~-----~l~-------~------~~~---------l~~~----~~---------~~i~~~i~~~l~~LH 181 (357)
+++|++|..+.. .+. + ..+ ..+. .. .....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999977762 111 0 000 1111 00 012334444555554
Q ss_pred h--------CC--ceecCCCCCCEEEcCCCc-EEEeecCCCc
Q psy7825 182 E--------RG--VVHRDIKCENLLIDGEYN-IKLSDFGFAR 212 (357)
Q Consensus 182 ~--------~~--ivH~dlkp~Nili~~~~~-~kl~Dfg~~~ 212 (357)
+ .+ +||+|+.|.||+++.+.. +.++||+.+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 24 999999999999999885 8999999874
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.014 Score=52.53 Aligned_cols=28 Identities=32% Similarity=0.499 Sum_probs=24.1
Q ss_pred ceecCCCCCCEEEcCC--C---cEEEeecCCCc
Q psy7825 185 VVHRDIKCENLLIDGE--Y---NIKLSDFGFAR 212 (357)
Q Consensus 185 ivH~dlkp~Nili~~~--~---~~kl~Dfg~~~ 212 (357)
++|||+.+.|||+..+ | .+++.||..++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999665 3 58999998874
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.12 Score=47.35 Aligned_cols=71 Identities=11% Similarity=0.002 Sum_probs=41.5
Q ss_pred cCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC--cceee---E--EEEeCCeEEEEEeccC
Q psy7825 75 GSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN--LIRFL---Q--AIETTHRVYIIMEYAE 147 (357)
Q Consensus 75 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~---~--~~~~~~~~~lv~e~~~ 147 (357)
+.-..||++.. .+|..+++|+.+..... ...+..|...+..|.... ++... | ....++..+.|+++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~----~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWS----DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCC----HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34457898874 34678999987533322 333556777777663211 22211 2 2234567888999998
Q ss_pred CCC
Q psy7825 148 KGS 150 (357)
Q Consensus 148 ~~~ 150 (357)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.014 Score=49.42 Aligned_cols=116 Identities=14% Similarity=0.161 Sum_probs=70.9
Q ss_pred cCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccCCCChHHH
Q psy7825 75 GSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDF 154 (357)
Q Consensus 75 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 154 (357)
|+.++.-.+..+- | +..+|.+......-. ...+..+..++.++. +|+++..- ..-.+.+++|+|-...
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~--~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~---- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCIN--DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK---- 140 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccc--hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc----
Confidence 3344444443332 3 445565543333211 234567788888776 57777732 4446778999884311
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 155 IQREGYIDEPRTKKWFRQLVDAIDYCHE--RGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 155 l~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
. ....++..=+.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|=+..
T Consensus 141 --------i-~~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 --------I-NFSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred --------c-chhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 0 111122222466777884 36999999999999999999999997754
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.0099 Score=53.97 Aligned_cols=71 Identities=23% Similarity=0.349 Sum_probs=54.7
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
..+.|++|++. |++|.-.- .....++..|+.+.+..+.-+... .+-|||+...||||+ +|++.|+||-+++
T Consensus 298 ~~y~yl~~kdh-gt~is~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeeeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 34667788876 44543321 134677888888888877777755 689999999999999 9999999999987
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.011 Score=50.44 Aligned_cols=29 Identities=34% Similarity=0.560 Sum_probs=20.7
Q ss_pred CceecCCCCCCEEE-cCCCcEEEeecCCCc
Q psy7825 184 GVVHRDIKCENLLI-DGEYNIKLSDFGFAR 212 (357)
Q Consensus 184 ~ivH~dlkp~Nili-~~~~~~kl~Dfg~~~ 212 (357)
-++|+|+.+.|||+ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 888999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.03 Score=51.70 Aligned_cols=60 Identities=25% Similarity=0.247 Sum_probs=45.0
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCEEEcC
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY-CHERGVVHRDIKCENLLIDG 199 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~ivH~dlkp~Nili~~ 199 (357)
..++-+|..|.++..++.... .++.....++.-.+.|+-- |--.+++|.|+.|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 456667888999999997654 4566777777766766544 44568999999999999953
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 357 | ||||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-52 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-51 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-51 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-50 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-50 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-50 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-50 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-49 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-49 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-47 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-44 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-43 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-43 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-42 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-41 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-40 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-40 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-40 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-40 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-36 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-36 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-36 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-35 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-35 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-35 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-35 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-35 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-35 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-35 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-35 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-35 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-35 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-35 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-35 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-35 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-34 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-34 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-34 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-34 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-34 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-34 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-34 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-34 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-34 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-34 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-34 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-34 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-34 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-34 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-34 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-34 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-34 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-34 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-34 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-34 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-34 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-33 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-33 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-33 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-33 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-31 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-31 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-30 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-30 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-30 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-30 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-30 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-30 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-30 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-30 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-30 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-30 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-30 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-30 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-30 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-30 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-29 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-29 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-29 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-29 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-29 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-29 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-29 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-29 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-29 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-29 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-29 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-29 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-29 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-29 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-29 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-29 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-29 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-29 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-29 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-29 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-29 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-29 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-28 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-28 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-28 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-28 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-28 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-28 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-28 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-28 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-28 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-28 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-28 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-28 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-28 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-28 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-28 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-28 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-28 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-28 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-28 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-28 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-28 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-28 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-28 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-28 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-28 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-28 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-28 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-27 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-27 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-27 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-27 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-27 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-27 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-27 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-27 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-27 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-27 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-26 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-26 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-26 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-26 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-26 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-25 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-25 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-25 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-25 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-25 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-25 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-25 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-25 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-25 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-25 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-25 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-25 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-25 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-25 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-25 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-25 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-25 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-25 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-25 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-25 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-25 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-25 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-25 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-25 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-25 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-25 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-25 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-25 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-25 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-25 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-25 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-25 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-25 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-25 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-25 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-25 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-24 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-24 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-24 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-24 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-24 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-24 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-24 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-24 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-24 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-24 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-24 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-24 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-24 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-23 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-23 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-23 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-23 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-23 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-23 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-23 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-23 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-23 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-23 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-22 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-22 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-22 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-22 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-22 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-22 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-22 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-22 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-22 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-22 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-22 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-22 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-22 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-22 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-22 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-22 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-22 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-22 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-22 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-21 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-21 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-21 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-21 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-21 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-21 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-21 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-21 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-21 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-21 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-21 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-21 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-21 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-21 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-21 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-21 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-21 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-21 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-21 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-21 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-21 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-21 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-20 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-20 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-19 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-19 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-19 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-19 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-19 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-18 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-18 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-16 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-15 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-15 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-15 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-15 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-12 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-11 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-11 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-11 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-11 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 |
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = e-101
Identities = 104/267 (38%), Positives = 157/267 (58%), Gaps = 11/267 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y L K IG G++A VKLA G +VA+K++ K + P L+K L RE+ ++K L HPN
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPN 75
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++ + IET +Y+IMEYA G + D++ G + E + FRQ+V A+ YCH++ +
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
VHRD+K ENLL+D + NIK++DFGF+ + G D FCG+ YA+PE+ +G
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSN---EFTVGG---KLDAFCGAPPYAAPELFQGKK 189
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305
Y DVWS+GV+LY + G LPFD N +L ++V + + +S +C+ LL +
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL-RGKYRIPFYMSTDCENLLKRF 248
Query: 306 FS--PIKFRIRLKDIKQDPWVKTEANP 330
PIK R L+ I +D W+
Sbjct: 249 LVLNPIK-RGTLEQIMKDRWINAGHEE 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 4e-97
Identities = 87/264 (32%), Positives = 135/264 (51%), Gaps = 10/264 (3%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ L + +G G+Y V+LA + VAVK+V + D + + +EI + K L H N
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPEN-IKKEICINKMLNHEN 66
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++F + Y+ +EY G L D I+ + + EP +++F QL+ + Y H G+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
HRDIK ENLL+D N+K+SDFG A + ++ L + CG+ Y +PE+LK
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLAT---VFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQ-VQTKVVFPTEPNVSAECKTLLS 303
+ DVWS G+VL AM G LP+D ++ Q + K + + LL
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 304 KIF--SPIKFRIRLKDIKQDPWVK 325
KI +P RI + DIK+D W
Sbjct: 244 KILVENPSA-RITIPDIKKDRWYN 266
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 7e-96
Identities = 87/265 (32%), Positives = 135/265 (50%), Gaps = 10/265 (3%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ L + +G G+Y V+LA + VAVK+V + D + + +EI + K L H N
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPEN-IKKEICINKMLNHEN 66
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++F + Y+ +EY G L D I+ + + EP +++F QL+ + Y H G+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
HRDIK ENLL+D N+K+SDFG A + ++ L + CG+ Y +PE+LK
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLAT---VFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQ-VQTKVVFPTEPNVSAECKTLLS 303
+ DVWS G+VL AM G LP+D ++ Q + K + + LL
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 304 KIF--SPIKFRIRLKDIKQDPWVKT 326
KI +P RI + DIK+D W
Sbjct: 244 KILVENPSA-RITIPDIKKDRWYNK 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 4e-95
Identities = 95/267 (35%), Positives = 148/267 (55%), Gaps = 10/267 (3%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
YVLG +G+G++ VK+ G VAVK++++ + + + REI +K RHP+
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+I+ Q I T +++MEY G L D+I + G ++E ++ F+Q++ A+DYCH V
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
VHRD+K EN+L+D N K++DFG + G T CGS YA+PE++ G
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGE---FLRTSCGSPNYAAPEVISGRL 186
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305
Y D+WS GV+LYA+ G LPFDD + L K+++ VF ++ TLL +
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR-GGVFYIPEYLNRSVATLLMHM 245
Query: 306 F--SPIKFRIRLKDIKQDPWVKTEANP 330
P+K R +KDI++ W K +
Sbjct: 246 LQVDPLK-RATIKDIREHEWFKQDLPS 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 3e-94
Identities = 90/276 (32%), Positives = 136/276 (49%), Gaps = 21/276 (7%)
Query: 60 VMENHG-YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV 118
+M + Y K IG G++ +L VAVK + + A + ++ REI
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ----REIINH 70
Query: 119 KGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
+ LRHPN++RF + I T + IIMEYA G L + I G E + +F+QL+ +
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 179 YCHERGVVHRDIKCENLLIDGEY--NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
YCH + HRD+K EN L+DG +K+ DFG++ KS + G+ AY
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYI 184
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-----FPTE 291
+PE+L Y +DVWS GV LY M G PF+D + ++ +++ P +
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244
Query: 292 PNVSAECKTLLSKIF--SPIKFRIRLKDIKQDPWVK 325
+S EC L+S+IF P RI + +IK W
Sbjct: 245 IRISPECCHLISRIFVADPAT-RISIPEIKTHSWFL 279
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 2e-93
Identities = 87/331 (26%), Positives = 144/331 (43%), Gaps = 28/331 (8%)
Query: 22 SSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVK 81
SS + S + + L A K+K + Y +G ++G G + +V
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQ--YQVGPLLGSGGFGSVY 60
Query: 82 LATSTRHGCDVAVKVVSKV----EAPPDYLKKFLPREIDVVKGLRH--PNLIRFLQAIET 135
VA+K V K + +P E+ ++K + +IR L E
Sbjct: 61 SGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFER 119
Query: 136 THRVYIIMEYAE-KGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194
+I+E E L DFI G + E + +F Q+++A+ +CH GV+HRDIK EN
Sbjct: 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 179
Query: 195 LLIDGEY-NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDV 253
+LID +KL DFG + F G+ Y+ PE ++ Y + V
Sbjct: 180 ILIDLNRGELKLIDFGSGALL------KDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 254 WSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI--FSPIKF 311
WS+G++LY M G +PF+ I ++ +V F VS+EC+ L+ P
Sbjct: 233 WSLGILLYDMVCGDIPFEHDEEI-----IRGQVFFR--QRVSSECQHLIRWCLALRPSD- 284
Query: 312 RIRLKDIKQDPWVKTEANPAASAGVETKTLN 342
R ++I+ PW++ P +A + +L+
Sbjct: 285 RPTFEEIQNHPWMQDVLLPQETAEIHLHSLS 315
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 3e-93
Identities = 65/268 (24%), Positives = 126/268 (47%), Gaps = 10/268 (3%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
YV G+ +G G +A + A K+V K + ++ + EI + + L H +
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ F E V++++E + SLL+ +R + EP + + RQ+V Y H V
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRD+K NL ++ + +K+ DFG A K + CG+ Y +PE+L
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305
++ DVWS+G ++Y + G+ PF+ + + +++ K + +++ +L+ K+
Sbjct: 192 HSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-KNEYSIPKHINPVAASLIQKM 249
Query: 306 FS--PIKFRIRLKDIKQDPWVKTEANPA 331
P R + ++ D + + PA
Sbjct: 250 LQTDPTA-RPTINELLNDEFFTSGYIPA 276
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 1e-92
Identities = 69/308 (22%), Positives = 133/308 (43%), Gaps = 12/308 (3%)
Query: 28 RPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHG--YVLGKVIGIGSYATVKLATS 85
P ++ AA + V YV G+ +G G +A +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISD 62
Query: 86 TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145
A K+V K + ++ + EI + + L H +++ F E V++++E
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122
Query: 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKL 205
+ SLL+ +R + EP + + RQ+V Y H V+HRD+K NL ++ + +K+
Sbjct: 123 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 182
Query: 206 SDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF 265
DFG A K + CG+ Y +PE+L ++ DVWS+G ++Y +
Sbjct: 183 GDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLV 236
Query: 266 GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFS--PIKFRIRLKDIKQDPW 323
G+ PF+ + + +++ K + +++ +L+ K+ P R + ++ D +
Sbjct: 237 GKPPFETSCLKETYLRIK-KNEYSIPKHINPVAASLIQKMLQTDPTA-RPTINELLNDEF 294
Query: 324 VKTEANPA 331
+ PA
Sbjct: 295 FTSGYIPA 302
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 2e-92
Identities = 80/290 (27%), Positives = 142/290 (48%), Gaps = 37/290 (12%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK----------VEAPPDYLKKFLP--- 112
Y L IG GSY VKLA + A+KV+SK PP +
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 113 ----------REIDVVKGLRHPNLIRFLQAIE--TTHRVYIIMEYAEKGSLLDFIQREGY 160
+EI ++K L HPN+++ ++ ++ +Y++ E +G +++
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KP 133
Query: 161 IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220
+ E + + +F+ L+ I+Y H + ++HRDIK NLL+ + +IK++DFG +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG---- 189
Query: 221 HQSPLSDTFCGSYAYASPEILKGV--PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQL 278
L G+ A+ +PE L ++ DVW+MGV LY FG+ PF D + L
Sbjct: 190 -SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 279 LKQVQT-KVVFPTEPNVSAECKTLLSKIF--SPIKFRIRLKDIKQDPWVK 325
++++ + FP +P+++ + K L++++ +P RI + +IK PWV
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPES-RIVVPEIKLHPWVT 297
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 3e-92
Identities = 80/275 (29%), Positives = 134/275 (48%), Gaps = 16/275 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK--VEAPPDYLKKFLPREIDVVKGLRH 123
Y++G ++G GSY VK + C AVK++ K + P+ + +EI +++ LRH
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRH 65
Query: 124 PNLIRFLQAI--ETTHRVYIIMEYAEKGS--LLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
N+I+ + + E ++Y++MEY G +LD + E + +F QL+D ++Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEY 124
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
H +G+VH+DIK NLL+ +K+S G A + T GS A+ PE
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD---TCRTSQGSPAFQPPE 181
Query: 240 ILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298
I G+ ++ D+WS GV LY + G PF+ N +L + + K + +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG-KGSYAIPGDCGPPL 240
Query: 299 KTLLSKIFS--PIKFRIRLKDIKQDPWVKTEANPA 331
LL + P K R ++ I+Q W + + PA
Sbjct: 241 SDLLKGMLEYEPAK-RFSIRQIRQHSWFRKKHPPA 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 4e-92
Identities = 94/262 (35%), Positives = 150/262 (57%), Gaps = 11/262 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y++ + +G GS+ VKLAT + VA+K +S+ + + REI +K LRHP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+I+ I T + +++EYA G L D+I + + E +++F+Q++ AI+YCH +
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
VHRD+K ENLL+D N+K++DFG + G+ T CGS YA+PE++ G
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSN---IMTDGN---FLKTSCGSPNYAAPEVINGKL 183
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305
Y DVWS G+VLY M GRLPFDD L K+V V+ +S ++L+ ++
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN-SCVYVMPDFLSPGAQSLIRRM 242
Query: 306 F--SPIKFRIRLKDIKQDPWVK 325
P++ RI +++I++DPW
Sbjct: 243 IVADPMQ-RITIQEIRRDPWFN 263
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 1e-91
Identities = 88/289 (30%), Positives = 134/289 (46%), Gaps = 20/289 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK-----VEAPPDYLKKFLPREIDVVKG 120
Y +G G++ V A +V VK + K D + EI ++
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGS-LLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
+ H N+I+ L E ++ME G L FI R +DEP FRQLV A+ Y
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
+ ++HRDIK EN++I ++ IKL DFG A +++ + L TFCG+ Y +PE
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLE-----RGKLFYTFCGTIEYCAPE 199
Query: 240 ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299
+L G PY ++WS+GV LY + F PF + V+ + P VS E
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----VEAAIHPP--YLVSKELM 252
Query: 300 TLLSKIFSPI-KFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKID 347
+L+S + P+ + R L+ + DPWV N A E +N+ +
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESG 301
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 9e-91
Identities = 72/268 (26%), Positives = 129/268 (48%), Gaps = 11/268 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ +G ++G GS+A V A S G +VA+K++ K + + + E+ + L+HP+
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERG 184
++ E ++ VY+++E G + +++ R E + + Q++ + Y H G
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
++HRD+ NLL+ NIK++DFG A +K T CG+ Y SPEI
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHE----KHYTLCGTPNYISPEIATRS 187
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSK 304
+ SDVWS+G + Y + GR PFD L +V + +S E K L+ +
Sbjct: 188 AHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-LADYEMPSFLSIEAKDLIHQ 245
Query: 305 I--FSPIKFRIRLKDIKQDPWVKTEANP 330
+ +P R+ L + P++ ++
Sbjct: 246 LLRRNPAD-RLSLSSVLDHPFMSRNSST 272
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 1e-90
Identities = 93/267 (34%), Positives = 149/267 (55%), Gaps = 10/267 (3%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y+LG +G+G++ VK+ G VAVK++++ + + + REI +K RHP+
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+I+ Q I T ++++MEY G L D+I + G +DE +++ F+Q++ +DYCH V
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
VHRD+K EN+L+D N K++DFG + G T CGS YA+PE++ G
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGE---FLRTSCGSPNYAAPEVISGRL 191
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305
Y D+WS GV+LYA+ G LPFDD + L K++ +F T ++ +LL +
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC-DGIFYTPQYLNPSVISLLKHM 250
Query: 306 F--SPIKFRIRLKDIKQDPWVKTEANP 330
P+K R +KDI++ W K +
Sbjct: 251 LQVDPMK-RATIKDIREHEWFKQDLPK 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 5e-90
Identities = 87/276 (31%), Positives = 132/276 (47%), Gaps = 26/276 (9%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK---VEAPPDYLKKFLPREIDVVKGLR 122
Y LG ++G G + TV VA+KV+ + + P P E+ ++ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 123 ----HPNLIRFLQAIETTHRVYIIMEYAEKGS-LLDFIQREGYIDEPRTKKWFRQLVDAI 177
HP +IR L ET +++E L D+I +G + E ++ +F Q+V AI
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 178 DYCHERGVVHRDIKCENLLIDGEY-NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
+CH RGVVHRDIK EN+LID KL DFG H P F G+ Y+
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL------HDEPY-TDFDGTRVYS 205
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSA 296
PE + Y + VWS+G++LY M G +PF+ I ++ ++ FP +VS
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-----LEAELHFP--AHVSP 258
Query: 297 ECKTLLSKI--FSPIKFRIRLKDIKQDPWVKTEANP 330
+C L+ + P R L++I DPW++T A
Sbjct: 259 DCCALIRRCLAPKPSS-RPSLEEILLDPWMQTPAED 293
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 3e-88
Identities = 89/282 (31%), Positives = 155/282 (54%), Gaps = 18/282 (6%)
Query: 53 DVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP 112
++ K+ +++ + +G+ +G G + V LA ++ +A+KV+ K + + ++ L
Sbjct: 5 EMPKRKFTIDD--FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 113 REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQ 172
REI++ LRHPN++R R+Y+++E+A +G L +Q+ G DE R+ + +
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 173 LVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH-QSPLSDTFCG 231
L DA+ YCHER V+HRDIK ENLL+ + +K++DFG+ S H S T CG
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW--------SVHAPSLRRRTMCG 174
Query: 232 SYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPT 290
+ Y PE+++G + D+W GV+ Y G PFD ++ + +++ + FP
Sbjct: 175 TLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP- 232
Query: 291 EPNVSAECKTLLSKI--FSPIKFRIRLKDIKQDPWVKTEANP 330
P +S K L+SK+ + P + R+ LK + + PWVK +
Sbjct: 233 -PFLSDGSKDLISKLLRYHPPQ-RLPLKGVMEHPWVKANSRR 272
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 4e-88
Identities = 82/283 (28%), Positives = 150/283 (53%), Gaps = 16/283 (5%)
Query: 55 KKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPRE 114
KK+ +E+ + +G+ +G G + V LA + +A+KV+ K + ++ L RE
Sbjct: 2 KKRQWALED--FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 115 IDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLV 174
+++ LRHPN++R RVY+I+EYA G++ +Q+ DE RT + +L
Sbjct: 60 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 175 DAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
+A+ YCH + V+HRDIK ENLL+ +K++DFG++ S CG+
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLD 172
Query: 235 YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPN 293
Y PE+++G + D+WS+GV+ Y G+ PF+ Y + K++ + FP
Sbjct: 173 YLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DF 229
Query: 294 VSAECKTLLSKI--FSPIKFRIRLKDIKQDPWVKTEANPAASA 334
V+ + L+S++ +P + R L+++ + PW+ ++ ++
Sbjct: 230 VTEGARDLISRLLKHNPSQ-RPMLREVLEHPWITANSSKPSNC 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 5e-86
Identities = 78/368 (21%), Positives = 145/368 (39%), Gaps = 27/368 (7%)
Query: 6 HERPQSENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHG 65
H + + + S + + + +D+ T + ++
Sbjct: 1 HHHHHHS---SGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI 57
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + K IG G + V + A+K V+ EA L + EI + L+ +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHS 115
Query: 126 L--IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
IR T +Y++ME L +++++ ID K +++ +++A+ H+
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
G+VH D+K N LI + +KL DFG A + + S + D+ G+ Y PE +K
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIAN---QMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 244 VPYTPHY----------SDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQ-VQTKVVFPTE 291
+ + SDVWS+G +LY M +G+ PF N I L +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 292 PNVSAECKTLLSKIF--SPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKIDTQ 349
+ + +L P + RI + ++ P+V+ + +P T + +
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQL 349
Query: 350 ANSNSLSS 357
NS +S
Sbjct: 350 VGLNSPNS 357
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 1e-85
Identities = 73/315 (23%), Positives = 133/315 (42%), Gaps = 24/315 (7%)
Query: 40 ASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK 99
S+ + ++ +S ++ Y + K IG G + V + A+K V+
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL 62
Query: 100 VEAPPDYLKKFLPREIDVVKGLRHPNL--IRFLQAIETTHRVYIIMEYAEKGSLLDFIQR 157
EA L + EI + L+ + IR T +Y++ME L ++++
Sbjct: 63 EEADNQTLDSYR-NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK 120
Query: 158 EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217
+ ID K +++ +++A+ H+ G+VH D+K N LI + +KL DFG A +
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN---QM 176
Query: 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHY----------SDVWSMGVVLYAMAFGR 267
+ S + D+ G+ Y PE +K + + SDVWS+G +LY M +G+
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 268 LPFDD-TNYIQLLKQ-VQTKVVFPTEPNVSAECKTLLSKIF--SPIKFRIRLKDIKQDPW 323
PF N I L + + + +L P + RI + ++ P+
Sbjct: 237 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPY 295
Query: 324 VKTEANPAASAGVET 338
V+ + +P T
Sbjct: 296 VQIQTHPVNQMAKGT 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-84
Identities = 74/311 (23%), Positives = 130/311 (41%), Gaps = 24/311 (7%)
Query: 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
Y + K IG G + V + A+K V+ EA L + EI + L+
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEIAYLNKLQ 65
Query: 123 HPNL--IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
+ IR T +Y++ME L +++++ ID K +++ +++A+
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H+ G+VH D+K N LI + +KL DFG A + + S + D+ G+ Y PE
Sbjct: 125 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN---QMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 241 LKGVPYTPHY----------SDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQ-VQTKVVF 288
+K + + SDVWS+G +LY M +G+ PF N I L +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
Query: 289 PTEPNVSAECKTLLSKIF--SPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKI 346
+ + +L P + RI + ++ P+V+ + +P T + +
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 299
Query: 347 DTQANSNSLSS 357
NS +S
Sbjct: 300 GQLVGLNSPNS 310
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-84
Identities = 68/332 (20%), Positives = 123/332 (37%), Gaps = 57/332 (17%)
Query: 39 DASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVS 98
D S + + + VK+K + + Y + + + G + + L A+K
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYIND--YRIIRTLNQGKFNKIILCEKDNKF--YALKKYE 63
Query: 99 KVEAPPDYLKKFLP--------------REIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144
K E+ ++ +++ + I VYII E
Sbjct: 64 KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123
Query: 145 YAEKGSLLDFIQREGYID--------EPRTKKWFRQLVDAIDYCH-ERGVVHRDIKCENL 195
Y E S+L F + +D K + ++++ Y H E+ + HRD+K N+
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183
Query: 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVW 254
L+D +KLSDFG + +M G+Y + PE Y D+W
Sbjct: 184 LMDKNGRVKLSDFGESE-YM------VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 255 SMGVVLYAMAFGRLPFDD-TNYIQLLKQVQT-KVVFPTEPN-----------------VS 295
S+G+ LY M + +PF + ++L ++T + +P + N +S
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS 296
Query: 296 AECKTLLSKIFS--PIKFRIRLKDIKQDPWVK 325
E L P + RI +D + W+
Sbjct: 297 NEDIDFLKLFLRKNPAE-RITSEDALKHEWLA 327
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 6e-78
Identities = 60/287 (20%), Positives = 122/287 (42%), Gaps = 33/287 (11%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ V+G G++ V A + A+K + E + E+ ++ L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVMLLASLNHQY 63
Query: 126 LIRF-------------LQAIETTHRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFR 171
++R+ + A++ ++I MEY E G+L D I E + FR
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD---- 227
Q+++A+ Y H +G++HRD+K N+ ID N+K+ DFG A+ + + +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 228 -----TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
+ G+ Y + E+L G + D++S+G++ + M + + +LK++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL 241
Query: 283 QT-KVVFPTE--PNVSAECKTLLSKIFSPI-KFRIRLKDIKQDPWVK 325
++ + FP + N K ++ + R + + W+
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 6e-76
Identities = 62/285 (21%), Positives = 114/285 (40%), Gaps = 20/285 (7%)
Query: 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
N Y+ + +G G ++ V L G A+K + E ++ RE D+ +
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQ-READMHRLFN 84
Query: 123 HPNLIRFLQAI----ETTHRVYIIMEYAEKGSLLDFI----QREGYIDEPRTKKWFRQLV 174
HPN++R + H ++++ + ++G+L + I + ++ E + +
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 175 DAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS----DTFC 230
++ H +G HRD+K N+L+ E L D G G + L+
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 231 GSYAYASPEILKGVPYTP--HYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ--VQTKV 286
+ +Y +PE+ + +DVWS+G VLYAM FG P+D VQ ++
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
Query: 287 VFPTEPNVSAECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANP 330
P P S+ LL+ + + R + + P
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 4e-75
Identities = 70/307 (22%), Positives = 119/307 (38%), Gaps = 55/307 (17%)
Query: 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
NH ++L ++G G+ A V + G A+KV + + RE +V+K L
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLN 65
Query: 123 HPNLIRFLQAIE--TTHRVYIIMEYAEKGSLLDFIQREGY---IDEPRTKKWFRQLVDAI 177
H N+++ E TT +IME+ GSL ++ + E R +V +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 178 DYCHERGVVHRDIKCENLLI----DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
++ E G+VHR+IK N++ DG+ KL+DFG AR + + + G+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDE---QFVSLYGTE 179
Query: 234 AYASPEILKGVPYTP----HYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV 286
Y P++ + Y D+WS+GV Y A G LPF + K+V K+
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 287 V------------------------FPTEPNVSAECKTLLSKIFS------PIKFRIRLK 316
+ P ++S + LL+ + + K
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK-CWGFD 298
Query: 317 DIKQDPW 323
+
Sbjct: 299 QFFAETS 305
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-74
Identities = 73/269 (27%), Positives = 133/269 (49%), Gaps = 14/269 (5%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
ME YV + IG GS+ L ST G +K ++ ++ RE+ V+
Sbjct: 23 MEK--YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR-REVAVLAN 79
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAID 178
++HPN++++ ++ E +YI+M+Y E G L I + E + WF Q+ A+
Sbjct: 80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
+ H+R ++HRDIK +N+ + + ++L DFG AR L+ G+ Y SP
Sbjct: 140 HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-----VLNSTVELARACIGTPYYLSP 194
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298
EI + PY + SD+W++G VLY + + F+ + L+ ++ + P + S +
Sbjct: 195 EICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDL 253
Query: 299 KTLLSKIFS--PIKFRIRLKDIKQDPWVK 325
++L+S++F P R + I + ++
Sbjct: 254 RSLVSQLFKRNPRD-RPSVNSILEKGFIA 281
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-74
Identities = 84/308 (27%), Positives = 143/308 (46%), Gaps = 24/308 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK-----VEAPPDYLKKFLPREIDVVKG 120
Y++ K +G G+ VKLA + VA+K++SK A + EI+++K
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
L HP +I+ + YI++E E G L D + + E K +F Q++ A+ Y
Sbjct: 72 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 181 HERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS 237
HE G++HRD+K EN+L+ + + IK++DFG ++ G S + T CG+ Y +
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLMR-TLCGTPTYLA 184
Query: 238 PEILKGVPYTPHYS--DVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQVQT-KVVFPTEP- 292
PE+L V + D WS+GV+L+ G PF + + L Q+ + K F E
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 293 -NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKIDTQ 349
VS + L+ K + P R ++ + PW++ E + ++ + +
Sbjct: 245 AEVSEKALDLVKKLLVVDPKA-RFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 303
Query: 350 ANSNSLSS 357
S S
Sbjct: 304 LAQPSTSR 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 8e-74
Identities = 75/285 (26%), Positives = 131/285 (45%), Gaps = 23/285 (8%)
Query: 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV 117
+ E+ Y + IG GSY + G + K + + + E+++
Sbjct: 2 PSRAED--YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNL 58
Query: 118 VKGLRHPNLIRFLQAI--ETTHRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFR 171
++ L+HPN++R+ I T +YI+MEY E G L I + Y+DE +
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 172 QLVDAIDYCHERG-----VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226
QL A+ CH R V+HRD+K N+ +DG+ N+KL DFG AR H + +
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-----ILNHDTSFA 173
Query: 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV 286
TF G+ Y SPE + + Y SD+WS+G +LY + PF + +L +++
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
Query: 287 VFPTEPNVSAECKTLLSKIFS--PIKFRIRLKDIKQDPWVKTEAN 329
S E +++++ + R +++I ++P + +
Sbjct: 233 FRRIPYRYSDELNEIITRMLNLKDYH-RPSVEEILENPLILEHHH 276
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 3e-73
Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK--VEAPPDYLKKFLPREIDVVKGLRH 123
Y L IG GS+ VK+A A K + K VE +EI+++K L H
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-----FKQEIEIMKSLDH 65
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
PN+IR + E +Y++ME G L + + + E + + ++ A+ YCH+
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 184 GVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
V HRD+K EN L + +KL DFG A + K G + T G+ Y SP++
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGK--MMR-TKVGTPYYVSPQV 179
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAE 297
L+G Y P D WS GV++Y + G PF +++ +++ FP + NVS +
Sbjct: 180 LEG-LYGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237
Query: 298 CKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEAN 329
++L+ + SP + RI + W + + +
Sbjct: 238 AESLIRRLLTKSPKQ-RITSLQALEHEWFEKQLS 270
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 9e-73
Identities = 80/339 (23%), Positives = 147/339 (43%), Gaps = 32/339 (9%)
Query: 4 KQHERPQSENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTL-IAANKRDVKKKSTVME 62
+ R + +PK + N L A ++ +K
Sbjct: 41 IRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK----- 95
Query: 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK-----VEAPPDYLKKFLPREIDV 117
Y VIG G + V+ G + AVK++ + +++ RE +
Sbjct: 96 ---YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 118 VKGLR-HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
++ + HP++I + + E++ ++++ + KG L D++ + + E T+ R L++A
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
+ + H +VHRD+K EN+L+D I+LSDFGF+ + G L CG+ Y
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGE--KLR-ELCGTPGYL 266
Query: 237 SPEILKGVPYTPH--YS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPT 290
+PEILK H Y D+W+ GV+L+ + G PF I +L+ + + F +
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326
Query: 291 EP--NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVK 325
+ S+ K L+S+ P R+ + Q P+ +
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEA-RLTAEQALQHPFFE 364
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 4e-72
Identities = 82/280 (29%), Positives = 137/280 (48%), Gaps = 26/280 (9%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK-----VEAPPDYLKKFLPREIDVVKG 120
Y++ K +G G+ VKLA + VA++++SK A + EI+++K
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
L HP +I+ + YI++E E G L D + + E K +F Q++ A+ Y
Sbjct: 197 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 181 HERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS 237
HE G++HRD+K EN+L+ + + IK++DFG ++ G S + T CG+ Y +
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLMR-TLCGTPTYLA 309
Query: 238 PEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQVQT-KVVFPTEP 292
PE+L V Y+ D WS+GV+L+ G PF + + L Q+ + K F E
Sbjct: 310 PEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 293 --NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEA 328
VS + L+ K + P R ++ + PW++ E
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKA-RFTTEEALRHPWLQDED 407
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 227 bits (579), Expect = 5e-72
Identities = 79/317 (24%), Positives = 126/317 (39%), Gaps = 54/317 (17%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF--LPREIDVVKGLRH 123
Y L IG GSY V++A + A+K+++K + K + E+ ++K L H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYID--------------------- 162
PN+ R + E + ++ME G LLD +
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 163 -------------------EPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI--DGEY 201
E RQ+ A+ Y H +G+ HRDIK EN L + +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV--PYTPHYSDVWSMGVV 259
IKL DFG ++ K +G ++ T G+ + +PE+L Y P D WS GV+
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMT-TKAGTPYFVAPEVLNTTNESYGPK-CDAWSAGVL 265
Query: 260 LYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECKTLLSKIFS--PIKFRIR 314
L+ + G +PF N + QV K+ F +S + LLS + + + R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE-RFD 324
Query: 315 LKDIKQDPWVKTEANPA 331
Q PW+ ++
Sbjct: 325 AMRALQHPWISQFSDKI 341
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 8e-72
Identities = 73/280 (26%), Positives = 135/280 (48%), Gaps = 24/280 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK------VEAPPDYLKKFLPREIDVVK 119
Y +++G G + V+ + AVK++ L++ +E+D+++
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 120 GL-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
+ HPN+I+ ET +++ + +KG L D++ + + E T+K R L++ I
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
H+ +VHRD+K EN+L+D + NIKL+DFGF+ + G L CG+ +Y +P
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGE--KLR-EVCGTPSYLAP 192
Query: 239 EILKGVPYTPH--YS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP 292
EI++ H Y D+WS GV++Y + G PF + +L+ + + F +
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 293 --NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEA 328
+ S K L+S+ + P K R ++ P+ +
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQK-RYTAEEALAHPFFQQYV 291
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 8e-72
Identities = 76/289 (26%), Positives = 136/289 (47%), Gaps = 24/289 (8%)
Query: 48 AANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYL 107
++ + ++ + T+ + ++ + +G G++ V L G + +K ++K +
Sbjct: 8 SSGRENLYFQGTIDDL--FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-- 63
Query: 108 KKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI----QREGYIDE 163
+ + EI+V+K L HPN+I+ + E H +YI+ME E G LL+ I R + E
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 164 PRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSG 220
+ +Q+++A+ Y H + VVH+D+K EN+L IK+ DFG A KS
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSD 180
Query: 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK 280
S G+ Y +PE+ K T D+WS GVV+Y + G LPF T+ ++ +
Sbjct: 181 EH---STNAAGTALYMAPEVFKR-DVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235
Query: 281 QVQT-KVVFPTEP-NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVK 325
+ + + E ++ + LL + P + R + W K
Sbjct: 236 KATYKEPNYAVECRPLTPQAVDLLKQMLTKDPER-RPSAAQVLHHEWFK 283
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 8e-72
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 24/241 (9%)
Query: 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
NH ++L ++G G+ A V + G A+KV + + RE +V+K L
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLN 65
Query: 123 HPNLIRFLQAIE--TTHRVYIIMEYAEKGSLLDFIQREGY---IDEPRTKKWFRQLVDAI 177
H N+++ E TT +IME+ GSL ++ + E R +V +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 178 DYCHERGVVHRDIKCENLLI----DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
++ E G+VHR+IK N++ DG+ KL+DFG AR + + G+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-----ELEDDEQFV-SLYGTE 179
Query: 234 AYASPEILKGVPYTPHYS-------DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV 286
Y P++ + + D+WS+GV Y A G LPF + K+V K+
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 287 V 287
+
Sbjct: 240 I 240
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 9e-71
Identities = 75/274 (27%), Positives = 132/274 (48%), Gaps = 17/274 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + + +G G+++ V+ G + A K+++ + +K RE + + L+HPN
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPN 66
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++R +I+ Y++ + G L + I + E +Q++++I YCH G+
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 186 VHRDIKCENLLIDGEYN---IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
VHR++K ENLL+ + +KL+DFG A + F G+ Y SPE+LK
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSE--AWH-GFAGTPGYLSPEVLK 180
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECK 299
PY+ D+W+ GV+LY + G PF D + +L Q++ +P+ V+ E K
Sbjct: 181 KDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 300 TLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPA 331
+L+ +P K RI + PW+ A
Sbjct: 240 SLIDSMLTVNPKK-RITADQALKVPWICNRERVA 272
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-70
Identities = 80/272 (29%), Positives = 131/272 (48%), Gaps = 18/272 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + ++G GS+ V + AVKV++K A L RE++++K L HPN
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHPN 82
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++ + +E + YI+ E G L D I + E + +Q+ I Y H+ +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 186 VHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
VHRD+K EN+L+ + + +IK+ DFG + + + G+ Y +PE+L+
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLST-----CFQQNTKMK-DRIGTAYYIAPEVLR 196
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECK 299
G Y DVWS GV+LY + G PF N +LK+V+T K F +S + K
Sbjct: 197 G-TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 300 TLLSK--IFSPIKFRIRLKDIKQDPWVKTEAN 329
L+ K F P RI + PW++ ++
Sbjct: 255 DLIRKMLTFHPSL-RITATQCLEHPWIQKYSS 285
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-69
Identities = 87/333 (26%), Positives = 145/333 (43%), Gaps = 30/333 (9%)
Query: 5 QHERPQSENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENH 64
H S + T + +S+ + +N+ +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDF------- 54
Query: 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
+ + +G G+ + V A+KV+ K KK + EI V+ L HP
Sbjct: 55 -FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHP 108
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
N+I+ + ET + +++E G L D I +GY E +Q+++A+ Y HE G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 185 VVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+VHRD+K ENLL + +K++DFG ++ HQ + T CG+ Y +PEIL
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSK-----IVEHQVLMK-TVCGTPGYCAPEIL 222
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPF-DDTNYIQLLKQVQT-KVVFPTEP--NVSAE 297
+G Y P D+WS+G++ Y + G PF D+ + +++ + F + VS
Sbjct: 223 RGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 298 CKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEA 328
K L+ K + P K R+ Q PWV +A
Sbjct: 282 AKDLVRKLIVLDPKK-RLTTFQALQHPWVTGKA 313
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-69
Identities = 82/325 (25%), Positives = 143/325 (44%), Gaps = 26/325 (8%)
Query: 29 PKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRH 88
P +S S + Y + + +G G+++ V+
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDN--------YDVKEELGKGAFSVVRRCVHKTT 53
Query: 89 GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148
G + A K+++ + +K RE + + L+HPN++R +I+ Y++ +
Sbjct: 54 GLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112
Query: 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN---IKL 205
G L + I + E +Q++++I YCH G+VHR++K ENLL+ + +KL
Sbjct: 113 GELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 172
Query: 206 SDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF 265
+DFG A + F G+ Y SPE+LK PY+ D+W+ GV+LY +
Sbjct: 173 ADFGLAI---EVNDSE--AWH-GFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLV 225
Query: 266 GRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECKTLLSK--IFSPIKFRIRLKDIKQ 320
G PF D + +L Q++ +P+ V+ E K+L+ +P K RI +
Sbjct: 226 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKK-RITADQALK 284
Query: 321 DPWVKTEANPAASAGVETKTLNQSK 345
PW+ ASA T++ K
Sbjct: 285 VPWIC-NRERVASAIHRQDTVDCLK 308
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 6e-69
Identities = 74/273 (27%), Positives = 123/273 (45%), Gaps = 20/273 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
++ +V+G G+++ V L G A+K + K A L EI V+K ++H N
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHEN 67
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ E+T Y++M+ G L D I G E +Q++ A+ Y HE G+
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 186 VHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
VHRD+K ENLL + I ++DFG + K +S T CG+ Y +PE+L
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLS------KMEQNGIMS-TACGTPGYVAPEVLA 180
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECK 299
PY+ D WS+GV+ Y + G PF + +L ++++ F + ++S K
Sbjct: 181 QKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239
Query: 300 TLLSK--IFSPIKFRIRLKDIKQDPWVKTEANP 330
+ P + R + PW+
Sbjct: 240 DFICHLLEKDPNE-RYTCEKALSHPWIDGNTAL 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 1e-68
Identities = 59/273 (21%), Positives = 109/273 (39%), Gaps = 22/273 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ + + +G G + V G VA+K + +P + ++ EI ++K L HPN
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPN 73
Query: 126 LIRFLQAIET------THRVYIIMEYAEKGSLLDFI---QREGYIDEPRTKKWFRQLVDA 176
++ + + + MEY E G L ++ + + E + + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 177 IDYCHERGVVHRDIKCENLLID---GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
+ Y HE ++HRD+K EN+++ K+ D G+A+ + G L F G+
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGE---LCTEFVGTL 187
Query: 234 AYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF-DDTNYIQLLKQVQTKVVFPTEP 292
Y +PE+L+ YT D WS G + + G PF + +Q +V+ K
Sbjct: 188 QYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 293 NVSAECKTLLSKIFSPIKFRIRLKDIKQDPWVK 325
S + + K + W++
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 5e-68
Identities = 77/294 (26%), Positives = 125/294 (42%), Gaps = 16/294 (5%)
Query: 40 ASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK 99
+ N + + K IG G ++ V A G VA+K V
Sbjct: 10 GPPVPQFQPQKALRPDMGYNTLAN--FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67
Query: 100 VEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG 159
+ + +EID++K L HPN+I++ + + + I++E A+ G L I+
Sbjct: 68 FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127
Query: 160 ----YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215
I E K+F QL A+++ H R V+HRDIK N+ I +KL D G R
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FF 186
Query: 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF--DDT 273
K+ + + G+ Y SPE + Y SD+WS+G +LY MA + PF D
Sbjct: 187 SSKTT----AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKM 241
Query: 274 NYIQLLKQVQTKVVFPTEPNV-SAECKTLLSKIFSPI-KFRIRLKDIKQDPWVK 325
N L K+++ P + S E + L++ +P + R + +
Sbjct: 242 NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-68
Identities = 88/309 (28%), Positives = 138/309 (44%), Gaps = 28/309 (9%)
Query: 29 PKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRH 88
P S + L + + + + Y +V+G GS+ V L
Sbjct: 2 PGSMMDHLHA---TPGMFVQHSTAIFSDR--------YKGQRVLGKGSFGEVILCKDKIT 50
Query: 89 GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK 148
G + AVKV+SK + K+ L RE+ ++K L HPN+++ + E Y++ E
Sbjct: 51 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110
Query: 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKL 205
G L D I E + RQ++ I Y H+ +VHRD+K ENLL+ + NI++
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRI 170
Query: 206 SDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF 265
DFG + ++ + G+ Y +PE+L G Y DVWS GV+LY +
Sbjct: 171 IDFGLST---HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEK-CDVWSTGVILYILLS 222
Query: 266 GRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECKTLLSKIFS--PIKFRIRLKDIKQ 320
G PF+ N +LK+V+ K F VS K L+ K+ + P RI +D
Sbjct: 223 GCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM-RISARDALD 281
Query: 321 DPWVKTEAN 329
W++T
Sbjct: 282 HEWIQTYTK 290
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-67
Identities = 70/324 (21%), Positives = 128/324 (39%), Gaps = 21/324 (6%)
Query: 5 QHERPQSENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENH 64
H ++ T+ + S +P+ S + + TL + + +S ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMHQLQPRRVSFR----GEASETLQSPGYDPSRPESFFQQS- 58
Query: 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RH 123
+ +G GSY V S G AVK P + L E+ + + +H
Sbjct: 59 -FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQH 116
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHE 182
P +R QA E +Y+ E SL + G + E + + R + A+ + H
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
+G+VH D+K N+ + KL DFG + + + G Y +PE+L+
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELG-----TAGAGEVQEGDPRYMAPELLQ 229
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302
G Y +DV+S+G+ + +A Q L+Q F +S+E +++L
Sbjct: 230 G-SYGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFT--AGLSSELRSVL 285
Query: 303 SKIFSP-IKFRIRLKDIKQDPWVK 325
+ P K R + + P ++
Sbjct: 286 VMMLEPDPKLRATAEALLALPVLR 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 3e-67
Identities = 79/277 (28%), Positives = 133/277 (48%), Gaps = 18/277 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + ++G GS+ V + AVKV++K A L RE++++K L HPN
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHPN 82
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++ + +E + YI+ E G L D I + E + +Q+ I Y H+ +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 186 VHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
VHRD+K EN+L+ + + +IK+ DFG + + + G+ Y +PE+L+
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTK---MKDRIGTAYYIAPEVLR 196
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECK 299
G Y DVWS GV+LY + G PF N +LK+V+T K F +S + K
Sbjct: 197 G-TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 300 TLLSKIFS--PIKFRIRLKDIKQDPWVKTEANPAASA 334
L+ K+ + P RI + PW++ ++ +
Sbjct: 255 DLIRKMLTFHPSL-RITATQCLEHPWIQKYSSETPTI 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 4e-67
Identities = 79/322 (24%), Positives = 136/322 (42%), Gaps = 29/322 (9%)
Query: 21 QSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATV 80
+ L + I + K + + Y K +G G+Y V
Sbjct: 5 HHHSSGRENLYFQGDLQA---TPGMFITSKKGHLSEM--------YQRVKKLGSGAYGEV 53
Query: 81 KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140
L + A+K++ K K L E+ V+K L HPN+++ E Y
Sbjct: 54 LLCRDKVTHVERAIKIIRKTSVSTSSNSKLL-EEVAVLKLLDHPNIMKLYDFFEDKRNYY 112
Query: 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI--- 197
++ME + G L D I +E +Q++ + Y H+ +VHRD+K ENLL+
Sbjct: 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 198 DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMG 257
+ + IK+ DFG + ++ + G+ Y +PE+L+ Y DVWS+G
Sbjct: 173 EKDALIKIVDFGLSA---VFENQKK---MKERLGTAYYIAPEVLRK-KYDEK-CDVWSIG 224
Query: 258 VVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECKTLLSKIFS--PIKFR 312
V+L+ + G PF ++L++V+ K F + NVS K L+ ++ + R
Sbjct: 225 VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQR-R 283
Query: 313 IRLKDIKQDPWVKTEANPAASA 334
I + + PW+K + S
Sbjct: 284 ISAQQALEHPWIKEMCSKKESG 305
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-66
Identities = 82/288 (28%), Positives = 141/288 (48%), Gaps = 17/288 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y L + +G G+++ V+ G + A +++ + +K RE + + L+HPN
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE-REARICRLLKHPN 71
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++R +I Y+I + G L + I Y E +Q+++A+ +CH+ GV
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 186 VHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
VHR++K ENLL+ +KL+DFG A + + Q F G+ Y SPE+L+
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQ--AWFGFAGTPGYLSPEVLR 186
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECK 299
PY D+W+ GV+LY + G PF D + +L +Q++ FP+ V+ E K
Sbjct: 187 KDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 300 TLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSK 345
L++K +P K RI + + PW+ + AS +T++ K
Sbjct: 246 DLINKMLTINPSK-RITAAEALKHPWIS-HRSTVASCMHRQETVDCLK 291
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 7e-66
Identities = 79/333 (23%), Positives = 135/333 (40%), Gaps = 39/333 (11%)
Query: 19 IAQSSKENKRPKS-SSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSY 77
+ + ++ + + + + + + + Y + +G G+Y
Sbjct: 1 MHHHHHHSSGRENLYFQGIAI---NPGMYVRKKEGKIGES--------YFKVRKLGSGAY 49
Query: 78 ATVKLATSTRHGCDVAVKVVSK----------VEAPPDYLKKFLPREIDVVKGLRHPNLI 127
V L + A+KV+ K + + + EI ++K L HPN+I
Sbjct: 50 GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
+ E Y++ E+ E G L + I DE +Q++ I Y H+ +VH
Sbjct: 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVH 169
Query: 188 RDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
RDIK EN+L+ + NIK+ DFG + ++ G+ Y +PE+LK
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYK---LRDRLGTAYYIAPEVLKK- 222
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECKTL 301
Y DVWS GV++Y + G PF N ++K+V+ K F N+S E K L
Sbjct: 223 KYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKEL 281
Query: 302 LSKIF--SPIKFRIRLKDIKQDPWVKTEANPAA 332
+ + K R ++ W+K AN
Sbjct: 282 IKLMLTYDYNK-RCTAEEALNSRWIKKYANNIN 313
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-65
Identities = 51/351 (14%), Positives = 103/351 (29%), Gaps = 60/351 (17%)
Query: 20 AQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYAT 79
+ + N R S + D+ ++L + + V G V+G
Sbjct: 29 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 88
Query: 80 VKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREI------------------------ 115
AT G V V E PP K + E+
Sbjct: 89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148
Query: 116 -DVVKGLRHPNLIRFLQAIETTH--RVYIIMEYAEK------GSLLDFIQREGYIDEPRT 166
D+VK + +IR + + + LL +
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 208
Query: 167 KKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226
+ Q++ + H G+VH ++ ++++D + L+ F + G +
Sbjct: 209 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARV--- 260
Query: 227 DTFCGSYAYASPEILKGVPYTPHY----------SDVWSMGVVLYAMAFGRLPFDDTNYI 276
S + PE+ ++ D W++G+V+Y + LP +
Sbjct: 261 -VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL 319
Query: 277 QLLKQVQTKVVFPTEPNVSAECKTLLSKI--FSPIKFRIRLKDIKQDPWVK 325
+ +F + N+ + LL + R+ + P +
Sbjct: 320 GGSEW-----IFRSCKNIPQPVRALLEGFLRYPKED-RLLPLQAMETPEYE 364
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-65
Identities = 73/340 (21%), Positives = 136/340 (40%), Gaps = 33/340 (9%)
Query: 40 ASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK 99
S ++ D ++ + + +V+ G +A V A G + A+K +
Sbjct: 4 PGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS 63
Query: 100 VEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQA-------IETTHRVYIIMEYAEKGSL 151
E + + + +E+ +K L HPN+++F A +T ++++ KG L
Sbjct: 64 NE--EEKNRAII-QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL 120
Query: 152 LDFIQR---EGYIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLIDGEYNIKLS 206
++F+++ G + K F Q A+ + H + ++HRD+K ENLL+ + IKL
Sbjct: 121 VEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180
Query: 207 DFGFARGHMKCKSGHQSPLSD-------TFCGSYAYASPEIL---KGVPYTPHYSDVWSM 256
DFG A S T + Y +PEI+ P D+W++
Sbjct: 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK-QDIWAL 239
Query: 257 GVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF--SPIKFRIR 314
G +LY + F + PF+D L+ V K P +L+ + +P + R+
Sbjct: 240 GCILYLLCFRQHPFEDGA---KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEE-RLS 295
Query: 315 LKDIKQDPWVKTEANPAASAGVETKTLNQSKIDTQANSNS 354
+ ++ A T+ L Q+ A +
Sbjct: 296 IAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-65
Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 20/276 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK---VEAPPDYLKKFLPREIDVVKGLR 122
Y +G+ +G G +A V+ G + A K + K + ++ + RE+++++ +R
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
HPN+I E V +I+E G L DF+ + + E ++ +Q++D + Y H
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 183 RGVVHRDIKCENLLI----DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
+ + H D+K EN+++ IKL DFG A K + G+ + +P
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-----KIEAGNEFK-NIFGTPEFVAP 180
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVS 295
EI+ P +D+WS+GV+ Y + G PF + L + F E N S
Sbjct: 181 EIVNYEPLGL-EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 296 AECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEAN 329
K + + + P + R+ + + W+K
Sbjct: 240 ELAKDFIRRLLVKDPKR-RMTIAQSLEHSWIKAIRR 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-65
Identities = 58/280 (20%), Positives = 110/280 (39%), Gaps = 40/280 (14%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ ++IG G + V A G +K V Y + RE+ + L H N
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHVN 65
Query: 126 LIRFLQAIE----------------TTHRVYIIMEYAEKGSLLDFI--QREGYIDEPRTK 167
++ + + T ++I ME+ +KG+L +I +R +D+
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 168 KWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD 227
+ F Q+ +DY H + +++RD+K N+ + +K+ DFG S
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV------TSLKNDGKRT 179
Query: 228 TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKV 286
G+ Y SPE + Y D++++G++L + F+ + + L+
Sbjct: 180 RSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETSKFFTDLR----DG 234
Query: 287 VFPTEPNVSAECKTLLSKIFSPI-KFRIRLKDIKQDPWVK 325
+ + KTLL K+ S + R +I + V
Sbjct: 235 IIS--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-65
Identities = 67/279 (24%), Positives = 124/279 (44%), Gaps = 20/279 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK---VEAPPDYLKKFLPREIDVVKGLR 122
Y +G+ +G G +A VK G + A K + K + ++ + RE+ +++ +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
H N+I E V +I+E G L DF+ ++ + E + +Q++D ++Y H
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 183 RGVVHRDIKCENLLI----DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
+ + H D+K EN+++ +IKL DFG A + G+ + +P
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFK-NIFGTPEFVAP 187
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVS 295
EI+ P +D+WS+GV+ Y + G PF + L + + F E + S
Sbjct: 188 EIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 296 AECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPAA 332
K + K + K R+ +++ + PW+ N A
Sbjct: 247 ELAKDFIRKLLVKETRK-RLTIQEALRHPWITPVDNQQA 284
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 7e-65
Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 20/279 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK---VEAPPDYLKKFLPREIDVVKGLR 122
Y G+ +G G +A VK G A K + K + ++ + RE+ ++K ++
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
HPN+I + E V +I+E G L DF+ + + E ++ +Q+++ + Y H
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 183 RGVVHRDIKCENLLI----DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
+ H D+K EN+++ + IK+ DFG A K + G+ + +P
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFK-NIFGTPEFVAP 186
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVS 295
EI+ P +D+WS+GV+ Y + G PF + L V F E N S
Sbjct: 187 EIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 296 AECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPAA 332
A K + + + P K R+ ++D Q PW+K + A
Sbjct: 246 ALAKDFIRRLLVKDPKK-RMTIQDSLQHPWIKPKDTQQA 283
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-64
Identities = 74/305 (24%), Positives = 136/305 (44%), Gaps = 23/305 (7%)
Query: 55 KKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK--VEAPPDYLKKFLP 112
V+ Y L +VIG G ++ V+ + G AVK+V + P + L
Sbjct: 15 MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK 74
Query: 113 REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYID----EPRTKK 168
RE + L+HP+++ L+ + +Y++ E+ + L I + E
Sbjct: 75 REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 169 WFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPL 225
+ RQ+++A+ YCH+ ++HRD+K +L+ + +KL FG A + +
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-----SGLV 189
Query: 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT- 284
+ G+ + +PE++K PY DVW GV+L+ + G LPF T +L + +
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGK-PVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKG 247
Query: 285 KVVFPTEP--NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKT 340
K ++S K L+ + + P + RI + + PW+K E + A +T
Sbjct: 248 KYKMNPRQWSHISESAKDLVRRMLMLDPAE-RITVYEALNHPWLK-ERDRYAYKIHLPET 305
Query: 341 LNQSK 345
+ Q +
Sbjct: 306 VEQLR 310
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 4e-64
Identities = 80/288 (27%), Positives = 133/288 (46%), Gaps = 30/288 (10%)
Query: 52 RDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFL 111
+ + + S + Y + + IG+GSY+ K + AVK++ K K+
Sbjct: 11 QQLHRNSIQFTDG-YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-------KRDP 62
Query: 112 PREIDVV-KGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF 170
EI+++ + +HPN+I + VY++ E + G LLD I R+ + E
Sbjct: 63 TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL 122
Query: 171 RQLVDAIDYCHERGVVHRDIKCENLLI----DGEYNIKLSDFGFARGHMKCKSGHQSPLS 226
+ ++Y H +GVVHRD+K N+L +I++ DFGFA K L
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA----KQLRAENGLLM 178
Query: 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF----DDTNYIQLLKQV 282
T C + + +PE+L+ Y D+WS+GV+LY M G PF DDT ++L ++
Sbjct: 179 -TPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPE-EILARI 235
Query: 283 QT-KVVFPTEP--NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVK 325
+ K +VS K L+SK P + R+ + + PW+
Sbjct: 236 GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQ-RLTAALVLRHPWIV 282
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 6e-64
Identities = 67/279 (24%), Positives = 122/279 (43%), Gaps = 20/279 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK---VEAPPDYLKKFLPREIDVVKGLR 122
Y +G+ +G G +A VK G + A K + K + ++ + RE+ +++ +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
HPN+I E V +I+E G L DF+ ++ + E + +Q++D ++Y H
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 183 RGVVHRDIKCENLLI----DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
+ + H D+K EN+++ +IKL DFG A + G+ + +P
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEFK-NIFGTPEFVAP 187
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVS 295
EI+ P +D+WS+GV+ Y + G PF + L + F E S
Sbjct: 188 EIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246
Query: 296 AECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPAA 332
K + K + K R+ +++ + PW+ A
Sbjct: 247 ELAKDFIRKLLVKETRK-RLTIQEALRHPWITPVDTQQA 284
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 9e-63
Identities = 60/291 (20%), Positives = 119/291 (40%), Gaps = 32/291 (10%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ + +G G + V A + C+ A+K + ++ +K + RE+ + L HP
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVM-REVKALAKLEHPG 64
Query: 126 LIRFLQAIETTHR------------VYIIMEYAEKGSLLDFIQREGYIDEPRTK---KWF 170
++R+ A + +YI M+ K +L D++ I+E F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 171 RQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-------GHMKCKSGHQS 223
Q+ +A+++ H +G++HRD+K N+ + +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-DTNYIQLLKQV 282
G+ Y SPE + G Y+ H D++S+G++L+ + + PF ++ L V
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240
Query: 283 QTKVVFPTEPN-VSAECKTLLSKIFSPI-KFRIRLKDIKQDPWVKTEANPA 331
+ + FP ++ + SP R +I ++ + P
Sbjct: 241 R-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 3e-62
Identities = 79/279 (28%), Positives = 137/279 (49%), Gaps = 29/279 (10%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HP 124
+ K +G GS++ + + AVK++SK ++ +EI +K HP
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHP 66
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
N+++ + +++ME G L + I+++ + E R+LV A+ + H+ G
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 185 VVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
VVHRD+K ENLL + IK+ DFGFA + K PL T C + YA+PE+L
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFA----RLKPPDNQPLK-TPCFTLHYAAPELL 181
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN-------YIQLLKQVQT-KVVFPTEP- 292
Y D+WS+GV+LY M G++PF + ++++K+++ F E
Sbjct: 182 NQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240
Query: 293 -NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEA 328
NVS E K L+ P K R+++ ++ + W++ +
Sbjct: 241 KNVSQEAKDLIQGLLTVDPNK-RLKMSGLRYNEWLQDGS 278
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 5e-62
Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 20/316 (6%)
Query: 21 QSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATV 80
+ + D D + V+ K + ++ Y + + +G G++ V
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY-YDILEELGSGAFGVV 67
Query: 81 KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140
G K ++ P D K + EI ++ L HP LI A E + +
Sbjct: 68 HRCVEKATGRVFVAKFINT-PYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124
Query: 141 IIMEYAEKGSLLDFIQREGYI-DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI-- 197
+I+E+ G L D I E Y E + RQ + + + HE +VH DIK EN++
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184
Query: 198 DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMG 257
++K+ DFG A K + T + +A+PEI+ P Y+D+W++G
Sbjct: 185 KKASSVKIIDFGLAT-----KLNPDEIVKVT-TATAEFAAPEIVDREPVGF-YTDMWAIG 237
Query: 258 VVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTE--PNVSAECKTLLSK--IFSPIKFR 312
V+ Y + G PF + ++ L+ V+ F + +VS E K + P K R
Sbjct: 238 VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK-R 296
Query: 313 IRLKDIKQDPWVKTEA 328
+ + D + PW+K +
Sbjct: 297 LTVHDALEHPWLKGDH 312
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 8e-62
Identities = 72/350 (20%), Positives = 134/350 (38%), Gaps = 20/350 (5%)
Query: 4 KQHERPQSENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMEN 63
P E + + + + D + V+ K + +
Sbjct: 98 APVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLD 157
Query: 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
H Y + + +G G++ V T G + A K V K+ + +EI + LRH
Sbjct: 158 H-YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRH 213
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHE 182
P L+ A E + + +I E+ G L + + + E ++ RQ+ + + HE
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 183 RGVVHRDIKCENLLI--DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
VH D+K EN++ +KL DFG G+ +A+PE+
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQS---VKVTTGTAEFAAPEV 327
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTE--PNVSAE 297
+G P Y+D+WS+GV+ Y + G PF N + L+ V++ +S +
Sbjct: 328 AEGKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386
Query: 298 CKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSK 345
K + K + P R+ + + PW+ P + + + + +
Sbjct: 387 GKDFIRKLLLADPNT-RMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 435
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 201 bits (511), Expect = 1e-61
Identities = 48/304 (15%), Positives = 82/304 (26%), Gaps = 54/304 (17%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
L + + +G + V L D A+KV + + L L +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 126 LIRFLQAI--------------------------ETTHRVYIIMEYA-----EKGSLLDF 154
++M A S LDF
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 155 IQREGYIDEPRTKKWF-RQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213
+ + QL+ +G+VH +NL I + + L D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW- 242
Query: 214 HMKCKSGHQSPLSDTFCGSYAYASPEIL--KGVPYTPHYSDVWSMGVVLYAMAFGRLPFD 271
K G + P YA E L +T + W +G+ +Y + LPF
Sbjct: 243 ----KVGTRGP---ASSVPVTYAPREFLNASTATFTHA-LNAWQLGLSIYRVWCLFLPFG 294
Query: 272 DTN--------YIQLLKQVQTKVVFPTEPNVSAECKTLLSKI--FSPIKFRIRLKDIKQD 321
L + F + + KTL+ + F + R+ + +
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR-RLLPLEAMET 353
Query: 322 PWVK 325
P
Sbjct: 354 PEFL 357
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-61
Identities = 74/315 (23%), Positives = 137/315 (43%), Gaps = 21/315 (6%)
Query: 43 RSTLIAANKRDVKKKSTVMENHGYVL-GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVE 101
S+ + ++ +S N+ Y+L K +G G +A V+ S G + A K + K
Sbjct: 7 HSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR 66
Query: 102 APPDYLKKFLPREIDVVKGLRH-PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI--QRE 158
D + L EI V++ + P +I + E T + +I+EYA G + +
Sbjct: 67 RGQDCRAEIL-HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA 125
Query: 159 GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHM 215
+ E + +Q+++ + Y H+ +VH D+K +N+L+ +IK+ DFG +R
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--- 182
Query: 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY 275
K GH L G+ Y +PEIL P T +D+W++G++ Y + PF +
Sbjct: 183 --KIGHACELR-EIMGTPEYLAPEILNYDPITT-ATDMWNIGIIAYMLLTHTSPFVGEDN 238
Query: 276 IQLLKQVQT-KVVFPTEP--NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEANP 330
+ + V + E +VS + + +P K R + W++
Sbjct: 239 QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEK-RPTAEICLSHSWLQQWDFE 297
Query: 331 AASAGVETKTLNQSK 345
ET + +Q++
Sbjct: 298 NLFHPEETSSSSQTQ 312
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-60
Identities = 78/305 (25%), Positives = 138/305 (45%), Gaps = 39/305 (12%)
Query: 66 YVLGK-VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-H 123
Y L + V+G G++A V+ + + AVK++ K P +++ + RE++++ + H
Sbjct: 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGH 70
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
N++ ++ E R Y++ E GS+L I + + +E + + A+D+ H +
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 184 GVVHRDIKCENLLI---DGEYNIKLSDFGFARG---HMKCKSGHQSPLSDTFCGSYAYAS 237
G+ HRD+K EN+L + +K+ DF G + C L T CGS Y +
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL-TPCGSAEYMA 189
Query: 238 PEILKGVPYTPH-YS---DVWSMGVVLYAMAFGRLPFDDTNYI---------------QL 278
PE+++ Y D+WS+GV+LY + G PF L
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 279 LKQVQT-KVVFPTEP--NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEA--NPA 331
+ +Q K FP + ++S K L+SK + + R+ + Q PWV+ A N
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQ-RLSAAQVLQHPWVQGCAPENTL 308
Query: 332 ASAGV 336
+ V
Sbjct: 309 PTPMV 313
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-60
Identities = 59/307 (19%), Positives = 126/307 (41%), Gaps = 27/307 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y++ + +G G + V T K V D + + +EI ++ RH N
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTD--QVLVKKEISILNIARHRN 62
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERG 184
++ ++ E+ + +I E+ + + I ++E + Q+ +A+ + H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 185 VVHRDIKCENLLI--DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
+ H DI+ EN++ IK+ +FG AR + K G + Y +PE+ +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPG--DNFRLL-FTAPEYYAPEVHQ 176
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEP--NVSAECK 299
+ +D+WS+G ++Y + G PF Q+++ + + F E +S E
Sbjct: 177 HDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 300 TLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPAASAGVET-------KTLNQSKIDTQA 350
+ + + R+ + Q PW+K + ++ + T TL + ++
Sbjct: 236 DFVDRLLVKERKS-RMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVV 294
Query: 351 NSNSLSS 357
++ +S
Sbjct: 295 SAARISC 301
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-60
Identities = 68/297 (22%), Positives = 123/297 (41%), Gaps = 44/297 (14%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHP 124
V K++G GS TV + G VAVK + D+ L EI ++ HP
Sbjct: 17 VVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLI-----DFCDIAL-MEIKLLTESDDHP 69
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYID-------EPRTKKWFRQLVDAI 177
N+IR+ + T +YI +E +L D ++ + D E RQ+ +
Sbjct: 70 NVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 178 DYCHERGVVHRDIKCENLLID-------------GEYNIKLSDFGFARGHMKCKSGHQSP 224
+ H ++HRD+K +N+L+ I +SDFG + +S ++
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 225 LSDTFCGSYAYASPEILKGVPYTP---HYS---DVWSMGVVLYAM-AFGRLPFDDTNY-- 275
L+ G+ + +PE+L+ + D++SMG V Y + + G+ PF D
Sbjct: 189 LN-NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 276 --IQLLKQVQTKVVFPTEPNVSAECKTLLSKIFS--PIKFRIRLKDIKQDPWVKTEA 328
I ++ + ++ AE L+S++ P+K R + + P ++
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK-RPTAMKVLRHPLFWPKS 303
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-59
Identities = 82/338 (24%), Positives = 141/338 (41%), Gaps = 22/338 (6%)
Query: 5 QHERPQSENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENH 64
+ N + + + + P S L + + R V K + +
Sbjct: 29 DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF 88
Query: 65 GYVLGK--VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
Y + K ++G G + V T G +A K++ D K+ + EI V+ L
Sbjct: 89 -YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-RGMKD--KEEVKNEISVMNQLD 144
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYI-DEPRTKKWFRQLVDAIDYCH 181
H NLI+ A E+ + + ++MEY + G L D I E Y E T + +Q+ + I + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 182 ERGVVHRDIKCENLLI--DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
+ ++H D+K EN+L IK+ DFG AR + K L G+ + +PE
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPR--EKLKVN-FGTPEFLAPE 258
Query: 240 ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTE--PNVSA 296
++ + +D+WS+GV+ Y + G PF N + L + + E ++S
Sbjct: 259 VVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317
Query: 297 ECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPAA 332
E K +SK I RI + + PW+ +
Sbjct: 318 EAKEFISKLLIKEKSW-RISASEALKHPWLSDHKLHSR 354
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-59
Identities = 62/301 (20%), Positives = 118/301 (39%), Gaps = 27/301 (8%)
Query: 43 RSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA 102
S + + D + ++ + V+G G+ T+ DVAVK +
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILP--- 58
Query: 103 PPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYI 161
+ F RE+ +++ HPN+IR+ + YI +E +L ++++++ +
Sbjct: 59 --ECFS-FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA 114
Query: 162 D-EPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI-----DGEYNIKLSDFGFARGHM 215
+Q + + H +VHRD+K N+LI G+ +SDFG +
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK--- 171
Query: 216 KCKSGHQS-PLSDTFCGSYAYASPEILKGVPYTPHY--SDVWSMGVVLYAM-AFGRLPFD 271
K G S G+ + +PE+L D++S G V Y + + G PF
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 272 DTNYIQLLKQVQTKVVFPTEP--NVSAECKTLLSKIFS--PIKFRIRLKDIKQDPWVKTE 327
+ Q + + P + + L+ K+ + P K R K + + P+ +
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQK-RPSAKHVLKHPFFWSL 290
Query: 328 A 328
Sbjct: 291 E 291
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-58
Identities = 67/243 (27%), Positives = 120/243 (49%), Gaps = 12/243 (4%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+G+ IG GS+ TV HG DVAVK+++ P L+ F E+ V++ RH N+
Sbjct: 27 TVGQRIGSGSFGTVYKGK--WHG-DVAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVNI 82
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+ F+ T ++ I+ ++ E SL + E + + RQ +DY H + +
Sbjct: 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRD+K N+ + + +K+ DFG A + HQ + GS + +PE+++
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ---FEQLSGSILWMAPEVIRMQD 198
Query: 246 YTP--HYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302
P SDV++ G+VLY + G+LP+ + N Q+++ V + P V + C +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 303 SKI 305
++
Sbjct: 259 KRL 261
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-57
Identities = 72/267 (26%), Positives = 137/267 (51%), Gaps = 20/267 (7%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
GK++G GS++TV LA + A+K++ K + ++ RE DV+ L HP +
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
+ + ++Y + YA+ G LL +I++ G DE T+ + ++V A++Y H +G++H
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIH 153
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYT 247
RD+K EN+L++ + +I+++DFG A+ + +++F G+ Y SPE+L
Sbjct: 154 RDLKPENILLNEDMHIQITDFGTAK---VLSPESKQARANSFVGTAQYVSPELLTEKSAC 210
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECKTLLSKIF 306
SD+W++G ++Y + G PF N + ++ ++ + FP + + L+ K+
Sbjct: 211 KS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP--EKFFPKARDLVEKLL 267
Query: 307 S--PIKFRIRL--------KDIKQDPW 323
K RL +K P+
Sbjct: 268 VLDATK---RLGCEEMEGYGPLKAHPF 291
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 8e-57
Identities = 75/340 (22%), Positives = 135/340 (39%), Gaps = 35/340 (10%)
Query: 5 QHERPQSENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENH 64
+ + QS + A + + K ++ K + +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD 62
Query: 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RH 123
V +V+G+G V + R A+K++ RE+++ +
Sbjct: 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------ARREVELHWRASQC 114
Query: 124 PNLIRFLQAIETT----HRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAI 177
P+++R + E + I+ME + G L IQ G E + + + +AI
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 178 DYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
Y H + HRD+K ENLL +KL+DFGFA+ + S + L+ T C +
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN--SLT-TPCYTPY 228
Query: 235 YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI----QLLKQVQT-KVVFP 289
Y +PE+L Y D+WS+GV++Y + G PF + + + +++ + FP
Sbjct: 229 YVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287
Query: 290 TEP--NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVK 325
VS E K L+ P + R+ + + PW+
Sbjct: 288 NPEWSEVSEEVKMLIRNLLKTEPTQ-RMTITEFMNHPWIM 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-56
Identities = 71/221 (32%), Positives = 120/221 (54%), Gaps = 14/221 (6%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+ + IG GS+ TV A HG DVAVK++ + + + + +FL RE+ ++K LRHPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRHPNI 96
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHER 183
+ F+ A+ + I+ EY +GSL + + G +DE R + ++Y H R
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 184 G--VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+VHR++K NLL+D +Y +K+ DFG +R +S G+ + +PE+L
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA-----AGTPEWMAPEVL 211
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
+ P SDV+S GV+L+ +A + P+ + N Q++ V
Sbjct: 212 RDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 189 bits (480), Expect = 1e-56
Identities = 49/357 (13%), Positives = 107/357 (29%), Gaps = 50/357 (14%)
Query: 18 TIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHG-YVLGKVIGIGS 76
+ + +S S ST + + + +S + E V G V+G
Sbjct: 31 ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 90
Query: 77 YATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-------------- 122
AT G V V E PP K + E+ ++ LR
Sbjct: 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 123 --------HPNLIRFLQAIETTHRVYIIMEY----AEKGSLLDFIQ-------REGYIDE 163
P + ++ ++++ + + +L F + +
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210
Query: 164 PRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223
+ Q++ + H G+VH ++ ++++D + L+ F
Sbjct: 211 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----SAV 266
Query: 224 PLSDTFCGSYAYASPEILKGVPYTP----HYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
+ +L + P D W++G+ +Y + LP D +
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326
Query: 280 KQVQTKVVFPTEPNVSAECKTLLSKI--FSPIKFRIRLKDIKQDPWVKTEANPAASA 334
+ +F + N+ + LL + R+ + P + ++A
Sbjct: 327 EW-----IFRSCKNIPQPVRALLEGFLRYPKED-RLLPLQAMETPEYEQLRTELSAA 377
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-56
Identities = 83/327 (25%), Positives = 135/327 (41%), Gaps = 43/327 (13%)
Query: 55 KKKSTVMENHGYVLGK-VIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPR 113
KK V ++ Y L K V+G+G V R G A+K++ +
Sbjct: 21 PKKYAVTDD--YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQ 70
Query: 114 EIDVVKGL-RHPNLIRFLQAIETTHR----VYIIMEYAEKGSLLDFIQREG--YIDEPRT 166
E+D P+++ L E H + IIME E G L IQ G E
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130
Query: 167 KKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQS 223
+ R + AI + H + HRD+K ENLL + + +KL+DFGFA K Q+
Sbjct: 131 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA------KETTQN 184
Query: 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN----YIQLL 279
L T C + Y +PE+L Y D+WS+GV++Y + G PF +
Sbjct: 185 ALQ-TPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 280 KQVQT-KVVFPTEP--NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEA----NP 330
++++ + FP VS + K L+ P + R+ + PW+ P
Sbjct: 243 RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE-RLTITQFMNHPWINQSMVVPQTP 301
Query: 331 AASAGVETKTLNQSKIDTQANSNSLSS 357
+A V + + + +++L++
Sbjct: 302 LHTARVLQEDKDHWDEVKEEMTSALAT 328
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-56
Identities = 70/338 (20%), Positives = 121/338 (35%), Gaps = 34/338 (10%)
Query: 18 TIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSY 77
++A +K + +L + ++ K E H +G GS+
Sbjct: 12 SLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSF 71
Query: 78 ATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137
V + G AVK V L+ F E+ GL P ++ A+
Sbjct: 72 GEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPRIVPLYGAVREGP 123
Query: 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI 197
V I ME E GSL I++ G + E R + Q ++ ++Y H R ++H D+K +N+L+
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183
Query: 198 DGE-YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSM 256
+ L DFG A G D G+ + +PE++ G P D+WS
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA-KVDIWSS 242
Query: 257 GVVLYAMAFGRLPFDDTNYIQLLKQV--QTKVVFPTEPNVSAECK--------------- 299
++ M G P+ L ++ + + P+ +
Sbjct: 243 CCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
Query: 300 ---TLLSKIFSPIKFRIRLKDIKQDPWVKTEANPAASA 334
L K+ ++ LK PW P ++
Sbjct: 303 SAMELRRKVGKALQEVGGLK----SPWKGEYKEPRGNS 336
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-55
Identities = 51/227 (22%), Positives = 109/227 (48%), Gaps = 16/227 (7%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+G++IG G + V HG +VA++++ D LK F RE+ + RH N+
Sbjct: 36 EIGELIGKGRFGQVYHGR--WHG-EVAIRLIDIERDNEDQLKAFK-REVMAYRQTRHENV 91
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+ F+ A + + II + +L ++ + +D +T++ +++V + Y H +G+
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV- 244
+H+D+K +N+ D + ++DFG ++G + G + +PEI++ +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 245 --------PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ 283
P++ +SDV+++G + Y + PF ++ Q+
Sbjct: 211 PDTEEDKLPFS-KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-53
Identities = 61/270 (22%), Positives = 121/270 (44%), Gaps = 20/270 (7%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
IG GS+ TV T +VA + + ++F E +++KGL+HPN++
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPNIV 88
Query: 128 RFL----QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
RF ++ + ++ E G+L +++R + + W RQ++ + + H R
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 184 G--VVHRDIKCENLLIDGEY-NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
++HRD+KC+N+ I G ++K+ D G A ++ + G+ + +PE+
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------LKRASFAKAVIGTPEFMAPEM 201
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTKVVFPTEPNV-SAEC 298
+ Y DV++ G+ + MA P+ + N Q+ ++V + V + V E
Sbjct: 202 YEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
Query: 299 KTLLSKIFSPI-KFRIRLKDIKQDPWVKTE 327
K ++ R +KD+ + + E
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-52
Identities = 57/287 (19%), Positives = 99/287 (34%), Gaps = 42/287 (14%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHP 124
+ + IG G + +V GC A+K K A + L RE+ L +H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL-REVYAHAVLGQHS 71
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYC 180
+++R+ A + I EY GSL D I Y E K Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 181 HERGVVHRDIKCENLLID-------------------GEYNIKLSDFGFARGHMKCKSGH 221
H +VH DIK N+ I + K+ D G
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--------- 182
Query: 222 QSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK 280
+ G + + E+L+ + P +D++++ + + A + + ++
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIR 241
Query: 281 QVQTKVVFPTEPNV-SAECKTLLSKIFSPI-KFRIRLKDIKQDPWVK 325
Q + P P V S E LL + P + R + + +
Sbjct: 242 QGR----LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-52
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVV--SKVEAPPDYLKKFLPREIDVVKGLRHP 124
L ++IGIG + V A G +VAVK E ++ +E + L+HP
Sbjct: 10 TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVR-QEAKLFAMLKHP 66
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
N+I + ++ME+A G L + + I W Q+ ++Y H+
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 185 ---VVHRDIKCENLLIDGEY--------NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
++HRD+K N+LI + +K++DFG AR ++ + G+Y
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTT-----KMSAAGAY 178
Query: 234 AYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
A+ +PE+++ ++ SDVWS GV+L+ + G +PF + + + V
Sbjct: 179 AWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 174 bits (441), Expect = 2e-51
Identities = 40/251 (15%), Positives = 86/251 (34%), Gaps = 33/251 (13%)
Query: 55 KKKSTVMENHGYVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKK 109
K + + + ++G G++A V AT ++ +KV +
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-----ANPWE 110
Query: 110 F--LPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-----EGYID 162
F + ++ +K ++F A + ++ E G+LL+ I E +
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 163 EPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI-----------DGEYNIKLSDFGFA 211
+ + +++ I+ H+ ++H DIK +N ++ D + L D G +
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF- 270
G C + + E+L P+ D + + +Y M FG
Sbjct: 231 IDMKLFPKGTI---FTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKV 286
Query: 271 DDTNYIQLLKQ 281
+ +
Sbjct: 287 KNEGGECKPEG 297
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-51
Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 13/238 (5%)
Query: 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVV-SKVEAPPDYLKKFLPREIDVVKGLRH 123
Y L +++G G V A T VA+K++ + + P + + RE L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ-REARTAGRLQE 93
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
P+++ E ++Y+ M L ++R+G + PR RQ+ A+D H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT--FCGSYAYASPEIL 241
G HRD+K EN+L+ + L DFG A + L+ G+ Y +PE
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIAS------ATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE--PNVSAE 297
T +D++++ VLY G P+ + + + P+ P +
Sbjct: 208 SESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-50
Identities = 65/294 (22%), Positives = 114/294 (38%), Gaps = 56/294 (19%)
Query: 51 KRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKF 110
K ++ K + + V +V+G+G V + R A+K++
Sbjct: 5 KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------- 56
Query: 111 LPREIDVVKGL-RHPNLIRFLQAIETTHR----VYIIMEYAEKGSLLDFIQREGYID--E 163
RE+++ + P+++R + E + + I+ME + G L IQ G E
Sbjct: 57 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 116
Query: 164 PRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSG 220
+ + + +AI Y H + HRD+K ENLL +KL+DFGFA
Sbjct: 117 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------- 167
Query: 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI---- 276
E Y D+WS+GV++Y + G PF + +
Sbjct: 168 -----------------KETTGE-KYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
Query: 277 QLLKQVQT-KVVFPTEP--NVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVK 325
+ +++ + FP VS E K L+ P + R+ + + PW+
Sbjct: 209 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ-RMTITEFMNHPWIM 261
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-50
Identities = 49/221 (22%), Positives = 96/221 (43%), Gaps = 14/221 (6%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+ G+V+G G + T G + +K + + + + + FL +E+ V++ L HPN+
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFL-KEVKVMRCLEHPNV 69
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++F+ + R+ I EY + G+L I+ + + + + + + Y H +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR---------GHMKCKSGHQSPLSDTFCGSYAYA 236
+HRD+ N L+ N+ ++DFG AR ++ T G+ +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ 277
+PE++ G Y DV+S G+VL + D
Sbjct: 190 APEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-50
Identities = 48/255 (18%), Positives = 102/255 (40%), Gaps = 30/255 (11%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD-----YLKKFLPREIDVVKGL 121
K IG G + V + VA+K + ++ + ++F RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ-REVFIMSNL 80
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAIDYC 180
HPN+++ + ++ME+ G L + + + I + + I+Y
Sbjct: 81 NHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 181 HERG--VVHRDIKCENLLID-----GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
+ +VHRD++ N+ + K++DFG ++ G++
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--------QSVHSVSGLLGNF 190
Query: 234 AYASPEILKG--VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE 291
+ +PE + YT +D +S ++LY + G PFD+ +Y ++ + +
Sbjct: 191 QWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIREEGL 247
Query: 292 -PNVSAECKTLLSKI 305
P + +C L +
Sbjct: 248 RPTIPEDCPPRLRNV 262
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-49
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+ +V+G G++ V A DVA+K + K F+ E+ + + HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAK--WRAKDVAIKQIE----SESERKAFI-VELRQLSRVNHPNI 63
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHER 183
++ A + V ++MEYAE GSL + + Y W Q + Y H
Sbjct: 64 VKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 184 ---GVVHRDIKCENLLIDGEYN-IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
++HRD+K NLL+ +K+ DFG A GS A+ +PE
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--------DIQTHMTNNKGSAAWMAPE 173
Query: 240 ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ 277
+ +G Y+ DV+S G++L+ + R PFD+
Sbjct: 174 VFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPA 210
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-49
Identities = 44/247 (17%), Positives = 95/247 (38%), Gaps = 22/247 (8%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+ + G D+ VKV+ + + F E ++ HPN+
Sbjct: 13 NFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFN-EECPRLRIFSHPNV 69
Query: 127 IRFLQAIET--THRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCH- 181
+ L A ++ +I + GSL + + +D+ + K+ + + + H
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 182 -ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
E + + +++ID + ++S S S + A+ +PE
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF----------SFQSPGRMYAPAWVAPEA 179
Query: 241 LKGVPYTPHY--SDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP-NVSAE 297
L+ P + +D+WS V+L+ + +PF D + +++ +V + + PT P +S
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 298 CKTLLSK 304
L+
Sbjct: 240 VSKLMKI 246
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-49
Identities = 74/274 (27%), Positives = 134/274 (48%), Gaps = 18/274 (6%)
Query: 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIR 128
V+G G+Y V + +A+K + + ++ Y + L EI + K L+H N+++
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQP-LHEEIALHKHLKHKNIVQ 83
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHERGV 185
+L + + I ME GSL ++ + +E + +Q+++ + Y H+ +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 186 VHRDIKCENLLIDGEY-NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
VHRDIK +N+LI+ +K+SDFG ++ + +P ++TF G+ Y +PEI+
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 245 P--YTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTKVVFPTEP-NVSAECKT 300
P Y +D+WS+G + MA G+ PF + + +V V P P ++SAE K
Sbjct: 199 PRGYGK-AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257
Query: 301 LLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAAS 333
+ K F P R D+ D ++K + +
Sbjct: 258 FILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT 291
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-48
Identities = 73/263 (27%), Positives = 126/263 (47%), Gaps = 14/263 (5%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
KVIG G++ V+L A+K++SK E F E D++ P +++
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
A + +Y++MEY G L+ + + E + + ++V A+D H G +HRD
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
+K +N+L+D ++KL+DFG MK DT G+ Y SPE+LK +
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTC---MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 250 YS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV---QTKVVFPTEPNVSAECKTLLS 303
Y D WS+GV LY M G PF + + ++ + + FP + ++S E K L+
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
Query: 304 KIFSPIKFRIR---LKDIKQDPW 323
+ + R+ +++IK+ +
Sbjct: 310 AFLTDREVRLGRNGVEEIKRHLF 332
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 80/312 (25%), Positives = 135/312 (43%), Gaps = 28/312 (8%)
Query: 22 SSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVK 81
++ K + S K L + L ++ + K +G GS+ V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQ--LDQ--FDRIKTLGTGSFGRVM 58
Query: 82 LATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141
L G A+K++ K + + E +++ + P L++ + + +Y+
Sbjct: 59 LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201
+MEY G + ++R G EP + + Q+V +Y H +++RD+K ENLLID +
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178
Query: 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLY 261
I+++DFGF K + T CG+ +PEI+ Y D W++GV++Y
Sbjct: 179 YIQVTDFGF------AKRVKGR--TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIY 229
Query: 262 AMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECKTLLSKIFS--PIKFRIRL--- 315
MA G PF IQ+ ++ V KV FP + S++ K LL + K R
Sbjct: 230 EMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTK---RFGNL 284
Query: 316 ----KDIKQDPW 323
DIK W
Sbjct: 285 KNGVNDIKNHKW 296
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-47
Identities = 60/268 (22%), Positives = 121/268 (45%), Gaps = 22/268 (8%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
+ IG GS+ V + A+K ++K + + + +E+ +++GL HP L+
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189
+ + ++++++ G L +Q+ + E K + +LV A+DY + ++HRD
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH 249
+K +N+L+D ++ ++DF + T G+ Y +PE+ +
Sbjct: 141 MKPDNILLDEHGHVHITDFNI------AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 250 YSDV--WSMGVVLYAMAFGRLPF---DDTNYIQLLKQVQT-KVVFPTEPNVSAECKTLLS 303
V WS+GV Y + GR P+ T+ +++ +T V +P S E +LL
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--SAWSQEMVSLLK 252
Query: 304 KIFS--PIKFRIRL---KDIKQDPWVKT 326
K+ P + R D++ P++
Sbjct: 253 KLLEPNPDQ---RFSQLSDVQNFPYMND 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-47
Identities = 69/237 (29%), Positives = 113/237 (47%), Gaps = 11/237 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVV-SKVEAPPDYLKKFLPREIDVVKGLRHP 124
Y + +G G +TV LA T VA+K + + LK+F RE+ L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE-REVHNSSQLSHQ 71
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
N++ + E Y++MEY E +L ++I+ G + + Q++D I + H+
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
+VHRDIK +N+LID +K+ DFG A+ S ++ G+ Y SPE KG
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKA----LSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQL-LKQVQTKVVFPTE---PNVSAE 297
+D++S+G+VLY M G PF+ + + +K +Q V T ++
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-47
Identities = 72/273 (26%), Positives = 137/273 (50%), Gaps = 38/273 (13%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREID-------VVKG 120
+ + +G GS+ V L S +G A+KV+ K ++ ++++ ++
Sbjct: 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK----EIVVRL---KQVEHTNDERLMLSI 62
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
+ HP +IR + ++++IM+Y E G L +++ P K + ++ A++Y
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H + +++RD+K EN+L+D +IK++DFGF K + T CG+ Y +PE+
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGF------AKYVPDV--TYTLCGTPDYIAPEV 174
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECK 299
+ PY D WS G+++Y M G PF D+N ++ ++ + ++ FP P + + K
Sbjct: 175 VSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVK 231
Query: 300 TLLSKIFS--PIKFRIRL-------KDIKQDPW 323
LLS++ + + RL +D+K PW
Sbjct: 232 DLLSRLITRDLSQ---RLGNLQNGTEDVKNHPW 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-47
Identities = 84/276 (30%), Positives = 137/276 (49%), Gaps = 39/276 (14%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPR--------EIDVVKGL 121
K++G G++ V L G A+K++ K + + + E V++
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRK--------EVIIAKDEVAHTVTESRVLQNT 62
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
RHP L A +T R+ +MEYA G L + RE E R + + ++V A++Y H
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEI 240
R VV+RDIK ENL++D + +IK++DFG CK G TFCG+ Y +PE+
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGL------CKEGISDGATMKTFCGTPEYLAPEV 176
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECK 299
L+ Y D W +GVV+Y M GRLPF + ++ +L + + ++ FP +S E K
Sbjct: 177 LEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAK 233
Query: 300 TLLSKIFS--PIKFRIRL-------KDIKQDPWVKT 326
+LL+ + P + RL K++ + + +
Sbjct: 234 SLLAGLLKKDPKQ---RLGGGPSDAKEVMEHRFFLS 266
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-46
Identities = 69/242 (28%), Positives = 115/242 (47%), Gaps = 16/242 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVV-SKVEAPPDYLKKFLPREIDVVKGLRHP 124
Y LG+++G G + V LA R DVAVKV+ + + P + +F RE L HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHP 72
Query: 125 NLIRFL----QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
++ YI+MEY + +L D + EG + R + A+++
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT--FCGSYAYASP 238
H+ G++HRD+K N++I +K+ DFG AR + + ++ T G+ Y SP
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARA----IADSGNSVTQTAAVIGTAQYLSP 188
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQL-LKQVQTKVVFPTE--PNVS 295
E +G SDV+S+G VLY + G PF + + + + V+ + P+ +S
Sbjct: 189 EQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247
Query: 296 AE 297
A+
Sbjct: 248 AD 249
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-46
Identities = 74/307 (24%), Positives = 130/307 (42%), Gaps = 15/307 (4%)
Query: 31 SSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGC 90
+L+LD R L A K+K +++ + +G G+ V + G
Sbjct: 2 KKLEELELDEQQRKRLEA--FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGL 59
Query: 91 DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGS 150
+A K++ +E P + + RE+ V+ P ++ F A + + I ME+ + GS
Sbjct: 60 VMARKLI-HLEIKPAIRNQ-IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 151 LLDFIQREGYIDEPRTKKWFRQLVDAIDYCH-ERGVVHRDIKCENLLIDGEYNIKLSDFG 209
L +++ G I E K ++ + Y + ++HRD+K N+L++ IKL DFG
Sbjct: 118 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 210 FARGHMKCKSGH-QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRL 268
SG ++++F G+ +Y SPE L+G Y+ SD+WSMG+ L MA GR
Sbjct: 178 V--------SGQLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRY 228
Query: 269 PFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPWVKTEA 328
P + +L +V + R + + ++ E
Sbjct: 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288
Query: 329 NPAASAG 335
P +G
Sbjct: 289 PPKLPSG 295
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-46
Identities = 62/273 (22%), Positives = 110/273 (40%), Gaps = 42/273 (15%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
L + +G G Y V + G +VAVK+ S D F E+ LRH N+
Sbjct: 11 TLLECVGKGRYGEVWRGS--WQGENVAVKIFS----SRDEKSWFRETELYNTVMLRHENI 64
Query: 127 IRFLQAIETTH----RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
+ F+ + T+ ++++I Y E GSL D++Q +D + + + + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHI 123
Query: 183 R--------GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
+ HRD+K +N+L+ ++D G A H + + ++ G+
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG-NNPRVGTKR 182
Query: 235 YASPEILKGVPYTPHY-----SDVWSMGVVLYAMAFG----------RLPFDDTNYIQL- 278
Y +PE+L + D+W+ G+VL+ +A + PF D
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 279 LKQVQTKVVF----PTEPN--VSAECKTLLSKI 305
+ ++ V P PN S T L+K+
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKL 275
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-45
Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 37/275 (13%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREID--------VVKGL 121
KVIG GS+ V LA AVKV+ K LKK +E ++K +
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQK----KAILKK---KEEKHIMSERNVLLKNV 96
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
+HP L+ + +T ++Y +++Y G L +QRE EPR + + ++ A+ Y H
Sbjct: 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEI 240
+V+RD+K EN+L+D + +I L+DFG CK + + TFCG+ Y +PE+
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGL------CKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECK 299
L PY D W +G VLY M +G PF N ++ + + PN++ +
Sbjct: 211 LHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSAR 267
Query: 300 TLLSKIFS--PIKFRIRL------KDIKQDPWVKT 326
LL + K RL +IK +
Sbjct: 268 HLLEGLLQKDRTK---RLGAKDDFMEIKSHVFFSL 299
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-45
Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 20/262 (7%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV-VKGLRHPNLIR 128
K++G GS+ V LA + A+K + K D + E V HP L
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+T ++ +MEY G L+ IQ D R + +++ + + H +G+V+R
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K +N+L+D + +IK++DFG CK ++TFCG+ Y +PEIL G Y
Sbjct: 143 DLKLDNILLDKDGHIKIADFGM------CKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 196
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECKTLLSKIF 306
H D WS GV+LY M G+ PF + +L +P + E K LL K+F
Sbjct: 197 -HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RWLEKEAKDLLVKLF 253
Query: 307 S--PIKFRIRL---KDIKQDPW 323
P K RL DI+Q P
Sbjct: 254 VREPEK---RLGVRGDIRQHPL 272
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 72/266 (27%), Positives = 127/266 (47%), Gaps = 16/266 (6%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
KVIG G++ V + A+K+++K E E DV+ +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
A + + +Y++M+Y G LL + + E + E + + ++V AID H+ VHR
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTP 248
DIK +N+L+D +I+L+DFG M+ + S G+ Y SPEIL+ +
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLKLME----DGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 249 H-YS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV---QTKVVFPTE-PNVSAECKT 300
Y D WS+GV +Y M +G PF + ++ ++ + + FPT+ +VS K
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
Query: 301 LLSKIFSPIKFRIR---LKDIKQDPW 323
L+ ++ + R+ ++D K+ P+
Sbjct: 316 LIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-45
Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 22/270 (8%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRF 129
KVIG G+++ V + + G A+K+++K + E DV+ + +
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAIDYCHERGVVHR 188
A + + +Y++MEY G LL + + G I + + ++V AID H G VHR
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL--SDTFCGSYAYASPEILKGVPY 246
DIK +N+L+D +I+L+DFG C S G+ Y SPEIL+ V
Sbjct: 187 DIKPDNILLDRCGHIRLADFGS------CLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 247 TPHYS------DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV---QTKVVFPTEP-NVSA 296
P D W++GV Y M +G+ PF + + ++ + + P V
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 297 ECKTLLSKIFSPIKFRI---RLKDIKQDPW 323
E + + ++ P + R+ D + P+
Sbjct: 301 EARDFIQRLLCPPETRLGRGGAGDFRTHPF 330
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-45
Identities = 77/281 (27%), Positives = 134/281 (47%), Gaps = 47/281 (16%)
Query: 70 KVIGIGSYATVKLATSTRHGCDV------AVKVVSKVEAPPDYLKKFLPR-------EID 116
KV+G GS+ V L + A+KV+ K LK R E D
Sbjct: 30 KVLGQGSFGKVFLV---KKISGSDARQLYAMKVLKK-----ATLKV---RDRVRTKMERD 78
Query: 117 VVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
++ + HP +++ A +T ++Y+I+++ G L + +E E K + +L A
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAY 235
+D+ H G+++RD+K EN+L+D E +IKL+DFG K + +FCG+ Y
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL------SKESIDHEKKAYSFCGTVEY 192
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNV 294
+PE++ +T +D WS GV+++ M G LPF + + + ++ K+ P +
Sbjct: 193 MAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP--QFL 249
Query: 295 SAECKTLLSKIFS--PIKFRIRL-------KDIKQDPWVKT 326
S E ++LL +F P RL ++IK+ + T
Sbjct: 250 SPEAQSLLRMLFKRNPAN---RLGAGPDGVEEIKRHSFFST 287
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-44
Identities = 92/329 (27%), Positives = 153/329 (46%), Gaps = 24/329 (7%)
Query: 7 ERPQSENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGY 66
E P+ T I + K+ ++ + S ++ + + K + + +
Sbjct: 91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEF 150
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
K++G G++ V L G A+K++ K E V++ RHP L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH-ERGV 185
+ +T R+ +MEYA G L + RE E R + + ++V A+DY H E+ V
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 270
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGV 244
V+RD+K ENL++D + +IK++DFG CK G TFCG+ Y +PE+L+
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGL------CKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECKTLLS 303
Y D W +GVV+Y M GRLPF + ++ +L + + ++ FP + E K+LLS
Sbjct: 325 DYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGPEAKSLLS 381
Query: 304 KIFS--PIKFRIRL-------KDIKQDPW 323
+ P + RL K+I Q +
Sbjct: 382 GLLKKDPKQ---RLGGGSEDAKEIMQHRF 407
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 2e-44
Identities = 46/232 (19%), Positives = 95/232 (40%), Gaps = 20/232 (8%)
Query: 108 KKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTK 167
+I + N + LQ +YI M+ K +L D++ R +++
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 168 ---KWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-------GHMKC 217
F Q+ +A+++ H +G++HRD+K N+ + +K+ DFG
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-DTNYI 276
G+ Y SPE + G Y+ H D++S+G++L+ + + F +
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLY---SFSTQMERV 280
Query: 277 QLLKQVQTKVVFPTEP-NVSAECKTLLSKIFS--PIKFRIRLKDIKQDPWVK 325
+++ V+ + FP + ++ + S P + R DI ++ +
Sbjct: 281 RIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTE-RPEATDIIENAIFE 330
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-44
Identities = 73/279 (26%), Positives = 136/279 (48%), Gaps = 41/279 (14%)
Query: 70 KVIGIGSYATVKLATSTRHGCDV------AVKVVSK---VEAPPD--YLKKFLPREIDVV 118
+V+G G Y V R A+KV+ K V D + K E +++
Sbjct: 23 RVLGKGGYGKVFQV---RKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA----ERNIL 75
Query: 119 KGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
+ ++HP ++ + A +T ++Y+I+EY G L ++REG E + ++ A+
Sbjct: 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYAS 237
+ H++G+++RD+K EN++++ + ++KL+DFG CK H ++ TFCG+ Y +
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL------CKESIHDGTVTHTFCGTIEYMA 189
Query: 238 PEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSA 296
PEIL + D WS+G ++Y M G PF N + + + ++ K+ P P ++
Sbjct: 190 PEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLTQ 246
Query: 297 ECKTLLSKIFS--PIKFRIRL-------KDIKQDPWVKT 326
E + LL K+ RL +++ P+ +
Sbjct: 247 EARDLLKKLLKRNAAS---RLGAGPGDAGEVQAHPFFRH 282
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 7e-44
Identities = 74/269 (27%), Positives = 127/269 (47%), Gaps = 24/269 (8%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV-VKGLRHPNLIR 128
V+G GS+ V L+ AVK++ K D + E V + P L +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+T R+Y +MEY G L+ IQ+ G EP + ++ + + +G+++R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K +N+++D E +IK++DFG CK + TFCG+ Y +PEI+ PY
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGM------CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 199
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECKTLLSKIF 306
D W+ GV+LY M G+ PF+ + +L + ++ V +P ++S E + +
Sbjct: 200 -KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVAICKGLM 256
Query: 307 S--PIKFRIRL-------KDIKQDPWVKT 326
+ P K RL +DIK+ + +
Sbjct: 257 TKHPGK---RLGCGPEGERDIKEHAFFRY 282
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-44
Identities = 81/276 (29%), Positives = 135/276 (48%), Gaps = 34/276 (12%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV-VKGLRHPNLIR 128
+VIG GSYA V L + A+KVV K D ++ E V + HP L+
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+T R++ ++EY G L+ +QR+ + E + + ++ A++Y HERG+++R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K +N+L+D E +IKL+D+G CK G + TFCG+ Y +PEIL+G Y
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 188
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ----------VQTKVVFPTEPNVSAE 297
D W++GV+++ M GR PFD Q ++ ++ P ++S +
Sbjct: 189 -FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVK 245
Query: 298 CKTLLSKIFS--PIKFRIRL--------KDIKQDPW 323
++L + P + RL DI+ P+
Sbjct: 246 AASVLKSFLNKDPKE---RLGCHPQTGFADIQGHPF 278
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-43
Identities = 80/270 (29%), Positives = 130/270 (48%), Gaps = 25/270 (9%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV-VKGLRHPNLIR 128
+V+G GS+ V LA G AVKV+ K D + E + HP L +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+T R++ +ME+ G L+ IQ+ DE R + + +++ A+ + H++G+++R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K +N+L+D E + KL+DFG CK G + TFCG+ Y +PEIL+ + Y
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGM------CKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECKTLLSKIF 306
D W+MGV+LY M G PF+ N L + + +VV+P + + +L
Sbjct: 203 -PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLHEDATGILKSFM 259
Query: 307 S--PIKFRIRL--------KDIKQDPWVKT 326
+ P RL I + P+ K
Sbjct: 260 TKNPTM---RLGSLTQGGEHAILRHPFFKE 286
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-43
Identities = 68/343 (19%), Positives = 143/343 (41%), Gaps = 58/343 (16%)
Query: 21 QSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLG-----KVIGIG 75
+E + D + K +++ + + KV+G G
Sbjct: 6 HHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTG 65
Query: 76 SYATVKLATSTRHGCDV------AVKVVSKVEAPPDYLKKFLPREIDV----------VK 119
+Y V L R A+KV+ K + +
Sbjct: 66 AYGKVFLV---RKISGHDTGKLYAMKVLKK--------ATIVQKAKTTEHTRTERQVLEH 114
Query: 120 GLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
+ P L+ A +T ++++I++Y G L + + E + + ++V A+++
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 174
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
H+ G+++RDIK EN+L+D ++ L+DFG ++ + ++ + FCG+ Y +P+
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA----DETERAYDFCGTIEYMAPD 230
Query: 240 ILKGVPYTPHYSDV--WSMGVVLYAMAFGRLPF----DDTNYIQLLKQ-VQTKVVFPTEP 292
I++G H V WS+GV++Y + G PF + + ++ ++ ++++ +P
Sbjct: 231 IVRGGDS-GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--Q 287
Query: 293 NVSAECKTLLSKIFS--PIKFRIRL-------KDIKQDPWVKT 326
+SA K L+ ++ P K RL +IK+ + +
Sbjct: 288 EMSALAKDLIQRLLMKDPKK---RLGCGPRDADEIKEHLFFQK 327
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-43
Identities = 80/276 (28%), Positives = 135/276 (48%), Gaps = 34/276 (12%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV-VKGLRHPNLIR 128
+VIG GSYA V L + A++VV K D ++ E V + HP L+
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+T R++ ++EY G L+ +QR+ + E + + ++ A++Y HERG+++R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K +N+L+D E +IKL+D+G CK G + TFCG+ Y +PEIL+G Y
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 231
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ----------VQTKVVFPTEPNVSAE 297
D W++GV+++ M GR PFD Q ++ ++ P ++S +
Sbjct: 232 -FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVK 288
Query: 298 CKTLLSKIFS--PIKFRIRL--------KDIKQDPW 323
++L + P + RL DI+ P+
Sbjct: 289 AASVLKSFLNKDPKE---RLGCHPQTGFADIQGHPF 321
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 3e-42
Identities = 74/269 (27%), Positives = 127/269 (47%), Gaps = 24/269 (8%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV-VKGLRHPNLIR 128
V+G GS+ V L+ AVK++ K D + E V + P L +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHR 188
+T R+Y +MEY G L+ IQ+ G EP + ++ + + +G+++R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSG-HQSPLSDTFCGSYAYASPEILKGVPYT 247
D+K +N+++D E +IK++DFG CK + TFCG+ Y +PEI+ PY
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGM------CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 520
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTEPNVSAECKTLLSKIF 306
D W+ GV+LY M G+ PF+ + +L + ++ V +P ++S E + +
Sbjct: 521 -KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVAICKGLM 577
Query: 307 S--PIKFRIRL-------KDIKQDPWVKT 326
+ P K RL +DIK+ + +
Sbjct: 578 TKHPGK---RLGCGPEGERDIKEHAFFRY 603
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 25/229 (10%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+ K IG G Y V + G VAVKV + F EI +RH N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFF----TTEEASWFRETEIYQTVLMRHENI 93
Query: 127 IRFLQAIETTH----RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
+ F+ A ++Y+I +Y E GSL D+++ +D K V + + H
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 183 R--------GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
+ HRD+K +N+L+ ++D G A + + P +T G+
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP-PNTRVGTKR 211
Query: 235 YASPEILKGVPYTPHY-----SDVWSMGVVLYAMAFGRLPFDDTNYIQL 278
Y PE+L H+ +D++S G++L+ +A + QL
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-42
Identities = 60/267 (22%), Positives = 107/267 (40%), Gaps = 40/267 (14%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
VL + IG G + V G +VAVK+ S + F EI LRH N+
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENI 98
Query: 127 IRFLQAIETTH----RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
+ F+ A + +++++ +Y E GSL D++ R + K + + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157
Query: 183 R--------GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
+ HRD+K +N+L+ ++D G A H + G+
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR 216
Query: 235 YASPEILKGVPYTPHY-----SDVWSMGVVLYAMAFG----------RLPFDDTNYIQL- 278
Y +PE+L H+ +D+++MG+V + +A +LP+ D
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 279 LKQVQTKVVF----PTEPNVSAECKTL 301
+++++ V P PN C+ L
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEAL 303
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-41
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 67 VLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
KV+G G++ TV + VA+K + + P K+ L E V+ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMASVD 75
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCH 181
+P++ R L I T V +I + G LLD+++ + I W Q+ ++Y
Sbjct: 76 NPHVCR-LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS---- 237
+R +VHRD+ N+L+ ++K++DFG A+ Y +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAK--------------LLGAEEKEYHAEGGK 180
Query: 238 -------PEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
E + YT H SDVWS GV ++ M FG P+D ++ ++
Sbjct: 181 VPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 25/230 (10%)
Query: 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVK 119
+ME Y IG GSY V + G VA+K +KK REI ++K
Sbjct: 1 MMEK--YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLK 57
Query: 120 GLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAID 178
L+HPNL+ L+ R++++ EY + ++L + + + + E K Q + A++
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA---- 234
+CH+ +HRD+K EN+LI IKL DFGFAR +G D
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR----LLTGPSDYYDD-----EVATRW 167
Query: 235 YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYI-QLLK 280
Y SPE+L G Y DVW++G V + G + + + QL
Sbjct: 168 YRSPELLVG---DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 28/225 (12%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
L +V G + V A VAVK+ D E+ + G++H N++
Sbjct: 28 LLEVKARGRFGCVWKAQ--LLNEYVAVKIFP----IQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 128 RFLQAIETTHRV----YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER 183
+F+ A + V ++I + EKGSL DF++ + + + Y HE
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHED 140
Query: 184 ----------GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
+ HRDIK +N+L+ ++DFG A ++G + + G+
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF---EAGKSAGDTHGQVGTR 197
Query: 234 AYASPEILKGVPYTPHY----SDVWSMGVVLYAMAFGRLPFDDTN 274
Y +PE+L+G D+++MG+VL+ +A D
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-39
Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 24/234 (10%)
Query: 41 SSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV 100
S+ + ++ +S ME Y ++G GSY V + G VA+K
Sbjct: 6 HHHSSGVDLGTENLYFQS--MEK--YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LE 60
Query: 101 EAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREG 159
+KK REI ++K LRH NL+ L+ + R Y++ E+ + ++LD +
Sbjct: 61 SDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN 119
Query: 160 YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219
+D +K+ Q+++ I +CH ++HRDIK EN+L+ +KL DFGFAR +
Sbjct: 120 GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR----TLA 175
Query: 220 GHQSPLSD---TFCGSYAYASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGR 267
D T Y +PE+L G Y DVW++G ++ M G
Sbjct: 176 APGEVYDDEVATR----WYRAPELLVG---DVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 67/345 (19%), Positives = 132/345 (38%), Gaps = 42/345 (12%)
Query: 4 KQHERPQSENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMEN 63
+ + D +E + S + T K M +
Sbjct: 131 HVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMND 190
Query: 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKK-------FLPREI- 115
+ + ++IG G + V G A+K + K +K R +
Sbjct: 191 --FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETLALNERIML 243
Query: 116 DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD 175
+V P ++ A T ++ I++ G L + + G E + + +++
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 303
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235
+++ H R VV+RD+K N+L+D ++++SD G A K K G++ Y
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-------ASVGTHGY 356
Query: 236 ASPEIL-KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI---QLLKQV-QTKVVFPT 290
+PE+L KGV Y +D +S+G +L+ + G PF ++ + V P
Sbjct: 357 MAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP- 414
Query: 291 EPNVSAECKTLLSKIFS--PIKFRIRL-------KDIKQDPWVKT 326
+ S E ++LL + + RL +++K+ P+ ++
Sbjct: 415 -DSFSPELRSLLEGLLQRDVNR---RLGCLGRGAQEVKESPFFRS 455
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 61/280 (21%), Positives = 113/280 (40%), Gaps = 39/280 (13%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKK-----FLPREIDVVKGLRHP 124
+V+G G + V G A K ++K LKK E ++ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNK-----KRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSL----LDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
++ A ET + ++M G + + + EPR + Q+V +++
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H+R +++RD+K EN+L+D + N+++SD G A ++ + + G+ + +PE+
Sbjct: 306 HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-----KTKGYAGTPGFMAPEL 360
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK-----VVFPTEPNVS 295
L G Y D +++GV LY M R PF K+++ + V +P S
Sbjct: 361 LLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFS 417
Query: 296 AECKTLLSKIFS--PIKFRIRL-------KDIKQDPWVKT 326
K + P K RL ++ P +
Sbjct: 418 PASKDFCEALLQKDPEK---RLGFRDGSCDGLRTHPLFRD 454
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-39
Identities = 56/281 (19%), Positives = 101/281 (35%), Gaps = 50/281 (17%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP-REIDVVKGLRHPN 125
L ++IG G Y V + VAVKV S + F+ + I V + H N
Sbjct: 16 KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDN 68
Query: 126 LIRFLQAIETTHRV-----YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
+ RF+ E ++MEY GSL ++ D + + + + Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYL 127
Query: 181 HE---------RGVVHRDIKCENLLIDGEYNIKLSDFGFAR---GHMKCKSGHQSPLSDT 228
H + HRD+ N+L+ + +SDFG + G+ + G + + +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 229 FCGSYAYASPEILKGVPYTPHY------SDVWSMGVVL------------------YAMA 264
G+ Y +PE+L+G D++++G++ Y MA
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 265 FGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKI 305
F + + + V + P P E + +
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 45/214 (21%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 66 YVLGKVIGIGSYATVKLATSTR-HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
Y + I G + LA +G V +K + + + E + + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAM-AERQFLAEVVHP 139
Query: 125 NLIRFLQAIETTHR-----VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
++++ +E T R YI+MEY SL ++ + + +++ A+ Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSY 197
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT--FCGSYAYAS 237
H G+V+ D+K EN+++ E +KL D G ++ G+ + +
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----------INSFGYLYGTPGFQA 245
Query: 238 PEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD 271
PEI++ P T +D++++G L A+ +
Sbjct: 246 PEIVRTGP-TV-ATDIYTVGRTLAALTLDLPTRN 277
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 59/278 (21%), Positives = 110/278 (39%), Gaps = 38/278 (13%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKK-----FLPREIDVVKGLRHP 124
+V+G G + V G A K + K +KK E +++ +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEK-----KRIKKRKGEAMALNEKQILEKVNSR 244
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHE 182
++ A ET + +++ G L I G E R + ++ ++ H
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
+V+RD+K EN+L+D +I++SD G + G+ Y +PE++K
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGL------AVHVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-----QTKVVFPTEPNVSAE 297
YT D W++G +LY M G+ PF ++V + + S +
Sbjct: 359 NERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQ 415
Query: 298 CKTLLSKIFS--PIKFRIRL-------KDIKQDPWVKT 326
++L S++ P + RL +++K+ P K
Sbjct: 416 ARSLCSQLLCKDPAE---RLGCRGGSAREVKEHPLFKK 450
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 67 VLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
KV+G G++ TV + VA+K + + P K+ L E V+ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMASVD 75
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCH 181
+P++ R L I T V +I + G LLD+++ + I W Q+ ++Y
Sbjct: 76 NPHVCR-LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS---- 237
+R +VHRD+ N+L+ ++K++DFG A+ Y +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAK--------------LLGAEEKEYHAEGGK 180
Query: 238 -------PEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
E + YT H SDVWS GV ++ M FG P+D ++ ++
Sbjct: 181 VPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 50/234 (21%), Positives = 90/234 (38%), Gaps = 35/234 (14%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGC----DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
KV+G G + TV G V +KV+ + ++ + + + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT-DHMLAIGSLD 73
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCH 181
H +++R L + + ++ +Y GSLLD ++ G + W Q+ + Y
Sbjct: 74 HAHIVR-LLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS---- 237
E G+VHR++ N+L+ ++++DFG A
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVAD--------------LLPPDDKQLLYSEAK 178
Query: 238 -------PEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
E + YT H SDVWS GV ++ M FG P+ ++ ++
Sbjct: 179 TPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 19/223 (8%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHPNLIR 128
+G G+Y V+ G +AVK + K+ L ++D+ + + P +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLL-MDLDISMRTVDCPFTVT 70
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDF----IQREGYIDEPRTKKWFRQLVDAIDYCH-ER 183
F A+ V+I ME + SL F I + I E K +V A+++ H +
Sbjct: 71 FYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
V+HRD+K N+LI+ +K+ DFG + G++ D G Y +PE +
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGIS-GYLV-----DDVAKDIDAGCKPYMAPERINP 183
Query: 244 VPYTPHY---SDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQV 282
Y SD+WS+G+ + +A R P+D Q LKQV
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 17/225 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHP 124
+G G+ V + G +AVK + + + K+ L ++DVV K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRIL-MDLDVVLKSHDCP 84
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH-ER 183
+++ T V+I ME + + +G I E K +V A+ Y +
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK- 242
GV+HRD+K N+L+D IKL DFG + G + D G AY +PE +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGIS-GRLV-----DDKAKDRSAGCAAYMAPERIDP 198
Query: 243 ----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQV 282
Y +DVWS+G+ L +A G+ P+ + ++L +V
Sbjct: 199 PDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-38
Identities = 81/288 (28%), Positives = 121/288 (42%), Gaps = 58/288 (20%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA----PPDYLKKFLPREID 116
ME Y+ +G G+YATV S VA+K + ++E P + RE+
Sbjct: 1 MET--YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAI-----REVS 52
Query: 117 VVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK--GSLLDFIQREGYIDEPRTKKWFRQLV 174
++K L+H N++ I T + ++ EY +K LD I+ K + QL+
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD--DCGNIINMHNVKLFLFQLL 110
Query: 175 DAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
+ YCH + V+HRD+K +NLLI+ +KL+DFG AR P +Y
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR-------AKSIPT-----KTYD 158
Query: 235 -------YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFD-DTNYIQLLKQVQ 283
Y P+IL G + YS D+W +G + Y MA GR F T QL
Sbjct: 159 NEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF--- 212
Query: 284 TKVVF-----PTE---PNVSA--ECKTLLSKIFSPIKFRIRLKDIKQD 321
+F PTE P + + E KT + + D
Sbjct: 213 ---IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSD 257
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-38
Identities = 69/262 (26%), Positives = 116/262 (44%), Gaps = 58/262 (22%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA-----PPDYLKKFLPREI 115
M+ Y + IG G+Y TV A + VA+K V +++ P L REI
Sbjct: 1 MQK--YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSAL-----REI 52
Query: 116 DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK--GSLLDFIQREGYIDEPRTKKWFRQL 173
++K L+H N++R + + ++ ++ E+ ++ D G +D K + QL
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQL 110
Query: 174 VDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
+ + +CH R V+HRD+K +NLLI+ +KL++FG AR P+ Y
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-------AFGIPV-----RCY 158
Query: 234 A-------YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPF--DDTNYIQLLKQ 281
+ Y P++L G YS D+WS G + +A P + QL +
Sbjct: 159 SAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR- 214
Query: 282 VQTKVVF-----PTE---PNVS 295
+F PTE P+++
Sbjct: 215 -----IFRLLGTPTEEQWPSMT 231
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 23/230 (10%)
Query: 67 VLGKVIGIGSYATV---KLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLR 122
L + +G GS+ V + + VAVK + V + P+ + F+ RE++ + L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLD 79
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCH 181
H NLIR L + T + ++ E A GSLLD ++ +G+ ++ Q+ + + Y
Sbjct: 80 HRNLIR-LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSYAY 235
+ +HRD+ NLL+ +K+ DFG R H + + P +A+
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--------FAW 190
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQT 284
+PE LK ++ H SD W GV L+ +G+ P+ N Q+L ++
Sbjct: 191 CAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 61/220 (27%), Positives = 115/220 (52%), Gaps = 10/220 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + IG G+ TV A G +VA++ + ++ P K+ + EI V++ ++PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPK--KELIINEILVMRENKNPN 78
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ +L + ++++MEY GSL D + E +DE + R+ + A+++ H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRDIK +N+L+ + ++KL+DFGF + + T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK 285
Y P D+WS+G++ M G P+ + N ++ L + T
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 67 VLGKVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
VL +++G G + V +VAVK K + D +KF+ E ++K L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFM-SEAVIMKNLDH 72
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHE 182
P++++ L I +IIME G L +++R + + + Q+ A+ Y
Sbjct: 73 PHIVK-LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS----- 237
VHRDI N+L+ +KL DFG +R + D Y Y +
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRY-----------IEDE---DY-YKASVTRL 176
Query: 238 ------PEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
PE + +T SDVW V ++ ++FG+ PF ++ ++
Sbjct: 177 PIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 54/220 (24%), Positives = 110/220 (50%), Gaps = 10/220 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
IG GS V LA G VAVK++ + ++ L E+ +++ +H N
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQR--RELLFNEVVIMRDYQHFN 103
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ ++ ++++ME+ + G+L D + + ++E + ++ A+ Y H +GV
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRDIK +++L+ + +KLSDFGF + P + G+ + +PE++
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK 285
Y D+WS+G+++ M G P+ + +Q +K+++
Sbjct: 218 YATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 256
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 35/233 (15%)
Query: 67 VLGKVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
LG+ IG G + V + VA+K K +KFL +E ++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFL-QEALTMRQFDH 75
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHE 182
P++++ L + T + V+IIME G L F+Q R+ +D + QL A+ Y
Sbjct: 76 PHIVK-LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS----- 237
+ VHRDI N+L+ +KL DFG +R +Y Y +
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSR--------------YMEDSTY-YKASKGKL 179
Query: 238 ------PEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
PE + +T SDVW GV ++ + G PF ++ +++
Sbjct: 180 PIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 53/226 (23%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGC--DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
+ K +G G++ TVK VAVK++ P + L E +V++ L +P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNP 78
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
++R + I ++ME AE G L ++Q+ ++ + + Q+ + Y E
Sbjct: 79 YIVR-MIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSYAYASP 238
VHRD+ N+L+ ++ K+SDFG ++ + K ++ + P+ + +P
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV--------KWYAP 189
Query: 239 EILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
E + ++ SDVWS GV+++ A ++G+ P+ ++ ++
Sbjct: 190 ECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 68/264 (25%), Positives = 118/264 (44%), Gaps = 57/264 (21%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA----PPDYLKKFLPREID 116
+ + +G G+YATV + G VA+K V K+++ P + REI
Sbjct: 4 SSQ--FKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAI-----REIS 55
Query: 117 VVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK--GSLLD---FIQREGYIDEPRTKKWFR 171
++K L+H N++R I T +++ ++ E+ + +D ++ K +
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
QL+ + +CHE ++HRD+K +NLLI+ +KL DFG AR P+
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-------AFGIPV-----N 163
Query: 232 SYA-------YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFD-DTNYIQLLK 280
+++ Y +P++L G + YS D+WS G +L M G+ F + QL
Sbjct: 164 TFSSEVVTLWYRAPDVLMG---SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220
Query: 281 QVQTKVVF-----PTE---PNVSA 296
+F P E P+V+
Sbjct: 221 ------IFDIMGTPNESLWPSVTK 238
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-37
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ + IG GS+ V R VA+K++ EA + + + +EI V+ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPY 81
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+ ++ + +++IIMEY GS LD + G +DE + R+++ +DY H
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRDIK N+L+ +KL+DFG A G + + +TF G+ + +PE++K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKR----NTFVGTPFWMAPEVIKQSA 195
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTN 274
Y +D+WS+G+ +A G P + +
Sbjct: 196 YDSK-ADIWSLGITAIELARGEPPHSELH 223
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 32/231 (13%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
VLG+ IG G++ V VAVK + PPD KFL +E ++K HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFL-QEARILKQYSHPNI 174
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF-RQLVDAIDYCHERGV 185
+R + +YI+ME + G L F++ EG +T ++Y +
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS-------- 237
+HRD+ N L+ + +K+SDFG +R + G Y AS
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR--------------EEADGVY-AASGGLRQVPV 279
Query: 238 ----PEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
PE L Y+ SDVWS G++L+ + G P+ + + Q + V+
Sbjct: 280 KWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 56/210 (26%), Positives = 106/210 (50%), Gaps = 12/210 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ + + +G GSY +V A G VA+K V + +K EI +++ P+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-----EISIMQQCDSPH 85
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERG 184
++++ + ++I+MEY GS+ D I+ R + E + + ++Y H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
+HRDIK N+L++ E + KL+DFG A G + + +T G+ + +PE+++ +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKR----NTVIGTPFWMAPEVIQEI 200
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTN 274
Y +D+WS+G+ MA G+ P+ D +
Sbjct: 201 GYNCV-ADIWSLGITAIEMAEGKPPYADIH 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 67/261 (25%), Positives = 112/261 (42%), Gaps = 45/261 (17%)
Query: 41 SSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV 100
+++ + +T ++ Y +G G+Y V A T VA+K + ++
Sbjct: 13 EAQTQGPGSMSVSAAPSATSIDR--YRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RL 69
Query: 101 EA-----PPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI 155
E P + RE+ ++K L+H N+I I HR+++I EYAE L ++
Sbjct: 70 EHEEEGVPGTAI-----REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM 123
Query: 156 QREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-----NIKLSDFGF 210
+ + K + QL++ +++CH R +HRD+K +NLL+ +K+ DFG
Sbjct: 124 DKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
Query: 211 ARGHMKCKSGHQSPLSDTFCGSYA-------YASPEILKGVPYTPHYS---DVWSMGVVL 260
AR P+ + Y PEIL G + HYS D+WS+ +
Sbjct: 184 AR-------AFGIPI-----RQFTHEIITLWYRPPEILLG---SRHYSTSVDIWSIACIW 228
Query: 261 YAMAFGRLPFD-DTNYIQLLK 280
M F D+ QL K
Sbjct: 229 AEMLMKTPLFPGDSEIDQLFK 249
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 76/261 (29%), Positives = 123/261 (47%), Gaps = 58/261 (22%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA-----PPDYLKKFLPREI 115
ME Y + IG G+Y V A + +G A+K + ++E P + REI
Sbjct: 1 MEK--YHGLEKIGEGTYGVVYKAQN-NYGETFALKKI-RLEKEDEGIPSTTI-----REI 51
Query: 116 DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK--GSLLDFIQREGYIDEPRTKKWFRQL 173
++K L+H N+++ I T R+ ++ E+ ++ LLD EG ++ K + QL
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQL 109
Query: 174 VDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
++ I YCH+R V+HRD+K +NLLI+ E +K++DFG AR P+ Y
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-------AFGIPV-----RKY 157
Query: 234 A-------YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFD-DTNYIQLLKQV 282
Y +P++L G + YS D+WS+G + M G F + QL++
Sbjct: 158 THEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-- 212
Query: 283 QTKVVF-----PTE---PNVS 295
+F P PNV+
Sbjct: 213 ----IFRILGTPNSKNWPNVT 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 40/250 (16%), Positives = 73/250 (29%), Gaps = 47/250 (18%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVV-SKVEAPPDYLKKFLPREIDVVKGLRHP 124
Y L G A T VA+ V + P D L++ L + + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKP 91
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
+ R L + T ++ E+ GSL + + + + L A D H G
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
V + + + ++ L+ A+P+
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATM----------------------PDANPQ----- 182
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL----KQVQTKVVFPTE------PNV 294
D+ +G LYA+ R P + L + + + P + +
Sbjct: 183 ------DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 295 SAECKTLLSK 304
SA +
Sbjct: 237 SAVAARSVQG 246
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-36
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 14/219 (6%)
Query: 66 YVLGKVIGIG--SYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
Y L VIG G TV LA G V V+ ++ +EA + + FL E+ V K H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLFNH 85
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDAIDYCH 181
PN++ + + ++++ + GS D I ++E + ++ A+DY H
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFA----RGHMKCKSGHQSPLSDTFCGSYAYAS 237
G VHR +K ++LI + + LS + + H P + S
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP--KYSVKVLPWLS 203
Query: 238 PEILK--GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN 274
PE+L+ Y SD++S+G+ +A G +PF D
Sbjct: 204 PEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMP 241
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-36
Identities = 66/229 (28%), Positives = 97/229 (42%), Gaps = 30/229 (13%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHPNLIR 128
IG G+Y +V G +AVK + + K+ L ++DVV + P +++
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLL-MDLDVVMRSSDCPYIVQ 85
Query: 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQ-----REGYIDEPRTKKWFRQLVDAIDYCH-E 182
F A+ +I ME S F + + I E K V A+++
Sbjct: 86 FYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT-----FCGSYAYAS 237
++HRDIK N+L+D NIKL DFG SG L D+ G Y +
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGI--------SGQ---LVDSIAKTRDAGCRPYMA 193
Query: 238 PEILKGVPYTPHY---SDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQV 282
PE + Y SDVWS+G+ LY +A GR P+ + L QV
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-36
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 67 VLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
+G G++ +V+L G VAVK + + P D + F REI ++K L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGP-DQQRDFQ-REIQILKALH 82
Query: 123 HPNLIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDY 179
++++ R + ++MEY G L DF+QR +D R + Q+ ++Y
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSY 233
R VHRD+ N+L++ E ++K++DFG A+ + + QSP+
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI-------- 194
Query: 234 AYASPEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPF 270
+ +PE L ++ SDVWS GVVLY +
Sbjct: 195 FWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSC 231
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-36
Identities = 53/216 (24%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y L +VIG G+ A V+ A VA+K ++ + L +EI + HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPN 74
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--------REGYIDEPRTKKWFRQLVDAI 177
++ + + ++++M+ GS+LD I+ + G +DE R++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 178 DYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS 237
+Y H+ G +HRD+K N+L+ + +++++DFG + ++ + TF G+ + +
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 238 PE-ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD 272
PE + + Y +D+WS G+ +A G P+
Sbjct: 195 PEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 60/289 (20%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA-----PPDYLKKFLPREI 115
ME Y + +G G+Y V A G VA+K + +++A P + REI
Sbjct: 20 MEK--YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRI-RLDAEDEGIPSTAI-----REI 70
Query: 116 DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK--GSLLDFIQREGYIDEPRTKKWFRQL 173
++K L HPN++ + I + + ++ E+ EK +LD + + + + + K + QL
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLD--ENKTGLQDSQIKIYLYQL 128
Query: 174 VDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
+ + +CH+ ++HRD+K +NLLI+ + +KL+DFG AR P+ SY
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-------AFGIPV-----RSY 176
Query: 234 A-------YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFD-DTNYIQLLKQV 282
Y +P++L G + YS D+WS+G + M G+ F T+ QL K
Sbjct: 177 THEVVTLWYRAPDVLMG---SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK-- 231
Query: 283 QTKVVF-----PTE---PNVSA--ECKTLLSKIFSPIKFRIRLKDIKQD 321
+F P P V K ++F + + Q+
Sbjct: 232 ----IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQE 276
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-36
Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 67 VLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
+ +G G + V+L G VAVK + K E+ +++ +EI++++ L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLK-KEIEILRNLY 81
Query: 123 HPNLIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDY 179
H N++++ + +IME+ GSL +++ + + I+ + K+ Q+ +DY
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSY 233
R VHRD+ N+L++ E+ +K+ DFG + + K SP+
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY----- 196
Query: 234 AYASPEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPF 270
+PE L + SDVWS GV L+ + +
Sbjct: 197 ---APECLMQSKFY-IASDVWSFGVTLHELLTYCDSDS 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 71/297 (23%), Positives = 119/297 (40%), Gaps = 61/297 (20%)
Query: 53 DVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP 112
DVK + + Y +G G +ATV A VA+K + K+ K +
Sbjct: 4 DVKSR---AKR--YEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHR-SEAKDGIN 56
Query: 113 ----REIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEK--GSLLDFIQREGYIDEPRT 166
REI +++ L HPN+I L A + ++ ++ E ++ +
Sbjct: 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK--DNSLVLTPSHI 114
Query: 167 KKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226
K + + ++Y H+ ++HRD+K NLL+D +KL+DFG A+ SP
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-------SFGSPN- 166
Query: 227 DTFCGSYA-------YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPF--DDTN 274
+Y Y +PE+L G Y D+W++G +L + PF D++
Sbjct: 167 ----RAYTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAELLLRV-PFLPGDSD 218
Query: 275 YIQLLKQVQTKVVF-----PTE---PNVSA--ECKTLLSKIFSPIKFRIRLKDIKQD 321
QL + +F PTE P++ + + T K F I D
Sbjct: 219 LDQLTR------IFETLGTPTEEQWPDMCSLPDYVTF--KSFPGIPLHHIFSAAGDD 267
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 52/229 (22%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 67 VLGKV-IGIGSYATVKLATSTRHG--CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
++ + +G G++ +V+ DVA+KV+ K ++ + RE ++ L +
Sbjct: 12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM-REAQIMHQLDN 69
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHE 182
P ++R L + + ++ME A G L F+ + I + Q+ + Y E
Sbjct: 70 PYIVR-LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSYAYA 236
+ VHRD+ N+L+ + K+SDFG ++ + +S + PL +
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL--------KWY 180
Query: 237 SPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
+PE I ++ SDVWS GV ++ A+++G+ P+ +++ ++
Sbjct: 181 APECINFRK-FS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 25/278 (8%)
Query: 1 MTLKQHERPQSENIKTDTIAQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTV 60
M+ H +I T + L + L K D +K
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELF--FKDDPEKL--- 55
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
+ + IG GS+ V A R+ VA+K +S + + + +E+ ++
Sbjct: 56 -----FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDY 179
LRHPN I++ H +++MEY GS D ++ + + E + + Y
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
H ++HRD+K N+L+ +KL DFG A +++F G+ + +PE
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---------ANSFVGTPYWMAPE 220
Query: 240 I---LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN 274
+ + Y DVWS+G+ +A + P + N
Sbjct: 221 VILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMN 257
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 55/224 (24%), Positives = 106/224 (47%), Gaps = 20/224 (8%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+ +G G Y V ++ VAVK + K + +++FL +E V+K ++HPNL
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME--VEEFL-KEAAVMKEIKHPNL 278
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERG 184
++ L YII E+ G+LLD+++ + Q+ A++Y ++
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEI 240
+HR++ N L+ + +K++DFG +R +G + P+ T +PE
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT--------APES 390
Query: 241 LKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
L ++ SDVW+ GV+L+ +G P+ + Q+ + ++
Sbjct: 391 LAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 21/226 (9%)
Query: 67 VLGKVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
LG+ IG G + V + VA+K K +KFL +E ++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFL-QEALTMRQFDH 450
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHE 182
P++++ L + T + V+IIME G L F+Q R+ +D + QL A+ Y
Sbjct: 451 PHIVK-LIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK----CKSGHQSPLSDTFCGSYAYASP 238
+ VHRDI N+L+ +KL DFG +R S + P+ + +P
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK--------WMAP 561
Query: 239 EILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
E + +T SDVW GV ++ + G PF ++ +++
Sbjct: 562 ESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-35
Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
L + IG G + V L G VAVK + K +A + FL E V+ LRH NL
Sbjct: 24 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCI-KNDATA---QAFL-AEASVMTQLRHSNL 76
Query: 127 IRFLQAIETTHR--VYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHE 182
++ L + + +YI+ EY KGSL+D+++ G + K+ + +A++Y
Sbjct: 77 VQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
VHRD+ N+L+ + K+SDFG + + + P+ T +PE L+
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------APEALR 187
Query: 243 GVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
++ SDVWS G++L+ +FGR+P+ ++ +V+
Sbjct: 188 EKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 31/233 (13%)
Query: 67 VLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
KVIG G + V S + VA+K + K FL E ++
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFL-GEAGIMGQFS 104
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCH 181
H N+IR I + II EY E G+L F++ ++G + R + + Y
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA------- 234
VHRD+ N+L++ K+SDFG +R L D +Y
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV-----------LEDDPEATYTTSGGKIP 213
Query: 235 --YASPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
+ +PE I +T SDVWS G+V++ M +G P+ + + +++K +
Sbjct: 214 IRWTAPEAISYRK-FT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 67 VLGKVIGIGSYATVKLA----TSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
+ +G G + V L T+ G VAVK + K +A P + + +EID+++ L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWK-QEIDILRTLY 91
Query: 123 HPNLIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
H ++I++ E + ++MEY GSL D++ R I + + +Q+ + + Y
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYL 150
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSYA 234
H + +HRD+ N+L+D + +K+ DFG A+ + + + SP+
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--------F 202
Query: 235 YASPEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLP 269
+ +PE LK + + SDVWS GV LY +
Sbjct: 203 WYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSS 237
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 60/246 (24%), Positives = 110/246 (44%), Gaps = 41/246 (16%)
Query: 67 VLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
+ +G G++ +V++ G VAVK + + L+ F REI+++K L+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEH-LRDFE-REIEILKSLQ 69
Query: 123 HPNLIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDY 179
H N++++ + R + +IMEY GSL D++Q+ + ID + ++ Q+ ++Y
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSY 233
+ +HRD+ N+L++ E +K+ DFG + K K +SP+
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI-------- 181
Query: 234 AYASPEILKGVPYTPHYSDVWSMGVVLY----------------AMAFGRLPFDDTNYIQ 277
+ +PE L ++ SDVWS GVVLY G
Sbjct: 182 FWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 278 LLKQVQ 283
L++ ++
Sbjct: 241 LIELLK 246
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 67 VLGKVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
+ K+IG G V +L + VA+K + K + FL E ++ H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDH 109
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHE 182
PN+IR + I+ EY E GSL F++ +G + R + + Y +
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS----- 237
G VHRD+ N+L+D K+SDFG +R L D AY +
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV-----------LEDD--PDAAYTTTGGKI 216
Query: 238 ------PEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
PE + ++ SDVWS GVV++ +A+G P+ + ++ V+
Sbjct: 217 PIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 22/228 (9%)
Query: 67 VLGKVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
+ KV+G G + V +L ++ VA+K + KV + FL E ++ H
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFL-GEASIMGQFDH 105
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHE 182
PN+IR + + V I+ EY E GSL F++ + + R + + Y +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARG------HMKCKSGHQSPLSDTFCGSYAYA 236
G VHRD+ N+LI+ K+SDFG R G + P+ T
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-------- 217
Query: 237 SPEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
SPE + +T SDVWS G+VL+ M++G P+ + + ++K V
Sbjct: 218 SPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-34
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 25/208 (12%)
Query: 67 VLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
+ +G G++ +V++ G VAVK + + L+ F REI+++K L+
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEH-LRDFE-REIEILKSLQ 100
Query: 123 HPNLIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDY 179
H N++++ + R + +IMEY GSL D++Q+ + ID + ++ Q+ ++Y
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSPLSDTFCGSY 233
+ +HRD+ N+L++ E +K+ DFG + + K K +SP+
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI-------- 212
Query: 234 AYASPEILKGVPYTPHYSDVWSMGVVLY 261
+ +PE L ++ SDVWS GVVLY
Sbjct: 213 FWYAPESLTESKFS-VASDVWSFGVVLY 239
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-34
Identities = 53/215 (24%), Positives = 111/215 (51%), Gaps = 15/215 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ + +G G++ V A + G A KV+ ++ + + EI+++ HP
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEE--LEDYIVEIEILATCDHPY 77
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERG 184
+++ L A +++I++E+ G++ + + + EP+ + RQ+++A+++ H +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI---- 240
++HRD+K N+L+ E +I+L+DFG + K+ D+F G+ + +PE+
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 241 -LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN 274
+K PY +D+WS+G+ L MA P + N
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELN 226
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 52/240 (21%), Positives = 108/240 (45%), Gaps = 22/240 (9%)
Query: 54 VKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHG--CDVAVKVVSKVEAPPDYLKKFL 111
KK + ++ + +G G++ +V+ DVA+KV+ K ++ +
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM 384
Query: 112 PREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWF 170
RE ++ L +P ++R L + + ++ME A G L F+ + I +
Sbjct: 385 -REAQIMHQLDNPYIVR-LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442
Query: 171 RQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR------GHMKCKSGHQSP 224
Q+ + Y E+ VHR++ N+L+ + K+SDFG ++ + +S + P
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
L +PE + ++ SDVWS GV ++ A+++G+ P+ +++ ++
Sbjct: 503 LKWY--------APECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
L + IG G + V L G VAVK + K +A + FL E V+ LRH NL
Sbjct: 196 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCI-KNDATA---QAFL-AEASVMTQLRHSNL 248
Query: 127 IRFLQAIETTHR--VYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHE 182
++ L + + +YI+ EY KGSL+D+++ G + K+ + +A++Y
Sbjct: 249 VQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
VHRD+ N+L+ + K+SDFG + + + P+ T +PE L+
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------APEALR 359
Query: 243 GVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
++ SDVWS G++L+ +FGR+P+ ++ +V+
Sbjct: 360 EKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 50/247 (20%), Positives = 98/247 (39%), Gaps = 47/247 (19%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD---VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
LG+++G G + +V+ A + VAVK++ +++FL RE +K H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL-REAACMKEFDH 84
Query: 124 PNLIRFL------QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD-A 176
P++ + + +A +I+ + + G L F+ + P + LV
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP-LQTLVRFM 143
Query: 177 ID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFC 230
+D Y R +HRD+ N ++ + + ++DFG +R +
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR--------------KIYS 189
Query: 231 GSYAYA-----------SPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQ 277
G Y + E + + YT +SDVW+ GV ++ M G+ P+ +
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNL-YT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 278 LLKQVQT 284
+ +
Sbjct: 248 IYNYLIG 254
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 43/227 (18%)
Query: 67 VLGKVIGIGSYATVKLATS--TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
G +G G+Y V A + D A+K + REI +++ L+HP
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLRELKHP 78
Query: 125 NLIRFLQAIETTH---RVYIIMEYAEK--GSLLDFIQREGY------IDEPRTKKWFRQL 173
N+I LQ + +H +V+++ +YAE ++ F + + K Q+
Sbjct: 79 NVIS-LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 174 VDAIDYCHERGVVHRDIKCENLLIDGEYN----IKLSDFGFARGHMKCKSGHQSPLSDTF 229
+D I Y H V+HRD+K N+L+ GE +K++D GFAR SPL
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-------LFNSPL-KPL 189
Query: 230 CGSYA------YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGR 267
Y +PE+L G HY+ D+W++G + +
Sbjct: 190 ADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
L +G G + V + T VA+K + P+ FL +E V+K LRH L
Sbjct: 187 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE---AFL-QEAQVMKKLRHEKL 241
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERG 184
++ + + +YI+ EY KGSLLDF++ E Y+ P+ Q+ + Y
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEI 240
VHRD++ N+L+ K++DFG AR + G + P + +PE
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--------IKWTAPEA 352
Query: 241 LKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
+T SDVWS G++L GR+P+ ++L QV+
Sbjct: 353 ALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 56/224 (25%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+ +G G Y V ++ VAVK + K + ++FL +E V+K ++HPNL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV--EEFL-KEAAVMKEIKHPNL 71
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDAIDYCHERG 184
++ L YII E+ G+LLD+++ + Q+ A++Y ++
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHM----KCKSGHQSPLSDTFCGSYAYASPEI 240
+HRD+ N L+ + +K++DFG +R +G + P+ T +PE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT--------APES 183
Query: 241 LKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
L ++ SDVW+ GV+L+ +G P+ + Q+ + ++
Sbjct: 184 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP----REIDVVKGLR---HP 124
IG+G+Y TV A G VA+K V +V P RE+ +++ L HP
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGL-PISTVREVALLRRLEAFEHP 74
Query: 125 NLIRFLQAIETTH-----RVYIIMEYAEK--GSLLDFIQREGYIDEPRTKKWFRQLVDAI 177
N++R + T+ +V ++ E+ ++ + LD + K RQ + +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD-KAPPPGLPAETIKDLMRQFLRGL 133
Query: 178 DYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD---TFCGSYA 234
D+ H +VHRD+K EN+L+ +KL+DFG AR +Q L+ T
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-----IYSYQMALTPVVVTLW---- 184
Query: 235 YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGR 267
Y +PE+L Y D+WS+G + M +
Sbjct: 185 YRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 68/280 (24%), Positives = 111/280 (39%), Gaps = 47/280 (16%)
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG G++ V A + G VA+K V +E + REI +++ L+H N++ L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVN-LI 82
Query: 132 AIETTHR---------VYIIMEYAEK--GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
I T +Y++ ++ E LL K+ + L++ + Y
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD---TFCGSYAYAS 237
H ++HRD+K N+LI + +KL+DFG AR K+ + ++ T Y
Sbjct: 141 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW----YRP 196
Query: 238 PEILKGVPYTPHYS---DVWSMGVVLYAMAFGR--LPFDDTNYIQLLKQVQTKVVF---- 288
PE+L G Y D+W G ++ M + +T QL +
Sbjct: 197 PELLLG---ERDYGPPIDLWGAGCIMAEMWTRSPIMQ-GNTEQHQLAL------ISQLCG 246
Query: 289 -PTE---PNVSA--ECKTLLSKIFSPIKFRIRLKDIKQDP 322
T PNV + L K + RLK +DP
Sbjct: 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDP 286
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
L +G G + V + T VA+K + P+ FL +E V+K LRH L+
Sbjct: 271 LEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE---AFL-QEAQVMKKLRHEKLV 325
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGV 185
+ + + +YI+ EY KGSLLDF++ E Y+ P+ Q+ + Y
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
VHRD++ N+L+ K++DFG AR + G + P + +PE
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--------IKWTAPEAA 436
Query: 242 KGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
+T SDVWS G++L GR+P+ ++L QV+
Sbjct: 437 LYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 20/223 (8%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
+ IG G + V L VA+K + + A + + F+ E +V+ L HP L
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSE--EDFI-EEAEVMMKLSHPKL 65
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ + ++ E+ E G L D+++ + G + + + Y E V
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+HRD+ N L+ IK+SDFG R +G + P+ SPE+
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA--------SPEVF 177
Query: 242 KGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
Y+ SDVWS GV+++ + G++P+++ + ++++ +
Sbjct: 178 SFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 49/246 (19%), Positives = 95/246 (38%), Gaps = 46/246 (18%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD---VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
+LGK++G G + +V + VAVK + + +++FL E +K H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL-SEAACMKDFSH 95
Query: 124 PNLIRFL-----QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD-AI 177
PN+IR L + + + +I+ + + G L ++ P+ + L+ +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP-LQTLLKFMV 154
Query: 178 D------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
D Y R +HRD+ N ++ + + ++DFG ++ + G
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK--------------KIYSG 200
Query: 232 SYAYA-----------SPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQL 278
Y + E + V YT SDVW+ GV ++ G P+ ++
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRV-YT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
Query: 279 LKQVQT 284
+
Sbjct: 259 YDYLLH 264
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 54/223 (24%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
L K +G G + VKL DVAVK++ K + + +F +E + L HP L
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQ-YDVAVKMI-KEGSMSE--DEFF-QEAQTMMKLSHPKL 65
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGV 185
++F + +YI+ EY G LL++++ G ++ + + + + + +
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+HRD+ N L+D + +K+SDFG R G + P+ + +PE+
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS--------APEVF 177
Query: 242 KGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
Y+ SDVW+ G++++ + G++P+D +++ +V
Sbjct: 178 HYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 22/224 (9%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
L + +G G + V + H VAVK + + PD FL E +++K L+H L
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPD---AFL-AEANLMKQLQHQRL 70
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDAIDYCHERG 184
+R L A+ T +YII EY E GSL+DF++ + + Q+ + + + ER
Sbjct: 71 VR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEI 240
+HRD++ N+L+ + K++DFG AR + G + P+ T +PE
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT--------APEA 181
Query: 241 LKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
+ +T SDVWS G++L + GR+P+ ++++ ++
Sbjct: 182 INYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 44/235 (18%), Positives = 91/235 (38%), Gaps = 31/235 (13%)
Query: 67 VLGKVIGIGSYATVKLAT-------STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVK 119
+ + +G G++ + H +V +KV+ +A +Y + F ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD--KAHRNYSESFF-EAASMMS 67
Query: 120 GLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAID 178
L H +L+ ++ E+ + GSL ++++ I+ + +QL A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 179 YCHERGVVHRDIKCENLLIDGEYN--------IKLSDFGFARGHMKCKSGHQSPLSDTFC 230
+ E ++H ++ +N+L+ E + IKLSD G + + K Q +
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-TVLPKDILQERIPWV-- 184
Query: 231 GSYAYASPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
PE I +D WS G L+ + G P + + L+ +
Sbjct: 185 ------PPECIENPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 64/224 (28%), Positives = 114/224 (50%), Gaps = 22/224 (9%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
L K +G G + V +AT +H VAVK + + FL E +V+K L+H L
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVE---AFL-AEANVMKTLQHDKL 245
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERG 184
++ L A+ T +YII E+ KGSLLDF++ + P+ + Q+ + + + +R
Sbjct: 246 VK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEI 240
+HRD++ N+L+ K++DFG AR + G + P+ T +PE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT--------APEA 356
Query: 241 LKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
+ +T SDVWS G++L + +GR+P+ + ++++ ++
Sbjct: 357 INFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 49/223 (21%), Positives = 102/223 (45%), Gaps = 20/223 (8%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL 126
K +G G + VK R DVA+K++ K + + +F+ E V+ L H L
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSE--DEFI-EEAKVMMNLSHEKL 81
Query: 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ ++II EY G LL++++ + + + + +A++Y +
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFAR----GHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+HRD+ N L++ + +K+SDFG +R G + P+ + PE+L
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--------PPEVL 193
Query: 242 KGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
++ SD+W+ GV+++ + G++P++ + + +
Sbjct: 194 MYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 58/246 (23%), Positives = 96/246 (39%), Gaps = 46/246 (18%)
Query: 67 VLGKVIGIGSY-----ATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
+ + +G GS+ K VA+K V A +FL E V+K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL-NEASVMKEF 85
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTK--------KWFR 171
+++R L + +IME +G L +++ R + P +
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
++ D + Y + VHRD+ N ++ ++ +K+ DFG R D +
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------------DIYET 191
Query: 232 SYAYA------------SPEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQL 278
Y Y SPE LK +T + SDVWS GVVL+ +A P+ + Q+
Sbjct: 192 DY-YRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 279 LKQVQT 284
L+ V
Sbjct: 250 LRFVME 255
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 46/230 (20%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRH-GCDVAVKVVSKVEA-----PPDYLKKFLPRE 114
+ Y IG G+Y V A ++ G VA+K V +V+ P + RE
Sbjct: 10 DQQ--YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTI-----RE 61
Query: 115 IDVVKGLR---HPNLIRFL-----QAIETTHRVYIIMEYAEK--GSLLDFIQREGYIDEP 164
+ V++ L HPN++R + ++ ++ E+ ++ + LD E +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTE 120
Query: 165 RTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224
K QL+ +D+ H VVHRD+K +N+L+ IKL+DFG AR +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-------IYSFQ 173
Query: 225 LSDTFCGSYA-------YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGR 267
+ + Y +PE+L Y D+WS+G + M +
Sbjct: 174 M------ALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRK 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 54/222 (24%), Positives = 103/222 (46%), Gaps = 22/222 (9%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHP 124
+ L +++G G+Y V + G A+KV+ ++ + +EI+++K H
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHR 81
Query: 125 NLIRFL------QAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDA 176
N+ + +++++ME+ GS+ D I+ + + E R+++
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 177 IDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
+ + H+ V+HRDIK +N+L+ +KL DFG + + G + +TF G+ +
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRR----NTFIGTPYWM 196
Query: 237 SPE-ILKGVPYTPHY---SDVWSMGVVLYAMAFGRLPFDDTN 274
+PE I Y SD+WS+G+ MA G P D +
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-31
Identities = 57/240 (23%), Positives = 96/240 (40%), Gaps = 44/240 (18%)
Query: 68 LGKVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
+VIG G + V L + AVK + + +FL E ++K HP
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSHP 86
Query: 125 NLIRFLQAI-ETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTK---KWFRQLVDAIDYC 180
N++ L + +++ Y + G L +FI+ E P K + Q+ + Y
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYL 144
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA---- 236
+ VHRD+ N ++D ++ +K++DFG AR D + Y Y+
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--------------DMYDKEY-YSVHNK 189
Query: 237 ----------SPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQT 284
+ E + +T SDVWS GV+L+ M G P+ D N + +
Sbjct: 190 TGAKLPVKWMALESLQTQK-FT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 37/283 (13%)
Query: 15 KTDTIAQSSKENKRPKSSSN---KLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKV 71
+T + A+S K ++P + + D D S +T++A + + V Y KV
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVS----YTDTKV 61
Query: 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131
IG GS+ V A G VA+K KV K+F RE+ +++ L H N++R
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIK---KVLQD----KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 132 AIETTHR------VYIIMEYAE---KGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
++ + ++++Y + + + + K + QL ++ Y H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 183 RGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
G+ HRDIK +NLL+D + +KL DFG A+ ++ P C Y Y +PE++
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----GEPNVSYICSRY-YRAPELI 228
Query: 242 KGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYI-QLLK 280
G Y+ DVWS G VL + G+ F + + QL++
Sbjct: 229 FG---ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 44/241 (18%)
Query: 67 VLGKVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
+VIG G + V + ++ A+K + ++ FL RE +++GL H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFL-REGLLMRGLNH 81
Query: 124 PNLIRFLQA-IETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTK---KWFRQLVDAIDY 179
PN++ + + ++++ Y G LL FI+ P K + Q+ ++Y
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEY 139
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA--- 236
E+ VHRD+ N ++D + +K++DFG AR D Y Y+
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLAR--------------DILDREY-YSVQQ 184
Query: 237 -----------SPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQ 283
+ E + +T SDVWS GV+L+ + G P+ + L +
Sbjct: 185 HRHARLPVKWTALESLQTYR-FT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
Query: 284 T 284
Sbjct: 243 Q 243
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 27/224 (12%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HP 124
Y L + +G G Y+ V A + + V VK++ V+ KK REI +++ LR P
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIK-REIKILENLRGGP 91
Query: 125 NLIRFLQAI--ETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
N+I + + ++ E+ Q + + + + +++ A+DYCH
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHS 148
Query: 183 RGVVHRDIKCENLLIDGEY-NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
G++HRD+K N++ID E+ ++L D+G A H + S + PE+L
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF------YHPGQEYNVRVASRYFKGPELL 202
Query: 242 KGVPYTPHYS---DVWSMGVVLYAMAFGRLPF--DDTNYIQLLK 280
Y D+WS+G +L +M F + PF NY QL++
Sbjct: 203 VDY---QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 54/240 (22%), Positives = 94/240 (39%), Gaps = 42/240 (17%)
Query: 67 VLGKVIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH 123
+VIG G + V L + AVK + + +FL E ++K H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 149
Query: 124 PNLIRFLQAI-ETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTK---KWFRQLVDAIDY 179
PN++ L + +++ Y + G L +FI+ E P K + Q+ + +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 207
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA--- 236
+ VHRD+ N ++D ++ +K++DFG AR D + +
Sbjct: 208 LASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--------------DMYDKEFDSVHNK 253
Query: 237 ----------SPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTNYIQLLKQVQT 284
+ E + +T SDVWS GV+L+ M G P+ D N + +
Sbjct: 254 TGAKLPVKWMALESLQTQK-FT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 61/301 (20%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y KVIG GS+ V A +VA+K KV K+F RE+ +++ ++HPN
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESD-EVAIK---KVLQD----KRFKNRELQIMRIVKHPN 93
Query: 126 LIRFLQAIETT------HRVYIIMEYAE---KGSLLDFIQREGYIDEPRTKKWFRQLVDA 176
++ + + +++EY + + + + + K + QL+ +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 177 IDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235
+ Y H G+ HRDIK +NLL+D +KL DFG A+ + + P C Y Y
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-----PNVSYICSRY-Y 207
Query: 236 ASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQVQ-------- 283
+PE++ G +Y+ D+WS G V+ + G+ F + I QL++ ++
Sbjct: 208 RAPELIFG---ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264
Query: 284 ---------TKVVFPT----------EPNVSAECKTLLSKI--FSPIKFRIRLKDIKQDP 322
+ FP P + L+S++ ++P R+ + P
Sbjct: 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA-RLTAIEALCHP 323
Query: 323 W 323
+
Sbjct: 324 F 324
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 55/246 (22%), Positives = 91/246 (36%), Gaps = 48/246 (19%)
Query: 67 VLGKVIGIGSY-----ATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
L + +G G++ V + VAVK + FL E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKF 90
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD-AID-- 178
H N++R + + +I+ME G L F++ + L+ A D
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 179 ----YCHERGVVHRDIKCENLLIDGE---YNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
Y E +HRDI N L+ K+ DFG AR D +
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--------------DIYRA 196
Query: 232 SYAYA------------SPE-ILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQ 277
SY Y PE ++G+ +T +D WS GV+L+ + G +P+ + +
Sbjct: 197 SY-YRKGGCAMLPVKWMPPEAFMEGI-FTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
Query: 278 LLKQVQ 283
+L+ V
Sbjct: 254 VLEFVT 259
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 52/252 (20%), Positives = 96/252 (38%), Gaps = 52/252 (20%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD-----VAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
+ +G + V VA+K + K +A ++F E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFR-HEAMLRARL 69
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR------EGYIDEPRTKKWFRQLVD 175
+HPN++ L + + +I Y G L +F+ G D+ RT K + D
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 176 AIDYCH----------ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL 225
+ VVH+D+ N+L+ + N+K+SD G R
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR------------- 176
Query: 226 SDTFCGSYAYA-----------SPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDD 272
+ + Y +PE I+ G ++ SD+WS GVVL+ ++G P+
Sbjct: 177 -EVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FS-IDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 273 TNYIQLLKQVQT 284
+ +++ ++
Sbjct: 234 YSNQDVVEMIRN 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 66/250 (26%), Positives = 106/250 (42%), Gaps = 53/250 (21%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGC--DVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RH 123
VIG G++ V A + G D A+K + K A D + F E++V+ L H
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFA-GELEVLCKLGHH 85
Query: 124 PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-------EGYIDEPRTKKWF--RQLV 174
PN+I L A E +Y+ +EYA G+LLDF+++ + T +QL+
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 175 D-AID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD 227
A D Y ++ +HRD+ N+L+ Y K++DFG +RG
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-------------- 191
Query: 228 TFCGSYAYA-----------SPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPFDDTN 274
+ E + V YT SDVWS GV+L+ ++ G P+
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYSV-YT-TNSDVWSYGVLLWEIVSLGGTPYCGMT 246
Query: 275 YIQLLKQVQT 284
+L +++
Sbjct: 247 CAELYEKLPQ 256
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 60/259 (23%)
Query: 67 VLGKVIGIGSYATVKLAT-----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
VLGK +G G + V AT VAVK++ K A P L+ L E +V+K +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLL-SEFNVLKQV 83
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-----EGYIDEPRTKKW------- 169
HP++I+ A + +I+EYA+ GSL F++ GY+ ++
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 170 -----FRQLVD-AID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217
L+ A Y E +VHRD+ N+L+ +K+SDFG +R
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR----- 198
Query: 218 KSGHQSPLSDTFCGSYAYA-----------SPE-ILKGVPYTPHYSDVWSMGVVLYAMA- 264
D + + E + + YT SDVWS GV+L+ +
Sbjct: 199 ---------DVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YT-TQSDVWSFGVLLWEIVT 247
Query: 265 FGRLPFDDTNYIQLLKQVQ 283
G P+ +L ++
Sbjct: 248 LGGNPYPGIPPERLFNLLK 266
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 58/252 (23%), Positives = 94/252 (37%), Gaps = 54/252 (21%)
Query: 67 VLGKVIGIGSY-----ATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
VL +G G++ A + VAVK + EA + F RE +++ L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDFQ-REAELLTML 100
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKW--------FRQL 173
+H +++RF + ++ EY G L F++ G + QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 174 VD-AID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226
+ A Y VHRD+ N L+ +K+ DFG +R
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-------------- 206
Query: 227 DTFCGSYAYA------------SPE-ILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDD 272
D + Y Y PE IL +T SDVWS GVVL+ + +G+ P+
Sbjct: 207 DIYSTDY-YRVGGRTMLPIRWMPPESILYRK-FT-TESDVWSFGVVLWEIFTYGKQPWYQ 263
Query: 273 TNYIQLLKQVQT 284
+ + + +
Sbjct: 264 LSNTEAIDCITQ 275
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-29
Identities = 53/246 (21%), Positives = 90/246 (36%), Gaps = 48/246 (19%)
Query: 67 VLGKVIGIGSY-----ATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
L + +G G++ V + VAVK + FL E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKF 131
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD-AID-- 178
H N++R + + +I++E G L F++ + L+ A D
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 179 ----YCHERGVVHRDIKCENLLIDGE---YNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
Y E +HRDI N L+ K+ DFG AR D +
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--------------DIYRA 237
Query: 232 SYAYA------------SPE-ILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQ 277
Y Y PE ++G+ +T +D WS GV+L+ + G +P+ + +
Sbjct: 238 GY-YRKGGCAMLPVKWMPPEAFMEGI-FTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
Query: 278 LLKQVQ 283
+L+ V
Sbjct: 295 VLEFVT 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 43/234 (18%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD-----VAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
GK +G G++ V AT+ VAVK++ K A + + E+ V+ L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALM-SELKVLSYL 83
Query: 122 -RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-----------EGYIDEPRTKKW 169
H N++ L A +I EY G LL+F++R +++
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 170 FRQLVD-AID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKC 217
L+ + + + +HRD+ N+L+ K+ DFG AR +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 218 KSGHQSPLSDTFCGSYAYASPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLP 269
K + P+ +PE I V YT SDVWS G+ L+ + G P
Sbjct: 204 KGNARLPVKWM--------APESIFNCV-YT-FESDVWSYGIFLWELFSLGSSP 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 63/255 (24%), Positives = 107/255 (41%), Gaps = 55/255 (21%)
Query: 67 VLGKVIGIGSYATVKLAT-------STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVK 119
LGK +G G++ V +A + VAVK++ K +A L + E++++K
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 95
Query: 120 GL-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKW--------- 169
+ +H N+I L A +Y+I+EYA KG+L ++++ +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 170 FRQLVD-AID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222
F+ LV Y + +HRD+ N+L+ +K++DFG AR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR---------- 205
Query: 223 SPLSDTFCGSYAYA-----------SPE-ILKGVPYTPHYSDVWSMGVVLYAMA-FGRLP 269
D Y +PE + V YT H SDVWS GV+++ + G P
Sbjct: 206 ----DINNIDYYKKTTNGRLPVKWMAPEALFDRV-YT-HQSDVWSFGVLMWEIFTLGGSP 259
Query: 270 FDDTNYIQLLKQVQT 284
+ +L K ++
Sbjct: 260 YPGIPVEELFKLLKE 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 56/252 (22%), Positives = 100/252 (39%), Gaps = 55/252 (21%)
Query: 67 VLGKVIGIGSYATVKLAT-----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
VL + +G G++ V LA T+ VAVK + + K F RE +++ L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKDFQ-REAELLTNL 74
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKW---------FRQ 172
+H ++++F + ++ EY + G L F++ G Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 173 LVD-AID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL 225
++ A Y + VHRD+ N L+ +K+ DFG +R
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR------------- 181
Query: 226 SDTFCGSYAYA------------SPE-ILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFD 271
D + Y Y PE I+ +T SDVWS GV+L+ + +G+ P+
Sbjct: 182 -DVYSTDY-YRVGGHTMLPIRWMPPESIMYRK-FT-TESDVWSFGVILWEIFTYGKQPWF 237
Query: 272 DTNYIQLLKQVQ 283
+ ++++ +
Sbjct: 238 QLSNTEVIECIT 249
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 66/255 (25%), Positives = 109/255 (42%), Gaps = 55/255 (21%)
Query: 67 VLGKVIGIGSYATVKLAT-------STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVK 119
LGK +G G + V +A + VAVK++ K +A L + E++++K
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 141
Query: 120 GL-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR------EGYIDEPRTKKW--- 169
+ +H N+I L A +Y+I+EYA KG+L ++++ E D R +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 170 FRQLVD-AID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222
F+ LV Y + +HRD+ N+L+ +K++DFG AR
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR---------- 251
Query: 223 SPLSDTFCGSYAYA-----------SPE-ILKGVPYTPHYSDVWSMGVVLYAMA-FGRLP 269
D Y +PE + V YT H SDVWS GV+++ + G P
Sbjct: 252 ----DINNIDYYKKTTNGRLPVKWMAPEALFDRV-YT-HQSDVWSFGVLMWEIFTLGGSP 305
Query: 270 FDDTNYIQLLKQVQT 284
+ +L K ++
Sbjct: 306 YPGIPVEELFKLLKE 320
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 65/254 (25%), Positives = 107/254 (42%), Gaps = 53/254 (20%)
Query: 67 VLGKVIGIGSYATVKLAT-------STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVK 119
VLGK +G G++ V LA VAVK++ K +A L + E++++K
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEMMK 129
Query: 120 GL-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR------EGYIDEPRTKKWFRQ 172
+ +H N+I L A +Y+I+EYA KG+L +++Q E + +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 173 LVDAIDYCH----------ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222
D + + + +HRD+ N+L+ + +K++DFG AR
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR---------- 239
Query: 223 SPLSDTFCGSYAYA-----------SPEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPF 270
D Y +PE L YT H SDVWS GV+L+ + G P+
Sbjct: 240 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPY 294
Query: 271 DDTNYIQLLKQVQT 284
+L K ++
Sbjct: 295 PGVPVEELFKLLKE 308
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y K IG G+ V A +VA+K +S+ + K+ RE+ ++K + H N
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 85
Query: 126 LIRFLQAI------ETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
+I L E VYI+ME + +L IQ E +D R Q++ I +
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKH 142
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA----Y 235
H G++HRD+K N+++ + +K+ DFG AR + Y Y
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG----------TSFMMTPYVVTRYY 192
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
+PE++ G+ Y D+WS+G ++ M G + F T++I +V
Sbjct: 193 RAPEVILGMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 59/248 (23%), Positives = 101/248 (40%), Gaps = 43/248 (17%)
Query: 67 VLGKVIGIGSYATVKLAT-----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
LGK +G G++ V A T VAVK++ K A + + E+ ++ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM-SELKILIHI 87
Query: 122 -RHPNLIRFLQA-IETTHRVYIIMEYAEKGSLLDFIQR------EGYIDEPRTKKWFRQL 173
H N++ L A + + +I+E+ + G+L +++ + K F L
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 174 VDAIDYCH----------ERGVVHRDIKCENLLIDGEYNIKLSDFGFAR-----GHMKCK 218
I Y R +HRD+ N+L+ + +K+ DFG AR K
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 219 SGHQSPLSDTFCGSYAYASPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPF-DDTNY 275
+ PL +PE I V YT SDVWS GV+L+ + G P+
Sbjct: 208 GDARLPLKWM--------APETIFDRV-YT-IQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 276 IQLLKQVQ 283
+ ++++
Sbjct: 258 EEFCRRLK 265
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 54/252 (21%)
Query: 67 VLGKVIGIGSYATVKLATSTRHGCD-----VAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
GK +G G++ V AT+ G + VAVK++ K A D + + E+ ++ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIMSHL 106
Query: 122 -RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKW-------FRQL 173
+H N++ L A V +I EY G LL+F++R+ + E R L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 174 VD-AID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226
+ + + + +HRD+ N+L+ + K+ DFG AR
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-------------- 212
Query: 227 DTFCGSYAYA-----------SPE-ILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPF--D 271
D S +PE I V YT SDVWS G++L+ + G P+
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCV-YT-VQSDVWSYGILLWEIFSLGLNPYPGI 270
Query: 272 DTNYIQLLKQVQ 283
N + K V+
Sbjct: 271 LVNS-KFYKLVK 281
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-27
Identities = 57/260 (21%), Positives = 94/260 (36%), Gaps = 62/260 (23%)
Query: 67 VLGKVIGIGSYATVKLAT-----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
+ IG G++ V A VAVK++ K EA D F RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQ-REAALMAEF 107
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR-----------------EGYIDEP 164
+PN+++ L + ++ EY G L +F++
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 165 RTKKWFRQLVD-AID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217
+ + A Y ER VHRD+ N L+ +K++DFG +R
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR----- 222
Query: 218 KSGHQSPLSDTFCGSYAYA------------SPE-ILKGVPYTPHYSDVWSMGVVLYAMA 264
+ + Y Y PE I YT SDVW+ GVVL+ +
Sbjct: 223 ---------NIYSADY-YKADGNDAIPIRWMPPESIFYNR-YT-TESDVWAYGVVLWEIF 270
Query: 265 -FGRLPFDDTNYIQLLKQVQ 283
+G P+ + +++ V+
Sbjct: 271 SYGLQPYYGMAHEEVIYYVR 290
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y K IG G+ V A +VA+K +S+ + K+ RE+ ++K + H N
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 122
Query: 126 LIRFL------QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFR-QLVDAID 178
+I L + +E VY++ME + + L + + E + Q++ I
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD--ANLCQVIQMELDHE--RMSYLLYQMLCGIK 178
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA---- 234
+ H G++HRD+K N+++ + +K+ DFG AR +G ++ Y
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTP-----YVVTRY 228
Query: 235 YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
Y +PE++ G+ Y D+WS+G ++ M ++ F +YI +V
Sbjct: 229 YRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 48/239 (20%)
Query: 67 VLGKVIGIGSYATVKLAT-----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
GKV+G G++ V AT T VAVK++ K +A + + E+ ++ L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALM-SELKMMTQL 105
Query: 122 -RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKW--------- 169
H N++ L A + +Y+I EY G LL++++ RE + ++ +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 170 -----FRQLVD-AID------YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR----- 212
F L+ A + + VHRD+ N+L+ +K+ DFG AR
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 213 GHMKCKSGHQSPLSDTFCGSYAYASPE-ILKGVPYTPHYSDVWSMGVVLY-AMAFGRLP 269
+ + + P+ +PE + +G+ YT SDVWS G++L+ + G P
Sbjct: 226 SNYVVRGNARLPVKWM--------APESLFEGI-YT-IKSDVWSYGILLWEIFSLGVNP 274
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 65/311 (20%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
YV +G G+Y +V A R G VA+K +S+ + K+ RE+ ++K ++H N
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHEN 84
Query: 126 LIRFLQAIETTHR------VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
+I L Y++M + + L + + E + + Q++ + Y
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA----Y 235
H GVVHRD+K NL ++ + +K+ DFG AR +D Y Y
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH------------ADAEMTGYVVTRWY 189
Query: 236 ASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE- 291
+PE++ HY+ D+WS+G ++ M G+ F +Y+ L Q+ P
Sbjct: 190 RAPEVILS---WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 292 -----------------------------PNVSAECKTLLSK--IFSPIKFRIRLKDIKQ 320
P S + LL K K R+
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK-RLTAAQALT 305
Query: 321 DPWVKTEANPA 331
P+ + +P
Sbjct: 306 HPFFEPFRDPE 316
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 71/284 (25%), Positives = 124/284 (43%), Gaps = 43/284 (15%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y +G G+Y +V A T+ G VAVK +S+ + K+ RE+ ++K ++H N
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 126 LIRFL------QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
+I L +++E + VY++ + L+ I + + + + Q++ + Y
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMG--ADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA----Y 235
H ++HRD+K NL ++ + +K+ DFG AR + Y Y
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARH------------TADEMTGYVATRWY 195
Query: 236 ASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP 292
+PEI+ HY+ D+WS+G ++ + GR F T++I LK + V P
Sbjct: 196 RAPEIMLN---WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 293 NVSAECKTLLSKIFSP--IKFRIRLKDIKQDPWVK--TEANPAA 332
LL KI S + L + + + ANP A
Sbjct: 253 --------LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA 288
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 56/268 (20%), Positives = 102/268 (38%), Gaps = 35/268 (13%)
Query: 20 AQSSKENKRPKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYAT 79
AQ + S ++ + + + S Y + +IG GSY
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68
Query: 80 VKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR- 138
V A VA+K + +V K+ L REI ++ L H ++++ L +
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 139 ----VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194
+Y+++E A+ + Y+ E K L+ + Y H G++HRD+K N
Sbjct: 128 KFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186
Query: 195 LLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA-------------------- 234
L++ + ++K+ DFG AR ++G+
Sbjct: 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246
Query: 235 --YASPEILKGVPYTPHYS---DVWSMG 257
Y +PE++ +Y+ DVWS+G
Sbjct: 247 RWYRAPELILL---QENYTEAIDVWSIG 271
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 35/208 (16%)
Query: 89 GCDVAVKVVSKVEAPPDY--LKKFLPREIDVVKGLRHPNLIRFL-QAIETTHR--VYIIM 143
VAVK ++ + ++F +EI V+ +H NL+ L + + VY
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFD-QEIKVMAKCQHENLVELLGFSSDGDDLCLVY--- 109
Query: 144 EYAEKGSLLDFIQREGYIDEPRTKK--WFRQLVDAID------YCHERGVVHRDIKCENL 195
Y GSLLD + T W + A + HE +HRDIK N+
Sbjct: 110 VYMPNGSLLDRL-----SCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 164
Query: 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT-FCGSYAYASPEILKGVPYTPHY---S 251
L+D + K+SDFG AR K + + G+ AY +PE L+G S
Sbjct: 165 LLDEAFTAKISDFGLARASEKFAQTVMT----SRIVGTTAYMAPEALRG-----EITPKS 215
Query: 252 DVWSMGVVLYAMAFGRLPFDDTNYIQLL 279
D++S GVVL + G D+ QLL
Sbjct: 216 DIYSFGVVLLEIITGLPAVDEHREPQLL 243
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 64/311 (20%), Positives = 124/311 (39%), Gaps = 64/311 (20%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + +G G+Y V A R G VA+K + + + K+ RE+ ++K +RH N
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHEN 85
Query: 126 LIRFL------QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
+I L + ++ Y++M + + L + + + E R + Q++ + Y
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMG--TDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA----Y 235
H G++HRD+K NL ++ + +K+ DFG AR +D+ Y Y
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ------------ADSEMTGYVVTRWY 191
Query: 236 ASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE- 291
+PE++ Y+ D+WS+G ++ M G+ F ++++ LK++ P
Sbjct: 192 RAPEVILN---WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248
Query: 292 -----------------------------PNVSAECKTLLSK--IFSPIKFRIRLKDIKQ 320
N S LL K + + R+ +
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ-RVTAGEALA 307
Query: 321 DPWVKTEANPA 331
P+ ++ +
Sbjct: 308 HPYFESLHDTE 318
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 80/343 (23%), Positives = 124/343 (36%), Gaps = 67/343 (19%)
Query: 39 DASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVS 98
S S AA + +K + + ++ G G++ TV+L G VA+K
Sbjct: 2 PGSMMSLNAAAAADERSRKEMD----RFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--- 54
Query: 99 KVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR-------VYIIMEYAEK--G 149
KV P + + L + + + L HPN+++ T + ++MEY
Sbjct: 55 KVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLH 113
Query: 150 SLLDFIQREGYIDEPRTKKWFR-QLVDAIDYCHER--GVVHRDIKCENLLIDGE-YNIKL 205
R P K F QL+ +I H V HRDIK N+L++ +KL
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173
Query: 206 SDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS---DVWSMGVVLYA 262
DFG A+ K P C Y Y +PE++ G HY+ D+WS+G +
Sbjct: 174 CDFGSAK-----KLSPSEPNVAYICSRY-YRAPELIFG---NQHYTTAVDIWSVGCIFAE 224
Query: 263 MAFGRLPFDDTNYI-QL-----------------------------LKQVQTKVVFPTE- 291
M G F N QL K + VF
Sbjct: 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHS 284
Query: 292 PNVSAECKTLLSK--IFSPIKFRIRLKDIKQDPWVKTEANPAA 332
+ E LLS + P + R++ + P+ +PA
Sbjct: 285 LKDAKEAYDLLSALLQYLPEE-RMKPYEALCHPYFDELHDPAT 326
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 25/229 (10%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y IG G+Y V A + VA+K +S E + REI ++ RH N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 126 LIRFL-----QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
+I IE VYI+ + E + L + + ++ + Q++ + Y
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLME--TDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA----YA 236
H V+HRD+K NLL++ ++K+ DFG AR H L++ Y Y
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTE-----YVATRWYR 198
Query: 237 SPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
+PEI+ + Y+ D+WS+G +L M R F +Y+ L +
Sbjct: 199 APEIMLN---SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 67/294 (22%), Positives = 114/294 (38%), Gaps = 51/294 (17%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV--EAPPDYLKKFLPREIDVVKGLRH 123
Y+ K +G G V A VA+K K+ P REI +++ L H
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHAL--REIKIIRRLDH 67
Query: 124 PNLIRFLQAIETTHR--------------VYIIMEYAEKGSLLDFIQREGYIDEPRTKKW 169
N+++ + + + VYI+ EY E + L + +G + E + +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--TDLANVLEQGPLLEEHARLF 125
Query: 170 FRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKCKSGHQSPLSDT 228
QL+ + Y H V+HRD+K NL I+ E +K+ DFG AR M H+ LS+
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI-MDPHYSHKGHLSE- 183
Query: 229 FCGSYA----YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ 281
Y SP +L +Y+ D+W+ G + M G+ F + ++ ++
Sbjct: 184 ----GLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236
Query: 282 VQTKVVFPTEPNVSAECKTLLSKIFSPIKFRIR-LKDIKQDPWVKT--EANPAA 332
+ + E ++ S I IR P + + A
Sbjct: 237 ILESIPVVHE--------EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREA 282
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 24/232 (10%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA--PPDYLKKFLPREIDVVKGLRH 123
+ L ++G G+Y V AT G VA+K K+E P + + L REI ++K +H
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 124 PNLIRFLQAIETTHR-----VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
N+I VYII E + + L + + + + + Q + A+
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQ--TDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT-FCGSYA--- 234
H V+HRD+K NLLI+ ++K+ DFG AR + + + P +
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 235 -YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV 282
Y +PE++ + YS DVWS G +L + R F +Y L +
Sbjct: 187 WYRAPEVMLT---SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-24
Identities = 71/307 (23%), Positives = 117/307 (38%), Gaps = 74/307 (24%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y LGK +G GS+ V G A+K KV P ++ RE+D++K L H N
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDP----RYKNRELDIMKVLDHVN 61
Query: 126 LIRFLQAIETTHR--------------------------------------VYIIMEYAE 147
+I+ + TT + +IMEY
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 148 KGSLLDFIQREGYIDEPRTK---KWFR-QLVDAIDYCHERGVVHRDIKCENLLIDGE-YN 202
+L ++ + QL A+ + H G+ HRDIK +NLL++ +
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 203 IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYS---DVWSMGVV 259
+KL DFG A+ + P C + Y +PE++ G Y+ D+WS+G V
Sbjct: 181 LKLCDFGSAKKLIP-----SEPSVAYICSRF-YRAPELMLG---ATEYTPSIDLWSIGCV 231
Query: 260 LYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPTEPNVSAECKTLLSKIFSPIKFRIRLKDI 318
+ G+ F I L ++ +++ PT+ + +P +R +
Sbjct: 232 FGELILGKPLFSGETSIDQLVRI-IQIMGTPTKEQMIR---------MNPHYTEVRFPTL 281
Query: 319 KQDPWVK 325
K W K
Sbjct: 282 KAKDWRK 288
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y++ +IG GSY V LA +VA+K V+++ K+ L REI ++ L+
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDY 86
Query: 126 LIRFLQAIETTHR-----VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
+IR I +YI++E A+ L + ++ E K L+ ++
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA------ 234
HE G++HRD+K N L++ + ++K+ DFG AR K + +
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 235 -----------YASPEILKGVPYTPHYS---DVWSMG 257
Y +PE++ +Y+ D+WS G
Sbjct: 206 KQLTSHVVTRWYRAPELILL---QENYTKSIDIWSTG 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 62/320 (19%), Positives = 111/320 (34%), Gaps = 70/320 (21%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP--------REIDV 117
Y + + I GSY V + G VA+K V + + REI +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 118 VKGLRHPNLIRFLQAIETTHR-----VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFR- 171
+ HPN++ +Y++ E L I + + P+ ++F
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141
Query: 172 QLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
++ + HE GVVHRD+ N+L+ +I + DF AR +D
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT----------ADANKT 191
Query: 232 SYA----YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT 284
Y Y +PE++ ++ D+WS G V+ M + F + + L ++
Sbjct: 192 HYVTHRWYRAPELVMQ---FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 285 KVVFPTE-------------------------------PNVSAECKTLLSK--IFSPIKF 311
V P P L++K F+P +
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR- 307
Query: 312 RIRLKDIKQDPWVKTEANPA 331
RI + + P+ ++ +P
Sbjct: 308 RISTEQALRHPYFESLFDPL 327
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-23
Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 47/245 (19%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HP 124
Y L K +G G+Y V + R G VAVK + ++ REI ++ L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHE 69
Query: 125 NLIRFLQAI--ETTHRVYIIMEYAE-------KGSLL--DFIQREGYIDEPRTKKWFRQL 173
N++ L + + VY++ +Y E + ++L Q Y+ QL
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ---YV--------VYQL 118
Query: 174 VDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
+ I Y H G++HRD+K N+L++ E ++K++DFG +R + + + +
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 234 A----------------YASPEILKGVPYTPHYS---DVWSMGVVLYAMAFGRLPFDDTN 274
Y +PEIL G + Y+ D+WS+G +L + G+ F ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLG---STKYTKGIDMWSLGCILGEILCGKPIFPGSS 235
Query: 275 YI-QL 278
+ QL
Sbjct: 236 TMNQL 240
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-22
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 50/226 (22%)
Query: 71 VIGIGSYATV---KLATSTRHGCDVAVKVVSKVEAPPDY--LKKFLPREIDVVKGLRHPN 125
+IG G + V L + VA+K + P +++F EI+ + RHP+
Sbjct: 46 LIGHGVFGKVYKGVLRDGAK----VALKRRT----PESSQGIEEFE-TEIETLSFCRHPH 96
Query: 126 LIRFL-QAIETTHR--VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID---- 178
L+ + E +Y +Y E G+L + + W ++L I
Sbjct: 97 LVSLIGFCDERNEMILIY---KYMENGNLKRHLYGSDLPTMSMS--WEQRLEICIGAARG 151
Query: 179 --YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYA 236
Y H R ++HRD+K N+L+D + K++DFG ++ + H LS G+ Y
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH---LSTVVKGTLGYI 208
Query: 237 SPEILKGVPYTPHY---------SDVWSMGVVLYAMAFGRLPFDDT 273
PE Y SDV+S GVVL+ + R +
Sbjct: 209 DPE----------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 7e-20
Identities = 55/266 (20%), Positives = 112/266 (42%), Gaps = 51/266 (19%)
Query: 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVK 119
++ Y+L + +G G ++TV LA + VA+K+V + Y + EI +++
Sbjct: 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAE-DEIKLLQ 70
Query: 120 GLR--------HPNLIRFLQAIET-THR------VYIIMEYAEKGSLLDFIQREGY--ID 162
+ L+ ++ H+ V ++ E +LL I++ + I
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIP 129
Query: 163 EPRTKKWFRQLVDAIDYCH-ERGVVHRDIKCENLLID------GEYNIKLSDFG---FAR 212
K+ +QL+ +DY H G++H DIK EN+L++ IK++D G +
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD- 271
H + + + + Y SPE+L G P+ +D+WS +++ + G F+
Sbjct: 190 EH------YTNSIQ-----TREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEP 237
Query: 272 ------DTNYIQLLKQVQTKVVFPTE 291
+ + + ++ P+
Sbjct: 238 DEGHSYTKDDDHIAQIIELLGELPSY 263
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 56/239 (23%), Positives = 103/239 (43%), Gaps = 29/239 (12%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-- 123
Y + KVIG GS+ V A + VA+K+V + ++ EI +++ LR
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAA-EEIRILEHLRKQD 154
Query: 124 ----PNLIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVD 175
N+I L+ R + + E +L + I++ + P +K+ ++
Sbjct: 155 KDNTMNVIHMLENFT--FRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 176 AIDYCHERGVVHRDIKCENLLI--DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
+D H+ ++H D+K EN+L+ G IK+ DFG + C + T+ S
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-----CYEHQRVY---TYIQSR 263
Query: 234 AYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-DTNYIQLLKQVQTKVVFPTE 291
Y +PE++ G Y D+WS+G +L + G + QL ++ + +
Sbjct: 264 FYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-19
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 36/204 (17%)
Query: 89 GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA--IETTHR--VYIIME 144
G VAVK + K E +F E++++ H NL+R L+ + T R VY
Sbjct: 54 GTLVAVKRL-KEERTQGGELQFQ-TEVEMISMAVHRNLLR-LRGFCMTPTERLLVY---P 107
Query: 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID------YCHERG---VVHRDIKCENL 195
Y GS+ ++ + W ++ A+ Y H+ ++HRD+K N+
Sbjct: 108 YMANGSVASCLR--ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165
Query: 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHY----- 250
L+D E+ + DFG A K + ++ G+ + +PE Y
Sbjct: 166 LLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPE------YLSTGKSSEK 215
Query: 251 SDVWSMGVVLYAMAFGRLPFDDTN 274
+DV+ GV+L + G+ FD
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLAR 239
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 55/241 (22%), Positives = 104/241 (43%), Gaps = 31/241 (12%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP- 124
Y + +IG GS+ V A VA+K++ +A +L + E+ +++ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA---FLNQAQ-IEVRLLELMNKHD 111
Query: 125 -----NLIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVD 175
++ + R + ++ E +L D ++ + + T+K+ +Q+
Sbjct: 112 TEMKYYIVHLKRHFM--FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 176 AIDYCHER--GVVHRDIKCENLLI--DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCG 231
A+ + ++H D+K EN+L+ IK+ DFG + C+ G + +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-----CQLGQRIY---QYIQ 220
Query: 232 SYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-DTNYIQLLKQVQTKVVFPT 290
S Y SPE+L G+PY D+WS+G +L M G F Q+ K V+ + P
Sbjct: 221 SRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279
Query: 291 E 291
Sbjct: 280 H 280
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-18
Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 20/214 (9%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-- 123
Y LG+ IG GS+ + L T G +VA+K+ P L E + K ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 65
Query: 124 --PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF-RQLVDAIDYC 180
P + E + ++ME SL D +T Q++ I+Y
Sbjct: 66 GIPTIRWCGA--EGDYN-VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 181 HERGVVHRDIKCENLLIDGEYN---IKLSDFGFARGHMKCKSGHQSPLSDT--FCGSYAY 235
H + +HRD+K +N L+ + + DFG A+ + ++ P + G+ Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP 269
AS G+ + D+ S+G VL G LP
Sbjct: 182 ASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLP 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 58/274 (21%), Positives = 99/274 (36%), Gaps = 80/274 (29%)
Query: 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
N Y + + +G G ++TV L+ + VA+KVV E + EI ++K +R
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL----DEIRLLKSVR 91
Query: 123 -----HPNLIRFLQAIET--------THRVYIIMEYAEKGSLLDFIQREGY--IDEPRTK 167
PN +Q ++ TH ++ E LL +I + Y + P K
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHIC-MVFEVLGH-HLLKWIIKSNYQGLPLPCVK 149
Query: 168 KWFRQLVDAIDYCH-ERGVVHRDIKCENLLI----------------------------- 197
K +Q++ +DY H + ++H DIK EN+L+
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 198 --------------------DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS 237
+ +K++D G A K + Y S
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR--------QYRS 261
Query: 238 PEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD 271
E+L G Y +D+WS + + +A G F+
Sbjct: 262 LEVLIGSGYNTP-ADIWSTACMAFELATGDYLFE 294
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 47/224 (20%), Positives = 83/224 (37%), Gaps = 38/224 (16%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-- 123
+ +GK IG G++ ++L + VA+K+ P L E K L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-----LHLEYRFYKQLGSGD 65
Query: 124 --PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF---------RQ 172
P + F + +++E SL D + F Q
Sbjct: 66 GIPQVYYFGP--CGKYN-AMVLELLGP-SLEDLFDLCD--------RTFSLKTVLMIAIQ 113
Query: 173 LVDAIDYCHERGVVHRDIKCENLLIDGEYN-----IKLSDFGFARGHMKCKSGHQSPLSD 227
L+ ++Y H + +++RD+K EN LI N I + DF A+ ++ ++ P +
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 228 T--FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP 269
G+ Y S G + D+ ++G + G LP
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLP 216
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-- 123
+ LG+ IG GS+ + L T+ + +VA+K+ + P L E + + L+
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKIYRILQGGT 63
Query: 124 --PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF-RQLVDAIDYC 180
PN+ F E + ++M+ SL D +T Q+++ +++
Sbjct: 64 GIPNVRWFGV--EGDYN-VLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 181 HERGVVHRDIKCENLLIDGEYN---IKLSDFGFARGHMKCKSGHQSPLSDT--FCGSYAY 235
H + +HRDIK +N L+ + + DFG A+ + + P + G+ Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP 269
AS G+ + D+ S+G VL G LP
Sbjct: 180 ASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLP 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-- 123
Y +G+ IG GS+ + T+ + VA+K + P L E K L
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----LRDEYRTYKLLAGCT 66
Query: 124 --PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWF---------RQ 172
PN+ F Q E H ++++ SL D + G + F +Q
Sbjct: 67 GIPNVYYFGQ--EGLHN-VLVIDLLGP-SLEDLLDLCG--------RKFSVKTVAMAAKQ 114
Query: 173 LVDAIDYCHERGVVHRDIKCENLLIDGEYN-----IKLSDFGFARGHMKCKSGHQSPLSD 227
++ + HE+ +V+RDIK +N LI + I + DFG + + + P +
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 228 --TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP 269
G+ Y S G + D+ ++G V G LP
Sbjct: 175 KKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLP 217
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-16
Identities = 51/251 (20%), Positives = 93/251 (37%), Gaps = 31/251 (12%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-- 123
+++ + +G G++ V L + AVKVV ++ Y + E D++K +++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK---YTRSAK-IEADILKKIQNDD 92
Query: 124 PNLIRFLQAIET-THR--VYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAID 178
N ++ + + +I E SL + I R Y K + +++ A++
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 179 YCHERGVVHRDIKCEN-LLIDGEYNIKLSDFGFARGHMKCKSGHQSPL--------SDTF 229
Y + + H D+K EN LL D + L K + TF
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 230 CGSYAYA--------SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-DTNYIQLLK 280
Y + +PE++ + + SD+WS G VL + G L F + L
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM 270
Query: 281 QVQTKVVFPTE 291
P
Sbjct: 271 MESIIQPIPKN 281
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 52/294 (17%), Positives = 99/294 (33%), Gaps = 61/294 (20%)
Query: 66 YVLGKVIGIGS----YATVKLATSTRHGCDVAVKVVSKVEA--------PPDYLKKFLPR 113
+ L + Y +T T K K++A + + P
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 114 EIDVVKGLRH------PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTK 167
+++ K L P + F + +R ++++ + SL + K
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGF-GVHQDKYR-FLVLPSLGR-SLQSALDVSP-------K 153
Query: 168 KWF---------RQLVDAIDYCHERGVVHRDIKCENLLI--DGEYNIKLSDFGFAR---- 212
+L+DA+++ HE VH ++ EN+ + + + + L+ +GFA
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 213 --GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP- 269
H+ G +SP G + S ++ KG + SD+ S+G + +G LP
Sbjct: 214 SGKHVAYVEGSRSPHE----GDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPW 268
Query: 270 ---FDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQ 320
+T I KQ P C + + LK +
Sbjct: 269 TNCLPNTEDIMKQKQKFVDKPGPFV----GPCGHWIR---PSETLQKYLKVVMA 315
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 51/259 (19%), Positives = 95/259 (36%), Gaps = 51/259 (19%)
Query: 66 YVLGKVIGIGSYATVKLAT-STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
Y + +G G++ V R VA+K++ V Y + EI+V+K ++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---YREAAR-LEINVLKKIKEK 76
Query: 125 ------NLIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLV 174
+ + I E K + +F++ + P + QL
Sbjct: 77 DKENKFLCVLMSDWFN--FHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 175 DAIDYCHERGVVHRDIKCEN-LLIDGEY------------------NIKLSDFGFARGHM 215
A+ + HE + H D+K EN L ++ E+ +I+++DFG A
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---- 189
Query: 216 KCKSG--HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-D 272
H + ++ Y PE++ + + DVWS+G +L+ G F
Sbjct: 190 -TFDHEHHTTIVATRH-----YRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTH 242
Query: 273 TNYIQLLKQVQTKVVFPTE 291
N L+ + P+
Sbjct: 243 ENREHLVMMEKILGPIPSH 261
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 49/274 (17%), Positives = 85/274 (31%), Gaps = 58/274 (21%)
Query: 59 TVMENHGYVLGKVIGIGSY-----ATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPR 113
T M + +G IG G + A + + S VKV + P L
Sbjct: 30 TDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS-DNGP------LFT 82
Query: 114 EIDVVKGLRHPNLIRFLQAIETTHRV-------------------YIIMEYAEKGSLLDF 154
E+ + P I+ + ++IM+ L
Sbjct: 83 ELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKI 141
Query: 155 IQREGYIDEPRTKKWF---------RQLVDAIDYCHERGVVHRDIKCENLLID-GEYN-I 203
+ K F +++D ++Y HE VH DIK NLL++ + +
Sbjct: 142 YEANA--------KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193
Query: 204 KLSDFGFARGHMKCKSGHQSPLSD--TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLY 261
L D+G A + G+ + S + GV + D+ +G +
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMI 252
Query: 262 AMAFGRLP----FDDTNYIQLLKQVQTKVVFPTE 291
G LP D Y++ K + +
Sbjct: 253 QWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLM 286
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 29/227 (12%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+VLGK IG G + + LA T A VV KVE L E+ + + +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV-KVEYQE---NGPLFSELKFYQRVAKKD 94
Query: 126 LIRFLQAIETTHRV-------------------YIIMEYAEKGSLLDFIQREGYIDEPRT 166
I+ + + +++ME L + G +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTV 153
Query: 167 KKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN--IKLSDFGFARGHMKCKSGHQSP 224
+ +++D ++Y HE VH DIK NLL+ + + L+D+G + + + Q
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 225 LSD--TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP 269
+ G+ + S + KGV + SDV +G + G+LP
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLP 259
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 55/265 (20%), Positives = 95/265 (35%), Gaps = 63/265 (23%)
Query: 66 YVLGKVIGIGSYATVKLAT-STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP 124
Y + +G G++ V G VAVK+V V+ Y + EI V++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR---YCEAAR-SEIQVLEHLNTT 71
Query: 125 ------NLIRFLQAIETTHR--VYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLV 174
++ L+ E H + I+ E S DFI+ G+ +K Q+
Sbjct: 72 DPNSTFRCVQMLEWFE--HHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 175 DAIDYCHERGVVHRDIKCEN-LLIDGEY------------------NIKLSDFGFARGHM 215
++++ H + H D+K EN L + +Y +IK+ DFG
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG------ 182
Query: 216 KCKSGHQSPLSDTFCGSYAYA--------SPEILKGVPYTPHYSDVWSMGVVLYAMAFGR 267
S T+ + +PE++ + ++ DVWS+G +L G
Sbjct: 183 ----------SATYDDEHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGF 231
Query: 268 LPFD-DTNYIQLLKQVQTKVVFPTE 291
F + L + P
Sbjct: 232 TVFPTHDSKEHLAMMERILGPLPKH 256
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 7e-12
Identities = 32/223 (14%), Positives = 62/223 (27%), Gaps = 48/223 (21%)
Query: 50 NKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVV-----SKVEAPP 104
+++ S + + IG G + V + VA+K++ V
Sbjct: 6 SQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSH 63
Query: 105 DYLKKFLPREIDVVKGL---------RHPNLIRFLQA----------------------- 132
+ + EI + K L R I
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 133 -------IETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER-G 184
+++I++E+ G L+ ++ + K QL ++
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLR 182
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD 227
HRD+ N+L+ KL + G Q + D
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID 225
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 8e-11
Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 19/124 (15%)
Query: 168 KWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC-----KSGHQ 222
+ Q+ +++ R +HRD+ N+L+ + +K+ DFG AR K K +
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLY-AMAFGRLPF----DDTNYIQ 277
PL +PE + YT SDVWS GV+L+ + G P+ D + +
Sbjct: 257 LPLKWM--------APETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307
Query: 278 LLKQ 281
LK+
Sbjct: 308 RLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 33/189 (17%), Positives = 72/189 (38%), Gaps = 14/189 (7%)
Query: 67 VLGKVIGIGSYATVKLAT-----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
LGK +G G++ V A T VAVK++ K A + + E+ ++ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM-SELKILIHI 82
Query: 122 -RHPNLIRFLQA-IETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDAI 177
H N++ L A + + +I+E+ + G+L +++ R ++ FRQ D +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 142
Query: 178 DYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS 237
D + ++ + ++ L+ Y++
Sbjct: 143 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF-- 200
Query: 238 PEILKGVPY 246
++ KG+ +
Sbjct: 201 -QVAKGMEF 208
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 357 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.19 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.0 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.9 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.85 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.68 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.65 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.52 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.4 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.33 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.14 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.07 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.97 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.81 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.7 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.65 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.55 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.5 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.3 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.24 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.02 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.39 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.78 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.95 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.67 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.08 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 84.43 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 83.62 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-67 Score=476.94 Aligned_cols=262 Identities=24% Similarity=0.446 Sum_probs=233.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
...|++.+.||+|+||.||+|+++.+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356999999999999999999999999999999997654332 45577999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||||+||+|.+++.+ +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.+.. .
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-----~ 223 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-----E 223 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-----S
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC-----C
Confidence 999999999999976 5699999999999999999999999999999999999999999999999999975422 2
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCCHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAECKT 300 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~ 300 (357)
.....+.+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+..+++..+..... .+.+..+|+++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 233456789999999999999989877 9999999999999999999999999998888876543 3334578999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCccc
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASA 334 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~ 334 (357)
||.+|| .||++|||++|+|+||||++...++...
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p~~l~ 337 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIV 337 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGTG
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCCCCcccC
Confidence 999999 9999999999999999999887665443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-68 Score=474.26 Aligned_cols=260 Identities=26% Similarity=0.533 Sum_probs=230.5
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||++++++|++++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999999999999999997643322223456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+.. ....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~---~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP---ESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT---TTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC---CCCc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999975422 1122
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
....+.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+..+++.++.... +..+..+|+++++||+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-YDFPEKFFPKARDLVE 266 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTCCHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCcccCHHHHHHHH
Confidence 33456789999999999999888876 999999999999999999999999999888876543 2334579999999999
Q ss_pred Hhc-CCCCCCCCHHH------HhcCCCCCCCC
Q psy7825 304 KIF-SPIKFRIRLKD------IKQDPWVKTEA 328 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~------ll~hp~~~~~~ 328 (357)
+|| .||.+||+++| |++||||++-.
T Consensus 267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 267 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 999 99999999988 58999998743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-67 Score=462.48 Aligned_cols=257 Identities=35% Similarity=0.647 Sum_probs=216.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999998765555555667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+ +|+|.+++.+++++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~------~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD------G 165 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC------C
Confidence 999 679999999999999999999999999999999999999999999999999999999999999974321 2
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
....+.+||+.|||||++.+..++..++|||||||++|+|++|+.||.+.+...+...+.... .+.+..+|+++++||+
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHH
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Confidence 223457899999999999998887666999999999999999999999999988888876543 3344579999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 304 KIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+|| .||.+|||++|+|+||||+...
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred HHccCChhHCcCHHHHHcCcccccCC
Confidence 999 9999999999999999998643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-67 Score=479.83 Aligned_cols=260 Identities=27% Similarity=0.495 Sum_probs=227.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|++++.||+|+||.||+|+++.+|+.||||++.+...... ..+.+.+|+.+|+.|+|||||+++++|.+++.+|+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH-HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999977655433 356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 143 MEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||||+||+|.+++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-- 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--
Confidence 9999999999999754 457999999999999999999999999999999999999999999999999997542211
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
......+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+..+++.++......+.+..+|+++++
T Consensus 180 ---~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 255 (350)
T 4b9d_A 180 ---ELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRS 255 (350)
T ss_dssp ---HHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred ---ccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 11235689999999999999988877 99999999999999999999999999999888877666677789999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
||.+|| .||.+|||++|+|+||||++..+
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 999999 99999999999999999987544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-65 Score=477.82 Aligned_cols=263 Identities=24% Similarity=0.443 Sum_probs=234.5
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
...|++.+.||+|+||.||+|+++.+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 356999999999999999999999999999999997654332 45678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||||+||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.+.. .
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~-----~ 300 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-----E 300 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS-----S
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC-----C
Confidence 999999999999965 4599999999999999999999999999999999999999999999999999975421 2
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCCHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAECKT 300 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~ 300 (357)
.....+.+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+..+++..+..... .+....+|+++++
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 233457789999999999999999877 9999999999999999999999999999888876543 3445679999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcccc
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAG 335 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~ 335 (357)
||.+|| .||.+||++.|||+||||+....++....
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~~l~p 415 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 415 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGG
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCCCCCccccc
Confidence 999999 99999999999999999998877655433
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-66 Score=468.01 Aligned_cols=263 Identities=23% Similarity=0.349 Sum_probs=224.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..+.|.+.++||+|+||.||+|+++.+|+.||||+++.... ..+|+.+++.++|||||+++++|.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34569999999999999999999999999999999975332 2379999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-NIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~ 220 (357)
|||||+||+|.+++.+.+++++..++.++.||+.||.|||++|||||||||+||||+.+| ++||+|||+++.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999999999999999999999999999999999999999999999987 6999999999865332222
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCCHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAEC 298 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~ 298 (357)
.........+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+..++...+..... ...++.+|+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 22223345689999999999999988877 9999999999999999999988777666666655432 22456899999
Q ss_pred HHHHHHhc-CCCCCCCCHHHH-------------hcCCCCCCCCCCCcc
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDI-------------KQDPWVKTEANPAAS 333 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~l-------------l~hp~~~~~~~~~~~ 333 (357)
++||.+|| .||.+|||+.|| |+|||+++..+|..+
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~n 335 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRGN 335 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC-
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCCC
Confidence 99999999 999999999998 679999988766543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-65 Score=459.90 Aligned_cols=259 Identities=27% Similarity=0.471 Sum_probs=221.5
Q ss_pred ccccCeEEceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
...++|++++.||+|+||.||+|++. .+++.||||++.+....... ...+.+|+.+|+.++||||++++++|.+++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34567999999999999999999874 46789999999754332211 234678999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~- 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID- 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999974321
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
......+.+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+..+++..+.... .+.+..+|++
T Consensus 179 ----~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~ 252 (304)
T 3ubd_A 179 ----HEKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQFLSPE 252 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHH
T ss_pred ----CCccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCcCCHH
Confidence 1223456789999999999999988877 999999999999999999999999999888876543 3345579999
Q ss_pred HHHHHHHhc-CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
+++||++|| .||.+||+ ++|+++||||++-
T Consensus 253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 999999999 99999998 5899999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-64 Score=447.33 Aligned_cols=251 Identities=24% Similarity=0.469 Sum_probs=216.6
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe----CCeEEE
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET----THRVYI 141 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 141 (357)
|++.+.||+|+||.||+|.+..++..||+|++........ ..+.+.+|+.+|+.++|||||+++++|.. +..+|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 4788899999999999999999999999999976544433 35668899999999999999999999875 356899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcC-CCcEEEeecCCCccccccc
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLIDG-EYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~ 218 (357)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. +|.+||+|||+|+...
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--- 183 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC---
Confidence 9999999999999999999999999999999999999999998 999999999999984 7999999999996321
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhhcccCC-CCCCCCH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQVQTKVVFP-TEPNVSA 296 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~-~~~~~s~ 296 (357)
.....+.+||+.|||||++.+ .|+.+ +|||||||++|||+||+.||.+. +...+...+......+ .+..+++
T Consensus 184 ----~~~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 184 ----ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ----CCccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence 123456789999999999875 57766 99999999999999999999764 4555666666554322 3456889
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
++++||.+|| .||.+|||++|+|+||||++
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999 99999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-62 Score=454.26 Aligned_cols=265 Identities=24% Similarity=0.424 Sum_probs=225.0
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe------C
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------T 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 136 (357)
.++|++++.||+|+||.||+|+++.+|+.||||++.+...... ..+.+.+|+.+|+.++|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVT-NAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHH-HHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchH-HHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3579999999999999999999999999999999966544333 34557799999999999999999998754 3
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+.+|+|||||+ |+|.+++...+++++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67999999996 58999999889999999999999999999999999999999999999999999999999999985532
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT------ 290 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------ 290 (357)
... .......+.+||+.|||||++.+..+...++||||+|||+|||++|+.||.+.+..+++..|......+.
T Consensus 211 ~~~-~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 211 SPA-EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred Ccc-ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 211 1223345678999999999998877655559999999999999999999999998888887754322211
Q ss_pred ------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 291 ------------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 291 ------------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+.+++++++||.+|| .||.+|||+.|+|+||||++...+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 1357999999999999 999999999999999999986544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-60 Score=432.99 Aligned_cols=255 Identities=21% Similarity=0.352 Sum_probs=217.7
Q ss_pred cccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
.+...+|.+.+.||+|+||.||+|++. .+++.||||+++.. .....+.|.+|+.+|++++|||||+++++|.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 455678999999999999999999864 35889999998642 3344567889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQRE---------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG 199 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~ 199 (357)
+...+|+|||||++|+|.+++... +++++..++.|+.||+.||.|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 999999999999999999999753 35899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q psy7825 200 EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQL 278 (357)
Q Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~ 278 (357)
++.+||+|||+++..... .........+||+.|||||++.+..++.+ +|||||||++|||+| |+.||.+.+..++
T Consensus 194 ~~~~Ki~DFGla~~~~~~---~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYST---DYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTEEEECCCC-------------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCcEEEcccccceeccCC---CcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999754221 11223345679999999999999999877 999999999999998 8999999999999
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 279 LKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 279 ~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+..+......+.+..+++++.+||.+|| .||++|||+.||+++
T Consensus 270 ~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 270 IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9998887777777889999999999999 999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-61 Score=433.37 Aligned_cols=259 Identities=20% Similarity=0.378 Sum_probs=201.6
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-------
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH------- 137 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 137 (357)
+|++++.||+|+||.||+|+++.+|+.||||++.... .+...+.+.+|+.+|+.++|||||+++++|...+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 5999999999999999999999999999999997543 3334567889999999999999999999987544
Q ss_pred -----eEEEEEeccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecC
Q psy7825 138 -----RVYIIMEYAEKGSLLDFIQREGYI---DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFG 209 (357)
Q Consensus 138 -----~~~lv~e~~~~~~L~~~l~~~~~l---~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg 209 (357)
.+|+|||||+||+|.+++...+.+ +...++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 479999999999999999876543 446688999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCC-------CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH-HHHHHH
Q psy7825 210 FARGHMKCKSGH-------QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQ 281 (357)
Q Consensus 210 ~~~~~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~ 281 (357)
+++......... ........+||+.|||||++.+..|+.+ +|||||||++|||++ ||..... ...+..
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 998653322111 1112235689999999999999888877 999999999999996 8865322 223333
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 282 VQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 282 i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
+......+..+..++.+.+||++|| .||.+|||+.|+|+||||++-..
T Consensus 240 ~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 3332222222345678899999999 99999999999999999997543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-61 Score=430.51 Aligned_cols=258 Identities=22% Similarity=0.390 Sum_probs=223.5
Q ss_pred cccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
.+..++|.+.+.||+|+||.||+|++. .++..||||+++.. .....+.|.+|+.+|++++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 456678999999999999999999864 35789999998643 3344567889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQRE-------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~ 201 (357)
+.+.+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 3699999999999999999999999999999999999999999
Q ss_pred cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy7825 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLK 280 (357)
Q Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~ 280 (357)
.+||+|||+++...... ........+||+.|||||++.+..++.+ +|||||||++|||+| |+.||.+.+..++..
T Consensus 166 ~~Ki~DFGla~~~~~~~---~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTD---YYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp CEEECCCSCHHHHTGGG---CEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred cEEECCcccceecCCCC---ceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999997442211 1112234569999999999999998877 999999999999998 899999999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
.+..+...+.++.+|+++.+||.+|| .||++|||+.+| ++||++
T Consensus 242 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 242 CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 99887777777889999999999999 999999999999 456654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-60 Score=428.49 Aligned_cols=256 Identities=21% Similarity=0.346 Sum_probs=223.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
.+...++++.+.||+|+||.||+|.+. .+++.||||++..... ....+.|.+|+.++++++|||||+++|++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC--C-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC--hHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 345567899999999999999999863 4578999999864332 223566889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID 198 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~ 198 (357)
.+..+++|||||++|+|.++|... ..+++..+..++.||+.||.|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999999999999653 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHH
Q psy7825 199 GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQ 277 (357)
Q Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~ 277 (357)
+++.+||+|||+++...... ........+||+.|||||++.+..++.+ +|||||||++|||+| |..||.+.+..+
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~---~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAAD---YYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGG---CBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CCCCEEECCcccceeccCCC---ceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999998543221 2223455679999999999999998877 999999999999998 899999999999
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 278 LLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 278 ~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+...+......+.++.+|+++.+||.+|| .||.+||++.+|+++
T Consensus 256 ~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 256 VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999888888888899999999999999 999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-60 Score=458.17 Aligned_cols=259 Identities=20% Similarity=0.363 Sum_probs=218.6
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhH---HHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFL---PREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
.+..++|.++++||+|+||.||+|+++.+|+.||||++.+...........+ ..++.++..++|||||+++++|++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 4556789999999999999999999999999999999975322111112222 3446777888999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+.+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999975421
Q ss_pred ccCCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhhcccCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDT---NYIQLLKQVQTKVVFPTEP 292 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~ 292 (357)
....+.+||+.|||||++.++ .|+.. +|||||||++|||++|..||.+. +...+...+.. .....+.
T Consensus 345 -------~~~~t~~GTp~YmAPEvl~~~~~y~~~-vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-~~~~~p~ 415 (689)
T 3v5w_A 345 -------KKPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MAVELPD 415 (689)
T ss_dssp -------CCCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-CCCCCCT
T ss_pred -------CCCCCccCCcCccCHHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-CCCCCCc
Confidence 223467899999999999754 56655 99999999999999999999753 33444444433 2233445
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
.+|+++++||.+|| .||.+|++ +++|++||||++-
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 79999999999999 99999998 7999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-59 Score=429.23 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=206.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCe
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHR 138 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 138 (357)
.++|++.+.||+|+||.||+|+++ .+++.||||++.+... ...+.+|+.+|..+ +||||++++++|.+.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 357999999999999999999874 4578999998865322 23466899999998 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~ 217 (357)
+|+||||++||+|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999984 48999999999999999999999999999999999999877 79999999999743221
Q ss_pred cCC-----------------------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCC-CC
Q psy7825 218 KSG-----------------------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD-DT 273 (357)
Q Consensus 218 ~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-~~ 273 (357)
... .........+||+.|+|||++.+......++||||+|||+|+|++|+.||. +.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 100 001122346899999999999887655455999999999999999999995 34
Q ss_pred CHHHHHHHHhhc-----------------------------------------------------ccCCCCCCCCHHHHH
Q psy7825 274 NYIQLLKQVQTK-----------------------------------------------------VVFPTEPNVSAECKT 300 (357)
Q Consensus 274 ~~~~~~~~i~~~-----------------------------------------------------~~~~~~~~~s~~~~~ 300 (357)
+..+.+..|... ...+....+|+++++
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 444444333210 001123468999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
||++|| .||.+|||++|+|+||||++-
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999 999999999999999999873
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-59 Score=416.38 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=205.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..+++.+.+.||+|+||.||+|++.. .||||+++..... ....+.|.+|+.+|++++|||||++++++.. +.+
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 5667789999999999999999998643 5999998654443 3345678899999999999999999998754 568
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++|||||+||+|.+++... +++++..+..|+.||+.||.|||+++||||||||+|||++.++.+||+|||+|+......
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999999999764 679999999999999999999999999999999999999999999999999997542211
Q ss_pred CCCCCCCCCcccCCccccccceecCC---CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhhcccCC----C
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGV---PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ-LLKQVQTKVVFP----T 290 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~----~ 290 (357)
........+||+.|||||++.+. .|+.+ +|||||||++|||+||+.||.+.+... +...+......| .
T Consensus 187 ---~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k-sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 187 ---GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ-SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ---cceeecccccCCCccCHHHhhccCCCCCCcH-HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 12223456899999999999643 45655 999999999999999999998765444 444444444333 2
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++.+++++.+||.+|| .||++|||+.+|++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 4578999999999999 99999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=448.73 Aligned_cols=259 Identities=25% Similarity=0.446 Sum_probs=228.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+++.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.+|+.|+||||++++++|.+...+|+||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999986532 223566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC--CcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE--YNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~--~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---- 309 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---- 309 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT----
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC----
Confidence 99999999999964 4679999999999999999999999999999999999999854 8999999999975421
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-cCC--CCCCCCHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-VFP--TEPNVSAE 297 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~--~~~~~s~~ 297 (357)
.......+||+.|||||++.+..|+.. +|||||||++|+|++|..||.+.+..+++..+.... .++ ..+.+|++
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred --CCceeeeEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 122345689999999999999988876 999999999999999999999999999988886543 222 23579999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
+++||++|| .||.+||++.|+|+||||+....+..
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 999999999 99999999999999999998766543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-58 Score=420.22 Aligned_cols=257 Identities=20% Similarity=0.328 Sum_probs=218.6
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC-CCcceeeEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRH-----GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-PNLIRFLQA 132 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~ 132 (357)
..+..++|++.+.||+|+||.||+|.+... ++.||||.+..... ....+.+.+|+.+|.++.| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 356678899999999999999999987643 36899999865332 2335668899999999975 899999999
Q ss_pred EEe-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7825 133 IET-THRVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENL 195 (357)
Q Consensus 133 ~~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Ni 195 (357)
|.. +..+++|||||++|+|.++|+.. ..+++..+..++.||+.||.|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 45789999999999999999752 3489999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCC
Q psy7825 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTN 274 (357)
Q Consensus 196 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~ 274 (357)
|++.++.+||+|||+++..... .........+||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+.+
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~---~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTC---TTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred eeCCCCCEEECcchhhhhcccC---CCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999754221 11122345679999999999999988877 999999999999998 999998865
Q ss_pred -HHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 275 -YIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 275 -~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
...+...+..+...+.++.+++++.+||.+|| .||.+|||+.+|++|
T Consensus 293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 34556667777777777889999999999999 899999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-55 Score=399.18 Aligned_cols=259 Identities=38% Similarity=0.701 Sum_probs=229.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++........ ..+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4569999999999999999999999999999999976544333 345577999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~------ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV------ 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS------
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC------
Confidence 99999999999999888999999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
.......+||+.|+|||++.+..+...++|||||||++|+|++|+.||.+.+..++...+.... +..+..++.++.+||
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-YRIPFYMSTDCENLL 245 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHH
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Confidence 1223456799999999999988887656999999999999999999999999888888776543 233446899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
++|| .||.+|||++|+++||||+....
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 9999 99999999999999999987644
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=400.02 Aligned_cols=259 Identities=30% Similarity=0.500 Sum_probs=227.0
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|.+.+.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.++..++||||+++++++.....+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 45679999999999999999999999999999999975322111123456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~----- 157 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----- 157 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc-----
Confidence 999999999999999888999999999999999999999999999999999999999999999999999874221
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+...+...+.... ...+..+++++++|
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSL 235 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHH
Confidence 1223446789999999999999888877 999999999999999999999998888887765432 22334699999999
Q ss_pred HHHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 302 LSKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 302 i~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
|++|| .||.+|| ++++|++||||++.
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 99999 8999999 99999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=404.19 Aligned_cols=260 Identities=28% Similarity=0.498 Sum_probs=222.7
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 139 (357)
+..++|++.++||+|+||.||+|+++.+|+.||||++.+...........+.+|..++..+ +||||+++++++.....+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4556799999999999999999999999999999999754322222345567899999988 699999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~---- 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI---- 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC----
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc----
Confidence 9999999999999999998899999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
.........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..++...+..... ..+..++.+++
T Consensus 176 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~ 252 (353)
T 3txo_A 176 -CNGVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDAT 252 (353)
T ss_dssp -C---------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHH
T ss_pred -cCCccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHH
Confidence 12223456789999999999988888776 9999999999999999999999999988888765432 22346999999
Q ss_pred HHHHHhc-CCCCCCCCH------HHHhcCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIRL------KDIKQDPWVKTE 327 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~------~~ll~hp~~~~~ 327 (357)
+||++|| .||.+||++ ++|++||||++.
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999 899999999 899999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=404.81 Aligned_cols=261 Identities=29% Similarity=0.506 Sum_probs=222.6
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 138 (357)
.+..++|.+.++||+|+||.||+|+++.+++.||||++.+.........+.+.+|..++..+ +||||++++++|.....
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45567899999999999999999999999999999999876555544456677899999887 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~--- 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--- 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC---
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc---
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999987321
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHhhcccCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT---------NYIQLLKQVQTKVVFP 289 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~ 289 (357)
.........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||... ....+...+.. ....
T Consensus 205 --~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~ 280 (396)
T 4dc2_A 205 --RPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIR 280 (396)
T ss_dssp --CTTCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CCCC
T ss_pred --cCCCccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cccC
Confidence 12233456789999999999999888876 99999999999999999999632 22233344332 2333
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCH------HHHhcCCCCCCC
Q psy7825 290 TEPNVSAECKTLLSKIF-SPIKFRIRL------KDIKQDPWVKTE 327 (357)
Q Consensus 290 ~~~~~s~~~~~li~~~L-~~p~~Rps~------~~ll~hp~~~~~ 327 (357)
.+..++.++++||++|| .||.+||++ ++|++||||++-
T Consensus 281 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 281 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 44579999999999999 999999985 899999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=397.60 Aligned_cols=258 Identities=25% Similarity=0.491 Sum_probs=226.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch---HHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD---YLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.++..++||||+++++++.....+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3569999999999999999999999999999999976543221 1235678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----cEEEeecCCCcccc
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY----NIKLSDFGFARGHM 215 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~----~~kl~Dfg~~~~~~ 215 (357)
++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999999888899999999999999999999999999999999999998877 79999999987442
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CCC--CC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPT--EP 292 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~--~~ 292 (357)
. .......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+..... ++. ++
T Consensus 171 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 171 D------GVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp T------TCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred C------CCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 2 122345679999999999998888776 9999999999999999999999998888888765432 221 25
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.+++++++||++|| .||.+||++.++|+||||++.
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 78999999999999 899999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=392.97 Aligned_cols=256 Identities=28% Similarity=0.530 Sum_probs=226.4
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|.+.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 34679999999999999999999999999999999975322111224556789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~------ 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------ 157 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS------
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC------
Confidence 99999999999999998889999999999999999999999999999999999999999999999999987432
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+.......+.... ...++.++.++++|
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~l 233 (318)
T 1fot_A 158 --DVTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDL 233 (318)
T ss_dssp --SCBCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred --CccccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHH
Confidence 12345679999999999999888877 999999999999999999999998888887775542 23345799999999
Q ss_pred HHHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 302 LSKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 302 i~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
|++|| .||.+|| ++++|++||||++.
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 99999 8999999 99999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=387.29 Aligned_cols=261 Identities=26% Similarity=0.465 Sum_probs=227.2
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+|++.+.||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 3457999999999999999999999999999999987544333 3557799999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 168 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----- 168 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-----
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC-----
Confidence 99999999999999765 589999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--cCCCCCCCCHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--VFPTEPNVSAECK 299 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~ 299 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+.......+.... ....+..++..++
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 1222345679999999999999888876 999999999999999999999888777666554332 2334457899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
+||.+|| .||.+||++.++|+||||+.......
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~ 281 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSS 281 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhcccCcccc
Confidence 9999999 99999999999999999998765543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=398.42 Aligned_cols=260 Identities=29% Similarity=0.494 Sum_probs=225.9
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 139 (357)
+..++|.+.+.||+|+||.||+|+++.+|+.||||++.+...........+..|..++..+ +||||+++++++.....+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 4567899999999999999999999999999999999753221111234466888888876 899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|+++|+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--- 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--- 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc---
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999874321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..++...+..... ..+..++.+++
T Consensus 171 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~ 246 (345)
T 1xjd_A 171 --GDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAK 246 (345)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHH
T ss_pred --CCCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCcccCHHHH
Confidence 1223456789999999999999888776 9999999999999999999999998888888765432 23346999999
Q ss_pred HHHHHhc-CCCCCCCCHH-HHhcCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIRLK-DIKQDPWVKTE 327 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~-~ll~hp~~~~~ 327 (357)
+||.+|| .||.+||++. +|++||||++.
T Consensus 247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 247 DLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 9999999 8999999998 99999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=392.48 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=225.0
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 139 (357)
+..++|.+.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.++..+ +||||+++++++.....+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 3456799999999999999999999999999999999876665555566788999999988 899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--- 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--- 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC---
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999874221
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHhhcccCCC
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD---------TNYIQLLKQVQTKVVFPT 290 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~---------~~~~~~~~~i~~~~~~~~ 290 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.. .....+...+... ....
T Consensus 163 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~ 238 (345)
T 3a8x_A 163 --PGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRI 238 (345)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCC
T ss_pred --CCCcccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCC
Confidence 1223456689999999999999888766 9999999999999999999965 2233344444332 2333
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCH------HHHhcCCCCCCC
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRL------KDIKQDPWVKTE 327 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~------~~ll~hp~~~~~ 327 (357)
+..++.++++||++|| .||.+||++ .++++||||++.
T Consensus 239 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 4579999999999999 899999995 899999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=397.09 Aligned_cols=258 Identities=27% Similarity=0.473 Sum_probs=228.3
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
....++|.+.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.++..++||||+++++++.....+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34567899999999999999999999999999999999654322212235577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999874321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..++...+.... ...+..++.+++
T Consensus 194 -----~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~ 266 (350)
T 1rdq_E 194 -----RTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLK 266 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHH
T ss_pred -----CcccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHH
Confidence 1345679999999999998888876 999999999999999999999999888888876543 233457999999
Q ss_pred HHHHHhc-CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
+||++|| .||.+||+ +++|++||||++.
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 9999999 89999998 9999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=397.00 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=225.9
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 138 (357)
.+..++|.+.+.||+|+||.||+|++..+|+.||||++.+.........+.+..|..++..+ +||||+++++++.....
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 34567799999999999999999999999999999999754221122245567899999988 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|+++|+|||+++....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--
Confidence 999999999999999999888899999999999999999999999999999999999999999999999999874211
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~ 298 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..++...+.... ...+..++.++
T Consensus 174 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 248 (353)
T 2i0e_A 174 ---DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEA 248 (353)
T ss_dssp ---TTCCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHH
T ss_pred ---CCcccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHH
Confidence 1223456789999999999998888776 999999999999999999999999888888876542 22335799999
Q ss_pred HHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 299 KTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
++||++|| .||.+|| ++++|++||||+.-
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 99999999 8999999 46999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=407.05 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=227.3
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.++||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..++||||++++++|.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 44567899999999999999999999999999999999753221111234577999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 145 ~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~-- 221 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-- 221 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC--
Confidence 9999999999999999764 5899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCcccCCccccccceecCCC----CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCCCCC
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVP----YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFPTEP 292 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~ 292 (357)
........+||+.|+|||++.+.. ++.+ +|||||||++|+|++|+.||.+.+...+...+... +.+|...
T Consensus 222 --~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 222 --GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp --SEEECCSCCSCGGGCCHHHHHTTTTTCEEETH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred --CcccccCCcCCccccCHHHhhccCCCcCCCCc-ceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence 111234568999999999997665 4445 99999999999999999999999998888887643 5666667
Q ss_pred CCCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKF--RIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~~ 328 (357)
.++.++++||++|| .+|.+ ||++++|++||||++..
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 89999999999999 77888 99999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=395.23 Aligned_cols=260 Identities=30% Similarity=0.538 Sum_probs=220.0
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHH-HHcCCCCCcceeeEEEEeCCeE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV-VKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
+..++|.+.+.||+|+||.||+|+++.+++.||||++.+...........+.+|..+ ++.++||||+++++++...+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 445679999999999999999999999999999999977554433334445567766 5678999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~--- 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--- 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC---
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999874221
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
........+||+.|+|||++.+..++.+ +|||||||++|||++|..||.+.+..++...+.... ...++.++.+++
T Consensus 192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 267 (373)
T 2r5t_A 192 --HNSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSAR 267 (373)
T ss_dssp --CCCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCCCSSSCHHHH
T ss_pred --CCCccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHH
Confidence 1223456789999999999998888776 999999999999999999999999888888876542 233457999999
Q ss_pred HHHHHhc-CCCCCCCCH----HHHhcCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIRL----KDIKQDPWVKTE 327 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~----~~ll~hp~~~~~ 327 (357)
+||++|| .||.+||++ .++++||||+..
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 9999999 899999997 699999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=397.21 Aligned_cols=259 Identities=36% Similarity=0.654 Sum_probs=221.1
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.....+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999998653222222234678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|||+ +|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~------ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD------ 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT------
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC------
Confidence 9999 679999998888899999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
.......+||+.|+|||++.+..+...++|||||||++|+|++|+.||.+.....+...+... ....+..+++++++||
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLI 239 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHHH
Confidence 122345679999999999998887555599999999999999999999876544443333222 2333457899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
++|| .||.+|||++|+++||||+...+
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 9999 99999999999999999987643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=388.87 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=191.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC----eE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH----RV 139 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 139 (357)
.+|.+.+.||+|+||.||+|++. |+.||||++.... ......+.|+..+..++||||+++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 35899999999999999999874 8999999986432 11223345666777899999999999997654 68
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER--------GVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
|+||||+++|+|.++++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999999765 589999999999999999999987 9999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCC------CCCCcccHHHHHHHHHHHHcCCCCCCC-------------
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP------YTPHYSDVWSMGVVLYAMAFGRLPFDD------------- 272 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~g~~pf~~------------- 272 (357)
+........ ........+||+.|||||++.+.. ++.+ +|||||||++|||+||..||..
T Consensus 156 ~~~~~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k-~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 156 VRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp EEEETTTTE-ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHH-HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccCCCCc-eeeecccccccccccCHHHhcccccccCCccChh-HhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 754322111 111233567999999999997653 3334 9999999999999999776532
Q ss_pred --CCHHHHHHHHhhcccCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 273 --TNYIQLLKQVQTKVVFPTEP------NVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 273 --~~~~~~~~~i~~~~~~~~~~------~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.....+...+......|..+ ..+..+.+||.+|| .||.+|||+.+|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12334444443332222211 13357899999999 999999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=379.08 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=215.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+++.++||||+++++++..+..+++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 47999999999999999999999999999999997654433 33455779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+++ +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~ 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-----P 154 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS-----C
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC-----c
Confidence 99987 55555544 67899999999999999999999999999999999999999999999999999974321 1
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHhhcccCC------------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP-FDDTNYIQLLKQVQTKVVFP------------ 289 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~------------ 289 (357)
........||+.|+|||++.+......++|||||||++|+|++|..| |.+.+..+.+..+......+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 22234557899999999998877444449999999999999988777 56667666666654322211
Q ss_pred ----------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 290 ----------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 290 ----------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
..+.++.++++||++|| .||.+|||++|+|+||||++..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 11357899999999999 99999999999999999998543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=399.92 Aligned_cols=257 Identities=29% Similarity=0.509 Sum_probs=225.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4699999999999999999999999999999999765433 333556789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc---CCCcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID---GEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||+.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~---- 165 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG---- 165 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT----
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC----
Confidence 9999999999999989999999999999999999999999999999999999998 467899999999964321
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc---CCCCCCCCHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---FPTEPNVSAE 297 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~ 297 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+...+...+..... .+..+.++++
T Consensus 166 -~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 166 -EQQAWFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp -TCCBCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred -CCceeecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 1122345679999999999998888876 9999999999999999999999998888888765432 2334578999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+++||.+|| .||.+||++.|+|+||||++.
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999 999999999999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=389.01 Aligned_cols=263 Identities=33% Similarity=0.519 Sum_probs=220.6
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ..+.+.+|+.+++.++||||+++++++......++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357999999999999999999999999999999986543322 245678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... .
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~ 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---R 160 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT---E
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC---c
Confidence 9999999999999888889999999999999999999999999999999999999999999999999997442211 1
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH-HhhcccCCCCCCCCHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQ-VQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~-i~~~~~~~~~~~~s~~~~~ 300 (357)
.......+||+.|+|||++.+..+...++|||||||++|+|++|+.||...... ..... .......+....++..+.+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence 222345679999999999988877555599999999999999999999765442 22222 2333333444579999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
||.+|| .||.+||++.|+++||||+.....
T Consensus 241 li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 271 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred HHHHHccCChhhCcCHHHHhhChhhcccccc
Confidence 999999 999999999999999999876443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-54 Score=404.18 Aligned_cols=266 Identities=27% Similarity=0.445 Sum_probs=226.6
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..+..++|.+.++||+|+||.||+|++..+++.||||++.+...........+.+|+.++..++||||++++++|.+...
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 34556789999999999999999999999999999999975322222223457899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
+|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999999999987 578999999999999999999999999999999999999999999999999998643211
Q ss_pred cCCCCCCCCCcccCCccccccceec-----CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---ccCC
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILK-----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VVFP 289 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~ 289 (357)
........+||+.|+|||++. ...++.+ +|||||||++|||++|+.||.+.+..+....+... +.+|
T Consensus 229 ----~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~-~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 229 ----GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp ----SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred ----CCcccccccCCcCeeChHHHhhcccCCCCCCCc-CeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 111223468999999999996 4456655 99999999999999999999999988888887542 3344
Q ss_pred CC-CCCCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCCCCCCC
Q psy7825 290 TE-PNVSAECKTLLSKIF-SPIKF--RIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 290 ~~-~~~s~~~~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~~~ 329 (357)
.. ..+++++++||++|| .+|++ ||+++++++||||++..+
T Consensus 304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 32 468999999999999 77877 999999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=384.93 Aligned_cols=258 Identities=27% Similarity=0.475 Sum_probs=224.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch---HHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD---YLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
++|.+.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.....++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 469999999999999999999999999999999976543221 12456789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----cEEEeecCCCccccc
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY----NIKLSDFGFARGHMK 216 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~----~~kl~Dfg~~~~~~~ 216 (357)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 9999999999999998888899999999999999999999999999999999999999887 799999999874421
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CCC--CCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPT--EPN 293 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~--~~~ 293 (357)
. ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+....+....+..... ++. .+.
T Consensus 171 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 171 G------NEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp T------SCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred C------CccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 1 12234579999999999988888776 9999999999999999999999888887777654322 221 246
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
++..+++||++|| .||.+||++.++|+||||++..
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 8999999999999 8999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=404.25 Aligned_cols=261 Identities=30% Similarity=0.497 Sum_probs=219.7
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.++..++||||+++++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34567799999999999999999999999999999999754322222344566899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++||||++||+|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 9999999999999999988899999999999999999999998 9999999999999999999999999999874221
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~ 298 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+...+...+.... ...+..+++++
T Consensus 302 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~ 376 (446)
T 4ejn_A 302 ---DGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEA 376 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHH
T ss_pred ---CCcccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHH
Confidence 1222345789999999999998888876 999999999999999999999999888887765432 22344699999
Q ss_pred HHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 299 KTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
.+||.+|| .||.+|| +++++++||||++.
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999 9999999 99999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=384.65 Aligned_cols=260 Identities=25% Similarity=0.485 Sum_probs=217.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCc-hHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAPP-DYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
+..++|.+.+.||+|+||.||+|++. .+|+.||+|++.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 45567999999999999999999985 679999999997643221 12244567899999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCH
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSA 296 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 296 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+.... ...++.++.
T Consensus 174 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~ 246 (327)
T 3a62_A 174 -----DGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLTQ 246 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTSCH
T ss_pred -----CCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCH
Confidence 1122345679999999999988888766 999999999999999999999988888877765432 233457999
Q ss_pred HHHHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
++++||.+|| .||.+|| ++.++++||||++.
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999999999 8999999 89999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=386.95 Aligned_cols=257 Identities=20% Similarity=0.351 Sum_probs=224.7
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.++||||+++++++.....+++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 357999999999999999999999999999999986422 2245678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCcEEEeecCCCcccccccC
Q psy7825 143 MEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG--EYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~--~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~--- 156 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--- 156 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC---
Confidence 9999999999999765 47999999999999999999999999999999999999987 78999999999874321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC---CCCCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT---EPNVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~ 296 (357)
........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+........ .+.++.
T Consensus 157 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 157 ---GDNFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ---TCEEEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ---CCccccccCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 112234579999999999988877766 9999999999999999999999998888887765433222 247899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
++++||.+|| .||.+||++.|+|+||||++....
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 267 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccCccc
Confidence 9999999999 999999999999999999987554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=389.65 Aligned_cols=257 Identities=29% Similarity=0.554 Sum_probs=225.7
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++......|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 346999999999999999999999999999999997655433 3345678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---cEEEeecCCCcccccccC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY---NIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~---~~kl~Dfg~~~~~~~~~~ 219 (357)
|||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~--- 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--- 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT---
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC---
Confidence 99999999999998888899999999999999999999999999999999999998654 599999999874421
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-cCCC--CCCCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-VFPT--EPNVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~s~ 296 (357)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+...+...+.... .++. .+.+++
T Consensus 184 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 184 ---SEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp ---CCSCCCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred ---CcccccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 122335679999999999998888876 999999999999999999999998888888776543 2232 346899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
++++||.+|| .||.+||++.++|+||||+..
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 9999999999 999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=398.48 Aligned_cols=266 Identities=26% Similarity=0.402 Sum_probs=224.8
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..+..++|.+.++||+|+||.||+|+++.+|+.||||++.+...........+.+|..++..++||||++++++|.+...
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 34566789999999999999999999999999999999975332222334568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
+|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999999875 47999999999999999999999999999999999999999999999999998743211
Q ss_pred cCCCCCCCCCcccCCccccccceec-------CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc---cc
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILK-------GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK---VV 287 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~ 287 (357)
........+||+.|+|||++. +..++.+ +|||||||++|||++|+.||.+.+..++...+... ..
T Consensus 216 ----~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 216 ----GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE-CDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ----SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred ----CccccceeccccCcCCHHHHhhcccCcCCCCCChH-HhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 111223468999999999997 3455655 99999999999999999999999988888777542 33
Q ss_pred CCC-CCCCCHHHHHHHHHhcCCCCCC---CCHHHHhcCCCCCCCCC
Q psy7825 288 FPT-EPNVSAECKTLLSKIFSPIKFR---IRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 288 ~~~-~~~~s~~~~~li~~~L~~p~~R---ps~~~ll~hp~~~~~~~ 329 (357)
+|. ...+|.++++||++||.+|.+| |++++|++||||++-.+
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp CC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred CCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 332 3579999999999999777766 69999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=390.97 Aligned_cols=258 Identities=34% Similarity=0.608 Sum_probs=214.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
...++|.+.+.||+|+||.||+|++..+|+.||||++....... +.+.+|+.+++.++||||+++++++.....++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 34567999999999999999999999999999999997644332 44679999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc--EEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN--IKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 218 (357)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~--- 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--- 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence 99999999999999998888999999999999999999999999999999999999987765 9999999986321
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHh-hcccCCCCCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN----YIQLLKQVQ-TKVVFPTEPN 293 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~-~~~~~~~~~~ 293 (357)
........+||+.|+|||++.+..++..++|||||||++|+|++|+.||.+.. .......+. .....+....
T Consensus 170 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (361)
T 3uc3_A 170 ---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred ---ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence 11222345799999999999888887666899999999999999999998643 334444433 3444555567
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+++++++||.+|| .||.+||++.+|++||||....
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 8999999999999 9999999999999999997653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=392.25 Aligned_cols=260 Identities=23% Similarity=0.407 Sum_probs=221.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||++++++|.....+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45567799999999999999999999999999999998753322222245577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~---- 166 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---- 166 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc----
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999997432
Q ss_pred CCCCCCCCcccCCccccccceecC---CCCCCCcccHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhhcccCCCCCC
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKG---VPYTPHYSDVWSMGVVLYAMAFGRLPFDDT---NYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~ 293 (357)
........+||+.|+|||++.+ ..++.. +|||||||++|+|++|+.||... ........+... ..+.+..
T Consensus 167 --~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~p~~ 242 (384)
T 4fr4_A 167 --RETQITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPSA 242 (384)
T ss_dssp --TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-CCCCCTT
T ss_pred --CCCceeccCCCccccCCeeeccCCCCCCCcc-ceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-ccCCCCc
Confidence 1223456789999999999964 346666 99999999999999999999743 344444444332 2334457
Q ss_pred CCHHHHHHHHHhc-CCCCCCCC-HHHHhcCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIR-LKDIKQDPWVKTE 327 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps-~~~ll~hp~~~~~ 327 (357)
++..+.+||++|| .||.+||+ +++|++||||++.
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 9999999999999 89999998 9999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=405.38 Aligned_cols=262 Identities=34% Similarity=0.656 Sum_probs=229.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.....+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 44556799999999999999999999999999999999753222222245678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~--- 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT---
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc---
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999874321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
.......+||+.|+|||++.+..+...++|||||||++|+|++|..||.+.+...+...+.... +..+..+++++.
T Consensus 169 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 244 (476)
T 2y94_A 169 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-FYTPQYLNPSVI 244 (476)
T ss_dssp ---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-CCCCTTCCHHHH
T ss_pred ---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-cCCCccCCHHHH
Confidence 1223456799999999999988776555999999999999999999999988888887776543 333457899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+||++|| .||.+||++.+|++||||++..
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 9999999 8999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=376.54 Aligned_cols=262 Identities=29% Similarity=0.582 Sum_probs=226.6
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|.+.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 34567999999999999999999999999999999986543322233456789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~---- 161 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 161 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc----
Confidence 9999999999999999888899999999999999999999999999999999999999999999999998753211
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
.......|++.|+|||++.+..++.+ +||||||+++|+|++|..||...+..+....+... ....+..+++.+++
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFVTEGARD 236 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCCCTTSCHHHHH
T ss_pred ---ccccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-CCCCCCcCCHHHHH
Confidence 12234578999999999998888777 99999999999999999999999888887776543 23344579999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
||.+|| .||.+||++.+||+||||++.....
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred HHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence 999999 8999999999999999999865443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=380.42 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=205.1
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.+++.++||||+++++++..++.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 356999999999999999999999999999999997543221 234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 143 MEYAEKGSLLDFIQRE------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
|||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999985 999999754 3589999999999999999999999999999999999999999999999999874421
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------ 289 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------ 289 (357)
. .......+||+.|+|||++.+.. ++.+ +|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 161 ~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 161 P-----VNTFSSEVVTLWYRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp C-----CCCCCCCCSCCTTCCHHHHTTCCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred C-----cccCCCCcccccccCchHhhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 1 12233457899999999998754 4544 999999999999999999999988877776654321111
Q ss_pred ---------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 290 ---------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 290 ---------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
....++.++.+||.+|| .||.+||++.|+|+||||++....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 11257899999999999 9999999999999999999876554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=390.64 Aligned_cols=272 Identities=22% Similarity=0.337 Sum_probs=220.8
Q ss_pred ccccccccCeEEceeeeec--CCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 57 KSTVMENHGYVLGKVIGIG--SYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
.......++|++.+.||+| +||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 3444567789999999999 9999999999999999999999765443 345667889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
..+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999999999999999875 679999999999999999999999999999999999999999999999999875
Q ss_pred ccccccC--CCCCCCCCcccCCccccccceecC--CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--
Q psy7825 213 GHMKCKS--GHQSPLSDTFCGSYAYASPEILKG--VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-- 286 (357)
Q Consensus 213 ~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-- 286 (357)
....... ..........+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+..+....+....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 4321111 111122234579999999999987 456665 999999999999999999998755443332221100
Q ss_pred -------------------------------------------cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy7825 287 -------------------------------------------VFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDP 322 (357)
Q Consensus 287 -------------------------------------------~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp 322 (357)
..+....+++++++||++|| .||.+||++.++|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 11223468999999999999 9999999999999999
Q ss_pred CCCCCCCC
Q psy7825 323 WVKTEANP 330 (357)
Q Consensus 323 ~~~~~~~~ 330 (357)
||++....
T Consensus 336 ~f~~~~~~ 343 (389)
T 3gni_B 336 FFKQIKRR 343 (389)
T ss_dssp GGGGC---
T ss_pred HHHHHhhc
Confidence 99986544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=378.48 Aligned_cols=260 Identities=30% Similarity=0.568 Sum_probs=216.4
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-----------------------hHHhhhHHHHHHH
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP-----------------------DYLKKFLPREIDV 117 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~ 117 (357)
+..++|.+.+.||+|+||.||+|.+..+|+.||||++....... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34567999999999999999999999999999999997543221 1123557899999
Q ss_pred HHcCCCCCcceeeEEEEe--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7825 118 VKGLRHPNLIRFLQAIET--THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENL 195 (357)
Q Consensus 118 l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Ni 195 (357)
++.++||||+++++++.. ...+++||||+++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999986 678999999999999988654 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCC--CCCcccHHHHHHHHHHHHcCCCCCCCC
Q psy7825 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPY--TPHYSDVWSMGVVLYAMAFGRLPFDDT 273 (357)
Q Consensus 196 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~ 273 (357)
|++.++.+||+|||++...... ........||+.|+|||++.+... ...++|||||||++|+|++|+.||.+.
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGS-----DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSS-----SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCCCCEEEecCCCccccccc-----cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999998744221 112234579999999999977653 234489999999999999999999998
Q ss_pred CHHHHHHHHhhc-ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 274 NYIQLLKQVQTK-VVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 274 ~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
........+... ..++..+.+++++++||.+|| .||.+||++.++|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 887777766543 445555689999999999999 99999999999999999963
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=379.30 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=211.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.....+++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 456999999999999999999985 489999999865432 222345677999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~----- 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI----- 171 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS-----
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC-----
Confidence 999986 888888764 4599999999999999999999999999999999999999999999999999874321
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC-----------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT----------- 290 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----------- 290 (357)
.........||+.|+|||++.+......++|||||||++|+|++|+.||.+....+....+......+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 112233457899999999998754434449999999999999999999987766665555433221111
Q ss_pred ------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 291 ------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 291 ------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.+.+++++.+||++|| .||.+|||++|+|+||||++-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 1357899999999999 8999999999999999999854
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=383.39 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=212.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.+++.++||||+++++++.....+++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 46999999999999999999999999999999986433211 1223447999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||++| +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..... .
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-----~ 153 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-----P 153 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC-----C
Confidence 99975 999988765 4599999999999999999999999999999999999999999999999999864321 1
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC------------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT------------ 290 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------------ 290 (357)
........||+.|+|||++.+......++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 12233457899999999998754434449999999999999999999999988887777654322221
Q ss_pred -----------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 291 -----------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 291 -----------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+.+++++.+||.+|| .||.+|||++|+|+||||.+..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 1357899999999999 899999999999999999987554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=376.21 Aligned_cols=261 Identities=28% Similarity=0.404 Sum_probs=216.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 569999999999999999999999999999999865433 3444566779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-----S 156 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-----c
Confidence 99999999999988888999999999999999999999999999999999999999999999999998643211 1
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc----------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---------------- 287 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------------- 287 (357)
.......||+.|+|||++.+......++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 1223457899999999998744433449999999999999999999999887776655432211
Q ss_pred ----CCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 288 ----FPT----------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 288 ----~~~----------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+. .+.++.++.+||++|| .||.+|||++|+|+||||++..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 111 1468999999999999 999999999999999999986544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=368.93 Aligned_cols=263 Identities=29% Similarity=0.538 Sum_probs=228.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++........ ..+.+.+|+.+++.++||||+++++++......++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHH-HHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4679999999999999999999999999999999976554333 345677999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc---EEEeecCCCcccccccC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN---IKLSDFGFARGHMKCKS 219 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~---~kl~Dfg~~~~~~~~~~ 219 (357)
|||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~--- 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--- 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS---
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc---
Confidence 999999999999998888999999999999999999999999999999999999987655 99999999864321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc---CCCCCCCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---FPTEPNVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~ 296 (357)
........||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.+.+.......+..... .+....+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 ---SEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ---SCBCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ---CccccCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 112234579999999999998888776 9999999999999999999999988888877655432 233357899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAAS 333 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 333 (357)
++.+||.+|| .||.+||++.|+|+||||++.......
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 9999999999 899999999999999999986554443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=374.12 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=211.0
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.+++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 4799999999999999999998 6789999999865432 2222355679999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP----- 153 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-----
Confidence 99976 999998764 67999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-------------
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------------- 289 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------------- 289 (357)
........||+.|+|||++.+......++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 1122345689999999999775533344999999999999999999999888777666553321110
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 290 ---------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 290 ---------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
....+++++.+||++|| .||.+||++.++|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01357999999999999 899999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=387.84 Aligned_cols=258 Identities=26% Similarity=0.497 Sum_probs=216.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCC--CchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA--PPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.+++.++||||+++++++.....+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4569999999999999999999999999999999864211 11112455789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc---EEEeecCCCcc
Q psy7825 141 IIMEYAEKGSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN---IKLSDFGFARG 213 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~---~kl~Dfg~~~~ 213 (357)
+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888643 35899999999999999999999999999999999999987654 99999999874
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-cCC--C
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-VFP--T 290 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~--~ 290 (357)
... ........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.. ..+...+.... ..+ .
T Consensus 183 ~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 183 LGE-----SGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp CCT-----TSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHH
T ss_pred ecC-----CCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccc
Confidence 422 1122345679999999999998888776 999999999999999999998754 34444444332 222 1
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.+.+++++++||++|| .||.+||++.++|+||||++.
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 2468999999999999 999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=387.94 Aligned_cols=265 Identities=27% Similarity=0.465 Sum_probs=209.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCC--eE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTH--RV 139 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--~~ 139 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.++..+. ||||+++++++...+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 357999999999999999999999999999999986543333 33455668999999997 999999999997544 79
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||+++ +|..++.. +.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 999999975 89999976 4689999999999999999999999999999999999999999999999999975422111
Q ss_pred C----------------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Q psy7825 220 G----------------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ 283 (357)
Q Consensus 220 ~----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 283 (357)
. .........+||+.|+|||++.+......++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 0 111223456899999999999874433444999999999999999999999998888777765
Q ss_pred hcccCCC----------------------------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHH
Q psy7825 284 TKVVFPT----------------------------------------------EPNVSAECKTLLSKIF-SPIKFRIRLK 316 (357)
Q Consensus 284 ~~~~~~~----------------------------------------------~~~~s~~~~~li~~~L-~~p~~Rps~~ 316 (357)
.....|. ...+++++.+||++|| .||.+|||++
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 4433332 1267999999999999 8999999999
Q ss_pred HHhcCCCCCCCCCC
Q psy7825 317 DIKQDPWVKTEANP 330 (357)
Q Consensus 317 ~ll~hp~~~~~~~~ 330 (357)
|+|+||||+....+
T Consensus 325 e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 325 DALKHPFVSIFHNP 338 (388)
T ss_dssp HHTTSTTTTTTCCG
T ss_pred HHhCCHHHHHhcCC
Confidence 99999999875443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=381.17 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=211.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++.....+++|
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 45699999999999999999999999999999998654332 22344566899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-----CCCcEEEeecCCCcccccc
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID-----GEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~-----~~~~~kl~Dfg~~~~~~~~ 217 (357)
|||++| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||++......
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 999975 9999999988899999999999999999999999999999999999994 4456999999998643211
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCC-----
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP----- 292 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----- 292 (357)
.......+||+.|+|||++.+......++|||||||++|+|++|..||.+.+..+.+..+......+...
T Consensus 191 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 191 -----IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp --------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -----ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 1223345689999999999876543444999999999999999999999988887777765443322211
Q ss_pred ------------------------CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 293 ------------------------NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 293 ------------------------~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.+++++.+||.+|| .||.+||+++|+|+||||++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 17899999999999 9999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=387.02 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=223.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.....+++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999986532 222456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG--EYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||++.....
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~---- 203 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---- 203 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT----
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC----
Confidence 999999999999765 36999999999999999999999999999999999999974 47799999999874321
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-c--CCCCCCCCHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-V--FPTEPNVSAE 297 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~--~~~~~~~s~~ 297 (357)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+.+..+.... . ......++.+
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 204 --DEIVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred --CcceeeeccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 112334579999999999998888776 999999999999999999999988888877765432 2 2233578999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
+++||.+|| .||.+||++.++|+||||++....
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCccc
Confidence 999999999 999999999999999999986443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=374.21 Aligned_cols=257 Identities=24% Similarity=0.436 Sum_probs=223.7
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|...+.||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++......++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888889999999999999999899999999997544332 4557799999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
|++|++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..... ...
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-----~~~ 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-----DVP 196 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-----SSC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc-----Ccc
Confidence 9999999999865 4599999999999999999999999999999999999999999999999999864422 112
Q ss_pred CCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC--CCCCCCCHHHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF--PTEPNVSAECKTLL 302 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~~~~li 302 (357)
......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||...+..+....+...... .....+++.+++||
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHH
Confidence 2345679999999999998888876 99999999999999999999998888877776554332 22346899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
.+|| .||.+||++.++|+||||++...+.
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 305 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQTGLPE 305 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred HHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence 9999 8999999999999999999865443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=372.67 Aligned_cols=263 Identities=31% Similarity=0.591 Sum_probs=228.3
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++......
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 34556799999999999999999999999999999998653222222245678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--- 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--- 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS---
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc---
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999853321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
.......|++.|+|||++.+..++.+ +||||||+++|+|++|..||...+..+....+... ....++.++..++
T Consensus 167 ----~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (284)
T 2vgo_A 167 ----LRRRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPFLSDGSK 240 (284)
T ss_dssp ----SCBCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCCTTSCHHHH
T ss_pred ----cccccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-ccCCCCcCCHHHH
Confidence 12234579999999999998888877 99999999999999999999988887777665543 2334457999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
+||.+|| .||.+||++.++++||||+......
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~ 273 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred HHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence 9999999 8999999999999999999765443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=373.92 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=213.4
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCc--hHHhhhHHHHHHHHHcCC---CCCcceeeEEEEeC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP--DYLKKFLPREIDVVKGLR---HPNLIRFLQAIETT 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~ 136 (357)
..++|++.+.||+|+||.||+|++..+|+.||||++....... ......+.+|+.+++.+. ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4568999999999999999999999999999999987543211 111233557777777664 99999999999875
Q ss_pred C-----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecC
Q psy7825 137 H-----RVYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFG 209 (357)
Q Consensus 137 ~-----~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg 209 (357)
. .+++||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5 58999999975 99999987654 9999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC
Q psy7825 210 FARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP 289 (357)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 289 (357)
++.... ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 166 ~a~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 166 LARIYS------YQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CTTTST------TCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccC------CCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 986432 1222345679999999999998888877 999999999999999999999998888777765432221
Q ss_pred C--------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 290 T--------------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 290 ~--------------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
. .+.+++++.+||.+|| .||.+|||+.++|+||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1 1358899999999999 9999999999999999999854
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=375.95 Aligned_cols=259 Identities=24% Similarity=0.459 Sum_probs=225.5
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch---HHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD---YLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.....+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3469999999999999999999999999999999976543221 1245678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----cEEEeecCCCcccc
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY----NIKLSDFGFARGHM 215 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~----~~kl~Dfg~~~~~~ 215 (357)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999999888899999999999999999999999999999999999999888 79999999987442
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC---CC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT---EP 292 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~~ 292 (357)
. ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+........ ..
T Consensus 171 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 171 D------GVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp T------TCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred c------cccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 2 112234569999999999998888776 9999999999999999999999888888777655432211 24
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.++..+++||.+|| .||.+||++.++|+||||++..
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 68999999999999 8999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=369.40 Aligned_cols=263 Identities=24% Similarity=0.464 Sum_probs=231.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34579999999999999999999999999999999987655555566778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++.....
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~----- 167 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY----- 167 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-----
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc-----
Confidence 999999999999999888899999999999999999999999999999999999999999999999999874321
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
.........|++.|+|||++.+..++.+ +||||||+++|+|++|+.||......+....+.... ...+..++..+.+|
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 245 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASL 245 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHH
T ss_pred CccccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHH
Confidence 1122334579999999999988887766 999999999999999999999988877776665432 33445789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
|.+|| .||.+||++.++++||||+....+.
T Consensus 246 i~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 246 IQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 99999 8999999999999999999875543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=383.11 Aligned_cols=257 Identities=32% Similarity=0.531 Sum_probs=208.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.+++.++||||+++++++.....+++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 34679999999999999999999999999999999875321 3456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcEEEeecCCCccccccc
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG---EYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~---~~~~kl~Dfg~~~~~~~~~ 218 (357)
||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++.....
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~-- 203 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-- 203 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc--
Confidence 9999999999999998888999999999999999999999999999999999999975 88999999999874321
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhhccc-C--CCCCCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ-LLKQVQTKVV-F--PTEPNV 294 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~-~--~~~~~~ 294 (357)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+..... ....+..... + +..+.+
T Consensus 204 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 204 ----QVLMKTVCGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred ----ccccccccCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 112335679999999999998888776 999999999999999999997665443 5555544322 2 233578
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
+.++++||++|| .||.+||++.++|+||||++....
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 999999999999 899999999999999999986554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=393.56 Aligned_cols=265 Identities=24% Similarity=0.371 Sum_probs=199.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-----CC
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET-----TH 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 137 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4679999999999999999999999999999999865433 33334567799999999999999999999843 35
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||+++.....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 7999999985 599999998888999999999999999999999999999999999999999999999999999865322
Q ss_pred cCCCC----------------------CCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHc---------
Q psy7825 218 KSGHQ----------------------SPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAF--------- 265 (357)
Q Consensus 218 ~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~--------- 265 (357)
..... .......+||+.|+|||++.. ..++.+ +||||||||+|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~-~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-IDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH-HHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH-hHHHHHHHHHHHHHHhcccccccc
Confidence 21100 012345678999999998754 445555 999999999999999
Q ss_pred --CCCCCCCCCH--------------------HHHHHHHhhcccCC------------------------------CCCC
Q psy7825 266 --GRLPFDDTNY--------------------IQLLKQVQTKVVFP------------------------------TEPN 293 (357)
Q Consensus 266 --g~~pf~~~~~--------------------~~~~~~i~~~~~~~------------------------------~~~~ 293 (357)
|+.+|.+.+. .+.+..+......+ ..+.
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 6777765431 12222221111110 1245
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+.++.+||++|| .||.+||+++|+|+||||++....
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 7999999999999 999999999999999999986443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=376.43 Aligned_cols=262 Identities=23% Similarity=0.462 Sum_probs=231.3
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34679999999999999999999999999999999987655555566778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~----- 193 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY----- 193 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS-----
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc-----
Confidence 999999999999999888899999999999999999999999999999999999999999999999999874421
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
.........|++.|+|||++.+..++.+ +||||||+++|+|++|+.||......+....+.... ...+..++..+.+|
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 271 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASL 271 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHH
T ss_pred CcccccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHH
Confidence 1122344679999999999988888766 999999999999999999999988777766665432 23345789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
|++|| .||.+||++.++|+||||+....+
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 99999 899999999999999999986544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=367.98 Aligned_cols=257 Identities=29% Similarity=0.533 Sum_probs=224.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..++..||+|++....... .+.+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 346999999999999999999999999999999987644333 45577999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEEeecCCCcccccccC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|||+++++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~--- 161 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--- 161 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT---
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC---
Confidence 9999999999999988889999999999999999999999999999999999999 7889999999999864321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC---CCCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE---PNVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~s~ 296 (357)
........||+.|+|||++.+. ++.+ +||||||+++|+|++|..||...+..+....+......... ..+++
T Consensus 162 ---~~~~~~~~~t~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 162 ---GKMMRTKVGTPYYVSPQVLEGL-YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ---TSCBCCCCSCTTTCCHHHHTTC-BCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred ---ccchhccCCCCCccChHHhccc-CCch-hhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 1223455799999999998765 6666 99999999999999999999998888887777654332221 36899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+.+||.+|| .||.+||++.++|+||||++....
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence 9999999999 899999999999999999875443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=382.46 Aligned_cols=252 Identities=29% Similarity=0.528 Sum_probs=216.0
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 141 (357)
.++|.+.+.||+|+||.||+|.++.+|+.||||++.+.... ..+|++++..+ +||||+++++++.+...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 35699999999999999999999999999999999764332 23688888887 79999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC----CcEEEeecCCCcccccc
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE----YNIKLSDFGFARGHMKC 217 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~----~~~kl~Dfg~~~~~~~~ 217 (357)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++.....
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~- 172 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA- 172 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC-
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC-
Confidence 99999999999999988889999999999999999999999999999999999998543 3599999999874422
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhhccc-CC--CC
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD---TNYIQLLKQVQTKVV-FP--TE 291 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~-~~--~~ 291 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+ ....++...+..... ++ .+
T Consensus 173 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 173 ----ENGLLMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp ----TTCCBCCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ----CCCceeccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 1123345679999999999988777766 9999999999999999999975 456666666654332 22 23
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+.+++++++||++|| .||.+||++.++|+||||.+.
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 579999999999999 999999999999999999763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=377.34 Aligned_cols=255 Identities=30% Similarity=0.536 Sum_probs=198.8
Q ss_pred CeEEc---eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEE
Q psy7825 65 GYVLG---KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 65 ~y~~~---~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 140 (357)
+|.+. +.||+|+||.||+|.+..+|+.||||++... ....+.+|+.++..+. ||||+++++++......|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 46664 7899999999999999999999999998642 2345678999999997 999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---cEEEeecCCCcccccc
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY---NIKLSDFGFARGHMKC 217 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~---~~kl~Dfg~~~~~~~~ 217 (357)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 161 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP- 161 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC-
Confidence 9999999999999999988999999999999999999999999999999999999998766 799999999864321
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHhhcccCCC
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN-------YIQLLKQVQTKVVFPT 290 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~ 290 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+ ..+....+........
T Consensus 162 ----~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 162 ----DNQPLKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp --------------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred ----CCCcccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 1222345678999999999998888876 999999999999999999997643 3455555544332211
Q ss_pred ---CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 291 ---EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 291 ---~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
...+++++++||++|| .||.+||++.++++||||++.....
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~ 281 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence 1368999999999999 8999999999999999999865543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=366.99 Aligned_cols=254 Identities=28% Similarity=0.499 Sum_probs=213.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..++..||+|++........ .+.+.+|+.+++.++||||+++++++......++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 469999999999999999999999999999999976543322 456779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEEeecCCCccccc
Q psy7825 144 EYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 144 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~ 216 (357)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 99999999999864 3679999999999999999999999999999999999999 4567899999999864322
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CC-CCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FP-TEPNV 294 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~-~~~~~ 294 (357)
........||+.|+|||++.+ .++.+ +||||||+++|+|++|+.||.+.+..+....+..... .+ ....+
T Consensus 180 ------~~~~~~~~~t~~y~aPE~~~~-~~~~~-~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 180 ------DEHSTNAAGTALYMAPEVFKR-DVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp -------------CTTGGGCCHHHHTT-CCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred ------cccCcCcccccCcCChHHhcc-CCCcc-cCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence 122345569999999999864 45555 9999999999999999999999888777766543322 21 22358
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
++++.+||++|| .||.+||++.|+|+||||+++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 999999999999 999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=402.74 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=221.5
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|.+.++||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|..++||||+++++++.....+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 56678999999999999999999999999999999996532222222345678999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~-- 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-- 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc--
Confidence 9999999999999998754 399999999999999999999999999999999999999999999999999974321
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhhcccCCCCCCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN----YIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 294 (357)
.......+||+.|+|||++.+..++.. +|||||||++|+|++|..||.+.. ...+...+... ....+..+
T Consensus 339 ----~~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~p~~~ 412 (576)
T 2acx_A 339 ----GQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYSERF 412 (576)
T ss_dssp ----TCCEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCCCCTTS
T ss_pred ----CccccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cccCCccC
Confidence 112334589999999999998888876 999999999999999999998753 34444444332 22334579
Q ss_pred CHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
+.++++||++|| .||.+|| ++++|++||||++.
T Consensus 413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 999999999999 8999999 89999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=368.61 Aligned_cols=263 Identities=35% Similarity=0.638 Sum_probs=220.1
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34556899999999999999999999999999999998653222222245677999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~--- 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC---
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
........|++.|+|||++.+..+...++||||||+++|+|++|..||...........+..... +.+..++..+.
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 239 (276)
T 2h6d_A 164 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-YIPEYLNRSVA 239 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHH
T ss_pred ---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-cCchhcCHHHH
Confidence 11223456899999999998877654459999999999999999999999888888777765432 33456899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
+||.+|| .||.+||++.++++||||++...
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 9999999 89999999999999999987643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=410.41 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=227.4
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 138 (357)
.+..++|.++++||+|+||.||+|++..+++.||||++.+.........+.+..|..++..+ +||+|+++++++.....
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34567899999999999999999999999999999999753221222244566899999988 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999873211
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~ 298 (357)
........+||+.|+|||++.+..++.+ +|||||||++|||++|..||.+.+..++...+.... ...+..++.++
T Consensus 495 ---~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 569 (674)
T 3pfq_A 495 ---DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEA 569 (674)
T ss_dssp ---TTCCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHH
T ss_pred ---CCcccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHH
Confidence 2223456789999999999999888877 999999999999999999999999999888876543 23334799999
Q ss_pred HHHHHHhc-CCCCCCCCH-----HHHhcCCCCCCC
Q psy7825 299 KTLLSKIF-SPIKFRIRL-----KDIKQDPWVKTE 327 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~-----~~ll~hp~~~~~ 327 (357)
++||++|| .||.+||++ ++|++||||++-
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 99999999 999999998 999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=369.81 Aligned_cols=259 Identities=27% Similarity=0.512 Sum_probs=196.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++......++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 46999999999999999999999999999999986532222222356789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~----- 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP----- 165 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC-----
Confidence 999999999999875 67999999999999999999999999999999999999999999999999998743221
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
........|++.|+|||++.+..++.+ +||||||+++|+|++|+.||...........+... ....+..++.++.+||
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKDLI 243 (278)
T ss_dssp --------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHHHH
T ss_pred CCcceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHHHH
Confidence 112234568999999999988888777 99999999999999999999876655554443221 2233456899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
.+|| .||.+||++.++|+||||.+...
T Consensus 244 ~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLDHPFMSRNSS 271 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred HHHcccCHhhCCCHHHHhcCccccCCCC
Confidence 9999 89999999999999999988543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=371.97 Aligned_cols=263 Identities=28% Similarity=0.495 Sum_probs=209.8
Q ss_pred ccCeEEc-eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEE
Q psy7825 63 NHGYVLG-KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 63 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 140 (357)
.+.|.+. +.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.++.++ +||||+++++++...+.++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3468885 7899999999999999999999999999754322 245577999999985 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc---EEEeecCCCcccccc
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN---IKLSDFGFARGHMKC 217 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~---~kl~Dfg~~~~~~~~ 217 (357)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999998888999999999999999999999999999999999999998776 999999998754321
Q ss_pred cCC--CCCCCCCcccCCccccccceecC-----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCC---------------H
Q psy7825 218 KSG--HQSPLSDTFCGSYAYASPEILKG-----VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN---------------Y 275 (357)
Q Consensus 218 ~~~--~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~---------------~ 275 (357)
... .........+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.. .
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 111 11122234569999999999975 445666 999999999999999999997653 2
Q ss_pred HHHHHHHhhcc-cCCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 276 IQLLKQVQTKV-VFPT--EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 276 ~~~~~~i~~~~-~~~~--~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
..+...+.... .++. ...++.++++||++|| .||.+||++.++|+||||++...
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 33444444332 2221 1468999999999999 99999999999999999998644
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-52 Score=394.25 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=210.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT------ 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 136 (357)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4679999999999999999999999999999999975432 233345677999999999999999999999654
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
..+|+||||+++ +|.+.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~- 215 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 215 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC-
Confidence 468999999976 57777754 48999999999999999999999999999999999999999999999999997432
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC-----
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE----- 291 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 291 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+.+..+......|.+
T Consensus 216 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 216 -----TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp ------CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred -----CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 1222345689999999999999888877 99999999999999999999999888877776543322210
Q ss_pred ---------------CC---------------------CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 292 ---------------PN---------------------VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 292 ---------------~~---------------------~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.. .++++++||++|| .||.+|||++|+|+||||+..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00 1567999999999 999999999999999999853
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=379.80 Aligned_cols=253 Identities=33% Similarity=0.532 Sum_probs=216.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch-----HHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD-----YLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
++|.+.+.||+|+||.||+|.+..+|+.||||++........ .....+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 469999999999999999999999999999999976543221 123456689999999999999999999999999
Q ss_pred EEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKG-SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~- 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER- 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC-
Confidence 99999998766 9999999988899999999999999999999999999999999999999999999999999864321
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
.......+||+.|+|||++.+..+...++|||||||++|+|++|..||..... .+. .....+..++++
T Consensus 183 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~--~~~~~~~~~~~~ 250 (335)
T 3dls_A 183 -----GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----TVE--AAIHPPYLVSKE 250 (335)
T ss_dssp -----TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----GTT--TCCCCSSCCCHH
T ss_pred -----CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----HHh--hccCCCcccCHH
Confidence 12234567999999999999888755559999999999999999999976321 111 122334468999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
+.+||.+|| .||.+||++.++++||||++...
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 283 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence 999999999 89999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=365.49 Aligned_cols=263 Identities=33% Similarity=0.521 Sum_probs=220.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++......++||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 46999999999999999999999999999999997544322 2456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---RE 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT---EE
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc---ch
Confidence 999999999999887789999999999999999999999999999999999999999999999999986442211 11
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHh-hcccCCCCCCCCHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQVQ-TKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~-~~~~~~~~~~~s~~~~~l 301 (357)
.......|++.|+|||++.+..+...++||||||+++|+|++|..||...... .....+. .....+....++..+.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 22345679999999999988776544599999999999999999999765432 2222222 222233345789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
|.+|| .||.+||++.++++||||++.....
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKPLKKG 272 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred HHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence 99999 8999999999999999999875543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=400.92 Aligned_cols=261 Identities=32% Similarity=0.527 Sum_probs=228.3
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
.-.++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.....++
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34457999999999999999999999999999999997665443334566889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEEeecCCCcccccc
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 217 (357)
+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 181 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc-
Confidence 999999999999999988899999999999999999999999999999999999999 5678999999999864321
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc---CCCCCCC
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---FPTEPNV 294 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~ 294 (357)
.......+||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+.+..++...+..... .+.+..+
T Consensus 182 -----~~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 182 -----SKKMKDKIGTAYYIAPEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp -----CCSHHHHTTGGGTCCHHHHHT-CCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred -----ccccccCCCCccccCceeecC-CCCCc-ceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 122344579999999999976 56655 9999999999999999999999999888888765432 2334578
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
++++++||++|| .+|.+||++.++|+||||+....
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 999999999999 89999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=396.20 Aligned_cols=261 Identities=21% Similarity=0.320 Sum_probs=222.3
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.++||+|+||.||+|++..+|+.||||++.+...........+.+|+.++..++||||+++++++.....+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35567899999999999999999999999999999999754322212234577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 140 YIIMEYAEKGSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999763 369999999999999999999999999999999999999999999999999997432
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhhcccCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT----NYIQLLKQVQTKVVFPTE 291 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~ 291 (357)
. ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+. ....+...+.... ...+
T Consensus 341 ~-----~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-~~~p 413 (543)
T 3c4z_A 341 A-----GQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-VTYP 413 (543)
T ss_dssp T-----TCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-CCCC
T ss_pred C-----CCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-cCCC
Confidence 1 1122345689999999999999888876 99999999999999999999765 3455555554332 2334
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
+.++.++++||++|| .||.+||+ +++|++||||++.
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 579999999999999 89999996 5899999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=375.42 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=217.7
Q ss_pred ccccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-----CCCccee
Q psy7825 55 KKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-----HPNLIRF 129 (357)
Q Consensus 55 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~ 129 (357)
..+...+..++|.+.+.||+|+||.||+|++..+++.||||++.. .......+..|+.+++.+. ||||+++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 334444556789999999999999999999999999999999863 2233455678999999986 9999999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--------
Q psy7825 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-------- 199 (357)
Q Consensus 130 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-------- 199 (357)
++++...+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999999 889999998754 5999999999999999999999999999999999999975
Q ss_pred -----------------CCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHH
Q psy7825 200 -----------------EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYA 262 (357)
Q Consensus 200 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 262 (357)
++.++|+|||++.... .......||+.|+|||++.+..++.+ +|||||||++|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~e 251 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS--------DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAE 251 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETT--------SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHH
T ss_pred chhcccccccccccccCCCCEEEEeccCceecC--------CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHH
Confidence 7899999999986421 12235679999999999999888877 999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHhhcccCCC---------------------------C------------------CCCCHH
Q psy7825 263 MAFGRLPFDDTNYIQLLKQVQTKVVFPT---------------------------E------------------PNVSAE 297 (357)
Q Consensus 263 ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------~------------------~~~s~~ 297 (357)
|++|+.||...+..+....+........ . ...++.
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 9999999998887777666543221110 0 123478
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
+.+||.+|| .||.+||++.++|+||||+
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 889999999 9999999999999999996
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=384.40 Aligned_cols=251 Identities=27% Similarity=0.499 Sum_probs=203.4
Q ss_pred cCeEEc-eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHH-HcCCCCCcceeeEEEEe----CC
Q psy7825 64 HGYVLG-KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHPNLIRFLQAIET----TH 137 (357)
Q Consensus 64 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~ 137 (357)
++|.+. ++||+|+||.||+|.+..+|+.||||++.. ...+.+|+.++ +..+||||++++++|.. ..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 457776 799999999999999999999999999863 12355788877 45589999999999876 66
Q ss_pred eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcEEEeecCCCc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG---EYNIKLSDFGFAR 212 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~---~~~~kl~Dfg~~~ 212 (357)
.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 7999999999999999998753 5999999999999999999999999999999999999997 7899999999987
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhh-ccc
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ----LLKQVQT-KVV 287 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~-~~~ 287 (357)
.... .......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+..... ....+.. ...
T Consensus 213 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 213 ETTS------HNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp ECC-----------------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred ccCC------CCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 4321 112345679999999999988888876 999999999999999999997654321 2223322 222
Q ss_pred C--CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 288 F--PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 288 ~--~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
+ +....++.++++||++|| .||.+||++.++|+||||.+...
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 2 334579999999999999 89999999999999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=393.99 Aligned_cols=260 Identities=30% Similarity=0.503 Sum_probs=222.7
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch----------HHhhhHHHHHHHHHcCCCCCcceeeEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD----------YLKKFLPREIDVVKGLRHPNLIRFLQA 132 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~ 132 (357)
.++|.+.+.||+|+||.||+|.+..+++.||||++........ ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4579999999999999999999999999999999976443211 224567899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---cEEEeecC
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY---NIKLSDFG 209 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~---~~kl~Dfg 209 (357)
+.....+++||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 999999999999999999999999888899999999999999999999999999999999999998776 69999999
Q ss_pred CCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC
Q psy7825 210 FARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP 289 (357)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 289 (357)
++..... .......+||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+.+..+++..+.......
T Consensus 195 ~a~~~~~------~~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 195 LSSFFSK------DYKLRDRLGTAYYIAPEVLKK-KYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp TCEECCT------TSCBCCCCSCTTTCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred CCEEcCC------CCccccccCCcCCCCHHHhcc-CCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9874321 122345679999999999874 56665 999999999999999999999999998888876654322
Q ss_pred ---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 290 ---TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 290 ---~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.++.+++++++||++|| .||.+||++.++|+||||+.....
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 23579999999999999 899999999999999999986544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=368.82 Aligned_cols=256 Identities=28% Similarity=0.518 Sum_probs=223.0
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+|+.+++.++||||+++++++.....+++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 346999999999999999999999999999999997543222 34577999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEEeecCCCcccccccC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|||+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~---- 160 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---- 160 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC----
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC----
Confidence 9999999999999888889999999999999999999999999999999999999 778999999999986321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc---CCCCCCCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---FPTEPNVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~ 296 (357)
........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.........+..... .+..+.++.
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 161 ---NGIMSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp ---CBTTHHHHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ---CCccccccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 112234568999999999998888766 9999999999999999999999888888877765432 233457899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
++.+||.+|| .||.+||++.++|+||||++...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 9999999999 89999999999999999987643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=374.00 Aligned_cols=260 Identities=22% Similarity=0.330 Sum_probs=224.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
..|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999997665555555667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||+.| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 99975 88888854 56799999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCcccCCccccccceec---CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CCCCCCCCHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPTEPNVSAEC 298 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~ 298 (357)
....+||+.|+|||++. +..++.+ +|||||||++|+|++|+.||.+.+.......+..... ......+++.+
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 282 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 23457999999999985 4556655 9999999999999999999998887776666544332 23345789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCccc
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASA 334 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~ 334 (357)
++||.+|| .||.+||+++++|+||||.....+....
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~~ 319 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 319 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHH
T ss_pred HHHHHHHcccChhhCcCHHHHhhChhhhccCCcchhh
Confidence 99999999 8999999999999999999876654443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=376.09 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=215.5
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCc--hHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP--DYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
..+|.+.+.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.+++.++||||+++++++......+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 356999999999999999999999999999999986533221 222345779999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 141 IIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--- 164 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--- 164 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS---
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC---
Confidence 99999986 899888765 4689999999999999999999999999999999999999999999999999875421
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC---------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT--------- 290 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------- 290 (357)
........+||+.|+|||++.+......++|||||||++|+|++|..||.+.+..+.+..+......+.
T Consensus 165 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 165 --PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp --CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred --CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 122234567899999999997755444449999999999999999999999888877776654322111
Q ss_pred ------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 291 ------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 291 ------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
...++.++++||++|| .||.+||++.|+|+||||++...+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 1356799999999999 89999999999999999998765543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=375.92 Aligned_cols=270 Identities=23% Similarity=0.311 Sum_probs=220.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------- 135 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 135 (357)
.++|.+.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 357999999999999999999999999999999986544332 223446689999999999999999999876
Q ss_pred -CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 136 -THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 136 -~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
.+.+++||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4578999999976 777777653 6799999999999999999999999999999999999999999999999999975
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC---
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT--- 290 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--- 290 (357)
....... .........||+.|+|||++.+......++|||||||++|+|++|..||.+.+.......+......+.
T Consensus 174 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp CCCCSSS-SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccc-cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 4322221 222234567899999999998755434449999999999999999999999888877776644222111
Q ss_pred CCC----------------------------CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcccc
Q psy7825 291 EPN----------------------------VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASAG 335 (357)
Q Consensus 291 ~~~----------------------------~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~ 335 (357)
.+. .++.+.+||.+|| .||.+||+++|+|+||||+....+.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~ 326 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSHH
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccccc
Confidence 111 2788999999999 89999999999999999998777655443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=364.30 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=221.1
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++..++||||+++++++...+.++
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34568999999999999999999999999999999997766666666778889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
+||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 164 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET--- 164 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc---
Confidence 99999999999999999889999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC----CCCCCCCH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF----PTEPNVSA 296 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~s~ 296 (357)
........+||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.+.+.............. ...+.+++
T Consensus 165 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 165 -SLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred -cccccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 1122334579999999999999888777 99999999999999999999988876665444332211 12457899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.+.++|.+|| .||.+||+..+.+.+.|..-..
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 9999999999 9999999777777666655433
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=373.92 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=217.4
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++......++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 45679999999999999999999999999999999865443 34445667799999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 177 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---- 177 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC----
Confidence 9999999999998887788999999999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc---------------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--------------- 286 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------- 286 (357)
........|++.|+|||++.+......++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 178 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 -GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred -ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 1223345689999999999876433444999999999999999999999888766655443211
Q ss_pred -----cCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 287 -----VFPT----------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 287 -----~~~~----------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
..+. .+.+++.+.+||.+|| .||.+||++.|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 1111 1368999999999999 899999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=373.72 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=221.6
Q ss_pred cccccCeEEc-eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCC
Q psy7825 60 VMENHGYVLG-KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTH 137 (357)
Q Consensus 60 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 137 (357)
..-.++|.+. +.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+.++..+. ||||+++++++....
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 3345568887 899999999999999999999999999976443332 2445778999999995 699999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcEEEeecCCCc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG---EYNIKLSDFGFAR 212 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~---~~~~kl~Dfg~~~ 212 (357)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 999999999999999998653 67999999999999999999999999999999999999988 7899999999987
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc---cCC
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV---VFP 289 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~ 289 (357)
.... ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+.... ..+
T Consensus 183 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 183 KIGH------ACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp EC---------------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred ccCC------ccccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 4421 112234579999999999998888876 999999999999999999999988887776664432 223
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 290 TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 290 ~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
....++..+++||.+|| .||.+||+++++|+||||++....
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 34578999999999999 899999999999999999986444
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=375.57 Aligned_cols=256 Identities=27% Similarity=0.515 Sum_probs=221.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC--c---hHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCC
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--P---DYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTH 137 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 137 (357)
++|.+.+.||+|+||.||+|.+..+|+.||||++...... . ....+.+.+|+.++..+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5699999999999999999999989999999998754321 1 22345677999999999 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
..++||||++|++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.+|.++|+|||++.....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~- 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP- 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT-
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC-
Confidence 9999999999999999999888899999999999999999999999999999999999999999999999999864421
Q ss_pred cCCCCCCCCCcccCCccccccceecCC------CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC--
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGV------PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP-- 289 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-- 289 (357)
.......+||+.|+|||++.+. .++.+ +|||||||++|+|++|..||.+.+.......+.......
T Consensus 253 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 253 -----GEKLRELCGTPGYLAPEILKCSMDETHPGYGKE-VDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp -----TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred -----CcccccCCCCCCccChhhccccccccCcCCCch-hhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 1123456799999999998632 45555 999999999999999999999988887777765543222
Q ss_pred -CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 290 -TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 290 -~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
.+..++..+.+||.+|| .||.+||++.++|+||||+.
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 22578999999999999 89999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=394.95 Aligned_cols=258 Identities=29% Similarity=0.535 Sum_probs=221.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+|+.||||++.+...... ....+.+|+.+++.++||||+++++++.....+++||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 469999999999999999999999999999999865322111 1345779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc---CCCcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID---GEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---- 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---- 176 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC----
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC----
Confidence 9999999999998888899999999999999999999999999999999999995 456799999999874421
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc---CCCCCCCCHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---FPTEPNVSAE 297 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~ 297 (357)
.......+||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+.+..+++..+..... .+.+..+|++
T Consensus 177 --~~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 177 --NTKMKDRIGTAYYIAPEVLRG-TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp --C----CCTTGGGGCCGGGGGS-CCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred --CCccCCCcCCCCCCCHHHhCC-CCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 122335579999999999976 46655 9999999999999999999999998888888765432 2334578999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
+++||++|| .||.+||++.++|+||||+.....
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence 999999999 899999999999999999876443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=377.04 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=211.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT------ 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 136 (357)
..+|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4579999999999999999999999999999999865433 334456677999999999999999999999765
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 3469999999 7799999976 5699999999999999999999999999999999999999999999999999974321
Q ss_pred ccCCCCCCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------ 289 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------ 289 (357)
.....+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 181 --------~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 181 --------EMTGYVVTRWYRAPEVILNWMRYTQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp --------SCCSSCSCGGGCCTHHHHTTTCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred --------ccCcCcCCCCcCCHHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 1234578999999999987 456655 999999999999999999999988877766654321111
Q ss_pred ------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 290 ------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 290 ------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
..+..++.+.+||.+|| .||.+|||+.++|+||||+....+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence 12467999999999999 8999999999999999999865443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=383.31 Aligned_cols=266 Identities=24% Similarity=0.366 Sum_probs=208.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC-----C
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT-----H 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 137 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4679999999999999999999999999999999965433 333345677999999999999999999999766 5
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.+|+||||+.+ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 79999999965 99999998888999999999999999999999999999999999999999999999999999754322
Q ss_pred cCCC-----------------CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCC-----------C
Q psy7825 218 KSGH-----------------QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRL-----------P 269 (357)
Q Consensus 218 ~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~-----------p 269 (357)
.... ........+||+.|+|||++........++|||||||++|||++|.. +
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 1110 00123567899999999997544433444999999999999998544 4
Q ss_pred CCCCC-----------------HHHHHHHHhhcccCCC------------------------------CCCCCHHHHHHH
Q psy7825 270 FDDTN-----------------YIQLLKQVQTKVVFPT------------------------------EPNVSAECKTLL 302 (357)
Q Consensus 270 f~~~~-----------------~~~~~~~i~~~~~~~~------------------------------~~~~s~~~~~li 302 (357)
|.+.+ ..+.+..+......|. .+.+++++.+||
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 342 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 43332 1222222211111110 146899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
++|| .||.+||+++|+|+||||++....
T Consensus 343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 343 ESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 9999 999999999999999999986544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=381.31 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=214.4
Q ss_pred CeEE--ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 65 GYVL--GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 65 ~y~~--~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.|.+ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.++..++||||+++++++.....+++|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3544 6789999999999999999999999999875322 2356688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE--cCCCcEEEeecCCCcccccccC
Q psy7825 143 MEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI--DGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-- 242 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-- 242 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--
Confidence 9999999999988654 469999999999999999999999999999999999999 56788999999998744211
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-cCC--CCCCCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-VFP--TEPNVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~--~~~~~s~ 296 (357)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+.+..+.... .++ ..+.+++
T Consensus 243 ----~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 243 ----EKLKVNFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp ----CBCCCCCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred ----cccccccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 11234569999999999988777766 999999999999999999999998888877765432 222 2357899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
++++||.+|| .||.+||++.++|+||||++...
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 9999999999 99999999999999999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=367.69 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=228.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.+.|.+.+.||+|+||.||+|.+..+++.||||++....... ..+.+.+|+.++..++||||+++++++.....+++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 456999999999999999999999999999999997654332 245678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|||+++++|.+++.. +.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~----- 172 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT----- 172 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT-----
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc-----
Confidence 999999999999865 56999999999999999999999999999999999999999999999999998644221
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
........|++.|+|||++.+..++.+ +||||||+++|+|++|..||...........+...........++..+.+||
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 251 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 251 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHH
T ss_pred ccccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHH
Confidence 112345579999999999998888876 9999999999999999999999888877777666555555668999999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 303 SKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
.+|| .||.+||++.++++||||.......
T Consensus 252 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 281 (303)
T 3a7i_A 252 EACLNKEPSFRPTAKELLKHKFILRNAKKT 281 (303)
T ss_dssp HHHCCSSGGGSCCHHHHTTCHHHHHHCCCG
T ss_pred HHHcCCChhhCcCHHHHhhChhhhcCCCcc
Confidence 9999 8999999999999999998765543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=374.34 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=220.1
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC----
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH---- 137 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 137 (357)
..++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3567999999999999999999999999999999998765556556677889999999999999999999987644
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 35999999999999999998889999999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC---CCCC
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT---EPNV 294 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~ 294 (357)
.. ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+......+. ...+
T Consensus 170 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 170 GN--SVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cc--ccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 11 1122334579999999999998888776 9999999999999999999999888777665544333222 3468
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+.++.+||.+|| .||.+||++.+++.|+|++..
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 999999999999 999999999999999999854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=392.21 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=217.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|++..++..||||++.+....... ...+.+|+.+++.++||||+++++++.....+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999999999999999999765432221 455779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE---YNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--- 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--- 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT---
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC---
Confidence 999999999999988889999999999999999999999999999999999999764 45999999998744221
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC---CCCCCCCHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF---PTEPNVSAE 297 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~ 297 (357)
......+||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+.+..++...+...... +.+..+++.
T Consensus 193 ---~~~~~~~gt~~y~aPE~l~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 193 ---KKMKERLGTAYYIAPEVLRK-KYDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp ---BCBCCCCSCTTTCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred ---ccccccCCCcCeeCHHHHcc-cCCCc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 12345679999999999864 56665 99999999999999999999999998888887654332 233579999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+++||++|| .||.+|||+.++|+||||+..
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999 899999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=377.64 Aligned_cols=267 Identities=29% Similarity=0.462 Sum_probs=217.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCC--CchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA--PPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+.+++.++||||+++++++......+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 4569999999999999999999999999999999865321 11222456789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q psy7825 141 IIMEYAEKGSLLDFIQR----------------------------------------EGYIDEPRTKKWFRQLVDAIDYC 180 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~----------------------------------------~~~l~~~~~~~i~~~i~~~l~~L 180 (357)
+||||++||+|.+++.. ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999852 11236778899999999999999
Q ss_pred HhCCceecCCCCCCEEEcCCC--cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecC--CCCCCCcccHHHH
Q psy7825 181 HERGVVHRDIKCENLLIDGEY--NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG--VPYTPHYSDVWSM 256 (357)
Q Consensus 181 H~~~ivH~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Diwsl 256 (357)
|+.||+||||||+|||++.++ .++|+|||++......... .........||+.|+|||++.+ ..++.+ +|||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~Diwsl 262 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG-EYYGMTTKAGTPYFVAPEVLNTTNESYGPK-CDAWSA 262 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------CCCGGGCCHHHHTCSSSCCCTH-HHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc-ccccccccCCCccccCchhhccCCCCCCcH-HHHHHH
Confidence 999999999999999998776 8999999999754332221 1122345679999999999975 455555 999999
Q ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC---CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 257 GVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT---EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 257 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
||++|+|++|+.||.+.+..+....+........ ...+++++++||.+|| .+|.+||++.++|+||||++.....
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHhh
Confidence 9999999999999999888887777655433222 2348999999999999 9999999999999999999865543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=369.39 Aligned_cols=251 Identities=24% Similarity=0.284 Sum_probs=204.0
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHH-HcCCCCCcceeeEEEEeCCeEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.............+ .|+..+ ....||||+++++++.....+++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHH-HHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHH-HHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3579999999999999999999999999999999866544444333444 445444 44589999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||||+ +++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---- 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---- 209 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc----
Confidence 99999 56999988764 4699999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CCCCCCCCHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPTEPNVSAECK 299 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~ 299 (357)
........||+.|+|||++.+ .++.+ +|||||||++|+|++|..||....... .+..... ......+++++.
T Consensus 210 --~~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~ 282 (311)
T 3p1a_A 210 --AGAGEVQEGDPRYMAPELLQG-SYGTA-ADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELR 282 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTH-HHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTCCCHHHHTTSCHHHH
T ss_pred --CCCCcccCCCccccCHhHhcC-CCCch-hhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccCCCcccccCCCHHHH
Confidence 122334569999999999876 56665 999999999999999977765543322 2222211 112346899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
+||.+|| .||.+||++.++|+||||++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999 89999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=374.19 Aligned_cols=258 Identities=20% Similarity=0.367 Sum_probs=206.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC------
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH------ 137 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 137 (357)
++|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.+++.++||||++++++|....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 359999999999999999999999999999999975442 223566889999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEeccCCCChHHHHHhcCC---CCH
Q psy7825 138 ---------------------------------------------------RVYIIMEYAEKGSLLDFIQREGY---IDE 163 (357)
Q Consensus 138 ---------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---l~~ 163 (357)
.+++||||++|++|.+++..... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999987543 455
Q ss_pred HHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC-------CCCCCcccCCcccc
Q psy7825 164 PRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ-------SPLSDTFCGSYAYA 236 (357)
Q Consensus 164 ~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~gt~~y~ 236 (357)
..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........... .......+||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 67899999999999999999999999999999999999999999999975433211110 12234567999999
Q ss_pred ccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCH
Q psy7825 237 SPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRL 315 (357)
Q Consensus 237 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~ 315 (357)
|||++.+..++.+ +|||||||++|+|++|..|+.. .......+............++++.+||.+|| .||.+||++
T Consensus 244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 9999998888776 9999999999999998776532 12222222222211112346788999999999 899999999
Q ss_pred HHHhcCCCCCC
Q psy7825 316 KDIKQDPWVKT 326 (357)
Q Consensus 316 ~~ll~hp~~~~ 326 (357)
.++|+||||++
T Consensus 321 ~~~l~~~~f~~ 331 (332)
T 3qd2_B 321 TDIIENAIFEN 331 (332)
T ss_dssp HHHHHSTTCCC
T ss_pred HHHhhchhhhc
Confidence 99999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=361.40 Aligned_cols=256 Identities=23% Similarity=0.449 Sum_probs=216.2
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe----CC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET----TH 137 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 137 (357)
....|.+.+.||+|+||.||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 4455999999999999999999999999999999997654443 335667899999999999999999999875 45
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEc-CCCcEEEeecCCCccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLID-GEYNIKLSDFGFARGH 214 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~-~~~~~kl~Dfg~~~~~ 214 (357)
.+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.| |+|+||||+|||++ .++.++|+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 68999999999999999998888999999999999999999999999 99999999999998 7899999999998532
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhhcccC-CCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQVQTKVVF-PTEP 292 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~-~~~~ 292 (357)
. ........||+.|+|||++.+ .++.+ +|||||||++|+|++|+.||... +.......+...... ..+.
T Consensus 183 ~-------~~~~~~~~~t~~y~aPE~~~~-~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (290)
T 1t4h_A 183 R-------ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253 (290)
T ss_dssp C-------TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred c-------ccccccccCCcCcCCHHHHhc-cCCCc-chHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCC
Confidence 1 122334579999999998875 46655 99999999999999999999874 445555555444322 2234
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
..++++.+||.+|| .||.+||++.++|+||||++.
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 67899999999999 899999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=360.31 Aligned_cols=252 Identities=20% Similarity=0.248 Sum_probs=209.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 142 (357)
++|.+.+.||+|+||.||+|.+..+++.||||++......... ...+.+|+..+..+ +||||+++++++...+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4699999999999999999999999999999999765444433 44566899999998 899999999999999999999
Q ss_pred EeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC------------------
Q psy7825 143 MEYAEKGSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE------------------ 200 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~------------------ 200 (357)
|||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999764 679999999999999999999999999999999999999844
Q ss_pred -CcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q psy7825 201 -YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL 279 (357)
Q Consensus 201 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 279 (357)
..++|+|||.+..... .....||+.|+|||++.+......++|||||||++|+|++|..|+..... .
T Consensus 170 ~~~~kl~Dfg~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~ 237 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS---------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237 (289)
T ss_dssp CCCEEECCCTTCEETTC---------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred ceEEEEcccccccccCC---------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence 4799999999864321 12345899999999998764443349999999999999999988765543 2
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 280 KQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 280 ~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
..+........+..+++++.+||.+|| .||.+||++.++++||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 333334334445679999999999999 8999999999999999999854
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=373.73 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=212.6
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC--CCcceeeEEEEeCC
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH--PNLIRFLQAIETTH 137 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~ 137 (357)
.+..++|.+.+.||+|+||.||+|.+. +++.||||++...... ....+.+.+|+.++..++| |||+++++++....
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 345677999999999999999999874 5899999999765443 3345667899999999986 99999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.+++|||+ .+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++......
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99999995 5779999999988999999999999999999999999999999999999997 578999999999754221
Q ss_pred cCCCCCCCCCcccCCccccccceecC-----------CCCCCCcccHHHHHHHHHHHHcCCCCCCCC-CHHHHHHH-Hhh
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKG-----------VPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQ-VQT 284 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~-i~~ 284 (357)
.........+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+. +....... +..
T Consensus 161 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 161 ---TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK-SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHH-HHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ---cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCch-hhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 11122345679999999999864 445555 99999999999999999999864 33333333 333
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 285 KVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 285 ~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
......+...+.++.+||.+|| .||.+||++.++|+||||+....+
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 3444445568899999999999 999999999999999999875544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=366.13 Aligned_cols=268 Identities=28% Similarity=0.477 Sum_probs=215.8
Q ss_pred cccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.....+..++|.+.+.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 334455677899999999999999999986 4889999998765443 3334567799999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREGY---IDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
...+++||||+++++|.+++...+. +++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999999987553 899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-hcccCC
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ-TKVVFP 289 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~ 289 (357)
++.... .........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+. .....+
T Consensus 186 a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 186 SRLKAS-----TFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259 (309)
T ss_dssp ---------------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred Cccccc-----cccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 863221 1122345679999999999999888877 999999999999999999999998888777664 333445
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc--CCCCCCCCCCCc
Q psy7825 290 TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ--DPWVKTEANPAA 332 (357)
Q Consensus 290 ~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~--hp~~~~~~~~~~ 332 (357)
.+..+++++.+||++|| .+|.+||++.+|++ .+|++....+..
T Consensus 260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 55689999999999999 89999999999998 777776554443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=378.28 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=213.4
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC--CCCcceeeEEEEeCCe
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR--HPNLIRFLQAIETTHR 138 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~ 138 (357)
+...+|.+.+.||+|+||.||+|.+.. ++.||||++...... ....+.+.+|+.++..+. ||||+++++++.....
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 445669999999999999999999765 899999999765443 334566889999999996 5999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+||| +.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++......
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999999 55789999999988899999999999999999999999999999999999995 5899999999997542211
Q ss_pred CCCCCCCCCcccCCccccccceecC-----------CCCCCCcccHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHh-hc
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKG-----------VPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQVQ-TK 285 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~-~~ 285 (357)
........+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||... +....+..+. ..
T Consensus 209 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 209 ---TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK-SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHH-HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred ---ccccCCCCCcCCCccChHHhhhccccccccccccCCCCh-hhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence 1122345679999999999865 245544 99999999999999999999865 3333343333 33
Q ss_pred ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 286 VVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 286 ~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
...+.+...+.++.+||.+|| .||.+||++.++|+||||+....+
T Consensus 285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 344445567899999999999 899999999999999999876544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=361.51 Aligned_cols=257 Identities=25% Similarity=0.465 Sum_probs=221.0
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch---HHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD---YLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
++|.+.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 469999999999999999999999999999999976443221 12456789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----cEEEeecCCCccccc
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY----NIKLSDFGFARGHMK 216 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~----~~kl~Dfg~~~~~~~ 216 (357)
+||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999999888899999999999999999999999999999999999998877 799999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC---CCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP---TEPN 293 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~ 293 (357)
. .......|++.|+|||++.+..++.+ +||||||+++|+|++|..||.+.+..+....+....... ..+.
T Consensus 165 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 165 G------NEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp -------------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred C------CcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 1 11234568999999999988888776 999999999999999999999988887777665432211 1246
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
++..+.+||.+|| .||.+||++.++|+||||+..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 8999999999999 899999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=378.81 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=213.3
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC------CCCCcceeeEEEEe
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL------RHPNLIRFLQAIET 135 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~ 135 (357)
...+|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.++..+ .|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 456799999999999999999999999999999998642 23345566788888776 57799999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc--EEEeecCCC
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN--IKLSDFGFA 211 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~--~kl~Dfg~~ 211 (357)
...+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999996 59999998753 4899999999999999999999999999999999999999987 999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC-
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT- 290 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~- 290 (357)
.... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+.+..+......+.
T Consensus 250 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 250 CYEH--------QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp EETT--------CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eecC--------CcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 6321 12335679999999999999888777 9999999999999999999999888777666543221111
Q ss_pred ---------------------------------------------------------CCCCCHHHHHHHHHhc-CCCCCC
Q psy7825 291 ---------------------------------------------------------EPNVSAECKTLLSKIF-SPIKFR 312 (357)
Q Consensus 291 ---------------------------------------------------------~~~~s~~~~~li~~~L-~~p~~R 312 (357)
....++++.+||++|| .||.+|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 1134789999999999 999999
Q ss_pred CCHHHHhcCCCCCCCCCC
Q psy7825 313 IRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 313 ps~~~ll~hp~~~~~~~~ 330 (357)
||+.|+|+||||++....
T Consensus 401 pta~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 401 MTPGQALRHPWLRRRLPK 418 (429)
T ss_dssp CCHHHHHTSTTTC-----
T ss_pred CCHHHHhCChhhccCCCC
Confidence 999999999999986443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=376.19 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=222.3
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
+...+..++|.+.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 344566778999999999999999999999999999999987542 334456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++....
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999999999999888899999999999999999999996 99999999999999999999999999986432
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV------------- 282 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------------- 282 (357)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+..+....+
T Consensus 184 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 184 DS-------MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp HH-------C----CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred cc-------cccCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 11 1234569999999999998888776 99999999999999999999877655433221
Q ss_pred -----------------------------hhccc-CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 283 -----------------------------QTKVV-FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 283 -----------------------------~~~~~-~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
..... ......++.++.+||++|| .||.+|||++++|+||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 11111 1112357999999999999 9999999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=375.85 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=209.0
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe------
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------ 135 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 135 (357)
..++|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+|+.+++.++||||++++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 456799999999999999999999999999999998653222 2379999999999999999999843
Q ss_pred --------------------------------CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q psy7825 136 --------------------------------THRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDY 179 (357)
Q Consensus 136 --------------------------------~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~ 179 (357)
...+++||||+++ +|.+.+.. ...+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3458999999985 77776653 5679999999999999999999
Q ss_pred HHhCCceecCCCCCCEEEc-CCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHH
Q psy7825 180 CHERGVVHRDIKCENLLID-GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGV 258 (357)
Q Consensus 180 LH~~~ivH~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 258 (357)
||+.||+||||||+|||++ .++.+||+|||+++.... ........||+.|+|||++.+......++|||||||
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP------SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT------TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC------CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 9999999999999999998 688999999999974421 122334568999999999987663334499999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHHhhcccCC----------------------------CCCCCCHHHHHHHHHhc-CCC
Q psy7825 259 VLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP----------------------------TEPNVSAECKTLLSKIF-SPI 309 (357)
Q Consensus 259 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------------------------~~~~~s~~~~~li~~~L-~~p 309 (357)
++|+|++|+.||.+.+..+.+..+......| .+..++.++.+||.+|| .||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999988877776654322111 12458999999999999 899
Q ss_pred CCCCCHHHHhcCCCCCCC
Q psy7825 310 KFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 310 ~~Rps~~~ll~hp~~~~~ 327 (357)
.+|||+.|+|+||||++.
T Consensus 311 ~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GGSCCHHHHHTSGGGHHH
T ss_pred hhCCCHHHHhcCHHHHHH
Confidence 999999999999999763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=361.14 Aligned_cols=260 Identities=27% Similarity=0.485 Sum_probs=222.7
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC------chHHhhhHHHHHHHHHcCC-CCCcceeeEEEEe
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP------PDYLKKFLPREIDVVKGLR-HPNLIRFLQAIET 135 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 135 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.++..+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 45799999999999999999999999999999999754321 1223456779999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
....++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCCCCCCCcccCCccccccceec------CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-C
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILK------GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-F 288 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~ 288 (357)
. ........|++.|+|||++. ...++.+ +||||||+++|+|++|..||...+.......+..... +
T Consensus 176 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 176 P------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE-VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp T------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred C------CcccccccCCccccCHHHhccccccccccCCcc-cccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 1 11233457899999999985 3345555 9999999999999999999999888777776654332 2
Q ss_pred --CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 289 --PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 289 --~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
+..+.++..+.+||.+|| .||.+||++.++|+||||++...
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 222468999999999999 89999999999999999997543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=371.41 Aligned_cols=262 Identities=25% Similarity=0.410 Sum_probs=217.5
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC-----C
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT-----H 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 137 (357)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++..++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 467999999999999999999999999999999986432 333456678999999999999999999998654 4
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
..++||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 78999999975 999999764 5999999999999999999999999999999999999999999999999999754322
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC-------
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT------- 290 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------- 290 (357)
.. ........+||+.|+|||++.+......++|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 182 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 182 HD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GC--BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CC--ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 11 112234567999999999976655333449999999999999999999998876666655532211111
Q ss_pred -----------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 291 -----------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 291 -----------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+.++.++.+||.+|| .||.+||++.++|+||||++...+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 1467999999999999 999999999999999999986444
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=382.58 Aligned_cols=257 Identities=30% Similarity=0.521 Sum_probs=204.7
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP-----PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
.++|.+.+.||+|+||.||+|.+..+++.||||++.+.... .......+.+|+.+|+.++||||+++++++. ..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 46799999999999999999999999999999999754321 1222345789999999999999999999985 45
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---cEEEeecCCCccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY---NIKLSDFGFARGH 214 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~---~~kl~Dfg~~~~~ 214 (357)
..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6899999999999999998888899999999999999999999999999999999999997544 5999999999754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecC---CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhhcccCC-
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKG---VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQVQTKVVFP- 289 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~- 289 (357)
.. .......+||+.|+|||++.+ ..++.+ +|||||||++|+|++|..||...... .....+.......
T Consensus 293 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 293 GE------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp C-----------------CTTCCTTTTC----CTTHHH-HHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred CC------CccccccCCCCCccCceeeecCCCCCCCch-hhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 21 222345679999999999864 344444 99999999999999999999765432 2333333322111
Q ss_pred --CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 290 --TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 290 --~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
....+++.+.+||.+|| .||.+||+++++|+||||++.
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 12468999999999999 899999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=373.14 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=221.2
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEEC-------CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceee
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATST-------RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFL 130 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 130 (357)
..+..++|.+.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 3456678999999999999999999864 345679999986532 333456688999999999 899999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7825 131 QAIETTHRVYIIMEYAEKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194 (357)
Q Consensus 131 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~N 194 (357)
+++...+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999998753 47899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCC
Q psy7825 195 LLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDT 273 (357)
Q Consensus 195 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~ 273 (357)
||++.++.+||+|||+++...... .........||+.|+|||++.+..++.+ +|||||||++|||++ |..||.+.
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCC---TTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEECCCCCEEEccccCCcccCccc---ceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999997442211 1122334557889999999998888876 999999999999999 99999998
Q ss_pred CHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 274 NYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 274 ~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
...++...+......+.+..++.++.+||.+|| .+|.+||++.+++++
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 888888888777666667789999999999999 899999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=378.44 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=207.3
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC-----
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT----- 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 136 (357)
...+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||++++++|...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 3456999999999999999999999999999999986532 1233799999999999999999988542
Q ss_pred -CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEEeecCC
Q psy7825 137 -HRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGF 210 (357)
Q Consensus 137 -~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-~~~kl~Dfg~ 210 (357)
..+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 246799999976 67766643 4679999999999999999999999999999999999999965 5689999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc---
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--- 286 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--- 286 (357)
++..... ......+||+.|+|||++.+. .++.+ +|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 204 a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 204 AKQLVRG------EPNVSYICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp CEECCTT------CCCCSCCSCTTSCCHHHHTTCSSCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred hhhcccC------CCceeeeeCCCcCCHHHHcCCCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9754211 122345789999999999776 45554 999999999999999999999988766665543321
Q ss_pred ---------------cCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 287 ---------------VFP----------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 287 ---------------~~~----------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
.++ ..+.++.++.+||.+|| .||.+||++.++|+||||++...
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 111 12357899999999999 99999999999999999986533
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=363.78 Aligned_cols=261 Identities=22% Similarity=0.393 Sum_probs=215.7
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEe--
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIET-- 135 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-- 135 (357)
.....++|.+.+.||+|+||.||+|.+..+|+.||||++...... ...+.+|+.++..+ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334567899999999999999999999999999999998754332 34567899999998 79999999999977
Q ss_pred ----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecC
Q psy7825 136 ----THRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFG 209 (357)
Q Consensus 136 ----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg 209 (357)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 56899999999999999999864 569999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCcccCCccccccceec-----CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh
Q psy7825 210 FARGHMKCKSGHQSPLSDTFCGSYAYASPEILK-----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT 284 (357)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 284 (357)
++...... ........|++.|+|||++. +..++.+ +|||||||++|+|++|..||.+.+.......+..
T Consensus 175 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 175 VSAQLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp TTC------------------CCGGGCCHHHHC--------CCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CceecCcC-----ccccccccCCccccChhhhccccccCcCCCcc-chHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 98643211 11233457999999999987 4556666 9999999999999999999998887776665544
Q ss_pred ccc-CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 285 KVV-FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 285 ~~~-~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
... ......++..+.+||.+|| .||.+||++.++++||||++...
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 322 2234578999999999999 89999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=368.11 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=221.6
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCc---EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGC---DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
..+...+|.+.+.||+|+||.||+|.+..+|. .||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34567789999999999999999999876554 59999986432 33345668899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
....++||||++|++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999754 57999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
..... .........+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+....+....+......+.+..
T Consensus 202 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T 3kul_A 202 EDDPD--AAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG 278 (325)
T ss_dssp C------CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred ccCcc--ceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCC
Confidence 32211 1111223446788999999988888776 999999999999998 9999999999999999888888888888
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++..+.+||.+|| .||.+||++.+|++
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999 89999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=368.41 Aligned_cols=267 Identities=21% Similarity=0.408 Sum_probs=195.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.++..++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 45667899999999999999999999888999999988643322 2245577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 140 YIIMEYAEKGSLLDFIQR--------EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
++||||++|++|.+++.. .+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999999974 456999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC--
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF-- 288 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-- 288 (357)
...................||+.|+|||++.+ ..++.+ +||||||+++|+|++|..||..................
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTH-HHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCch-hhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 64432211112222345679999999999976 345555 99999999999999999999887655544333222111
Q ss_pred -------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 289 -------PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 289 -------~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
.....++.++.+||.+|| .||.+||++.++++||||++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 112468899999999999 89999999999999999987543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=360.24 Aligned_cols=260 Identities=28% Similarity=0.495 Sum_probs=223.7
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--CCeEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--THRVY 140 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 140 (357)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 35699999999999999999999999999999999765443 3345678899999999999999999998754 67899
Q ss_pred EEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 141 IIMEYAEKGSLLDFIQRE----GYIDEPRTKKWFRQLVDAIDYCHERG-----VVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~-----ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.| |+|+||||+|||++.++.++|+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999753 34999999999999999999999999 999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE 291 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 291 (357)
...... ........|++.|+|||++.+..++.+ +||||||+++|+|++|..||...+..+....+......+.+
T Consensus 164 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 164 RILNHD-----TSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237 (279)
T ss_dssp HHC--------CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC
T ss_pred eeeccc-----cccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC
Confidence 643211 111123468999999999988887766 99999999999999999999999888888887766555556
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
..++.++.+||.+|| .||.+||++.+||+|+|+.+...
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 679999999999999 89999999999999999998644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=373.16 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=201.2
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT------ 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 136 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4679999999999999999999999999999999865432 333345677999999999999999999998654
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
..+++|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 6799999876 5699999999999999999999999999999999999999999999999999874321
Q ss_pred ccCCCCCCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC-----
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT----- 290 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----- 290 (357)
.....+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+..+.+..+......|.
T Consensus 185 --------~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 185 --------EMTGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred --------cCCCcCcCcCccChHHHcCCcCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 1234579999999999987 455555 9999999999999999999999888777766543221110
Q ss_pred -------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 291 -------------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 291 -------------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
.+..++.+.+||++|| .||.+||++.++|+||||++...+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 1357899999999999 9999999999999999999865443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=360.67 Aligned_cols=261 Identities=23% Similarity=0.403 Sum_probs=219.6
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|.+.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.++..++||||+++++++.....+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 45679999999999999999999999999999999975432 3446789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||||+++++|.+++. ....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--- 178 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT---
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh---
Confidence 999999999999997 4567999999999999999999999999999999999999999999999999998644221
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCCHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAEC 298 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~ 298 (357)
........|++.|+|||++.+..++.+ +||||||+++|+|++|..||...+.......+..... +..+..++..+
T Consensus 179 --~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (314)
T 3com_A 179 --MAKRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF 255 (314)
T ss_dssp --BSCBCCCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred --ccccCccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHH
Confidence 112334568999999999998888877 9999999999999999999998877666555543322 22344689999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAAS 333 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 333 (357)
.+||.+|| .||.+||++.++|+||||+........
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGG
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHH
Confidence 99999999 899999999999999999987655443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=374.42 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=208.0
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH----- 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 137 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4679999999999999999999999999999999975433 3334556779999999999999999999997654
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 138 -RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 138 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
.+++||||+++ +|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 78999999976 7888886 3489999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC-----
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE----- 291 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 291 (357)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+......+.+
T Consensus 180 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 180 ------SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ------ccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 112334679999999999999888877 99999999999999999999998887777666543222110
Q ss_pred ---------------C---------------------CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 292 ---------------P---------------------NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 292 ---------------~---------------------~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
. ..+.++++||++|| .||.+|||++++|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 0 01578999999999 9999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=360.16 Aligned_cols=259 Identities=25% Similarity=0.343 Sum_probs=204.2
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.++...++.++||||+++++++...+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 3556789999999999999999999999999999999865432 333344555666678889999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 140 YIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
++||||++| +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 88887754 46799999999999999999999998 9999999999999999999999999998643
Q ss_pred ccccCCCCCCCCCcccCCcccccccee----cCCCCCCCcccHHHHHHHHHHHHcCCCCCCC-CCHHHHHHH-HhhcccC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEIL----KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQ-VQTKVVF 288 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~-i~~~~~~ 288 (357)
.. ........||+.|+|||++ .+..++.+ +|||||||++|+|++|+.||.. ......... +......
T Consensus 161 ~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 161 VD------DVAKDIDAGCKPYMAPERINPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHH-HHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC
T ss_pred cc------cccccccCCCccccChhhcChhhcCcCCCcH-HHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC
Confidence 22 1122334699999999997 44455555 9999999999999999999985 333333333 3333333
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 289 PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 289 ~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.....++.++.+||.+|| .||.+||++.++++||||+..
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 334578999999999999 899999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=361.24 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=208.5
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEe--C
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIET--T 136 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~ 136 (357)
....++|++.+.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++.+. ||||+++++++.. .
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 345678999999999999999999999999999999986322 345779999999997 9999999999987 6
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-NIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-~~kl~Dfg~~~~~~ 215 (357)
...++||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++....
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred CceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 789999999999999998854 89999999999999999999999999999999999999776 89999999986432
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhhc---------
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTK--------- 285 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~--------- 285 (357)
. ........|++.|+|||++.+......++|||||||++|+|++|+.||.. .+..+.+..+...
T Consensus 183 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 183 P------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp T------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred C------CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 1 11234457899999999998744334449999999999999999999953 3333322222110
Q ss_pred ---c------------------------cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 286 ---V------------------------VFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 286 ---~------------------------~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
. .......+++++.+||++|| .||.+|||++++|+||||++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0 00111237999999999999 8999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=361.59 Aligned_cols=261 Identities=23% Similarity=0.426 Sum_probs=216.9
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
....++|++.+.||+|+||.||+|.+..+|+.||+|++....... .+.+.+|+.++..++||||+++++++......
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 345677999999999999999999999999999999986543222 45577899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999999876 4669999999999999999999999999999999999999999999999999874221111
Q ss_pred CCCCCCCCCcccCCccccccceec-----CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILK-----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTE 291 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~ 291 (357)
.......|++.|+|||++. +..++.+ +||||||+++|+|++|..||...+.......+..... ...+
T Consensus 172 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T 2j7t_A 172 -----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245 (302)
T ss_dssp -----HC-----CCGGGCCHHHHHHHHTTSTTTTTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred -----cccccccCChhhcCCeeeccccCCCCCCchh-hhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCc
Confidence 1122346899999999983 4555555 9999999999999999999999888777666554332 2234
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
..++..+.+||.+|| .||.+||++.++++||||++...
T Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 568999999999999 89999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=368.98 Aligned_cols=255 Identities=26% Similarity=0.468 Sum_probs=213.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE---
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV--- 139 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--- 139 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4579999999999999999999999999999999865433 344456677999999999999999999999876654
Q ss_pred ---EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 140 ---YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 140 ---~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
++||||+.+ +|.+++.. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 120 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQT-DLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCCE-EHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEccccc-cHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 999999974 88888743 499999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------ 289 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------ 289 (357)
.....+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 197 --------~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 197 --------EMTGYVVTRWYRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred --------CcCCcccCccccCHHHhcCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 1234568999999999987 455655 999999999999999999999988877776654322111
Q ss_pred ------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 290 ------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 290 ------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
..+.+++++++||++|| .||.+||++.|+|+||||++...+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 01357999999999999 999999999999999999976444
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=386.05 Aligned_cols=249 Identities=16% Similarity=0.214 Sum_probs=202.7
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHH---HHHHcCCCCCcceee-------EE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREI---DVVKGLRHPNLIRFL-------QA 132 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~iv~~~-------~~ 132 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999999889999999999865444444567788999 455556799999988 66
Q ss_pred EEeCC-----------------eEEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCceec
Q psy7825 133 IETTH-----------------RVYIIMEYAEKGSLLDFIQREGYIDE-------PRTKKWFRQLVDAIDYCHERGVVHR 188 (357)
Q Consensus 133 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~l~~-------~~~~~i~~~i~~~l~~LH~~~ivH~ 188 (357)
+...+ ..|+||||+ +|+|.+++...+.+++ ..++.++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66553 288999999 5799999987655666 7788899999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCC-----------CCCCCcccHHHHH
Q psy7825 189 DIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV-----------PYTPHYSDVWSMG 257 (357)
Q Consensus 189 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG 257 (357)
||||+|||++.++.+||+|||+++... ......+| +.|+|||++.+. .++.+ +||||||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~--------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DvwSlG 300 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG--------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS-FDAWALG 300 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT--------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH-HHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC--------CcccCCCC-cCccChhhhcccccccccccccccCChh-hhHHHHH
Confidence 999999999999999999999987321 12234567 999999999877 67666 9999999
Q ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 258 VVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 258 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
|++|+|++|+.||.+.+.......+. ...+.+++++.+||.+|| .||.+||++.++++||||++.
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHCCCCCcccccccchhhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 99999999999998765443332222 223579999999999999 899999999999999999763
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=364.53 Aligned_cols=269 Identities=19% Similarity=0.335 Sum_probs=206.4
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCc---EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGC---DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
+...+..++|.+.+.||+|+||.||+|.+..++. .||||++........ ..+.+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CH-HHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHH-HHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3445677889999999999999999999877664 899999865433333 245677999999999999999999999
Q ss_pred EeCCeE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7825 134 ETTHRV------YIIMEYAEKGSLLDFIQREG------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201 (357)
Q Consensus 134 ~~~~~~------~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~ 201 (357)
...... ++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 877655 99999999999999997532 589999999999999999999999999999999999999999
Q ss_pred cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy7825 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLK 280 (357)
Q Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~ 280 (357)
.++|+|||++....... .........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+..+...
T Consensus 175 ~~kl~Dfg~a~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 250 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGD---YYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250 (323)
T ss_dssp CEEECCCCC--------------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred CEEEeeccccccccccc---cccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence 99999999987442211 1122233456889999999988888766 999999999999999 999999988888888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCC-------HHHHhcCCCCCCCCCC
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIR-------LKDIKQDPWVKTEANP 330 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps-------~~~ll~hp~~~~~~~~ 330 (357)
.+......+.++.+++++.+||.+|| .||.+||+ +++++.|||+......
T Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 88777777777789999999999999 89999999 8899999999986544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=363.76 Aligned_cols=265 Identities=26% Similarity=0.409 Sum_probs=215.5
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC-----
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT----- 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 136 (357)
..++|.+.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 346799999999999999999999999999999998543 2333455677999999999999999999987654
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
...++||||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 87 ~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 678999999975 99999876 4699999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCC-----CCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-
Q psy7825 217 CKSGHQ-----SPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP- 289 (357)
Q Consensus 217 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~- 289 (357)
...... .......+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRA-MDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccch-hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 211110 011234578999999999865 445544 999999999999999999999988766655443211111
Q ss_pred ------------------------C------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 290 ------------------------T------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 290 ------------------------~------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
. .+.++.++.+||++|| .||.+||++.++|+||||+....+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 0 1468999999999999 8999999999999999999876554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=369.24 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=206.2
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC----
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH---- 137 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 137 (357)
...+|.+.+.||+|+||.||+|.+..++. ||+|.+...... ..+|+.+++.++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 34579999999999999999999887665 888877543221 237999999999999999999986543
Q ss_pred --eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-CCCcEEEeecCC
Q psy7825 138 --RVYIIMEYAEKGSLLDFIQ----REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID-GEYNIKLSDFGF 210 (357)
Q Consensus 138 --~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~-~~~~~kl~Dfg~ 210 (357)
.+++||||+++ ++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 110 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 110 EVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp CEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 38899999987 4444443 256799999999999999999999999999999999999999 789999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP- 289 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~- 289 (357)
++.... ........||+.|+|||++.+......++|||||||++|+|++|+.||.+.+..+.+..+......|
T Consensus 189 a~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 189 AKILIA------GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CEECCT------TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccC------CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 974421 1223355789999999999776533444999999999999999999999988777666554321111
Q ss_pred ---------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 290 ---------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 290 ---------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
..+.+++++.+||.+|| .||.+||++.++|+||||++-...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 12358899999999999 999999999999999999975443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=370.32 Aligned_cols=262 Identities=25% Similarity=0.447 Sum_probs=216.0
Q ss_pred cccccCeEEceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCC-chHHhhhHHHHHHHHHcC-CCCCcceeeEEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAP-PDYLKKFLPREIDVVKGL-RHPNLIRFLQAIE 134 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 134 (357)
.+..++|.+.+.||+|+||.||+|++. .+|+.||||++...... .....+.+.+|+.++..+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 445578999999999999999999984 57999999998643211 111134455799999999 6999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
....+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999998744
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCC--CCCCcccHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhhcccC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVP--YTPHYSDVWSMGVVLYAMAFGRLPFDDT----NYIQLLKQVQTKVVF 288 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~ 288 (357)
.... .......+||+.|+|||++.+.. ++.+ +|||||||++|+|++|+.||... ....+...+... ..
T Consensus 210 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~ 283 (355)
T 1vzo_A 210 VADE----TERAYDFCGTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EP 283 (355)
T ss_dssp CGGG----GGGGCGGGSCCTTCCHHHHTTCC---CTH-HHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CC
T ss_pred ccCC----CCcccCcccCcCccChhhhcCCCCCCCch-hhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CC
Confidence 2211 11223457999999999998633 4444 99999999999999999999643 333444443322 23
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 289 PTEPNVSAECKTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 289 ~~~~~~s~~~~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
+.+..++..+++||.+|| .||.+|| +++++++||||++.
T Consensus 284 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 284 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 444579999999999999 9999999 99999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=360.46 Aligned_cols=265 Identities=28% Similarity=0.517 Sum_probs=218.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-hHHhhhHHHHHHHHHcCCCCCcceeeEEEE--eCCeEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP-DYLKKFLPREIDVVKGLRHPNLIRFLQAIE--TTHRVY 140 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~ 140 (357)
++|.+.+.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++. .....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 46999999999999999999999999999999986532111 122456789999999999999999999984 456889
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 141 IIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+||||++++ |.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999875 8787765 4569999999999999999999999999999999999999999999999999987442111
Q ss_pred CCCCCCCCCcccCCccccccceecCCCC-CCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPY-TPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
.........|++.|+|||++.+... ...++||||||+++|+|++|..||.+.+.......+.... .+.+..++..
T Consensus 164 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~ 239 (305)
T 2wtk_C 164 ---ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPP 239 (305)
T ss_dssp ---SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCHH
T ss_pred ---cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccCHH
Confidence 1112234568999999999976443 2334999999999999999999999998888877765543 3444579999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAAS 333 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 333 (357)
+.+||.+|| .||.+||++.++++||||++...++..
T Consensus 240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~ 276 (305)
T 2wtk_C 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEA 276 (305)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCC
Confidence 999999999 899999999999999999987665443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=363.83 Aligned_cols=256 Identities=30% Similarity=0.527 Sum_probs=207.4
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP-----PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
++|.+.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 4699999999999999999999999999999998654321 1122345779999999999999999999987665
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc---EEEeecCCCcccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN---IKLSDFGFARGHM 215 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~---~kl~Dfg~~~~~~ 215 (357)
.++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988888999999999999999999999999999999999999987664 9999999986432
Q ss_pred cccCCCCCCCCCcccCCccccccceec---CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhhcccCC--
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQVQTKVVFP-- 289 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~-- 289 (357)
. ........||+.|+|||++. ...++.+ +|||||||++|+|++|..||...... .+...+.......
T Consensus 169 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 169 E------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp C------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTH-HHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred c------ccccccccCCcCccCchhhccCCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 1 11122456899999999974 3445555 99999999999999999999764332 2223333221111
Q ss_pred -CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 290 -TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 290 -~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
....++..+.+||.+|| .||.+||++.++|+||||++.
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 12468999999999999 899999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=351.99 Aligned_cols=253 Identities=21% Similarity=0.375 Sum_probs=221.6
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..+..++|.+.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3566778999999999999999999986 4778999999754433 2457799999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.++||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999999754 56899999999999999999999999999999999999999999999999998743221
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCH
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSA 296 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 296 (357)
. ........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+........+..+++
T Consensus 160 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T 4hcu_A 160 Q----YTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 234 (269)
T ss_dssp H----HHSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred c----cccccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCH
Confidence 1 111223457788999999988888776 999999999999999 9999999999999988888777777778999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+.+||.+|| .+|.+||++.++++|
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999 899999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=373.27 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=224.3
Q ss_pred ccccccCeEEceeeeecCCeEEEEEE-----ECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLAT-----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
..+..++|.+.+.||+|+||.||+|. ...+++.||||++.... .......+.+|+.++..++||||+++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34566789999999999999999999 44567899999985432 223344577899999999999999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC---cE
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQREG-------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY---NI 203 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~---~~ 203 (357)
......++||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999998653 489999999999999999999999999999999999999555 59
Q ss_pred EEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q psy7825 204 KLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQV 282 (357)
Q Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i 282 (357)
||+|||+++...... .........||+.|+|||++.+..++.+ +|||||||++|+|++ |..||...+..+....+
T Consensus 224 kL~DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 224 KIGDFGMARDIYRAG---YYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp EECCCHHHHHHHHHS---SCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EECCCcccccccccc---ccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999986432211 1122334568999999999988888876 999999999999998 99999999999999888
Q ss_pred hhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 283 QTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 283 ~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
......+.+..++..+.+||.+|| .+|.+||++.+|+++.|+...
T Consensus 300 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 300 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 887777777789999999999999 899999999999999877543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=349.58 Aligned_cols=252 Identities=21% Similarity=0.389 Sum_probs=220.0
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++..++||||+++++++......
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456778999999999999999999876 4778999999764433 24467999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++||||+++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD- 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT-
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh-
Confidence 99999999999999998754 5999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
.........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||...........+........+..+++.
T Consensus 158 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 158 ---QYVSSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT 233 (268)
T ss_dssp ---CEEECCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred ---hhhcccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHH
Confidence 1111223446778999999988888877 999999999999999 99999999988888888777766666778999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+.+||.+|| .+|.+||++.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999 899999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=370.86 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=223.3
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
....+..++|.+.+.||+|+||.||+|.+..+++.||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 34456778899999999999999999999989999999998643 2233455677999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999999999865 359999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
... .........+++.|+|||++.+..++.+ +|||||||++|||++ |..||.+....+....+......+.+..+
T Consensus 265 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (377)
T 3cbl_A 265 DGV---YAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC 340 (377)
T ss_dssp TSE---EECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred CCc---eeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 110 0111122335778999999988877776 999999999999998 99999999988888888877777777889
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++++.+||.+|| .||.+||++.+|++
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999 89999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=371.87 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=194.9
Q ss_pred CeEE-ceeeeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--CCeE
Q psy7825 65 GYVL-GKVIGIGSYATVKLATST--RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--THRV 139 (357)
Q Consensus 65 ~y~~-~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 139 (357)
.|.+ +++||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+|+.++||||+++++++.. ...+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 4776 568999999999999965 56899999998654332 346689999999999999999999954 6789
Q ss_pred EEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCcEEEe
Q psy7825 140 YIIMEYAEKGSLLDFIQRE---------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI----DGEYNIKLS 206 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili----~~~~~~kl~ 206 (357)
++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||| +.++.+||+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999999975 888888632 249999999999999999999999999999999999999 677899999
Q ss_pred ecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH---------HH
Q psy7825 207 DFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY---------IQ 277 (357)
Q Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~ 277 (357)
|||+++....... ........+||+.|+|||++.+......++|||||||++|+|++|+.||.+... .+
T Consensus 175 Dfg~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 175 DMGFARLFNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp CTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred ECCCceecCCCCc--ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 9999975432111 112234567999999999998865444449999999999999999999976543 23
Q ss_pred HHHHHhhcccCCCC-------------------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy7825 278 LLKQVQTKVVFPTE-------------------------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIK 319 (357)
Q Consensus 278 ~~~~i~~~~~~~~~-------------------------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll 319 (357)
.+..+......+.. ...+..+.+||++|| .||.+|||++|+|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 33333332222221 123788999999999 9999999999999
Q ss_pred cCCCCCCCCCCC
Q psy7825 320 QDPWVKTEANPA 331 (357)
Q Consensus 320 ~hp~~~~~~~~~ 331 (357)
+||||++...+.
T Consensus 333 ~hp~f~~~~~~~ 344 (405)
T 3rgf_A 333 QDPYFLEDPLPT 344 (405)
T ss_dssp TSGGGTSSSCCC
T ss_pred cChhhccCCCCc
Confidence 999999876553
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=354.20 Aligned_cols=255 Identities=30% Similarity=0.535 Sum_probs=219.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||.||+|.+..+++.||||++........ ....+.+|+.+++.++||||+++++++......++|+
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 469999999999999999999999999999999975433222 2455779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC---CcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE---YNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~--- 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--- 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC---
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC---
Confidence 999999999999888889999999999999999999999999999999999999764 46999999998643211
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc---CCCCCCCCHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---FPTEPNVSAE 297 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~ 297 (357)
.......|++.|+|||++.+. ++.+ +||||||+++|+|++|..||.+.+..+....+..... .+....++.+
T Consensus 178 ---~~~~~~~~~~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 178 ---TKMKDRIGTAYYIAPEVLRGT-YDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp ---SSCSCHHHHHTTCCHHHHTTC-CCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred ---CccccccCcccccChHHhcCC-CCCc-hhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 112344689999999998764 5555 9999999999999999999999988888777655432 2223578999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+.+||++|| .||.+||++.++|+||||++.
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999 899999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=366.53 Aligned_cols=260 Identities=25% Similarity=0.353 Sum_probs=202.2
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe---
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR--- 138 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 138 (357)
..++|.+.+.||+|+||.||+|.+..+|+.||||++...... .....+++..+..++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 345799999999999999999999999999999998654332 2334577888888999999999999865433
Q ss_pred ----EEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEEcC-CCcEEEee
Q psy7825 139 ----VYIIMEYAEKGSLLDFIQ----REGYIDEPRTKKWFRQLVDAIDYCH--ERGVVHRDIKCENLLIDG-EYNIKLSD 207 (357)
Q Consensus 139 ----~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dlkp~Nili~~-~~~~kl~D 207 (357)
+++||||+++ +|...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.++|+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 8899999987 5554443 4567899999999999999999999 999999999999999997 89999999
Q ss_pred cCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc
Q psy7825 208 FGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV 287 (357)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 287 (357)
||++..... ........||+.|+|||++.+......++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 176 fg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 176 FGSAKKLSP------SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp CTTCBCCCT------TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CCCceecCC------CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 999974422 12233456899999999997766444449999999999999999999999888777766643221
Q ss_pred CC-------------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 288 FP-------------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 288 ~~-------------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
.+ .....+.++.+||.+|| .||.+||++.++|+||||++...+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 11 11236789999999999 99999999999999999998765543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=356.87 Aligned_cols=261 Identities=24% Similarity=0.350 Sum_probs=216.5
Q ss_pred cccCeEEceeeeecCCeEEEEEEEC-CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC---CCCCcceeeEEEE---
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATST-RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL---RHPNLIRFLQAIE--- 134 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~--- 134 (357)
..++|.+.+.||+|+||.||+|.+. .+|+.||+|++........ ....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3467999999999999999999985 6789999999865433221 123455777777766 8999999999987
Q ss_pred --eCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 135 --TTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 135 --~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
.....++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5668899999997 49999998753 489999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP- 289 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~- 289 (357)
+....... ......|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 167 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 167 ARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp CCCCCGGG------GGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccCCC------CccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 87442211 1234568999999999998888776 999999999999999999999988877776664322111
Q ss_pred -------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 290 -------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 290 -------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
..+.++..+++||.+|| .||.+||++.++|+||||++.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 12468999999999999 8999999999999999999865443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=368.10 Aligned_cols=259 Identities=23% Similarity=0.411 Sum_probs=219.0
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchH--------------HhhhHHHHHHHHHcCCCCCc
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDY--------------LKKFLPREIDVVKGLRHPNL 126 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i 126 (357)
...++|.+.+.||+|+||.||+|.+ +|+.||||++......... ..+.+.+|+.++..++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3456899999999999999999998 7999999998653222111 11667899999999999999
Q ss_pred ceeeEEEEeCCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEE
Q psy7825 127 IRFLQAIETTHRVYIIMEYAEKGSLLDF------IQR--EGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLI 197 (357)
Q Consensus 127 v~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili 197 (357)
+++++++...+..++||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ .||+|+||+|+|||+
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999998 665 5679999999999999999999999 999999999999999
Q ss_pred cCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCH-
Q psy7825 198 DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV-PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY- 275 (357)
Q Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~- 275 (357)
+.++.++|+|||++...... ......|++.|+|||++.+. .++..++|||||||++|+|++|..||.....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred cCCCcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999998743221 23345699999999999887 5555249999999999999999999987766
Q ss_pred HHHHHHHhhc-ccCCCC-----------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 276 IQLLKQVQTK-VVFPTE-----------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 276 ~~~~~~i~~~-~~~~~~-----------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.+....+... ..++.. ..++.++.+||.+|| .||.+||++.++++||||++..
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 6666666543 223321 568999999999999 8999999999999999999754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=359.10 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=222.3
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeE
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 131 (357)
....+...+|.+.+.||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 34456678899999999999999999987 3456899999986432 2333566789999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7825 132 AIETTHRVYIIMEYAEKGSLLDFIQREGY------------------------IDEPRTKKWFRQLVDAIDYCHERGVVH 187 (357)
Q Consensus 132 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~i~~~i~~~l~~LH~~~ivH 187 (357)
++......++||||+++++|.+++..... +++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999987543 899999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-C
Q psy7825 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-G 266 (357)
Q Consensus 188 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g 266 (357)
|||||+|||++.++.++|+|||++....... .........+++.|+|||++.+..++.+ +|||||||++|+|++ |
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEED---SYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTS---CEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTS
T ss_pred cccchheEEEcCCCCEEEccccccccccccc---cceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999986432211 1112234457889999999988877776 999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 267 RLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 267 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
..||.+.....+...+......+.+..+++.+.+||.+|| .||.+||++.+|+++
T Consensus 250 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999998888888877777666667789999999999999 899999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=363.79 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=223.9
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCccee
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTR-------HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRF 129 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 129 (357)
...+..++|.+.+.||+|+||.||+|.+.. .+..||||++.... .......+.+|+.+++.+ +||||+++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 345667789999999999999999999753 33679999986542 233346677999999999 89999999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7825 130 LQAIETTHRVYIIMEYAEKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCE 193 (357)
Q Consensus 130 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~ 193 (357)
++++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 999999999999999999999999998753 4899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCC
Q psy7825 194 NLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDD 272 (357)
Q Consensus 194 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~ 272 (357)
|||++.++.+||+|||++....... .........||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHID---YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCC---TTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eEEEcCCCcEEEcccCccccccccc---ccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999997542211 1122334567889999999998888777 999999999999999 9999999
Q ss_pred CCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 273 TNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 273 ~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+..++...+........+..+++++.+||.+|| .||.+||++.+|+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 297 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999998888887777777789999999999999 899999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=352.08 Aligned_cols=254 Identities=20% Similarity=0.370 Sum_probs=219.2
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
...+..++|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++..++||||+++++++....
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 34567778999999999999999999876 5778999999754433 244679999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999999976 46799999999999999999999999999999999999999999999999999874422
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s 295 (357)
.. ........+|+.|+|||++.+..++.+ +||||||+++|+|++ |+.||...+.......+........+..++
T Consensus 173 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T 3gen_A 173 DE----YTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 247 (283)
T ss_dssp HH----HHSTTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred cc----cccccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCC
Confidence 11 111223446788999999988887766 999999999999998 999999999999888888877777777899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+.+.+||.+|| .+|.+||++.++++|
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999 899999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=357.10 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=208.2
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE--------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE-------- 134 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-------- 134 (357)
.++|.+.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 46799999999999999999999999999999998643 2334566779999999999999999998873
Q ss_pred ------eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-CCCcEEEee
Q psy7825 135 ------TTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID-GEYNIKLSD 207 (357)
Q Consensus 135 ------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~-~~~~~kl~D 207 (357)
.....++||||++ |+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4468899999997 499999865 5689999999999999999999999999999999999997 567999999
Q ss_pred cCCCcccccccCCCCCCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc
Q psy7825 208 FGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV 286 (357)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 286 (357)
||++........ .........|++.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+..+....+....
T Consensus 165 fg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 165 FGLARIMDPHYS--HKGHLSEGLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CTTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred CccccccCCCcc--cccccccccccccccCcHHhcCcccCCch-hhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999875422111 1122234567999999999876 445544 999999999999999999999988777666554332
Q ss_pred cC-----------------------C------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 287 VF-----------------------P------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 287 ~~-----------------------~------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
.. + ..+.++.++++||++|| .||.+||++.++|+||||+....+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 11 1 11468999999999999 8999999999999999999866554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=364.29 Aligned_cols=264 Identities=23% Similarity=0.390 Sum_probs=209.8
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCc--------hHHhhhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP--------DYLKKFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
..++|.+.+.||+|+||.||+|.+.. |+.||||++....... ....+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34679999999999999999999765 9999999986543321 22236678999999999999999999998
Q ss_pred Ee-----CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEee
Q psy7825 134 ET-----THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSD 207 (357)
Q Consensus 134 ~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~D 207 (357)
.. ...+++||||+.| +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 54 3468999999975 888888654 4699999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc
Q psy7825 208 FGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV 287 (357)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 287 (357)
||++..... ........||+.|+|||++.+......++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 178 fg~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 178 FNLAREDTA------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp TTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cCccccccc------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999863221 12233457899999999998744334449999999999999999999999887777666543221
Q ss_pred CC-------------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCcc
Q psy7825 288 FP-------------------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAAS 333 (357)
Q Consensus 288 ~~-------------------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 333 (357)
.+ ..+.+++.+.+||.+|| .||.+||++.++|+||||+....+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 329 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDL 329 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGG
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccc
Confidence 11 12457899999999999 999999999999999999987655443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=358.65 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=212.3
Q ss_pred ccccCeEEceeeeecCCeEEEEEEE-CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCC------CcceeeEEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATS-TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP------NLIRFLQAI 133 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~ 133 (357)
...++|++.+.||+|+||.||+|.+ ..+|+.||||++... ....+.+.+|+.++..++|+ +++++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 3456899999999999999999998 567899999998642 23355677899999988655 499999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC------------
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG------------ 199 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~------------ 199 (357)
...+.+++||||+ +++|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 789999998765 6899999999999999999999999999999999999987
Q ss_pred -------CCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q psy7825 200 -------EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD 272 (357)
Q Consensus 200 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 272 (357)
++.++|+|||++.... .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDD--------EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETT--------SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCceEeeCcccccCc--------cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCC
Confidence 6689999999986421 11234579999999999998888776 9999999999999999999998
Q ss_pred CCHHHHHHHHhhcccC-------------------------------------------CCCCCCCHHHHHHHHHhc-CC
Q psy7825 273 TNYIQLLKQVQTKVVF-------------------------------------------PTEPNVSAECKTLLSKIF-SP 308 (357)
Q Consensus 273 ~~~~~~~~~i~~~~~~-------------------------------------------~~~~~~s~~~~~li~~~L-~~ 308 (357)
.+..+....+...... ......++++.+||.+|| .|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 8776655544321110 011224578999999999 89
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q psy7825 309 IKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 309 p~~Rps~~~ll~hp~~~~~ 327 (357)
|.+||++.|+|+||||+..
T Consensus 317 P~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 317 PAKRITLREALKHPFFDLL 335 (339)
T ss_dssp TTTSCCHHHHTTSGGGGGG
T ss_pred cccccCHHHHhcCHHHHHH
Confidence 9999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=361.47 Aligned_cols=255 Identities=25% Similarity=0.455 Sum_probs=212.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR---- 138 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 138 (357)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 467999999999999999999999999999999986543 333445667799999999999999999999977653
Q ss_pred --EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 139 --VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 139 --~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+++||||+.+ +|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 5999999974 88887753 489999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCCCCCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC-------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF------- 288 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------- 288 (357)
......||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 179 --------~~~~~~~t~~y~aPE~~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 179 --------EMTGYVVTRWYRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTT-HHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred --------CccccccCcCcCCHHHHhCcCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 1234568999999999987 455555 99999999999999999999988877766655331111
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 289 -----------------------PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 289 -----------------------~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
...+.++.++.+||.+|| .||.+||++.++|+||||+....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence 112467999999999999 899999999999999999876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=351.04 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=208.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|....+||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 334455599999999999999999999999999875432 22456779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-CCcEEEeecCCCcccccccC
Q psy7825 144 EYAEKGSLLDFIQRE---GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-EYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 144 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~ 219 (357)
||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 176 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-- 176 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence 999999999999865 24678999999999999999999999999999999999987 899999999998643211
Q ss_pred CCCCCCCCcccCCccccccceecCCC--CCCCcccHHHHHHHHHHHHcCCCCCCCCCHH-H-HHHHHhhcccCCCCCCCC
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVP--YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-Q-LLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~-~~~~i~~~~~~~~~~~~s 295 (357)
........|++.|+|||++.+.. ++.+ +||||||+++|+|++|+.||...... . .............+..++
T Consensus 177 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (295)
T 2clq_A 177 ---NPCTETFTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHH-HHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC
T ss_pred ---CCcccccCCCccccChhhhcCCCCCCCcH-HHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC
Confidence 12233457999999999997643 4544 99999999999999999999754322 2 222222233334456799
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
.++.+||.+|| .||.+||++.++|+||||+....
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 99999999999 89999999999999999997654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=360.25 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=207.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC--e
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH--R 138 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 138 (357)
..+++|.+.+.||+|+||.||+|.+..+|+.||||++........ .+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 345679999999999999999999999999999999865332221 345679999999999999999999998755 7
Q ss_pred EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCcEEEeecCCC
Q psy7825 139 VYIIMEYAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI----DGEYNIKLSDFGFA 211 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili----~~~~~~kl~Dfg~~ 211 (357)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999999999999998643 39999999999999999999999999999999999999 77788999999999
Q ss_pred cccccccCCCCCCCCCcccCCccccccceec--------CCCCCCCcccHHHHHHHHHHHHcCCCCCCCC----CHHHHH
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILK--------GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT----NYIQLL 279 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~ 279 (357)
..... ........||+.|+|||++. +..++.+ +|||||||++|+|++|+.||... ...+..
T Consensus 164 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 164 RELED------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp EECCT------TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred eecCC------CCceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 74322 12233457999999999986 4566666 99999999999999999999643 223334
Q ss_pred HHHhhccc--------------------CCCC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy7825 280 KQVQTKVV--------------------FPTE----PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPW 323 (357)
Q Consensus 280 ~~i~~~~~--------------------~~~~----~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~ 323 (357)
..+..... .+.. ..++..+.+||++|| .||++||+++|+|+||-
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 34332221 1111 234568899999999 99999999999999973
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=374.25 Aligned_cols=255 Identities=17% Similarity=0.130 Sum_probs=195.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC--CCCCcceee-------EEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL--RHPNLIRFL-------QAIE 134 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~~~ 134 (357)
..|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3499999999999999999999999999999999876655555566777885444444 699987754 4554
Q ss_pred eC-----------------CeEEEEEeccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceecCC
Q psy7825 135 TT-----------------HRVYIIMEYAEKGSLLDFIQRE-GYIDEPRT------KKWFRQLVDAIDYCHERGVVHRDI 190 (357)
Q Consensus 135 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~------~~i~~~i~~~l~~LH~~~ivH~dl 190 (357)
.. ..+|+||||++ ++|.+++... ..+++... ..++.||+.||.|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33 34899999998 7999999864 33455555 677799999999999999999999
Q ss_pred CCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecC--CCCCCCcccHHHHHHHHHHHHcCCC
Q psy7825 191 KCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG--VPYTPHYSDVWSMGVVLYAMAFGRL 268 (357)
Q Consensus 191 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~ 268 (357)
||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.+ +|||||||++|+|++|+.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGT--------RGPASSVPVTYAPREFLNASTATFTHA-LNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTC--------EEEGGGSCGGGCCHHHHTCSEEECCHH-HHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEECCCCCEEEEecceeeecCC--------CccCccCCcCCcChhhccCCCCCcCcc-ccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999874321 1114457799999999987 567666 999999999999999999
Q ss_pred CCCCCCHHHH--HH------HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 269 PFDDTNYIQL--LK------QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 269 pf~~~~~~~~--~~------~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
||.+...... .. .......++..+.+++.+.+||.+|| .||.+||++.++|+||||++..
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 9987632211 00 00112334444688999999999999 9999999999999999998743
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=356.14 Aligned_cols=257 Identities=20% Similarity=0.339 Sum_probs=211.2
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..+...
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 46677899999999999999999999999999999988432 344466788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999987 5679999999999999999999999999999999999999999999999999997543221
Q ss_pred CCC---------CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHhhccc
Q psy7825 219 SGH---------QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL--KQVQTKVV 287 (357)
Q Consensus 219 ~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~ 287 (357)
... ........+||+.|+|||++.+..++.+ +||||||+++|+|++|..||......... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 111 0111225679999999999999888877 99999999999999999998653211100 00011111
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
...++.+++.+.+||.+|| .||.+||++.+|++
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1224568999999999999 89999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=361.41 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=221.6
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
..+..++|.+.+.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456678999999999999999999986 345899999986432 333456788999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQRE------------------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~d 189 (357)
.....+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999863 5689999999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCC
Q psy7825 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRL 268 (357)
Q Consensus 190 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~ 268 (357)
|||+|||++.++.++|+|||++....... .........||+.|+|||++.+..++.+ +||||||+++|+|++ |..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSAD---YYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGG---CBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCc---cccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999986442211 1122334568899999999988887766 999999999999999 999
Q ss_pred CCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 269 PFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 269 pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
||.+.+..+....+......+.+..++..+.+||++|| .||.+||++.+++++
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99999998888888776666666789999999999999 899999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=354.22 Aligned_cols=273 Identities=26% Similarity=0.401 Sum_probs=213.1
Q ss_pred cccccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC--CCCcceeeE
Q psy7825 54 VKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR--HPNLIRFLQ 131 (357)
Q Consensus 54 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~ 131 (357)
.......+...+|.+.+.||+|+||.||+|.+. +++.||||++...... ....+.+.+|+.++..+. ||||+++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 334455566778999999999999999999975 4899999999765443 334566789999999997 599999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 132 AIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 132 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
++.....+++||| +.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+++ +.++|+|||++
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccc
Confidence 9999999999999 557799999999888999999999999999999999999999999999999975 89999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecC-----------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-HHHHH
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-----------VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN-YIQLL 279 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~ 279 (357)
....... .........|++.|+|||++.+ ..++.+ +||||||+++|+|++|..||.... .....
T Consensus 174 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 174 NQMQPDT---TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK-SDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CC-----------------CCGGGCCHHHHTTCC----------CCCHH-HHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccCcc---ccccccCCCCCCCcCCHHHHhhcccccccccccccCCch-HHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 7542211 1112234579999999999875 244444 999999999999999999997653 33333
Q ss_pred HHH-hhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCccc
Q psy7825 280 KQV-QTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAASA 334 (357)
Q Consensus 280 ~~i-~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~ 334 (357)
..+ ........+...+.++.+||.+|| .||.+||++.++|+||||+....+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~ 306 (313)
T 3cek_A 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 306 (313)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-------
T ss_pred HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchhhh
Confidence 333 333333445567999999999999 8999999999999999999876655443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=364.49 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=210.4
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CC-----CcceeeEEEEe
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HP-----NLIRFLQAIET 135 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~ 135 (357)
..++|.+.+.||+|+||.||+|.+..+++.||||++... ......+..|+.++..+. |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 356899999999999999999999999999999998632 233455668888888885 44 49999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEEc--CCCcEEEeecC
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCH--ERGVVHRDIKCENLLID--GEYNIKLSDFG 209 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dlkp~Nili~--~~~~~kl~Dfg 209 (357)
...+++||||+.+ +|.+++... ..+++..++.++.||+.||.||| ..||+||||||+|||++ .++.+||+|||
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999999965 999999875 46999999999999999999999 57999999999999995 47889999999
Q ss_pred CCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC
Q psy7825 210 FARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP 289 (357)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 289 (357)
++.... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 207 ~a~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 207 SSCQLG--------QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp TCEETT--------CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred Cceecc--------cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 987432 11235679999999999999888876 999999999999999999999988877776664422211
Q ss_pred CC-----------------------------------CC----------------------------CCHHHHHHHHHhc
Q psy7825 290 TE-----------------------------------PN----------------------------VSAECKTLLSKIF 306 (357)
Q Consensus 290 ~~-----------------------------------~~----------------------------~s~~~~~li~~~L 306 (357)
.. +. .++++++||++||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 10 00 0147899999999
Q ss_pred -CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 307 -SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 307 -~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.||.+|||++|+|+||||++..
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGCC--
T ss_pred CCChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=365.60 Aligned_cols=257 Identities=20% Similarity=0.332 Sum_probs=215.1
Q ss_pred ccccccCeEEceeeeecCCeEEEEEE-----ECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLAT-----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQA 132 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 132 (357)
..+..++|.+.+.||+|+||.||+|. ...+++.||||++.... .....+.+.+|+.++..+ +||||++++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 34567789999999999999999998 45667999999986432 223345678999999999 78999999999
Q ss_pred EEeCC-eEEEEEeccCCCChHHHHHhcCC---------------------------------------------------
Q psy7825 133 IETTH-RVYIIMEYAEKGSLLDFIQREGY--------------------------------------------------- 160 (357)
Q Consensus 133 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------- 160 (357)
+...+ .+++||||+++|+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 98754 48999999999999999976532
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCC
Q psy7825 161 ---------------IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL 225 (357)
Q Consensus 161 ---------------l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 225 (357)
+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC---TTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc---ccchh
Confidence 899999999999999999999999999999999999999999999999998744221 11122
Q ss_pred CCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCH-HHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNY-IQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 226 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
.....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+... ......+......+.+..+++++.+||.
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 330 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 334568899999999988888766 999999999999998 9999987654 3444555555566666789999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcC
Q psy7825 304 KIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~ll~h 321 (357)
+|| .||.+||++.+|++|
T Consensus 331 ~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHH
Confidence 999 899999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=350.81 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=209.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|.+.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.++..++||||+++++++..++.+++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 35699999999999999999999999999999999765554555567788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|||++|++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...... .
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE----K 188 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc----c
Confidence 999999999999998888999999999999999999999999999999999999999999999999998643221 1
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC--CCCCCCCHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF--PTEPNVSAECKT 300 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~~~~ 300 (357)
........|++.|+|||++.+..++.+ +||||||+++|+|++|+.||...+.......+...... ...+.++.++.+
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp --------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence 112234568999999999998888877 99999999999999999999988776555555443322 234579999999
Q ss_pred HHHHhc-CCCCCCC-CHHHHhc
Q psy7825 301 LLSKIF-SPIKFRI-RLKDIKQ 320 (357)
Q Consensus 301 li~~~L-~~p~~Rp-s~~~ll~ 320 (357)
||.+|| .||.+|| +++++++
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHhccCCHHHHHHhHHHHHH
Confidence 999999 8999999 8888875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=358.99 Aligned_cols=257 Identities=20% Similarity=0.340 Sum_probs=216.2
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcE----EEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCD----VAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
...+..++|++.+.||+|+||.||+|.+..+++. ||+|.+...... .....+.+|+.++..++||||+++++++
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 3456778899999999999999999999888876 666766432211 1134466899999999999999999988
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
. +...++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 6 56688999999999999999764 579999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCC
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTE 291 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 291 (357)
..... ..........|++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.........+......+.+
T Consensus 164 ~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
T 3kex_A 164 LLPPD---DKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP 239 (325)
T ss_dssp GSCCC---TTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC
T ss_pred ccCcc---cccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC
Confidence 54221 12222345568889999999988888776 999999999999999 99999998888888887777666667
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
..++.++.+||.+|| .||.+||++.+++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 240 QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999 999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=349.50 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=209.0
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
..+..++|++.+.||+|+||.||+|.+..+ +..||+|++... ......+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 355677899999999999999999998653 457999987543 23444567889999999999999999999984
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
++..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 567889999999999999998654 6999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
.... ........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+....+....+......+.++.
T Consensus 167 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (281)
T 1mp8_A 167 EDST----YYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 241 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred Cccc----ccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCC
Confidence 2211 111233457789999999988887766 999999999999996 9999998888888888877766677778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+++.+.+||.+|| .||.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999 899999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=363.72 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=211.5
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATST---RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
..+...+|.+.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.++..++||||+++++++..
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3556678999999999999999999876 457889999986532 33345668899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999999875 36999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
..... .........+++.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+..+....+......+.+..
T Consensus 198 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 274 (373)
T 2qol_A 198 EDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTT
T ss_pred ccCCc--cceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 32111 1111222345778999999988888876 999999999999997 9999999999888888888777777778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++..+.+||.+|| .||.+||++.+|++
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999 89999999999886
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=359.05 Aligned_cols=255 Identities=29% Similarity=0.502 Sum_probs=215.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch---HHhhhHHHHHHHHHcCC--CCCcceeeEEEEeC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD---YLKKFLPREIDVVKGLR--HPNLIRFLQAIETT 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 136 (357)
...+|.+.+.||+|+||.||+|.+..+|+.||||++........ .....+.+|+.+++.+. ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 45679999999999999999999999999999999976433221 11244568999999996 59999999999999
Q ss_pred CeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-CCCcEEEeecCCCccc
Q psy7825 137 HRVYIIMEYAEK-GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID-GEYNIKLSDFGFARGH 214 (357)
Q Consensus 137 ~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~-~~~~~kl~Dfg~~~~~ 214 (357)
...++|+|++.+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++...
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999999976 89999999888999999999999999999999999999999999999999 7899999999998744
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
.. .......||+.|+|||++.+..+...++|||||||++|+|++|+.||..... ..... ......+
T Consensus 201 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~--~~~~~~~ 266 (320)
T 3a99_A 201 KD-------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIRGQ--VFFRQRV 266 (320)
T ss_dssp CS-------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHHCC--CCCSSCC
T ss_pred cc-------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hhccc--ccccccC
Confidence 21 1223456999999999998777755558999999999999999999976421 11222 2234579
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
++++.+||.+|| .||.+||++.+|++||||++...+
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 999999999999 899999999999999999986543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=358.25 Aligned_cols=257 Identities=22% Similarity=0.366 Sum_probs=212.0
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEE----EEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDV----AVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
...+..++|.+.+.||+|+||.||+|.+..+|+.+ |+|.+.... .......+.+|+.+++.++||||+++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34566778999999999999999999988777665 666654322 122245678999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.... .++|+||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 8765 7789999999999999987 4679999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCC
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTE 291 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 291 (357)
...... .........||+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.....+...+......+.+
T Consensus 166 ~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3poz_A 166 LLGAEE---KEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp HHTTTC---C-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred EccCCc---ccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC
Confidence 542211 1122234457889999999998888876 999999999999999 99999998888888777777777777
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+.++.++.+||.+|| .+|.+||++.+++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 889999999999999 899999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=348.90 Aligned_cols=260 Identities=21% Similarity=0.321 Sum_probs=217.3
Q ss_pred cccccccccCeEEce-eeeecCCeEEEEEEE--CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEE
Q psy7825 56 KKSTVMENHGYVLGK-VIGIGSYATVKLATS--TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA 132 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 132 (357)
.....+...+|.+.+ .||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+++.++||||++++++
T Consensus 8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 344556677899999 999999999999954 56679999999865433 23335668899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
+ .....++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 9 567789999999999999999998889999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCC
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTE 291 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 291 (357)
....... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.+..+....+......+.+
T Consensus 166 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T 1xbb_A 166 ALRADEN--YYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 242 (291)
T ss_dssp ECCTTCS--EEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred eeccCCC--cccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 4422111 0111223346789999999988777766 999999999999999 99999999988888888776666666
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..++..+.+||.+|| .||.+||++.++++
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 789999999999999 89999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=358.51 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=185.0
Q ss_pred cccCeEEc-eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe----C
Q psy7825 62 ENHGYVLG-KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET----T 136 (357)
Q Consensus 62 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 136 (357)
..++|.+. ++||+|+||.||+|.+..+|+.||||++... . ....+....+..+.||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P---KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 34569985 4799999999999999999999999998642 1 112233345677799999999999876 5
Q ss_pred CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcEEEeecCCC
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG---EYNIKLSDFGFA 211 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~---~~~~kl~Dfg~~ 211 (357)
..+++||||++||+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56899999999999999998753 6999999999999999999999999999999999999986 455999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----Hh---h
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ----VQ---T 284 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----i~---~ 284 (357)
..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||........... +. .
T Consensus 179 ~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 179 KETTQ-------NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp EEC-----------------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred eeccc-------cccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 64321 12234568999999999988877766 9999999999999999999977655443221 11 1
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 285 KVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 285 ~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
....+....++.++++||.+|| .||.+||++.++|+||||++....
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 297 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGS
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccC
Confidence 2223334578999999999999 999999999999999999986433
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=366.33 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=204.6
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC--------CCCcceeeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR--------HPNLIRFLQAI 133 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~~~~~ 133 (357)
..++|.+.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+. |+||+++++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 357899999999999999999999999999999998632 334556779999999885 78899999998
Q ss_pred E----eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCC-----
Q psy7825 134 E----TTHRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEY----- 201 (357)
Q Consensus 134 ~----~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~----- 201 (357)
. ....+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 7 556899999999 55777776554 5699999999999999999999998 999999999999999775
Q ss_pred --------------------------------------------cEEEeecCCCcccccccCCCCCCCCCcccCCccccc
Q psy7825 202 --------------------------------------------NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS 237 (357)
Q Consensus 202 --------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~a 237 (357)
.++|+|||++..... .....+||+.|+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--------~~~~~~gt~~y~a 261 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--------HFTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--------CSCSCCSCGGGCC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--------cCccCCCCCcccC
Confidence 799999999864321 1234579999999
Q ss_pred cceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHhhcccC-----------------------
Q psy7825 238 PEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN------YIQLLKQVQTKVVF----------------------- 288 (357)
Q Consensus 238 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~----------------------- 288 (357)
||++.+..++.+ +|||||||++|+|++|+.||...+ ....+..+......
T Consensus 262 PE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 262 LEVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp HHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred ChhhcCCCCCcH-HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 999999888876 999999999999999999997543 22222222111000
Q ss_pred ------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 289 ------------------PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 289 ------------------~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
......+..+.+||.+|| .||.+||++.|||+||||++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 011223567899999999 99999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=350.38 Aligned_cols=255 Identities=23% Similarity=0.398 Sum_probs=209.6
Q ss_pred cccccCeEEceeeeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.+..++|++.+.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567789999999999999999998 5668999999998643 33335668899999999999999999999854
Q ss_pred --CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 136 --THRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 136 --~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
...+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999998753 59999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH----------------
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI---------------- 276 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------- 276 (357)
....... .........++..|+|||++.+..++.+ +||||||+++|+|++|..||......
T Consensus 163 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 163 VLPQDKE--FFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccCCcc--eeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 5432211 1122234457888999999988888776 99999999999999999998653221
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 277 QLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 277 ~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.....+......+.+..+++++.+||.+|| .||.+||++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 333444555566667789999999999999 89999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=347.10 Aligned_cols=257 Identities=23% Similarity=0.422 Sum_probs=202.4
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--------
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET-------- 135 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 135 (357)
++|.+.+.||+|+||.||+|.+..+|+.||||++.. .....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 469999999999999999999999999999999864 23335667899999999999999999998865
Q ss_pred -----CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecC
Q psy7825 136 -----THRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFG 209 (357)
Q Consensus 136 -----~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg 209 (357)
....++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 457899999999999999998643 57889999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCC---------CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC-CHHHHH
Q psy7825 210 FARGHMKCKSG---------HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLL 279 (357)
Q Consensus 210 ~~~~~~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~ 279 (357)
++......... ..........|++.|+|||++.+......++|||||||++|+|++ ||... +.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 98754321100 001222345789999999999876433344999999999999998 66532 333444
Q ss_pred HHHhhc-cc--CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 280 KQVQTK-VV--FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 280 ~~i~~~-~~--~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
..+... .. .......+..+++||++|| .||.+||++.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 444332 11 2223467889999999999 899999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=355.78 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=220.5
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEEC-------CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcce
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATST-------RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIR 128 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~ 128 (357)
....+..++|.+.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.+ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 334566788999999999999999999975 457889999986432 233355677999999999 8999999
Q ss_pred eeEEEEeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7825 129 FLQAIETTHRVYIIMEYAEKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKC 192 (357)
Q Consensus 129 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp 192 (357)
+++++...+.+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 9999999999999999999999999998653 389999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCC
Q psy7825 193 ENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFD 271 (357)
Q Consensus 193 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~ 271 (357)
+|||++.++.+||+|||++....... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTS---SEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred ceEEEcCCCCEEEccccccccccccc---cccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcC
Confidence 99999999999999999987442211 1111233457889999999988777766 999999999999999 999999
Q ss_pred CCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 272 DTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 272 ~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+....++...+......+.+..++..+.+||.+|| .+|.+||++.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99988888888777666666789999999999999 899999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=350.73 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=223.4
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
....+...+|.+.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3455677889999999999999999999999999999999864322 245677999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
...++||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999874 45899999999999999999999999999999999999999999999999998743
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.+.......+......+.+..
T Consensus 162 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 3kfa_A 162 TGD----TYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236 (288)
T ss_dssp CSS----SSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred cCC----ccccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCC
Confidence 211 1112233457889999999988888766 999999999999999 9999999888888888877777777778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+++.+.+||++|| .||.+||++.++++
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999 89999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=355.24 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=217.7
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEE--EEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDV--AVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIET 135 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 135 (357)
..+..++|.+.+.||+|+||.||+|++..+|..+ |+|.+..... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 3455678999999999999999999998888765 8998864322 22345678999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREG----------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG 199 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~ 199 (357)
.+.+++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 999999999999999999997654 6999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q psy7825 200 EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQL 278 (357)
Q Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~ 278 (357)
++.++|+|||++...... .......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+..+.
T Consensus 178 ~~~~kL~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~ 250 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250 (327)
T ss_dssp GGCEEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCeEEEcccCcCcccccc------ccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence 999999999998632211 11223457889999999988777766 999999999999998 9999999999888
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 279 LKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 279 ~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
...+......+.+..++..+.+||.+|| .+|.+||++.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 251 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8888777666667789999999999999 899999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=355.48 Aligned_cols=255 Identities=31% Similarity=0.521 Sum_probs=205.7
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch---HHhhhHHHHHHHHHcC----CCCCcceeeEEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD---YLKKFLPREIDVVKGL----RHPNLIRFLQAIE 134 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~iv~~~~~~~ 134 (357)
-.++|.+.+.||+|+||.||+|.+..+|+.||||++........ .....+.+|+.++..+ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 34579999999999999999999999999999999865433221 1233455799999888 8999999999999
Q ss_pred eCCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc-CCCcEEEeecCCCc
Q psy7825 135 TTHRVYIIMEY-AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID-GEYNIKLSDFGFAR 212 (357)
Q Consensus 135 ~~~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~-~~~~~kl~Dfg~~~ 212 (357)
..+..++|+|+ +.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++ .++.++|+|||++.
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 99999999999 78899999999888899999999999999999999999999999999999999 88999999999987
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCC
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP 292 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 292 (357)
.... .......|++.|+|||++.+..+...++||||||+++|+|++|+.||..... . ..... ....
T Consensus 189 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~---~~~~~--~~~~ 254 (312)
T 2iwi_A 189 LLHD-------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--I---LEAEL--HFPA 254 (312)
T ss_dssp ECCS-------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H---HHTCC--CCCT
T ss_pred hccc-------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--H---hhhcc--CCcc
Confidence 4422 1223456899999999998777765459999999999999999999976321 1 12222 2335
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.++..+.+||.+|| .+|.+||++.++++||||+...+.
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence 69999999999999 899999999999999999987554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=343.59 Aligned_cols=252 Identities=21% Similarity=0.378 Sum_probs=219.9
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 456678999999999999999999986 5788999999754433 34577999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++||||+++++|.+++... +.+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999999999875 568999999999999999999999999999999999999999999999999986432111
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
........|++.|+|||++.+..++.+ +||||||+++|+|++ |..||...+..+....+........+..++..
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 159 ----YTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 233 (267)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred ----ccccccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHH
Confidence 111223457889999999988777766 999999999999999 89999999998888888877666666789999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+.+||.+|| .+|.+||++.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999 899999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=351.33 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=216.5
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCC----cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHG----CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
...+...+|.+.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34567788999999999999999999876543 459999986432 233355678999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
......++||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999999764 679999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCC
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTE 291 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 291 (357)
....... .........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+..+....+......+.+
T Consensus 196 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~ 272 (333)
T 1mqb_A 196 VLEDDPE--ATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred hhccccc--cccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc
Confidence 5432111 1111223346789999999988888776 999999999999998 99999999988888888877777777
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
..++..+.+||.+|| .+|.+||++.+++++
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999 899999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=353.19 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=212.5
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEE----EEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDV----AVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
..+..++|++.+.||+|+||.||+|.+..+++.+ |+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence 3466788999999999999999999998888766 5555533222 122456779999999999999999999998
Q ss_pred eCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
... .++|++++.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred cCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 765 7889999999999999987 45799999999999999999999999999999999999999999999999999975
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCC
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEP 292 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 292 (357)
..... .........||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.........+......+.++
T Consensus 167 ~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (327)
T 3lzb_A 167 LGAEE---KEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred ccCcc---ccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 42211 1122233457889999999998888876 999999999999999 999999988888888888777777788
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.++.++.+||++|| .||.+||++.++++
T Consensus 243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 243 ICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 89999999999999 89999999999997
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=354.49 Aligned_cols=253 Identities=20% Similarity=0.313 Sum_probs=210.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCC-cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC------cceeeEEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHG-CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN------LIRFLQAI 133 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~ 133 (357)
...++|.+.+.||+|+||.||+|.+..++ ..||+|++... ....+.+.+|+.+++.+.|++ ++.+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 34568999999999999999999998776 78999998632 233566778999999987655 89999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE--------------
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI-------------- 197 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili-------------- 197 (357)
......++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999999 55787777665 369999999999999999999999999999999999999
Q ss_pred -----cCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q psy7825 198 -----DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD 272 (357)
Q Consensus 198 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 272 (357)
+.++.++|+|||++.... .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDH--------EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETT--------SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCCcEEEeecCcccccc--------ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCC
Confidence 667899999999986421 11234579999999999998888876 9999999999999999999998
Q ss_pred CCHHHHHHHHhhcccC-------------------------------------------CCCCCCCHHHHHHHHHhc-CC
Q psy7825 273 TNYIQLLKQVQTKVVF-------------------------------------------PTEPNVSAECKTLLSKIF-SP 308 (357)
Q Consensus 273 ~~~~~~~~~i~~~~~~-------------------------------------------~~~~~~s~~~~~li~~~L-~~ 308 (357)
.+..+....+...... ......+.++.+||++|| .|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 8776655544322110 001122468999999999 99
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q psy7825 309 IKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 309 p~~Rps~~~ll~hp~~~~~ 327 (357)
|.+||++.++|+||||++.
T Consensus 322 P~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 322 PAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTTSCCHHHHTTSGGGGGC
T ss_pred hhhCcCHHHHhcChhhcCC
Confidence 9999999999999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=357.29 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=215.4
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQA 132 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 132 (357)
..+..++|.+.+.||+|+||.||+|.+ ..++..||||++..... ....+.+.+|+.++..+ .||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 345677899999999999999999997 34567899999864322 22346678999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQREG-----------------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~d 189 (357)
+...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999999999999997643 378999999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCC
Q psy7825 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRL 268 (357)
Q Consensus 190 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~ 268 (357)
|||+|||++.++.++|+|||++....... .........||+.|+|||++.+..++.+ +|||||||++|+|++ |..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDS---NYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCT---TSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCC
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCc---cceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999987543211 1112334567889999999988888776 999999999999998 999
Q ss_pred CCCCCCHHH-HHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy7825 269 PFDDTNYIQ-LLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPW 323 (357)
Q Consensus 269 pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~ 323 (357)
||.+..... ....+......+.+..+++++.+||.+|| .||.+||++.+|++|..
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 998766443 33445555555666789999999999999 89999999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=351.21 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=209.7
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 138 (357)
.+...+|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++.....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 3445789999999999999999999999999999999865432 23477999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc-----EEEeecCCCc
Q psy7825 139 VYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN-----IKLSDFGFAR 212 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~-----~kl~Dfg~~~ 212 (357)
.++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 8899999987 467999999999999999999999999999999999999998887 9999999997
Q ss_pred ccccccCCCC--CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhhc-c
Q psy7825 213 GHMKCKSGHQ--SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT---NYIQLLKQVQTK-V 286 (357)
Q Consensus 213 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~-~ 286 (357)
.......... .......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+. +..+....+... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 5433222111 112346689999999999999888766 99999999999999999999873 444444444321 1
Q ss_pred cCCC---CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 287 VFPT---EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 287 ~~~~---~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+. ...++ ++.+||..|| .||.+||++++|++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111 12355 9999999999 99999999999887
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=345.46 Aligned_cols=258 Identities=20% Similarity=0.346 Sum_probs=218.3
Q ss_pred cccccCeEEce-eeeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 60 VMENHGYVLGK-VIGIGSYATVKLATST--RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 60 ~~~~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
.+..++|.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.++..++||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 45566788877 9999999999999854 467889999986542 333456688999999999999999999999 45
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 6689999999999999999754 569999999999999999999999999999999999999999999999999987542
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
.... .........||+.|+|||++.+..++.+ +||||||+++|+|++ |+.||......+....+......+.++.+
T Consensus 162 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 238 (287)
T 1u59_A 162 ADDS--YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 238 (287)
T ss_dssp TCSC--EECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTC
T ss_pred cCcc--eeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCc
Confidence 2111 1112233457899999999988777766 999999999999998 99999998888888887776666666789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQDPW 323 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~hp~ 323 (357)
++++.+||.+|| .+|.+||++.+++++.|
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999 89999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=365.25 Aligned_cols=247 Identities=25% Similarity=0.440 Sum_probs=215.7
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
...+..++|.+.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+|+.++||||+++++++....
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 34566788999999999999999999876 7899999986533 2455779999999999999999999987665
Q ss_pred -eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 138 -RVYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 138 -~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
.+++||||+++|+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999987653 799999999999999999999999999999999999999999999999998732
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
.. ......+++.|+|||++.+..++.+ +|||||||++|||++ |..||.+.+..+....+......+.+..
T Consensus 340 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~ 410 (450)
T 1k9a_A 340 SS--------TQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 410 (450)
T ss_dssp C--------------CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred cc--------cccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 11 1122357889999999998888877 999999999999998 9999998888888888887777777788
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+++.+.+||.+|| .||.+||++.+|++
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999 89999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=347.82 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=200.3
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
.....++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.++..+++.++||||+++++++.....
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 34456779999999999999999999999999999999975433 33334455566667888999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+++||||+ ++.+..+... .+.+++..++.++.||+.||.|||+. ||+|+||||+|||++.++.++|+|||++.....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999999 5566666554 46799999999999999999999995 999999999999999999999999999864322
Q ss_pred ccCCCCCCCCCcccCCccccccceec-----CCCCCCCcccHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhhccc--C
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILK-----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTKVV--F 288 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~ 288 (357)
. .......|++.|+|||++. +..++.+ +|||||||++|+|++|+.||.. ....+....+..... .
T Consensus 178 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 178 D------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTH-HHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC
T ss_pred C------ccccccCCCccccChhhcccccccccCCccc-cchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC
Confidence 1 1223456899999999995 3445555 9999999999999999999987 345555555544322 3
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 289 PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 289 ~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+....++.++.+||.+|| .||.+||++.+|++||||++.
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 334568999999999999 899999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=342.32 Aligned_cols=250 Identities=25% Similarity=0.452 Sum_probs=203.7
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-hHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP-DYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
+...+|.+.+.||+|+||.||+|.+. |+.||||++....... ....+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45678999999999999999999875 8899999986543322 22245678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEEcC--------CCcEEEeec
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG---VVHRDIKCENLLIDG--------EYNIKLSDF 208 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dlkp~Nili~~--------~~~~kl~Df 208 (357)
++||||+++++|.+++. ...+++..++.++.||+.||.|||+.| |+||||||+|||++. ++.++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999985 456999999999999999999999999 899999999999986 678999999
Q ss_pred CCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-hccc
Q psy7825 209 GFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ-TKVV 287 (357)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~ 287 (357)
|++..... .......|++.|+|||++.+..++.+ +||||||+++|+|++|+.||.+.+.......+. ....
T Consensus 161 g~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 161 GLAREWHR-------TTKMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232 (271)
T ss_dssp CC--------------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred Cccccccc-------ccccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence 99864321 11224569999999999988877766 999999999999999999999888777665554 3444
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+.+..+++.+.+||.+|| .||.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 5556789999999999999 899999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=358.43 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=207.7
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-----------CCCcc
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-----------HPNLI 127 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv 127 (357)
..+...+|.+.+.||+|+||.||+|.+..+|+.||||++.. .......+.+|+.++..+. ||||+
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 34566789999999999999999999999999999999863 2223456778999998886 89999
Q ss_pred eeeEEEEeCC----eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEc--
Q psy7825 128 RFLQAIETTH----RVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLID-- 198 (357)
Q Consensus 128 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~-- 198 (357)
++++++.... .+++|||++ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 9999987654 789999999 88999999863 4599999999999999999999998 999999999999994
Q ss_pred ----CCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Q psy7825 199 ----GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN 274 (357)
Q Consensus 199 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 274 (357)
..+.++|+|||++..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC----
T ss_pred CCCcCcceEEEcccccccccCC--------CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCc
Confidence 344799999999864321 1234568999999999999888776 999999999999999999998654
Q ss_pred ------HHHHHHHHhhcc-----------------------------------------cCCCCCCCCHHHHHHHHHhc-
Q psy7825 275 ------YIQLLKQVQTKV-----------------------------------------VFPTEPNVSAECKTLLSKIF- 306 (357)
Q Consensus 275 ------~~~~~~~i~~~~-----------------------------------------~~~~~~~~s~~~~~li~~~L- 306 (357)
....+..+.... ....+..++.++.+||.+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 319 (373)
T 1q8y_A 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 319 (373)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhc
Confidence 222222221100 01112245678999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 307 SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 307 ~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.||.+||++.+||+||||++....
T Consensus 320 ~dP~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 320 LDPRKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp SSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred cCccccCCHHHHhhChhhhcccCc
Confidence 899999999999999999986443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=352.56 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=221.0
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEE
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA 132 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 132 (357)
...+..++|.+.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 33456678999999999999999999876 357889999986432 22334557799999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQRE----------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN 202 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~ 202 (357)
+......++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 99999999999999999999999753 45789999999999999999999999999999999999999999
Q ss_pred EEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q psy7825 203 IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQ 281 (357)
Q Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~ 281 (357)
++|+|||++........ ........|++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+..+....
T Consensus 177 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp EEECCTTCCCGGGGGGC---EEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred EEECcCccccccccccc---cccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 99999999874422111 111233457889999999988887766 999999999999999 8999999998888888
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 282 VQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 282 i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+......+.+..++..+.+||.+|| .||.+||++.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 253 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7776666666789999999999999 899999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=355.37 Aligned_cols=262 Identities=19% Similarity=0.270 Sum_probs=218.3
Q ss_pred cccccCeEEceeeeecCCeEEEEEE-----ECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLAT-----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
.+...+|.+.+.||+|+||.||+|. ...++..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3556779999999999999999998 55678899999986432 2333456779999999999999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcEE
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQREG-------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG---EYNIK 204 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~---~~~~k 204 (357)
.....++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998753 4899999999999999999999999999999999999984 44699
Q ss_pred EeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q psy7825 205 LSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQ 283 (357)
Q Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~ 283 (357)
|+|||++....... .........|++.|+|||++.+..++.+ +|||||||++|+|++ |..||......+....+.
T Consensus 184 l~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 184 IGDFGMARDIYRAS---YYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp ECCCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ECcccccccccccc---ccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 99999986432111 1122234568899999999988887766 999999999999998 999999999888888887
Q ss_pred hcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 284 TKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.......+..++..+.+||.+|| .||.+||++.+|++|.|+...
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 77666666789999999999999 899999999999999887543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=372.54 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=222.7
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
...+...+|.+.+.||+|+||.||+|.+..++..||||++...... .+.+.+|+.+|+.++||||+++++++....
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 3455677899999999999999999999988999999998654332 455779999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999999864 458999999999999999999999999999999999999999999999999987542
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
.. .........+++.|+|||++.+..++.+ +|||||||++|||++ |..||.+.+..++...+......+.+..+
T Consensus 370 ~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (495)
T 1opk_A 370 GD----TYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 444 (495)
T ss_dssp TC----CEECCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred CC----ceeecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 11 1112233456789999999988888776 999999999999999 99999998888888888777777777889
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++.+.+||.+|| .||.+||++.+|++
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 999999999999 89999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=343.25 Aligned_cols=254 Identities=29% Similarity=0.420 Sum_probs=204.8
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 34569999999999999999999999999999999976555555556778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 142 IMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999999975 456999999999999999999999999999999999999999999999999998643221
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhhcccCC-CCCCC
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT--NYIQLLKQVQTKVVFP-TEPNV 294 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~-~~~~~ 294 (357)
........|++.|+|||++.+..++.+ +||||||+++|+|++|..||.+. ........+......+ ....+
T Consensus 190 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 190 -----TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred -----CccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence 112234568999999999998887766 99999999999999999999754 3444445444332222 23578
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+.++.+||.+|| .||.+||++.+|+++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999 899999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=339.26 Aligned_cols=248 Identities=17% Similarity=0.255 Sum_probs=214.0
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC--C
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT--H 137 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 137 (357)
.+..++|.+.+.||+|+||.||+|.+. |+.||||++....... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 455677999999999999999999985 8899999997654333 3345688999999999999999999999876 7
Q ss_pred eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.| ++||||||+|||++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8899999999999999998765 4899999999999999999999999 99999999999999999999999998752
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCC--cccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-hcccCCC
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH--YSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ-TKVVFPT 290 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~ 290 (357)
. ......||+.|+|||++.+..+... ++|||||||++|+|++|+.||.+.+.......+. .....+.
T Consensus 163 ~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3kmu_A 163 F----------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232 (271)
T ss_dssp T----------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred e----------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC
Confidence 1 1234568999999999987665542 4999999999999999999999988877766554 4444555
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+..++.++.+||.+|| .||.+||++.++++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6689999999999999 89999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=340.81 Aligned_cols=253 Identities=18% Similarity=0.192 Sum_probs=211.0
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 139 (357)
+..++|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.++..+ +|+|++++++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 456679999999999999999999999999999999865432 34467899999999 799999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc-----EEEeecCCCcc
Q psy7825 140 YIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN-----IKLSDFGFARG 213 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~-----~kl~Dfg~~~~ 213 (357)
++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++..
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 88999999875 45999999999999999999999999999999999999987776 99999999975
Q ss_pred cccccCCCC--CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhhccc-
Q psy7825 214 HMKCKSGHQ--SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT---NYIQLLKQVQTKVV- 287 (357)
Q Consensus 214 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~- 287 (357)
......... ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+. ........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 533222111 122345679999999999998888766 99999999999999999999873 34444444332211
Q ss_pred CC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 288 FP---TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 288 ~~---~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+ ..+.+++++.+||.+|| .||.+||++++|++
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11 12468999999999999 99999999999976
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=349.93 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=216.5
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQA 132 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 132 (357)
..+..++|.+.+.||+|+||.||+|.+ ..+++.||||++..... ....+.+.+|+.++..+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 345667899999999999999999985 45678999999865432 23356688999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQREG------------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~N 194 (357)
+...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999999999999999999998754 48999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCC
Q psy7825 195 LLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDT 273 (357)
Q Consensus 195 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~ 273 (357)
||++.++.++|+|||++....... .........|++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDS---NYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCT---TSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred EEEcCCCCEEEccccccccccccc---cceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999987542211 1112234557889999999988887766 999999999999998 99999876
Q ss_pred CHHH-HHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 274 NYIQ-LLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 274 ~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.... ....+......+.+..++..+.+||.+|| .||.+||++.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 6433 33444555555556689999999999999 899999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=346.69 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=211.8
Q ss_pred ccccccCeEEceeeeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
..+...+|++.+.||+|+||.||+|. +..+++.||||++....... ..+.+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 34556679999999999999999998 56789999999986543222 2456779999999999999999999998
Q ss_pred eC--CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 135 TT--HRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 135 ~~--~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
.. ..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 76 678999999999999999955 467999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC---------------CHH
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT---------------NYI 276 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---------------~~~ 276 (357)
....... ..........||..|+|||++.+..++.+ +||||||+++|+|++|..|+... ...
T Consensus 174 ~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 174 KAIETDK--EYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp EECCTTC--CEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred ccccCCC--cceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 7542211 11122334568889999999988888766 99999999999999999886321 233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 277 QLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 277 ~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.....+......+.++.+++.+.+||.+|| .||.+||++.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 344455556666677789999999999999 89999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=366.59 Aligned_cols=253 Identities=24% Similarity=0.431 Sum_probs=219.6
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
....+..++|.+.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 3446677889999999999999999999864 778999998654322 456779999999999999999999986 6
Q ss_pred CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 6789999999999999999754 36899999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
.... ........+++.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+..++...+......+.+..
T Consensus 335 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 409 (454)
T 1qcf_A 335 EDNE----YTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN 409 (454)
T ss_dssp CCHH----HHTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred CCCc----eeccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 2211 111223446789999999988888776 999999999999999 9999999999999888888888888888
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+++++.+||.+|| .||.+||++++|++
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999 89999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=347.73 Aligned_cols=261 Identities=18% Similarity=0.310 Sum_probs=211.7
Q ss_pred cccccccccCeEEceeeeecCCeEEEEEEECC---CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEE
Q psy7825 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTR---HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA 132 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 132 (357)
.....+..++|.+.+.||+|+||.||+|.+.. ++..||+|++....... ...+.+.+|+.+++.++||||++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34455677889999999999999999998765 45689999986544433 334567799999999999999999999
Q ss_pred EEeCC-----eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7825 133 IETTH-----RVYIIMEYAEKGSLLDFIQR------EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201 (357)
Q Consensus 133 ~~~~~-----~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~ 201 (357)
+.... ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 97654 35999999999999999953 35699999999999999999999999999999999999999999
Q ss_pred cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy7825 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLK 280 (357)
Q Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~ 280 (357)
.++|+|||++....... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||..........
T Consensus 185 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGD---YYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp CEEECSCSCC-------------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred cEEEeecCcceeccccc---ccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 99999999987442211 1112233457889999999998888776 999999999999999 999999888888887
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+......+.+..+++.+.+||.+|| .||.+||++.+|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 261 YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77776666666789999999999999 899999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=340.95 Aligned_cols=252 Identities=22% Similarity=0.386 Sum_probs=216.6
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
...+..++|.+.+.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.+++.++||||+++++++. .+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CC
Confidence 34566778999999999999999999975 4678999998654332 345779999999999999999999886 45
Q ss_pred eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 6889999999999999997543 69999999999999999999999999999999999999999999999999987442
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
.. .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.+..+....+........+..+
T Consensus 161 ~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T 1qpc_A 161 DN----EYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235 (279)
T ss_dssp SS----CEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred Cc----ccccccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccc
Confidence 21 1112233457889999999988777766 999999999999999 99999999988888888777666667789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+..+.+||.+|| .+|.+||++.++++
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999 89999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=347.30 Aligned_cols=247 Identities=19% Similarity=0.332 Sum_probs=207.9
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCC-------cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHG-------CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA 132 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 132 (357)
.+..++|.+.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 356678999999999999999999988776 479999986432 2234567899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc--------E
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN--------I 203 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~--------~ 203 (357)
+...+..++||||++|++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 999999999999999999999999999999999999998887 9
Q ss_pred EEeecCCCcccccccCCCCCCCCCcccCCccccccceecC-CCCCCCcccHHHHHHHHHHHHcC-CCCCCCCCHHHHHHH
Q psy7825 204 KLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-VPYTPHYSDVWSMGVVLYAMAFG-RLPFDDTNYIQLLKQ 281 (357)
Q Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~ 281 (357)
+|+|||++.... ......|++.|+|||++.+ ..++.+ +|||||||++|+|++| ..||...+.......
T Consensus 161 kl~Dfg~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 161 KLSDPGISITVL---------PKDILQERIPWVPPECIENPKNLNLA-TDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EECCCCSCTTTS---------CHHHHHHTTTTSCHHHHHCGGGCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeccCccccccc---------CccccCCcCcccCHHHhCCCCCCCch-hHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 999999985321 1233458899999999987 445554 9999999999999995 566666666655555
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 282 VQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 282 i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.......+ ...+.++.+||.+|| .||.+||++.++++|
T Consensus 231 ~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 231 YEDRHQLP--APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHTTCCCC--CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhccCCCC--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44444333 357899999999999 899999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=349.98 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=192.9
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHH-HHHcCCCCCcceeeEEEEeCC
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREID-VVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~ 137 (357)
..+..++|.+.+.||+|+||.||+|.+..+|+.||||++..... ... ...+..|+. +++.++||||+++++++...+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chH-HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 34566789999999999999999999999999999999975432 222 333445555 778889999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 138 RVYIIMEYAEKGSLLDFIQR-----EGYIDEPRTKKWFRQLVDAIDYCHER-GVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
..++||||+++ +|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999999986 88888864 56799999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCcccCCcccccccee----cCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhhcc
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEIL----KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY-IQLLKQVQTKV 286 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~ 286 (357)
...... .......||+.|+|||++ .+..++.+ +|||||||++|+|++|+.||.+... .+....+....
T Consensus 174 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (327)
T 3aln_A 174 GQLVDS------IAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246 (327)
T ss_dssp CC------------------------------------CCSH-HHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred eecccc------cccccCCCCccccCceeeccccCcCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence 744221 112334699999999999 44556655 9999999999999999999987542 22222222211
Q ss_pred cC----CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 287 VF----PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 287 ~~----~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.. .....++..+.+||.+|| .||.+||++.+|++||||....+.
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence 11 112468999999999999 899999999999999999875443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=340.70 Aligned_cols=252 Identities=19% Similarity=0.365 Sum_probs=208.3
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHh----hhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLK----KFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
...+..++|.+.+.||+|+||.||+|.+..+++.||||++........... +.+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 334667889999999999999999999999999999999865443332211 5678999999999999999999998
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCCc-----EEE
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLIDGEYN-----IKL 205 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~~~~~-----~kl 205 (357)
.... ++||||+++++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++. ++|
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7655 6899999999999988654 47999999999999999999999999 999999999999988776 999
Q ss_pred eecCCCcccccccCCCCCCCCCcccCCccccccceec--CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH
Q psy7825 206 SDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK--GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ--LLKQ 281 (357)
Q Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~ 281 (357)
+|||++.... .......||+.|+|||++. ...++.+ +|||||||++|+|++|+.||....... ....
T Consensus 171 ~Dfg~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 171 ADFGLSQQSV--------HSVSGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CCCTTCBCCS--------SCEECCCCCCTTSCGGGSSCSSCEECHH-HHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred CCCCcccccc--------ccccccCCCccccCchhhccCCCCcCch-hhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 9999986321 1233457999999999984 3344555 999999999999999999998654332 2333
Q ss_pred H-hhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 282 V-QTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 282 i-~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+ ........+..+++.+.+||.+|| .||.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3 334444556689999999999999 89999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=350.59 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=216.6
Q ss_pred cccccccccCeEEceeeeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeE
Q psy7825 56 KKSTVMENHGYVLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQ 131 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 131 (357)
...+.+..++|++.+.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+++.++||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp --CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEE
Confidence 44567788899999999999999999999 4678999999998643 2333566889999999999999999999
Q ss_pred EEE--eCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeec
Q psy7825 132 AIE--TTHRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDF 208 (357)
Q Consensus 132 ~~~--~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Df 208 (357)
++. ....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence 886 46679999999999999999987 456999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH-------------
Q psy7825 209 GFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY------------- 275 (357)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------------- 275 (357)
|++........ .........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.....
T Consensus 172 g~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3lxl_A 172 GLAKLLPLDKD--YYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248 (327)
T ss_dssp GGCEECCTTCS--EEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC
T ss_pred ccceecccCCc--cceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc
Confidence 99875422111 1112334568889999999988877766 9999999999999999999865332
Q ss_pred --HHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 276 --IQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 276 --~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
......+......+.++.+++.+.+||.+|| .||.+||++.+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2344445556666667789999999999999 89999999999964
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=343.10 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=213.9
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECC---CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTR---HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
..+..++|.+.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 34566789999999999999999998653 34569999986542 23335668899999999999999999999865
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
+ ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 568999999999999999765 45999999999999999999999999999999999999999999999999998744
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||......+....+......+.+..
T Consensus 164 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (281)
T 3cc6_A 164 EDE----DYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 238 (281)
T ss_dssp -------------CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTT
T ss_pred ccc----cccccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCC
Confidence 221 1112233457889999999988887766 999999999999998 9999988777777777776666677778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+++.+.+||.+|| .||.+||++.+++++
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999 899999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=349.37 Aligned_cols=256 Identities=22% Similarity=0.297 Sum_probs=204.3
Q ss_pred cccccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 54 VKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 54 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
.......+..++|++.+.||+|+||.||+|++. ++.||||++.... .......+|+.++..++||||+++++++
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~ 87 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAE 87 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhccee
Confidence 344556677889999999999999999999876 7899999985432 2233455789999999999999999999
Q ss_pred EeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCCEEEcC
Q psy7825 134 ETTH----RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER----------GVVHRDIKCENLLIDG 199 (357)
Q Consensus 134 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~ivH~dlkp~Nili~~ 199 (357)
.... .+++||||+++|+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 88 KRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166 (322)
T ss_dssp EEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred ccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence 8744 479999999999999999765 489999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCC-----CCCCcccHHHHHHHHHHHHcCCCCCCCC-
Q psy7825 200 EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP-----YTPHYSDVWSMGVVLYAMAFGRLPFDDT- 273 (357)
Q Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~- 273 (357)
++.+||+|||+++...... .........||+.|+|||++.+.. ++.+ +|||||||++|+|++|+.||.+.
T Consensus 167 ~~~~kL~DFg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 167 NLTACIADFGLALKFEAGK---SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp TCCEEECCCTTCEEECTTS---CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHH-HHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred CCeEEEccCCccccccccc---CccccccCccCccccCHhhcccccccCcCCCcc-chhHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999997543221 122233467999999999998742 2333 79999999999999999999653
Q ss_pred ---------------CHHHHHHHHhhcccCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 274 ---------------NYIQLLKQVQTKVVFPTEP------NVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 274 ---------------~~~~~~~~i~~~~~~~~~~------~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
........+......+..+ ..+.++.+||.+|| .||.+|||+.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2233333333333222211 23456999999999 99999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=341.00 Aligned_cols=249 Identities=24% Similarity=0.443 Sum_probs=208.9
Q ss_pred cccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.....+..++|.+.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3344566778999999999999999999875 8899999986432 24557789999999999999999998754
Q ss_pred C-CeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 136 T-HRVYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 136 ~-~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
. ..+++||||+++++|.+++...+. +++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence 4 478999999999999999987543 8999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCC
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTE 291 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 291 (357)
.... ......+++.|+|||++.+..++.+ +||||||+++|+|++ |..||...+..+....+......+.+
T Consensus 166 ~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (278)
T 1byg_A 166 EASS--------TQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 236 (278)
T ss_dssp ------------------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC
T ss_pred cccc--------cccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCc
Confidence 3321 1123357889999999988877776 999999999999998 99999988888888777777666667
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+++.+.+||.+|| .||.+||++.++++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 789999999999999 89999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=349.23 Aligned_cols=256 Identities=20% Similarity=0.339 Sum_probs=213.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAI 133 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 133 (357)
.+..++|.+.+.||+|+||.||+|.+ ..+++.||||++.... .......+.+|+.++..+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 45567899999999999999999985 4567899999986543 233345678999999999 699999999998
Q ss_pred EeCC-eEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7825 134 ETTH-RVYIIMEYAEKGSLLDFIQREGY----------------IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLL 196 (357)
Q Consensus 134 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nil 196 (357)
...+ .+++||||+++++|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 58999999999999999987543 889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCH
Q psy7825 197 IDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNY 275 (357)
Q Consensus 197 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~ 275 (357)
++.++.++|+|||++...... ..........||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+...
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTC---TTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ECCCCCEEECCCccccccccC---ccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999998744221 11112234567889999999988888766 999999999999998 9999987653
Q ss_pred -HHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 276 -IQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 276 -~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
......+......+.+..+++.+.+||.+|| .||.+||++.++++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3444555555555566679999999999999 899999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=362.11 Aligned_cols=259 Identities=24% Similarity=0.408 Sum_probs=219.0
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
...+..++|.+.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.. .
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 345677889999999999999999999875 567999998654332 3457799999999999999999999866 6
Q ss_pred eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
.+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 78999999999999999975 3569999999999999999999999999999999999999999999999999997542
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
.. .........+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||.+....+....+......+.++.+
T Consensus 332 ~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 406 (452)
T 1fmk_A 332 DN----EYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred CC----ceecccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 11 1112233457889999999988888776 999999999999999 99999999999998888888777878889
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhc--CCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQ--DPWVKTE 327 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~--hp~~~~~ 327 (357)
++.+.+||.+|| .+|.+||++++|++ ..++...
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 999999999999 89999999999987 4566543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=373.85 Aligned_cols=266 Identities=19% Similarity=0.335 Sum_probs=217.5
Q ss_pred ccccccCeEEce-eeeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 59 TVMENHGYVLGK-VIGIGSYATVKLATST--RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 59 ~~~~~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
..+...++.+.+ .||+|+||.||+|.+. .++..||||++...... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 344556677776 8999999999999875 35677999998654322 224567899999999999999999999976
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
+.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 5689999999999999999754 56999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
..... .........+++.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+..++...+......+.++.
T Consensus 487 ~~~~~--~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 563 (613)
T 2ozo_A 487 GADDS--YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 563 (613)
T ss_dssp C----------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTT
T ss_pred cCCCc--eeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 22111 1111223346789999999988888876 999999999999998 9999999988888888888777777778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHh---cCCCCCCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIK---QDPWVKTEANP 330 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll---~hp~~~~~~~~ 330 (357)
++.++.+||..|| .+|.+||++.+|+ ++.|+......
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 9999999999999 8999999999985 45555544333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=339.53 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=212.5
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCc---EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE-E
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGC---DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV-Y 140 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~ 140 (357)
.|.+.++||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+++.++||||+++++++...+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 47788999999999999999755444 79999986422 333456678999999999999999999999766654 9
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 141 IIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999986 45689999999999999999999999999999999999999999999999999975432211
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~ 298 (357)
..........+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..+....+......+.+..+++.+
T Consensus 180 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 180 -YSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257 (298)
T ss_dssp -GCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred -cccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence 11222334568899999999998888876 999999999999999 556677777777777777777777777899999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+||.+|| .+|.+||++.++++
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHH
Confidence 99999999 89999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=351.98 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=201.6
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECC---CCcEEEEEEeecCCCCchH--------HhhhHHHHHHHHHcCCCCCccee
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTR---HGCDVAVKVVSKVEAPPDY--------LKKFLPREIDVVKGLRHPNLIRF 129 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~ 129 (357)
+..++|.+.+.||+|+||.||+|.+.. ++..||||++......... ....+.+|+..+..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345779999999999999999999987 7899999998754321110 11235578899999999999999
Q ss_pred eEEEEe----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC--cE
Q psy7825 130 LQAIET----THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY--NI 203 (357)
Q Consensus 130 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~--~~ 203 (357)
++++.. ....++||||+ |++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999987 77899999999 899999998877899999999999999999999999999999999999999887 99
Q ss_pred EEeecCCCcccccccCCC--CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC--CCHHHHH
Q psy7825 204 KLSDFGFARGHMKCKSGH--QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD--TNYIQLL 279 (357)
Q Consensus 204 kl~Dfg~~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--~~~~~~~ 279 (357)
+|+|||+++......... .........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+ .+.....
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999997553322211 1111245679999999999998877776 9999999999999999999964 2222222
Q ss_pred HHHhhccc--CC-------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 280 KQVQTKVV--FP-------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 280 ~~i~~~~~--~~-------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.. ..... .+ ....+++++.+||..|| .||.+||++.+|++.
T Consensus 272 ~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 272 TA-KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HH-HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HH-HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 11 11111 11 11268999999999999 899999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=348.71 Aligned_cols=261 Identities=23% Similarity=0.372 Sum_probs=208.4
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE---
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE--- 134 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 134 (357)
...+..++|.+.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 3456678899999999999999999999999999999998653 2334566789999999999999999999986
Q ss_pred -eCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecC
Q psy7825 135 -TTHRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFG 209 (357)
Q Consensus 135 -~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg 209 (357)
.....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 24478999999999999999976 4679999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCC----CCCCCcccCCccccccceecCCC---CCCCcccHHHHHHHHHHHHcCCCCCCCCCH--HHHHH
Q psy7825 210 FARGHMKCKSGHQ----SPLSDTFCGSYAYASPEILKGVP---YTPHYSDVWSMGVVLYAMAFGRLPFDDTNY--IQLLK 280 (357)
Q Consensus 210 ~~~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~ 280 (357)
++........... ........||+.|+|||++.+.. ++.+ +||||||+++|+|++|+.||..... .....
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER-TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTH-HHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCch-hhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 8764321110000 00001234799999999987654 4544 9999999999999999999953211 11222
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDP 322 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp 322 (357)
.+......+..+.++..+.+||.+|| .||.+||++.+++++-
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 33444556666789999999999999 8999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=349.56 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=215.3
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCc-----EEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGC-----DVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQA 132 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 132 (357)
..+..++|.+.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.++..+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34567789999999999999999999876654 79999986533 223356688999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q psy7825 133 IETTHRVYIIMEYAEKGSLLDFIQRE--------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID 198 (357)
Q Consensus 133 ~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~ 198 (357)
+...+.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999999753 3579999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHH
Q psy7825 199 GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQ 277 (357)
Q Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~ 277 (357)
.++.++|+|||++....... .........|++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCT---TSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCeEEECcccccccccccc---ceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999987543211 1112234557889999999988887766 999999999999998 999998765444
Q ss_pred HH-HHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 278 LL-KQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 278 ~~-~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.. ..+......+.+..++..+.+||.+|| .||.+||++.+|+++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 33 334445555556678999999999999 899999999999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=337.55 Aligned_cols=247 Identities=21% Similarity=0.341 Sum_probs=208.1
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------- 135 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 135 (357)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 346999999999999999999999899999999986532 345689999999999999999998864
Q ss_pred ---------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEE
Q psy7825 136 ---------THRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIK 204 (357)
Q Consensus 136 ---------~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~k 204 (357)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45689999999999999999754 5799999999999999999999999999999999999999999999
Q ss_pred EeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh
Q psy7825 205 LSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT 284 (357)
Q Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 284 (357)
|+|||++...... .......|++.|+|||++.+..++.+ +||||||+++|+|++|..||... ......+..
T Consensus 163 l~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~ 233 (284)
T 2a19_B 163 IGDFGLVTSLKND------GKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET--SKFFTDLRD 233 (284)
T ss_dssp ECCCTTCEESSCC------SCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred ECcchhheecccc------ccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence 9999998744221 12234569999999999998888776 99999999999999999987532 222233322
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 285 KVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 285 ~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
. .....++..+++||.+|| .||.+||++.++++|.|.-...
T Consensus 234 ~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 234 G---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp T---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred c---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 2 223468999999999999 8999999999999998876543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=351.90 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=205.6
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|.+.+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 4567999999999999999999964 6899999987654322 24567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 142 IMEYAEKGSLLDFIQREG----YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999996543 5899999999999999999999999999999999999999999999999998643211
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHH------H-HHhh-c----
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLL------K-QVQT-K---- 285 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~-~i~~-~---- 285 (357)
..........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......+.. . .... .
T Consensus 193 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 193 ---DQTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp ---SCCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred ---cccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 11222344568999999999988888776 99999999999999999999754322111 0 1100 0
Q ss_pred ----ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy7825 286 ----VVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDP 322 (357)
Q Consensus 286 ----~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp 322 (357)
......+.++..+.+||.+|| .||.+||++.+++++.
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 001112235678999999999 8999999999999764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=339.51 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=210.3
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE-EeCC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI-ETTH 137 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 137 (357)
...+|.+.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++ ..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 345699999999999999999996543 3458899876422 333456678999999999999999999985 4566
Q ss_pred eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 88999999999999999976 35689999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s 295 (357)
.... .........||+.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.+..+....+........+..++
T Consensus 181 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (298)
T 3f66_A 181 KEYY-SVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 258 (298)
T ss_dssp GGGC-BC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred cchh-ccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence 2211 1122334567889999999988888776 999999999999999 677888777777777776666666667899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+.+||.+|| .+|.+||++.++++
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999 89999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=337.93 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=198.1
Q ss_pred cccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.....+..++|.+.+.||+|+||.||+|.+.. .||+|++..... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 44556778889999999999999999998643 599999865543 333456688999999999999999999954 5
Q ss_pred CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 6678999999999999999964 456999999999999999999999999999999999999999999999999998643
Q ss_pred ccccCCCCCCCCCcccCCccccccceec---CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhhcccCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILK---GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQVQTKVVFPT 290 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~ 290 (357)
.... .........||+.|+|||++. +..++.+ +||||||+++|+|++|+.||.+.... .....+......+.
T Consensus 171 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 171 SRWS---GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ-SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHH-HHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred cccc---ccccccccCCCccccCchhhcccCCCCCCcc-cchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 2211 112223456999999999986 4455555 99999999999999999999875444 44444433322221
Q ss_pred ----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 291 ----EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 291 ----~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
...+++.+.+||.+|| .+|.+||++.++++
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3468999999999999 89999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=372.15 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=213.3
Q ss_pred ccccCeEEc-eeeeecCCeEEEEEEE--CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 61 MENHGYVLG-KVIGIGSYATVKLATS--TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 61 ~~~~~y~~~-~~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
+....+.+. +.||+|+||.||+|.+ ..+++.||||++...... ....+.+.+|+.+|..++||||+++++++.. .
T Consensus 365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~ 442 (635)
T 4fl3_A 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-E 442 (635)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 334445553 4899999999999954 456789999998654332 2334668899999999999999999999975 4
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 58899999999999999998888999999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCH
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSA 296 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 296 (357)
.. .........||+.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+..++...+......+.+..++.
T Consensus 523 ~~--~~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 599 (635)
T 4fl3_A 523 EN--YYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 599 (635)
T ss_dssp --------------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cc--ccccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 11 1122233457889999999988888877 999999999999998 9999999999999988888877777788999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
++.+||..|| .||.+||++.+|++
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999 89999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=351.91 Aligned_cols=258 Identities=17% Similarity=0.229 Sum_probs=200.7
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCchHH--------hhhHHHHHHHHHcCCCCCcc
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRH-----GCDVAVKVVSKVEAPPDYL--------KKFLPREIDVVKGLRHPNLI 127 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv 127 (357)
+..++|.+.+.||+|+||.||+|.+..+ ++.||||++.......... ...+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456799999999999999999998764 5889999986543111000 11233566677888999999
Q ss_pred eeeEEEEeC----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc--CC
Q psy7825 128 RFLQAIETT----HRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID--GE 200 (357)
Q Consensus 128 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~--~~ 200 (357)
++++++... ...++||||+ |++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 5689999999 99999999876 6799999999999999999999999999999999999999 88
Q ss_pred CcEEEeecCCCcccccccCCCC--CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-HHH
Q psy7825 201 YNIKLSDFGFARGHMKCKSGHQ--SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN-YIQ 277 (357)
Q Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~ 277 (357)
+.+||+|||+++.......... .......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.. ...
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 9999999999975543222111 112234569999999999998888776 999999999999999999998532 122
Q ss_pred HHHHHhhccc---------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 278 LLKQVQTKVV---------FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 278 ~~~~i~~~~~---------~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.......... ......++.++.+||..|| .+|.+||++.+|++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111111000 0012468999999999999 89999999999885
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=341.10 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=207.1
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECC-CCc--EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTR-HGC--DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
...+..++|++.+.||+|+||.||+|.+.. +++ .||||++...........+.+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 345667789999999999999999998643 333 68999987654444445667889999999999999999999998
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
... .++|+||+++++|.+++... +.+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|+|||++..
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred cCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 765 88999999999999999764 5699999999999999999999999999999999999999999999999999875
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhh-cccCCCC
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQT-KVVFPTE 291 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~-~~~~~~~ 291 (357)
...... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.+..+....+.. ....+..
T Consensus 171 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 171 LPQNDD--HYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247 (291)
T ss_dssp CCC-CC--EEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred cccccc--chhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC
Confidence 422111 1112234457889999999988777766 999999999999999 9999999988888777654 3445556
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..++.++.+||.+|| .||.+||++.++++
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 689999999999999 89999999999997
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=342.93 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=208.9
Q ss_pred cccccCeEEceeeeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATS----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.+....|++.+.||+|+||.||++.+ ..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 34455569999999999999988764 4478999999986542 23345668899999999999999999999987
Q ss_pred --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 136 --THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 136 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
...+++||||+++++|.+++.... +++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 468999999999999999997654 89999999999999999999999999999999999999999999999999875
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH---------------HH
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI---------------QL 278 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------~~ 278 (357)
...... .........|++.|+|||++.+..++.+ +|||||||++|+|++|..||...... ..
T Consensus 184 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 184 VPEGHE--YYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CCTTCS--EEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccc--ccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 422111 1112334568889999999988887766 99999999999999999999753221 22
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 279 LKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 279 ~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
...+......+.+..++.++.+||++|| .||.+||++.++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 3334445556667789999999999999 89999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=357.57 Aligned_cols=258 Identities=21% Similarity=0.315 Sum_probs=198.0
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeC
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETT 136 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 136 (357)
...+...+|.+.++||+|+||+||.. ...+|+.||||++.... ...+.+|+.+++.+ +||||+++++++...
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT------EEECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred cEEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 44566677999999999999997643 34568999999985422 22355899999999 799999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-----CCcEEEeecCC
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-----EYNIKLSDFGF 210 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-----~~~~kl~Dfg~ 210 (357)
...|+||||+.| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ...++|+|||+
T Consensus 91 ~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 91 QFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp TEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred CEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999999999965 9999997653 4666678899999999999999999999999999999953 23588999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceecC---CCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcc
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG---VPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKV 286 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 286 (357)
++....... ........+||+.|+|||++.+ ..++.+ +|||||||++|+|++ |..||...........+....
T Consensus 170 a~~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~-~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 246 (432)
T 3p23_A 170 CKKLAVGRH--SFSRRSGVPGTEGWIAPEMLSEDCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS 246 (432)
T ss_dssp EECC--------------CCSCTTSCCGGGTSCC---CCCTH-HHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCC
T ss_pred eeeccCCCc--ceeeccccCCCcCccChhhhhcccccCCCcH-HHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCC
Confidence 875432211 1122345679999999999974 344444 999999999999999 999997665444332222111
Q ss_pred c--CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 287 V--FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 287 ~--~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
. .......+..+++||.+|| .||.+||++.+|++||||..
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 1 1112234667899999999 89999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=345.15 Aligned_cols=248 Identities=18% Similarity=0.219 Sum_probs=202.5
Q ss_pred ccCeEEceeeeecCCeEEEEEEECC--------CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcce------
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTR--------HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIR------ 128 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~------ 128 (357)
.++|.+.+.||+|+||.||+|.+.. .++.||||++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4789999999999999999999887 4899999998653 34678999999999999887
Q ss_pred ---------eeEEEEe-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7825 129 ---------FLQAIET-THRVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLL 196 (357)
Q Consensus 129 ---------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nil 196 (357)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5677766 78899999999 89999999875 77999999999999999999999999999999999999
Q ss_pred EcCCC--cEEEeecCCCcccccccCCC--CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q psy7825 197 IDGEY--NIKLSDFGFARGHMKCKSGH--QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD 272 (357)
Q Consensus 197 i~~~~--~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 272 (357)
++.++ .++|+|||+++......... .........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCccc
Confidence 99998 89999999997554322211 1112234579999999999998888776 9999999999999999999986
Q ss_pred C--CHHHHHHHHhh---ccc-CC----CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 273 T--NYIQLLKQVQT---KVV-FP----TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 273 ~--~~~~~~~~i~~---~~~-~~----~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
. ....+...... ... +. ....++.++.+||.+|| .||.+||++.+|++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 5 33333333221 111 11 11257999999999999 99999999999976
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=352.20 Aligned_cols=254 Identities=20% Similarity=0.303 Sum_probs=202.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE-eCCeE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE-TTHRV 139 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 139 (357)
..|.+.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4588999999999999999987543 2468999886432 2233566789999999999999999999864 45688
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 458899999999999999999999999999999999999999999999999997542211
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAE 297 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 297 (357)
. ..........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+..+....+......+.+..++..
T Consensus 247 ~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 247 F-DSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHH
T ss_pred c-ccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 1 11112234457889999999988888776 999999999999999 78889877766666666666555666789999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+.+||.+|| .||.+||++.+++++
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999 899999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=336.79 Aligned_cols=252 Identities=25% Similarity=0.443 Sum_probs=205.9
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+...+|.+.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|+.+++.++||||+++++++.+ ..+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45677999999999999999999875 789999998532 124567799999999999999999998763 478
Q ss_pred EEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCCEEEcCCCc-EEEeecCCCcc
Q psy7825 141 IIMEYAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHE---RGVVHRDIKCENLLIDGEYN-IKLSDFGFARG 213 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dlkp~Nili~~~~~-~kl~Dfg~~~~ 213 (357)
+||||++|++|.+++.... .++...++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998654 37889999999999999999999 89999999999999998887 79999999864
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhhcccCCCC
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT--NYIQLLKQVQTKVVFPTE 291 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~ 291 (357)
... ......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||... ........+......+..
T Consensus 156 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
T 2eva_A 156 IQT--------HMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCB
T ss_pred ccc--------ccccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcc
Confidence 321 1223458999999999998888776 99999999999999999999754 334444445555555556
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhc-----CCCCCCCCCC
Q psy7825 292 PNVSAECKTLLSKIF-SPIKFRIRLKDIKQ-----DPWVKTEANP 330 (357)
Q Consensus 292 ~~~s~~~~~li~~~L-~~p~~Rps~~~ll~-----hp~~~~~~~~ 330 (357)
..++..+.+||.+|| .||.+||++.++++ ..++.+...+
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 689999999999999 89999999999997 4666554443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=364.96 Aligned_cols=259 Identities=24% Similarity=0.399 Sum_probs=222.2
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
....+..++|.+.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3445677889999999999999999999875 567999998754332 3457799999999999999999999865
Q ss_pred CeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
..+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 678999999999999999975 356999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
.... ........++..|+|||++.+..++.+ +|||||||++|||++ |+.||.+....++...+......+.+..
T Consensus 414 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 488 (535)
T 2h8h_A 414 EDNE----YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 488 (535)
T ss_dssp CCHH----HHTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred CCCc----eecccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 2111 011223446789999999988888776 999999999999999 9999999999999988888877777788
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcC--CCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQD--PWVKT 326 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~h--p~~~~ 326 (357)
++..+.+||.+|| .||.+||++++|++. .++..
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999 899999999999873 55544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=336.05 Aligned_cols=231 Identities=26% Similarity=0.505 Sum_probs=188.6
Q ss_pred cCeEEc-eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHH-HcCCCCCcceeeEEEEe----CC
Q psy7825 64 HGYVLG-KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV-KGLRHPNLIRFLQAIET----TH 137 (357)
Q Consensus 64 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~ 137 (357)
++|.+. +.||+|+||.||+|.+..+|+.||||++.. ...+.+|+.++ +.++||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 347776 889999999999999999999999999863 23355788887 66689999999999987 77
Q ss_pred eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcEEEeecCCCc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG---EYNIKLSDFGFAR 212 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~---~~~~kl~Dfg~~~ 212 (357)
.+++||||++|++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 8999999999999999998754 6999999999999999999999999999999999999998 7889999999985
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC---C
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF---P 289 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~ 289 (357)
... +..++.+ +|||||||++|+|++|..||.+.........+...... +
T Consensus 169 ~~~---------------------------~~~~~~~-~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 169 ETT---------------------------GEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp ECT---------------------------TCGGGGH-HHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred ccc---------------------------cccCCch-hhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 221 1223444 99999999999999999999876654443222221111 1
Q ss_pred CC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 290 TE----PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 290 ~~----~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.+ ..+++++++||.+|| .||.+||++.++|+||||++....
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 11 468999999999999 999999999999999999887543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=345.43 Aligned_cols=262 Identities=18% Similarity=0.282 Sum_probs=207.1
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
....+..++|.+.+.||+|+||.||+|.+ .+|+.||||++........ ...+.+|+.++..++||||+++++++...
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 33445667899999999999999999984 4689999999865432221 23577999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEcCCCcEEEeecC
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREG----YIDEPRTKKWFRQLVDAIDYCHER---GVVHRDIKCENLLIDGEYNIKLSDFG 209 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dlkp~Nili~~~~~~kl~Dfg 209 (357)
...++||||+++|+|.+++.... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999998643 499999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHH
Q psy7825 210 FARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT--------NYIQLLKQ 281 (357)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~ 281 (357)
++...... .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||... ...+....
T Consensus 180 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 180 LAKLMDYK----DTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp SCEECCSS----SSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred cccccCcc----cccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 98744211 1222334569999999999988887766 99999999999999999999521 11111111
Q ss_pred HhhcccC----------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 282 VQTKVVF----------PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 282 i~~~~~~----------~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
....... ...+..+..+.+||.+|| .||.+||++.+|++|-+-..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 1111000 011123478999999999 89999999999999876443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=344.64 Aligned_cols=262 Identities=23% Similarity=0.396 Sum_probs=193.3
Q ss_pred ccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEE-
Q psy7825 57 KSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIE- 134 (357)
Q Consensus 57 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~- 134 (357)
....+...+|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.++..+. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 34456667899999999999999999999999999999988543 2333556779999999996 999999999984
Q ss_pred -------eCCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEcCCCc
Q psy7825 135 -------TTHRVYIIMEYAEKGSLLDFIQR---EGYIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLIDGEYN 202 (357)
Q Consensus 135 -------~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~~~~~ 202 (357)
....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 3446899999996 599998865 467999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCcccccccCCCC-------CCCCCcccCCcccccccee---cCCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Q psy7825 203 IKLSDFGFARGHMKCKSGHQ-------SPLSDTFCGSYAYASPEIL---KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD 272 (357)
Q Consensus 203 ~kl~Dfg~~~~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 272 (357)
++|+|||++........... ........||+.|+|||++ .+..++.+ +|||||||++|+|++|..||.+
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK-QDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHH-HHHHHHHHHHHHHHHSSCCC--
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChH-HhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999975432211100 0111245689999999998 45555555 9999999999999999999987
Q ss_pred CCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 273 TNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 273 ~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
........ .....+.....+..+.+||++|| .||.+||++.++++|-+--.
T Consensus 256 ~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 256 GAKLRIVN---GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHhhc---CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 65544332 33444555678899999999999 89999999999999865443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=331.73 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=200.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEE-EEeCCeEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA-IETTHRVYI 141 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~l 141 (357)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..+.|++++..+.. +......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 4679999999999999999999999999999998754332 2346789999999998877666554 477888999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEEeecCCCcccccc
Q psy7825 142 IMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 217 (357)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 8899999985 4679999999999999999999999999999999999999 78899999999999755332
Q ss_pred cCCCC--CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH-hhcccCC--
Q psy7825 218 KSGHQ--SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI---QLLKQV-QTKVVFP-- 289 (357)
Q Consensus 218 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i-~~~~~~~-- 289 (357)
..... ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.. .....+ ......+
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 22111 122345679999999999998888766 99999999999999999999764321 122221 1112222
Q ss_pred -CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 290 -TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 290 -~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
....+++++.+||.+|| .+|.+||++.+|++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 12468999999999999 89999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=330.70 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=203.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEE-EEeCCeEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA-IETTHRVYI 141 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~l 141 (357)
.++|.+.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.+.|++++..+.. +......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 46799999999999999999999999999999998654332 346789999999998886665554 467788999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEEeecCCCcccccc
Q psy7825 142 IMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 217 (357)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 8899999974 4579999999999999999999999999999999999999 47889999999999754332
Q ss_pred cCCCC--CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhh-cccCC--
Q psy7825 218 KSGHQ--SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN---YIQLLKQVQT-KVVFP-- 289 (357)
Q Consensus 218 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~-~~~~~-- 289 (357)
..... ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.. .......+.. ....+
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 22111 112345679999999999998888766 999999999999999999997632 1122222211 11222
Q ss_pred -CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 290 -TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 290 -~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
....+++++.+||.+|| .||.+||++.+|++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 12468999999999999 89999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=342.14 Aligned_cols=259 Identities=20% Similarity=0.347 Sum_probs=210.2
Q ss_pred cccccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 56 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.....+..++|.+.+.||+|+||.||+|.+.. .||+|++........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNED-QLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCC-CCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHH-HHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 34455667889999999999999999998764 499999865433222 23446689999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
...+++||||++|++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++ ++.++|+|||++...
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999998754 699999999999999999999999999999999999998 679999999998654
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCC---------CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhc
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGV---------PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK 285 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 285 (357)
................|++.|+|||++.+. .++.+ +|||||||++|+|++|..||...........+...
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHH-HHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 322222222333445699999999999752 34444 99999999999999999999999888887777655
Q ss_pred ccCCC-CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 286 VVFPT-EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 286 ~~~~~-~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..... ...++.++.+||.+|| .||.+||++.++++
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 44332 3368999999999999 89999999999997
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=355.84 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=202.6
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC--e
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH--R 138 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 138 (357)
..+++|.+.+.||+|+||.||+|.+..+|+.||||++........ .+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 345679999999999999999999999999999999865332221 345678999999999999999999998755 7
Q ss_pred EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----cCCCcEEEeecCCC
Q psy7825 139 VYIIMEYAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI----DGEYNIKLSDFGFA 211 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili----~~~~~~kl~Dfg~~ 211 (357)
.++||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997643 39999999999999999999999999999999999999 77788999999999
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecC--------CCCCCCcccHHHHHHHHHHHHcCCCCCCC----CCHHHHH
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKG--------VPYTPHYSDVWSMGVVLYAMAFGRLPFDD----TNYIQLL 279 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~----~~~~~~~ 279 (357)
+..... .......||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.. ....+..
T Consensus 164 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 164 RELEDD------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp EECCCG------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHH-HHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred eEccCC------CccccccCCccccCHHHhhccccccccccCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 744221 12234569999999999865 344444 9999999999999999999964 2233444
Q ss_pred HHHhhccc--------------------CCCC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 280 KQVQTKVV--------------------FPTE----PNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 280 ~~i~~~~~--------------------~~~~----~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+..... .+.. ..++..+.+||++|| .||++||++.++++
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 44433221 1111 234568899999999 99999999999854
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=335.22 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=194.1
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHc--CCCCCcceeeEEEEe----
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG--LRHPNLIRFLQAIET---- 135 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~---- 135 (357)
..++|.+.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 456799999999999999999987 58999999985421 2334456666665 789999999998654
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEEcCCCcEEEee
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH--------ERGVVHRDIKCENLLIDGEYNIKLSD 207 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~ivH~dlkp~Nili~~~~~~kl~D 207 (357)
...+++||||+++|+|.++++. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 3468999999999999999954 46999999999999999999999 99999999999999999999999999
Q ss_pred cCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCC-----CcccHHHHHHHHHHHHcC----------CCCCCC
Q psy7825 208 FGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTP-----HYSDVWSMGVVLYAMAFG----------RLPFDD 272 (357)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~ell~g----------~~pf~~ 272 (357)
||++......... .........||+.|+|||++.+..... .++|||||||++|+|++| ..||..
T Consensus 157 fg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 157 LGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CTTCEEEETTTTE-EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCeeeccccccc-ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9998643222111 111123457999999999998763322 239999999999999999 888854
Q ss_pred C-----CHHHHHHHHhhcccCCCC------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 273 T-----NYIQLLKQVQTKVVFPTE------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 273 ~-----~~~~~~~~i~~~~~~~~~------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
. ........+......+.. ..++..+.+||.+|| .||.+||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2 233333333222222221 125578999999999 89999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=351.33 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=191.7
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 141 (357)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .+.+.+|+.++..+ +||||+++++++.....+++
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 4458888999999999998754 4569999999986421 33466899999876 89999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-------------C
Q psy7825 142 IMEYAEKGSLLDFIQREGYI-------DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-------------Y 201 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l-------~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-------------~ 201 (357)
||||+. |+|.+++...... ++..++.++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999996 5999999875432 223457899999999999999999999999999999754 4
Q ss_pred cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecC-------CCCCCCcccHHHHHHHHHHHHc-CCCCCCCC
Q psy7825 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG-------VPYTPHYSDVWSMGVVLYAMAF-GRLPFDDT 273 (357)
Q Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~-g~~pf~~~ 273 (357)
.++|+|||++......... ........+||+.|+|||++.+ ..++.+ +|||||||++|+|++ |..||.+.
T Consensus 166 ~~kL~DFG~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSS-FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EEEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTH-HHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEEEcccccceecCCCCcc-ceeeecCCCCCCCccCHHHhccccccccccCcchh-hhhHhHHHHHHHHHhCCCCCCCCc
Confidence 8999999999754321111 0111234579999999999976 445544 999999999999998 99999765
Q ss_pred CHHHHHHHHhhcccCCCC-----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 274 NYIQLLKQVQTKVVFPTE-----PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 274 ~~~~~~~~i~~~~~~~~~-----~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.... ...+......+.. ..++.++++||.+|| .||.+||++.+|++||||...
T Consensus 244 ~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 244 YSRE-SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp TTHH-HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred hhhH-HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 4333 1222222222221 234589999999999 899999999999999999753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=338.75 Aligned_cols=255 Identities=23% Similarity=0.404 Sum_probs=209.1
Q ss_pred cccccCeEEceeeeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLAT----STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.+...+|++.+.||+|+||.||+|. ...+|+.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 4556779999999999999999998 4567999999998653 22335668899999999999999999998865
Q ss_pred CC--eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 136 TH--RVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 136 ~~--~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.. .+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 43 789999999999999999875 469999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCH----------------H
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNY----------------I 276 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------------~ 276 (357)
....... .........++..|+|||++.+..++.+ +||||||+++|+|++|..||..... .
T Consensus 194 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 194 VLPQDKE--YYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp ECCSSCS--EEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred hcccccc--ccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 5422111 0111233457888999999988777766 9999999999999999999864311 1
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 277 QLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 277 ~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.+...+......+.+..++.++.+||++|| .||.+||++.+|++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222334444455666789999999999999 89999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=334.50 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=195.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC--CCCCcceeeEEEEeC----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL--RHPNLIRFLQAIETT---- 136 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~---- 136 (357)
.++|++.+.||+|+||.||+|.+. |+.||||++.... .....+|.+++..+ +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 457999999999999999999876 8999999985421 22233555565554 899999999999887
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEcCCCcEEEeec
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER--------GVVHRDIKCENLLIDGEYNIKLSDF 208 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~ivH~dlkp~Nili~~~~~~kl~Df 208 (357)
..+++||||+++|+|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 7899999999999999999765 589999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCC-----cccHHHHHHHHHHHHcC----------CCCCCCC
Q psy7825 209 GFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPH-----YSDVWSMGVVLYAMAFG----------RLPFDDT 273 (357)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwslG~il~ell~g----------~~pf~~~ 273 (357)
|++......... ........+||+.|+|||++.+...... ++|||||||++|+|++| ..||...
T Consensus 187 g~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNE-VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeecccccc-ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 998644322111 1111235579999999999987766654 38999999999999999 7777543
Q ss_pred -----CHHHHHHHHhhcccCCCC------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 274 -----NYIQLLKQVQTKVVFPTE------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 274 -----~~~~~~~~i~~~~~~~~~------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
........+......+.. ..+++++.+||.+|| .||.+||++.+|++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 223333333222212211 246778999999999 899999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=362.86 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=215.4
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
..+..++|.+.+.||+|+||.||+|.+..+ +..||||.+... ......+.+.+|+.+++.++||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 345567899999999999999999998643 467999987543 23444567889999999999999999999984
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
++..++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 566899999999999999998653 6899999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
... .........+++.|+|||++.+..++.+ +|||||||++|||++ |..||.+....+....+......+.++.
T Consensus 542 ~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 616 (656)
T 2j0j_A 542 EDS----TYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616 (656)
T ss_dssp CC--------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred CCC----cceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 221 1112223457889999999988887776 999999999999997 9999999999888888887777777788
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+++.+.+||.+|| .||.+||++.+|++
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999 89999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=347.37 Aligned_cols=252 Identities=19% Similarity=0.254 Sum_probs=205.8
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC-CCcceeeEEEEeCCeEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-PNLIRFLQAIETTHRVY 140 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 140 (357)
..++|.+.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.| ++|..+..++......+
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 346799999999999999999999999999999988654432 346789999999986 55666667778888999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---cCCCcEEEeecCCCccccc
Q psy7825 141 IIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLI---DGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~ 216 (357)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 8899999985 5679999999999999999999999999999999999999 6889999999999975533
Q ss_pred ccCCCC--CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhhccc-C--
Q psy7825 217 CKSGHQ--SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN---YIQLLKQVQTKVV-F-- 288 (357)
Q Consensus 217 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~-~-- 288 (357)
...... .......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.. ....+..+..... .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 222111 122336679999999999999888776 999999999999999999998643 3333333322111 1
Q ss_pred -CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 289 -PTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 289 -~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.....++.++.+||..|| .+|.+||++.+|++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 112468999999999999 89999999998765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=335.17 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=200.0
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCC-CchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA-PPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
|...+.||+|+||.||+|.+ +++.||||++..... ......+.+.+|+.+++.++||||+++++++......++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 55568999999999999986 488999999865332 233445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 145 YAEKGSLLDFIQR---EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 145 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 187 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--- 187 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS---
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc---
Confidence 9999999999974 3469999999999999999999999999999999999999999999999999986432111
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhhc----------cc
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ----LLKQVQTK----------VV 287 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~----------~~ 287 (357)
.........||+.|+|||++.+. ++.+ +||||||+++|+|++|..||....... +...+... ..
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRGE-ITPK-SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTTE-ECTH-HHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccCCCcCcCChHHhcCC-CCcc-chhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 11123345799999999998763 5555 999999999999999999997654322 11211110 01
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
......++..+.+||.+|| .+|.+||++.+|+++
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1112235678999999999 899999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=342.57 Aligned_cols=253 Identities=15% Similarity=0.230 Sum_probs=199.0
Q ss_pred ccccccCeEEceeeeecCCeEEEEE-----EECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC---CCCcceee
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLA-----TSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR---HPNLIRFL 130 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~ 130 (357)
..+..++|.+.+.||+|+||.||+| .+..+++.||||++.... ...+..|+.++..+. |+||++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 3455678999999999999999999 467789999999986432 234567888888887 89999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC------
Q psy7825 131 QAIETTHRVYIIMEYAEKGSLLDFIQR-----EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG------ 199 (357)
Q Consensus 131 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~------ 199 (357)
+++...+..++||||++||+|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999999974 456999999999999999999999999999999999999998
Q ss_pred -----CCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Q psy7825 200 -----EYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN 274 (357)
Q Consensus 200 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 274 (357)
++.+||+|||+++...... ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFP---KGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSC---TTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred ccccccCCEEEeeCchhhhhhccC---CCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCC
Confidence 8999999999996442211 1222345679999999999999888876 999999999999999999996432
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCC-HHHHhc--CCCCCC
Q psy7825 275 YIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIR-LKDIKQ--DPWVKT 326 (357)
Q Consensus 275 ~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps-~~~ll~--hp~~~~ 326 (357)
... ......+. ....++.+.+++..|| .+|.+|++ +.++.+ ..|+..
T Consensus 290 ~~~----~~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 290 GGE----CKPEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp TTE----EEECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCc----eeechhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 210 00000111 1135789999999999 78877754 444443 445544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=332.92 Aligned_cols=260 Identities=19% Similarity=0.315 Sum_probs=192.6
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHH--HHcCCCCCcceeeEEEEe--
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDV--VKGLRHPNLIRFLQAIET-- 135 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~~~~~~~~-- 135 (357)
.+..++|.+.+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 35567899999999999999999976 58999999986432 1223334444 455899999999986543
Q ss_pred ---CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEEEcCCCcE
Q psy7825 136 ---THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER---------GVVHRDIKCENLLIDGEYNI 203 (357)
Q Consensus 136 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~ivH~dlkp~Nili~~~~~~ 203 (357)
...+++||||+++|+|.+++.... +++..++.++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 336789999999999999997655 58999999999999999999999 99999999999999999999
Q ss_pred EEeecCCCcccccccCC---CCCCCCCcccCCccccccceecCC-------CCCCCcccHHHHHHHHHHHHcCCCCCCCC
Q psy7825 204 KLSDFGFARGHMKCKSG---HQSPLSDTFCGSYAYASPEILKGV-------PYTPHYSDVWSMGVVLYAMAFGRLPFDDT 273 (357)
Q Consensus 204 kl~Dfg~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~ 273 (357)
||+|||++......... .........+||+.|+|||++.+. .++.+ +|||||||++|+|++|..||...
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ-VDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH-HHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccc-cchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999754322111 112223355799999999999873 33334 89999999999999997776321
Q ss_pred ------------------CHHHHHHHHhhcccCCC-C------CCCCHHHHHHHHHhc-CCCCCCCCHHHH------hcC
Q psy7825 274 ------------------NYIQLLKQVQTKVVFPT-E------PNVSAECKTLLSKIF-SPIKFRIRLKDI------KQD 321 (357)
Q Consensus 274 ------------------~~~~~~~~i~~~~~~~~-~------~~~s~~~~~li~~~L-~~p~~Rps~~~l------l~h 321 (357)
........+......+. + ..+++++.+||.+|| .||.+||++.++ +-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11122222222211111 1 124458999999999 899999999999 558
Q ss_pred CCCCCCCC
Q psy7825 322 PWVKTEAN 329 (357)
Q Consensus 322 p~~~~~~~ 329 (357)
+|-+++..
T Consensus 319 ~~~~~~~~ 326 (336)
T 3g2f_A 319 IWERNKSV 326 (336)
T ss_dssp CCCC----
T ss_pred HHHhcccC
Confidence 99888644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=364.73 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=205.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe------CC
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------TH 137 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~ 137 (357)
++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 57999999999999999999999999999999986532 33345667899999999999999999998755 67
Q ss_pred eEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCc---EEEeecCCC
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREG---YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN---IKLSDFGFA 211 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~---~kl~Dfg~~ 211 (357)
..++||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999999999999998743 5999999999999999999999999999999999999997765 899999998
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------HH
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK---------QV 282 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---------~i 282 (357)
..... ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+........ .+
T Consensus 172 ~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 172 KELDQ------GELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CBTTS------CCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred ccccc------ccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 74421 122345679999999999998888877 999999999999999999997654322110 00
Q ss_pred ------hhcccC----CC----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 283 ------QTKVVF----PT----EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 283 ------~~~~~~----~~----~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.....+ +. .+.+++.+.+||.+|| .||.+||++.+++.||||+.-
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 000001 11 1236789999999999 999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=352.99 Aligned_cols=249 Identities=18% Similarity=0.218 Sum_probs=193.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC-CCcce--------------
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-PNLIR-------------- 128 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~-------------- 128 (357)
..|.+.++||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++..+.| +|+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458899999999999999999999999999999875444444445668899999999987 32111
Q ss_pred -------eeEEEEe-----CCeEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7825 129 -------FLQAIET-----THRVYIIMEYAEKGSLLDFIQR-------EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189 (357)
Q Consensus 129 -------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~d 189 (357)
+...+.. ...++++|+++ +++|.+++.. ...+++..++.++.||+.||.|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 22467778776 5699999852 23477888999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCcccccccee----------cCCCCCCCcccHHHHHHH
Q psy7825 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL----------KGVPYTPHYSDVWSMGVV 259 (357)
Q Consensus 190 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~DiwslG~i 259 (357)
|||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.+ +|||||||+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~-~DvwSlGvi 306 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA-FDTWTLGLA 306 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH-HHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCCch-hhHHHHHHH
Confidence 9999999999999999999998643221 334567 999999999 44445555 999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 260 LYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 260 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+|+|++|+.||...+.......+ +.....+|+.+.+||.+|| .||.+||++.++++||||++..
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGG-----GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHH-----HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 99999999999876543332222 2333468999999999999 8999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=328.88 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=199.2
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHc--CCCCCcceeeEEEEeCC---
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG--LRHPNLIRFLQAIETTH--- 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~--- 137 (357)
.++|.+.+.||+|+||.||+|.+. |+.||||++.... ...+.+|++++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 356999999999999999999874 8999999985421 3345678888887 78999999999998876
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEEcCCCcEEEeec
Q psy7825 138 -RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH--------ERGVVHRDIKCENLLIDGEYNIKLSDF 208 (357)
Q Consensus 138 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~ivH~dlkp~Nili~~~~~~kl~Df 208 (357)
.+++||||+++|+|.+++.+. .+++..++.++.||+.||.||| +.||+||||||+|||++.++.++|+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 899999999999999999764 5899999999999999999999 899999999999999999999999999
Q ss_pred CCCcccccccCCCCCCCCCcccCCccccccceecCCCCCC-----CcccHHHHHHHHHHHHcC----------CCCCCCC
Q psy7825 209 GFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTP-----HYSDVWSMGVVLYAMAFG----------RLPFDDT 273 (357)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~ell~g----------~~pf~~~ 273 (357)
|++......... .........||+.|+|||++.+..... .++|||||||++|+|++| ..||...
T Consensus 192 g~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 192 GLAVRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp TTCEEEETTTTE-EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeccccccc-cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 998644221110 001223457999999999997763322 248999999999999999 7898654
Q ss_pred -----CHHHHHHHHhhcccCCCC------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 274 -----NYIQLLKQVQTKVVFPTE------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 274 -----~~~~~~~~i~~~~~~~~~------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
........+......+.. ..++..+.+||.+|| .||.+||++.+|++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 334444444333222221 134468999999999 999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=341.98 Aligned_cols=245 Identities=14% Similarity=0.180 Sum_probs=192.3
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----chHHhhhHHHHHHHHHcCC---------CCCc
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP-----PDYLKKFLPREIDVVKGLR---------HPNL 126 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~i 126 (357)
+..++|.+.+.||+|+||.||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3456799999999999999999987 5899999999765432 1112355778999888885 7777
Q ss_pred ceeeEEEE-----------------e-------------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q psy7825 127 IRFLQAIE-----------------T-------------THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDA 176 (357)
Q Consensus 127 v~~~~~~~-----------------~-------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~ 176 (357)
+++.+++. . ...+|+||||+++|++.+.+.+ +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 77766542 2 6789999999999977666644 568999999999999999
Q ss_pred HHHHH-hCCceecCCCCCCEEEcCCC--------------------cEEEeecCCCcccccccCCCCCCCCCcccCCccc
Q psy7825 177 IDYCH-ERGVVHRDIKCENLLIDGEY--------------------NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235 (357)
Q Consensus 177 l~~LH-~~~ivH~dlkp~Nili~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y 235 (357)
|.||| ++||+||||||+|||++.++ .+||+|||+++.... ...+||+.|
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----------TEEECCCCT
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----------CcEEEeecc
Confidence 99999 99999999999999999887 899999999975421 245799999
Q ss_pred cccceecCCCCCCCcccHHHHHHH-HHHHHcCCCCCCCCCH-HHHHHHHhhcccCCC------CCCCCHHHHHHHHHhc-
Q psy7825 236 ASPEILKGVPYTPHYSDVWSMGVV-LYAMAFGRLPFDDTNY-IQLLKQVQTKVVFPT------EPNVSAECKTLLSKIF- 306 (357)
Q Consensus 236 ~aPE~~~~~~~~~~~~DiwslG~i-l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~------~~~~s~~~~~li~~~L- 306 (357)
+|||++.+.. +. ++||||||++ .++++.|..||.+... ......+........ .+.+++++++||++||
T Consensus 244 ~aPE~~~g~~-~~-~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 321 (336)
T 2vuw_A 244 MDEDLFTGDG-DY-QFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN 321 (336)
T ss_dssp TCSGGGCCCS-SH-HHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred cChhhhcCCC-cc-ceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhc
Confidence 9999998766 44 4999998776 7888899999965322 222333332222211 1247899999999999
Q ss_pred CCCCCCCCHHHHh-cCCCCC
Q psy7825 307 SPIKFRIRLKDIK-QDPWVK 325 (357)
Q Consensus 307 ~~p~~Rps~~~ll-~hp~~~ 325 (357)
.| |++|+| +||||+
T Consensus 322 ~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 322 FS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SS-----SHHHHHHHCGGGC
T ss_pred cC-----CHHHHHhcCCCcC
Confidence 55 999999 999996
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=316.68 Aligned_cols=225 Identities=16% Similarity=0.160 Sum_probs=187.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+..++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++..++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44567999999999999999999999999999999998766555555677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
+||||++|++|.+++... .....+..++.||+.||.|||++||+||||||+|||++.+|.++|+++|.
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~---------- 175 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---------- 175 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc----------
Confidence 999999999999999643 46677899999999999999999999999999999999999999985543
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHhhcccC--CCCCCC
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLK----QVQTKVVF--PTEPNV 294 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~i~~~~~~--~~~~~~ 294 (357)
++| ++.+ +|||||||++|+|++|+.||.+.+....+. .+...... ...+.+
T Consensus 176 ---------------~~~-------~~~~-~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 176 ---------------MPD-------ANPQ-DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp ---------------CTT-------CCHH-HHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred ---------------cCC-------CCch-hHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence 222 3444 999999999999999999998765422110 01111110 112579
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
++++.+||.+|| .||.+| |+.++++.
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999 999999 99999973
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=351.40 Aligned_cols=241 Identities=20% Similarity=0.279 Sum_probs=197.0
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECC-CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe-
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTR-HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR- 138 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 138 (357)
+..++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.++..++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 345789999999999999999999876 78999999886432 33445667899999999999999999999987655
Q ss_pred ----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 139 ----VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 139 ----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999998865 69999999999999999999999999999999999999885 9999999998743
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC-CCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF-PTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~ 293 (357)
.. ....+||+.|+|||++.+.. +. ++|||||||++|+|++|..||.+.... .... .....
T Consensus 232 ~~---------~~~~~gt~~y~aPE~~~~~~-~~-~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~ 292 (681)
T 2pzi_A 232 NS---------FGYLYGTPGFQAPEIVRTGP-TV-ATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLK 292 (681)
T ss_dssp TC---------CSCCCCCTTTSCTTHHHHCS-CH-HHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHH
T ss_pred cc---------CCccCCCccccCHHHHcCCC-CC-ceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccc
Confidence 21 13457999999999987654 44 499999999999999999998753210 0000 00012
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
.++.+.+||.+|| .||.+||+..+.+.|+|+.
T Consensus 293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 4688999999999 9999999999999998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=296.85 Aligned_cols=188 Identities=17% Similarity=0.109 Sum_probs=135.7
Q ss_pred eeecCCeEEEEEEECCCCcEEEEEEeecCCCC-------chHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCCeEEEEE
Q psy7825 72 IGIGSYATVKLATSTRHGCDVAVKVVSKVEAP-------PDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 72 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++.|++|.+..++..-.|+.|++|++.+.... .+...+.+.+|+++|+++ .|+||++++++++++..+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56777777777777777999999999764322 122235688999999999 6999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++|++|.++|.+.+++++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+++.... ..
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~-----~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ-----DC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--------
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC-----CC
Confidence 999999999999999888765 4789999999999999999999999999999999999999999974422 12
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCC
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLP 269 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 269 (357)
....+.+||+.|||||++.+. +... +|+|++|+++|+|.++..+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~-~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWN-GFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCCC-CCCc-ccccccccchhhhccccch
Confidence 234567899999999999875 3334 8999999998877665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=248.20 Aligned_cols=192 Identities=17% Similarity=0.166 Sum_probs=144.4
Q ss_pred EEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchH-----HhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDY-----LKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 67 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
...+.||+|+||.||+|. ..+..+++|........... ..+.+.+|+.+++.++||||+++..++......|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 456799999999999994 34789999987543332221 13457899999999999999966666667777899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||++|++|.+++.. +..++.||+.+|.|||++||+||||||+|||++. .+||+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999976 6689999999999999999999999999999998 99999999997542211000
Q ss_pred --CCCCCCcccCCccccccceecC--CCCCCCcccHHHHHHHHHHHHcCCCCCC
Q psy7825 222 --QSPLSDTFCGSYAYASPEILKG--VPYTPHYSDVWSMGVVLYAMAFGRLPFD 271 (357)
Q Consensus 222 --~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~ 271 (357)
........+||+.|+|||++.+ ..|... +|+|+..+-..+.+.++-+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence 0001135679999999999976 455555 899999998888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=211.31 Aligned_cols=146 Identities=18% Similarity=0.208 Sum_probs=116.7
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch---------------HHhhhHHHHHHHHHcCCCCCcceee
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD---------------YLKKFLPREIDVVKGLRHPNLIRFL 130 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~iv~~~ 130 (357)
|.+.+.||+|+||.||+|.+ .+|+.||||++........ .....+.+|+.+++.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 34449999999999999999 7899999999864322110 12455789999999999 4 6666
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 131 QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 131 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
+++.. +..|+||||++|++|.+ +. ......++.||+.||.|||+.||+||||||+|||++ ++.++|+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 65544 45699999999999988 42 123557999999999999999999999999999999 99999999999
Q ss_pred CcccccccCCCCCCCCCcccCCccccccceec
Q psy7825 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242 (357)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 242 (357)
++ .+..++|||.+.
T Consensus 239 a~------------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SV------------------EVGEEGWREILE 252 (282)
T ss_dssp CE------------------ETTSTTHHHHHH
T ss_pred Ce------------------ECCCCCHHHHHH
Confidence 85 345678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.4e-23 Score=180.10 Aligned_cols=138 Identities=19% Similarity=0.257 Sum_probs=108.1
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcE--EEEEEeecCCCCc---------------------hHHhhhHHHHHHHHHcCC
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCD--VAVKVVSKVEAPP---------------------DYLKKFLPREIDVVKGLR 122 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 122 (357)
|.+.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998677989 9999975432110 111235778999999998
Q ss_pred CCCc--ceeeEEEEeCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCC
Q psy7825 123 HPNL--IRFLQAIETTHRVYIIMEYAEK-G----SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH-ERGVVHRDIKCEN 194 (357)
Q Consensus 123 h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~dlkp~N 194 (357)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.||+.+|.||| +.||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8764 344432 246899999942 3 67665432 245678899999999999999 9999999999999
Q ss_pred EEEcCCCcEEEeecCCCc
Q psy7825 195 LLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 195 ili~~~~~~kl~Dfg~~~ 212 (357)
||++. .++|+|||++.
T Consensus 202 ILl~~--~~~liDFG~a~ 217 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAV 217 (258)
T ss_dssp EEESS--SEEECCCTTCE
T ss_pred EEEcC--cEEEEECcccc
Confidence 99998 99999999986
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.2e-20 Score=168.95 Aligned_cols=138 Identities=17% Similarity=0.227 Sum_probs=100.5
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC-------ch------------HHhhhHHHHHHHHHcCCCCCc
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP-------PD------------YLKKFLPREIDVVKGLRHPNL 126 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~------------~~~~~~~~E~~~l~~l~h~~i 126 (357)
|.++..||.|+||.||+|.+. +|+.||||+++..... .+ ..+-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999964 6999999997532110 00 001112357777777755444
Q ss_pred ceeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-----
Q psy7825 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY----- 201 (357)
Q Consensus 127 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~----- 201 (357)
....-+.... .++||||++|++|..+. ....+..++.||+.+|.+||..|||||||||.|||++++|
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 2211111222 36999999998886543 2234567889999999999999999999999999998877
Q ss_pred -----cEEEeecCCCc
Q psy7825 202 -----NIKLSDFGFAR 212 (357)
Q Consensus 202 -----~~kl~Dfg~~~ 212 (357)
.+.|+||+.+.
T Consensus 248 ~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMV 263 (397)
T ss_dssp TSEEEEEEECCCTTCE
T ss_pred cccccceEEEEeCCcc
Confidence 38999999875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=7.6e-14 Score=122.32 Aligned_cols=138 Identities=17% Similarity=0.084 Sum_probs=111.0
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 143 (357)
+|.+...+|.|+.+.||++... +..+++|+........ ...+.+|+.+++.+. +..++++++++...+..|+||
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 5889999999999999999744 6899999986422111 235778999999885 677889999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE----------------------------------------- 182 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~----------------------------------------- 182 (357)
|+++|.+|.+.+. +......++.+++.+|..||+
T Consensus 90 e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999998877631 223345788999999999998
Q ss_pred ------------------CCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 183 ------------------RGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 183 ------------------~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.3e-12 Score=113.95 Aligned_cols=133 Identities=17% Similarity=0.103 Sum_probs=98.0
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC--cceeeEEEEeCCeEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN--LIRFLQAIETTHRVYII 142 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv 142 (357)
+|.+..+.+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ ++++++++...+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 355554445666799999964 457889999875421 244678999999886444 56688888888889999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG-------------------------------------- 184 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 184 (357)
|||++|.+|. .. ... ...++.+++..|..||...
T Consensus 94 ~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999998884 21 111 2356677777777777643
Q ss_pred --------------------ceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 185 --------------------VVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 185 --------------------ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
++|+|++|.|||+++++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877666799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.29 E-value=1e-11 Score=113.90 Aligned_cols=139 Identities=16% Similarity=0.198 Sum_probs=104.6
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEee--cCCCCchHHhhhHHHHHHHHHcCC--CCCcceeeEEEEeC---CeEE
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVS--KVEAPPDYLKKFLPREIDVVKGLR--HPNLIRFLQAIETT---HRVY 140 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~ 140 (357)
..+.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.+. +..+++++..+.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4567899999999999754 4688999764 22111 11345778999999997 45578888888766 4578
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-------------------------------------- 182 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------- 182 (357)
+||||++|..+.+.. ...++......++.+++..|..||.
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999998775421 1236788888999999999999997
Q ss_pred --------------------CCceecCCCCCCEEEcCCCc--EEEeecCCCc
Q psy7825 183 --------------------RGVVHRDIKCENLLIDGEYN--IKLSDFGFAR 212 (357)
Q Consensus 183 --------------------~~ivH~dlkp~Nili~~~~~--~kl~Dfg~~~ 212 (357)
..++|+|+++.|||++.++. +.|+||+.+.
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999997753 6899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.19 E-value=6.7e-12 Score=112.41 Aligned_cols=187 Identities=13% Similarity=0.158 Sum_probs=119.4
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCC--cceeeEEEEeCC---eEEEE
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPN--LIRFLQAIETTH---RVYII 142 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv 142 (357)
.+.++.|.+..||++. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3458999999999873 56999985321 23456789999998874 333 345554443333 34789
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE---------------------------------------- 182 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~---------------------------------------- 182 (357)
|++++|.+|.+.... .++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999999888764432 36788888888888888888885
Q ss_pred ------------------CCceecCCCCCCEEEcC--CCcEEEeecCCCcccccccCCCCCCCC-----C----cccCCc
Q psy7825 183 ------------------RGVVHRDIKCENLLIDG--EYNIKLSDFGFARGHMKCKSGHQSPLS-----D----TFCGSY 233 (357)
Q Consensus 183 ------------------~~ivH~dlkp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~-----~----~~~gt~ 233 (357)
..++|+|++|.||++++ ++.+.|+||+.+.......+-...... . ......
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 13699999999999998 456789999987522100000000000 0 000000
Q ss_pred cccc-cceecCCCCCCCcccHHHHHHHHHHHHcCCCCC
Q psy7825 234 AYAS-PEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF 270 (357)
Q Consensus 234 ~y~a-PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 270 (357)
.... |+......+ ..+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~---~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRM---KEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHH---HHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHH---HHHHHHHHHHHHHHHcCCHHH
Confidence 1111 222211111 158999999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=1.9e-08 Score=88.13 Aligned_cols=132 Identities=14% Similarity=0.108 Sum_probs=97.7
Q ss_pred eeeecCCe-EEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEEEeccCC
Q psy7825 71 VIGIGSYA-TVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYIIMEYAEK 148 (357)
Q Consensus 71 ~lG~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 148 (357)
.+..|..| .||+......+..+++|+.... ....+.+|...|+.+. +-.+.+++.++...+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445555 6999887777888999986431 2345778999998885 33477889999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q psy7825 149 GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE---------------------------------------------- 182 (357)
Q Consensus 149 ~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~---------------------------------------------- 182 (357)
.++.+..... ......+..++...|..||.
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8887765432 22234456666666666663
Q ss_pred -----C-------CceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 183 -----R-------GVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 183 -----~-------~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
. .++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0 27899999999999988777899999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=5.6e-08 Score=86.87 Aligned_cols=132 Identities=14% Similarity=0.127 Sum_probs=92.1
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCC---CcceeeEEEE-eCCeEEEEEe
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP---NLIRFLQAIE-TTHRVYIIME 144 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e 144 (357)
.+.++.|....||+. |..+++|+.. .......+.+|+.+|..+.+. .+.+++.++. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 345788999999988 5679999842 123345678999999999742 3566666664 4556789999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER----------------------------------------- 183 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------- 183 (357)
+++|.+|....- ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988876321 1234444555555555555555532
Q ss_pred -------------------CceecCCCCCCEEEcC---CCcE-EEeecCCCc
Q psy7825 184 -------------------GVVHRDIKCENLLIDG---EYNI-KLSDFGFAR 212 (357)
Q Consensus 184 -------------------~ivH~dlkp~Nili~~---~~~~-kl~Dfg~~~ 212 (357)
.++|+|++|.|||++. ++.+ .|+||+.+.
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3599999999999987 4554 899999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=2.9e-07 Score=85.22 Aligned_cols=80 Identities=15% Similarity=0.069 Sum_probs=49.3
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCC-Cch---HHhhhHHHHHHHHHcCCC--CC-cceeeEEEEeCCeEE
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEA-PPD---YLKKFLPREIDVVKGLRH--PN-LIRFLQAIETTHRVY 140 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~~-iv~~~~~~~~~~~~~ 140 (357)
-.+.||.|.++.||++....+++.++||....... ..+ .....+..|..++..+.. +. +++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35679999999999997665678999998643211 000 112345678888887742 33 4455543 344567
Q ss_pred EEEeccCCC
Q psy7825 141 IIMEYAEKG 149 (357)
Q Consensus 141 lv~e~~~~~ 149 (357)
+|||+++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.7e-07 Score=85.45 Aligned_cols=86 Identities=14% Similarity=0.148 Sum_probs=55.5
Q ss_pred EEceee-eecCCeEEEEEEEC--C----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-C--CCcceeeEEEEeC
Q psy7825 67 VLGKVI-GIGSYATVKLATST--R----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-H--PNLIRFLQAIETT 136 (357)
Q Consensus 67 ~~~~~l-G~G~~g~V~~~~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~ 136 (357)
...+.| +.|....+|++... . ++..+++|+..............+.+|+.+++.+. + -.+.+++.++...
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88889999988653 1 25689999764321000000234668888888885 2 3467788777654
Q ss_pred ---CeEEEEEeccCCCChH
Q psy7825 137 ---HRVYIIMEYAEKGSLL 152 (357)
Q Consensus 137 ---~~~~lv~e~~~~~~L~ 152 (357)
+..++|||+++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3468999999986643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.33 E-value=8.8e-06 Score=73.36 Aligned_cols=135 Identities=15% Similarity=0.078 Sum_probs=76.6
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC--CCCcceeeE------EEEeCCeEE
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR--HPNLIRFLQ------AIETTHRVY 140 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~------~~~~~~~~~ 140 (357)
.+.|+.|..+.||++... +..+++|+.... . ..+..|+.++..|. .-.+++++. +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---E----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC---H----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC---H----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 345677788999999754 345999988641 1 22334555555443 112333332 123567789
Q ss_pred EEEeccCCCChH-----------HHH---Hh-cCCC--C-----------HH--------H-------------------
Q psy7825 141 IIMEYAEKGSLL-----------DFI---QR-EGYI--D-----------EP--------R------------------- 165 (357)
Q Consensus 141 lv~e~~~~~~L~-----------~~l---~~-~~~l--~-----------~~--------~------------------- 165 (357)
+||+|++|..+. ..+ +. ...+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 111 11 1101 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHH-------------hCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 166 ----TKKWFRQLVDAIDYCH-------------ERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 166 ----~~~i~~~i~~~l~~LH-------------~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
+..+...+..++.+|+ ..+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111122334566665 2579999999999999888899999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.14 E-value=2.1e-05 Score=70.12 Aligned_cols=76 Identities=14% Similarity=0.124 Sum_probs=59.6
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC---CCCcceeeEEEEeCCeEEEEEe
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR---HPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e 144 (357)
-.+.|+.|.+..+|+... ++..+++|+.... ....+..|+..|+.|. ...+++++.+....+..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 356789999999999974 4678999987532 1455778988888884 3567888888888889999999
Q ss_pred ccCCCCh
Q psy7825 145 YAEKGSL 151 (357)
Q Consensus 145 ~~~~~~L 151 (357)
+++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9999754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.2e-05 Score=74.82 Aligned_cols=30 Identities=13% Similarity=0.368 Sum_probs=26.7
Q ss_pred hCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 182 ~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
...++|+|++|.|||++.++ +.|+||+.+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 45799999999999998876 9999999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.07 E-value=3.7e-05 Score=63.79 Aligned_cols=120 Identities=14% Similarity=0.103 Sum_probs=79.5
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCC
Q psy7825 149 GSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLS 226 (357)
Q Consensus 149 ~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 226 (357)
.+|.++|+. +.+++++++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 379999975 5789999999999999999877622 1222344567999999999998764 2110
Q ss_pred CcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc
Q psy7825 227 DTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF 306 (357)
Q Consensus 227 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L 306 (357)
.....+.|||... ...+.+ .=|||||+++|.-+--..| ...+..+|+.+.+||..|.
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~-~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt 154 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMET-EVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMA 154 (229)
T ss_dssp ------------CCSS-SSSCHH-HHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHH-HHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHH
Confidence 0123466888763 122223 6899999999999854333 1123369999999999998
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.97 E-value=7.5e-05 Score=65.71 Aligned_cols=80 Identities=10% Similarity=-0.015 Sum_probs=55.1
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC---CCcceeeEEEEeCCeEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH---PNLIRFLQAIETTHRVY 140 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~ 140 (357)
....-.+.+|.|..+.||+++.. +|+.|++|+........ ...+..|+..|+.|.. -.++++++.. . -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ce
Confidence 34566778999999999999854 68999999864332221 3457789999988842 2345555542 2 36
Q ss_pred EEEeccCCCCh
Q psy7825 141 IIMEYAEKGSL 151 (357)
Q Consensus 141 lv~e~~~~~~L 151 (357)
+|||+++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.89 E-value=4.9e-05 Score=67.37 Aligned_cols=71 Identities=11% Similarity=-0.007 Sum_probs=44.6
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-ceeeEEEEeCCeEEEEEecc-
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-IRFLQAIETTHRVYIIMEYA- 146 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~- 146 (357)
.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ .++++.. ...-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 678999999999999 46899987542111 1123468877777753233 4555443 33346899999
Q ss_pred CCCCh
Q psy7825 147 EKGSL 151 (357)
Q Consensus 147 ~~~~L 151 (357)
+|.+|
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.81 E-value=4.2e-05 Score=68.39 Aligned_cols=139 Identities=22% Similarity=0.170 Sum_probs=78.6
Q ss_pred EEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC--cceeeE------EEEeCCe
Q psy7825 67 VLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN--LIRFLQ------AIETTHR 138 (357)
Q Consensus 67 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~------~~~~~~~ 138 (357)
.-.+.|+.|....+|++... +..+++|+...... ...+..|+.++..|...+ +++++. .....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEeC--CccEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 34567888888999999754 33789998864211 233556777777664212 233332 1233567
Q ss_pred EEEEEeccCCCChH----HH----------HHhc--C---C----CCHHHHHHH---------------HHHHHHHHHHH
Q psy7825 139 VYIIMEYAEKGSLL----DF----------IQRE--G---Y----IDEPRTKKW---------------FRQLVDAIDYC 180 (357)
Q Consensus 139 ~~lv~e~~~~~~L~----~~----------l~~~--~---~----l~~~~~~~i---------------~~~i~~~l~~L 180 (357)
.++++++++|..+. .. ++.. . + ......... ...+...+..+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 78999999986431 11 1110 0 0 111111110 01134445555
Q ss_pred Hh-------CCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 181 HE-------RGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 181 H~-------~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.. .+++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 53 369999999999999987666899999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00026 Score=63.34 Aligned_cols=75 Identities=7% Similarity=-0.046 Sum_probs=47.1
Q ss_pred eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCC--CcceeeEE-----EEeCCeEEEE
Q psy7825 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHP--NLIRFLQA-----IETTHRVYII 142 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~-----~~~~~~~~lv 142 (357)
..|+ |....||++.. .+|+.+++|+....... ...+..|..++..+... .+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3466 88889998864 34678999998633222 23455677777776421 23444432 2335677899
Q ss_pred EeccCCCC
Q psy7825 143 MEYAEKGS 150 (357)
Q Consensus 143 ~e~~~~~~ 150 (357)
+++++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998854
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00013 Score=65.58 Aligned_cols=134 Identities=16% Similarity=0.150 Sum_probs=70.6
Q ss_pred eeeeecCCeE-EEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC--CCcceeeEEEEeCCeEEEEEecc
Q psy7825 70 KVIGIGSYAT-VKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH--PNLIRFLQAIETTHRVYIIMEYA 146 (357)
Q Consensus 70 ~~lG~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~ 146 (357)
+.|+.|+... +|+... .+|..+++|...... ...+..|+.++..+.. -.+++++.+....+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 3565555544 667653 236678888643321 0234467777776642 23556666533333 6899999
Q ss_pred CCCChHHHHHhc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH
Q psy7825 147 EKGSLLDFIQRE--------------------------GYIDEPRTK-------K-WF------------RQLVDAIDYC 180 (357)
Q Consensus 147 ~~~~L~~~l~~~--------------------------~~l~~~~~~-------~-i~------------~~i~~~l~~L 180 (357)
.+..+.+++... ..++..... . +. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 776665444211 012221110 0 00 0111222333
Q ss_pred H------hCCceecCCCCCCEEEcCC----CcEEEeecCCCc
Q psy7825 181 H------ERGVVHRDIKCENLLIDGE----YNIKLSDFGFAR 212 (357)
Q Consensus 181 H------~~~ivH~dlkp~Nili~~~----~~~kl~Dfg~~~ 212 (357)
. ...++|+|+.+.|||++.+ +.+.|+||+.+.
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 1 2469999999999999875 679999999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=0.0001 Score=67.42 Aligned_cols=136 Identities=13% Similarity=0.099 Sum_probs=79.0
Q ss_pred ceeeeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC-cceeeEEEEeCCeEE
Q psy7825 69 GKVIGIGSYATVKLATSTR-------HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN-LIRFLQAIETTHRVY 140 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~ 140 (357)
.+.|..|-...+|++.... ++..|++|+....... ...+.+|..+++.|...+ ..++++.+.. .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~----~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG----VDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC----HHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch----HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3467778888899998642 3578999986332111 233458999888885222 3566666543 2
Q ss_pred EEEeccCCCChHH--------------HHHh---c-----CCCC--HHHHHHHHHHHHH-------------------HH
Q psy7825 141 IIMEYAEKGSLLD--------------FIQR---E-----GYID--EPRTKKWFRQLVD-------------------AI 177 (357)
Q Consensus 141 lv~e~~~~~~L~~--------------~l~~---~-----~~l~--~~~~~~i~~~i~~-------------------~l 177 (357)
+|+||++|.+|.. .+.+ . .... ...+..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998854421 1111 0 0111 2344555443321 23
Q ss_pred HHHH----hC----CceecCCCCCCEEEcCC----CcEEEeecCCCc
Q psy7825 178 DYCH----ER----GVVHRDIKCENLLIDGE----YNIKLSDFGFAR 212 (357)
Q Consensus 178 ~~LH----~~----~ivH~dlkp~Nili~~~----~~~kl~Dfg~~~ 212 (357)
..|. .. .++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3332 22 48999999999999876 789999999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00029 Score=65.66 Aligned_cols=74 Identities=15% Similarity=0.049 Sum_probs=48.6
Q ss_pred EceeeeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-ceeeEEEEeCCeE
Q psy7825 68 LGKVIGIGSYATVKLATSTR-------HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-IRFLQAIETTHRV 139 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~ 139 (357)
-.+.|+.|....||++.... .+..+++|+.... .. ...+.+|..++..|...++ +++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 34578888889999998653 2578999987431 11 1223378888888853333 56666553 2
Q ss_pred EEEEeccCCCC
Q psy7825 140 YIIMEYAEKGS 150 (357)
Q Consensus 140 ~lv~e~~~~~~ 150 (357)
.+|+||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00088 Score=60.33 Aligned_cols=29 Identities=28% Similarity=0.396 Sum_probs=26.4
Q ss_pred CceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 184 GVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 184 ~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 58999999999999988889999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00069 Score=61.70 Aligned_cols=74 Identities=16% Similarity=0.009 Sum_probs=43.8
Q ss_pred ceeeeecCCeEEEEEEECC--------CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC-cceeeEEEEeCCeE
Q psy7825 69 GKVIGIGSYATVKLATSTR--------HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN-LIRFLQAIETTHRV 139 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~ 139 (357)
.+.|+.|....+|++.... .+..+++|+.... ... ......|..++..+...+ ++++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4567788888999998653 1368999986432 111 112357888888875333 44666544 22
Q ss_pred EEEEeccCCCC
Q psy7825 140 YIIMEYAEKGS 150 (357)
Q Consensus 140 ~lv~e~~~~~~ 150 (357)
++|+||++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998854
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0021 Score=60.24 Aligned_cols=76 Identities=12% Similarity=0.046 Sum_probs=48.7
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-ceeeEEEEeCCeEEEEEecc
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-IRFLQAIETTHRVYIIMEYA 146 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 146 (357)
-.+.|+.|-...+|++.....+..+++|+....... .. ...+|..++..|...++ +++++.+. + .+|+||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 456788888899999987644578999987432111 11 12478999998875444 56777662 2 2599999
Q ss_pred CCCCh
Q psy7825 147 EKGSL 151 (357)
Q Consensus 147 ~~~~L 151 (357)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.011 Score=54.77 Aligned_cols=75 Identities=15% Similarity=0.053 Sum_probs=47.2
Q ss_pred EceeeeecCCeEEEEEEECCC-------CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC-cceeeEEEEeCCeE
Q psy7825 68 LGKVIGIGSYATVKLATSTRH-------GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN-LIRFLQAIETTHRV 139 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~ 139 (357)
-.+.|..|-...+|++..... +..|++|+..... +.. -...+|..+++.+...+ ..++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKF-YDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 345666788889999986521 5789999864321 111 12347888888875323 34566533 22
Q ss_pred EEEEeccCCCC
Q psy7825 140 YIIMEYAEKGS 150 (357)
Q Consensus 140 ~lv~e~~~~~~ 150 (357)
++|+||++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 68899999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.78 E-value=0.12 Score=47.43 Aligned_cols=28 Identities=25% Similarity=0.496 Sum_probs=24.2
Q ss_pred ceecCCCCCCEEE------cCCCcEEEeecCCCc
Q psy7825 185 VVHRDIKCENLLI------DGEYNIKLSDFGFAR 212 (357)
Q Consensus 185 ivH~dlkp~Nili------~~~~~~kl~Dfg~~~ 212 (357)
++|+|+.+.|||+ +++..+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 345679999999875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.95 E-value=0.35 Score=39.92 Aligned_cols=115 Identities=10% Similarity=0.099 Sum_probs=77.8
Q ss_pred CCCCcceeeEEEEeCCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC
Q psy7825 122 RHPNLIRFLQAIETTHRVYIIMEYAEKG-SLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE 200 (357)
Q Consensus 122 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~ 200 (357)
.||+++.. ..-+.++.+.+.++.-+.+ ++.. ++ .++....++++.+|+....+ ...-+|--|+|+||+++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~--~~~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEV--NRTRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGG--GGSSEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHH--hcCceEEEEecceEEEcCC
Confidence 47877765 4556677777777665432 2332 33 26889999999999987733 3445788899999999999
Q ss_pred CcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCC
Q psy7825 201 YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD 271 (357)
Q Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 271 (357)
+.+++.-.|+-. -++|..+ +.. .=+-..=|++..+++++..|+
T Consensus 116 ~~p~i~~RGik~----------------------~l~P~~~-----~ee-~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 116 GLPIAKTRGLQN----------------------VVDPLPV-----SEA-EFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp SCEEESCCEETT----------------------TBSCCCC-----CHH-HHHHHHHHHHHHHHCTTCCHH
T ss_pred CCEEEEEccCcc----------------------CCCCCCC-----CHH-HHHHHHHHHHHHHHcCCCCHH
Confidence 999998777532 2233211 111 224456688899999988874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.67 E-value=1.2 Score=36.89 Aligned_cols=115 Identities=13% Similarity=0.115 Sum_probs=77.4
Q ss_pred CCCCcceeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7825 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201 (357)
Q Consensus 122 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~ 201 (357)
.||++ -...-..++.+.+.++.-+++.=+..++ .++....++++.+|+..... |...-+|--|+|+||+++.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~-~~~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKH-HSARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSS-CCSSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHH-hhhCceeEEEeCceEEEeCCC
Confidence 46777 3334467777777777665543344443 37899999999998886551 225567888999999999999
Q ss_pred cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccH-HHHHHHHHHHHcCCCCCC
Q psy7825 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDV-WSMGVVLYAMAFGRLPFD 271 (357)
Q Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~ 271 (357)
.+++.-.|+-. -++|..+.. .|. -.+=|++..++.++..|+
T Consensus 122 ~p~i~hRGi~~----------------------~lpP~e~~e-------e~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 122 EPFFLHVGVKE----------------------SLPPDEWDD-------ERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CEEESCCEETT----------------------TBSSCSCCH-------HHHHHHHHHHHHHHTTCSSCHH
T ss_pred cEEEEEcCCcc----------------------cCCCCCCCH-------HHHHHHHHHHHHHHHcCCCCHH
Confidence 99998777632 344432211 233 356688888888877763
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.08 E-value=0.037 Score=51.86 Aligned_cols=64 Identities=11% Similarity=0.083 Sum_probs=18.0
Q ss_pred EEceeeeecCCeEEEEEEECCCCcEEEE------EEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 67 VLGKVIGIGSYATVKLATSTRHGCDVAV------KVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 67 ~~~~~lG~G~~g~V~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
.+.+.|| ||.||+|.......+||+ |.........+. ...+.+|..++..++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~-~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKR-LTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccc-cccccccccccccccccccCCCcceEE
Confidence 3456676 999999998765578888 655332222222 234567888999999999999887653
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=84.43 E-value=21 Score=34.29 Aligned_cols=81 Identities=17% Similarity=0.294 Sum_probs=48.4
Q ss_pred ceeeEEEEeCCeEEEEEeccCCCChHHHHH----------hcCC-------CCHHHHHHHHHHHH--HHHHHHHhCCcee
Q psy7825 127 IRFLQAIETTHRVYIIMEYAEKGSLLDFIQ----------REGY-------IDEPRTKKWFRQLV--DAIDYCHERGVVH 187 (357)
Q Consensus 127 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----------~~~~-------l~~~~~~~i~~~i~--~~l~~LH~~~ivH 187 (357)
+..+.+........+ .|++++.++.+.+. +..+ ........++..++ ..+.|+= ||
T Consensus 402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YIL--Gi-- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYIL--GV-- 476 (614)
T ss_dssp CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHH--TC--
T ss_pred eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheee--ec--
Confidence 344555555555444 46666555555443 2211 11233445555544 3444543 43
Q ss_pred cCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 188 RDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 188 ~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
+|=.++||||+.+|++.=+|||.+-
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 5888999999999999999999873
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=83.62 E-value=23 Score=34.66 Aligned_cols=44 Identities=25% Similarity=0.383 Sum_probs=31.2
Q ss_pred HHHHHHHHHH--HHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 165 RTKKWFRQLV--DAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 165 ~~~~i~~~i~--~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
....++..++ ..+.|+= || +|-.++||||+..|++.=+|||.+-
T Consensus 530 ar~nF~~SlA~~Svv~YIL--Gl--GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 530 VMDTYIKSCAGYCVITYLL--GV--GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHHH--TC--CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHHc--cC--CCCCCcceEEeCCCCEEEEeehhhh
Confidence 3444554443 3344443 33 6889999999999999999999873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 357 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-75 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-72 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-71 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-70 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-70 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-68 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-68 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-67 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-67 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-67 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-66 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-65 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-65 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-63 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-61 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-61 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-60 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-60 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-59 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-59 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-57 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-57 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-55 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-54 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-54 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-51 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-51 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-49 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-48 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-46 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-46 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-45 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-41 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 1e-75
Identities = 79/270 (29%), Positives = 143/270 (52%), Gaps = 12/270 (4%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
+E+ + +G+ +G G + V LA + +A+KV+ K + ++ L RE+++
Sbjct: 5 LED--FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
LRHPN++R RVY+I+EYA G++ +Q+ DE RT + +L +A+ YC
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H + V+HRDIK ENLL+ +K++DFG++ + T CG+ Y PE+
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-------RTTLCGTLDYLPPEM 175
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300
++G + D+WS+GV+ Y G+ PF+ Y + K++ +V F V+ +
Sbjct: 176 IEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-RVEFTFPDFVTEGARD 233
Query: 301 LLSKIFSP-IKFRIRLKDIKQDPWVKTEAN 329
L+S++ R L+++ + PW+ ++
Sbjct: 234 LISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 2e-72
Identities = 85/263 (32%), Positives = 131/263 (49%), Gaps = 8/263 (3%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ L + +G G+Y V+LA + VAVK+V + D + +EI + K L H N
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIK-KEICINKMLNHEN 64
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
+++F + Y+ +EY G L D I+ + + EP +++F QL+ + Y H G+
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
HRDIK ENLL+D N+K+SDFG A + ++ L + CG+ Y +PE+LK
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLAT---VFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTN--YIQLLKQVQTKVVFPTEPNVSAECKTLLS 303
+ DVWS G+VL AM G LP+D + + + K + + LL
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 304 KIFSP-IKFRIRLKDIKQDPWVK 325
KI RI + DIK+D W
Sbjct: 242 KILVENPSARITIPDIKKDRWYN 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 3e-72
Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 19/271 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + IG GSY + G + K + + + E+++++ L+HPN
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHPN 64
Query: 126 LIRFLQAI--ETTHRVYIIMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDY 179
++R+ I T +YI+MEY E G L I + Y+DE + QL A+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 180 CHERG-----VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYA 234
CH R V+HRD+K N+ +DG+ N+KL DFG AR H + + F G+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-----ILNHDTSFAKAFVGTPY 179
Query: 235 YASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294
Y SPE + + Y SD+WS+G +LY + PF + +L +++
Sbjct: 180 YMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 295 SAECKTLLSKIFSPI-KFRIRLKDIKQDPWV 324
S E +++++ + R +++I ++P +
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (564), Expect = 7e-71
Identities = 57/270 (21%), Positives = 112/270 (41%), Gaps = 13/270 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ + IG GS+ V A R+ VA+K +S + + + +E+ ++ LRHPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
I++ H +++MEY + + + E + + Y H +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRD+K N+L+ +KL DFG A +++F G+ + +PE++ +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAP---------ANSFVGTPYWMAPEVILAMD 187
Query: 246 YTPH--YSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECKTLL 302
+ DVWS+G+ +A + P + N + L + Q + + S + +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 303 SKIFSPI-KFRIRLKDIKQDPWVKTEANPA 331
I + R + + + +V E P
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 1e-70
Identities = 67/273 (24%), Positives = 131/273 (47%), Gaps = 18/273 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ + +G G++ V A + A KV+ + L+ ++ EID++ HPN
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYM-VEIDILASCDHPN 70
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCHERG 184
+++ L A + ++I++E+ G++ + + E + E + + +Q +DA++Y H+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL--- 241
++HRD+K N+L + +IKL+DFG + K+ D+F G+ + +PE++
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 242 --KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK--VVFPTEPNVSAE 297
K PY +DVWS+G+ L MA P + N +++L ++ S+
Sbjct: 186 TSKDRPYDYK-ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 298 CKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEAN 329
K L K + R + Q P+V ++N
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 7e-70
Identities = 69/269 (25%), Positives = 138/269 (51%), Gaps = 14/269 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ GK++G GS++TV LA + A+K++ K + ++ RE DV+ L HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ + ++Y + YA+ G LL +I++ G DE T+ + ++V A++Y H +G+
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRD+K EN+L++ + +I+++DFG A+ + +++F G+ Y SPE+L
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAK---VLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECKTLLSK 304
SD+W++G ++Y + G PF N + +++ + + FP + + L+ K
Sbjct: 187 ACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP--EKFFPKARDLVEK 243
Query: 305 IFSP-------IKFRIRLKDIKQDPWVKT 326
+ + +K P+ ++
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-68
Identities = 70/271 (25%), Positives = 134/271 (49%), Gaps = 14/271 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + IG G+ TV A G +VA++ ++ + P K+ + EI V++ ++PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPN 78
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ +L + ++++MEY GSL D + DE + R+ + A+++ H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQV 137
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
+HRDIK +N+L+ + ++KL+DFGF + + T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCA-----QITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVSAECKTLLS 303
Y P D+WS+G++ M G P+ + N ++ L + T +SA + L+
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 304 KIFSP-IKFRIRLKDIKQDPWVKTEANPAAS 333
+ ++ R K++ Q ++K A P +S
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKI-AKPLSS 281
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 216 bits (550), Expect = 3e-68
Identities = 70/297 (23%), Positives = 132/297 (44%), Gaps = 19/297 (6%)
Query: 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREI 115
K V+++ Y + + +G G++ V T G + A K V P + K+ + +EI
Sbjct: 20 KHDHVLDH--YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT---PHESDKETVRKEI 74
Query: 116 DVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLV 174
+ LRHP L+ A E + + +I E+ G L + + E + E ++ RQ+
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 175 DAIDYCHERGVVHRDIKCENLLIDGEYN--IKLSDFGFARGHMKCKSGHQSPLSDTFCGS 232
+ + HE VH D+K EN++ + + +KL DFG +S G+
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK------VTTGT 188
Query: 233 YAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE- 291
+A+PE+ +G P Y+D+WS+GV+ Y + G PF N + L+ V++ +
Sbjct: 189 AEFAAPEVAEGKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 247
Query: 292 --PNVSAECKTLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSK 345
+S + K + K+ R+ + + PW+ P + + + + +
Sbjct: 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 212 bits (540), Expect = 1e-67
Identities = 68/276 (24%), Positives = 128/276 (46%), Gaps = 22/276 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP------DYLKKFLPREIDVVK 119
Y +++G G + V+ + AVK++ L++ +E+D+++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 120 GLR-HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAID 178
+ HPN+I+ ET +++ + +KG L D++ + + E T+K R L++ I
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 179 YCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
H+ +VHRD+K EN+L+D + NIKL+DFGF+ CG+ +Y +P
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS------CQLDPGEKLREVCGTPSYLAP 178
Query: 239 EILKGVPYTPH-----YSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---FPT 290
EI++ H D+WS GV++Y + G PF + +L+ + + P
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 291 EPNVSAECKTLLSKIFSP-IKFRIRLKDIKQDPWVK 325
+ S K L+S+ + R ++ P+ +
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-67
Identities = 60/270 (22%), Positives = 117/270 (43%), Gaps = 20/270 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
IG GS+ TV T +VA + + ++F E +++KGL+HPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPN 69
Query: 126 LIRFLQAIETT----HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
++RF + E+T + ++ E G+L +++R + + W RQ++ + + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 182 ERG--VVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
R ++HRD+KC+N+ I G ++K+ D G A ++ + G+ + +P
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------LKRASFAKAVIGTPEFMAP 182
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE--PNVSA 296
E+ + Y DV++ G+ + MA P+ + + + T V P
Sbjct: 183 EMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 297 ECKTLLSKIFSP-IKFRIRLKDIKQDPWVK 325
E K ++ R +KD+ + +
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 214 bits (546), Expect = 1e-67
Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 17/275 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + + +G G++ V G K ++ P D K + EI ++ L HP
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINT-PYPLD--KYTVKNEISIMNQLHHPK 87
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAIDYCHERG 184
LI A E + + +I+E+ G L D I E Y + E + RQ + + + HE
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 185 VVHRDIKCENLLIDGEYN--IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
+VH DIK EN++ + + +K+ DFG A + + + +A+PEI+
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKL------NPDEIVKVTTATAEFAAPEIVD 201
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE---PNVSAECK 299
P + D+W++GV+ Y + G PF + ++ L+ V+ E +VS E K
Sbjct: 202 REPVGFYT-DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 300 TLLSKIFSP-IKFRIRLKDIKQDPWVKTEANPAAS 333
+ + + R+ + D + PW+K + + S
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 295
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-66
Identities = 66/251 (26%), Positives = 119/251 (47%), Gaps = 16/251 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+G+ IG GS+ TV + DVAVK+++ P L+ F E+ V++ RH N
Sbjct: 10 ITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVN 65
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERG 184
++ F+ T ++ I+ ++ E SL + E + + RQ +DY H +
Sbjct: 66 ILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
++HRD+K N+ + + +K+ DFG A + HQ + GS + +PE+++
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ---FEQLSGSILWMAPEVIRMQ 181
Query: 245 PYTPHY--SDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTKVVFPT----EPNVSAE 297
P+ SDV++ G+VLY + G+LP+ + N Q++ V + P N
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 298 CKTLLSKIFSP 308
K L+++
Sbjct: 242 MKRLMAECLKK 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (530), Expect = 9e-66
Identities = 81/270 (30%), Positives = 128/270 (47%), Gaps = 18/270 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y V+G G+++ V LA R VA+K ++K + + EI V+ ++HPN
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPN 68
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
++ E+ +Y+IM+ G L D I +G+ E + Q++DA+ Y H+ G+
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 186 VHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
VHRD+K ENLL D + I +SDFG K + T CG+ Y +PE+L
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGL------SKMEDPGSVLSTACGTPGYVAPEVLA 182
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---FPTEPNVSAECK 299
PY+ D WS+GV+ Y + G PF D N +L +Q+ P ++S K
Sbjct: 183 QKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 300 TLLSKIFS--PIKFRIRLKDIKQDPWVKTE 327
+ + P K R + Q PW+ +
Sbjct: 242 DFIRHLMEKDPEK-RFTCEQALQHPWIAGD 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 6e-65
Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 13/258 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ +G G+ V + G +A K++ E P + + RE+ V+ P
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQII-RELQVLHECNSPY 65
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHER-G 184
++ F A + + I ME+ + GSL +++ G I E K ++ + Y E+
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
++HRD+K N+L++ IKL DFG + + + +F G+ +Y SPE L+G
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-------SFVGTRSYMSPERLQGT 178
Query: 245 PYTPHYSDVWSMGVVLYAMAFGRLPFD--DTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302
Y+ SD+WSMG+ L MA GR P D ++L+ Q + P L
Sbjct: 179 HYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 303 SKIFSPIKFRIRLKDIKQ 320
S + + + ++
Sbjct: 238 SSYGMDSRPPMAIFELLD 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 6e-65
Identities = 78/269 (28%), Positives = 135/269 (50%), Gaps = 14/269 (5%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVK 119
+E+ ++L K++G GS+ V LA + A+K + K V D ++ + + +
Sbjct: 1 IED--FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 58
Query: 120 GLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
HP L +T ++ +MEY G L+ IQ D R + +++ + +
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
H +G+V+RD+K +N+L+D + +IK++DFG + ++ ++TFCG+ Y +PE
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTPDYIAPE 173
Query: 240 ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299
IL G Y D WS GV+LY M G+ PF + +L ++ F + E K
Sbjct: 174 ILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY-PRWLEKEAK 231
Query: 300 TLLSKIFS--PIKFRIRLK-DIKQDPWVK 325
LL K+F P K R+ ++ DI+Q P +
Sbjct: 232 DLLVKLFVREPEK-RLGVRGDIRQHPLFR 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-63
Identities = 57/306 (18%), Positives = 123/306 (40%), Gaps = 25/306 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y++ + +G G + V T K V +K +EI ++ RH N
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK----KEISILNIARHRN 62
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY-IDEPRTKKWFRQLVDAIDYCHERG 184
++ ++ E+ + +I E+ + + I + ++E + Q+ +A+ + H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 185 VVHRDIKCENLLID--GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
+ H DI+ EN++ IK+ +FG AR + + Y +PE+ +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR------LLFTAPEYYAPEVHQ 176
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE---PNVSAECK 299
+ +D+WS+G ++Y + G PF Q+++ + E +S E
Sbjct: 177 HDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 300 TLLSKIFSPI-KFRIRLKDIKQDPWVKTEANPAASAGVET-------KTLNQSKIDTQAN 351
+ ++ K R+ + Q PW+K + ++ + T TL + ++ +
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVS 295
Query: 352 SNSLSS 357
+ +S
Sbjct: 296 AARISC 301
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 196 bits (500), Expect = 1e-61
Identities = 73/251 (29%), Positives = 118/251 (47%), Gaps = 12/251 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGLRHP 124
Y LG+++G G + V LA R DVAVKV+ + P + +F RE L HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHP 67
Query: 125 NLIRFLQAIETTH----RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
++ E YI+MEY + +L D + EG + R + A+++
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H+ G++HRD+K N++I +K+ DFG AR SG+ + G+ Y SPE
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQ-VQTKVVFPTE--PNVSAE 297
+G SDV+S+G VLY + G PF + + + Q V+ + P+ +SA+
Sbjct: 186 ARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 298 CKTLLSKIFSP 308
++ K +
Sbjct: 245 LDAVVLKALAK 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-61
Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 18/271 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSK---VEAPPDYLKKFLPREIDVVKGLR 122
Y G+ +G G +A VK G A K + K + ++ + RE+ ++K ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
HPN+I + E V +I+E G L DF+ + + E ++ +Q+++ + Y H
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 183 RGVVHRDIKCENLLID----GEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
+ H D+K EN+++ + IK+ DFG A G+ + +P
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------KIDFGNEFKNIFGTPEFVAP 185
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE---PNVS 295
EI+ P +D+WS+GV+ Y + G PF + L V + N S
Sbjct: 186 EIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 296 AECKTLLSKIFSP-IKFRIRLKDIKQDPWVK 325
A K + ++ K R+ ++D Q PW+K
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 195 bits (496), Expect = 2e-60
Identities = 72/272 (26%), Positives = 139/272 (51%), Gaps = 20/272 (7%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
+++ + + + +G GS+ V L S +G A+KV+ K + E ++
Sbjct: 3 LQD--FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
+ HP +IR + ++++IM+Y E G L +++ P K + ++ A++Y
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H + +++RD+K EN+L+D +IK++DFGFA+ + ++ T CG+ Y +PE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAK--------YVPDVTYTLCGTPDYIAPEV 172
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV-QTKVVFPTEPNVSAECK 299
+ PY D WS G+++Y M G PF D+N ++ +++ ++ FP P + + K
Sbjct: 173 VSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVK 229
Query: 300 TLLSKIFS------PIKFRIRLKDIKQDPWVK 325
LLS++ + + +D+K PW K
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-60
Identities = 78/277 (28%), Positives = 128/277 (46%), Gaps = 22/277 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD---YLKKFLPREIDVVKGLR 122
Y +G ++G G + +V VA+K V K +P E+ ++K +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 123 --HPNLIRFLQAIETTHRVYIIMEYAEKGSLL-DFIQREGYIDEPRTKKWFRQLVDAIDY 179
+IR L E +I+E E L DFI G + E + +F Q+++A+ +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 180 CHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASP 238
CH GV+HRDIK EN+LID +KL DFG + + F G+ Y+ P
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-------LLKDTVYTDFDGTRVYSPP 178
Query: 239 EILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298
E ++ Y + VWS+G++LY M G +PF+ I ++ +V F VS+EC
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IRGQVFFR--QRVSSEC 231
Query: 299 KTLLSKIFSPI-KFRIRLKDIKQDPWVKTEANPAASA 334
+ L+ + R ++I+ PW++ P +A
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 8e-60
Identities = 70/288 (24%), Positives = 127/288 (44%), Gaps = 34/288 (11%)
Query: 56 KKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREI 115
KK+ +++++ V +V+G+G V + R A+K++ RE+
Sbjct: 5 KKNAIIDDY-KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREV 55
Query: 116 DV-VKGLRHPNLIRFLQAIETTHR----VYIIMEYAEKGSLLDFIQREG--YIDEPRTKK 168
++ + + P+++R + E + + I+ME + G L IQ G E +
Sbjct: 56 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 169 WFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYN---IKLSDFGFARGHMKCKSGHQSPL 225
+ + +AI Y H + HRD+K ENLL + +KL+DFGFA+ S
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---- 171
Query: 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTK 285
T C + Y +PE+L Y D+WS+GV++Y + G PF + + + ++T+
Sbjct: 172 --TPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228
Query: 286 VV-------FPTEPNVSAECKTLLSKIFSP-IKFRIRLKDIKQDPWVK 325
+ P VS E K L+ + R+ + + PW+
Sbjct: 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-59
Identities = 65/260 (25%), Positives = 113/260 (43%), Gaps = 21/260 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
L + IG G + V L G VAVK + + FL E V+ LRH N
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN----DATAQAFL-AEASVMTQLRHSN 61
Query: 126 LIRFLQA-IETTHRVYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHE 182
L++ L +E +YI+ EY KGSL+D+++ G + K+ + +A++Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
VHRD+ N+L+ + K+SDFG + S DT + +PE L+
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALR 173
Query: 243 GVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301
++ SDVWS G++L+ + +FGR+P+ ++ +V+ +
Sbjct: 174 EKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232
Query: 302 LSKIFSPI-KFRIRLKDIKQ 320
+ + R +++
Sbjct: 233 MKNCWHLDAAMRPSFLQLRE 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 192 bits (488), Expect = 9e-59
Identities = 54/271 (19%), Positives = 114/271 (42%), Gaps = 18/271 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPRE---IDVVKGLR 122
+ + ++IG G + V G A+K + K + E + +V
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE 182
P ++ A T ++ I++ G L + + G E + + +++ +++ H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILK 242
R VV+RD+K N+L+D ++++SD G A K K G++ Y +PE+L+
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-------SVGTHGYMAPEVLQ 178
Query: 243 GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE--PNVSAECKT 300
+D +S+G +L+ + G PF + + + E + S E ++
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 301 LLSKIFSP-IKFRIRL-----KDIKQDPWVK 325
LL + + R+ +++K+ P+ +
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-57
Identities = 78/267 (29%), Positives = 129/267 (48%), Gaps = 15/267 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ K++G G++ V L G A+K++ K E V++ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGV 185
L A +T R+ +MEYA G L + RE E R + + ++V A++Y H R V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 186 VHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP 245
V+RDIK ENL++D + +IK++DFG + + TFCG+ Y +PE+L+
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 246 YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAECKTLLSK 304
Y D W +GVV+Y M GRLPF + ++ +L + + ++ FP +S E K+LL+
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAG 238
Query: 305 IFS------PIKFRIRLKDIKQDPWVK 325
+ K++ + +
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-57
Identities = 53/255 (20%), Positives = 115/255 (45%), Gaps = 9/255 (3%)
Query: 70 KVIGIGSYATVKLAT--STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLI 127
K +G G++ TVK + VAVK++ P + L E +V++ L +P ++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNPYIV 71
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
R + E ++ME AE G L ++Q+ ++ + + Q+ + Y E VH
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYT 247
RD+ N+L+ ++ K+SDFG ++ ++ +++ + +PE + ++
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA--QTHGKWPVKWYAPECINYYKFS 188
Query: 248 PHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF 306
SDVWS GV+++ ++G+ P+ ++ ++ E L++ +
Sbjct: 189 SK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247
Query: 307 SP-IKFRIRLKDIKQ 320
+ ++ R ++
Sbjct: 248 TYDVENRPGFAAVEL 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 6e-57
Identities = 52/278 (18%), Positives = 114/278 (41%), Gaps = 15/278 (5%)
Query: 57 KSTVMENHGYVLGKV-IGIGSYATVKLAT--STRHGCDVAVKVVSKVEAPPDYLKKFLPR 113
K ++ ++ + +G G++ +V+ + DVA+KV+ + ++ + R
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-GTEKADTEEMM-R 58
Query: 114 EIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQ 172
E ++ L +P ++R + + + ++ME A G L F+ + I + Q
Sbjct: 59 EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 173 LVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGS 232
+ + Y E+ VHRD+ N+L+ + K+SDFG ++
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK--ALGADDSYYTARSAGKWP 175
Query: 233 YAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTE 291
+ +PE + ++ SDVWS GV ++ ++G+ P+ +++ ++
Sbjct: 176 LKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 234
Query: 292 PNVSAECKTLLSKIFSP-IKFRIRLKDIKQ---DPWVK 325
P E L+S + + R ++Q +
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (474), Expect = 7e-57
Identities = 76/308 (24%), Positives = 134/308 (43%), Gaps = 21/308 (6%)
Query: 30 KSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHG-----YVLGKVIGIGSYATVKLAT 84
+++ K + S +A K D KK + + K +G GS+ V L
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 85 STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144
G A+K++ K + + E +++ + P L++ + + +Y++ME
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIK 204
Y G + ++R G EP + + Q+V +Y H +++RD+K ENLLID + I+
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181
Query: 205 LSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA 264
++DFGFA+ T CG+ +PEI+ Y D W++GV++Y MA
Sbjct: 182 VTDFGFAKRVKGRTW--------TLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMA 232
Query: 265 FGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFS------PIKFRIRLKDI 318
G PF IQ+ +++ + S++ K LL + + + DI
Sbjct: 233 AGYPPFFADQPIQIYEKIV-SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291
Query: 319 KQDPWVKT 326
K W T
Sbjct: 292 KNHKWFAT 299
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-56
Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 37/296 (12%)
Query: 70 KVIGIGSYATVKLATSTRHGCDVAVKVVSK--VEAPPDYLKKFLPREIDVVKGLRHPNLI 127
+G G +ATV A VA+K + D + + REI +++ L HPN+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 128 RFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVH 187
L A + ++ ++ E + + K + + ++Y H+ ++H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 188 RDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYT 247
RD+K NLL+D +KL+DFG A+ G + + Y +PE+L G
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAK-----SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 248 PHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE---------------- 291
D+W++G +L + + + L ++ + PTE
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 292 -----------PNVSAECKTLLSKI--FSPIKFRIRLKDIKQDPWVKTEANPAASA 334
+ L+ + F+P RI + + P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA-RITATQALKMKYFSNRPGPTPGC 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-55
Identities = 49/245 (20%), Positives = 105/245 (42%), Gaps = 12/245 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
K +G G + VK R DVA+K++ + D E V+ L H
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEK 60
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERG 184
L++ ++II EY G LL++++ + + + + +A++Y +
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
+HRD+ N L++ + +K+SDFG +R + S ++ PE+L
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSR----YVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 245 PYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303
++ SD+W+ GV+++ + + G++P++ + + + + S + T++
Sbjct: 177 KFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 304 KIFSP 308
+
Sbjct: 236 SCWHE 240
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (460), Expect = 2e-55
Identities = 59/271 (21%), Positives = 107/271 (39%), Gaps = 16/271 (5%)
Query: 66 YVLGKVIGIGSYATVKLAT---STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
+ +VIG G + V + VA+K + + FL E ++
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS-GYTEKQRRDFL-SEASIMGQFD 85
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDF-IQREGYIDEPRTKKWFRQLVDAIDYCH 181
HPN+I + + V II E+ E GSL F Q +G + R + + Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+ VHRD+ N+L++ K+SDFG +R S + + +PE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 242 KGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300
+ +T SDVWS G+V++ + ++G P+ D ++ ++ P + +
Sbjct: 206 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 301 LLSKIFSPI-KFRI-------RLKDIKQDPW 323
L+ + R L + ++P
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 7e-55
Identities = 60/250 (24%), Positives = 115/250 (46%), Gaps = 12/250 (4%)
Query: 66 YVLGKVIGIGSYATVKLAT---STRHGCDVAVKVVSK-VEAPPDYLKKFLPREIDVVKGL 121
L + +G GS+ V+ + VAVK + V + P+ + F+ RE++ + L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSL 68
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYC 180
H NLIR + T + ++ E A GSLLD + + +G+ ++ Q+ + + Y
Sbjct: 69 DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
+ +HRD+ NLL+ +K+ DFG R ++ + + +A+ +PE
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 241 LKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQT-KVVFPTEPNVSAEC 298
LK ++ SD W GV L+ M +G+ P+ N Q+L ++ P + +
Sbjct: 186 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 299 KTLLSKIFSP 308
++ + ++
Sbjct: 245 YNVMVQCWAH 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 9e-55
Identities = 67/301 (22%), Positives = 120/301 (39%), Gaps = 42/301 (13%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y IG G+Y V A + VA+K +S E Y ++ L REI ++ RH N
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTL-REIKILLRFRHEN 67
Query: 126 LIRFLQAIET----THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
+I I + ++ + L + + ++ + Q++ + Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
V+HRD+K NLL++ ++K+ DFG AR + + + + Y +PEI+
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLAR--VADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE---------- 291
D+WS+G +L M R F +Y+ L + + P++
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 292 --------------------PNVSAECKTLLSKI--FSPIKFRIRLKDIKQDPWVKTEAN 329
PN ++ LL K+ F+P K RI ++ P+++ +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK-RIEVEQALAHPYLEQYYD 303
Query: 330 P 330
P
Sbjct: 304 P 304
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-54
Identities = 65/267 (24%), Positives = 114/267 (42%), Gaps = 17/267 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
L +G G + V + T VA+K + P+ +E V+K LRH
Sbjct: 19 LRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEK 73
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREG--YIDEPRTKKWFRQLVDAIDYCHER 183
L++ A+ + +YI+ EY KGSLLDF++ E Y+ P+ Q+ + Y
Sbjct: 74 LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
VHRD++ N+L+ K++DFG AR ++ + +PE
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 244 VPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302
+T SDVWS G++L + GR+P+ ++L QV+ P P L+
Sbjct: 189 GRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247
Query: 303 SKIFSPI-KFRIRLKDIKQ--DPWVKT 326
+ + + R + ++ + + +
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-54
Identities = 63/269 (23%), Positives = 117/269 (43%), Gaps = 18/269 (6%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
L + +G G + V + VAVK + + PD E +++K L+H
Sbjct: 15 LKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQR 69
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY--IDEPRTKKWFRQLVDAIDYCHER 183
L+R A+ T +YII EY E GSL+DF++ + + Q+ + + + ER
Sbjct: 70 LVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
+HRD++ N+L+ + K++DFG AR ++ + + +PE +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 244 VPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302
+T SDVWS G++L + GR+P+ ++++ ++ N E L+
Sbjct: 185 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 303 SKIFSPI-KFRIRLKDIKQ---DPWVKTE 327
+ + R ++ D + TE
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 176 bits (448), Expect = 7e-54
Identities = 72/295 (24%), Positives = 121/295 (41%), Gaps = 40/295 (13%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
ME Y + IG G+Y V A + +G A+K + + + REI ++K
Sbjct: 1 MEK--YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI-REISILKE 56
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
L+H N+++ I T R+ ++ E+ ++ EG ++ K + QL++ I YC
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H+R V+HRD+K +NLLI+ E +K++DFG AR G + Y +P++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLAR-----AFGIPVRKYTHEIVTLWYRAPDV 171
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE--------- 291
L G D+WS+G + M G F + L ++ + P
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 292 -------------------PNVSAECKTLLSKI--FSPIKFRIRLKDIKQDPWVK 325
+ LLSK+ P + RI K + + K
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ-RITAKQALEHAYFK 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-53
Identities = 80/301 (26%), Positives = 127/301 (42%), Gaps = 40/301 (13%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
MEN + + IG G+Y V A + G VA+K + + REI ++K
Sbjct: 1 MEN--FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKE 57
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSL-LDFIQREGYIDEPRTKKWFRQLVDAIDY 179
L HPN+++ L I T +++Y++ E+ + I P K + QL+ + +
Sbjct: 58 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
CH V+HRD+K +NLLI+ E IKL+DFG AR + + Y +PE
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-----HEVVTLWYRAPE 172
Query: 240 ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE-------- 291
IL G Y D+WS+G + M R F + I L ++ + P E
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 292 --------------------PNVSAECKTLLSKI--FSPIKFRIRLKDIKQDPWVKTEAN 329
P + + ++LLS++ + P K RI K P+ +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK-RISAKAALAHPFFQDVTK 291
Query: 330 P 330
P
Sbjct: 292 P 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-53
Identities = 64/271 (23%), Positives = 116/271 (42%), Gaps = 19/271 (7%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV---EAPPDYLKKFLPREIDVVKGLR 122
+ KV+G G++ TV G V + V K P K+ L E V+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVD 69
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCH 181
+P++ R L T V +I + G LLD++ + + I W Q+ ++Y
Sbjct: 70 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+R +VHRD+ N+L+ ++K++DFG A+ + + ++ + + E +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAK---LLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 242 KGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300
YT SDVWS GV ++ + FG P+D ++ ++ P P + +
Sbjct: 186 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244
Query: 301 LLSKIFSP-----IKFR---IRLKDIKQDPW 323
++ K + KFR I + +DP
Sbjct: 245 IMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 175 bits (444), Expect = 4e-53
Identities = 58/259 (22%), Positives = 112/259 (43%), Gaps = 13/259 (5%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ +G G Y V ++ VAVK + + +++FL +E V+K ++HPN
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFL-KEAAVMKEIKHPN 74
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQ--REGYIDEPRTKKWFRQLVDAIDYCHER 183
L++ L YII E+ G+LLD+++ + Q+ A++Y ++
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 184 GVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKG 243
+HRD+ N L+ + +K++DFG +R +G + +PE L
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSR----LMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 244 VPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302
++ SDVW+ GV+L+ +A +G P+ + Q+ + ++ + L+
Sbjct: 191 NKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249
Query: 303 SKIFSPI-KFRIRLKDIKQ 320
+ R +I Q
Sbjct: 250 RACWQWNPSDRPSFAEIHQ 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (444), Expect = 4e-53
Identities = 61/286 (21%), Positives = 107/286 (37%), Gaps = 37/286 (12%)
Query: 66 YVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
+ IG G++ V A + VAVK++ + EA D F RE ++
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQ-REAALMAE 72
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY-------------------- 160
+PN+++ L + ++ EY G L +F++
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 161 ----IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216
+ RQ+ + Y ER VHRD+ N L+ +K++DFG +R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR---N 189
Query: 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNY 275
S + PE + YT SDVW+ GVVL+ + ++G P+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 276 IQLLKQVQTKVVFPTEPNVSAECKTLLSKIFSPI-KFRIRLKDIKQ 320
+++ V+ + N E L+ +S + R I +
Sbjct: 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 6e-53
Identities = 64/262 (24%), Positives = 109/262 (41%), Gaps = 14/262 (5%)
Query: 66 YVLGKVIGIGSYATVKLAT---STRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR 122
LG+ IG G + V VA+K + +KFL +E ++
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFL-QEALTMRQFD 66
Query: 123 HPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFI-QREGYIDEPRTKKWFRQLVDAIDYCH 181
HP++++ + I T + V+IIME G L F+ R+ +D + QL A+ Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
+ VHRDI N+L+ +KL DFG +R + + +PE +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR----YMEDSTYYKASKGKLPIKWMAPESI 181
Query: 242 KGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKT 300
+T SDVW GV ++ + G PF ++ +++ P PN +
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 301 LLSKIFSP-IKFRIRLKDIKQD 321
L++K ++ R R ++K
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 9e-53
Identities = 59/287 (20%), Positives = 112/287 (39%), Gaps = 38/287 (13%)
Query: 66 YVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
GKV+G G++ V AT+ T VAVK++ + +A + + E+ ++
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALM-SELKMMTQ 96
Query: 121 L-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQRE--------------------- 158
L H N++ L A + +Y+I EY G LL++++ +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 159 --GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216
+ + Q+ +++ + VHRD+ N+L+ +K+ DFG AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR---D 213
Query: 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNY 275
S + + +PE L YT SDVWS G++L+ + + G P+
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 276 IQLL-KQVQTKVVFPTEPNVSAECKTLLSKIFSP-IKFRIRLKDIKQ 320
K +Q + E ++ ++ + R ++
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 1e-52
Identities = 52/245 (21%), Positives = 104/245 (42%), Gaps = 12/245 (4%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
+ IG G + V L + VA+K + + + F+ E +V+ L HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE---EDFI-EEAEVMMKLSHPK 61
Query: 126 LIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYI-DEPRTKKWFRQLVDAIDYCHERG 184
L++ + ++ E+ E G L D+++ + + + + + Y E
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 185 VVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGV 244
V+HRD+ N L+ IK+SDFG + Q S +ASPE+
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGM----TRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 245 PYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303
Y+ SDVWS GV+++ + + G++P+++ + ++++ + T S +++
Sbjct: 178 RYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 304 KIFSP 308
+
Sbjct: 237 HCWKE 241
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-52
Identities = 58/307 (18%), Positives = 104/307 (33%), Gaps = 44/307 (14%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y IG G++ V A + G VA+K V + L REI +++ L+H N
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLKHEN 70
Query: 126 LIRFLQAIETT--------HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAI 177
++ ++ T +Y++ ++ E K+ + L++ +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 178 DYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYAS 237
Y H ++HRD+K N+LI + +KL+DFG AR K+ + + + Y
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT-NRVVTLWYRP 189
Query: 238 PEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP----- 292
PE+L G D+W G ++ M L + T
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 293 --------------------------NVSAECKTLLSKIFS--PIKFRIRLKDIKQDPWV 324
L+ K+ P + RI D +
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ-RIDSDDALNHDFF 308
Query: 325 KTEANPA 331
++ P+
Sbjct: 309 WSDPMPS 315
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-51
Identities = 61/274 (22%), Positives = 107/274 (39%), Gaps = 26/274 (9%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHP 124
VIG G++ V A + G + + E + E++V+ L HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 125 NLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKK 168
N+I L A E +Y+ +EYA G+LLDF+++ + +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 169 WFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDT 228
+ + +DY ++ +HRD+ N+L+ Y K++DFG +RG
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT------M 185
Query: 229 FCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVV 287
+ + E L YT + SDVWS GV+L+ + + G P+ +L +++
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 288 FPTEPNVSAECKTLLSKIFSPI-KFRIRLKDIKQ 320
N E L+ + + R I
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 4e-51
Identities = 58/278 (20%), Positives = 106/278 (38%), Gaps = 25/278 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y LG+ IG GS+ + L T G +VA+K+ P L E + K ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63
Query: 126 LIRFLQAIETT-HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
I ++ ++ME F Q++ I+Y H +
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 185 VVHRDIKCENLLI---DGEYNIKLSDFGFARGHMKCKSG--HQSPLSDTFCGSYAYASPE 239
+HRD+K +N L+ + + DFG A+ + ++ + G+ YAS
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 240 ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFD----DTNYIQLLKQVQTKVVFPTE---P 292
G+ + D+ S+G VL G LP+ T + + + K+ P E
Sbjct: 184 THLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 293 NVSAECKTLLSKIFSPIKFRIR-----LKDIKQDPWVK 325
+E T L+ S +F + L+ + ++ + +
Sbjct: 243 GYPSEFATYLNFCRSL-RFDDKPDYSYLRQLFRNLFHR 279
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 7e-51
Identities = 66/280 (23%), Positives = 130/280 (46%), Gaps = 21/280 (7%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDY-LKKFLPREID 116
+EN + L KV+G G+Y V L G A+KV+ K + E
Sbjct: 23 IEN--FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 117 VVKGLRH-PNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVD 175
V++ +R P L+ A +T ++++I++Y G L + + E + + ++V
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235
A+++ H+ G+++RDIK EN+L+D ++ L+DFG ++ + ++ + FCG+ Y
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER----AYDFCGTIEY 196
Query: 236 ASPEILKGVPYTPHY-SDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---FPTE 291
+P+I++G D WS+GV++Y + G PF ++ +++ P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
Query: 292 PNVSAECKTLLSKIFS------PIKFRIRLKDIKQDPWVK 325
+SA K L+ ++ +IK+ + +
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 9e-51
Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 40/301 (13%)
Query: 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
M+ Y + IG G+Y TV A + VA+K V + L REI ++K
Sbjct: 1 MQK--YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKE 57
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYC 180
L+H N++R + + ++ ++ E+ ++ F G +D K + QL+ + +C
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
H R V+HRD+K +NLLI+ +KL++FG AR G + Y P++
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLAR-----AFGIPVRCYSAEVVTLWYRPPDV 172
Query: 241 LKGVPYTPHYSDVWSMGVVLYAMAFGRLP-FDDTNYIQLLKQVQTKVVFPTE-------- 291
L G D+WS G + +A P F + LK++ + PTE
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 292 --------------------PNVSAECKTLLSKIFS--PIKFRIRLKDIKQDPWVKTEAN 329
P ++A + LL + P++ RI ++ Q P+
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ-RISAEEALQHPYFSDFCP 291
Query: 330 P 330
P
Sbjct: 292 P 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-50
Identities = 75/349 (21%), Positives = 133/349 (38%), Gaps = 58/349 (16%)
Query: 41 SSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKV 100
S +T++A + + V Y KVIG GS+ V A G VA+K V +
Sbjct: 1 SKVTTVVATPGQGPDRPQEV----SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD 56
Query: 101 EAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR------VYIIMEYAEKG---SL 151
K+F RE+ +++ L H N++R ++ + ++++Y +
Sbjct: 57 -------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 152 LDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGF 210
+ + + + K + QL ++ Y H G+ HRDIK +NLL+D + +KL DFG
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF 270
A+ + + ++ S Y +PE++ G DVWS G VL + G+ F
Sbjct: 170 AK------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223
Query: 271 DDTNYIQLLKQVQTKVVFPTE----------------------------PNVSAECKTLL 302
+ + L ++ + PT P E L
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283
Query: 303 SKI--FSPIKFRIRLKDIKQDPWVKTEANPAASAGVETKTLNQSKIDTQ 349
S++ ++P R+ + + +P T TQ
Sbjct: 284 SRLLEYTPTA-RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ 331
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 4e-49
Identities = 58/260 (22%), Positives = 103/260 (39%), Gaps = 29/260 (11%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
VL + IG G + V G +VAVK+ S E F EI LRH N
Sbjct: 5 IVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER----SWFREAEIYQTVMLRHEN 58
Query: 126 LIRFLQAIE----TTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
++ F+ A T +++++ +Y E GSL D++ R + K + + H
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLH 117
Query: 182 E--------RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSY 233
+ HRD+K +N+L+ ++D G A + + G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-RHDSATDTIDIAPNHRVGTK 176
Query: 234 AYASPEILKGVPYTPHY-----SDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF 288
Y +PE+L H+ +D+++MG+V + +A Q+ +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE----DYQLPYYDLV 232
Query: 289 PTEPNVSAECKTLLSKIFSP 308
P++P+V K + + P
Sbjct: 233 PSDPSVEEMRKVVCEQKLRP 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 5e-49
Identities = 64/297 (21%), Positives = 112/297 (37%), Gaps = 45/297 (15%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGC-DVAVKVVSKVEAPPDYLKKFLPREIDVVKGL--- 121
Y IG G+Y V A ++G VA+K V + RE+ V++ L
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLETF 67
Query: 122 RHPNLIRFLQAIETTH-----RVYIIMEYAEKGSL-LDFIQREGYIDEPRTKKWFRQLVD 175
HPN++R + ++ ++ E+ ++ E + K QL+
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 176 AIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAY 235
+D+ H VVHRD+K +N+L+ IKL+DFG AR + + + + Y
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT------SVVVTLWY 181
Query: 236 ASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE---- 291
+PE+L Y D+WS+G + M + F ++ + L ++ + P E
Sbjct: 182 RAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 292 ----------------------PNVSAECKTLLSKIFSPI-KFRIRLKDIKQDPWVK 325
++ K LL K + RI P+ +
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 6e-49
Identities = 68/282 (24%), Positives = 121/282 (42%), Gaps = 32/282 (11%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCD-------VAVKVVSKVEAPPDYLKKFLPREIDVV 118
VLGK +G G++ V LA + D VAVK++ +A L + E++++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLI-SEMEMM 72
Query: 119 KGL-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR----------------EGYI 161
K + +H N+I L A +Y+I+EYA KG+L +++Q E +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 162 DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221
Q+ ++Y + +HRD+ N+L+ + +K++DFG AR
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLK 280
++ + +PE L YT SDVWS GV+L+ + G P+ +L K
Sbjct: 193 KTT---NGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 281 QVQTKVVFPTEPNVSAECKTLLSKIFSPI-KFRIRLKDIKQD 321
++ N + E ++ + + R K + +D
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-48
Identities = 59/279 (21%), Positives = 115/279 (41%), Gaps = 13/279 (4%)
Query: 36 LDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRH---GCDV 92
+ +D S+ + + + V + + H +VIG G + V T +
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDNDGKKIHC 58
Query: 93 AVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQA-IETTHRVYIIMEYAEKGSL 151
AVK ++++ + +FL E ++K HPN++ L + + +++ Y + G L
Sbjct: 59 AVKSLNRITDI-GEVSQFL-TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 152 LDFIQREGY-IDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210
+FI+ E + + Q+ + + + VHRD+ N ++D ++ +K++DFG
Sbjct: 117 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 176
Query: 211 ARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLP 269
AR M K + + E L+ +T SDVWS GV+L+ + G P
Sbjct: 177 AR-DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPP 234
Query: 270 FDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIFSP 308
+ D N + + ++ K + P
Sbjct: 235 YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHP 273
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-48
Identities = 62/303 (20%), Positives = 118/303 (38%), Gaps = 50/303 (16%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y + +G G+Y V A R G VA+K + + + K+ RE+ ++K +RH N
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHEN 78
Query: 126 LIRFLQAIETTHR------VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDY 179
+I L Y++M + G+ L + + + E R + Q++ + Y
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 180 CHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPE 239
H G++HRD+K NL ++ + +K+ DFG AR + + Y +PE
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVVTRWYRAPE 188
Query: 240 ILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE-------- 291
++ D+WS+G ++ M G+ F ++++ LK++ P
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 292 ----------------------PNVSAECKTLLSKIFS--PIKFRIRLKDIKQDPWVKTE 327
N S LL K+ + R+ + P+ ++
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ-RVTAGEALAHPYFESL 307
Query: 328 ANP 330
+
Sbjct: 308 HDT 310
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 6e-48
Identities = 60/262 (22%), Positives = 107/262 (40%), Gaps = 12/262 (4%)
Query: 66 YVLGKVIGIGSYATVKLA----TSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL 121
KVIG G + V +S + VA+K + FL E ++
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQRVDFL-GEAGIMGQF 66
Query: 122 RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDF-IQREGYIDEPRTKKWFRQLVDAIDYC 180
H N+IR I + II EY E G+L F +++G + R + + Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 181 HERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEI 240
VHRD+ N+L++ K+SDFG +R + + + + +PE
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR--VLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 241 LKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299
+ +T SDVWS G+V++ + +G P+ + + +++K + PT + +
Sbjct: 185 ISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243
Query: 300 TLLSKIFSPI-KFRIRLKDIKQ 320
L+ + + R + DI
Sbjct: 244 QLMMQCWQQERARRPKFADIVS 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 9e-47
Identities = 60/282 (21%), Positives = 104/282 (36%), Gaps = 33/282 (11%)
Query: 66 YVLGKVIGIGSYATVKLATSTRH-----GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
GK +G G++ V AT+ VAVK++ A + + E+ V+
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALM-SELKVLSY 82
Query: 121 L-RHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQR------------------EGYI 161
L H N++ L A +I EY G LL+F++R E +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 162 DEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221
D + Q+ + + + +HRD+ N+L+ K+ DFG AR K+
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDS 199
Query: 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI--QLL 279
+ + +PE + YT SDVWS G+ L+ + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 280 KQVQTKVVFPTEPNVSAECKTLLSKIFSPI-KFRIRLKDIKQ 320
K ++ + + AE ++ + R K I Q
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-46
Identities = 54/259 (20%), Positives = 98/259 (37%), Gaps = 22/259 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCD-----VAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
+ + +G GS+ V + D VA+K V++ A +FL E V+K
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIEFL-NEASVMKE 79
Query: 121 LRHPNLIRFLQAIETTHRVYIIMEYAEKGSLLDFIQREGY----------IDEPRTKKWF 170
+++R L + +IME +G L +++ + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 171 RQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFC 230
++ D + Y + VHRD+ N ++ ++ +K+ DFG
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM---TRDIYETDYYRKGGKGL 196
Query: 231 GSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA-FGRLPFDDTNYIQLLKQVQTKVVFP 289
+ SPE LK +T + DVWS GVVL+ +A P+ + Q+L+ V +
Sbjct: 197 LPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255
Query: 290 TEPNVSAECKTLLSKIFSP 308
N L+ +
Sbjct: 256 KPDNCPDMLFELMRMCWQY 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 157 bits (397), Expect = 3e-46
Identities = 44/257 (17%), Positives = 81/257 (31%), Gaps = 21/257 (8%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y +G+ IG GS+ + T+ + VA+K + P E K L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR-----DEYRTYKLLAGCT 61
Query: 126 LIRFLQAI-ETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG 184
I + + ++++ +Q++ + HE+
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 185 VVHRDIKCENLLID-----GEYNIKLSDFGFARGHMKCKSGHQSPL--SDTFCGSYAYAS 237
+V+RDIK +N LI I + DFG + + + P G+ Y S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 238 PEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ----TKVVFPTE-- 291
G + D+ ++G V G LP+ ++ + K P
Sbjct: 182 INTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 292 -PNVSAECKTLLSKIFS 307
E + +
Sbjct: 241 CAGFPEEFYKYMHYARN 257
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-46
Identities = 64/301 (21%), Positives = 115/301 (38%), Gaps = 46/301 (15%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN 125
Y +G G+Y +V A T+ G VAVK +S+ + K+ RE+ ++K ++H N
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 126 LIRFLQAIETTHRV----YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCH 181
+I L + + + G+ L+ I + + + + Q++ + Y H
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 182 ERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEIL 241
++HRD+K NL ++ + +K+ DFG AR H + + Y +PEI+
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMTGYVATRWYRAPEIM 190
Query: 242 KGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE---------- 291
+ D+WS+G ++ + GR F T++I LK + V P
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 292 --------------------PNVSAECKTLLSKIFS--PIKFRIRLKDIKQDPWVKTEAN 329
+ LL K+ K RI + +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK-RITAAQALAHAYFAQYHD 309
Query: 330 P 330
P
Sbjct: 310 P 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 155 bits (392), Expect = 4e-45
Identities = 70/341 (20%), Positives = 135/341 (39%), Gaps = 61/341 (17%)
Query: 29 PKSSSNKLDLDASSRSTLIAANKRDVKKKSTVMENHGYVLGKVIGIGSYATVKLATSTRH 88
P S ++ D ++ + + ++ Y L + +G G Y+ V A + +
Sbjct: 2 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDD--YQLVRKLGRGKYSEVFEAINITN 59
Query: 89 GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIE--TTHRVYIIMEY 145
V VK++ V+ KK + REI +++ LR PN+I ++ + ++ E+
Sbjct: 60 NEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113
Query: 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIK 204
Q + + + + +++ A+DYCH G++HRD+K N++ID E ++
Sbjct: 114 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 170
Query: 205 LSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMA 264
L D+G A + + + S + PE+L + D+WS+G +L +M
Sbjct: 171 LIDWGLAEFYHPGQEYNV------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224
Query: 265 FGRLPF--DDTNYIQLLKQVQTK-----------------------------------VV 287
F + PF NY QL++ + V
Sbjct: 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 284
Query: 288 FPTEPNVSAECKTLLSKI--FSPIKFRIRLKDIKQDPWVKT 326
+ VS E L K+ + R+ ++ + P+ T
Sbjct: 285 SENQHLVSPEALDFLDKLLRYDHQS-RLTAREAMEHPYFYT 324
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-41
Identities = 63/290 (21%), Positives = 125/290 (43%), Gaps = 20/290 (6%)
Query: 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVV 118
TV++ Y K IG G+ V A +VA+K +S+ + K+ RE+ ++
Sbjct: 14 TVLKR--YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLM 70
Query: 119 KGLRHPNLIRFLQA------IETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQ 172
K + H N+I L +E VY++ME + +D R Q
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQ 127
Query: 173 LVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGS 232
++ I + H G++HRD+K N+++ + +K+ DFG AR + S + + +
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVT 181
Query: 233 YAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP 292
Y +PE++ G+ Y + D+WS+G ++ M ++ F +YI +V ++ P
Sbjct: 182 RYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 293 NVSAECKTLLSKIFSPIKF-RIRLKDIKQDPWVKTEANPAASAGVETKTL 341
+ T+ + + + K+ + + D ++ + + L
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-41
Identities = 51/280 (18%), Positives = 109/280 (38%), Gaps = 30/280 (10%)
Query: 66 YVLGKVIGIGSYATVKLATS-----TRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG 120
LGK +G G++ V A + T VAVK++ + A + + ++
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE-GATHSEHRALMSELKILIHI 73
Query: 121 LRHPNLIRFLQAI-ETTHRVYIIMEYAEKGSLLDFIQREG----------------YIDE 163
H N++ L A + + +I+E+ + G+L +++ + ++
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 164 PRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223
+ Q+ +++ R +HRD+ N+L+ + +K+ DFG AR K +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR- 192
Query: 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAM-AFGRLPFDDTNYIQ-LLKQ 281
+ +PE + YT SDVWS GV+L+ + + G P+ + ++
Sbjct: 193 --KGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 282 VQTKVVFPTEPNVSAECKTLLSKIFSPI-KFRIRLKDIKQ 320
++ + E + + R ++ +
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (295), Expect = 6e-31
Identities = 53/282 (18%), Positives = 98/282 (34%), Gaps = 22/282 (7%)
Query: 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD-------YLKKFLP 112
++ Y+L + +G G ++TV LA + VA+K+V + + L++
Sbjct: 9 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVND 68
Query: 113 REIDVVKGLRHPNLIRFLQAIET-----THRVYIIMEYAEKGSLLDFIQREGYIDEPRTK 167
+ + ++++ L H V + E L I K
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 168 KWFRQLVDAIDYC-HERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHMKCKSGHQSPL 225
+ +QL+ +DY G++H DIK EN+L++ L A C
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT- 187
Query: 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV--- 282
+ Y SPE+L G P+ +D+WS +++ + G F+ K
Sbjct: 188 --NSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244
Query: 283 -QTKVVFPTEPNVSAECKTLLSKIFSPIKFRIRLKDIKQDPW 323
Q + P+ F+ + +K P
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 286
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.3 bits (218), Expect = 2e-21
Identities = 26/160 (16%), Positives = 50/160 (31%), Gaps = 20/160 (12%)
Query: 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVV-------SKVEAPPDYLKKFLPREIDVV 118
+GK++G G + V S + + VK KV+ DY
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 119 KGLRHPNLIRFLQAIETTH----RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLV 174
L + ++ME + + + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113
Query: 175 DAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214
+ + + RG+VH D+ N+L+ E I + DF +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 357 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.89 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.73 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.22 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-65 Score=448.21 Aligned_cols=255 Identities=30% Similarity=0.604 Sum_probs=227.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999987543323333566789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~------- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-------
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC-------
Confidence 9999999999999988999999999999999999999999999999999999999999999999999964321
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..++...+.... ++.++.+|+++++||.
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLIS 236 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHH
T ss_pred CcccccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHH
Confidence 22345679999999999999888877 999999999999999999999999988888875533 3344579999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 304 KIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+|| .||.+|||++|+|+||||+.+
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCCc
Confidence 999 899999999999999999753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-65 Score=448.40 Aligned_cols=260 Identities=33% Similarity=0.526 Sum_probs=220.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||+|+++.+|+.||||++....... ..+.+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 46999999999999999999999999999999997643322 2456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~---~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---RE 159 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT---EE
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC---cc
Confidence 999999999999888889999999999999999999999999999999999999999999999999997543221 12
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHh-hcccCCCCCCCCHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI-QLLKQVQ-TKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~-~~~~~~~~~~~s~~~~~l 301 (357)
......+||+.|+|||++.+..++..++|||||||++|+|++|+.||...... .....+. .....+..+.+|+++++|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 33456789999999999998888665599999999999999999999765432 2223332 233333345789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
|.+|| .||.+|||++|+|+||||++..
T Consensus 240 i~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 99999 8999999999999999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-64 Score=448.88 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=227.7
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.+|++.+.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+++.++||||++++++|...+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 46999999999999999999999999999999997654333 456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.. ..
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~-----~~ 170 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQ 170 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-----TT
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc-----cc
Confidence 99999999998866 4699999999999999999999999999999999999999999999999999975421 22
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--cCCCCCCCCHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV--VFPTEPNVSAECKTL 301 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~l 301 (357)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+.+..+.... ..+.++.+|+++++|
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence 33456689999999999999888876 999999999999999999999988877766654432 234456799999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 302 LSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 302 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
|.+|| .||.+|||++|+|+||||+...+.+.
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~~~~~~~ 281 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCCCCCCc
Confidence 99999 99999999999999999987655443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-64 Score=449.02 Aligned_cols=258 Identities=26% Similarity=0.543 Sum_probs=224.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999997543222223456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... ..
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~---~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES---KQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC---cc
Confidence 999999999999999999999999999999999999999999999999999999999999999999997542211 12
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..++..++.... ...+..+++++++||+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVE 242 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHHH
T ss_pred cccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHHH
Confidence 22345679999999999999888876 999999999999999999999999988888876542 2334579999999999
Q ss_pred Hhc-CCCCCCCCHHH------HhcCCCCCC
Q psy7825 304 KIF-SPIKFRIRLKD------IKQDPWVKT 326 (357)
Q Consensus 304 ~~L-~~p~~Rps~~~------ll~hp~~~~ 326 (357)
+|| .||.+|||++| |++||||++
T Consensus 243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp TTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 999 99999999998 578999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-62 Score=446.55 Aligned_cols=259 Identities=30% Similarity=0.499 Sum_probs=230.1
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
..++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||++++++|.+...+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 45679999999999999999999999999999999975432222224557799999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~----- 157 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----- 157 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999974321
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTL 301 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 301 (357)
........+||+.|+|||++.+..|+.+ +|||||||++|||++|+.||.+.+..++...+.... .+.+..+|+++++|
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dl 235 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSL 235 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred CCcccccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHH
Confidence 1223456789999999999999999877 999999999999999999999999988888776543 34455799999999
Q ss_pred HHHhc-CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 302 LSKIF-SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 302 i~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
|++|| .||.+|++ ++++++||||++.
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 99999 99999994 9999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-63 Score=445.79 Aligned_cols=257 Identities=30% Similarity=0.542 Sum_probs=212.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.+.|++.+.||+|+||.||+|+++.+|+.||||++.+...... ...+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4569999999999999999999999999999999976543322 35577999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc---CCCcEEEeecCCCcccccccC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID---GEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+. +++.+||+|||+++....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence 99999999999999988999999999999999999999999999999999999995 578999999999974321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc---CCCCCCCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV---FPTEPNVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~ 296 (357)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....++...+..... .+..+.+|+
T Consensus 163 ---~~~~~~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 163 ---GSVLSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred ---CCeeeeeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence 122345679999999999999888876 9999999999999999999999998888888765432 233467999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
++++||.+|| .||.+|||++|+|+||||++..
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 9999999999 8999999999999999998743
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-63 Score=436.34 Aligned_cols=254 Identities=29% Similarity=0.509 Sum_probs=215.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--CCeEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET--THRVYI 141 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 141 (357)
++|++.+.||+|+||.||+|+++.+|+.||||++....... ...+.+.+|+.++++++||||+++++++.+ +..+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 46999999999999999999999999999999997655443 345668899999999999999999999864 556899
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 142 IMEYAEKGSLLDFIQR----EGYIDEPRTKKWFRQLVDAIDYCHERG-----VVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~-----ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
||||++||+|.+++.+ ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999864 467999999999999999999999976 9999999999999999999999999997
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCC
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP 292 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 292 (357)
.... ........+||+.|+|||++.+..++.+ +|||||||++|||++|+.||.+.+..++...+......+.+.
T Consensus 163 ~~~~-----~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (269)
T d2java1 163 ILNH-----DTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236 (269)
T ss_dssp HC----------------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT
T ss_pred eccc-----CCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 5422 1222345689999999999999888876 999999999999999999999999999988887766556667
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
.+|+++++||++|| .||.+|||+.|||+|||+
T Consensus 237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 89999999999999 899999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-62 Score=440.61 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=228.6
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIME 144 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 144 (357)
.|.+++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987666666666778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCC
Q psy7825 145 YAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSP 224 (357)
Q Consensus 145 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 224 (357)
||.||+|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-------- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--------
Confidence 999999988888888899999999999999999999999999999999999999999999999999974321
Q ss_pred CCCcccCCccccccceecCC---CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CCCCCCCCHHHHH
Q psy7825 225 LSDTFCGSYAYASPEILKGV---PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPTEPNVSAECKT 300 (357)
Q Consensus 225 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~ 300 (357)
....+||+.|+|||++.+. .|+.+ +|||||||++|+|++|..||.+.+..+.+..+..... ......+|+++++
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~-~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcCch-hhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 2346799999999999643 45555 9999999999999999999999888877776655433 3345578999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
||.+|| .||.+|||++|+|+||||+....+..
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~~ 278 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTH
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcCCCCchh
Confidence 999999 99999999999999999998765543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-63 Score=438.38 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=221.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
+.|++++.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4699999999999999999999999999999998754322 2456779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 144 EYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 144 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
||++||+|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999999865 4679999999999999999999999999999999999999999999999999986432211
Q ss_pred CCCCCcccCCccccccceec-----CCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc--CCCCCCCC
Q psy7825 223 SPLSDTFCGSYAYASPEILK-----GVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV--FPTEPNVS 295 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s 295 (357)
......+||+.|+|||++. +..++.+ +|||||||++|+|++|+.||.+.+..+++..+..... .+.++.+|
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k-~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 242 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTH-HHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSC
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChh-hhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCC
Confidence 1123567999999999984 3445555 9999999999999999999999888887777665432 33345789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
+++++||++|| .||.+|||++|+|+||||+..
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999 899999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-61 Score=437.01 Aligned_cols=254 Identities=28% Similarity=0.539 Sum_probs=227.8
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999999999999999997533222222456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~------- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-------
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999975421
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLS 303 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 303 (357)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..++...+.... .+.++.+|+++++||.
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLS 233 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred -ccccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Confidence 2345689999999999999989877 999999999999999999999999998888876543 3344579999999999
Q ss_pred Hhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 304 KIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 304 ~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
+|| .||.+|+ ++++||+||||++.
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 999 8999996 99999999999885
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-61 Score=432.21 Aligned_cols=259 Identities=26% Similarity=0.463 Sum_probs=226.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCch---HHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPD---YLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.++|++++.||+|+||.||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++||||++++++|.+...+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3579999999999999999999999999999999976443221 2245688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC----cEEEeecCCCcccc
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY----NIKLSDFGFARGHM 215 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~----~~kl~Dfg~~~~~~ 215 (357)
|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999988999999999999999999999999999999999999998776 49999999987442
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC-C--CCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF-P--TEP 292 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~--~~~ 292 (357)
. ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+...... + ..+
T Consensus 169 ~------~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 169 F------GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp T------SCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred C------CccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 2 122345679999999999998888877 99999999999999999999999998888887654322 2 235
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
.+|.++++||++|| .||.+|||++|+|+||||++..
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 79999999999999 8999999999999999998643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-62 Score=443.60 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=217.8
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
+.+++|++.+.||+|+||.||+|++..+|+.||+|+++.... ....+.+.+|+.+|+.++||||++++++|.+...+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456789999999999999999999999999999999975432 233566789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 141 IIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999999998899999999999999999999997 59999999999999999999999999999754321
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHH---------------------
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQL--------------------- 278 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------------------- 278 (357)
...+.+||+.|+|||++.+..|+.+ +|||||||++|||++|+.||.+.+....
T Consensus 159 -----~~~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 159 -----MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp -----TC---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred -----ccccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 1235689999999999999999887 9999999999999999999976542211
Q ss_pred ---------------------HHHHhhcccCC-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 279 ---------------------LKQVQTKVVFP-TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 279 ---------------------~~~i~~~~~~~-~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
...+....... ....+|.++++||.+|| .||.+|||++|+|+||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 11111111111 11246899999999999 999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-61 Score=425.40 Aligned_cols=250 Identities=23% Similarity=0.457 Sum_probs=215.2
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe----CCeEEE
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET----THRVYI 141 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 141 (357)
|++.+.||+|+||.||+|++..+++.||+|++....... ...+.+.+|+++|++++||||++++++|.. +..+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 478889999999999999999999999999997655433 335668899999999999999999999865 456899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEc-CCCcEEEeecCCCccccccc
Q psy7825 142 IMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERG--VVHRDIKCENLLID-GEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~ 218 (357)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||+++...
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc---
Confidence 9999999999999999889999999999999999999999998 99999999999996 57899999999996421
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhhcccCC-CCCCCCH
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDT-NYIQLLKQVQTKVVFP-TEPNVSA 296 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~-~~~~~s~ 296 (357)
.......+||+.|+|||++.+ .++.+ +|||||||++|+|++|+.||.+. +...+...+......+ .+..+++
T Consensus 167 ----~~~~~~~~GT~~Y~aPE~~~~-~~~~~-~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 167 ----ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ----CCccCCcccCccccCHHHhCC-CCCCc-CchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence 122345689999999999876 46665 99999999999999999999765 4555666666544322 2346899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIRLKDIKQDPWVK 325 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps~~~ll~hp~~~ 325 (357)
++++||.+|| .||++|||++|+|+||||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999 8999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-61 Score=442.46 Aligned_cols=258 Identities=25% Similarity=0.448 Sum_probs=226.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 47999999999999999999999999999999986432 233567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC--CCcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQ-REGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG--EYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||++||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~----- 177 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD----- 177 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC-----
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc-----
Confidence 9999999999995 4567999999999999999999999999999999999999964 5789999999987442
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CC--CCCCCCHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FP--TEPNVSAE 297 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~--~~~~~s~~ 297 (357)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+++..+..... ++ ..+.+|++
T Consensus 178 -~~~~~~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 178 -PKQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp -TTSCEEEECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred -cccccceecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 1223345789999999999999888866 9999999999999999999999999888888765432 22 22468999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
+++||++|| .||.+|||++|+|+||||++...+.
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 999999999 9999999999999999999865543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-61 Score=439.77 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=225.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++++.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+|+.++||||++++++|.+++.+|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999987543 222456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc--CCCcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLID--GEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~--~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|||+||+|.+++... .++++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---- 181 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---- 181 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT----
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC----
Confidence 999999999988654 4699999999999999999999999999999999999998 578999999999975421
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-cCC--CCCCCCHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-VFP--TEPNVSAE 297 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~--~~~~~s~~ 297 (357)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+++..+.... .++ ..+.+|++
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 182 --DEIVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred --CCceeeccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 223345679999999999999988877 999999999999999999999999988888876543 222 34579999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+++||.+|| .||.+|||+.|+|+||||++..
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 999999999 9999999999999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-61 Score=439.16 Aligned_cols=255 Identities=28% Similarity=0.481 Sum_probs=227.6
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.....+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46799999999999999999999999999999998653322222245577999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|||+.||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~------ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ 193 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS------
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc------
Confidence 99999999999999988999999999999999999999999999999999999999999999999999975421
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
.....+||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.+...+...+..... ..+..+++++.+||
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLL 269 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHH
T ss_pred --ccccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHH
Confidence 2335679999999999999888876 9999999999999999999999999888888765542 33457999999999
Q ss_pred HHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 303 SKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 303 ~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
++|| .||.+|+ ++++|++||||++.
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 9999 8999984 99999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-60 Score=418.83 Aligned_cols=257 Identities=26% Similarity=0.484 Sum_probs=224.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCc------hHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeC
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPP------DYLKKFLPREIDVVKGLR-HPNLIRFLQAIETT 136 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 136 (357)
++|++.+.||+|+||+||+|++..+|+.||||++.+..... ....+.+.+|+.+++.++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57999999999999999999999999999999997654332 223456779999999997 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+.+|+||||++||+|.+++..++++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999975422
Q ss_pred ccCCCCCCCCCcccCCccccccceecC------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc-c--
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKG------VPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-V-- 287 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~-- 287 (357)
.......+||+.|+|||++.+ ..++.+ +||||+||++|+|++|+.||.+.+.......+.... .
T Consensus 163 ------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~-~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 163 ------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE-VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp ------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred ------CCceeeeeccCCCCCHHHhhccccccCCCCCch-heEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 122345679999999999853 234444 999999999999999999999999888887766543 2
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCC
Q psy7825 288 FPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTE 327 (357)
Q Consensus 288 ~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 327 (357)
.+..+.+|+++++||.+|| .||.+||+++|||+||||++.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 2333579999999999999 999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=431.19 Aligned_cols=257 Identities=30% Similarity=0.503 Sum_probs=223.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHH-cCCCCCcceeeEEEEeCCeEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVK-GLRHPNLIRFLQAIETTHRVYII 142 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 142 (357)
++|++++.||+|+||.||+|+++.+|+.||||++.+.....+...+.+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46999999999999999999999999999999997532211111333446666554 78999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCC
Q psy7825 143 MEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQ 222 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 222 (357)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~-----~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-----G 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-----T
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc-----c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999974322 2
Q ss_pred CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q psy7825 223 SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLL 302 (357)
Q Consensus 223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 302 (357)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..++...+.... ++.+..+|+++++||
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli 234 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLL 234 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHH
Confidence 233445679999999999999999876 999999999999999999999999999888876543 344457999999999
Q ss_pred HHhc-CCCCCCCCHH-HHhcCCCCCCC
Q psy7825 303 SKIF-SPIKFRIRLK-DIKQDPWVKTE 327 (357)
Q Consensus 303 ~~~L-~~p~~Rps~~-~ll~hp~~~~~ 327 (357)
++|| .||.+||++. +|++||||++-
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHhcccCCCCCcCHHHHHHhCchhccC
Confidence 9999 9999999996 89999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-60 Score=438.02 Aligned_cols=257 Identities=20% Similarity=0.345 Sum_probs=215.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHH---HHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLP---REIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.++|++.++||+|+||.||+|++..+|+.||||++.+...........+. .|+.+++.++||||++++++|...+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46799999999999999999999999999999998653322211122233 447778888999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
|+||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--- 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS---
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999975422
Q ss_pred CCCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--hhcccCCCCCCCCH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV--QTKVVFPTEPNVSA 296 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~s~ 296 (357)
......+||+.|+|||++.+.. ++.+ +|||||||++|+|++|+.||.+.+..+..... ......+.++.+|+
T Consensus 160 ----~~~~~~~GT~~y~APE~~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (364)
T d1omwa3 160 ----KKPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234 (364)
T ss_dssp ----SCCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred ----CcccccccccccchhHHhhcCCCCCcc-cchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence 1234567999999999997654 5555 99999999999999999999865433322222 22333444567999
Q ss_pred HHHHHHHHhc-CCCCCCCC-----HHHHhcCCCCCCC
Q psy7825 297 ECKTLLSKIF-SPIKFRIR-----LKDIKQDPWVKTE 327 (357)
Q Consensus 297 ~~~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 327 (357)
++++||.+|| .||.+||+ +++|++||||++.
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999 99999999 7999999999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-60 Score=425.78 Aligned_cols=260 Identities=21% Similarity=0.317 Sum_probs=216.9
Q ss_pred EceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC--chHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEec
Q psy7825 68 LGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP--PDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEY 145 (357)
Q Consensus 68 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 145 (357)
.+++||+|+||+||+|++..+|+.||||++...... .+...+.+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 467899999999999999999999999998654332 222345678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCC
Q psy7825 146 AEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPL 225 (357)
Q Consensus 146 ~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 225 (357)
+.|+++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~-----~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-----PNRA 156 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS-----CCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC-----Cccc
Confidence 99988777777677899999999999999999999999999999999999999999999999999974322 1223
Q ss_pred CCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC---------------
Q psy7825 226 SDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT--------------- 290 (357)
Q Consensus 226 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 290 (357)
....+||+.|+|||++.+......++|||||||++|+|++|..||.+.+..+.+..+......+.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 34567999999999997665544459999999999999999999999988888777654322111
Q ss_pred ------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 291 ------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 291 ------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
.+.+++++++||++|| .||++|||++|+|+||||++.+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~ 291 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence 1357899999999999 99999999999999999998765443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-60 Score=427.97 Aligned_cols=257 Identities=20% Similarity=0.377 Sum_probs=224.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++++.||+|+||.||+|.++.+|+.||||++.... .....+.+|+.+|+.++||||++++++|++++.+|+||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999996532 12345779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC--CcEEEeecCCCcccccccCC
Q psy7825 144 EYAEKGSLLDFIQREG-YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE--YNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~--~~~kl~Dfg~~~~~~~~~~~ 220 (357)
|||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.++|+|||+++...
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~----- 155 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK----- 155 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC-----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc-----
Confidence 9999999999998764 79999999999999999999999999999999999999854 479999999987432
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhccc-CCC--CCCCCHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVV-FPT--EPNVSAE 297 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~--~~~~s~~ 297 (357)
........+||+.|+|||.+.+..++.+ +|||||||++|+|++|..||.+.+..++...+..... ++. .+.+|++
T Consensus 156 -~~~~~~~~~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 156 -PGDNFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -TTCEEEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -cCCcccccccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 1222345679999999999999888876 9999999999999999999999999988888765432 222 2478999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 298 CKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 298 ~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
+++||++|| .||.+|||++|+|+||||++..+..
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~~ 268 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccCcccc
Confidence 999999999 8999999999999999998764443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=414.08 Aligned_cols=262 Identities=29% Similarity=0.467 Sum_probs=218.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++++.||+|+||.||+|.+..+|+.||||++..... .+...+.+.+|+.+|++++||||++++++|.++..+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 479999999999999999999999999999999965432 2233456779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 144 EYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 144 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
||+.+ .+.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~----- 154 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----- 154 (298)
T ss_dssp ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-----
T ss_pred eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC-----
Confidence 99976 55555533 35699999999999999999999999999999999999999999999999999974322
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC-----------
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT----------- 290 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----------- 290 (357)
.........||+.|+|||++....+...++|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 222344567999999999998888766679999999999999999999999887776665532211110
Q ss_pred -----------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCCc
Q psy7825 291 -----------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPAA 332 (357)
Q Consensus 291 -----------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 332 (357)
.+.++.++++||++|| .||.+|||++|||+||||++...|.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 1357899999999999 89999999999999999998766643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-59 Score=413.58 Aligned_cols=252 Identities=29% Similarity=0.515 Sum_probs=214.3
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchH---HhhhHHHHHHHHHcCC--CCCcceeeEEEEeCC
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDY---LKKFLPREIDVVKGLR--HPNLIRFLQAIETTH 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 137 (357)
.++|++.+.||+|+||.||+|++..+|+.||||++.+....... ....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999999999999999999764332211 1233568999999986 899999999999999
Q ss_pred eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCC-CcEEEeecCCCcccc
Q psy7825 138 RVYIIMEYAEK-GSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGE-YNIKLSDFGFARGHM 215 (357)
Q Consensus 138 ~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~-~~~kl~Dfg~~~~~~ 215 (357)
.+++||||+.+ +++.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 6888999888899999999999999999999999999999999999999854 799999999986432
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s 295 (357)
.......+||+.|+|||++.+..+...++|||||||++|+|++|+.||.+.+ .+ +.... ..++.+|
T Consensus 163 -------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i---~~~~~--~~~~~~s 228 (273)
T d1xwsa_ 163 -------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EI---IRGQV--FFRQRVS 228 (273)
T ss_dssp -------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH---HHCCC--CCSSCCC
T ss_pred -------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HH---hhccc--CCCCCCC
Confidence 1223456799999999999888776665899999999999999999997642 11 12222 3345799
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
+++++||++|| .||.+|||++|+|+||||++..
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 99999999999 8999999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-58 Score=413.38 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=212.2
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCc---EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGC---DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
.+...+|++.++||+|+||.||+|.++.+|+ .||||.+.... .....+.+.+|+.+|++++||||+++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3455679999999999999999999876664 57888765432 233355688999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
+.+++||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988774 579999999999999999999999999999999999999999999999999997554
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
...............||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+....++...+......+.+..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC 258 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 3222222222233568999999999998888877 999999999999998 89999999999999999888888888899
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
++++.+||.+|| .||.+||++.||+++
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999 899999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-58 Score=412.37 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=221.0
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..+..++|++.+.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+.+|+.++||||++++++|.+++.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 356677899999999999999999999999999999998654332 3457799999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+++||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999764 5689999999999999999999999999999999999999999999999999975422
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCC-CCCCCCHHHHHHHHhhcccCCCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRL-PFDDTNYIQLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~s 295 (357)
. .........|++.|+|||++.+..++.+ +|||||||++|||++|.. ||.+.+...+.+.+......+.++.++
T Consensus 168 ~----~~~~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 242 (287)
T d1opja_ 168 D----TYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 242 (287)
T ss_dssp S----SSEEETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred C----CceeeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccch
Confidence 1 1112233458899999999998888876 999999999999999655 456777777777787777777778899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+++++||.+|| .||++|||+.+|++
T Consensus 243 ~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 243 EKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999 99999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=420.02 Aligned_cols=251 Identities=27% Similarity=0.477 Sum_probs=207.3
Q ss_pred cCeEEc-eeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHc-CCCCCcceeeEEEEe----CC
Q psy7825 64 HGYVLG-KVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKG-LRHPNLIRFLQAIET----TH 137 (357)
Q Consensus 64 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~----~~ 137 (357)
++|.+. ++||+|+||.||+|++..+|+.||||++.. ...+.+|+.++.+ ++||||++++++|++ +.
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 458876 569999999999999999999999999864 2346689988654 589999999999976 46
Q ss_pred eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcEEEeecCCCc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG---EYNIKLSDFGFAR 212 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~---~~~~kl~Dfg~~~ 212 (357)
.+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 789999999999999999864 46999999999999999999999999999999999999985 4679999999997
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhh-----ccc
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQT-----KVV 287 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-----~~~ 287 (357)
.... .......+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+.......+.. ...
T Consensus 163 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 163 ETTS------HNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp ECCC------CCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred eccC------CCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 4422 122345679999999999999888877 9999999999999999999987654444333322 122
Q ss_pred CCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 288 FPT--EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 288 ~~~--~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
+|. .+.+|+++++||++|| .||.+|||+.|+|+||||++...
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 222 2368999999999999 89999999999999999987543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.1e-58 Score=407.75 Aligned_cols=256 Identities=27% Similarity=0.386 Sum_probs=215.3
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|.+.+.||+|+||+||+|+++ +|+.||||++..... .+...+.+.+|+.+|+.++||||+++++++...+..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 57999999999999999999986 689999999965432 2233456779999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
|++.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+..... ..
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~-----~~ 154 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI-----PV 154 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc-----Cc
Confidence 9998877777777788899999999999999999999999999999999999999999999999999864321 12
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC--------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP-------------- 289 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------- 289 (357)
.......|++.|+|||.+.+..+.+.++|||||||++|||++|+.||.+.+..+.+.++......+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 223445689999999999877665566999999999999999999999988877776653321111
Q ss_pred --------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCC
Q psy7825 290 --------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKT 326 (357)
Q Consensus 290 --------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 326 (357)
..+.+++++++||++|| .||++|||++|+|+||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 12457899999999999 99999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-58 Score=407.36 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=213.4
Q ss_pred eeeeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEEeccC
Q psy7825 70 KVIGIGSYATVKLATST--RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIMEYAE 147 (357)
Q Consensus 70 ~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 147 (357)
+.||+|+||.||+|.+. .+++.||||++..... .....+.+.+|+.+|++++||||+++++++..+ ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 46999999999999864 3567899999865433 334456788999999999999999999999754 5789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCC
Q psy7825 148 KGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSD 227 (357)
Q Consensus 148 ~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 227 (357)
+|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~--~~~~~~ 168 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQT 168 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS--EEEC--
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc--cccccc
Confidence 999999999988999999999999999999999999999999999999999999999999999975432111 112233
Q ss_pred cccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc
Q psy7825 228 TFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF 306 (357)
Q Consensus 228 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L 306 (357)
...||+.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+..++...+..+...+.+..+|+++++||.+||
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence 4568999999999998888876 999999999999997 89999999999998888887777777889999999999999
Q ss_pred -CCCCCCCCHHHH---hcCCCCC
Q psy7825 307 -SPIKFRIRLKDI---KQDPWVK 325 (357)
Q Consensus 307 -~~p~~Rps~~~l---l~hp~~~ 325 (357)
.||.+|||+.+| |+|+|++
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCHHhh
Confidence 899999999998 4676653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-58 Score=407.58 Aligned_cols=260 Identities=20% Similarity=0.346 Sum_probs=222.8
Q ss_pred cccccCeEEcee-eeecCCeEEEEEEECC--CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 60 VMENHGYVLGKV-IGIGSYATVKLATSTR--HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 60 ~~~~~~y~~~~~-lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
.+..++|.+.+. ||+|+||.||+|.+.. ++..||||++.... .....+.+.+|+.+|++++||||+++++++..
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 456677999985 9999999999998754 45679999986533 23335668899999999999999999999875
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
+.+|+||||+++|+|.+++.. +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 457899999999999999865 4679999999999999999999999999999999999999999999999999997553
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
.... .........||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+..++...+..+...+.++.+
T Consensus 161 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 237 (285)
T d1u59a_ 161 ADDS--YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 237 (285)
T ss_dssp TCSC--EECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTC
T ss_pred cccc--ccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence 2211 1222345568999999999988888877 999999999999998 99999998888888888888777778899
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHH---hcCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDI---KQDPWVK 325 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~l---l~hp~~~ 325 (357)
|+++.+||.+|| .+|++||++.+| |+|+|+.
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999 899999999988 5678764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=401.20 Aligned_cols=251 Identities=22% Similarity=0.380 Sum_probs=212.2
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEE
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVY 140 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 140 (357)
++..+|.+.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+.+++.++||||+++++++..++.++
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 45668999999999999999999976 4778999998654333 345779999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccC
Q psy7825 141 IIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKS 219 (357)
Q Consensus 141 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 219 (357)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~-- 154 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-- 154 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC--
Confidence 999999999999998764 56899999999999999999999999999999999999999999999999999754221
Q ss_pred CCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHH
Q psy7825 220 GHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAEC 298 (357)
Q Consensus 220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~ 298 (357)
.........||+.|+|||++.+..++.+ +|||||||++|||+| |..||...+..++...+......+.+..+++++
T Consensus 155 --~~~~~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 231 (263)
T d1sm2a_ 155 --QYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred --CceeecceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence 1122234568999999999999888876 999999999999998 577788888888888888887777777899999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 299 KTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 299 ~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+||.+|| .||++||++++|++|
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999 999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-57 Score=403.84 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=214.8
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC----e
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH----R 138 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~ 138 (357)
.++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 457999999999999999999999999999999998766666666677889999999999999999999987643 4
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|+||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999886443221
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccC---CCCCCCC
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVF---PTEPNVS 295 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s 295 (357)
. ........+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+..+....+...... ...+.+|
T Consensus 166 ~--~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 166 N--SVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred c--cccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 1 2223445689999999999999888877 99999999999999999999999888877665543332 2246799
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQDPWV 324 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~hp~~ 324 (357)
+++++||.+|| .||.+||+..+.+.|+|+
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 99999999999 999999954444456654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=402.62 Aligned_cols=257 Identities=21% Similarity=0.370 Sum_probs=221.4
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCe
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHR 138 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 138 (357)
..+..++|++.+.||+|+||.||+|.++ +++.||||++...... .+.+.+|+.++++++||||+++++++.. +.
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 3466678999999999999999999976 5788999998654332 3457899999999999999999998754 56
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+++||||+++|+|.+++... .++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 78999999999999987543 3699999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhhcccCCCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFG-RLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s 295 (357)
. .........||+.|+|||++.+..++.+ +|||||||++|||+|| .+||...+..++...+......+.++.++
T Consensus 162 ~----~~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~ 236 (272)
T d1qpca_ 162 N----EYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236 (272)
T ss_dssp S----CEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred C----ccccccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccCh
Confidence 1 1122345568999999999998888876 9999999999999995 56677788888888888888777788999
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc--CCCCCC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQ--DPWVKT 326 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~--hp~~~~ 326 (357)
+++.+||.+|| .||++|||+++|++ |+||..
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999 89999999999998 788753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-57 Score=395.90 Aligned_cols=250 Identities=20% Similarity=0.377 Sum_probs=222.9
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEE
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 141 (357)
+.++|++.+.||+|+||.||+|+++ +++.||||++++.... .+.+.+|+.++..++||||+++++++.+++.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 3467999999999999999999985 6889999999765443 3457799999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCC
Q psy7825 142 IMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSG 220 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 220 (357)
||||+++|+|.+++.. ...+++..++.++.||++||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~--- 153 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--- 153 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS---
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC---
Confidence 9999999999999765 467899999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCCHHHH
Q psy7825 221 HQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVSAECK 299 (357)
Q Consensus 221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 299 (357)
.........||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+..++...+......+.+..+++++.
T Consensus 154 -~~~~~~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 154 -EYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231 (258)
T ss_dssp -SCCCCCCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -CceeecccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHH
Confidence 1122334679999999999998888876 999999999999998 8999999999999999988887788889999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 300 TLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 300 ~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+||++|| .||.+|||+++|++|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999 899999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-57 Score=404.28 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=212.7
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCC-CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC---CCCCcceeeEEEEe---
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRH-GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL---RHPNLIRFLQAIET--- 135 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~--- 135 (357)
+++|++++.||+|+||.||+|++..+ ++.||||++........ ....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46799999999999999999999655 67799999865433221 133455777777665 79999999999853
Q ss_pred --CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 136 --THRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 136 --~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
...++++|||+.++.+...... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3478999999988766544433 4569999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC---
Q psy7825 213 GHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP--- 289 (357)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--- 289 (357)
..... ......+||+.|+|||++.+..++.+ +|||||||++|||++|+.||.+.+..+.+..+......+
T Consensus 165 ~~~~~------~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 165 IYSFQ------MALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCCGG------GGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhccc------ccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 43221 22345679999999999999999877 999999999999999999999998888777764321111
Q ss_pred -----------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 290 -----------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 290 -----------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
....+++.+++||++|| .||.+|||++|+|+||||++-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 12467999999999999 99999999999999999987543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=399.62 Aligned_cols=253 Identities=25% Similarity=0.443 Sum_probs=206.0
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRV 139 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 139 (357)
.+..++|.+.+.||+|+||.||+|+.. ..||||+++....... ..+.+.+|+.+|.+++||||+++++++. +..+
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTT-HHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence 456778999999999999999999754 3599999875544333 3566889999999999999999999865 4568
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 140 YIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
++||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999999764 569999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCCCCCCcccCCccccccceecCC---CCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhhcccCC----C
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGV---PYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQ-LLKQVQTKVVFP----T 290 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~----~ 290 (357)
.........||+.|||||++.+. .++.+ +|||||||++|||+||+.||.+.+... +...+......| .
T Consensus 159 ---~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~-sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 159 ---GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ-SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred ---CcccccccccCcccCCHHHHhcccCCCCCch-hhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 12223456799999999999653 34544 999999999999999999998866544 444444443333 3
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 291 EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 291 ~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+..+++++++||.+|| .||.+|||+++|+++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4578999999999999 899999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=409.40 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=214.2
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCc-----EEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGC-----DVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAI 133 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 133 (357)
.+..++|++.++||+|+||.||+|++...++ .||+|.+...... .....+.+|+.++.++ +||||+++++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 3556789999999999999999999865443 6999988543322 2245677999999998 899999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQRE-----------------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDI 190 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dl 190 (357)
...+.+++||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9999999999999999999999754 24889999999999999999999999999999
Q ss_pred CCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCC
Q psy7825 191 KCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLP 269 (357)
Q Consensus 191 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~p 269 (357)
||+|||++.++.+||+|||+++...... .........||+.|||||++.+..++.+ +|||||||++|||+| |..|
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDS---NYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCT---TSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCS
T ss_pred chhccccccCCeEEEeeccccccccCCC---ceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCC
Confidence 9999999999999999999997543221 1112235568999999999998888877 999999999999997 8999
Q ss_pred CCCCCHHHH-HHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 270 FDDTNYIQL-LKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 270 f~~~~~~~~-~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
|.+.+..+. ...+......+.+..+|+++++||.+|| .||++|||++||++|
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 988665444 4445666666777789999999999999 899999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=403.02 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=215.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe--------
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET-------- 135 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 135 (357)
++|++++.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|+.++||||+++++.+..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 56999999999999999999999999999999986544332 234556799999999999999999998854
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
...+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999887666666666789999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCCC---
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTEP--- 292 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--- 292 (357)
..... ........+||+.|+|||++.+......++|||||||++|+|++|+.||.+.+.......+......+...
T Consensus 169 ~~~~~-~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 169 LAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp C------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccc-ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 32222 12233456799999999999876544445999999999999999999999988888777664432211110
Q ss_pred ----------------------------CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 293 ----------------------------NVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 293 ----------------------------~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
..++++++||.+|| .||++|||++|+|+||||+..+.|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 13778899999999 9999999999999999999876654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=394.34 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=221.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCCeEEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 143 (357)
++|++++.||+|+||+||+|++..+|+.||||+++.... .+.....+.+|+.+|+.++||||+++++++......++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 579999999999999999999999999999999976543 3344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCCCC
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQS 223 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 223 (357)
+++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++..... .
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-----~ 155 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----V 155 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-----C
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC-----C
Confidence 99999999999988889999999999999999999999999999999999999999999999999999754321 2
Q ss_pred CCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhhcccCC-------------
Q psy7825 224 PLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPF-DDTNYIQLLKQVQTKVVFP------------- 289 (357)
Q Consensus 224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~------------- 289 (357)
.......+++.|+|||++.+..+.+.++|||||||++|+|++|+.|| .+.+..+....+......+
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 22334567889999999987776555599999999999999999985 5556666666553221111
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy7825 290 ---------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEAN 329 (357)
Q Consensus 290 ---------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 329 (357)
..+.+++.+++||++|| .||.+|||++|||+||||++--+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 11457899999999999 89999999999999999987543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=406.66 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=210.0
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH----- 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 137 (357)
.++|++++.||+|+||+||+|.++.+|+.||||++.+... .+...+.+.+|+.+|+.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 5689999999999999999999999999999999975433 3444566779999999999999999999997654
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 138 -RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 138 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
.+|+||||+ +.+|..+++ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 557777765 4569999999999999999999999999999999999999999999999999997432
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC-------
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP------- 289 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------- 289 (357)
.......||+.|+|||++.+..+...++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 173 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 173 -------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp -------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred -------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 123456799999999999876655555999999999999999999999888776655443211110
Q ss_pred -----------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 290 -----------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 290 -----------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
..+.+++++.+||++|| .||.+|||++|||+||||++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 12467999999999999 8999999999999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=395.02 Aligned_cols=261 Identities=23% Similarity=0.394 Sum_probs=219.9
Q ss_pred cccccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC
Q psy7825 58 STVMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH 137 (357)
Q Consensus 58 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 137 (357)
...+..++|++.+.||+|+||.||+|++.. ++.||||++...... .+.+.+|+.++++++||||+++++++. ++
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EE 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe-cC
Confidence 344667789999999999999999999875 467999998654332 345779999999999999999999985 45
Q ss_pred eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQR--EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
.+++||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 67899999999999998864 3579999999999999999999999999999999999999999999999999997542
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFG-RLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
.. .........||+.|+|||++.+..++.+ +|||||||++|||++| .+||......+++..+......+.++.+
T Consensus 165 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 239 (285)
T d1fmka3 165 DN----EYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 239 (285)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred CC----CceeeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCccc
Confidence 21 1122344679999999999998888876 9999999999999995 5566777888888888888888888899
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhc--CCCCCCCCC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQ--DPWVKTEAN 329 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~--hp~~~~~~~ 329 (357)
++++++||.+|| .||++||++++|++ ++||....+
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 999999999999 99999999999998 999987543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-56 Score=394.12 Aligned_cols=257 Identities=22% Similarity=0.335 Sum_probs=214.1
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCC----cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHG----CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIE 134 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 134 (357)
+.+....|.+.++||+|+||.||+|.+..++ ..||||++..... +.....+.+|+.++++++||||+++++++.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 4566678999999999999999999976554 4799999854332 233456789999999999999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcc
Q psy7825 135 TTHRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARG 213 (357)
Q Consensus 135 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~ 213 (357)
.....++||||+.++++.+++... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999999988764 6799999999999999999999999999999999999999999999999999975
Q ss_pred cccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhhcccCCCCC
Q psy7825 214 HMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFG-RLPFDDTNYIQLLKQVQTKVVFPTEP 292 (357)
Q Consensus 214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~ 292 (357)
...... .........||+.|+|||++.+..++.+ +|||||||++|||++| ..||...+..++...+......+.+.
T Consensus 160 ~~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 236 (283)
T d1mqba_ 160 LEDDPE--ATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 236 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccCCCc--cceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCch
Confidence 432211 1222334568999999999999888877 9999999999999985 55567778888888888888888888
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.++..+.+||.+|| .+|.+||++.+|++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 89999999999999 89999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=404.34 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=208.0
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe------CCe
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------THR 138 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~ 138 (357)
+|...++||+|+||+||+|++..+|+.||||++..... ...+|+.+|++++||||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 59999999999999999999999999999999965432 23379999999999999999999854 335
Q ss_pred EEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecCCCccc
Q psy7825 139 VYIIMEYAEKGSLLDFI---QREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-NIKLSDFGFARGH 214 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-~~kl~Dfg~~~~~ 214 (357)
+|+||||++++.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999875433332 3456799999999999999999999999999999999999999775 8999999998744
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcc--------
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKV-------- 286 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------- 286 (357)
.. .......+||+.|+|||++.+......++|||||||++|||++|+.||...+..+.+..+....
T Consensus 174 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VR------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CT------TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cC------CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 21 1223456799999999998766544445999999999999999999999888777666553211
Q ss_pred ----------cCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 287 ----------VFP----------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 287 ----------~~~----------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
.++ ..+.+++++.+||.+|| .||++|||+.|+|+||||++-..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 111 12457999999999999 999999999999999999876444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=401.09 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=213.2
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC-----e
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH-----R 138 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~ 138 (357)
.+|++++.||+|+||+||+|.+..+|+.||||++.+.. .....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 56999999999999999999999999999999986543 3334556779999999999999999999986543 3
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 218 (357)
+|++ +++.||+|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 4555 556688999999764 59999999999999999999999999999999999999999999999999997543322
Q ss_pred CCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCC---------
Q psy7825 219 SGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFP--------- 289 (357)
Q Consensus 219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------- 289 (357)
. ........+||+.|+|||++........++||||+||++|+|++|+.||.+.+..+...........+
T Consensus 164 ~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 164 D--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp C--BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred c--cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 2 12223456799999999999766655565999999999999999999999887666554432211111
Q ss_pred ---------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7825 290 ---------------------TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANPA 331 (357)
Q Consensus 290 ---------------------~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 331 (357)
..+.++.++++||.+|| .||.+|||+.|+|+||||++...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence 12467899999999999 9999999999999999999765553
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=389.97 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=210.9
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCC---CcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRH---GCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
.+..++|++.+.||+|+||.||+|.+..+ +..||||.+... ..+...+.+.+|+.+++.++||||+++++++. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 35567899999999999999999998654 356888877432 33444667889999999999999999999985 5
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
+.+++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 678999999999999998765 4579999999999999999999999999999999999999999999999999997542
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNV 294 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 294 (357)
.. .........||+.|+|||++.+..++.+ +|||||||++|||++ |..||.+.+..++...+......+.++.+
T Consensus 160 ~~----~~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (273)
T d1mp8a_ 160 DS----TYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred CC----cceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 21 1222344568999999999998888876 999999999999997 89999999998999888888878888899
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 295 SAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 295 s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
|+++.+||.+|| .||.+|||+.+|++|
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999 899999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=397.66 Aligned_cols=256 Identities=22% Similarity=0.363 Sum_probs=212.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCc----EEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGC----DVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET 135 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 135 (357)
.+...+|+++++||+|+||.||+|.+..+|+ .||+|.+..... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3455679999999999999999999988776 577777754322 2224567899999999999999999999986
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccc
Q psy7825 136 THRVYIIMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGH 214 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~ 214 (357)
+ ..++++|++.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 83 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred C-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 5 567788999999999988764 57999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCC
Q psy7825 215 MKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPN 293 (357)
Q Consensus 215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 293 (357)
... ..........||+.|+|||++.+..++.+ +|||||||++|||+| |..||.+.+..++...+..+...+.++.
T Consensus 162 ~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~ 237 (317)
T d1xkka_ 162 GAE---EKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237 (317)
T ss_dssp TTT---CC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTT
T ss_pred ccc---cccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 321 11222334568999999999999888876 999999999999998 8999999888888888888887788889
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQDP 322 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~hp 322 (357)
+++++.+||.+|| .||.+|||+.+|+.|.
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 9999999999999 9999999999999873
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=398.81 Aligned_cols=262 Identities=26% Similarity=0.439 Sum_probs=216.5
Q ss_pred cccCeEEceeeeecCCeEEEEEEE---CCCCcEEEEEEeecCCCC-chHHhhhHHHHHHHHHcCCC-CCcceeeEEEEeC
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATS---TRHGCDVAVKVVSKVEAP-PDYLKKFLPREIDVVKGLRH-PNLIRFLQAIETT 136 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 136 (357)
..++|++++.||+|+||.||+|.+ +.+|+.||||++.+.... .....+.+.+|+.++++++| |||+++++++...
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 346799999999999999999987 346899999998653321 12224556789999999976 8999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
..+++||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh---hcccCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVP-YTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQ---TKVVFPTEP 292 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~ 292 (357)
.. ........|++.|+|||.+.+.. +...++|||||||++|+|++|+.||.+.+..+....+. .....+.+.
T Consensus 182 ~~----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 182 DE----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp GG----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred cc----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 21 11234567999999999997654 23444999999999999999999997754433333332 223344455
Q ss_pred CCCHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCCCCC
Q psy7825 293 NVSAECKTLLSKIF-SPIKFRI-----RLKDIKQDPWVKTE 327 (357)
Q Consensus 293 ~~s~~~~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 327 (357)
.+|+++.+||++|| .||.+|| +++|+|+||||++-
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 79999999999999 8999999 58999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=384.46 Aligned_cols=246 Identities=24% Similarity=0.443 Sum_probs=210.5
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-CCe
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET-THR 138 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 138 (357)
.+..++|++.+.||+|+||.||+|+++ |+.||||+++... ..+.+.+|+.++++++||||+++++++.. .+.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence 456678999999999999999999985 7899999986432 23557799999999999999999998854 566
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQRE--GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMK 216 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 216 (357)
+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||+++...
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~- 154 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS- 154 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC-
Confidence 89999999999999999764 358999999999999999999999999999999999999999999999999987431
Q ss_pred ccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhhcccCCCCCCCC
Q psy7825 217 CKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQTKVVFPTEPNVS 295 (357)
Q Consensus 217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s 295 (357)
.......+++.|+|||++.+..++.+ +|||||||++|||+| |+.||...+..++...+......+.++.++
T Consensus 155 -------~~~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (262)
T d1byga_ 155 -------STQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 226 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCC
T ss_pred -------CCCccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 12334568899999999998888876 999999999999998 799999999889999998888888888899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 296 AECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 296 ~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
+++++||++|| .||.+|||+.+|+++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999 899999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=399.37 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=213.9
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC-----C
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT-----H 137 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 137 (357)
.++|++++.||+|+||+||+|++..+|+.||||++.+..... ...+.+.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 468999999999999999999999999999999997654433 3345577999999999999999999998643 3
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
..+++++++.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence 34566677789999999965 469999999999999999999999999999999999999999999999999986432
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCC-------
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPT------- 290 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------- 290 (357)
.......|++.|+|||++.+..+...++|||||||++|+|++|+.||.+.+.......+......+.
T Consensus 173 ------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 173 ------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp ------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 1234567999999999988877655559999999999999999999999887777766543222111
Q ss_pred -----------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy7825 291 -----------------------EPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEANP 330 (357)
Q Consensus 291 -----------------------~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 330 (357)
...+++++++||++|| .||.+|||++|+|+||||++...+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 1358999999999999 999999999999999999976443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=387.17 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=207.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECC-CC--cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeC
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTR-HG--CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETT 136 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 136 (357)
.+..++|++.+.||+|+||.||+|++.. ++ ..||||++.+.....+...+.+.+|+.+|+.++||||+++++++.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 4566789999999999999999998643 33 4789999876655555556778899999999999999999999965
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccc
Q psy7825 137 HRVYIIMEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHM 215 (357)
Q Consensus 137 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 215 (357)
...++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 467899999999999988765 4569999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhh-cccCCCCCC
Q psy7825 216 KCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTNYIQLLKQVQT-KVVFPTEPN 293 (357)
Q Consensus 216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~ 293 (357)
.... .........|+..|+|||++.+..++.+ +|||||||++|||+| |..||.+.+..+....+.. ....+.++.
T Consensus 163 ~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 163 QNDD--HYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp C-CC--EEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred cCCC--cceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccc
Confidence 2211 1223334568889999999999888776 999999999999998 8999999999998888754 455566778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 294 VSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 294 ~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+|+++++||.+|| .||++|||+.+|++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999 89999999999963
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-55 Score=391.12 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=221.1
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
..+..++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+|+.++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3455678999999999999999999875 356889999986432 333456788999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQREG------------------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRD 189 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~d 189 (357)
......++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999997532 388999999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCC-C
Q psy7825 190 IKCENLLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGR-L 268 (357)
Q Consensus 190 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~ 268 (357)
|||+|||++.++.+||+|||+++..... .........+|++.|+|||++.+..++.+ +|||||||++|||++|. .
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSA---DYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGG---GCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCC
T ss_pred EcccceEECCCCcEEEccchhheeccCC---ccccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCC
Confidence 9999999999999999999998744222 12223345678999999999999888876 99999999999999985 6
Q ss_pred CCCCCCHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 269 PFDDTNYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 269 pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
||.+.+..++...+......+.+..+++++.+||.+|| .+|.+|||+.||++
T Consensus 242 p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 89999999999999888777777789999999999999 89999999999965
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-54 Score=391.63 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=206.4
Q ss_pred cccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEe--CCe
Q psy7825 62 ENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIET--THR 138 (357)
Q Consensus 62 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~ 138 (357)
..++|++++.||+|+||+||+|++..+|+.||||++.... .+.+.+|+.+|+.+. ||||++++++|.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3467999999999999999999999999999999986432 345678999999995 9999999999974 457
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC-cEEEeecCCCcccccc
Q psy7825 139 VYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY-NIKLSDFGFARGHMKC 217 (357)
Q Consensus 139 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~ 217 (357)
+++||||+.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+||||+.++ .++|+|||+++....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 99999999999998764 4599999999999999999999999999999999999998665 689999999874321
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhhc-----------
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN-YIQLLKQVQTK----------- 285 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~----------- 285 (357)
.......+||+.|+|||++.+......++|||||||++|+|++|+.||.... ..+....+...
T Consensus 183 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 183 -----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp -----TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred -----CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 1223456799999999999887654455999999999999999999996543 22222111100
Q ss_pred -------------------------ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 286 -------------------------VVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 286 -------------------------~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
...+....+++++++||++|| .||.+|||++|+|+||||++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 001111347899999999999 9999999999999999999854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=390.93 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=216.6
Q ss_pred ccccCeEEceeeeecCCeEEEEEEECCCCcE--EEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEEEeCC
Q psy7825 61 MENHGYVLGKVIGIGSYATVKLATSTRHGCD--VAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAIETTH 137 (357)
Q Consensus 61 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 137 (357)
+.-++|++.++||+|+||.||+|+++.+|.. ||||.+..... ....+.+.+|+.+|.++ +||||+++++++..++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4557899999999999999999999888765 56676643322 22355688999999999 6999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCC
Q psy7825 138 RVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEY 201 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~ 201 (357)
.+++||||++||+|.++++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999753 5699999999999999999999999999999999999999999
Q ss_pred cEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCC-CCCCCCCHHHHHH
Q psy7825 202 NIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGR-LPFDDTNYIQLLK 280 (357)
Q Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~ 280 (357)
.+||+|||+++..... .......||..|+|||.+.+..++.+ +|||||||++|||++|. .||.+.+..++..
T Consensus 165 ~~kl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp CEEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred ceEEcccccccccccc------ccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999998743221 12234568999999999999888877 99999999999999965 6899999999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 281 QVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 281 ~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.+......+.+..+++++++||.+|| .||++||++.+|+++
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 98887777777889999999999999 899999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=386.56 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=217.7
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECCCC-------cEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceee
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTRHG-------CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFL 130 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 130 (357)
..+..++|++++.||+|+||.||+|+...++ ..||||++.+... ......+.+|...+.++ +||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 4567788999999999999999999875543 4799999865332 22345566888888887 799999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy7825 131 QAIETTHRVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCEN 194 (357)
Q Consensus 131 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~N 194 (357)
++|.++..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.|||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999999999999754 348999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCC
Q psy7825 195 LLIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDT 273 (357)
Q Consensus 195 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~ 273 (357)
||++.++.+||+|||+++...... .........|++.|+|||++.+..++.+ +|||||||++|||++ |..||.+.
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHID---YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCC---TTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eeecCCCCeEeccchhhccccccc---cccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999998653322 2223445678999999999999888877 999999999999998 79999999
Q ss_pred CHHHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 274 NYIQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 274 ~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
+..++...+..+...+.+..+++++++||.+|| .||.+|||+.||++
T Consensus 242 ~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 999999888888888888899999999999999 99999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=394.84 Aligned_cols=254 Identities=27% Similarity=0.414 Sum_probs=204.7
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe------CC
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET------TH 137 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~ 137 (357)
++|++++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.+++.++||||++++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 5799999999999999999999999999999999765543 3334567899999999999999999999953 46
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccc
Q psy7825 138 RVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKC 217 (357)
Q Consensus 138 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 217 (357)
.+|+||||+.+ ++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++....
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~- 171 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 171 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc-
Confidence 89999999976 5555553 4589999999999999999999999999999999999999999999999999864322
Q ss_pred cCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhhcccCCCC------
Q psy7825 218 KSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQVQTKVVFPTE------ 291 (357)
Q Consensus 218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 291 (357)
.......+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+......++......+.+
T Consensus 172 -----~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 172 -----SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred -----ccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 222345579999999999999888887 99999999999999999999988877766655332211100
Q ss_pred -----------------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCCCCC
Q psy7825 292 -----------------------------------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 292 -----------------------------------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 328 (357)
...++++++||++|| .||++|||++|||+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 124678999999999 9999999999999999998743
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=382.44 Aligned_cols=256 Identities=20% Similarity=0.327 Sum_probs=203.6
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTR-----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAI 133 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 133 (357)
.+..++|++.+.||+|+||.||+|.+.. +++.||||++..... ....+.+.+|..++.++ +|+||+.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3556789999999999999999999753 357899999864332 22234456777777766 689999999987
Q ss_pred Ee-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy7825 134 ET-THRVYIIMEYAEKGSLLDFIQRE----------------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLL 196 (357)
Q Consensus 134 ~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nil 196 (357)
.. +..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 65 45689999999999999999753 24889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcC-CCCCCCCCH
Q psy7825 197 IDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFG-RLPFDDTNY 275 (357)
Q Consensus 197 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~ 275 (357)
|+.++.+||+|||+++..... .........+||+.|+|||++.+..++.+ +|||||||++|||++| ..||.+...
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp ECGGGCEEECC------CCSC---TTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ECCCCcEEEccCcchhhcccc---ccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999754221 12223445679999999999999888876 9999999999999986 568877654
Q ss_pred -HHHHHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 276 -IQLLKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 276 -~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
......+......+.++.+++++++||.+|| .||.+|||+.||++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4445556666667777789999999999999 899999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-54 Score=384.33 Aligned_cols=261 Identities=21% Similarity=0.326 Sum_probs=225.7
Q ss_pred ccccccCeEEceeeeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEE
Q psy7825 59 TVMENHGYVLGKVIGIGSYATVKLATSTR-----HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAI 133 (357)
Q Consensus 59 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 133 (357)
..+..++|.+.+.||+|+||.||+|.+.. +++.||||+++... .......+.+|+.++++++||||+++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 45677889999999999999999998752 35789999986433 333345678999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcE
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQRE----------GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNI 203 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~ 203 (357)
..+...++||||+++|+|.+++... ..++...+..++.|++.||.|||+++|+||||||+|||++.++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 9999999999999999999998642 247889999999999999999999999999999999999999999
Q ss_pred EEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHH
Q psy7825 204 KLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFG-RLPFDDTNYIQLLKQV 282 (357)
Q Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i 282 (357)
||+|||+++....... ........||+.|+|||.+.+..++.+ +|||||||++|||+|| ..||.+.+..+.+..+
T Consensus 173 Kl~DFGla~~~~~~~~---~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp EECCTTCCCGGGGGGC---EEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred EEeecccceeccCCcc---eeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999975432221 122334568999999999999888876 9999999999999998 5889999999999988
Q ss_pred hhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc------CCCCC
Q psy7825 283 QTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ------DPWVK 325 (357)
Q Consensus 283 ~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~------hp~~~ 325 (357)
......+.++.+++.+.+||.+|| .+|.+|||+.+|++ +|+|+
T Consensus 249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 887777777899999999999999 99999999999998 66654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=377.63 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=215.6
Q ss_pred cccccCeEEceeeeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcC-CCCCcceeeEEE
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATST-----RHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGL-RHPNLIRFLQAI 133 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 133 (357)
.+..++|++.+.||+|+||.||+|++. .+++.||||++..... ......+.+|+.++..+ +||||+++++++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 456678999999999999999999863 4568999999865432 33355678999999999 699999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy7825 134 ETTHRVYIIMEYAEKGSLLDFIQREG------------------YIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENL 195 (357)
Q Consensus 134 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Ni 195 (357)
.....+++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++|++||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 99999999999999999999997643 589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCC
Q psy7825 196 LIDGEYNIKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAF-GRLPFDDTN 274 (357)
Q Consensus 196 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~ 274 (357)
|++.++.++|+|||.++..... .........+||+.|+|||++.+..++.+ +|||||||++|||+| |.+||...+
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKND---SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSC---TTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccCcccccccchheeccCC---CcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999754221 12223345679999999999998888877 999999999999998 566676655
Q ss_pred HHHH-HHHHhhcccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 275 YIQL-LKQVQTKVVFPTEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 275 ~~~~-~~~i~~~~~~~~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
.... .+.+..+...+.+..+++++.+||.+|| .||++|||+.+|++
T Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5444 4445666666667789999999999999 89999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-52 Score=371.11 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=206.8
Q ss_pred EEceeeeecCCeEEEEEEECCCC---cEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEe-CCeEEEE
Q psy7825 67 VLGKVIGIGSYATVKLATSTRHG---CDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIET-THRVYII 142 (357)
Q Consensus 67 ~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 142 (357)
...++||+|+||+||+|++..++ ..||||++++.. .....+.+.+|+.+|++++||||+++++++.. +...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34689999999999999986543 368999986432 33345668899999999999999999999865 5689999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCCCcccccccCCC
Q psy7825 143 MEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGFARGHMKCKSGH 221 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 221 (357)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC-
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc-
Confidence 9999999999998754 45778889999999999999999999999999999999999999999999999865432222
Q ss_pred CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhhcccCCCCCCCCHHHHH
Q psy7825 222 QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDD-TNYIQLLKQVQTKVVFPTEPNVSAECKT 300 (357)
Q Consensus 222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 300 (357)
.........||+.|+|||.+.+..++.+ +||||||+++|||++|..||.. .+..+....+..+...+.++.+++++.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence 2222334578999999999998888877 9999999999999998777754 4445566666666666677789999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcC
Q psy7825 301 LLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 301 li~~~L-~~p~~Rps~~~ll~h 321 (357)
||.+|| .||++||++.||++|
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 999999 999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-50 Score=360.22 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=202.5
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-ceeeEEEEeCCeEEEE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-IRFLQAIETTHRVYII 142 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv 142 (357)
++|++.+.||+|+||.||+|++..+|+.||||++..... ...+..|+++++.++|+|+ +.+.+++......++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 569999999999999999999999999999999865432 2346789999999987665 5556667888899999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC---CCcEEEeecCCCccccccc
Q psy7825 143 MEYAEKGSLLDFIQR-EGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG---EYNIKLSDFGFARGHMKCK 218 (357)
Q Consensus 143 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~---~~~~kl~Dfg~~~~~~~~~ 218 (357)
|||+.+ +|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+++......
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999955 66666544 567999999999999999999999999999999999999864 4579999999998654332
Q ss_pred CCCC--CCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----hhcccCC---
Q psy7825 219 SGHQ--SPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYIQLLKQV----QTKVVFP--- 289 (357)
Q Consensus 219 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i----~~~~~~~--- 289 (357)
.... ........||+.|+|||++.+..++.+ +|||||||++|||++|+.||...........+ ......+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 2211 122345679999999999999888877 99999999999999999999876544433222 1111111
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHH---HHhcCCCCCCC
Q psy7825 290 TEPNVSAECKTLLSKIF-SPIKFRIRLK---DIKQDPWVKTE 327 (357)
Q Consensus 290 ~~~~~s~~~~~li~~~L-~~p~~Rps~~---~ll~hp~~~~~ 327 (357)
..+.+|+++.+||..|| .+|.+||++. ++|+|+|.+..
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 23479999999999999 9999999987 55788876554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-49 Score=350.47 Aligned_cols=251 Identities=18% Similarity=0.190 Sum_probs=206.4
Q ss_pred ccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC-CCcceeeEEEEeCCeEEE
Q psy7825 63 NHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH-PNLIRFLQAIETTHRVYI 141 (357)
Q Consensus 63 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 141 (357)
.++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|++.+..+.| +|++.+++++..+...++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4679999999999999999999999999999999865432 2346689999999975 899999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcC-----CCcEEEeecCCCcccc
Q psy7825 142 IMEYAEKGSLLDFIQRE-GYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDG-----EYNIKLSDFGFARGHM 215 (357)
Q Consensus 142 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~-----~~~~kl~Dfg~~~~~~ 215 (357)
||||+ +++|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++. ++.++|+|||+++...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 67999999765 46999999999999999999999999999999999999974 5789999999998654
Q ss_pred cccCCC--CCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhhccc-CC
Q psy7825 216 KCKSGH--QSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTN---YIQLLKQVQTKVV-FP 289 (357)
Q Consensus 216 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~-~~ 289 (357)
...... ........+||+.|||||++.+..++.+ +|||||||++|||++|..||.+.. .......+..... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 332221 1223445689999999999999888877 999999999999999999997543 3333333322111 11
Q ss_pred ---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy7825 290 ---TEPNVSAECKTLLSKIF-SPIKFRIRLKDIKQ 320 (357)
Q Consensus 290 ---~~~~~s~~~~~li~~~L-~~p~~Rps~~~ll~ 320 (357)
..+.+|+++.+|+..|+ .+|..||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 12468999999999999 89999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=356.59 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=190.6
Q ss_pred cCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCcceeeEEEEeCC----eE
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNLIRFLQAIETTH----RV 139 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 139 (357)
.+|.+.+.||+|+||.||+|+. +|+.||||++.... ......+.|+..+..++||||+++++++.... .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4699999999999999999986 48999999985432 11222334566667789999999999997644 68
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCCEEEcCCCcEEEeecCCC
Q psy7825 140 YIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE--------RGVVHRDIKCENLLIDGEYNIKLSDFGFA 211 (357)
Q Consensus 140 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~--------~~ivH~dlkp~Nili~~~~~~kl~Dfg~~ 211 (357)
|+||||+++|+|.+++++. .+++...+.++.|++.||.|||+ +||+||||||+||||+.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999875 58999999999999999999996 59999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcccCCccccccceecCCC------CCCCcccHHHHHHHHHHHHcCCCCCCC-------------
Q psy7825 212 RGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVP------YTPHYSDVWSMGVVLYAMAFGRLPFDD------------- 272 (357)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~g~~pf~~------------- 272 (357)
+........ ........+||+.|+|||++.+.. ++.+ +|||||||++|||+||..||..
T Consensus 156 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k-~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 156 VRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp EEEETTTTE-ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHH-HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccCCCcc-eeccccceecccCcCChhhccccccccCCCcCcc-hhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 755332211 112234567999999999987654 2333 8999999999999999887732
Q ss_pred --CCHHHHHHHHhhcccCCCC------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy7825 273 --TNYIQLLKQVQTKVVFPTE------PNVSAECKTLLSKIF-SPIKFRIRLKDIKQD 321 (357)
Q Consensus 273 --~~~~~~~~~i~~~~~~~~~------~~~s~~~~~li~~~L-~~p~~Rps~~~ll~h 321 (357)
.........+......|.. ......+.+|+.+|| .||++|||+.||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1223333333222221211 123356899999999 899999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-47 Score=349.81 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=195.8
Q ss_pred cccccCeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-----------CCCcce
Q psy7825 60 VMENHGYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-----------HPNLIR 128 (357)
Q Consensus 60 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~ 128 (357)
.+.+.+|+++++||+|+||+||+|++..+|+.||||++++. ....+.+.+|+.+++.+. |+||++
T Consensus 9 ~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~ 84 (362)
T d1q8ya_ 9 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 84 (362)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence 44556799999999999999999999999999999998643 223455678888888775 578999
Q ss_pred eeEEEEe--CCeEEEEEeccCCCChHHHH-H--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcCCCc
Q psy7825 129 FLQAIET--THRVYIIMEYAEKGSLLDFI-Q--REGYIDEPRTKKWFRQLVDAIDYCHE-RGVVHRDIKCENLLIDGEYN 202 (357)
Q Consensus 129 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l-~--~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dlkp~Nili~~~~~ 202 (357)
+++++.. ....+++++++..+...... . ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred EEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc
Confidence 9988754 45667777766554433322 2 24578999999999999999999998 89999999999999986653
Q ss_pred ------EEEeecCCCcccccccCCCCCCCCCcccCCccccccceecCCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCHH
Q psy7825 203 ------IKLSDFGFARGHMKCKSGHQSPLSDTFCGSYAYASPEILKGVPYTPHYSDVWSMGVVLYAMAFGRLPFDDTNYI 276 (357)
Q Consensus 203 ------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 276 (357)
++++|||.+..... .....+||+.|+|||++.+..++.+ +|||||||++++|++|+.||......
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp TTTEEEEEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC------
T ss_pred ccccceeeEeeccccccccc--------ccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccc
Confidence 89999999864321 2245679999999999999888876 99999999999999999999754321
Q ss_pred ------HHHHHHhhcc-----------------------------------------cCCCCCCCCHHHHHHHHHhc-CC
Q psy7825 277 ------QLLKQVQTKV-----------------------------------------VFPTEPNVSAECKTLLSKIF-SP 308 (357)
Q Consensus 277 ------~~~~~i~~~~-----------------------------------------~~~~~~~~s~~~~~li~~~L-~~ 308 (357)
+........+ ........++++++||.+|| .|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 1111110000 00011234678999999999 99
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q psy7825 309 IKFRIRLKDIKQDPWVKTEA 328 (357)
Q Consensus 309 p~~Rps~~~ll~hp~~~~~~ 328 (357)
|.+|||++|+|+||||++..
T Consensus 316 P~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTCT
T ss_pred hhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=7.3e-27 Score=193.96 Aligned_cols=135 Identities=18% Similarity=0.206 Sum_probs=106.4
Q ss_pred eEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCC---------------chHHhhhHHHHHHHHHcCCCCCcceee
Q psy7825 66 YVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAP---------------PDYLKKFLPREIDVVKGLRHPNLIRFL 130 (357)
Q Consensus 66 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 130 (357)
+.+++.||+|+||.||+|.+. +|+.||||+++..... .........+|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999975 6899999987532111 011123345788899999999999887
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcCCCcEEEeecCC
Q psy7825 131 QAIETTHRVYIIMEYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHERGVVHRDIKCENLLIDGEYNIKLSDFGF 210 (357)
Q Consensus 131 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dlkp~Nili~~~~~~kl~Dfg~ 210 (357)
++. . .+++|||+++..+.. ++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 653 2 269999998865432 5566678899999999999999999999999999999965 589999999
Q ss_pred Ccc
Q psy7825 211 ARG 213 (357)
Q Consensus 211 ~~~ 213 (357)
+..
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred ccc
Confidence 863
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.89 E-value=6.9e-09 Score=88.36 Aligned_cols=138 Identities=16% Similarity=0.069 Sum_probs=93.7
Q ss_pred CeEEceeeeecCCeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCC-CCCcceeeEEEEeCCeEEEEE
Q psy7825 65 GYVLGKVIGIGSYATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLR-HPNLIRFLQAIETTHRVYIIM 143 (357)
Q Consensus 65 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 143 (357)
.|++.+..+.++.+.||++. .++..+++|+........ ...+.+|...+..+. +--+.+++.++..++..++||
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 46676666555667899885 346678889875432221 234668888888775 333678888888889999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy7825 144 EYAEKGSLLDFIQREGYIDEPRTKKWFRQLVDAIDYCHE----------------------------------------- 182 (357)
Q Consensus 144 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~i~~~l~~LH~----------------------------------------- 182 (357)
++++|.++.+.... ......++.++...+..||+
T Consensus 90 ~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 90 SEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred Eecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 99999777554321 11122234444444444442
Q ss_pred ------------------CCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 183 ------------------RGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 183 ------------------~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127999999999999987667899999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.43 E-value=5e-07 Score=76.03 Aligned_cols=135 Identities=16% Similarity=0.080 Sum_probs=82.0
Q ss_pred eeeecC-CeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCC--CCcceeeEEEEeCCeEEEEEeccC
Q psy7825 71 VIGIGS-YATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRH--PNLIRFLQAIETTHRVYIIMEYAE 147 (357)
Q Consensus 71 ~lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~ 147 (357)
.+..|. .+.||+... ..+..+++|...... ...+..|...++.+.. -.+.+++.+..+.+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 344454 468999874 457778999764432 2336678888877743 336778888888889999999998
Q ss_pred CCChHH--------------HHHhcC-------CCC--HHHHHHHH--------------------HHHHHHHHHHHhC-
Q psy7825 148 KGSLLD--------------FIQREG-------YID--EPRTKKWF--------------------RQLVDAIDYCHER- 183 (357)
Q Consensus 148 ~~~L~~--------------~l~~~~-------~l~--~~~~~~i~--------------------~~i~~~l~~LH~~- 183 (357)
|.++.+ .+.+-. ++. ......-. ......+..+...
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 865432 111100 000 00000000 0111223333322
Q ss_pred ------CceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 184 ------GVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 184 ------~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999987667899999763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.32 E-value=1.2e-06 Score=78.81 Aligned_cols=80 Identities=16% Similarity=0.059 Sum_probs=47.7
Q ss_pred ceeeeecCCeEEEEEEECCCCcEEEEEEeecC-CCC---chHHhhhHHHHHHHHHcCC-C-C-CcceeeEEEEeCCeEEE
Q psy7825 69 GKVIGIGSYATVKLATSTRHGCDVAVKVVSKV-EAP---PDYLKKFLPREIDVVKGLR-H-P-NLIRFLQAIETTHRVYI 141 (357)
Q Consensus 69 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~---~~~~~~~~~~E~~~l~~l~-h-~-~iv~~~~~~~~~~~~~l 141 (357)
.+.||.|....||++....+++.|+||.-... ... -.........|...|..+. + | .+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45689999999999998777889999965321 000 0011223446888777663 2 3 35555543 3445578
Q ss_pred EEeccCCCC
Q psy7825 142 IMEYAEKGS 150 (357)
Q Consensus 142 v~e~~~~~~ 150 (357)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.73 E-value=6.9e-05 Score=65.05 Aligned_cols=68 Identities=9% Similarity=0.011 Sum_probs=43.9
Q ss_pred CeEEEEEEECCCCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCCc-----ceee--EEEEeCCeEEEEEeccCCC
Q psy7825 77 YATVKLATSTRHGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPNL-----IRFL--QAIETTHRVYIIMEYAEKG 149 (357)
Q Consensus 77 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~--~~~~~~~~~~lv~e~~~~~ 149 (357)
--.||++.. .+|..|++|+.+..... .+.+..|...+..|...++ +..- ..+......+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 358999975 46889999998654333 3445578877777642222 1111 2345677889999999774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.25 E-value=0.00079 Score=59.76 Aligned_cols=77 Identities=14% Similarity=0.064 Sum_probs=49.9
Q ss_pred cCeEEceeeeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCchHHhhhHHHHHHHHHcCCCCC-cceeeEEEEe
Q psy7825 64 HGYVLGKVIGIGSYATVKLATSTR-------HGCDVAVKVVSKVEAPPDYLKKFLPREIDVVKGLRHPN-LIRFLQAIET 135 (357)
Q Consensus 64 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~ 135 (357)
+...+ +.|+.|-.-.+|++.... ..+.|++++..... .. ....+|..+++.+.-.+ .+++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TE---SHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CH---HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34444 567778888999998643 24668888865321 11 22447888888885334 4567776642
Q ss_pred CCeEEEEEeccCCCC
Q psy7825 136 THRVYIIMEYAEKGS 150 (357)
Q Consensus 136 ~~~~~lv~e~~~~~~ 150 (357)
.+|+||++|..
T Consensus 117 ----g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ----GRLEEYIPSRP 127 (395)
T ss_dssp ----EEEECCCCEEE
T ss_pred ----ceEEEEecccc
Confidence 57899998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.22 E-value=0.00078 Score=57.71 Aligned_cols=30 Identities=37% Similarity=0.499 Sum_probs=26.8
Q ss_pred CCceecCCCCCCEEEcCCCcEEEeecCCCc
Q psy7825 183 RGVVHRDIKCENLLIDGEYNIKLSDFGFAR 212 (357)
Q Consensus 183 ~~ivH~dlkp~Nili~~~~~~kl~Dfg~~~ 212 (357)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777999999874
|